Citrus Sinensis ID: 005750
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.991 | 0.724 | 0.736 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.930 | 0.683 | 0.371 | 1e-105 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.857 | 0.629 | 0.379 | 1e-102 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.857 | 0.656 | 0.372 | 6e-99 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.846 | 0.660 | 0.339 | 9e-95 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.865 | 0.677 | 0.353 | 7e-94 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.840 | 0.654 | 0.342 | 6e-93 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.888 | 0.677 | 0.336 | 1e-92 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.854 | 0.645 | 0.341 | 2e-92 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.873 | 0.676 | 0.331 | 5e-92 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 994 bits (2571), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/682 (73%), Positives = 578/682 (84%), Gaps = 9/682 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF DYSNAVV
Sbjct: 254 MQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVV 313
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+ KT+
Sbjct: 314 NIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS 373
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP
Sbjct: 374 DVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPG 433
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IE
Sbjct: 434 INYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIE 493
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL+L SL+
Sbjct: 494 NNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLV 552
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+N
Sbjct: 553 LLCALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDN 607
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIG
Sbjct: 608 FSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIG 667
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP I
Sbjct: 668 YCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSI 727
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEK
Sbjct: 728 IHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEK 787
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES
Sbjct: 788 SDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIES 847
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTL 657
+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK QSSRKTL
Sbjct: 848 VWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTL 907
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
LTSFLE+ESPD+S LAPAAR
Sbjct: 908 LTSFLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 252/678 (37%), Positives = 368/678 (54%), Gaps = 46/678 (6%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
+QTA+ E + + LE YF E+ D K Q F Y N+ +
Sbjct: 245 LQTALTHPERLEFVHVGLETDDYEYSVLLYFLELND-------TLKAGQRVFDIYLNSEI 297
Query: 61 -----NIAENANG-SYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIA 114
++ E + SYT+ +N++ N L+ + VK S GPLLNA EI + +
Sbjct: 298 KKEGFDVLEGGSKYSYTV-----LNISANGSLNITLVKASGSKFGPLLNAYEILQARPWI 352
Query: 115 AKTEWQDVMVLEALR-----SISDESERTNDRGDPCVPVPWEWVTCSTTTPPR-ITKIAL 168
+T+ D+ V++ +R D + GDPC+ PW+ V C + ITK+ L
Sbjct: 353 DETDQTDLEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVITKLDL 412
Query: 169 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 228
S NLKG IP + M L L L N G +P L V L N+LTG LP +
Sbjct: 413 SSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQLPESI 472
Query: 229 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLILGTSIGV 287
SLP+L L+ N + + A L +I N + + ++ +F ++ + +I
Sbjct: 473 ISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFMIGAITS 527
Query: 288 LAILLVLFLCSLIVLRKLRRKISNQ----KSYEKADSLRTSTKPSNTAYSIARGGHFMDE 343
+IL+ L + L R + I+ + K+Y A +N +S+ F +
Sbjct: 528 GSILITLAVVILFFCRYRHKSITLEGFGGKTYPMA---------TNIIFSLPSKDDFFIK 578
Query: 344 GVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 402
V+ L +E AT + IG+G FGSVY G + DG+EVAVK+ + + + T++F
Sbjct: 579 SVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFDN 638
Query: 403 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQI 461
E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G +K LDW TRL I
Sbjct: 639 ELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLSI 698
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVA 520
A AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++S
Sbjct: 699 ALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLEV 758
Query: 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580
RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+ I+
Sbjct: 759 RGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYIR 818
Query: 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 640
V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 819 ASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNAS 878
Query: 641 QKFSSSSSKGQSSRKTLL 658
+ S S G S+R +++
Sbjct: 879 EYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-102, Method: Compositional matrix adjust.
Identities = 230/606 (37%), Positives = 338/606 (55%), Gaps = 24/606 (3%)
Query: 62 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 121
+A + SYT +N++ N L+ + VK S GPLLNA EI + + +T +D
Sbjct: 307 LAGGSKNSYTA-----LNISANGSLNITLVKASGSEFGPLLNAYEILQARSWIEETNQKD 361
Query: 122 VMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTPPRI-TKIALSGKNLKG 175
+ V++ +R + N+ GDPC+ PW+ +TC +T I TK+ LS NLKG
Sbjct: 362 LEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTGSSIITKLDLSSNNLKG 421
Query: 176 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 235
IP + M L L L N P L + L N+L+G LP + SLP+L+
Sbjct: 422 AIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYNDLSGWLPESIISLPHLK 481
Query: 236 ELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLF 295
L+ N + + L +I N + ++ +F + LL+
Sbjct: 482 SLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQVFVIGAITSGSLLITL 536
Query: 296 LCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF-IPLPEL 354
++ + R K + + K + T N +S+ F + V+ L +
Sbjct: 537 AVGILFFCRYRHKSITLEGFGKTYPMAT-----NIIFSLPSKDDFFIKSVSVKPFTLEYI 591
Query: 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 414
E+AT + IG+G FGSVY G + DG+EVAVK+ + + + T++F E+ LLS I H N
Sbjct: 592 EQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLSAIQHEN 651
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLH 473
LVPL+GYC E Q+ILVY +M NG+L DRL+G ++ K LDW TRL IA AA+GL YLH
Sbjct: 652 LVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPTRLSIALGAARGLAYLH 711
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYY 532
T +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++S RGT GYLDPEYY
Sbjct: 712 TFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYY 771
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592
QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+ I+ V IVDP +
Sbjct: 772 KTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVDEIVDPGI 831
Query: 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQS 652
G E++WR+ EVA+QC+E RP M +IV ++D++ IE + S S G S
Sbjct: 832 KGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSIDSLGGS 891
Query: 653 SRKTLL 658
+R +++
Sbjct: 892 NRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 6e-99, Method: Compositional matrix adjust.
Identities = 239/641 (37%), Positives = 355/641 (55%), Gaps = 59/641 (9%)
Query: 27 AFAYFAEIQDLGPSETRKFKL--EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF 84
A+ YFAEIQ L +ETR+FK+ Y+ DY + TL P+ +
Sbjct: 279 AYLYFAEIQQLKANETRQFKILVNGVYYIDY-------IPRKFEAETLITPAALKCG-GG 330
Query: 85 VLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGD 143
V KT STL P +NAIEI S Q + T +V+ ++ ++S S R + +GD
Sbjct: 331 VCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVIAIKNIQSTYKVS-RISWQGD 389
Query: 144 PCVPVPWEW--VTCST---TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 198
PCVP+ + W V+C+ +TPPRI + LS L G I P ++N+ L EL L N LT
Sbjct: 390 PCVPIQFSWMGVSCNVIDISTPPRIISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNLT 449
Query: 199 GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKV 257
G +P + L LR + L NN LTG +P ++ ++ L +H+ N+ G +P AL
Sbjct: 450 GVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQ---- 505
Query: 258 IFKYDNNP--KLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSY 315
+NN KL + + + + + SI +A+ +++ L + + R RRK S +K
Sbjct: 506 --DRENNDGLKLLRGKHQPKSWLVAIVASISCVAVTIIV-LVLIFIFR--RRKSSTRKV- 559
Query: 316 EKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYY 375
+R S + N + + E++E TNNF +GKG FG VY+
Sbjct: 560 -----IRPSLEMKNRRFKYS-----------------EVKEMTNNFEVVLGKGGFGVVYH 597
Query: 376 GKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435
G + + ++VAVK+++ S + ++F TEV LL R+HH NLV L+GYC++ + L+YE+M
Sbjct: 598 GFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFM 656
Query: 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495
NG L++ L G L+W RL+IA ++A G+EYLH GC P ++HRDVKS+NILL +
Sbjct: 657 ENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLR 716
Query: 496 MRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 554
AK++DFGLSR TH+S+ GT+GYLDPEYY LTEKSDVYSFG+VLLE+I
Sbjct: 717 FEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEII 776
Query: 555 SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQ 614
+G +PV +E + IV WA+SM+ GD+ SI+D L + S W+ E+A+ C+
Sbjct: 777 TG-QPV-IEQSRDKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINP 834
Query: 615 RGFSRPKMQEIVLAIQDSIKI---EKGGDQKFSSSSSKGQS 652
RP M + + + ++I K Q +SS S G +
Sbjct: 835 SSTLRPNMTRVAHELNECLEIYNLTKRRSQDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 9e-95, Method: Compositional matrix adjust.
Identities = 229/674 (33%), Positives = 359/674 (53%), Gaps = 99/674 (14%)
Query: 1 MQTAVV---GTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSN 57
M+TAV + + + NLE + F +FAE+Q L +ETR+F
Sbjct: 241 MKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF------------ 288
Query: 58 AVVNIAENANGSYTLYEPSYMNVTLNFVLS----------FSFVKTRDSTLGPLLNAIE- 106
N+ N N ++ Y P ++ + + + VKT STL PL+NA+E
Sbjct: 289 ---NVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEA 345
Query: 107 --ISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCSTT---T 159
+ + +I +T +V+ ++ ++S S +T +GDPCVP W+ + C+ + T
Sbjct: 346 YTVLDFPQI--ETNVDEVIAIKNIQSTYGLS-KTTWQGDPCVPKKFLWDGLNCNNSDDST 402
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
PP IT + LS L G I ++N+ L EL L NN
Sbjct: 403 PPIITSLNLSSSGLTGIIVLTIQNLANLQEL-----------------------DLSNNN 439
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPKLH---------- 268
L+G +P ++ + +L +++ N+ G +P L+ K++ + NPKL+
Sbjct: 440 LSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTVESCVNKD 499
Query: 269 KESRRRMRFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKP 327
+E R+++ I + SIG + V F +L++ +R+ N S ++A + + P
Sbjct: 500 EEGGRQIKSMTIPIVASIGSV----VAFTVALMIFCVVRK---NNPSNDEAPT--SCMLP 550
Query: 328 SNTAYS----IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE 383
+++ S + + F E+ TNNF K +GKG FG VYYG + ++
Sbjct: 551 ADSRSSEPTIVTKNKKFT---------YAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQ 601
Query: 384 VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDR 443
VAVK+++ S + +QF EV LL R+HH+NLV L+GYCEE + L+YEYM NG L +
Sbjct: 602 VAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEH 661
Query: 444 LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 503
+ G L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NILL+ + K++DF
Sbjct: 662 MSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADF 721
Query: 504 GLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 562
GLSR E TH+S+V GT+GYLDPEYY LTEKSDVYSFGVVLL +I+ +PV +
Sbjct: 722 GLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMIT-NQPV-I 779
Query: 563 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 622
+ + +I W M+ KGD+ SI DP L+G+ S+W+ E+A+ C+ +RP M
Sbjct: 780 DQNREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTM 839
Query: 623 QEIVLAIQDSIKIE 636
++V +++ + E
Sbjct: 840 SQVVFELKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (885), Expect = 7e-94, Method: Compositional matrix adjust.
Identities = 238/674 (35%), Positives = 360/674 (53%), Gaps = 86/674 (12%)
Query: 1 MQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNA 58
+QTA + T G L++ NLE A+ +FAEIQ L +ETR+FK+ +N
Sbjct: 250 IQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKI-------LANG 302
Query: 59 V--VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAA 115
V ++ + TL P+ + V KT STL PL+NAIEI S Q +
Sbjct: 303 VDYIDYTPWKFEARTLSNPAPLKCE-GGVCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQS 361
Query: 116 KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSG 170
T +V+ ++ ++S S R + +GDPCVP + W V+C+ +TPPRI + LS
Sbjct: 362 DTNTDEVIAIKKIQSTYQLS-RISWQGDPCVPKQFSWMGVSCNVIDISTPPRIISLDLSL 420
Query: 171 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 230
L G I P ++N+ L EL L NN LTG +P ++ +
Sbjct: 421 SGLTGVISPSIQNLTMLREL-----------------------DLSNNNLTGEVPEFLAT 457
Query: 231 LPNLQELHIENNSFVGEIPPALLT-----GKVIFKYDNNPKLHKESRRRMRFKLI-LGTS 284
+ L +H+ N+ G +P AL G +F +P + + + + + L+ + S
Sbjct: 458 IKPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFV---DPNITRRGKHQPKSWLVAIVAS 514
Query: 285 IGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEG 344
I +A+ +++ L + + R RRK S +K +R S + N + +
Sbjct: 515 ISCVAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS--------- 556
Query: 345 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEV 404
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV
Sbjct: 557 --------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEV 607
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
LL R+HH NLV L+GYC+E L+YE+M NG L++ L G L+W +RL+IA +
Sbjct: 608 ELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIE 667
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGT 523
+A G+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR H+S+ GT
Sbjct: 668 SALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGT 727
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
+GYLDPEYY LTEKSDVYSFG+VLLE I+G +PV +E + IV WA+SM+ GD
Sbjct: 728 LGYLDPEYYLKNWLTEKSDVYSFGIVLLESITG-QPV-IEQSRDKSYIVEWAKSMLANGD 785
Query: 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF 643
+ SI+DP L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 786 IESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI-----YNL 840
Query: 644 SSSSSKGQSSRKTL 657
+ S+ Q+S K+L
Sbjct: 841 TKIRSQDQNSSKSL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 221/646 (34%), Positives = 347/646 (53%), Gaps = 75/646 (11%)
Query: 12 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 71
L + L++ + + + +FAEIQ L ++ R+F N N +N Y+
Sbjct: 260 LIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREF-----------NITYNGGQNV---YS 305
Query: 72 LYEPSYMNVTLNF----------VLSFSFVKTRDSTLGPLLNAIEISK-YQKIAAKTEWQ 120
P ++ F S SF KT +STL PL+N +EI K + +T+
Sbjct: 306 YLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLELETDQD 365
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCS--TTTPPRITKIALSGKNLKGE 176
+V + +++ D S++ + +GDPC P ++W + CS + PRI + L+ L G
Sbjct: 366 EVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAENKLTGT 425
Query: 177 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 236
I PE+ + L EL L N L+G +P+ D++++ L N L+G+L ++P+ +
Sbjct: 426 ITPEISKLTQLIELDLSKNDLSGEIPEF--FADMKLLKLIN--LSGNL-GLNSTIPDSIQ 480
Query: 237 LHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFL 296
+++ S + L+ K + K K +++ I+ + GV A+L++L +
Sbjct: 481 QRLDSKSLI------LILSKTVTK----TVTLKGKSKKVPMIPIVASVAGVFALLVILAI 530
Query: 297 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 356
++ RRK N +S K + TK Y PE+ +
Sbjct: 531 FFVV-----RRK--NGES-NKGTNPSIITKERRITY-------------------PEVLK 563
Query: 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 416
TNNF + +GKG FG+VY+G ++D +VAVK+++ S + ++F EV LL R+HHRNLV
Sbjct: 564 MTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRNLV 622
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L+GYC++ L+YEYM NG L++ + G L W R+QIA +AA+GLEYLH GC
Sbjct: 623 GLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGC 682
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQ 535
P ++HRDVK++NILL+ AK++DFGLSR D +H+S+V GT GYLDPEYY
Sbjct: 683 TPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYRTN 742
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595
L+EKSDVYSFGVVLLE+++ +PV+ + +I W SM+ KGD+ SI+DP L+G+
Sbjct: 743 WLSEKSDVYSFGVVLLEIVT-NQPVT-DKTRERTHINEWVGSMLTKGDIKSILDPKLMGD 800
Query: 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQ 641
W+I E+A+ CV RP M +V + + + +E Q
Sbjct: 801 YDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALENARRQ 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 226/671 (33%), Positives = 363/671 (54%), Gaps = 68/671 (10%)
Query: 1 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKLEQP----YFAD 54
M+TA V + L L++ A + + +FAE+Q+L +ETR+F + +F+
Sbjct: 248 MKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNGGLRWFSY 307
Query: 55 YSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIA 114
++I+ T++ P ++ + N + +F+F T +STL PLLNA+EI I
Sbjct: 308 LRPPNLSIS-------TIFNPRAVSSS-NGIFNFTFAMTGNSTLPPLLNALEIYTVVDIL 359
Query: 115 A-KTEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS--TTTPPRITKIALS 169
+T +V + ++ S++ + +GDPC P WE + CS + RI + L+
Sbjct: 360 QLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLN 419
Query: 170 GKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMG 229
G L G I D+S+L L ++ L NN+L+G +P++
Sbjct: 420 GSELTGSI-----------------------TSDISKLTLLTVLDLSNNDLSGDIPTFFA 456
Query: 230 SLPNLQELHIENNSFVG--EIPPAL---LTGK--VIFKYDNNPKLHKESRRRMRFKLILG 282
+ +L+ +++ N + IP +L + K + +N K+ +++ I
Sbjct: 457 EMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAA 516
Query: 283 TSIGVLAILLVLFLCSLIVLRKLR-RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFM 341
+ GV A+L++L + +I + ++ K +++ T+ SN + I R
Sbjct: 517 SVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSI-ITR----- 570
Query: 342 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV 401
+ + Y PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S + ++F
Sbjct: 571 ERKITY----PEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFK 625
Query: 402 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 461
EV LL R+HHR+LV L+GYC++ L+YEYM NG LR+ + G L W R+QI
Sbjct: 626 AEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQI 685
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVA 520
A +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLSR D H+S+V
Sbjct: 686 AVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVV 745
Query: 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580
GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV ++ +I W M+
Sbjct: 746 AGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPV-IDKTRERPHINDWVGFMLT 803
Query: 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE---- 636
KGD+ SIVDP L+G+ W+I E+A+ CV RP M +V+ + D + +E
Sbjct: 804 KGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARR 863
Query: 637 KGGDQKFSSSS 647
+G ++ +S S
Sbjct: 864 QGSEEMYSMGS 874
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (873), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 221/647 (34%), Positives = 346/647 (53%), Gaps = 67/647 (10%)
Query: 24 NARAFAYFAEIQDLGPSETRKFKL---EQPYFADYSNAVVNIAENANGSYTLYEPSYMNV 80
+ + +FAEIQ L PS+TR+F + + DY + + +A+ T+ +
Sbjct: 291 DVHVYLHFAEIQALKPSDTREFSILWNKNTIIRDYYSPLEFMAD------TVPIRTSSKC 344
Query: 81 TLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAAKTEWQDVMVLEALRSISDESERTN 139
+ S +T+ STL P NA+E+ Q + +T+ DV L+ +++ + ++TN
Sbjct: 345 GDDGFCSLDLTRTKSSTLPPYCNAMEVFGLLQLLQTETDENDVTTLKNIQA-TYRIQKTN 403
Query: 140 DRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDG 194
+GDPCVP+ + W + CS + PPRIT I S L G I +++ + L +L L
Sbjct: 404 WQGDPCVPIQFIWTGLNCSNMFPSIPPRITSIDFSNFGLNGTITSDIQYLNQLQKLDLSN 463
Query: 195 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 253
N LTG +P+ ++++ L ++L N L+GS+P + L++E N +
Sbjct: 464 NNLTGKVPEFLAKMKLLTFINLSGNNLSGSIPQSL--------LNMEKNGLI-------- 507
Query: 254 TGKVIFKYDN---NPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 310
+++ +N +P E+ K +L + IL +I+ L I
Sbjct: 508 --TLLYNGNNLCLDPSCESETGPGNNKKKLL------VPILASAASVGIIIAVLLLVNIL 559
Query: 311 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 370
+ + + + R+S + +Y+ E+ TNNF + +G+G F
Sbjct: 560 LLRKKKPSKASRSSMVANKRSYTYE-----------------EVAVITNNFERPLGEGGF 602
Query: 371 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430
G VY+G + D ++VAVK++++S + +QF EV LL R+HH NLV L+GYC+E +L
Sbjct: 603 GVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHLVL 662
Query: 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 490
+YEYM NG L+ L G ++ PL W RL+IA + A+GLEYLH GC P +IHRD+KS NI
Sbjct: 663 IYEYMSNGNLKQHLSGENSRSPLSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSMNI 722
Query: 491 LLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 549
LLD N +AK+ DFGLSR TH+S+ G+ GYLDPEYY LTEKSDV+SFGVV
Sbjct: 723 LLDNNFQAKLGDFGLSRSFPVGSETHVSTNVAGSPGYLDPEYYRTNWLTEKSDVFSFGVV 782
Query: 550 LLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAI 609
LLE+I+ +PV ++ + +I W + GD+ +IVDP + G+ S+W+ E+A+
Sbjct: 783 LLEIIT-SQPV-IDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWKALELAM 840
Query: 610 QCVEQRGFSRPKMQEIVLAIQDSIKIE---KGGDQKFSSSSSKGQSS 653
CV RP M ++ +Q+ + E KGG S SS QS+
Sbjct: 841 SCVSPSSSGRPNMSQVANELQECLLTENSRKGGRHDVDSKSSLEQST 887
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 218/657 (33%), Positives = 347/657 (52%), Gaps = 64/657 (9%)
Query: 2 QTAVVGTEGVLSYRLN--LEDFPANARAFAYFAEIQDLGPSETRKFKLE----QPYFADY 55
+TA V ++N L+D + + + +FAEI++L +ETR+F + + +F+ +
Sbjct: 244 KTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGENWFSYF 303
Query: 56 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAA 115
I T+Y P+ ++ +L+ +F+F T +ST PL+N +EI + ++
Sbjct: 304 RPPKFRIT-------TVYNPAAVS-SLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQ 355
Query: 116 KTEWQD-VMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS--TTTPPRITKIALSG 170
+QD V + +++I S+R++ +GDPC P WE + CS PP+I + LSG
Sbjct: 356 LDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSG 415
Query: 171 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 230
NL G I D+S+L LR + L NN+L+G +P
Sbjct: 416 SNLSGTI-----------------------TSDISKLTHLRELDLSNNDLSGDIPFVFSD 452
Query: 231 LPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK--LHKESRRRMRFKLILGTSIGVL 288
+ NL +++ N + P L ++ DN + E+ + + + S+ +
Sbjct: 453 MKNLTLINLSGNKNLNRSVPETLQKRI----DNKSLTLIRDETGKNSTNVVAIAASVASV 508
Query: 289 AILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 348
+LV+ +V+RK +R +A R+ T + T S AR
Sbjct: 509 FAVLVILAIVFVVIRKKQRT-------NEASGPRSFT--TGTVKSDARSSSSSIITKERK 559
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 408
E+ + T NF + +GKG FG+VY+G + D +VAVK+++ S + ++F EV LL
Sbjct: 560 FTYSEVLKMTKNFERVLGKGGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKEFKAEVELLL 618
Query: 409 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
R+HHR+LV L+GYC++ L+YEYM G LR+ + G + L W TR+QIA +AA+G
Sbjct: 619 RVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQG 678
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 527
LEYLH GC P ++HRDVK +NILL+ +AK++DFGLSR D +H+ +V GT GYL
Sbjct: 679 LEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYL 738
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587
DPEYY L+EKSDVYSFGVVLLE+++ + ++ +N W M+ GD+ SI
Sbjct: 739 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNRERPHIN--EWVMFMLTNGDIKSI 796
Query: 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE---KGGDQ 641
VDP L + +W++ E+A+ CV RP M +V+ + + + +E K G Q
Sbjct: 797 VDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLALEIERKQGSQ 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.998 | 0.725 | 0.790 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.998 | 0.727 | 0.803 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.997 | 0.727 | 0.773 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.991 | 0.726 | 0.770 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.964 | 0.718 | 0.772 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.725 | 0.756 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.992 | 0.724 | 0.743 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.724 | 0.749 | 0.0 | |
| 18408845 | 929 | putative LRR receptor-like serine/threon | 0.991 | 0.724 | 0.736 | 0.0 | |
| 358248570 | 882 | probable LRR receptor-like serine/threon | 0.989 | 0.761 | 0.730 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1124 bits (2907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/683 (79%), Positives = 607/683 (88%), Gaps = 5/683 (0%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G+LSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKL+QPYF DYSNAVV
Sbjct: 253 MQTAVVGTQGILSYRLNLDDFPANARAYAYFAEIEDLGANETRKFKLQQPYFPDYSNAVV 312
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGS+TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNAIEISKY KI +T+ Q
Sbjct: 313 NIAENANGSHTLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLLNAIEISKYLKIEPRTDSQ 372
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL ALRS+S ES TN++GDPCVP W+WV C++TTPPRITKIALSGKNLKGEIPPE
Sbjct: 373 DVTVLNALRSLSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIALSGKNLKGEIPPE 432
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y+GSLP+LQEL+I+
Sbjct: 433 INNMETLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKYLGSLPDLQELYIQ 492
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NN F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG SIG+LA LLV+ + SL+
Sbjct: 493 NNYFSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGILAALLVVLIGSLL 552
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
LR L+RK S+QK+ + SLR S KPS TAYS++RG H MDEGV+Y+IPL E+EEAT N
Sbjct: 553 FLRNLQRKTSHQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMDEGVSYYIPLSEIEEATKN 611
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KKIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVTEVALLSRIHHRNLVPLIG
Sbjct: 612 FSKKIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTEVALLSRIHHRNLVPLIG 671
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA D+AKGLEYLHTGCNP I
Sbjct: 672 YCEEENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAEDSAKGLEYLHTGCNPSI 731
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEK
Sbjct: 732 IHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEK 791
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD +SIVDPVLIGNVKIES
Sbjct: 792 SDVYSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKGDAMSIVDPVLIGNVKIES 851
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLL 658
IWRIAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G QK S SSK QSSRKTLL
Sbjct: 852 IWRIAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQKLPSGSSKAQSSRKTLL 911
Query: 659 TSFLEIE--SPDLSNECLAPAAR 679
TSFLEIE SPDLSN CL PAAR
Sbjct: 912 TSFLEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1119 bits (2895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/681 (80%), Positives = 608/681 (89%), Gaps = 3/681 (0%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGTEG+LSYRLNLEDFPANARA+AYFAEI+DLG +ETRKFKL+QP+ +DYSNAVV
Sbjct: 253 MQTAVVGTEGILSYRLNLEDFPANARAYAYFAEIEDLGANETRKFKLQQPFLSDYSNAVV 312
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNV+L+FVLSFSF KTRDSTLGPLLNAIEISKY KI KT+ +
Sbjct: 313 NIAENANGSYTLYEPSYMNVSLDFVLSFSFAKTRDSTLGPLLNAIEISKYLKIEPKTDSK 372
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL ALR +S ES N++GDPCVP WEWV CS+TTPPRITKIALSGKNLKGEIPPE
Sbjct: 373 DVTVLNALRFLSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIALSGKNLKGEIPPE 432
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y+GSLP LQ L+I+
Sbjct: 433 INNMEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKYLGSLPKLQALYIQ 492
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF GEIP LTGKVIF Y++NP LHKE+R++M KLI+G SIG+LA LLV+ + SL+
Sbjct: 493 NNSFSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGILAGLLVVVIGSLL 552
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
LR L+RK S++KS + +SLR STKPS TAYS+ARG H MDEGV+Y+IPLPELEEAT N
Sbjct: 553 FLRNLQRKTSHKKSEVQGNSLRASTKPS-TAYSVARGWHMMDEGVSYYIPLPELEEATKN 611
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KKIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVTEVALLSRIHHRNLVPL+G
Sbjct: 612 FSKKIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTEVALLSRIHHRNLVPLLG 671
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA DAAKGLEYLHTGCNP I
Sbjct: 672 YCEEEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAEDAAKGLEYLHTGCNPSI 731
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEK
Sbjct: 732 IHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEK 791
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KGDV+SIVDPVLIGN KIES
Sbjct: 792 SDVYSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKGDVMSIVDPVLIGNAKIES 851
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLL 658
IWRIAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG G QK S+SSK QSSRKTLL
Sbjct: 852 IWRIAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQKQQSASSKAQSSRKTLL 911
Query: 659 TSFLEIESPDLSNECLAPAAR 679
TSFLEIESPDLSN CL PAAR
Sbjct: 912 TSFLEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/681 (77%), Positives = 588/681 (86%), Gaps = 4/681 (0%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E+PY DYSNAVV
Sbjct: 252 MQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRMERPYLPDYSNAVV 311
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEISKY +IA KT+
Sbjct: 312 NIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEISKYVQIAPKTDKG 371
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI LSGKNL G IP E
Sbjct: 372 DVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSE 431
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
LKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++
Sbjct: 432 LKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQ 491
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+LA+LLVL + SL
Sbjct: 492 NNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLLALLLVLCIGSLF 550
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L RRK S KS +K SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT N
Sbjct: 551 LLCNTRRKESQSKSNDKGSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKN 609
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIG
Sbjct: 610 FAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIG 669
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP I
Sbjct: 670 YCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSI 729
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEK
Sbjct: 730 IHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEK 789
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIVDP L+GNVKIES
Sbjct: 790 SDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIES 849
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLL 658
IWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S SSKGQSSRKTLL
Sbjct: 850 IWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLL 909
Query: 659 TSFLEIESPDLSNECLAPAAR 679
T+FL+IESPDLSN+CL P+AR
Sbjct: 910 TNFLDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1053 bits (2722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/681 (77%), Positives = 586/681 (86%), Gaps = 8/681 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E+PY DYSNAVV
Sbjct: 252 MQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRMERPYLPDYSNAVV 311
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEISKY +IA KT+
Sbjct: 312 NIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEISKYVQIAPKTDKG 371
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI LSGKNL G IP E
Sbjct: 372 DVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSE 431
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
LKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++
Sbjct: 432 LKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQ 491
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+LA+LLVL + SL
Sbjct: 492 NNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLLALLLVLCIGSLF 550
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L RRK +S K SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT N
Sbjct: 551 LLCNTRRK----ESQSKRSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKN 605
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIG
Sbjct: 606 FAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIG 665
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP I
Sbjct: 666 YCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSI 725
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEK
Sbjct: 726 IHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEK 785
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIVDP L+GNVKIES
Sbjct: 786 SDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIES 845
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLL 658
IWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S SSKGQSSRKTLL
Sbjct: 846 IWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLL 905
Query: 659 TSFLEIESPDLSNECLAPAAR 679
T+FL+IESPDLSN+CL P+AR
Sbjct: 906 TNFLDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1050 bits (2716), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/682 (77%), Positives = 586/682 (85%), Gaps = 27/682 (3%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGTEG+LSYRLNLEDFPANARA+AYF+EI+DLG +ETRKFKL +PY +DYSNAVV
Sbjct: 254 MQTAVVGTEGLLSYRLNLEDFPANARAYAYFSEIEDLGSNETRKFKLMKPYISDYSNAVV 313
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSY LYEPSYMNVTL+FVLSFSFVKTRDST GPL+NAIEISKY KI +KT+ Q
Sbjct: 314 NIAENANGSYRLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLINAIEISKYLKIESKTDIQ 373
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
D VL A RSIS S T + GDPCVP WEWV CS+T+PPRITKIALSGKNLKGE+PPE
Sbjct: 374 DANVLNAFRSISAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIALSGKNLKGEVPPE 433
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ NM L+EL HLENN+L+GSLP Y+GSLPNL+EL+I+
Sbjct: 434 INNMVELSEL-----------------------HLENNKLSGSLPKYLGSLPNLRELYIQ 470
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSFVG++P ALLTGKV Y++NP LHKE ++M FKL LG SIGVLAILLVL L +LI
Sbjct: 471 NNSFVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGVLAILLVLLLGTLI 530
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
LR+L+RK S+QK+ +S+R STKPS TAYSI RG H MDEG +Y+I ELEEAT N
Sbjct: 531 YLRRLQRKTSHQKTDNPGNSMRASTKPS-TAYSITRGWHLMDEGGSYYISFAELEEATKN 589
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KKIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVTEVALLSRIHHRNLVPLIG
Sbjct: 590 FFKKIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVTEVALLSRIHHRNLVPLIG 649
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+CEEEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA DAAKGLEYLHTGC+P I
Sbjct: 650 FCEEEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAEDAAKGLEYLHTGCSPSI 709
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARGTVGYLDPEYY NQQLTEK
Sbjct: 710 IHRDVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARGTVGYLDPEYYANQQLTEK 769
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KGDV+SIVDPVLIGNVKIES
Sbjct: 770 SDVYSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKGDVVSIVDPVLIGNVKIES 829
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS-SSKGQSSRKTL 657
IWR+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G QK S+S SSK QSSRKTL
Sbjct: 830 IWRVAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQKLSNSGSSKAQSSRKTL 889
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
LTSFLEIESPDLSN CL PAAR
Sbjct: 890 LTSFLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/682 (75%), Positives = 578/682 (84%), Gaps = 8/682 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVV
Sbjct: 253 MQTAVVGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVV 312
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ Q
Sbjct: 313 NIAENANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYVSIASKTDRQ 372
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
D + A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP E
Sbjct: 373 DSNFVNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRE 431
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
L NMEALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+
Sbjct: 432 LNNMEALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQ 491
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVLAILL+LFL SL+
Sbjct: 492 NNSFSGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLGISIGVLAILLILFLTSLV 549
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNN
Sbjct: 550 LLLNLRRKTSRQKCDEKGISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATNN 608
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIG
Sbjct: 609 FSKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIG 668
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DA+KGLEYLHTGCNP I
Sbjct: 669 YCEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPSI 728
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEK
Sbjct: 729 IHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEK 788
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK ES
Sbjct: 789 SDVYSFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTES 848
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTL 657
+WR+AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + + SS SK QSSRKTL
Sbjct: 849 VWRVAEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKTL 908
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
L SFLEIESPDLSN CL P+AR
Sbjct: 909 LASFLEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2626), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/682 (74%), Positives = 573/682 (84%), Gaps = 8/682 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQ+AVVGT+G+LSYRLNLEDFP NARA+AY AEI+DL +ETRKFKLEQP+ ADYSNAVV
Sbjct: 254 MQSAVVGTKGLLSYRLNLEDFPGNARAYAYLAEIEDLSQNETRKFKLEQPFIADYSNAVV 313
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNV+L FVLSFSF +T DST GPLLNA+EISKYQ+IA+KT Q
Sbjct: 314 NIAENANGSYTLYEPSYMNVSLEFVLSFSFKRTPDSTRGPLLNAMEISKYQEIASKTFKQ 373
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
D + A S+SDE N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP E
Sbjct: 374 DSNFVNAFSSLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPRE 432
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
L NMEALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+
Sbjct: 433 LNNMEALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQ 492
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGVL IL+V+FL SL+
Sbjct: 493 NNSFTGDIPAGLLSTKITFIYDDNPGLHKRSKKH--FPLMIGISIGVLVILMVMFLASLV 550
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+LR LRRK S QKS E+A S RT TK T YS R G+ MDEG AY+I L +L+ ATNN
Sbjct: 551 LLRYLRRKASQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVATNN 609
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KKIGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALLSRIHHRNLVPLIG
Sbjct: 610 FSKKIGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVPLIG 669
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEE+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAKGLEYLHTGCNP I
Sbjct: 670 YCEEEYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCNPSI 729
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQLTEK
Sbjct: 730 IHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQLTEK 789
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK ES
Sbjct: 790 SDVYSFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVKTES 849
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSRKTL 657
IWR+AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + SSSS QSSRKTL
Sbjct: 850 IWRVAEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSRKTL 909
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
LTSFLEIESPDLSN CL P+AR
Sbjct: 910 LTSFLEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1011 bits (2615), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/683 (74%), Positives = 577/683 (84%), Gaps = 9/683 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVV
Sbjct: 253 MQTAVVGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVV 312
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ Q
Sbjct: 313 NIAENANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYMPIASKTDRQ 372
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
D + A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +
Sbjct: 373 DSNFVNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGK 431
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
L NMEALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+
Sbjct: 432 LNNMEALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQ 491
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVL ILL+LFL SL+
Sbjct: 492 NNSFSGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLGISIGVLVILLILFLTSLV 549
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNN
Sbjct: 550 LLLILRRKTSQQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNN 608
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIG
Sbjct: 609 FSKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIG 668
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DAAKGLEYLHTGCNP I
Sbjct: 669 YCEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSI 728
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEK
Sbjct: 729 IHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEK 788
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES
Sbjct: 789 SDVYSFGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTES 848
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKT 656
+WR+AE+A+QCVEQ G RP+MQE++LAIQD+ IEKG + + SSS G QSSRKT
Sbjct: 849 VWRVAEIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKT 908
Query: 657 LLTSFLEIESPDLSNECLAPAAR 679
LL SFLEIESPDLSN CL P+AR
Sbjct: 909 LLASFLEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18408845|ref|NP_564904.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|263430191|sp|C0LGI2.1|Y1677_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g67720; Flags: Precursor gi|224589467|gb|ACN59267.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332196566|gb|AEE34687.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2571), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/682 (73%), Positives = 578/682 (84%), Gaps = 9/682 (1%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF DYSNAVV
Sbjct: 254 MQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVV 313
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+ KT+
Sbjct: 314 NIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS 373
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP
Sbjct: 374 DVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPG 433
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IE
Sbjct: 434 INYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIE 493
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL+L SL+
Sbjct: 494 NNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLV 552
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+N
Sbjct: 553 LLCALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDN 607
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIG
Sbjct: 608 FSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIG 667
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP I
Sbjct: 668 YCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSI 727
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEK
Sbjct: 728 IHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEK 787
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES
Sbjct: 788 SDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIES 847
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTL 657
+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK QSSRKTL
Sbjct: 848 VWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTL 907
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
LTSFLE+ESPD+S LAPAAR
Sbjct: 908 LTSFLELESPDISRNSLAPAAR 929
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248570|ref|NP_001239648.1| probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] gi|223452327|gb|ACM89491.1| leucine-rich repeat family protein / protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2553), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/686 (73%), Positives = 572/686 (83%), Gaps = 14/686 (2%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQ+AVVGT+GVLSYRLNLEDFPANARA+AYFAEI+DLG +E+RKFKL+QPY ADYSNAVV
Sbjct: 204 MQSAVVGTKGVLSYRLNLEDFPANARAYAYFAEIEDLGQNESRKFKLKQPYIADYSNAVV 263
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNVTL FVLSFSFV DST GPLLNA+EISKY +IA+KT+ Q
Sbjct: 264 NIAENANGSYTLYEPSYMNVTLEFVLSFSFVMAPDSTRGPLLNALEISKYVQIASKTDKQ 323
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
D V+ A + +S ES +TN+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEI PE
Sbjct: 324 DSTVVTAFQLLSAESSQTNE-GDPCVPTPWEWVNCSTTTPPRITKIILSRRNVKGEISPE 382
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
L NMEALTELWLDGN LTG LPDMS+LI+L+IVHLENN+LTG LPSYMGSLP+LQ L I+
Sbjct: 383 LSNMEALTELWLDGNLLTGQLPDMSKLINLKIVHLENNKLTGRLPSYMGSLPSLQALFIQ 442
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
NNSF GEIP L++ K++F YD NP+L++ +++ FK+++G SIGVL ILL+LFL SL+
Sbjct: 443 NNSFSGEIPAGLISKKIVFNYDGNPELYRGNKKH--FKMVVGISIGVLVILLILFLVSLV 500
Query: 301 VLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
+L K RRK S +K EK S RT++KP YS RGG+ MDE I L EL+EAT+N
Sbjct: 501 LLLKTRRKASQKKREEKGISGRTNSKP---GYSFLRGGNLMDENTTCHITLSELKEATDN 557
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KKIGKGSFGSVYYGKM+DGKE+AVK M +S H QQFV EVALLSRIHHRNLVPLIG
Sbjct: 558 FSKKIGKGSFGSVYYGKMRDGKEIAVKSMNESSCHGNQQFVNEVALLSRIHHRNLVPLIG 617
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEEE Q ILVYEYMHNGTLRD +H S +K LDWLTRL+IA DAAKGLEYLHTGCNP I
Sbjct: 618 YCEEECQHILVYEYMHNGTLRDHIHESSKKKNLDWLTRLRIAEDAAKGLEYLHTGCNPSI 677
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+K+ NILLDINMRAKVSDFGLSR AEEDLTHISS+ARGTVGYLDPEYY +QQLTEK
Sbjct: 678 IHRDIKTGNILLDINMRAKVSDFGLSRLAEEDLTHISSIARGTVGYLDPEYYASQQLTEK 737
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVLLELISGKKPVS ED+G E+NIVHWARS+ +KGD +SI+DP L GN K ES
Sbjct: 738 SDVYSFGVVLLELISGKKPVSSEDYGDEMNIVHWARSLTRKGDAMSIIDPSLAGNAKTES 797
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS-------SSSSKGQSS 653
IWR+ E+A+QCV Q G SRP+MQEI+LAIQD+ KIEKG + K SSS SS
Sbjct: 798 IWRVVEIAMQCVAQHGASRPRMQEIILAIQDATKIEKGTENKLKSSSFSGSSSSKPQHSS 857
Query: 654 RKTLLTSFLEIESPDLSNECLAPAAR 679
RKTLLTSFLEIESPD+SN CL P+AR
Sbjct: 858 RKTLLTSFLEIESPDVSNGCL-PSAR 882
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.991 | 0.724 | 0.708 | 7.2e-258 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.920 | 0.669 | 0.490 | 1.1e-158 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.625 | 0.485 | 0.397 | 2.5e-100 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.643 | 0.494 | 0.372 | 1.4e-97 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.415 | 0.317 | 0.491 | 1.3e-96 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.412 | 0.316 | 0.461 | 6.9e-96 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.412 | 0.322 | 0.464 | 6.2e-93 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.410 | 0.332 | 0.471 | 3.4e-92 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.415 | 0.319 | 0.470 | 1.7e-90 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.419 | 0.320 | 0.477 | 5e-89 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2482 (878.8 bits), Expect = 7.2e-258, P = 7.2e-258
Identities = 483/682 (70%), Positives = 553/682 (81%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF DYSNAVV
Sbjct: 254 MQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVV 313
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+ KT+
Sbjct: 314 NIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS 373
Query: 121 DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPE 180
DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP
Sbjct: 374 DVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPG 433
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
+ MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IE
Sbjct: 434 INYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIE 493
Query: 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXX 300
NNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG S
Sbjct: 494 NNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLV 552
Query: 301 XXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+N
Sbjct: 553 LLCALRKT----KRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDN 607
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIG
Sbjct: 608 FSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIG 667
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP I
Sbjct: 668 YCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSI 727
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEK
Sbjct: 728 IHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEK 787
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES
Sbjct: 788 SDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIES 847
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXXXXXXXXRKTL 657
+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE RKTL
Sbjct: 848 VWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTL 907
Query: 658 LTSFLEIESPDLSNECLAPAAR 679
LTSFLE+ESPD+S LAPAAR
Sbjct: 908 LTSFLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 314/640 (49%), Positives = 414/640 (64%)
Query: 1 MQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV 60
MQTAVVGT G L+YR+NL+ FP AF YFAEI+DL E+RKF+L P +YS +VV
Sbjct: 256 MQTAVVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVV 315
Query: 61 NIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ 120
NI EN Y +Y P Y N+TL FVL+F F KT DS+ GP+LNA+EISKY + K++
Sbjct: 316 NIKENTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLR---KSDGS 372
Query: 121 -DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPP 179
D V+ + S+ +E + GDPC P PW WV C++ PR+ I LS NL G IP
Sbjct: 373 VDATVMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPS 432
Query: 180 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239
+L + L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS + LPNL+EL++
Sbjct: 433 DLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYL 492
Query: 240 ENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXX 299
+NN G IP L VI + N L K + + +I+G S
Sbjct: 493 QNNVLTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCI 551
Query: 300 XXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN 359
+ + + S E + + S+T S A G A+ L E+EEAT
Sbjct: 552 VMCKSKKNNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHCFTLYEIEEATK 604
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
F K+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LLSRIHHRNLV +
Sbjct: 605 KFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFL 664
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
GYC+EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA+G+EYLHTGC P
Sbjct: 665 GYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVP 724
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
IIHRD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGYLDPEYY +QQLT
Sbjct: 725 AIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLT 784
Query: 539 EKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLI-GNV 596
EKSDVYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+ I+DP L +
Sbjct: 785 EKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDY 844
Query: 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
++S+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 845 SLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 2.5e-100, Sum P(2) = 2.5e-100
Identities = 178/448 (39%), Positives = 251/448 (56%)
Query: 192 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
L + LTG + P + L + + L NN LTG +P ++ SLPNL EL++E N G IP
Sbjct: 416 LSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPA 475
Query: 251 ALLT----GKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXRKLR 306
LL G + ++ NP L + + K +G
Sbjct: 476 KLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALAL--- 532
Query: 307 RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIG 366
I + K + ++ S KP + G +D YFI E+ TNNF + +G
Sbjct: 533 --IWHFKKRSRRGTI--SNKP----LGVNTGP--LDTAKRYFI-YSEVVNITNNFERVLG 581
Query: 367 KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 426
KG FG VY+G + +G +VAVKI+++ + ++F EV LL R+HH NL LIGYC E++
Sbjct: 582 KGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDN 640
Query: 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 486
L+YEYM NG L D L G + L W RLQI+ DAA+GLEYLH GC P I+HRDVK
Sbjct: 641 HMALIYEYMANGNLGDYLSGK-SSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVK 699
Query: 487 SSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 545
+NILL+ N++AK++DFGLSR E + +S+V GT+GYLDPEYY +Q+ EKSDVYS
Sbjct: 700 PANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYS 759
Query: 546 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 605
FGVVLLE+I+GK P +++ SM+ GD+ IVD L ++ S W+I
Sbjct: 760 FGVVLLEVITGK-PAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKIT 818
Query: 606 EVAIQCVEQRGFSRPKMQEIVLAIQDSI 633
E+A+ C + RP M ++V+ ++ SI
Sbjct: 819 ELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 1.4e-97, Sum P(2) = 1.4e-97
Identities = 169/454 (37%), Positives = 256/454 (56%)
Query: 187 LTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 245
+ L L + L G +P + L+ + L NN LTG +P ++ ++ L +++ N+
Sbjct: 407 IISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLS 466
Query: 246 GEIPPALLTGK---VIFKYDNNPKLHKES--RRRMRFKLILGTSXXXXXXXXXXXXXXXX 300
G +P ALL + ++ K + NP L K S + K +L
Sbjct: 467 GSVPQALLDKEKEGLVLKLEGNPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALF 526
Query: 301 XXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 360
R+K ++ + S+ S P + + S + F + + + E++E TNN
Sbjct: 527 FV--FRKKKASPSNLHAPPSMPVSN-PGHNSQSESS---FTSKKIRF--TYSEVQEMTNN 578
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K +G+G FG VY+G + ++VAVK+++ S S + F EV LL R+HH NLV L+G
Sbjct: 579 FDKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVG 638
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
YC+E L+YEYM NG L+ L G L W +RL+I DAA GLEYLHTGC P +
Sbjct: 639 YCDEGEHLALIYEYMPNGDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPPM 698
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+HRD+K++NILLD +++AK++DFGLSR + ++S+V GT GYLDPEYY LTE
Sbjct: 699 VHRDIKTTNILLDQHLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTE 758
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599
KSD+YSFG+VLLE+IS + P+ ++ + +IV W MI KGD+ SI+DP L + I
Sbjct: 759 KSDIYSFGIVLLEIISNR-PI-IQQSREKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIG 816
Query: 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633
S+W+ E+A+ CV RP M +V +++ +
Sbjct: 817 SVWKAIELAMSCVSLSSARRPNMSRVVNELKECL 850
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 1.3e-96, Sum P(2) = 1.3e-96
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 531
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 6.9e-96, Sum P(2) = 6.9e-96
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 531
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 6.2e-93, Sum P(2) = 6.2e-93
Identities = 132/284 (46%), Positives = 187/284 (65%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 557 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 615
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
NLV L+GYC+E L+YE+M NG L++ L G L+W +RL+IA ++A G+EYL
Sbjct: 616 VNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYL 675
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 531
H GC P ++HRDVKS+NILL + AK++DFGLSR H+S+ GT+GYLDPEY
Sbjct: 676 HIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEY 735
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
Y LTEKSDVYSFG+VLLE I+G+ PV +E + IV WA+SM+ GD+ SI+DP
Sbjct: 736 YLKNWLTEKSDVYSFGIVLLESITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDPN 793
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 794 LHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 3.4e-92, Sum P(2) = 3.4e-92
Identities = 133/282 (47%), Positives = 184/282 (65%)
Query: 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 415
+ TNNF + +G+G FG VY+G + ++VAVK+++ S ++F EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L+GYC++ + LVYEYM NG L+ L G N L W TRLQIA DAA GLEYLH G
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 534
C P ++HRDVKS+NILL AK++DFGLSR + D HIS+V GT GYLDPEYY
Sbjct: 648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707
Query: 535 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594
+L EKSD+YSFG+VLLE+I+ + +++ + +I W S+I +GD+ I+DP L G
Sbjct: 708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765
Query: 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
N S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 1.7e-90, Sum P(2) = 1.7e-90
Identities = 134/285 (47%), Positives = 184/285 (64%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E+ E T F K +G+G FG VY+G +K+ ++VAVK+++ S S + F EV LL R+HH
Sbjct: 570 EVVEMTKKFEKALGEGGFGIVYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHH 629
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
NLV L+GYC+E+ L+YEYM NG L+D L G L+W TRLQIA D A GLEYL
Sbjct: 630 INLVSLVGYCDEKDHLALIYEYMPNGDLKDHLSGKQGDSVLEWTTRLQIAVDVALGLEYL 689
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEY 531
H GC P ++HRDVKS+NILLD AK++DFGLSR + D + IS+V GT GYLDPEY
Sbjct: 690 HYGCRPSMVHRDVKSTNILLDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEY 749
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
Y +L E SDVYSFG+VLLE+I+ ++ + +++I W M+ +GD+ IVDP
Sbjct: 750 YRTSRLAEMSDVYSFGIVLLEIITNQRVF--DQARGKIHITEWVAFMLNRGDITRIVDPN 807
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
L G S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 808 LHGEYNSRSVWRAVELAMSCANPSSEYRPNMSQVVIELKECLTTE 852
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 5.0e-89, Sum P(2) = 5.0e-89
Identities = 138/289 (47%), Positives = 191/289 (66%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 408
I PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S + ++F EV LL
Sbjct: 574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632
Query: 409 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
R+HHR+LV L+GYC++ L+YEYM NG LR+ + G L W R+QIA +AA+G
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 527
LEYLH GC P ++HRDVK++NILL+ AK++DFGLSR D H+S+V GT GYL
Sbjct: 693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587
DPEYY L+EKSDVYSFGVVLLE+++ + PV ++ +I W M+ KGD+ SI
Sbjct: 753 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ-PV-IDKTRERPHINDWVGFMLTKGDIKSI 810
Query: 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
VDP L+G+ W+I E+A+ CV RP M +V+ + D + +E
Sbjct: 811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALE 859
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7360 | 0.9911 | 0.7244 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 679 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 2e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-54
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 414
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 533
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 534 NQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 6e-53
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 414
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 535 QQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 7e-53
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 483 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 540
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 541 SDVYSFGVVLLEL 553
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 414
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 535 QQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 417
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 471
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 530
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 531 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 541 SDVYSFGVVLLELISGKKP 559
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 536
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 537 LTEKSDVYSFGVVLLELISGKKP 559
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 419
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 420 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 534
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 478
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 539 EKSDVYSFGVVLLELISGKKP 559
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-35
Identities = 125/487 (25%), Positives = 210/487 (43%), Gaps = 45/487 (9%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 219
+ ++ LS L GEIP EL + + L L L N L+G +P S + L + L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 270
L+G +P +G++ +L +++I +N G +P A L G + +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 271 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNT 330
+R + L LVL L + + R K E D
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------ 672
Query: 331 AYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIM 389
F D V+ I + ++ + I +G G+ Y GK +K+G + VK +
Sbjct: 673 --------QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 390 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 449
D S + +E+A + ++ H N+V LIG C E L++EY+ L + L
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 450 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509
L W R +IA AK L +LH C+P ++ ++ I++D + L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 569
D S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E FG
Sbjct: 833 CTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHG 886
Query: 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVL 627
+IV WAR + +DP + G+V + I + +A+ C +RP +++
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 628 AIQDSIK 634
++ + +
Sbjct: 947 TLESASR 953
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 365 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 424
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 484
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 485 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 544
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 545 SFGVVLLELIS-GKKP 559
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 7e-34
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 419
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 420 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 466
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 525
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 526 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+E + +V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH- 120
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQL 537
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y+ PE +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESY 177
Query: 538 TEKSDVYSFGVVLLELISGKKP 559
+ +D++S G+ LLE GK P
Sbjct: 178 SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 417
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 535
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 536 QLTEKSDVYSFGVVLLELISG 556
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 361 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 413
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 414 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 529
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELIS 555
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 7e-32
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 415
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 476 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 529
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 530 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 364 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 477
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 538 TEKSDVYSFGVVLLELISGKKP 559
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 419 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 474
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 411
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 532 YGNQQLTEKSDVYSFGVVLLEL 553
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 415
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 521
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 522 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 539
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 542 DVYSFGVVLLELIS-GKKP 559
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 420
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 539 EKSDVYSFGVVLLELISGKKPVSVED 564
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 416
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 417 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 466
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 467 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 524
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 525 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 423 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 539
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 363 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 417
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 536
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 537 LTEKSDVYSFGVVLLELIS-GKKP 559
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 413
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 462
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 521
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 423 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 541 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 401
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 402 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 449
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 450 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 509 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 365 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 424
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 425 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 543
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 544 YSFGVVLLELIS-GKKP 559
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 420 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 535
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 536 QLTEK---SDVYSFGVVLLELISGKKP 559
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 365 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 413
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 530
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 531 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 567
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 363 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 417
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 531
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 363 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 416
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 417 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 465
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 524
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 352 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 404
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 460
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 516
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 365 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 418
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 537 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 572
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 363 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 535
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 355 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 409
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 410 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 525
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 363 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 535
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 536 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 416
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 471
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 472 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 365 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 414
IG GSFGSVY G G+ +AVK + A S + E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 415 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 471
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 526
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 533
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 534 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 561
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 363 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 417
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 363 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 417
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 474
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 532
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 476
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 534
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 535 QQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 364 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 422 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 472
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 529
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 420
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 479
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 537
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 538 TEKSDVYSFGVVLLELIS 555
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 365 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 423
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 543
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 544 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 603
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 604 IAEVAIQCVEQRGFSRPKMQEI 625
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 364 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 479
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 540 KSDVYSFGVVLLELISGKKPVS 561
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 416
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 417 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 530
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 404
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 523
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 420
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 541 SDVYSFGVVLLELISGKKP 559
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 364 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 420
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGA 567
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 417
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 418 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 471
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 524
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 525 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 365 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 419
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 420 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 476
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 533
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 361 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 413
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 454
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 455 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 508
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 509 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 363 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 478
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 533
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 534 NQQL---TEKSDVYSFGVVLLELISGKKPVS 561
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 363 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 416
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 466
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 525
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 532
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 471
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKP 559
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 365 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 417
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 471
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 420
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 421 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 528
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 529 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 561
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 418
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 535
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 363 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 416
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 463
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 522
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 364 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 417
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 465
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 524
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 360 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 474
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 365 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 419
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 535
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 536 QLTEKSDVYSFGVVLLELIS-GKKP 559
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 362 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 536
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 537 LTEKSDVYSFGVVLLELISGKKPVS 561
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 406
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 452
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 511
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 333 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 391
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 392 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 448
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 449 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 509 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 560
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 417
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 418 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 469
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 527
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 570
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 365 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 421
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 479
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 540 KSDVYSFGVVLLELISGKK 558
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 364 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 417
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 474
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 533
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 542
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 543 VYSFGVVLLELIS-GKKP 559
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 543
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 544 YSFGVVLLELIS-GKKP 559
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 543
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 544 YSFGVVLLELIS-GKKP 559
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 352 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 405
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 406 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 454
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 455 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 350 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 402
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 403 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 451
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 452 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 509 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 555
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 365 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 419
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 420 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 464
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 524
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 363 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 417
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 418 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 468
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 527
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 365 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 531
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 542
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 543 VYSFGVVLLELISGKKP 559
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 365 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 419
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 420 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 464
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 524
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 415
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 416 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 475 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 530
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 418
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 532
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPV 560
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 363 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 416
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 417 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 467
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 526
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 419
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 536
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 537 LTEKSDVYSFGVVLLELISGKKPV 560
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 361 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 411
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 472 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 529
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELIS 555
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 423 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 363 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 415
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 468
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 527
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS 555
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 412
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 471
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 362 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 411
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 530
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGK 557
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 361 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 411
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 412 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 468
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 526
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 416
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 472
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 563
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 417
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 533
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 534 NQQLTEKSDVYSFGVVLLELISGK 557
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 362 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 414
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 415 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 526
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLEL 553
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 363 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 415
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 454
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 455 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 515 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 363 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 412
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 459
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 460 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 517
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 363 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 412
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 459
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 518
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 38/115 (33%), Positives = 52/115 (45%), Gaps = 13/115 (11%)
Query: 1 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKL---EQPYFADY 55
+QTAV T +L D + +FAEIQ L ETR+F + + + D
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDV 285
Query: 56 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 110
S + LY +NV+ +L+ S V T STL PLLNA+EI K
Sbjct: 286 S-----PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 359 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 412
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 506
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 507 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 565 -FGAELNIVHWARS 577
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 416
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 417 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 529
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 360 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 401
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 402 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 453
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 454 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 512
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 368 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 421
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 422 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 473
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 532
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKP 559
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 416
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 417 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 529
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 363 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 417
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+IG CE E +LV E G L L + + + +T L H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKN-ITEL--VHQVSMGMKYLE---E 113
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 535
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 536 QLTEKSDVYSFGVVLLELIS-GKKP 559
+ + KSDV+SFGV++ E S G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 423 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 365 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 416
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 472
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 473 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 526
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 416
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 417 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 529
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 419
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 474
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 531
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGK 557
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 424 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 479 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 535
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 421
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 422 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 538
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 539 EKSDVYSFGVVLLELISGKKPVSVED 564
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-18
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 381 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 436
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 493
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 494 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 546
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 547 GVVLLELISGKKPV 560
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 419
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 420 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 471
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 472 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 567
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 360 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 417
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 472
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 529
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 350 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 400
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 401 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 446
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 447 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 507 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 418
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 419 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 528
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 529 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 363 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 412
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 459
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 520 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 565
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 416
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 537 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 404
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 455
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 456 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 514
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 562
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 414
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 415 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 466
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 467 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 520
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 521 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 537
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 538 TEKSDVYSFGVVLLELISGKKPVS 561
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 364 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 419
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 418
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 533
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 534 NQQLTEKSDVYSFGVVLLELISG 556
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 358 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 411
NF KKIGKG F VY DG+ VA V+I + Q + E+ LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 466
H N++ + E ++ +V E G L + QK L W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
LE++H+ I+HRD+K +N+ + K+ D GL R T S+ GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK--- 122
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 539
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 540 KSDVYSFGVVLLELISGKKPVS 561
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 420 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 471
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 532 Y-------GNQQLTEKSDVYSFGVVLLELISGK 557
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 420
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 541 SDVYSFGVVLLELISGKKP 559
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 407
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 408 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 525
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 402
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 403 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 454
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 455 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 507 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 418
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 534
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 535 QQ-------LTEKSDVYSFGVVLLEL 553
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 412
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 465
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 524
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 361 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 411
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 412 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 527
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS 555
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 541 SDVYSFGVVLLELISGKKPVS 561
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 421
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 422 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 536 QLTE-----KSDVYSFGVVLLELISGKKPV 560
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 423 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 536 QLTE-----KSDVYSFGVVLLELISGKKPV 560
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 350 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 404
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 465 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 520
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 521 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 562
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 422
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 479
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 533
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 365 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 539
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 540 KSDVYSFGVVLLELISGKKP 559
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 349 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 405
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 406 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 458
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 517
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 518 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 560
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 354 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 407
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 408 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 463
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 522
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 539
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 540 KSDVYSFGVVLLELISGK 557
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 538
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 539 EKSDVYSFGVVLLELISG 556
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 365 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 418
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 419 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 470
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 531 YYGN-QQLTEKSDVYSFGVVLLELISGK 557
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 418 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 471
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 567
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 541 SDVYSFGVVLLELISGKKPVS 561
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 492
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 493 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 549
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 550 LLELISGKKPVSVEDFGAELNIVH 573
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 412
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 463
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 523
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 524 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 365 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 416
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 477 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 526
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 527 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 564
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 372 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 424
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 483
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 541
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 542 DVYSFGVVLLELISGKKP 559
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 415
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 416 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 462
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 522
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 523 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 365 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 411
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 465
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 525
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 538
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 539 EKSDVYSFGVVLLELISGKKPV 560
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-15
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 418
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 474
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 532
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 533 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 570
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 420
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 533
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 364 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 417
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 418 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 521
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 522 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 555
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 420
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 479
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 540 KSDVYSFGVVLLELISGKKP 559
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 419
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 420 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 472
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVS 561
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 420
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 541 SDVYSFGVVLLELISGKKP 559
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 405
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 406 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 458
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 459 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 511
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 415
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 416 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 365 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 421
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 422 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 474
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 533
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 534 NQQL----TEKSDVYSFGVVLLELISGKKPVS 561
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 356 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 410
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 411 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 530 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 557
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 410
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 411 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 461
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 462 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 516
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 418
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 419 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 416
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 472
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 531
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 561
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 65/261 (24%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 414
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 415 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 461
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 519
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL-------------------ISGKKPV 560
GT Y+ PE +Q KSD++S G +L E+ + G P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224
Query: 561 SVEDFGAELNIVHWARSMIKK 581
E + +LN + +SM+ K
Sbjct: 225 LPETYSRQLNSI--MQSMLNK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 418
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 419 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 524
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 525 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 560
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 361 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 402
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 403 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 454
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 455 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 513
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 531
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 532 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 559
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 365 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 416
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 475
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 536 QLTEK----SDVYSFGVVLLELISGKKP 559
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 415
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 418
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 539 EKSDVYSFGVVLLELISGKKPVSVED 564
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 420
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 479
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 535
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 536 QLTEKSDVYSFGVVLLELISG 556
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 420
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 421 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 540 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 570
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 362 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 416
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 417 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 473
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 529
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 530 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 559
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 360 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 412
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 413 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 459
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 516
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 517 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-14
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)
Query: 150 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 207
W+ +TC+ ++ R+ I LSGKN+ G+I + + + + L N L+GP+PD +
Sbjct: 60 WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 208 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
LR ++L NN TGS+P GS+PNL+ L + NN GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 414
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 531
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 365 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 539 EKSDVYSFGVVLLELISGKKP 559
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 361 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 415
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 472
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 524
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 525 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 561
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 417
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 538 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 573
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 478
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 535
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 536 QLTEKSDVYSFGVVLLELISGKKPV 560
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 418
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 419 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 470
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 531 YYGNQQLTEKSDVYSFGVVLLEL 553
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 414
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 415 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 459
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 520 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 412
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 468
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 529 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 570
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 420
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 421 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 537
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 538 TEKSDVYSFGVVLLELISG 556
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 410
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 411 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 466
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 527 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 570
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 341 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 393
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 394 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 444
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 445 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 498
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 499 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 540
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 541 SDVYSFGVVLLELISGK 557
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 363 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 418
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 476
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 531
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 532 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 559
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 415
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 536 ----QLTEKSDVYSFGVVLLELISGKKP 559
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 365 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 419
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 475
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 531
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 532 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 559
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 410
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 411 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 468
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 526
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 417
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 538 TEKSDVYSFGVVLLELISGKKPVSVED 564
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 406
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 407 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 463
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 464 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 416
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 472
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 530
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 531 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 420
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 541 SDVYSFGVVLLELISGKKP 559
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 360 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 414
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 471
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 530
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGK 557
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 417
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 535
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 573
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 417
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 530
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 573
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 363 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 414
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 472
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 533 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 420
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 421 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 537
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 538 TEKSDVYSFGVVLLELISGKKPV----SVED 564
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 473
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 414
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 416
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 471
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 539
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 540 --KSDVYSFGVVLLELISGKKP 559
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 420
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 541 SDVYSFGVVLLELISGKKP 559
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 414
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 529 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 364 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 418
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 419 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 529 PE------YYGNQQLTEKSDVYSFGVVLLELIS 555
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 354 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 407
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 408 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 460
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 519
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 409
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 410 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 583
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 584 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 637 KGGDQKFSSSSSKGQSSRKTLLTS 660
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 64/239 (26%)
Query: 101 LLNAIEISKYQKIAA--KTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVTC- 155
++NAIE+ ++ I A KT ++V L+ L+S R GDPCVP PW C
Sbjct: 353 IINAIEV--FEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQ 410
Query: 156 --STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 213
ST I + L + L+G IP D+S+L L+ +
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPN-----------------------DISKLRHLQSI 447
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV- 257
+L N + G++P +GS+ +L+ L + NSF G IP +L L+G+V
Sbjct: 448 NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
Query: 258 -----------IFKYDNNPKL-----HKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 300
F + +N L + + +G + GV L L +C++
Sbjct: 508 AALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 414
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 471
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 528
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 529 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 418
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 419 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 522
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 420
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 472
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 358 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 413
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 414 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 470
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 411
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 412 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 415
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 533
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 581
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 399 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 458
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 519 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 422
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 537
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 538 TEKSDVYSFGVVLLELISGKKP 559
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 419
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 535
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 536 QLTEKSDVYSFGVVLLELISGKKPV 560
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 419
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 420 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 467
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 525
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 526 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 560
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 365 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 414
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 415 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 474 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 526
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 527 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 561
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 452 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 511 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 419
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 420 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 471
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 525
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 526 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 557
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 418
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 419 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 533 GNQQLTEKS-DVYSFGVVLLELISGKKP 559
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 416
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 417 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 468
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 529 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 557
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 399 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 458
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 519 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 414
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 471
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 529
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 577
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 578 MIKK 581
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 365 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 539 EKSDVYSFGVVLLELISGKKP 559
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 416
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 417 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 468
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 469 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 507
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 508 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 559
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 173 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 231
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 232 PNLQELHIENNSFVGEIPPAL 252
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 417
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 535
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVED 564
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 363 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 414
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 415 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 530
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 531 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 418
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 475
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 513
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 514 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 418
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 469
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 521
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 522 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 565
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 363 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 414
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 415 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 452
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 453 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 474
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 475 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 532
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 364 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 418
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 419 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 533
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPV 560
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 420 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 534 NQQLTEKSDVYSFGVVLLELISG 556
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 421
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 422 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 469
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 530 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 559
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 365 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 419 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 471
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 532 YGN-QQLTEKSDVYSFGVVLLELISGK 557
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 411
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 470
H + E I LV +Y + G LR + R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148
Query: 471 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 521
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 418
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 530
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 365 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 419
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 420 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 534
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 535 QQLTEKSDVYSFGVVLLELISGK 557
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 417
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 538 TEKSDVYSFGVVLLELISGKKP 559
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 363 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 417
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 418 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 532 YGN-QQLTEKSDVYSFGVVLLELISGK 557
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 415
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSV 562
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 417
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 533
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 534 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 564
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 418
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 419 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 470
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 518
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 519 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 553
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 554 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 584
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 416
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 474
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 532
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 533 GNQQLTEKSDVYSFGVVLLELISGK 557
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 420
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 537 LTEKSDVYSFGVVLLELISGKKPVSVED 564
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 474
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 531
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 532 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 578
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 160 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 212
P +T + L+ L G+IP EL M++L ++L N L+G +P ++ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 213 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L N LTG +PS +G+L NLQ L + N G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 466 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 523
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 363 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 412
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 413 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 525
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 418
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 530
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 474
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 533
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 534 NQQLTEKSDVYSFGVVLLELISGK 557
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 352 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 407
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 408 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 465
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 402 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 460
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 519
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 513 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 415
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSV 562
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 361 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 414
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 415 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 463
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 464 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 516
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 517 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 570
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 365 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 417
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 418 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 473
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 529
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 530 EYYGN--QQLTEKSDVYSFGVVLLELISGK 557
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 466 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 523
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 364 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 418
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 419 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 473
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 474 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 527
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 528 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 363 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 418
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 419 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 534 NQQLTEKSDVYSFGVVLLELISGK 557
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 417
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 418 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 466
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 523
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 524 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 583 D 583
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 413
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 469
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 525
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 526 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 363 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 418
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 419 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 534 NQQLTEKSDVYSFGVVLLELISGK 557
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 419
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 420 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 525
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 526 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 166 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 224
I L NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 225 PSYMGSLPNLQELHIENNSFVGEIP 249
P + SL L L + +NS GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 364 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 418
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 419 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 473
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 474 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 527
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 528 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 363 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 414
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 467
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 468 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 525
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 526 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 563
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 364 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 422 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 538
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 539 EKSDVYSFGVVLLELISGK 557
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 415
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 468
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 529 PE-YYGNQQLTEKSDVYSFGVVLLELISG 556
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 365 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 415
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 533
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 414
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
I++RD+K N+LLD + K++DFG ++ + + GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 365 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 421
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 422 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 536
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 537 LTEKSDVYSFGVVLLELISGK 557
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 537
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 538 TEKSDVYSFGVVLLELISGK 557
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 372 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 423
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 424 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 542 DVYSFGVVLLELIS 555
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 364 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 417
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 418 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 470
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 525
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 526 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 560
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 418
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 477
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 537 -------LTEKSDVYSFGVVLLELI-SGKKPVS 561
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 429 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 487
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 488 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 546
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 547 GVVLLELISGKKPVSVEDFGAELNI 571
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 438 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 497 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 552
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 553 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 611
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 612 VEQRGFSRPKMQEIVLAIQD 631
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 226
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 260
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 219
P + + LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
L G +P +G + +L+ +++ N+ GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 513 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 418
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 419 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 529
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELIS 555
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 416
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 417 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 469
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 470 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 525
+ H G++HRD+K N+L+D K++D GL R + TH T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLW 176
Query: 526 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 556
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 421
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 422 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 463
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 517
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 612
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 30/189 (15%)
Query: 380 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 438 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 492
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 493 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 544
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 545 SFGVVLLEL 553
SFG LLE+
Sbjct: 206 SFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 220
R+ + LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+G +P+ +P L +L + N GEIP L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 364 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 414
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 415 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 465
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 525
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 168 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 225
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPAL 252
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 34/105 (32%), Positives = 50/105 (47%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
T P + + +S NL+G I +M +L L L N G LPD L + L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 262
N+ +G++P +GSL L +L + N GEIP L + K + D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 531
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 581
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 221
+T + LS NL GEIP L + L +L L N L G +P + LR V L++N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 222 GSLPSYMGSLPNLQELHIENNSFVGEI 248
G LPS LP + L I NN+ G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 402 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 459
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 520 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 574
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 575 ARSMIK 580
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 365 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 424 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 476 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 530
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISG 556
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 365 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 411
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 472 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 519
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 520 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL-ISGKKPV 560
A PE ++ L+ +D +SFG L E+ +G+ P+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 456 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 505
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 506 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 533
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 578
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 418
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 419 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 505
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 506 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 558
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 559 PVSVE 563
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 210
T+ PR+ + L GEIP L LT L L N LTG +P+ + +LI
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386
Query: 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
L +N L G +P +G+ +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 381 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 439 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 496 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 546
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 547 GVVLLELISGKKP 559
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 418
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 507
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 508 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 563
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 363 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 418
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 472
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 517
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 518 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 546
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 547 GVVLLELISGKKPVSVED 564
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 226
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 227 YMGSLPNLQELHIENNSFVGEIPPAL 252
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 505
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 506 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 549
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 550 LLELISGKKP-VSVEDFGAELNIVHWARSM 578
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 514
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 515 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 552
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 553 LISGKKP-VSVEDFGAELNIVHWARSM 578
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 364 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 418
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 530
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 531 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 559
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 362 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 418
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSR 507
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 451 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 511 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 552
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 361 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 411
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 440
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 187 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
+ + LSG N ++PPE++ + AL EL L N + L +S L +L + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 220 LTGSLPSYMGSLPNLQELHIENN 242
L LP +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 361 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
K +G+G+FG V K + VAVK++ + + + +TE+ +L I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 413 RNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHG 446
N+V L+G C + ++V EY G L + L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS 105
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.71 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.71 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.71 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.48 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.47 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.46 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.45 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.43 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.38 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.31 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.26 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.17 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.15 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.07 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.01 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.99 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.98 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=518.15 Aligned_cols=441 Identities=27% Similarity=0.478 Sum_probs=294.8
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
+|+.|+|++|.+.|.+|..+++|++|+.|+|++|.++|.+| .+.++++|+.|+|++|+++|.+|..+..+++|+.|+++
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 45555566666665666666666666666666666666655 36666666666666666666666666666666666666
Q ss_pred ccCCCCCCCccc-cCCceeeeecCCCCccccc-------ccc----cceeeeeechhhhhHHHHHHHhHhhhhhhhhhcc
Q 005750 241 NNSFVGEIPPAL-LTGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRK 308 (679)
Q Consensus 241 ~N~l~g~ip~~~-~~~~~~~~~~~n~~~~~~~-------~~~----~~~~ii~~~~i~~~~~l~v~~~~~~~~~~r~~~~ 308 (679)
+|+++|.+|..- +.......+.+|+.+|+.. |.. ....++++++++++++++++. ++++++|++++
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 657 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA--FGFVFIRGRNN 657 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHH--HHHHHHHhhhc
Confidence 666666666431 1122334567888888532 221 111222222222222222222 22222222211
Q ss_pred cccccchhccccccccCCCCCcccccccCCccccCCccccCChhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEE
Q 005750 309 ISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVK 387 (679)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK 387 (679)
... +..+.... . +.. .+........+.+.++.. .+...+.||+|+||.||+|+.. +++.||||
T Consensus 658 ~~~-~~~~~~~~--------~--~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK 721 (968)
T PLN00113 658 LEL-KRVENEDG--------T--WEL----QFFDSKVSKSITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVK 721 (968)
T ss_pred ccc-cccccccc--------c--ccc----cccccccchhhhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEE
Confidence 111 10010000 0 000 000001111123344433 2344678999999999999874 78999999
Q ss_pred EecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHH
Q 005750 388 IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467 (679)
Q Consensus 388 ~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~ 467 (679)
.+...... ..+|++.+++++||||++++++|.+.+..++||||+++|+|.++++ .++|..+.+++.|+++
T Consensus 722 ~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~ 791 (968)
T PLN00113 722 EINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAK 791 (968)
T ss_pred EccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHH
Confidence 98654321 2346889999999999999999999999999999999999999986 2789999999999999
Q ss_pred HHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHH
Q 005750 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFG 547 (679)
Q Consensus 468 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlG 547 (679)
||+|||..+..+|+||||||+||+++.++..++. ||........ ....+++.|+|||++.+..++.++||||||
T Consensus 792 ~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~G 865 (968)
T PLN00113 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFG 865 (968)
T ss_pred HHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHH
Confidence 9999996555899999999999999998888875 6654432211 122478999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005750 548 VVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEI 625 (679)
Q Consensus 548 vll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 625 (679)
|++|||+||+.||. ........+.+|++...........+|+.+... ...++..++.+++.+||+.+|++||||+||
T Consensus 866 vvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev 944 (968)
T PLN00113 866 LILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944 (968)
T ss_pred HHHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence 99999999999996 333444567777776665555566677766443 345667789999999999999999999999
Q ss_pred HHHHHhhhhhhc
Q 005750 626 VLAIQDSIKIEK 637 (679)
Q Consensus 626 l~~L~~~~~~~~ 637 (679)
++.|+++.....
T Consensus 945 l~~L~~~~~~~~ 956 (968)
T PLN00113 945 LKTLESASRSSS 956 (968)
T ss_pred HHHHHHhhcccc
Confidence 999998877443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=430.16 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=252.6
Q ss_pred cccCChhHHHHHHHhhc--cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccc
Q 005750 346 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 346 ~~~~~~~~l~~~~~~~~--~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
...+++.+|..+|.+|. +.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 44577999999999997 6999999999999999999999999887654321456999999999999999999999999
Q ss_pred ccc-eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 424 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 424 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
+.+ +.+|||||+++|+|.++|+..... .++|.++++|+.++|+||+|||+.+...|+|||||++|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 988 599999999999999999975433 899999999999999999999998888999999999999999999999999
Q ss_pred ccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 503 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 503 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
||+|+..............||.+|+|||++..+..+.|+|||||||+|+|++||+.+.+.........+++|+...+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654411111111169999999999999999999999999999999999999987444345566999999999999
Q ss_pred Ceeeeeccccc-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 583 DVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 583 ~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...+++|+.+. +.+.. +++.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999987 66664 6888999999999999999999999999999665554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.48 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=211.1
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccc-eEEEEEEecC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMH 436 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~ 436 (679)
+..+.||+|..|+||+++++ +++.+|+|.+... .....+++.+|+++++..+||+||.+||.|..+. ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999988 6899999999543 3456789999999999999999999999999988 4999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++.. .+++++...-+|+.++++||.|||+ .++||||||||+|||++..|.+||||||.+....+. .
T Consensus 162 gGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 162 GGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999984 4789999999999999999999995 399999999999999999999999999999887655 4
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ........+.+.....+ .. |.+...
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~-pp-----P~lP~~- 305 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDE-PP-----PRLPEG- 305 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcC-CC-----CCCCcc-
Confidence 45677999999999999999999999999999999999999999843 22222333333333321 11 122111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....++.+++..||++||.+||+++|+++.
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 245578999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=380.18 Aligned_cols=260 Identities=37% Similarity=0.543 Sum_probs=214.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcch--hHHHHHHHHHHHHhccCCCcccccccccccc-eEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVY 432 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lV~ 432 (679)
.....+.+.||+|+||+||+|.++....||+|++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3334455679999999999999995445999999865322 2568999999999999999999999999887 799999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ccccCCCCCCccccCCC-cEEEeeccCccccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 510 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~ 510 (679)
||+++|+|.++++.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999864 36789999999999999999999999 77 99999999999999997 99999999998765
Q ss_pred cCcccccccccCCccccCCcccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.... ......||+.|||||++. ...++.|+||||||+++|||+||+.||..... .+.+......+.
T Consensus 196 ~~~~-~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~----- 263 (362)
T KOG0192|consen 196 ISKT-SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL----- 263 (362)
T ss_pred cccc-cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC-----
Confidence 4321 222356999999999999 56999999999999999999999999973322 122222222222
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+...+...+..+..++.+||+.||.+||++.|++..|+.+...
T Consensus 264 ----Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 264 ----RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ----CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 2222333556889999999999999999999999999988774
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=384.41 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=212.8
Q ss_pred HHHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
...+|...+.||+|||+.||.++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.++.|+
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 335677789999999999999998 78999999999763 34566789999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|.|+|..++|..+++ ..+.+++.+++.+++||+.||.|||+ ++|+|||||..|+|++++.++||+|||+|....
T Consensus 96 vLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999998 46889999999999999999999999 999999999999999999999999999999887
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.+.. .....+|||.|+|||++.....+..+||||+||++|.|++|++||+..+..+. -..++..+. .-
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~Y---~~- 237 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNEY---SM- 237 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcCc---cc-
Confidence 5433 34556899999999999999999999999999999999999999983322221 112222211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.....+..+||.++|+++|.+|||+++|+..
T Consensus 238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11223367799999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=370.64 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=208.8
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-------hHHHHHHHHHHHHhccCCCccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
++.....|.+.+.||+|+||.|-+|..+ +|+.||||++.+.... ....+.+|+++|++|+|||||+++++|+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3445666778999999999999999755 7999999999754211 2334679999999999999999999999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC---CcEEE
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 500 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL 500 (679)
..+..|+||||++||.|.+++- ..+.+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999998 46678888889999999999999999 999999999999999765 78999
Q ss_pred eeccCccccccCcccccccccCCccccCCcccCCCCC---CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 577 (679)
+|||+|+..+. .......+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||...... ..+ ..
T Consensus 321 tDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl----~e 392 (475)
T KOG0615|consen 321 TDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSL----KE 392 (475)
T ss_pred cccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccH----HH
Confidence 99999998763 334567789999999999976533 34889999999999999999999833221 112 22
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+..|.+.. .+....+..++..++|.+||..||++|||+.|+++
T Consensus 393 QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 333343321 11223455668899999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=362.16 Aligned_cols=196 Identities=33% Similarity=0.561 Sum_probs=177.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.++||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 456678999999999999987 5899999998765 4556677889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC------CcEEEeeccCcccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 509 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kL~Dfgla~~~ 509 (679)
.||+|.++++ ..+.+++..++.++.|||.||++||+ ++||||||||+|||++.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999 45689999999999999999999999 999999999999999764 56899999999988
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCc
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 562 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~ 562 (679)
... ......+|++-|||||+++.++|+.|+|+||+|+++|++++|+.||+.
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 743 234557899999999999999999999999999999999999999983
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.74 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=224.3
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
-++.+....+.+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|++||+++++|..++..+||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 35667777889999999999999999998889999999864 34457889999999999999999999999998899999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999863 47789999999999999999999999 9999999999999999999999999999997666
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
+.........-+..|.|||.+....++.|||||||||+||||+| |+.||.+.+. .+.+. .+..|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~-~le~G-------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLE-LLERG-------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHH-HHhcc--------
Confidence 65544444456789999999999999999999999999999999 9999863322 12111 22222
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+-..+..++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 421 -yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 -YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22233455677899999999999999999999999999887664
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=350.36 Aligned_cols=264 Identities=28% Similarity=0.366 Sum_probs=216.8
Q ss_pred HHHHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccc-cccccce-E
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-R 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~ 428 (679)
...+.|++.++||+|.||+||++.. .+|..||.|.++-. .....+++..|+.+|++|+|||||++++ .|.++.. .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3456788899999999999999975 48999999988633 3445678999999999999999999999 5555555 8
Q ss_pred EEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCc
Q 005750 429 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
++|||+|.+|+|..+++... .++.+++..+|+++.|++.||.++|+...+ -|.||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999998665 566799999999999999999999974323 3789999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
+......+. ....+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. ++.+ +...+.+++...
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC
Confidence 988765443 33456999999999999999999999999999999999999999854 3333 334455555433
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
+.+ .-....+.+||..|+..||+.||+...+++.+..-.
T Consensus 248 ~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 248 LPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred CcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 322 233457889999999999999999766666665543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=376.84 Aligned_cols=267 Identities=31% Similarity=0.497 Sum_probs=224.6
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE 424 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 424 (679)
.++......+.+.||+|+||.||+|+.. +.+.||||.+++.... ..++|++|++++..++|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4566666778899999999999999754 3567999999987666 77899999999999999999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
++.+++|+|||..|+|.++|+... . ..+++..+.+.|+.|||.||.||-+ +.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence 999999999999999999998543 1 2338899999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCcccccc-CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 005750 494 INMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 571 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~ 571 (679)
++..|||+|||+++.+-. +.........-+++|||||.+..+.+|.+||||||||+|||+++ |+.||.+....+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999987533 33333323345789999999999999999999999999999999 999997443321
Q ss_pred HHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+...+++++.. ..+..++.++..|+..||+.+|.+||+++||-..|+......+
T Consensus 714 ---VIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 714 ---VIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ---HHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 33344555542 2344567789999999999999999999999999998877543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=332.63 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=204.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|+-..++|+|+||.||+++.+ +|+.||||++..... .-.+-.++|+++|++++|||+|.++++|......+||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 455678999999999999987 599999999975432 33466789999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+..-| +-|.. ....++...+.++++|++.|+.|+|+ ++++||||||+||||+.+|.+||||||+|+...... .
T Consensus 84 dhTvL-~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d 156 (396)
T KOG0593|consen 84 DHTVL-HELER--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-D 156 (396)
T ss_pred chHHH-HHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc-c
Confidence 76444 44443 34568899999999999999999999 999999999999999999999999999999876432 2
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHH-HH-------HhHhcCCeee
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW-AR-------SMIKKGDVIS 586 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~-------~~~~~~~~~~ 586 (679)
..+..+.|.+|+|||.+-+ .+|+...||||+||++.||++|.+.|.+.+.-+....+.. +. +......+..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3345568999999999877 6899999999999999999999999986554433222221 11 1111121111
Q ss_pred ------eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 ------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.-++.......+.....+++++.+||+.||.+|++.+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111112233346889999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=343.03 Aligned_cols=242 Identities=28% Similarity=0.373 Sum_probs=202.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
...+++.+.||+|+||.||.++.+ +++.+|+|++++.. ....+....|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 345567899999999999999866 58999999998753 23467788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+||+.||.|..+|+ .++.+++..++-++..|+.||.|||+ +|||||||||+|||+|.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998 57789999999999999999999999 9999999999999999999999999999996544
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... .....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.. ++.....+. +. .
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~-k~------~ 243 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKG-KL------P 243 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcC-cC------C
Confidence 322 334578999999999999999999999999999999999999999744332 222222222 10 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRP 620 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RP 620 (679)
..+.-......+++.++|..||++|.
T Consensus 244 ---~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 ---LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 01111223577999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.81 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=206.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV 431 (679)
..+.|.+.||+|+|++|++|+.+ +++++|||++.+.. ....+.+..|-++|.+| .||.|++|+..|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45678999999999999999866 69999999997642 23345678899999999 799999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+||+++|+|.++|+ +.+.+++...+.++.+|+.||+|||+ +|||||||||+|||+|.+++++|+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999998 45789999999999999999999999 9999999999999999999999999999988654
Q ss_pred Cccc------------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH
Q 005750 512 DLTH------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 512 ~~~~------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
.... ....++||..|.+||++.....++.+|+|+|||+||+|+.|++||.+... ..+. +..+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliF---qkI~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIF---QKIQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHH---HHHH
Confidence 3221 11346799999999999999999999999999999999999999973321 1111 1111
Q ss_pred hcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 580 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. ++- .++...++.+.+|+.+.|..||.+|+|.+||-+.
T Consensus 301 ~-------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 A-------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H-------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 011 1222233578899999999999999999988764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=342.36 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=206.4
Q ss_pred HHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc--eEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lV~E~ 434 (679)
.+...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45567899999999999998774 8999999987654333677899999999999999999999854444 68999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCcccccc--
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla~~~~~-- 511 (679)
+++|+|.+++.... + .+++..+..+.+||++||+|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998642 2 79999999999999999999999 99999999999999999 79999999999987763
Q ss_pred CcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||... . ....+.-........ |
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~----~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F----EEAEALLLIGREDSL-----P 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c----chHHHHHHHhccCCC-----C
Confidence 222233456799999999999853 4446999999999999999999999732 1 111222222222111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+.....+..+++.+|++.+|++||||+++++..--....
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 22233445788999999999999999999999876544443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=346.15 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=210.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-hHHHHHHHHHHHHhcc-CCCcccccccccccc-eEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~~l 430 (679)
...+|...++||.|.||.||+|+.+ +|..||||.+++.... ....=++|++.|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568889999999999999999865 6899999999765332 2334468999999998 999999999998887 9999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|||||+ .+|.++++.. +..+++..++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999994 6999999875 7889999999999999999999999 999999999999999999999999999999876
Q ss_pred cCcccccccccCCccccCCccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 511 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.... .+..+.|..|+|||++ +.+.|+.+.||||+||+++|+.+-++.|.+.+..++. ..+...+......+...
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchh
Confidence 5433 3445679999999986 6678999999999999999999999999765443221 11222222211111111
Q ss_pred ------------ccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 ------------PVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ------------~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
|.. .+..-+....+..+++.+|+++||.+|||++|.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 011122355678999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=348.51 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=205.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccccc-
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE- 425 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~- 425 (679)
....|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456788999999999999999742 35689999987543 23456789999999999 899999999988664
Q ss_pred ceEEEEEEecCCCcHhhhhcccCC--------------------------------------------------------
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 449 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 449 (679)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468899999999999998874311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc-ccccccCCcc
Q 005750 450 ---QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVG 525 (679)
Q Consensus 450 ---~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~ 525 (679)
...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2347888999999999999999999 99999999999999999999999999999865432221 1122345678
Q ss_pred ccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHH
Q 005750 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 604 (679)
Q Consensus 526 y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 604 (679)
|+|||++.+..++.++|||||||++|||++ |..||....... .. ...+..+.... .+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~~~---------~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTRMR---------APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCCCC---------CCCCCCHHH
Confidence 999999998899999999999999999997 999997433221 11 11222222111 011223468
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 605 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 605 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=340.60 Aligned_cols=268 Identities=24% Similarity=0.261 Sum_probs=208.4
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc--ce
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 427 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 427 (679)
......|+-.++||+|.||.||+|+.. +|+.||+|+++-.. .....-..+|+.+|++|+||||+++.+...+. ..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 344556677889999999999999754 79999999987543 34455677999999999999999999988765 68
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.|||+|||+. +|.-++.. .+..+++.++..+++||+.||+|||+ +||+|||||.+|||||.+|.+||+|||+|+
T Consensus 193 iYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEecccccee
Confidence 9999999975 88777763 35689999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
.+........+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|++.|.+.+..++...+-.+.....+ ..+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e-~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE-DYWP 345 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh-hccc
Confidence 8776655545556689999999998775 7999999999999999999999999865543333222211111111 1111
Q ss_pred eecc------cccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDP------VLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~------~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+- .....+. .......++|+..+|..||.+|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110 0001111 112235789999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=348.21 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=204.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC----cc-hhHHHHHHHHHHHHhcc-CCCcccccccccccce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 427 (679)
....|.+.+.||+|+||.|++|.+. +++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3446778899999999999999765 6899999987653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLS 506 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla 506 (679)
.++||||+.||+|.+++.. .+++.+..+..+++|++.|++|||+ +||+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999983 5788999999999999999999999 999999999999999999 99999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCC-CC-chhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ....... +..+.+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKGEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcCCc
Confidence 9874 2223345567999999999999876 74 89999999999999999999998421 1111111 222221
Q ss_pred eeeecccccCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 005750 585 ISIVDPVLIGNVKIES-IWRIAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl 626 (679)
. ++... ..++..++.+||..+|.+|+|+.||+
T Consensus 241 ~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 K----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 11111 34788999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=340.85 Aligned_cols=256 Identities=28% Similarity=0.392 Sum_probs=215.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.. ....+.+.+|+++++.++||||+.++++|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556789999999999999877 68899999997643 34567799999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.| +|..++. ..+.++++.+..++.|++.||.|||+ .+|+|||+||+|||++.++.+|+||||+|+.+... +
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 976 9999998 57789999999999999999999999 99999999999999999999999999999987653 4
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.......|||-|||||+..+++|+..+|+||+||++||+++|++||.. ..+.+.++....+. ..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v~-- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------VK-- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------CC--
Confidence 445556799999999999999999999999999999999999999962 23444444433321 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhhhcC
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEKG 638 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~~ 638 (679)
.+......+.+++...|.+||.+|.|..+++.. .++...+.+.
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~ 263 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAEL 263 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcc
Confidence 122444578899999999999999999999864 4554444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=333.11 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=208.8
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|++.++||.|..++||+|+.. .++.||||++.-. +....+.+.+|+..|+.++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 345778899999999999999865 6899999999643 44557889999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
||.+||+.++++... ...+++..+..|++++++||.|||+ +|.||||||+.||||+.+|.|||+|||.+..+.+..
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998765 4459999999999999999999999 999999999999999999999999999876654332
Q ss_pred cc---ccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 514 TH---ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 514 ~~---~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.. ......|++.|||||++.. ..|+.|+||||||++..||.+|+.||..... ...+.. .+++ ......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~----tLqn-~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLL----TLQN-DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHH----HhcC-CCCCcc
Confidence 21 1144579999999999643 4789999999999999999999999973322 111111 1222 211111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+..+........+.+++..||++||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111222233447899999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.59 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=209.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
|.-.++||+|+.|.||.|... +++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+++||||++|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 333578999999999999654 7899999999877666778899999999999999999999999988999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.|.+. ...+++.++..|++++++||+|||. +||+|||||.+|||++.+|.+||+|||++..+...... .
T Consensus 355 gsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R 426 (550)
T KOG0578|consen 355 GSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-R 426 (550)
T ss_pred Cchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-c
Confidence 99999987 4559999999999999999999999 99999999999999999999999999999988766553 4
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....||+.|||||+.....|++|.||||||++++||+-|.+||-.+..- +.+ ..+......++-. +
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAl-yLIa~ng~P~lk~-------~ 492 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RAL-YLIATNGTPKLKN-------P 492 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHH-HHHhhcCCCCcCC-------c
Confidence 4556999999999999999999999999999999999999999742221 111 1222222222211 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......+.+++.+||+.|+++||+++|+|+.
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233478899999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=370.19 Aligned_cols=269 Identities=31% Similarity=0.496 Sum_probs=222.6
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEcC--Cc----EEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
++++......+.+.||+|+||.||.|...+ |. .||+|.+++.. .....+|.+|..+|+.++|||||+++|++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 666777888889999999999999998763 43 48999988754 456788999999999999999999999999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
+....++++|||++|+|..+|++.+ ....++..+.+.++.|||+|+.||++ +++|||||.++|+|++....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence 9999999999999999999999764 35578999999999999999999999 9999999999999999999999
Q ss_pred EeeccCccccc-cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 005750 500 VSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 500 L~Dfgla~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 577 (679)
|+|||+|+.+. .+.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+.. .+ ...
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v---~~~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EV---LLD 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HH---HHH
Confidence 99999999543 333332333234579999999999999999999999999999999 99999633221 11 111
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
....+++ +.+..++.++.+++..||+.+|++||++..|++.+..+...-..
T Consensus 917 ~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 917 VLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 2223321 33456677899999999999999999999999999888875433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=309.13 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=205.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+|.-.++||+|.||.||+|++. +|+.||||+++-.. ..-.....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4566789999999999999865 79999999987542 22345678999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++ .+|...++. +...++...+..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 599999986 36789999999999999999999999 9999999999999999999999999999999876544
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---eeeeec-
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVD- 589 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d- 589 (679)
.... .+.|..|+|||.+.| ..|+...||||.||++.||+-|.+-|.+...-++...+-.+..-..... ...+.|
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3332 257899999998866 5799999999999999999999988875443332221111110000100 001111
Q ss_pred -------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 -------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 -------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......-.......++++.+|+..||.+|+|++|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 001111223444567999999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.90 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=207.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++++.||.|+.|.|-+|++. +|+.+|||++.+.. ......+.+|+-+|+.+.||||+++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456789999999999999875 79999999997652 23346688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|-|++++. ..+++++.+..++++||+.|+.|||. .+|+||||||+|+|+|..+++||+|||+|....++.
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 99999999998 47889999999999999999999999 999999999999999999999999999998754432
Q ss_pred cccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.-...+|.+.|.|||++.+.+| +.++||||+|||||.|+||+.||+++ ....+.. .++.|.+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLl----KV~~G~f--------- 229 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLL----KVQRGVF--------- 229 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHH----HHHcCcc---------
Confidence 2345679999999999999887 67999999999999999999999721 1122222 2222322
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.+.....+..+|+.+|+..||++|.|++||++.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122334478899999999999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=359.63 Aligned_cols=265 Identities=26% Similarity=0.474 Sum_probs=221.2
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 426 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 426 (679)
.||......+.++||.|.||.||+|+++- ...||||.++... .....+|+.|..||.+++||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 34555555567889999999999999872 4579999998754 445678999999999999999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
...+|.|||++|+|..+|+.. .+.+++.++..+++.||.|++||-+ .++|||||.++|||++.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999975 4669999999999999999999998 99999999999999999999999999999
Q ss_pred cccccCcccccccccC--CccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 507 RQAEEDLTHISSVARG--TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+..+++.........| +.+|.|||.+....++.++||||||+++||.++ |..||...... +.+. .+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIk----aI---- 847 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIK----AI---- 847 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHH----HH----
Confidence 9886655333322222 468999999999999999999999999999876 99999722211 1111 11
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+...+-..+++++..|.+|++.||++|-.+||.+.||+..|.+++....
T Consensus 848 -----e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 848 -----EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -----HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1222334466778899999999999999999999999999999987533
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=329.84 Aligned_cols=258 Identities=22% Similarity=0.399 Sum_probs=206.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
+....+++.+.||+|+||.||+|.++ .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34566788899999999999999764 367899999876533 3446789999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998743 3578999999999999999999998 9999999999999999999999999998765
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ....+. +..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~----~~~~~~~-- 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKA----VEDGFRL-- 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH----HHCCCCC--
Confidence 43222111112234678999999999999999999999999999775 9999973322 112221 1111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
..+...+..+.+++.+||+.+|.+||+++||++.|.++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11222345788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.72 Aligned_cols=235 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.+++.+.||.|+||+|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||.++++++.|.+.+..+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4567789999999999999987 588999999986533 334567889999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++||.|..+++ +.+++++..++.++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||.|+.....
T Consensus 125 yv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999998 46789999999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
....+|||.|+|||++....+..++|.|||||++|||+.|.+||..... ..+.+ .+-+++.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~----KI~~~~v--------- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYE----KILEGKV--------- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHH----HHHhCcc---------
Confidence 4567899999999999999999999999999999999999999973322 11111 1111211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCC
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSR 619 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~R 619 (679)
.++......+.+|+.+.|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122223367899999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.64 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=213.7
Q ss_pred ccccCChhHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc
Q 005750 345 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 424 (679)
Q Consensus 345 ~~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 424 (679)
..|.+|+++|.+.. -||.|+-|.||+|+++ ++.||||+++... ..+++-|++|+||||+.+.|+|..
T Consensus 117 e~WeiPFe~IsELe-----WlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 117 ELWEIPFEEISELE-----WLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhccCCHHHhhhhh-----hhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 35667888877654 4999999999999998 7899999876322 246888999999999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
...+|+|||||..|.|...|+ .+..++......|..+||.|+.|||. +.|||||||.-||||+.+..|||+|||
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred CceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999998 46788899999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
-++...+..+. -.++||..|||||++++.+.++|.|||||||+||||+||..||..-+... -+
T Consensus 258 TS~e~~~~STk--MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------II 320 (904)
T KOG4721|consen 258 TSKELSDKSTK--MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------II 320 (904)
T ss_pred chHhhhhhhhh--hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eE
Confidence 99876654222 23569999999999999999999999999999999999999997333210 01
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
+-+=...+.-.++..+++.+.-|+++||+-.|..||++.+|+..|+-...
T Consensus 321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 11111223334566778889999999999999999999999999875443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=354.73 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=214.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCC-cEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCccccccccc-c------cc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCE-E------EH 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~-~------~~ 426 (679)
....++.+.|.+|||+.||+|....+ ..||+|++--......+.+.+|+++|++|+ |+|||.+++... . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34456678999999999999998765 999999987777788899999999999996 999999999421 1 23
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..+|.||||.||.|-|++.... ...+++.++++|+.|+++|+++||. +..+|||||||.+||||+.++++||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5789999999999999998664 3449999999999999999999997 4567999999999999999999999999998
Q ss_pred cccccCccccc--------ccccCCccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHH
Q 005750 507 RQAEEDLTHIS--------SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 575 (679)
Q Consensus 507 ~~~~~~~~~~~--------~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 575 (679)
...-....... -...-|+.|+|||.+ .+..+++|+|||||||+||-|+....||+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------ 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------ 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC------------
Confidence 76433221100 112368999999976 6779999999999999999999999999722
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
....+++....-...+.....+.+||+.||+++|.+||++.||+..+.++...+..
T Consensus 262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 12233333332222346677899999999999999999999999999998886554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.48 Aligned_cols=271 Identities=27% Similarity=0.445 Sum_probs=225.2
Q ss_pred ChhHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 350 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 350 ~~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
.+.|+......|.++||+|-||.|.+.....+..||||+++.... ....+|.+|+++|.+++||||++++|+|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 466788888889999999999999999999889999999987644 4458999999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++|+||+++|+|.+++..+. ...+.-....+|+.||+.||+||.+ .++|||||.++|+|++.++++||+|||+++.
T Consensus 611 cmI~EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999998653 2224556677899999999999999 9999999999999999999999999999985
Q ss_pred c-ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 509 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 509 ~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
. ..+..+......-+.+|||||.+..++++.++|||+||+++||+++ ...||... ...+.++......+.+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcc
Confidence 4 3344444455556789999999999999999999999999999876 77888622 2234455455555444333
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.++. .+.-++..+.+++.+||+.+-.+||+++++...|++..
T Consensus 764 ~~l~------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VVLS------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eecc------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3222 23456678999999999999999999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.28 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=204.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC-----------------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 417 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 417 (679)
...|.+.++||+|+||.||++.+++ +..||+|++.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567788999999999999997542 3479999987643 334567999999999999999999
Q ss_pred ccccccccceEEEEEEecCCCcHhhhhcccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcc
Q 005750 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481 (679)
Q Consensus 418 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 481 (679)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 12347888999999999999999999 9999
Q ss_pred ccCCCCCCccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCC
Q 005750 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 558 (679)
Q Consensus 482 H~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt--G~~ 558 (679)
||||||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976533221 12223345788999999988889999999999999999987 566
Q ss_pred CCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 559 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 559 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
||..... ......+............. ..+...+..+.+++.+||+.+|.+|||++||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7753221 22223232222221111000 0112234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.52 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=199.8
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchh---HHHHHHHHHHHHhccCCCcccccccccc----cceEEEEEEec
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 435 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV~E~~ 435 (679)
..||+|++|.||+|.+ +|+.||||.++...... .+.+.+|+++|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48999999987643322 4678899999999999999999999866 34689999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++|+|.+++.. ...+++.....++.|++.||.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999974 4578999999999999999999997 2488999999999999999999999999987654321
Q ss_pred ccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 516 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.+ .....+.. +
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~-----~--- 241 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNS-----L--- 241 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCC-----C---
Confidence 12347889999999976 68899999999999999999999999733221 1111 11111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+...+..+.+++.+||+.||++|||++|+++.|+....
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111234578899999999999999999999999987653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=322.45 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=212.2
Q ss_pred HHHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcch---hHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
.+.+|+|.+.||+|.||.|-+|.. ..|+.||||.+++.... +.-.+.+|++||..|+||||+.++.+|++.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 467899999999999999999975 68999999999875433 34467899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||..+|.|.|++. ....+++.+.+.+++||..|+.|||. ++++|||||.+|||+|.++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998 46789999999999999999999999 999999999999999999999999999998876
Q ss_pred cCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
+.. .-..++|++-|.+||++.+.+| ++..|-|||||+||.|+.|..||++.+.. .+ + ..+..|.+.+.
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---v-rQIs~GaYrEP-- 273 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---V-RQISRGAYREP-- 273 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH---H-HHhhcccccCC--
Confidence 543 3456789999999999999887 68999999999999999999999865542 11 2 23334433222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.+....-||++||..+|++|.|+.+|...
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 122245689999999999999999999754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.38 Aligned_cols=259 Identities=28% Similarity=0.502 Sum_probs=206.9
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....+.+.||+|.||+||+|.|. -.||||++.-. .....+.|++|+.++++-+|.||+-+.|+|..+.. .+|+.+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 33446789999999999999997 35999998754 34567889999999999999999999999998887 999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC-c
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~-~ 513 (679)
|+|.+|+.+++-. ...++..+.+.|++||++|+.|||. ++|||||||..|||+.+++.|||+|||++..-..- .
T Consensus 469 CeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999999864 4678999999999999999999999 99999999999999999999999999998753221 1
Q ss_pred ccccccccCCccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 514 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
........|...|||||+++.+ +|++++|||||||++|||++|..||.....+. +.-.+..|.. ..|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG~l--~pd~ 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRGYL--MPDL 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccccc--Cccc
Confidence 1111223367889999998643 78999999999999999999999997222110 0000111100 0010
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
......+++++.+|+..||..++++||.+.+|+..|+++...
T Consensus 615 ---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 ---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 112335667899999999999999999999999999988874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.34 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=201.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.++..+.||+|+||.||+|+-+ +|+.+|+|++++.. ....+.++.|-.+|....+|+||+++..|++.+.+|||||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 3455789999999999999766 69999999998754 3445678889999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc--
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-- 511 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~-- 511 (679)
|++||++..+|. ....+++..+..++.+++-|+..+|+ .|+|||||||+|+|||..|++||+|||++.....
T Consensus 222 ylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 222 YLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred ecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999998 57889999999999999999999999 9999999999999999999999999999853211
Q ss_pred ---------------------Cccc----c-------------------cccccCCccccCCcccCCCCCCchhHHHHHH
Q 005750 512 ---------------------DLTH----I-------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFG 547 (679)
Q Consensus 512 ---------------------~~~~----~-------------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlG 547 (679)
.... . ....+|||.|+|||++.+..|+..+|.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0 0113599999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcccccc-hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005750 548 VVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 621 (679)
Q Consensus 548 vll~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 621 (679)
||+|||+.|.+||...+... ...++.|........ ......+..+||.+|+. ||++|.-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999998655543 345556544322211 11112477899999999 9999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.61 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=207.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
...+.+.+.||+|++|.||+|..+ .++.||+|++... ......+.+|++++++++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345667889999999999999876 5889999998754 33456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998753 24568999999999999999999998 9999999999999999999999999999987654332
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. ...+. +..+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~~--------- 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKGYR--------- 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCC---------
Confidence 22222234568999999998899999999999999999998 99998743321 11111 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
...+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.87 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=208.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....+++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345677889999999999999998888999999986532 3457889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998754 34568899999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+ ..+... +
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~--- 224 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGYRM----P--- 224 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----C---
Confidence 22222335678999999988889999999999999999998 99999632211 122211 111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.19 Aligned_cols=266 Identities=31% Similarity=0.478 Sum_probs=214.0
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC--C--cE-EEEEEecC---CcchhHHHHHHHHHHHHhccCCCcccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 424 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 424 (679)
++......+.++||+|+||.||+|+++. + .. ||+|..+. .......++.+|.++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444555567899999999999998763 2 23 89999885 235667889999999999999999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+..+++|||+|+||+|.++|+.. ...++..++..++.+.|.||+|||+ ++++||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999963 3369999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+++.-.. .........-+..|+|||.+....+++++|||||||++||+++ |..||.+.... .... ....++.
T Consensus 308 Ls~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~---kI~~~~~ 380 (474)
T KOG0194|consen 308 LSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA---KIVKNGY 380 (474)
T ss_pred cccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH---HHHhcCc
Confidence 9876431 1111111134679999999999999999999999999999999 88899743221 1111 1112222
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 639 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 639 (679)
.. ..+...+..+..++.+||..+|++||+|.++.+.|+.+....+..
T Consensus 381 r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 381 RM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred cC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 11 122244557888899999999999999999999999988865543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.73 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=208.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+....+++.+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4456678889999999999999998888899999987543 335678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997542 4568999999999999999999999 999999999999999999999999999998765332
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.........+..|+|||++.+..++.++||||||+++|+|++ |+.||..... ...... +......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQ----VDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCC-------
Confidence 211111223457999999998899999999999999999999 9999963321 111111 1111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.........+.+++.+|++.+|.+||+++++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111234578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.04 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=205.2
Q ss_pred HHHHHhhccccCcCccEEEEEEEE------cCCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
....+++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345678899999999999999964 236689999987543 33456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC----------------------------------------------------------
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 448 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 448 (679)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886421
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 449 --------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 449 --------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 01257888999999999999999999 9999999999999999999999999999986543322
Q ss_pred c-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 515 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 515 ~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....+. +..+....
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~----~~~~~~~~------ 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKM----IKEGYRML------ 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHH----HHhCccCC------
Confidence 1 1122334668999999999999999999999999999998 8899863222 1122222 22211100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.+...+.++.+++.+||+.||++||+++||++.|++.
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.78 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=203.2
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..+++.+.||+|+||.||+|.++++..+|+|.+... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 456678899999999999999988889999988643 2334678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2468899999999999999999999 999999999999999999999999999987654332222
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+. ....+.+. .+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~----~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS----RGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCC--CCCCC----
Confidence 222235668999999988889999999999999999999 8999973322 12222211 1111 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
.....+.+++.+||+.+|.+||+++|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1224688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=303.37 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=210.9
Q ss_pred HHHHHHhhccccCcCccEEEEEEE-EcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccccc-----ce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 427 (679)
+-..+|++.+.||+|||+-||+++ ..+++.+|+|++.-....+.+..++|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678899999999999999997 457899999998766667788899999999999999999999987443 35
Q ss_pred EEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCccccCCCcEEEeecc
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
.|++++|...|+|.+.+.... ++..+++.+++.|+.++++||++||+ .. ++||||||.|||+.+++.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEecc
Confidence 899999999999999998765 55689999999999999999999998 55 9999999999999999999999999
Q ss_pred CccccccCccc--------ccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHH
Q 005750 505 LSRQAEEDLTH--------ISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 573 (679)
Q Consensus 505 la~~~~~~~~~--------~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~ 573 (679)
.+....-.... .......|..|+|||.+. +...++++|||||||+||.|+.|..||+..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------- 244 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------- 244 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------
Confidence 98764321111 111224789999999984 456789999999999999999999999711
Q ss_pred HHHHhHhcCCeee--eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 574 WARSMIKKGDVIS--IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 574 ~~~~~~~~~~~~~--~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
...|.... +..+.+.-.......+.+.+++..|++.||.+||++.+++..++++.
T Consensus 245 -----~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 -----YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222211 22222221222235668999999999999999999999999988764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.45 Aligned_cols=263 Identities=19% Similarity=0.205 Sum_probs=200.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 567889999999999999987 58899999987542 233467889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+++.+..+.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 24568999999999999999999999 99999999999999999999999999999876443322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHH---------HHhHhcCCeee
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA---------RSMIKKGDVIS 586 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 586 (679)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+........ ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 223345889999999999888999999999999999999999999743322111111100 00000000000
Q ss_pred eecccccC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010000 001112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=321.94 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=211.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...|.+.++||.|+||.||+|...+++.+++|++.........++.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999999889999999998766556678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 24568999999999999999999999 99999999999999999999999999999876443222
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....+... .+.. .
T Consensus 161 ~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~---------~ 223 (261)
T cd05148 161 SS-DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----AGYR---------M 223 (261)
T ss_pred cc-CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----hCCc---------C
Confidence 11 2335678999999988889999999999999999998 8999963321 11222111 1100 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
..+...+..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11123345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.45 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=196.7
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 99999873 5678999999999999999999999 9999999999999999999999999999875322211 122
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+. +..+.. ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~----~~~~~~----------~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEEI----------RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH----HHcCCC----------CCCC
Confidence 345899999999999999999999999999999999999999733221 11111 111111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.....+.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234688999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.25 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=207.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|+-.+.||+|.||.||+|... .++.||+|++.-. .....+++.+|+.+|.+++++||.++|+.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3444588999999999999865 6899999999754 3445678899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
.||++.+.++ .+..+++..+..++++++.||.|||. .+.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999998 34555888888999999999999999 99999999999999999999999999999887665444
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+...... +..-++-....+.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~ 230 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPR 230 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCc
Confidence 3 5677999999999999889999999999999999999999999733321 1112222222222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........+.+++..||.++|+.||+|+++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22344456899999999999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.71 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=199.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 567789999999999999876 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999873 4578999999999999999999999 999999999999999999999999999988654321
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+ ... .+..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~---~i~-~~~~---------- 215 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYE---KIL-AGKL---------- 215 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-hCCc----------
Confidence 2345899999999999988999999999999999999999999743221 1111 111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 628 (679)
..+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112346789999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.57 Aligned_cols=252 Identities=29% Similarity=0.398 Sum_probs=198.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--------------hhHHHHHHHHHHHHhccCCCcccccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------HRTQQFVTEVALLSRIHHRNLVPLIG 420 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~l~~ 420 (679)
-..|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+.+.+|+.+|++++|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 356777899999999999999876 799999999964311 12357899999999999999999999
Q ss_pred cccc--cceEEEEEEecCCCcHhhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc
Q 005750 421 YCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 497 (679)
Q Consensus 421 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 497 (679)
+..+ .+..|||+|||..|.+...=. .+. +++.++++++++++.||+|||. +||+||||||+|+|++++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 9876 568999999999998765432 344 9999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCccccccCc----ccccccccCCccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCcccccchh
Q 005750 498 AKVSDFGLSRQAEEDL----THISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 569 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~ 569 (679)
+||+|||.+....... ...-....|||.|+|||.+.++ ..+.+.||||+||+||.|+.|+.||.+. .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~---- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-F---- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-h----
Confidence 9999999998652211 1112235699999999998763 3467999999999999999999999722 1
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
..+.... +.+. .+.....++....+.+||.+||++||++|.+..+|....
T Consensus 324 -~~~l~~K-Ivn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -ELELFDK-IVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHHHHHH-HhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1221111 2221 121112224456789999999999999999999986543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=328.36 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=199.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 456789999999999999875 79999999986432 22334678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998887643 23468999999999999999999999 9999999999999999999999999999976543221
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... +.+...+.... .
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~ 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------E 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc----------c
Confidence 12345899999999999999999999999999999999999999743322111 11111111111 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.+.......+.+++.+||+.||.+||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346889999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=332.63 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=203.8
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|++.+.||+|+||.||+++.+ ++..||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 445677889999999999999877 68899999987543 2345679999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999873 4568999999999999999999997 2469999999999999999999999999987654322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---ee-----
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI----- 585 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~----- 585 (679)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+... +..........+. ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 223458999999999999899999999999999999999999997433211 1111110000000 00
Q ss_pred ----------------------eeec----ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 586 ----------------------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 586 ----------------------~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+..+ .............++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000011234578999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.39 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=206.0
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
+....+++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44567788999999999999999743 24579999997543 33456788999999999 899999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC---------------------------------------------------------
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 448 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 448 (679)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885421
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc-cc
Q 005750 449 ----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-IS 517 (679)
Q Consensus 449 ----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~ 517 (679)
...++++..+++++.||+.||.|||+ ++|+||||||+||++++++.+||+|||++......... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 11347888999999999999999999 99999999999999999999999999999765433211 11
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .... ....+.. +..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~~-----~~~---- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGYQ-----MSR---- 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcccC-----ccC----
Confidence 22235668999999988899999999999999999997 999997322211 1111 1111110 000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
+...+..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112347889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.51 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=207.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
...+|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 35668888999999999999998643 478999998765444 45789999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence 999999999999999997532 23457899999999999999999998 9999999999999999999
Q ss_pred cEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 005750 497 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 574 (679)
.++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.. ...+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH
Confidence 999999999876432211 11223335778999999999999999999999999999998 99998633221 12221
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
. ..+.... .+......+.+++.+||+.+|++||+++||++.|++
T Consensus 237 ~----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 I----TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 1222111 111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=336.35 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=202.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++..++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 566789999999999999887 58999999987532 22345688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999997 34578999999999999999999999 9999999999999999999999999999976543
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...+... .. .+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~---~~---~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENLKYW---KE---TLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHHHhc---cc---cccCCCCC
Confidence 22334589999999999998999999999999999999999999974332211 1111110 00 00000000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.........+.+++.+||+.+|.+||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234468899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.42 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=197.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|.+.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3667899999999999999876 68999999986432 223456789999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+ |+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 86 D-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred C-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 7 4898888642 3457889999999999999999999 99999999999999999999999999998764332211
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc------------C
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------G 582 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------------~ 582 (679)
.....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+... ........ .
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccch
Confidence 223357899999998865 568999999999999999999999997543322111 11111100 0
Q ss_pred CeeeeecccccCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DVISIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+...... ......+..+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111100000 0112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.52 Aligned_cols=244 Identities=24% Similarity=0.373 Sum_probs=204.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 428 (679)
+....++|.++||+|.||.|+++..+ +++.+|||++++.. .++.+..+.|.+|+... +||.+++++..|++.++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44455677899999999999999987 58899999998864 34567788899998888 599999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
|+||||+.||++..+.+ ...+++..+.-++..++.||+|||+ +||||||||.+|||+|.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999655543 5679999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.-.. .......+||+.|+|||++.+..|+.+.|.|||||+||||+.|..||.+++.++..+ ..+..
T Consensus 518 ~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~~d------- 583 (694)
T KOG0694|consen 518 GMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIVND------- 583 (694)
T ss_pred cCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHhcC-------
Confidence 4322 224567889999999999999999999999999999999999999998655432211 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
| ..++.-...+.+.+++++|..+|++|.-+
T Consensus 584 ~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0 12344445678899999999999999976
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=356.80 Aligned_cols=294 Identities=25% Similarity=0.428 Sum_probs=225.3
Q ss_pred CcceeecCCceEEEEEec-ccCcccceeeeehhhhcc-cCCCcceeeecccCcccCC-CCceEEEeecCCcccccccCcc
Q 005750 1 MQTAVVGTEGVLSYRLNL-EDFPANARAFAYFAEIQD-LGPSETRKFKLEQPYFADY-SNAVVNIAENANGSYTLYEPSY 77 (679)
Q Consensus 1 ~~~a~~~~~~~~~~~~~~-~~~~~~~~~~~~f~e~~~-~~~~~~r~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~p~~ 77 (679)
||||+++.++..+++|.+ .+...+|+++|||||++. ....++|+||| |.++. ....+||.......+.++...|
T Consensus 255 yqTA~~~~~~~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V---~ing~~~~~~~di~~~~g~~~~~~~~~~ 331 (623)
T PLN03150 255 YQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDV---LINGDTAFKDVDIVKMSGERYTALVLNK 331 (623)
T ss_pred hhhhccccCCCCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEE---EECCEEeecccChhhhcCCcccceEEEe
Confidence 689988777655566666 577889999999999985 45779999997 66652 1233455432222222222222
Q ss_pred cccccceEEEEEEeecCCCccccceeeeeeeeeeeccCCCchhHHHHHHHHHhhcCCCCCCCCCCCCCCCC--CCceEEE
Q 005750 78 MNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVTC 155 (679)
Q Consensus 78 ~~~~~~~~~~~~l~~~~~s~l~p~~na~e~~~~~~~~~~t~~~~~~~l~~l~~~~~~~~~~~w~~~~c~~~--~w~~~~c 155 (679)
......+.+++++.++..+ +|+|||+|||++.+....|.++|+.+|..+|.........+|.+|||+|. +|.|+.|
T Consensus 332 ~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv~C 409 (623)
T PLN03150 332 TVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADC 409 (623)
T ss_pred EEeecCCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCccccccccee
Confidence 2122237899999998765 79999999999999988999999999999998775443458999999875 7999999
Q ss_pred eCCC---CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCC
Q 005750 156 STTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSL 231 (679)
Q Consensus 156 ~~~~---~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 231 (679)
+... ...++.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|+.+++|
T Consensus 410 ~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L 489 (623)
T PLN03150 410 QFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489 (623)
T ss_pred eccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcC
Confidence 6432 1359999999999999999999999999999999999999999 59999999999999999999999999999
Q ss_pred CccceecccccCCCCCCCccccC---CceeeeecCCCCccccc----ccc-cceeeeeechhhhhHHHHHHHhHhh
Q 005750 232 PNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES----RRR-MRFKLILGTSIGVLAILLVLFLCSL 299 (679)
Q Consensus 232 ~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~----~~~-~~~~ii~~~~i~~~~~l~v~~~~~~ 299 (679)
++|+.|+|++|+|+|.+|..+.. ....+.+.+|+.+|+.+ |.. ....+++++++++++++++++++.+
T Consensus 490 ~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~ 565 (623)
T PLN03150 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAM 565 (623)
T ss_pred CCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHHHHHHHHHHHh
Confidence 99999999999999999998764 23467899999999642 322 2333444445444443333333333
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.21 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=195.4
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 234456778999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|..++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99988873 4578999999999999999999999 9999999999999999999999999999875322211 122
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..+ .... ... . .+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~-~~~------~----~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EEI------R----FPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CCC------C----CCC
Confidence 3458999999999999899999999999999999999999997332211 111 1111 110 0 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234678999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.24 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=202.3
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..+++.+.||+|+||.||+|.++++..+|+|++.+.. .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3466889999999999999998878899999986432 234568889999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998743 3468999999999999999999999 999999999999999999999999999987654332221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||.+.+..++.++||||||+++|++++ |+.||...+.. ..... +..+.. . .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VSAGYR-----L----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HHcCCc-----C----C
Confidence 222223457999999998899999999999999999999 89999733221 11111 111100 0 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
.+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112344789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.39 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=200.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45678899999999999999886 58999999986532 223466889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999873 4578899999999999999999999 99999999999999999999999999999866433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+ .+..+...
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~----~i~~~~~~------- 233 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYE----KILAGRLK------- 233 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHH----HHhcCCcC-------
Confidence 2 234589999999999999999999999999999999999999973321 11111 11122110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 628 (679)
.+......+.+++.+||+.||.+||+ +++++..
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112236789999999999999997 6777643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.82 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=176.0
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+....|++.++||+|+||.||++.++ +++.+|+|++.... ......+.+|++++++++||||++++++|.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34567888999999999999999887 68889999887543 33456789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999973 4568899999999999999999997 24799999999999999999999999999876533
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12345889999999999988999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.32 Aligned_cols=249 Identities=39% Similarity=0.610 Sum_probs=195.1
Q ss_pred hccccCcCccEEEEEEEEc-----CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 361 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.+.||.|.||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999887 36789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC-c
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~-~ 513 (679)
+++|+|.+++... ....+++..+..|+.||++||.|||+ ++++|+||+++||++++++.+||+|||++...... .
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 35679999999999999999999999 89999999999999999999999999999876322 1
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
............|+|||.+.+..++.++||||||+++||+++ |+.||...+ ...+.+.+ .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~----~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKL----KQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHH----HTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----cccccce------
Confidence 122233346778999999988889999999999999999999 788886321 12222221 2222111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
.+...+..+.+++.+||+.+|++|||++++++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=331.12 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=193.7
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5889999998643 223446678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999873 4568999999999999999999999 9999999999999999999999999999876432221 22334
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....... +.. ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC----------CCCCcC
Confidence 589999999999999999999999999999999999999973322 111222221 110 111122
Q ss_pred HHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 627 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt---~~evl~ 627 (679)
...+.+++.+||+.||.+||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.75 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=196.8
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||++..+ +++.||+|++.+.. ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 68999999997542 234467888999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99988873 4578999999999999999999999 9999999999999999999999999999875332211 122
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .. ..... .+.. . .+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~---~~~~~-~~~~------~----~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL---FELIL-MEDI------K----FPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HH---HHHhc-cCCc------c----CCC
Confidence 345899999999999889999999999999999999999999743221 11 11111 1110 1 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
.....+.+++.+||+.||.+|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234688999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.89 Aligned_cols=256 Identities=29% Similarity=0.517 Sum_probs=205.7
Q ss_pred HHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
..+++.+.||+|+||.||+|.... ...|++|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356778999999999999998653 2579999987543 334567899999999999999999999999988999
Q ss_pred EEEEecCCCcHhhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 430 LVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999875321 1568899999999999999999999 9999999999999999999
Q ss_pred cEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 005750 497 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 574 (679)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.... .+.+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999876433221 11223346788999999988899999999999999999998 99999743321 22221
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
+..+... ..+...+..+.+++.+||+.+|.+||+++||++.|+.
T Consensus 239 ----i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2222211 1122334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.85 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=204.7
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....+++.++||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3456788999999999999999988888999999875433 34678999999999999999999998854 457899999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 24468999999999999999999999 9999999999999999999999999999976544322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. ....+. +..+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~--------- 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ----VERGYR--------- 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCC---------
Confidence 22222235668999999988889999999999999999999 8999963221 111221 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
...+......+.+++.+|++++|.+|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.43 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=205.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...|++.++||+|+||.||+|.++++..||+|++..... ..+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456888999999999999999988777899999875332 34678999999999999999999998754 5579999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999753 24467899999999999999999999 99999999999999999999999999999766443322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||+..+..++.++|||||||++|+|++ |+.||...... ...+ .+..+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~----~~~~~~~---------~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYR---------M 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH----HHhcCCC---------C
Confidence 2223345678999999988889999999999999999999 88888632211 1111 1111110 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
......+..+.+++.+|++.+|++||+++++++.|++..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 112234457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.24 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=207.7
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
++...++++.++||+|+||.||+|..++++.||+|.+.... ....++.+|++++++++|+||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34567888999999999999999999889999999987543 33467899999999999999999999875 45689999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++... .+..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998753 34578999999999999999999998 99999999999999999999999999999776532
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.........++..|+|||++.+..++.++||||||+++|++++ |+.||...+.. ...+.. ..+...
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~------ 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNL----ERGYRM------ 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH----HcCCCC------
Confidence 2222222335678999999998889999999999999999999 99999733221 122211 111100
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
......+..+.+++.+|++.+|++||++++++..|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111223468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.42 Aligned_cols=252 Identities=30% Similarity=0.478 Sum_probs=203.1
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..+.+.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4567789999999999999998877789999887543 334678999999999999999999999998888999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998743 3368999999999999999999999 999999999999999999999999999987654332222
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||..... ......+ ..+....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~--------- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKV----SQGLRLY--------- 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----hcCCCCC---------
Confidence 222235678999999988889999999999999999998 9999863221 1111111 1111100
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112357889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=298.59 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=206.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.+++.+.||+|-||.||.|+.+ ++-.||+|++.+.. ..-.+++.+|+++-..|+||||++++++|.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 4567899999999999999876 67889999997643 2334789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|..+|.+...|.+. ....+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+.+||+|||.+....
T Consensus 103 ya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 103 YAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred ecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999865 35678899999999999999999999 999999999999999999999999999887643
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......+||..|.+||...+...+...|+|++|++.||++.|.+||...... ....+ +.. .++.+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkr-----I~k---~~~~~p--- 242 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKR-----IRK---VDLKFP--- 242 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHH-----HHH---ccccCC---
Confidence 22345667999999999999999999999999999999999999999743321 11111 111 111122
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........++|.+|+..+|.+|.+..|+++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2223467899999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.55 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=194.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..+++.++||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999876 689999999865432 3456789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+. ....+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998653 234677788999999999999999 9999999999999999999999999999987543322
Q ss_pred cccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 515 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
. .....|+..|+|||++.. ...+.++|||||||++|||++|+.||............. .... ...
T Consensus 224 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~~----- 293 (353)
T PLN00034 224 P-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM-SQP----- 293 (353)
T ss_pred c-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc-cCC-----
Confidence 1 223458999999998743 334569999999999999999999997322222111111 1110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..........+.+++.+||+.||++|||++|+++.
T Consensus 294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233468899999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.21 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=205.9
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
...+.+.+.||+|+||.||+|.++. ...||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3456778999999999999998752 4589999987543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998753 3478999999999999999999999 999999999999999999999999999998765
Q ss_pred cCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC---
Confidence 2211 11112234678999999998899999999999999999998 9999863221 1122211 111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
+ .+...+..+.+++.+|++.+|++||+++||++.|+++
T Consensus 228 -~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.00 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=212.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccce-EEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lV~ 432 (679)
..|...+.+|+|+||.+++++++ +++.+++|.+.-. .....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35677899999999999999877 6789999988543 23344578899999999999999999999999888 99999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
+||+||++.+.+.... +..++++.+..|+.|++.|+.|||+ ++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998764 6789999999999999999999998 99999999999999999999999999999998766
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.. ......||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+... ++. ...+ +. ++
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---ki~~-~~----~~--- 224 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---KINR-GL----YS--- 224 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH---HHhh-cc----CC---
Confidence 42 3445679999999999999999999999999999999999999998554421 111 1111 11 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+.....++..++..||+.+|..||++.+++..
T Consensus 225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2233444578899999999999999999999976
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.22 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=198.0
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999876 68999999876543 34456789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc-cc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SV 519 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~-~~ 519 (679)
.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 4468999999999999999999998 9999999999999999999999999999876443211111 11
Q ss_pred ccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 520 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...+..|+|||.+.+..++.++|||||||++|+|++ |..||...... .... .+..... ...+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~----~~~~~~~---------~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE----AIEQGVR---------LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH----HHHcCCC---------CCCcc
Confidence 123457999999998889999999999999999998 88888632211 1111 1111100 01112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
..+..+.+++.+||+.+|++|||+.||+++|+.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 224578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.42 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=210.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
++..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4556677899999999999999752 3567999998766556667899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcE
Q 005750 429 ILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 498 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 498 (679)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999999987431 12358999999999999999999998 999999999999999999999
Q ss_pred EEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 005750 499 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 576 (679)
Q Consensus 499 kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 576 (679)
+|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ...+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence 9999999876533221 11222335678999999998899999999999999999998 99998633221 1111
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+..+..... .. .....+.+++.+||+.+|.+|||++||++.|+++...
T Consensus 234 -~i~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1222221111 11 1234689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.57 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=202.0
Q ss_pred hhccccCcCccEEEEEEEE-----cCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccc--cceEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV 431 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV 431 (679)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.. ....+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 3578999999875432 345678899999999999999999998755 3467899
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 358999999999999999999999 9999999999999999999999999999987543
Q ss_pred Cccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 512 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 512 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....................++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 3221 111223566799999998888999999999999999999999998632211 1111110000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.......+...+..+.+++.+||+++|++|||+++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111122234467999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.74 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=209.8
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
...+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 344667789999999999999753 35679999987665556678999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 430 LVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence 9999999999999986432 12458999999999999999999999 9999999999999999999
Q ss_pred cEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 005750 497 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 574 (679)
.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... ...+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~- 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE- 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence 999999999976543221 12223346788999999999899999999999999999999 99998633221 1111
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+..+..... ....+..+.+++.+||+.+|.+||++++|++.|+++..
T Consensus 237 ---~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 ---CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222221111 11234578899999999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.37 Aligned_cols=241 Identities=26% Similarity=0.375 Sum_probs=194.9
Q ss_pred cccCcCccEEEEEEEEc----CCcEEEEEEecCCc----chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.||+|+||.||+++.. +++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999753 57899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 4568888999999999999999999 9999999999999999999999999999875432221
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. +...... .+..
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~---------- 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL---------- 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC----------
Confidence 122345899999999999888999999999999999999999999743221 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01112234678999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=304.73 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=202.8
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecC--CcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
...|++.+.||+|.|+.||+.... +|+.+|+|++.- -...+.+++.+|+.|.+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345777899999999999998765 799999998753 23446788999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~~ 509 (679)
|++.|++|..-+- .+..+++..+-.+++||++||.|+|. ++|||||+||+|+++- ...-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999876554 23567888888999999999999999 9999999999999994 4456999999999988
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
++ ........|||+|||||+++..+|+..+|||+.||+||-|+.|.+||.+++.. .+.+ .+..+... ++
T Consensus 164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAYD--YP 232 (355)
T ss_pred CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhccccC--CC
Confidence 73 23344567999999999999999999999999999999999999999854432 1211 22222211 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+...+ ...+...+|+++||..||.+|.|+.|.++
T Consensus 233 ~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111 22335779999999999999999999873
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.93 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=207.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3567889999999999999876 6899999987542 23344678899999999999999999999999899999999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998886432 24558899999999999999999998 99999999999999999999999999998875433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....+.+. +.......
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~----~~~~~~~~------ 227 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQK----IEQCDYPP------ 227 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHH----HhcCCCCC------
Confidence 221 1223478899999999888899999999999999999999999963222 11112221 11111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.........+.+++.+||+.+|++||++.||++.|+++.
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111223457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.43 Aligned_cols=260 Identities=24% Similarity=0.419 Sum_probs=205.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
+....|+..+.||+|+||.||+|.+. +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 44566778899999999999999864 333 48999987543 34557788999999999999999999998765 4
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++++||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999999753 3468899999999999999999999 999999999999999999999999999998
Q ss_pred ccccCccccc-ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 508 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 508 ~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
.......... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCCCC
Confidence 7654322111 11224668999999999999999999999999999998 99999733221 1111 11111110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+......+.+++.+||+.+|.+||++.+++..|..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111234688999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.38 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=203.0
Q ss_pred HhhccccCcCccEEEEEEEEc-C-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 677899999999999999765 3 67889998765555555678889999999999999999999999999999999999
Q ss_pred CCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc-
Q 005750 437 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 514 (679)
Q Consensus 437 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~- 514 (679)
+|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999998886432 34568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +....... +... +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~~----~---- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKYD----P---- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC----C----
Confidence 1233446899999999999999999999999999999999999999733221 11111111 1111 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346889999999999999999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.06 Aligned_cols=260 Identities=18% Similarity=0.192 Sum_probs=197.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
....|.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3446788899999999999999875 68999999753 2456789999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
++. ++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 788888763 4568999999999999999999999 999999999999999999999999999997543322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc----hhhHHHHHHHhHhcC--Ce---
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA----ELNIVHWARSMIKKG--DV--- 584 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~----~~~~~~~~~~~~~~~--~~--- 584 (679)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .......+....... ..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222334568999999999999899999999999999999999998875322110 001111110000000 00
Q ss_pred -----eeee---------cccccCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 -----ISIV---------DPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 -----~~~~---------d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+ .+..... .....+..+.+++.+||+.||.+|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000 00123457889999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.79 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=196.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34677899999999999999886 689999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+. ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 85 VH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 95 6787777642 4568899999999999999999999 9999999999999999999999999999875432221
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe---e-----
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---I----- 585 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~----- 585 (679)
......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..... .....+.+......... .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhc
Confidence 1223457899999998865 4578999999999999999999999974322 11111111111110000 0
Q ss_pred eeeccc-cc--CCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPV-LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~-l~--~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...++. .. ..... .....+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 00000 01235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=310.66 Aligned_cols=247 Identities=29% Similarity=0.463 Sum_probs=200.0
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHh
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 441 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 441 (679)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999876543 33457889999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccccccc
Q 005750 442 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 521 (679)
Q Consensus 442 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~ 521 (679)
+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988643 3467899999999999999999998 99999999999999999999999999998764433222222223
Q ss_pred CCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 522 gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
++..|+|||++.+..++.++||||||+++|++++ |..||...... .... .+..+... ..+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKGYRM---------SCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCCCC---------CCCCCC
Confidence 4668999999998889999999999999999998 99999633221 1111 11111110 111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.72 Aligned_cols=266 Identities=22% Similarity=0.304 Sum_probs=197.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc-----ceEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 430 (679)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 567789999999999999876 68999999986432 23345688999999999999999999987432 35799
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+. ++|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 82 v~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 689888873 4568999999999999999999999 999999999999999999999999999997643
Q ss_pred cCcc--cccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH-------
Q 005750 511 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI------- 579 (679)
Q Consensus 511 ~~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~------- 579 (679)
.... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... ..+....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence 2211 11233458999999999866 67899999999999999999999999744321111 1110000
Q ss_pred ----hcCCeeeee---cccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 005750 580 ----KKGDVISIV---DPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 634 (679)
Q Consensus 580 ----~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 634 (679)
........+ .+.... .........+.+++.+||+.+|++|||++|+++. ++....
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000 000000 0001123467899999999999999999999864 444333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.45 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=198.4
Q ss_pred HhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc----chhHHHHHHHHHHHHhc-cCCCcccccccccccceEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 429 (679)
|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+++++.+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 567789999999999999753 58899999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999873 4568999999999999999999999 99999999999999999999999999999865
Q ss_pred ccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ........ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-C------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-C------
Confidence 43333333345689999999998765 47889999999999999999999997433221111 11111111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
++.+ +......+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 112234678999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.48 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=201.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC--CcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
+....|++.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 344567888999999999999998653 3689999986432 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 107 ~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999973 4578999999999999999999999 9999999999999999999999999999986
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ...+ .+..+..
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~----~i~~~~~---- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ----KILEGII---- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC----
Confidence 5432 12345899999999999888999999999999999999999999743221 1111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
..+......+.+++.+||+.+|++|+ +++|+++.
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111223578999999999999995 89888764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.56 Aligned_cols=256 Identities=26% Similarity=0.468 Sum_probs=203.1
Q ss_pred HHHhhccccCcCccEEEEEEEE-----cCCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
..+++.+.||+|+||.||+|.+ .+++.|++|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999975 246789999987533 3344678899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 431 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
||||+++++|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999885321 12357889999999999999999999 9999999999999999999
Q ss_pred cEEEeeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 005750 497 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 574 (679)
.+||+|||++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 99999999997653322 112223335678999999988889999999999999999998 9999863221 122221
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
+ ....... .+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 239 ~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1111110 111223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.14 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=203.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
....|++.+.||+|+||.||+|.++ .++.||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778899999999999999754 25679999986432 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 428 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 2346788899999999999999999 99999999999999999999999
Q ss_pred eeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 005750 501 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----
Confidence 999998765432221 1112235678999999998899999999999999999999 7889863322 111111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
...+.... .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111233478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.49 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=197.2
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 68999999997532 23345678899999998 799999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 99998886 34679999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .....++....+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------
Confidence 33468999999999999999999999999999999999999996332211 112223333333322210
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 627 (679)
.+......+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11122346889999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.75 Aligned_cols=262 Identities=29% Similarity=0.434 Sum_probs=202.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-----CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc--cceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 429 (679)
..+++.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35667889999999999999753 578999999887666666789999999999999999999997643 44689
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998742 3468999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccc--cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch---------hhHHHHHHHh
Q 005750 510 EEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---------LNIVHWARSM 578 (679)
Q Consensus 510 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~---------~~~~~~~~~~ 578 (679)
....... .....++..|+|||++.+..++.++|||||||++|||++|..|+........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332211 1112234569999999988899999999999999999999877642211100 0000001111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
...+.. ..........+.+++.+||+.+|++|||++||++.|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111100 011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=312.97 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=203.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...+++.+.||+|++|.||+|.++++..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34577889999999999999998877789999876532 234678899999999999999999998754 5678999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 24458899999999999999999998 99999999999999999999999999999765433222
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||...+..++.++||||||+++|+|++ |+.||..... ....++. ..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV----ERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC---------
Confidence 2222335678999999988889999999999999999999 9999973221 1111211 111100
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
..+...+..+.+++.+||+++|.+||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=313.32 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=207.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+....+.+.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3455677889999999999999998888999999987543 335678999999999999999999999998889999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999753 24568999999999999999999999 999999999999999999999999999988765422
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........++..|+|||.+.+..++.++||||+|+++|++++ |+.||..... ....+... .+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~----~~~~-------- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVE----RGYR-------- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----cCCC--------
Confidence 221222234568999999998889999999999999999998 9999963221 11111111 1100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111124478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.90 Aligned_cols=240 Identities=28% Similarity=0.401 Sum_probs=191.1
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|..+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999987532 22344556677777654 899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998873 4578999999999999999999999 999999999999999999999999999997643222 222
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .... . +.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~-i~~~~------~----~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---S-ILNDR------P----HFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHcCC------C----CCC
Confidence 3445899999999999989999999999999999999999999743321 1111 1 11110 0 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 626 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl 626 (679)
......+.+++.+||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12234678999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.09 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=207.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|++|.||+|... +++.++||.+.... .....++.+|+++++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4667889999999999999865 78999999876432 2344678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886432 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... +.... .+..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCD-----YPPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-hhcCC-----CCCC
Confidence 221 12335788999999998888999999999999999999999999633221 1111111 11111 0111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
........+.+++.+||+.+|.+|||+.+|++.++++-
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11123457889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.41 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=222.5
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
|+++....+.++||-|.||.||.|.|+. .-.||||.++.. ....++|++|..+|+.++|||+|+++|+|..+...|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 4555556678999999999999999984 567999999754 45578999999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+|||..|+|.++|++. +...++...++.++.||+.|+.||.. +++|||||..+|+|+.++..+|++|||+++.+..
T Consensus 342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999976 35567777889999999999999998 9999999999999999999999999999999876
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
+.........-++.|.|||-+....++.|+|||+|||+|||+.| |-.||.+-+......+ +.+
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-------LEk--------- 481 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-------LEK--------- 481 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-------Hhc---------
Confidence 65444444445789999999999999999999999999999998 9999976554332222 222
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+-+.+..++.++.+|++.||+++|.+||++.|+-+.++.+...
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 222334556677899999999999999999999999999988764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.18 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=205.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhcc-CCCcccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 427 (679)
...+.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456677899999999999999753 134799999975433 34567899999999996 9999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC-----------------------------------------------------------
Q 005750 428 RILVYEYMHNGTLRDRLHGSV----------------------------------------------------------- 448 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 448 (679)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998886421
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 449 ----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 449 ----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
....+++..+..++.|+++||+|||+ .+|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01347888899999999999999999 99999999999999999
Q ss_pred CCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHH
Q 005750 495 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 572 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~ 572 (679)
++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence 999999999999865432221 1222346778999999998899999999999999999997 99998632211 1111
Q ss_pred HHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 573 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
. .+..+... ..+...+..+.+++.+||+.+|++||++.+|.+.|+++..
T Consensus 351 ~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 N----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 11111110 1112234578899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.20 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=203.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...+++.+.||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3557788999999999999998642 578999999755333 346788999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC
Q 005750 429 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 495 (679)
++++||+.+++|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985321 12358888999999999999999998 999999999999999999
Q ss_pred CcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 005750 496 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 573 (679)
Q Consensus 496 ~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~ 573 (679)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE 237 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999876533221 11223345778999999988889999999999999999998 8888863221 11222
Q ss_pred HHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 574 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
. +..+... ......+..+.+++.+||+.+|.+||+++||++.|+.
T Consensus 238 ~----i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 M----IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 2222111 1112334568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.95 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=193.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHH---HhccCCCcccccccccccceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
|++.+.||+|+||.||+|.++ +++.||+|++++.. ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 356789999999999999876 68999999997532 22345566776665 456799999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|...+. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998875 3568999999999999999999999 9999999999999999999999999999875332
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.. .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. .. ...... +.. .
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~---~~~i~~-~~~------~ 219 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EV---FDSIVN-DEV------R 219 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCC------C
Confidence 21 1223456899999999999999999999999999999999999999743321 11 111111 111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.+......+.+++.+||+.||.+|| +++++++
T Consensus 220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112234678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.11 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=205.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccc-cc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-EH 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~ 426 (679)
...|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+++++++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456888999999999999999643 257899999875432 3346688899999999 89999999998754 45
Q ss_pred eEEEEEEecCCCcHhhhhcccCC---------------------------------------------------------
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVN--------------------------------------------------------- 449 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 449 (679)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78899999999999998864211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc-cccccCCcccc
Q 005750 450 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYL 527 (679)
Q Consensus 450 -~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~ 527 (679)
...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.++|+|||++.......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1368899999999999999999999 999999999999999999999999999998754332211 22234567899
Q ss_pred CCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHH
Q 005750 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 606 (679)
Q Consensus 528 aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (679)
|||++.+..++.++|||||||++|||++ |..||......+ .+. ..+..+.... .+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCCC---------CCccCCHHHHH
Confidence 9999999999999999999999999998 999997422211 111 1122211110 01122346889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 607 VAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 607 li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
++.+||+.+|++||++.||++.|+++.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.33 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=193.5
Q ss_pred HHhhccccCcCccEEEEEEEEc--CCcEEEEEEecCCc--chhHHHHHHHHHHHHhc---cCCCccccccccc-----cc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 425 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~~ 425 (679)
.|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+++++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 4667889999999999999863 47889999986432 22234566788777766 6999999999874 34
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
...++||||+. ++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 56899999996 6898888743 24568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh---cC
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KG 582 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~ 582 (679)
+...... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......+ ....+..... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9765433 12233458999999999988889999999999999999999999997433221 1111111110 00
Q ss_pred Cee-------eeeccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DVI-------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ..+.+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 0000122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.01 Aligned_cols=236 Identities=25% Similarity=0.382 Sum_probs=190.9
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999987532 23445677888888877 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ... .... .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~-~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF---EAIL-NDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHh-cCCC----------CCC
Confidence 3345899999999999989999999999999999999999999743221 111 1111 1111 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
......+.+++.+||+.||.+||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.10 Aligned_cols=264 Identities=30% Similarity=0.504 Sum_probs=206.5
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCc--EEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccce
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 427 (679)
.+....+++.+.||+|+||.||+|.++ ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 455567788899999999999999875 454 46777766432 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
.++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999987432 12368899999999999999999998 99999999999999999
Q ss_pred CCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 005750 495 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 573 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~ 573 (679)
++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|+| |..||...+.. ...+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~ 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE 234 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence 99999999999864321111 111224567999999988889999999999999999998 99999633221 1111
Q ss_pred HHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 574 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
. ...+... .........+.+++.+||+.+|++||+++++++.|+++...+.
T Consensus 235 ~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 K----LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred H----HhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 1111000 0111123468899999999999999999999999998877554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.78 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=196.7
Q ss_pred ccCcCccEEEEEEEEc---CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 364 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 57899999986543 2345678999999999999999999998864 4678999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc-
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS- 517 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~- 517 (679)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999873 4568999999999999999999998 9999999999999999999999999999987644332111
Q ss_pred -ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 518 -SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 518 -~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+. +..+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----i~~~~~~~--------- 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQM----IESGERME--------- 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCC---------
Confidence 12224578999999988889999999999999999998 9999973322 112221 22222111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.+......+.+++.+||+.+|++||++++|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112335788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.12 Aligned_cols=266 Identities=24% Similarity=0.456 Sum_probs=211.2
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
++....+.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455667778899999999999999742 24579999987543 34457789999999999 899999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
......++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ +|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12457888999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
|+++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 999999999999999998764332211 122235678999999988889999999999999999998 78888633211
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
...+ .+..+... ..+......+.+++.+||+.+|.+|||+.||++.|+++.....
T Consensus 247 --~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 247 --ELFK----LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --HHHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111 12222111 0111234578899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.38 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=195.7
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++.. ...+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 99988863 4578999999999999999999996 269999999999999999999999999998753322211 22
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ...+. +..... . .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~----i~~~~~------~----~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEEI------R----FPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHH----HhcCCC------C----CCC
Confidence 345899999999999989999999999999999999999999743221 11111 111110 0 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1234688999999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.30 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=192.9
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 58899999987542 23445677899988877 799999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999988863 4578999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc--chhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 2345899999999999999999999999999999999999999632211 111222223222222211 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
.+......+.+++.+||+.||.+||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.13 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=206.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+...++++.+.||+|+||.||+|.+.++..+++|.+... ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345667788999999999999999888888999988754 3345678899999999999999999999887 77899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999754 24568889999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........++..|+|||++....++.++|+|||||++|++++ |+.||...+.. ...+.. ..+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~------- 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM------- 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCC-------
Confidence 222222335678999999998889999999999999999999 99999733221 122211 111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.92 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=207.8
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 424 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 424 (679)
++....+++.+.||+|+||.||++.... ...+|+|.+.... ......+.+|+++++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445567778999999999999998642 3689999987542 33446788999999999 79999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
++..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+ ++|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence 99999999999999999998642 134568999999999999999999998 99999999999999
Q ss_pred ccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchh
Q 005750 492 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 569 (679)
Q Consensus 492 l~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~ 569 (679)
++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999875433211 1122234678999999988899999999999999999997 999986332211
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
..+ .+..+... ..+......+.+++.+||+.+|.+|||++|+++.|+++.
T Consensus 243 -~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFK----LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 11111110 111223447889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.54 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=195.2
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||+|+||+||++..+ +++.||+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 689999999865322 2335677899999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccccc
Q 005750 441 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519 (679)
Q Consensus 441 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~ 519 (679)
.+.+.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 88875322 34578999999999999999999999 99999999999999999999999999998765443221 223
Q ss_pred ccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHH
Q 005750 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599 (679)
Q Consensus 520 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 599 (679)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ......... .... ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccCC----------CCccc
Confidence 4588999999999999999999999999999999999999974322111 111111111 1100 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 600 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 600 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
....+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 345688999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.43 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=194.4
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677889998876 799999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999988873 4578999999999999999999999 9999999999999999999999999999875432221 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+ .... +.. . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~~-~~~---~-------~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SILH-DDV---L-------YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CCC---C-------CC
Confidence 2345899999999999989999999999999999999999999743221 1111 1111 111 0 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 628 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 628 (679)
......+.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11234688999999999999999 77877754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.98 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=205.6
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...+++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 345677899999999999999876 88999999976544 5678899999999999999999999999889999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999998743 23368999999999999999999999 9999999999999999999999999999987643222
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....+..|+|||.+.+..++.++||||||+++|++++ |..||..... ..+... ...+...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~--------- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPH----VEKGYRM--------- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhcCCCC---------
Confidence 2224568999999988889999999999999999997 9999863321 112111 1111110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
..+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11112345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.20 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=206.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
....+.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 44567788999999999999998653 3478999887654 3455689999999999999999999998876 4568
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999743 3468999999999999999999998 99999999999999999999999999998765
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
............++..|+|||.+....++.++||||||+++|++++ |+.||...... ..... +..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~~-- 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERLP-- 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcCC--
Confidence 4433222222334568999999988889999999999999999986 99999743321 11111 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+...+..+.+++.+|+..+|.+|||+.++++.|+++...
T Consensus 229 -------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 -------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112334788999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.09 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=202.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 567889999999999999877 68999999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~- 513 (679)
+++++|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999974 3678999999999999999999999 999999999999999999999999999998754432
Q ss_pred ---------------------------ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc
Q 005750 514 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 566 (679)
Q Consensus 514 ---------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~ 566 (679)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11122345899999999999999999999999999999999999999743321
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 628 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 628 (679)
. ........... +...........+.+++.+|++ +|.+||+ ++|+++.
T Consensus 237 ~------~~~~i~~~~~~-------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E------TYNKIINWKES-------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHhccCCc-------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111110000 0000001124578899999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.76 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=208.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|.+.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4667889999999999999887 7999999988632 22335678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999886532 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+.... +..+....
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~------ 227 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCDYPP------ 227 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCCCCC------
Confidence 221 1223478899999999888899999999999999999999999963322 11111111 11111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.........+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 228 --~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 --LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 011133457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.63 Aligned_cols=265 Identities=25% Similarity=0.442 Sum_probs=208.9
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
++....|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344566888999999999999999753 23579999987542 34456788999999999 799999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
...+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 99999999999999999999997532 12358899999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
|+++.++.+||+|||.+.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999987654321111 111224568999999998889999999999999999998 8888863221
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
....+ .+..+... ..+......+.+++.+||+.+|.+|||+.||++.|+++....
T Consensus 249 -~~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 -EELFK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -HHHHH----HHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 12222111 111223457889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.50 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=204.2
Q ss_pred HhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+++.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+++++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 456789999999999999754 235799998875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCc
Q 005750 432 YEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 490 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 490 (679)
+||+.+++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999886421 12357899999999999999999998 9999999999999
Q ss_pred cccCCCcEEEeeccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccch
Q 005750 491 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 568 (679)
Q Consensus 491 ll~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~ 568 (679)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999987653322211 122235678999999988889999999999999999998 9999963321
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+.+.. ..+.. ...+......+.+++.+||+.+|.+||+++|+++.|+++..
T Consensus 236 ~~~~~~~----~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLL----KTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHH----hCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1222221 11110 01111223478899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.38 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=203.2
Q ss_pred HHhhccccCcCccEEEEEEEEcC-C--cEEEEEEecCC-cchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKD-G--KEVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35678899999999999998763 3 34788888743 233456789999999999 7999999999999999999999
Q ss_pred EecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 433 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999986432 12358899999999999999999999 9999999999999999999999
Q ss_pred EeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 005750 500 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 500 L~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
|+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .... .
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~---~- 230 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYE---K- 230 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H-
Confidence 999999864322111 111123557999999988889999999999999999997 99999733221 1111 1
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+..+.. . ..+......+.+++.+||+.+|.+||+++++++.|+++....+
T Consensus 231 ~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGYR-----M----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111110 0 1111223468899999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.33 Aligned_cols=241 Identities=27% Similarity=0.373 Sum_probs=194.5
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|.++ +++.||+|++++.. ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999987532 23345677899999888 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999988873 4579999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .... . +..... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~---~-i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ---S-ILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH---H-HHcCCC----------CCC
Confidence 2345899999999999999999999999999999999999999743321 1111 1 111111 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 627 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 627 (679)
......+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223468899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.26 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=204.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
...+.+.++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 345567899999999999999642 36689999988766666778999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc
Q 005750 430 LVYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 497 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 497 (679)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence 99999999999999875321 1358899999999999999999998 99999999999999999999
Q ss_pred EEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 005750 498 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 575 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 575 (679)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...... ...+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~- 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIEC- 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHH-
Confidence 99999999876533221 11122235678999999998899999999999999999998 99998622211 11111
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
...+... ..+...+..+.+++.+||+.||.+||+++||++.|+.
T Consensus 237 ---~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ---ITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111110 0111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.49 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=192.1
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|.+. +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 23345566788888765 899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 4568899999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ...+.+ .... +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i----~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI----RMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCC------CCC----C
Confidence 2345899999999999989999999999999999999999999743321 111111 1111 101 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 627 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 627 (679)
......+.+++.+||+.+|.+||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11224678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.22 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=198.2
Q ss_pred hccccCcCccEEEEEEEEcC-Cc--EEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc------cceEE
Q 005750 361 FCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRI 429 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~ 429 (679)
+.+.||+|+||.||+|.+.+ ++ .||+|.++.. .....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56889999999999998764 32 6899988653 23445778899999999999999999997642 22568
Q ss_pred EEEEecCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 430 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
++|||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874322 23458999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 507 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 507 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||..... ..+.+ .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCC
Confidence 8764332211 122235678999999999899999999999999999999 8899863222 11212 1222221
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.. ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=324.51 Aligned_cols=240 Identities=25% Similarity=0.339 Sum_probs=192.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccC-CCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E 433 (679)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|.+++..++| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 567789999999999999876 57899999987532 2345667889999999976 568889999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998873 4568899999999999999999999 999999999999999999999999999987532211
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
. ......|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. .....+ .....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i----~~~~~--------- 218 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI----MEHNV--------- 218 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCCC---------
Confidence 1 122345899999999999999999999999999999999999999743321 111111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111223467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.60 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=191.9
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|.++ +|+.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999887 68899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999998873 4568999999999999999999999 999999999999999999999999999987532211 122
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ...+. +.... +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~----~~~~~------~~~----~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFES----IRVDT------PHY----P 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC------CCC----C
Confidence 3345899999999999999999999999999999999999999743321 11111 11111 111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 626 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl 626 (679)
.....++.+++.+||+.||.+||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.78 Aligned_cols=238 Identities=25% Similarity=0.359 Sum_probs=192.9
Q ss_pred cccCcCccEEEEEEEE----cCCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 363 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3589999999975322 234567789999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999999863 4578999999999999999999999 9999999999999999999999999999876543322 1
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ... ..... ... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~---~~i~~-~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETM---TMILK-AKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHH---HHHHc-CCC----------CC
Confidence 22345899999999999888999999999999999999999999743221 111 11111 111 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQE 624 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 624 (679)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.70 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=202.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC---------------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 418 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l 418 (679)
....|++.+.||+|+||.||+++..+ ...||+|.++... ......+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45567888999999999999987642 2358999987643 3345679999999999999999999
Q ss_pred cccccccceEEEEEEecCCCcHhhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 419 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999886421 11247888999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 566 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt--G~~pf~~~~~~ 566 (679)
|++++++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999876433221 11122335678999999988889999999999999999998 6677753222
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.................... ..+...+..+.+++.+|++.+|++||++++|++.|++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --EQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11222221111111110000 0111223479999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.85 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=208.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC-----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccc-cce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 427 (679)
....|.+.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45667788999999999999998875 7889999987543 3445678899999999999999999998765 567
Q ss_pred EEEEEEecCCCcHhhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 568999999999999999999998 9999999999999999999999999
Q ss_pred ccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHh
Q 005750 503 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 503 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
||+++........ ......++..|+|||++.+..++.++|||||||++|++++ |+.||..... ..+..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----
Confidence 9999865432221 1122335678999999988889999999999999999999 9999973221 22222221
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+... ......+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 234 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11100 0111223468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.52 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=195.1
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||+|+||.||+++.+ +|+.||+|.+.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 68999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 24468899999999999999999999 9999999999999999999999999999877644322 1234
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.|+..|+|||++.+..++.++||||+||++|+|++|+.||...... ....+....... .... . . ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~-~-----~---~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVK-F-----E---HQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-cccc-c-----c---cccC
Confidence 5889999999999888999999999999999999999999733221 111111111111 1110 0 0 0112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
..++.+++.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 346889999999999999999988765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.33 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=203.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456789999999999999876 6899999998643 3345677899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999754 24678999999999999999999998 99999999999999999999999999998866543222
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+. ..... . ...+... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~~---------~ 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---K-IIRGVFP---------P 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCCCC---------C
Confidence 2233578899999999998899999999999999999999999973331 11111 1 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.62 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=201.1
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc-----cceEEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 433 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~lV~E 433 (679)
.+.||+|+||.|+.|..+ +|+.||+|++.+. .....++..+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 7899999998743 34456778899999999999999999998754 457899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC-
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~- 512 (679)
+| +.+|...++ .+..++...+..++.|+++||+|+|+ .+|+||||||+|++++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 679999998 45669999999999999999999999 99999999999999999999999999999987543
Q ss_pred cccccccccCCccccCCccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH--------hHhcCC
Q 005750 513 LTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIKKGD 583 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~--------~~~~~~ 583 (679)
.....+....|..|.|||++ ....|+.+.||||.|||+.||++|++.|.+.+.-.+..++..+.. .+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 11122445679999999986 456899999999999999999999999987665433332221111 111000
Q ss_pred eeeeeccc---cc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPV---LI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~---l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+... .. ...-+......++|+.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00011000 00 00111223367899999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.25 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=201.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+|+..+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3566789999999999999875 689999999865321 223457789999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888643 24568999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
. .....|+..|+|||++.+..++.++||||+||++|+|++|+.||....... ..+.+...+....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~---------- 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ---------- 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------
Confidence 2 122358899999999998889999999999999999999999997433211 1111111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
..++......+.+++.+||+.||.+|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111222344688999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.67 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=196.8
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc-----eEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 431 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lV 431 (679)
++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45689999999999999875 78999999986532 234567889999999999999999999998766 78999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+||+. ++|.+.+. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 57877775 35678999999999999999999999 9999999999999999999999999999986543
Q ss_pred CcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHH----------------H
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH----------------W 574 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~----------------~ 574 (679)
..........+++.|+|||++.+. .++.++||||+||++|||++|+.||...+......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 322222334578899999998764 57899999999999999999999997543321111100 0
Q ss_pred HHHhHhcCC-eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 575 ARSMIKKGD-VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 575 ~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+.... ....... + ..........+.+++.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPV-L-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHH-h-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0000000 0 00111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.95 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=201.8
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
+....|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34456778899999999999999876 68899999986431 223455778999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999863 357888899999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
............|++.|+|||++.+. .++.++|||||||++|||++|+.||...+.. .............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC
Confidence 44332223345689999999998653 4789999999999999999999999743321 1111111111110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
...+ .......+.+++.+||+.+|.+ ||+++|+++.
T Consensus 267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1000 1112347889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.60 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=201.6
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...+.+.+.||+|++|.||+|.+.+ +..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3456678899999999999998753 5689999886543 33446789999999999999999999999988899
Q ss_pred EEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cEEEe
Q 005750 429 ILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS 501 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~ 501 (679)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987543 12358999999999999999999999 9999999999999998654 59999
Q ss_pred eccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhH
Q 005750 502 DFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 502 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |+.||...... .+.+.+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---H
Confidence 999998763322111 112223568999999998899999999999999999997 99999743322 111111 1
Q ss_pred hcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 580 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11110 1112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.65 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=203.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CC---cEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..++..+.||+|+||.||+|... ++ ..+++|.+.... ....+.+.+|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45566789999999999999875 33 379999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998742 3568999999999999999999999 9999999999999999999999999999876543
Q ss_pred Cccccc--ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 512 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 512 ~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
...... .....+..|+|||++.+..++.++|||||||++||+++ |+.||..... ..... . +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~---~-i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMK---A-INDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH---H-HhcCCCC---
Confidence 222111 11123457999999988889999999999999999997 9999963321 11111 1 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
......+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011123457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.69 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=206.3
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 426 (679)
+....+.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445667788999999999999998652 4689999987543 344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 9999999999999999987532 12347889999999999999999998 9999999999999999999999
Q ss_pred EeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 005750 500 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 500 L~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 577 (679)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...+. ....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV-- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH--
Confidence 999999876543321 11223346788999999988889999999999999999998 9999863322 1122211
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
..+.... .+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1221111 111224578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.04 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=202.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
....|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 4456788899999999999999875 688999999876544555678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.++++. ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998873 4568999999999999999999998 999999999999999999999999999998654322
Q ss_pred ccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 514 THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
. ......++..|+|||.+. ...++.++|||||||++|+|++|+.||........ ... +..... ..+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~~---~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-----MSKSNF---QPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-----eecCCC---CCC
Confidence 1 112335788999999874 34578899999999999999999999862221110 000 000000 001
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 112335788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.58 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=200.4
Q ss_pred hhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccce------
Q 005750 360 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 427 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------ 427 (679)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 457899999999999998652 3789999987532 2345678999999999999999999998765443
Q ss_pred EEEEEEecCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 428 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
.++++||+++|+|..++.... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 799999999999999885432 23468999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 505 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 505 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+.. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC
Confidence 998754332211 112234678999999988899999999999999999999 8899863221 1122211 111
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
... ..+......+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.41 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=194.2
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 999988863 4579999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||............++....+...... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 33468999999999999999999999999999999999999996433222222222333322222110 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
......+.+++.+||+.||.+|++++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11224678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.93 Aligned_cols=262 Identities=29% Similarity=0.443 Sum_probs=222.9
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC---C--cEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 426 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 426 (679)
+|.++.....+.||+|-||.||.|...+ | -.||||..+.. ...+.+.|+.|..+|++++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5666666778999999999999997643 3 35899998874 456678899999999999999999999999875
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++|||.++.|.|.++|+. +...++......++.||..||+|||+ .++|||||..+|||+.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57999999999999999986 35679999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
+.+.++.....+...-++.|||||.+.-..++.++|||-|||.+||++. |..||.+-.. .+..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI 602 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVI 602 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceE
Confidence 9988776555555556789999999999999999999999999999887 9999984332 2222
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
-.++..-+-..++.++..+..|+.+||..+|.+||.+.|+...|.++...+
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 233333333456677788999999999999999999999999999988743
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.85 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=204.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..+++.+.||+|+||.||+|.+. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677899999999999999864 23479999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999743 3468999999999999999999999 9999999999999999999999999999987654
Q ss_pred Ccccccc--cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 512 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 512 ~~~~~~~--~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
....... ...++..|+|||.+.+..++.++|+|||||++|++++ |+.||...... .....+ ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAI----EEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHH----hCCCc----
Confidence 3322111 1123467999999998889999999999999999886 99999733221 122211 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
. ......+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 228 -~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 01112244688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=331.78 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=194.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999875 68899999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999873 4568899999999999999999999 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------cccccccCCccccCCcccCCCCCCchhHHHHHHH
Q 005750 515 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 548 (679)
Q Consensus 515 ----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGv 548 (679)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0011245899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHH
Q 005750 549 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 626 (679)
Q Consensus 549 ll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl 626 (679)
++|||++|+.||........ . ............ + .......++.+++.+ |+..+|..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~--~----~~i~~~~~~~~~--~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET--Q----LKVINWENTLHI--P-----PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH--H----HHHHccccccCC--C-----CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999974332111 0 111110000000 0 000122356778877 5566777799999998
Q ss_pred HH
Q 005750 627 LA 628 (679)
Q Consensus 627 ~~ 628 (679)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.87 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=197.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 556789999999999999876 68999999997532 23345678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999875432110
Q ss_pred c-------------------------------------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC
Q 005750 515 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557 (679)
Q Consensus 515 ~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~ 557 (679)
. ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005750 558 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 628 (679)
Q Consensus 558 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 628 (679)
.||...+.. +.............. + . .......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 237 ~Pf~~~~~~------~~~~~i~~~~~~~~~--~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQ------ETYRKIINWKETLQF--P---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHH------HHHHHHHcCCCccCC--C---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999743321 111111111100000 0 0 01123467789999997 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.22 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=201.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccc-------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 426 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------- 426 (679)
..|.+.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 46778899999999999999865 6999999998653 2344567889999999999999999988764322
Q ss_pred -eEEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 427 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 427 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3689999999999999987533 34578999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~-~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA-GR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CC
Confidence 9987543221 122345689999999999999999999999999999999999999974322 111222111 11
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 262 ~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 0112233578899999999999999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.52 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=203.9
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-----CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc--ce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 427 (679)
...+.+.+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 456677899999999999999742 57889999987543 33456789999999999999999999988765 56
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 88999999999999998643 3468999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHHH
Q 005750 508 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 576 (679)
Q Consensus 508 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~~ 576 (679)
........ ......++..|+|||++.+..++.++|||||||++|+|++++.|....... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-V 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-H
Confidence 75433221 112334667899999998888999999999999999999987765321100 00011111 1
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.....+... .........+.+++.+||+.+|.+|||++++++.|+++
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111211111 11112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.67 Aligned_cols=247 Identities=25% Similarity=0.443 Sum_probs=196.1
Q ss_pred ccCcCccEEEEEEEEc---CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCc
Q 005750 364 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 356799999876533 334678999999999999999999998864 46799999999999
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc--
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-- 517 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~-- 517 (679)
|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4578999999999999999999999 9999999999999999999999999999976543322111
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....++..|+|||.+.+..++.++|||||||++|++++ |..||..... ..... .+..+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMS----FIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHCCCC---------CCC
Confidence 11223568999999988889999999999999999996 9999973221 11111 1112111 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 222345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=294.81 Aligned_cols=257 Identities=26% Similarity=0.342 Sum_probs=205.6
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCCc----c----hhHHHHHHHHHHHHhc-cCCCcccccccccccceEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----S----HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~----~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 430 (679)
-.+.||.|..++|-+..++ +|+++|+|++.... . .-.+.-.+|+.+|+++ .||+|+++.++++.+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 3578999999999988766 68999999985321 1 1234556799999999 59999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|+|.|+.|.|+|+|. ....++++..++|++|+.+|+.|||. ++||||||||+|||++++.++||+|||+++...
T Consensus 101 VFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999998 46789999999999999999999999 999999999999999999999999999999876
Q ss_pred cCcccccccccCCccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 511 EDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
.... -...+|||+|+|||.+. ...|+...|+||+||++|.|+.|.+||.... .-.+.+.+-+|.+
T Consensus 175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGky 245 (411)
T KOG0599|consen 175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGKY 245 (411)
T ss_pred Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhccc
Confidence 5432 34567999999999874 3578899999999999999999999997211 0112223334433
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhhhcC
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEKG 638 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~~ 638 (679)
.- ......+......+||.+||+.||.+|.|++|+++. +..+...+..
T Consensus 246 qF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 246 QF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred cc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 11 111122334468899999999999999999999864 5555554443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=301.07 Aligned_cols=263 Identities=20% Similarity=0.208 Sum_probs=200.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch--hHHHHHHHHHHHHhccCCCcccccccccc--cceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~ 432 (679)
.|+...+|++|.||.||+|+++ +++.||+|+++-.... -----++|+.+|.+++|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3455688999999999999887 6899999999754321 12345789999999999999999887644 45699999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|||+. +|...+... ..++...++..+..|+++|++|||. +.|+|||||++|+|+++.|.+||+|||+|+.++..
T Consensus 157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99965 888888854 3678999999999999999999999 99999999999999999999999999999998876
Q ss_pred cccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec-c
Q 005750 513 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD-P 590 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~ 590 (679)
... .+..+-|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....++.+.+-.......+ .++.-++ .
T Consensus 231 ~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte-~iwpg~~~l 308 (419)
T KOG0663|consen 231 LKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE-AIWPGYSEL 308 (419)
T ss_pred ccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc-ccCCCcccc
Confidence 433 233457999999999866 47899999999999999999999999865543332221111111111 1111110 0
Q ss_pred --------------cccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 --------------VLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 --------------~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.++..+... ..+.-.+|+..+|..||.+|.|++|.++.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 011111111 22456789999999999999999998763
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.38 Aligned_cols=263 Identities=26% Similarity=0.437 Sum_probs=206.3
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhcc-CCCcccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 424 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 424 (679)
++....+.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 445556667899999999999999864 246899999975432 33457889999999997 9999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccC--------------------------------------------------------
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 448 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 448 (679)
.+..++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 449 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 449 ---------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11246778889999999999999998 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 899986322111
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.. ...+..+... ..+.....++.+++.+||+.+|.+||+++||++.|++++
T Consensus 350 --~~----~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QF----YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HH----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111111110 011122357889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=313.32 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=195.0
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc-----eEEEEEEec
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 435 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~ 435 (679)
.+.+|.|+||.||.|... +++.||||+.-.... --.+|+++|+.++|||||++.-+|.... ...+||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 588999999999999876 579999998865432 2346999999999999999998874322 345899999
Q ss_pred CCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCccccccCc
Q 005750 436 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 436 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~~~~~~ 513 (679)
+. +|.+.++... .+..++...+.-+.+||.+||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|+......
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 75 8888887532 45678888889999999999999999 999999999999999965 999999999999876655
Q ss_pred ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-------HhcC--C
Q 005750 514 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IKKG--D 583 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-------~~~~--~ 583 (679)
...+ ...+..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..++ +++.++-. +..- .
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcc
Confidence 4433 346889999999866 4799999999999999999999999987554332 22222111 1111 1
Q ss_pred eeeeecccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+.-.+.+... .......+..+++.++|+.+|.+|.++.|++..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111222111 223445578999999999999999999999853
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.03 Aligned_cols=251 Identities=30% Similarity=0.519 Sum_probs=201.9
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
.+++.+.||+|+||.||+|.+.+++.+|+|.+.... ....++.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 456788999999999999998878899999987542 2346788999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3467899999999999999999999 9999999999999999999999999999876543322112
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....+. +..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVET----INAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HhCCC--CCCCCCC----
Confidence 22234678999999998889999999999999999998 9999973221 111111 11111 1111111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
....+.+++.+||+.+|++|||++|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2347889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=323.89 Aligned_cols=237 Identities=29% Similarity=0.385 Sum_probs=188.7
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHH-HHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||+||+|+.+ +|+.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999886 68999999986532 122344555554 56788999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence 999998873 5578999999999999999999999 9999999999999999999999999999875322211 22
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +....... +.. .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~~~---- 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KPL------RLK---- 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CCC------CCC----
Confidence 3345899999999999999999999999999999999999999743221 11111111 111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11234688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.33 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=200.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
..+++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45566789999999999999875 344 478888754332 234677888889999999999999998864 45788
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 4568999999999999999999999 999999999999999999999999999998654
Q ss_pred cCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.... ...+ .+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPD----LLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcCC--
Confidence 32221 1223346778999999998899999999999999999998 99999733221 1111 222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+. .....+.+++.+|+..+|.+|||+.|+++.|+.+..
T Consensus 232 ~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 112357889999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.19 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=200.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 567789999999999999876 68999999987542 22445688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999743 3578999999999999999999999 9999999999999999999999999999987654433
Q ss_pred cccccccCCccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 515 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.......|++.|+|||++. ...++.++|||||||++|+|++|+.||...... ................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCC
Confidence 3333346899999999986 456789999999999999999999999733221 1111111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+ .......+.+++.+|++ +|.+||+++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 11223467899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.36 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=210.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcch---hHHHHHHHHHHHHhcc-CCCcccccccccccceEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 430 (679)
...|++.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+++|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567778999999999999999874 999999999765432 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC----CCcEEEeeccCc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLS 506 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~Dfgla 506 (679)
|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .||+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999854 39999999999999999999999 99999999999999953 357999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+....... . .+..++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~--~-----~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF--L-----AILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--H-----HHHcCCC--
Confidence 98776 33345567999999999999999999999999999999999999999854432211 1 2222322
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.............+.+++.+|+..||.+|+|+.++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122223334578899999999999999999999984
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.03 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=206.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
+....+.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44556778899999999999999742 35689999987543 33456789999999999 799999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999987432 3348999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 506 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 506 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||....... .... ....+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCC
Confidence 9865433221 1122335678999999998889999999999999999998 999986332211 1111 111111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.. ..+......+.+++.+||+++|++|||+.|+++.|++.
T Consensus 262 ~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 00111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.57 Aligned_cols=267 Identities=25% Similarity=0.386 Sum_probs=204.6
Q ss_pred hhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc--cCCCcccccccccccc----eEEEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVYE 433 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~~----~~~lV~E 433 (679)
++.+.+|+|.||.||+|.++ ++.||||++. ....+.|.+|-+|++.. +|+||++++++-.... .+.||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45688999999999999998 5999999987 44567788888887764 8999999999875544 7899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
|.+.|+|.++|+ ...++|....+|+..+++||+|||+. .+.+|+|||||.+||||.+|++..|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999997 56799999999999999999999973 46789999999999999999999999999998
Q ss_pred ccccCcccc-cccccCCccccCCcccCCCC------CCchhHHHHHHHHHHHHHhCCCCCCccccc-----------chh
Q 005750 508 QAEEDLTHI-SSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFG-----------AEL 569 (679)
Q Consensus 508 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvll~elltG~~pf~~~~~~-----------~~~ 569 (679)
.+....... .-..+||.+|||||++.+.. .=.+.||||+|.+|||+++...-++....+ ...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 876443222 12256999999999997642 124789999999999999876554311111 111
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
.+.+.-....++.....+.|... ....+..+.+.+..||..||+.|.|+.=|-+.+.++....+.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11111111122222222222211 114456788999999999999999999999999999887665
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=318.69 Aligned_cols=265 Identities=26% Similarity=0.466 Sum_probs=209.5
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC--------CcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
++...+|++.+.||+|+||.||+|.... +..||+|.+.... ....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 5566778899999999999999997531 2368999887543 33457889999999999 799999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
...+..++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999987532 23458889999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999987654322111 111224567999999999899999999999999999998 88888633211
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
...+ .+..+... ..+......+.+++.+||+.+|.+||++.|+++.|+++....
T Consensus 244 --~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 --ELFK----LLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --HHHH----HHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111 11111111 111122347889999999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.84 Aligned_cols=251 Identities=32% Similarity=0.528 Sum_probs=200.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhH--HHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 457789999999999999987 467899999987644332 23456999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++. ....+++..++.++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 35678999999999999999999999 99999999999999999999999999998764221 22
Q ss_pred ccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH-HhHhcCCeeeeeccccc
Q 005750 516 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-SMIKKGDVISIVDPVLI 593 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~ 593 (679)
......++..|+|||++. +..++.++||||+|+++|+|++|..||................ .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----------
Confidence 233455889999999998 8889999999999999999999999998441111111111111 0000000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.04 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=199.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
|...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 556789999999999999865 68999999986432 123356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999873 4568899999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccc--ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 513 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 513 ~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
..... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AA---IFKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HH---HHHHhccCCC------
Confidence 21111 2334778999999999988999999999999999999999999632211 11 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122233468899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.74 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=192.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
|++.+.||+|+||.||+|..+ +++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999876 57899999987542 22334567788888877 58999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998873 4568999999999999999999999 999999999999999999999999999987543221
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+.+.+ . ....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~-~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---M-EHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---H-hCCC---------
Confidence 1 122345899999999999999999999999999999999999999743221 111111 1 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
.++.....++.+++.+||+.+|.+|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.41 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCC-cccccccccccc-----
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH----- 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~----- 426 (679)
...|...++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345566788999999999999876 789999999875433 23355689999999999999 999999998877
Q ss_pred -eEEEEEEecCCCcHhhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 427 -QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 427 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
..++|+||+. -+|..++...... ..++...+..+++||++||+|||+ ++|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 7899999995 5999999865321 467778899999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+|+...-+... ....++|..|+|||++.+. .|+...||||+||++.||++++..|.+....+ ....+-..+....
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCC
Confidence 99976533322 2334578999999998776 79999999999999999999999997544321 1111111211110
Q ss_pred e------eeeeccc--ccCC-----CCHHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 V------ISIVDPV--LIGN-----VKIES---IWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~------~~~~d~~--l~~~-----~~~~~---~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. ....+-. .... ..... .....+++.+||+.+|.+|.|++.++++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0000100 0000 00111 1267899999999999999999999875
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.07 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=205.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC-----------------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 417 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 417 (679)
...|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4567788999999999999997652 2468999987543 344577899999999999999999
Q ss_pred ccccccccceEEEEEEecCCCcHhhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 418 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
+++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12368999999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 566 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt--G~~pf~~~~~~ 566 (679)
|+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876433221 12223346778999999988889999999999999999998 6778753221
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.................... ..+...+..+.+++.+||+.+|.+|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 12222222221111111111 1111233578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.86 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=196.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
+|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4667889999999999999876 68899999986443 223346778999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 888877642 3458899999999999999999999 99999999999999999999999999998764332221
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh--------HhcC-Cee
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IKKG-DVI 585 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~--------~~~~-~~~ 585 (679)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+........... +... ...
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 222347889999998865 46889999999999999999999999754432221111110000 0000 000
Q ss_pred eeecccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..-.+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.20 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=203.3
Q ss_pred HHHhhccccCcCccEEEEEEEEcC-C---cEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..+++.+.||+|+||.||+|.++. + ..||+|++... ......++..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 456778999999999999998763 3 36999998754 334567899999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 4568999999999999999999999 9999999999999999999999999999876543
Q ss_pred Cccccc--cccc--CCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 512 DLTHIS--SVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 512 ~~~~~~--~~~~--gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
...... .... .+..|+|||.+.+..++.++|||||||++||+++ |..||...+. ....+++.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~---~~~~-- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ---DYRL-- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc---CCcC--
Confidence 221111 1111 2357999999998899999999999999999886 9999963322 122222211 0000
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
......+..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112344688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=312.41 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=204.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
....|++.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34667888999999999999997542 45899998865432 334568889999999999999999999999899
Q ss_pred EEEEEEecCCCcHhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997432 12345677889999999999999999 99999999999999999999999
Q ss_pred eeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 005750 501 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+ .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~---~- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK---F- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-
Confidence 999998764332211 1122234678999999998899999999999999999998 78898632221 1111 1
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
+..+.... .+......+.+++.+||+.+|++|||+.++++.|++...
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11111111 111223578999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=305.17 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=203.3
Q ss_pred cccCcCccEEEEEEEEcC----CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|.... +..|++|++...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998764 889999999765443 367899999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 438 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 438 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
++|.+++..... ...+++..++.++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3779999999999999999999999 9999999999999999999999999999987654
Q ss_pred Ccc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 512 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 512 ~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ....+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYL----RKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCC----
Confidence 321 11223346889999999988889999999999999999999 6999974321 1222211 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
..+......+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.08 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=193.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||+||+|... +++.||+|++.+.. ......+.+|+.++.+++||||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58999999997532 22345678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999973 5678999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 515 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 515 ----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346899999999999999999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 005750 561 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE--QRGFSRPKMQEIVLA 628 (679)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 628 (679)
....... .. .......... .+.+. . .....+.+++.+|+. .++..||+++||++.
T Consensus 237 ~~~~~~~---~~---~~i~~~~~~~-~~p~~----~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQE---TY---KKVMNWKETL-IFPPE----V--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHH---HH---HHHHcCcCcc-cCCCc----C--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 7433211 11 1111100000 01110 0 112356677777553 334457899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.56 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=202.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.+|++.+.||+|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 35667789999999999999865 68999999987655555677889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999986 3457899999999999999999999 99999999999999999999999999998765432211
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .... ....+. +.+ .
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~~~~~~------~~~--~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATNGT------PEL--Q 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----HhcCCC------CCC--C
Confidence 122357889999999998888999999999999999999999997332211 1111 111110 000 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11223356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.93 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=198.1
Q ss_pred cccCcCccEEEEEEEEcC----CcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999997542 36899999876543 345678999999999999999999998764 467999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3478999999999999999999998 9999999999999999999999999999987644332221
Q ss_pred cc--ccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 518 SV--ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 518 ~~--~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.. ..++..|+|||.+.+..++.++|||||||++|++++ |..||...+. .....++. .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcC---------
Confidence 11 123467999999998899999999999999999998 9999973321 22222221 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
..+......+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122347889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.11 Aligned_cols=250 Identities=30% Similarity=0.502 Sum_probs=200.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccc-cccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E~ 434 (679)
...+.+.+.||+|+||.||++... |+.|++|.++... ..+.+.+|+.++++++|+|++++++++ ...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 345677899999999999999876 7889999986532 346788999999999999999999975 455678999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998753 23458899999999999999999998 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ...... +..+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCC--------
Confidence 12234568999999998899999999999999999997 9999863222 111111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
......+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11112345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.24 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=207.8
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 423 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 423 (679)
+....+.+.++||+|+||.||+|+.. ....+|+|.++... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456678899999999999999752 24579999987543 33456788999999999 6999999999999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCc
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 490 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 490 (679)
..+..+++|||+++|+|.+++.... ....+++.++..++.|++.||.|||+ +|++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 9889999999999999999997532 12458899999999999999999998 9999999999999
Q ss_pred cccCCCcEEEeeccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccch
Q 005750 491 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 568 (679)
Q Consensus 491 ll~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~ 568 (679)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998654322111 111224467999999988889999999999999999999 89998633221
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
...+ .+..+... .........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 244 -~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 -ELFK----LLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -HHHH----HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 11222111 111222346889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.36 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=190.7
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHH-HHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999987532 122234444444 56788999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++.. ...+.+..+..++.||++||+|||+ +||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4568888899999999999999999 9999999999999999999999999999875432211 22
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+ .... ... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~-~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILN-KPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHHh-CCc----------CCC
Confidence 3345899999999999999999999999999999999999999733221 1111 1111 110 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
......+.+++.+||+.+|.+||++.+.+..+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 122346889999999999999999886544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.65 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
+++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456789999999999999865 68999999986542 3345678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99986542 36788889999999999999999 999999999999999999999999999997654322
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||........ ....+.... +..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCC--
Confidence 2234588999999999988899999999999999999999999963222111 111111111 111110 0110
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.99 Aligned_cols=243 Identities=28% Similarity=0.394 Sum_probs=191.3
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHH-HHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986532 223345555655 46778999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|..++. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99998887 35678999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +....... +.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~------~~~~--- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL------VLRP--- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc------cCCC---
Confidence 3345899999999999999999999999999999999999999743221 11111111 111 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
.....+.+++.+|++.+|.+||++.+.++.+
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1234677999999999999999987444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=307.95 Aligned_cols=250 Identities=30% Similarity=0.523 Sum_probs=196.7
Q ss_pred cccCcCccEEEEEEEEcC-Cc--EEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|.+++ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998764 43 57888887543 34456788999999999 799999999999999999999999999
Q ss_pred CcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 438 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 438 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 12357899999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...+.. .... . +..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---K-LPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHH---H-HhCCC
Confidence 9864321111 111223567999999988889999999999999999997 99999633221 1111 1 11111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.. .........+.+++.+|++.+|.+|||+.|+++.|+++.
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 10 011122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=303.72 Aligned_cols=248 Identities=32% Similarity=0.472 Sum_probs=200.0
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHh
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 441 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 441 (679)
++||+|++|.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765443 5578999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc-ccc
Q 005750 442 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 520 (679)
Q Consensus 442 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~-~~~ 520 (679)
+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||.+........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3468899999999999999999998 9999999999999999999999999999876543221111 112
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 599 (679)
..+..|+|||.+.+..++.++|+|||||++|+|++ |..||...... ...+. +..... ...+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~----~~~~~~---------~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER----IESGYR---------MPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH----HhcCCC---------CCCCcc
Confidence 23567999999988889999999999999999999 88888633221 11111 111100 011112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 600 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 23478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=329.11 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=198.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
...|++.+.||+|+||.||+++.+ +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 356777899999999999999886 5889999998642 122345678899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 358889999999999999999999 9999999999999999999999999999987644
Q ss_pred CcccccccccCCccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+.. ...............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCC
Confidence 332223345689999999998654 3788999999999999999999999743321 111111111111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
. ........+.+++.+|++.++.+ ||+++|+++.
T Consensus 269 p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 P-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01122346778999999855543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.61 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=199.9
Q ss_pred cccCcCccEEEEEEEEcC--C--cEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3699999987655 566789999999999999999999999888 889999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc--
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 515 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~-- 515 (679)
++|.+++..... ..+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975422 568999999999999999999999 99999999999999999999999999999876442211
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ...+.. .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~~~~~--------- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DKEGERL--------- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HhcCCcC---------
Confidence 1112346778999999998899999999999999999998 99999632211 122211 1111110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.43 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=203.8
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
....+++.+.||+|+||+||+|.+. +++ .||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3455667899999999999999864 444 58999987543 34456788999999999999999999998764 46
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 8999999999999998742 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 509 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 509 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..++ ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCcCC
Confidence 64322211 111224678999999988899999999999999999998 9999863221 1222222 1111110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+......+.+++.+||+.||++||++.++++.|+++...
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1112334688999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.01 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=201.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++||||+++++++.+++..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999876 6899999998643 23455678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ....+++..++.++.|++.||.|||+ ++++|+||||+||++++++.++++|||.+........ .
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999988643 24568899999999999999999999 9999999999999999999999999999876543322 1
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.. ..... +..+.... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~---------~ 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-VCQGSYKP---------L 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-HhcCCCCC---------C
Confidence 22345788999999999888999999999999999999999999733211 11111 11122111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+......+.+++.+||+.+|++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.02 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=201.7
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45667788999999999999875 57899999987443 34456789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++. ...+++..+..++.|+++|+.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999886 3468899999999999999999998 9999999999999999999999999999876543321
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .... .+..+. .+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~---- 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF----LIPKNS-----PP---- 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh----hhhcCC-----CC----
Confidence 122234788999999999988999999999999999999999998622211 1111 111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122334578899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=330.65 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=195.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 567789999999999999876 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~- 513 (679)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999973 4568889999999999999999999 999999999999999999999999999975321000
Q ss_pred -----------------------------------------ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHH
Q 005750 514 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 552 (679)
Q Consensus 514 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~e 552 (679)
........||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112358999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 005750 553 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 628 (679)
Q Consensus 553 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 628 (679)
|++|+.||........ ............. + ........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET------QLKVINWETTLHI--P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH------HHHHhccCccccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999974432111 1111110000000 0 00112335677888876 5999999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.66 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=203.4
Q ss_pred HHHHHhhccccCcCccEEEEEEEE------cCCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccc-c
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E 425 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~ 425 (679)
....|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456788999999999999999974 247899999997543 23456788999999999 68999999998765 4
Q ss_pred ceEEEEEEecCCCcHhhhhcccCC--------------------------------------------------------
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 449 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 449 (679)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998864210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc-ccccc
Q 005750 450 --------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVA 520 (679)
Q Consensus 450 --------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~~~~ 520 (679)
...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 1246788889999999999999999 99999999999999999999999999998765332211 11222
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 599 (679)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... .+..+..... + ..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~--~-------~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMRA--P-------DY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCCCCC--C-------CC
Confidence 35678999999988899999999999999999997 999986332211 1111 1222211110 0 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 600 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
....+.+++.+||+.+|++|||+.||++.|+.+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12368899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.71 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=192.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 467789999999999999876 68999999987532 233456778899988885 5778889999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999873 4568999999999999999999999 999999999999999999999999999987543221
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
. ......|++.|+|||++.+..++.++||||+||++|+|++|+.||..... ....+ .... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~---~i~~-~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQ---SIME-HNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-CCC---------
Confidence 1 12234589999999999998999999999999999999999999974322 11111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
.++......+.+++.+||+.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=311.84 Aligned_cols=264 Identities=24% Similarity=0.402 Sum_probs=203.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-----------------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 417 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 417 (679)
...|++.+.||+|+||.||++... ++..||+|++.... .....++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 445778899999999999998543 23468999987543 334568999999999999999999
Q ss_pred ccccccccceEEEEEEecCCCcHhhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 418 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
+++++...+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999987532 12347788999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 566 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt--G~~pf~~~~~~ 566 (679)
|+++.++.++|+|||++......... ......++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998765332211 1122234678999999888889999999999999999998 77888633221
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
................... + .+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111111110 0 111233578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.58 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=195.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|.+.+.||+|+||.||++..+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 556789999999999999875 68999999986432 23346688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999873 4678899999999999999999999 9999999999999999999999999999864221000
Q ss_pred c----------------------------------------------ccccccCCccccCCcccCCCCCCchhHHHHHHH
Q 005750 515 H----------------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 548 (679)
Q Consensus 515 ~----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGv 548 (679)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 005750 549 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 625 (679)
Q Consensus 549 ll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ev 625 (679)
++|||++|+.||...+... . ..............+ .......+.+++.+|++ +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE---T---YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH---H---HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997433211 1 111111000000000 00122467899999997 66665 599998
Q ss_pred HHH
Q 005750 626 VLA 628 (679)
Q Consensus 626 l~~ 628 (679)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.00 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=192.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456789999999999999875 68899999987532 23345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~- 513 (679)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999873 4568899999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------ccccccccCCccccCCcccCCCCCCchhHHHHHHH
Q 005750 514 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 548 (679)
Q Consensus 514 ---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGv 548 (679)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 005750 549 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 625 (679)
Q Consensus 549 ll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 625 (679)
++|||++|+.||...+.... ............. + ........+.+++.+|+ .+|.+|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHI--P-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCC--C-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999974332111 1111110000000 0 00111235667777776 49999997 8887
Q ss_pred HH
Q 005750 626 VL 627 (679)
Q Consensus 626 l~ 627 (679)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=323.92 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=205.3
Q ss_pred ccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhh
Q 005750 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 442 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 442 (679)
+||+|.||+||.|++. +...+|||.+........+.+.+|+.+.++|+|.|||+++|.+.++++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999876 467899999987777777889999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEeeccCccccccCccccccccc
Q 005750 443 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 521 (679)
Q Consensus 443 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~ 521 (679)
+++..-..-.-.+.++-.+.+||++||+|||+ ..|||||||-+||||+ -.|.+||+|||-++.... .......+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 99864322223788888899999999999999 9999999999999996 689999999999988654 334455667
Q ss_pred CCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHH
Q 005750 522 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599 (679)
Q Consensus 522 gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 599 (679)
||..|||||++..+ .|+.++|||||||++.||.||++||..-..+... ..+-|-+ ...+..+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcce------ecCCCCcHH
Confidence 99999999999765 6889999999999999999999999732221110 0111111 123455667
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 600 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+...+|.+|+.++|.+||+++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 77789999999999999999999999863
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.39 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=200.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
-|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677889999999999999877 478899999876655566788999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|..++.. ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988764 24568999999999999999999999 9999999999999999999999999999876533221 1
Q ss_pred cccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 517 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.....++..|+|||++. +..++.++|||||||++|+|++|+.||...+. ...... .... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~----~~~~-~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLK----IAKS-EPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHH----Hhhc-CCCCCC---
Confidence 22345788999999973 44577899999999999999999999973321 111111 1111 100100
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223478899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.65 Aligned_cols=256 Identities=25% Similarity=0.283 Sum_probs=207.2
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
.+.-..+++.+.||.|.-|+||++.+++ +..+|+|++.+..- ....+...|-+||+.++||.++.+|..|+.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4445566778999999999999999884 68999999987533 3445677899999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
|+|||||+||+|....+.+ .++.+++..++.++..++-||+|||- .|||+|||||+||||.++|++-|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999887755 57889999999999999999999998 9999999999999999999999999988754
Q ss_pred cccC--------------------------------c-c----------------------cccccccCCccccCCcccC
Q 005750 509 AEED--------------------------------L-T----------------------HISSVARGTVGYLDPEYYG 533 (679)
Q Consensus 509 ~~~~--------------------------------~-~----------------------~~~~~~~gt~~y~aPE~l~ 533 (679)
.... . . ..+...+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 2110 0 0 0011235899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcc
Q 005750 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 613 (679)
Q Consensus 534 ~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 613 (679)
+...+.+.|.|+|||++|||+.|..||.+..... .+...+. +.+.-...+.....+.+||++.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999998655432 2222111 111111122444578999999999
Q ss_pred cCCCCCCC----HHHHHH
Q 005750 614 QRGFSRPK----MQEIVL 627 (679)
Q Consensus 614 ~dP~~RPt----~~evl~ 627 (679)
+||.+|.. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.39 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=205.7
Q ss_pred HHHhhccccCcCccEEEEEEEEc-----CCcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccc--cceE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 428 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 428 (679)
..+++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667799999999999999864 3689999999765443 56789999999999999999999999877 5578
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999753 3368999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchh--------hHHHHHHHh
Q 005750 509 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 578 (679)
Q Consensus 509 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~--------~~~~~~~~~ 578 (679)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998889999999999999999999999998632221100 001111111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
+..+.. ...+...+..+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111110 011122335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.06 Aligned_cols=264 Identities=21% Similarity=0.252 Sum_probs=193.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc--------cce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EHQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~~~ 427 (679)
..|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 35777899999999999999875 68999999885432 234579999999999999999887632 124
Q ss_pred EEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccC
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGL 505 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgl 505 (679)
.++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6799999975 6766664322 45678999999999999999999999 9999999999999998654 799999999
Q ss_pred ccccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--- 581 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 581 (679)
++....... .....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+ .+..... .+..
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTE 292 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCH
Confidence 987543322 123457899999998865 468999999999999999999999997443221 1111111 1100
Q ss_pred -------CCeee-----eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 005750 582 -------GDVIS-----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 633 (679)
Q Consensus 582 -------~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 633 (679)
..... .....+...++.....++.+++.+||+.||.+|||+.|+++. ++++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000 000001111111234578899999999999999999999843 55443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.54 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=201.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
...|.+.+.||+|+||.||+|... +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999875 6899999998765555556788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++.. ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 515 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
......|+..|+|||++. ...++.++|||||||++|+|++|+.||....... .... .. ..... .+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~----~~-~~~~~---~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL----MT-KSNFQ---PPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh----hh-ccCCC---CCc
Confidence 122345889999999874 4568899999999999999999999986322111 1111 00 01100 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .......+.+++.+||+.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 0112235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=310.67 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=203.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...+++.+.||+|+||.||+|... ++..||+|++..... ....++.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345667889999999999999864 468899999875433 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 429 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999987421 12357888999999999999999998 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875432211 11112234667999999988899999999999999999998 88888632221
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
+... .+..+.... .+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 240 -----~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 122222211 011223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.93 Aligned_cols=237 Identities=27% Similarity=0.386 Sum_probs=188.0
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHH-HHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 68899999986532 122334555554 67888999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|...+. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence 99998886 34568889999999999999999999 9999999999999999999999999999875322211 22
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ... .... .... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~---~~i~-~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMY---DNIL-HKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHH---HHHh-cCCC----------CCC
Confidence 3345899999999999989999999999999999999999999743221 111 1111 1110 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.31 Aligned_cols=240 Identities=23% Similarity=0.408 Sum_probs=190.0
Q ss_pred cccCcCccEEEEEEEEcC-------------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 363 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997542 2358999887655555667889999999999999999999999988999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc-------EEEee
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 502 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kL~D 502 (679)
+||||+++|+|..++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887642 3568999999999999999999999 99999999999999986654 89999
Q ss_pred ccCccccccCcccccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHH-hCCCCCCcccccchhhHHHHHHHhHh
Q 005750 503 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 503 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||........ . ...
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~---~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E---RFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H---HHH-
Confidence 9998754322 1234678899999886 467899999999999999997 58888863222111 0 011
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.+.. .. .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 223 ~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 00 0112346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.03 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=202.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
..+...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45566789999999999999865 2467999988654433 4577999999999999999999999999989999
Q ss_pred EEEEecCCCcHhhhhcccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeec
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 503 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 503 (679)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 268999999999999999999998 99999999999999999999999999
Q ss_pred cCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 504 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 504 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HHcC
Confidence 9987543322222222345678999999988888999999999999999998 8889862211 111111 1111
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.... ......+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 235 ~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 011123347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.59 Aligned_cols=268 Identities=22% Similarity=0.251 Sum_probs=207.5
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-C-----CCccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-----RNLVPLIGYCE 423 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~ 423 (679)
..|....+|.+.+.||+|.||.|-+|.+. +++.||||++++. .....+...|+.+|..|+ | -|+|+++++|.
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34444448888999999999999999765 6999999999865 344566778999999996 4 38999999999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC--CcEEEe
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVS 501 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~ 501 (679)
..++.|||+|.+ .-+|.++++... -..++...++.++.||+.||.+||+ .+|||+||||+|||+.+. ..+||+
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEE
Confidence 999999999999 569999999763 5569999999999999999999999 999999999999999653 469999
Q ss_pred eccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh---
Q 005750 502 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--- 578 (679)
Q Consensus 502 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~--- 578 (679)
|||.|+....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+..+...
T Consensus 334 DFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 334 DFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999987654322 445688999999999999999999999999999999999988865543332222111100
Q ss_pred ------------Hhc-CCeeeee----------------------cccccC--------CCCHHHHHHHHHHHHHhcccC
Q 005750 579 ------------IKK-GDVISIV----------------------DPVLIG--------NVKIESIWRIAEVAIQCVEQR 615 (679)
Q Consensus 579 ------------~~~-~~~~~~~----------------------d~~l~~--------~~~~~~~~~l~~li~~cl~~d 615 (679)
... ....... +..... .........+++++++||++|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 011 0000000 000000 011133457899999999999
Q ss_pred CCCCCCHHHHHHH
Q 005750 616 GFSRPKMQEIVLA 628 (679)
Q Consensus 616 P~~RPt~~evl~~ 628 (679)
|.+|+|+.|+++.
T Consensus 490 P~~R~tp~qal~H 502 (586)
T KOG0667|consen 490 PAERITPAQALNH 502 (586)
T ss_pred chhcCCHHHHhcC
Confidence 9999999999864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.01 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=201.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 4667789999999999999864 689999999876555556778899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999886 3458999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... . . .... ...... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~-~---~~~~-~~~~~~-------~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L-Y---LIAT-NGTPEL-------QN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---HHHh-cCCccc-------CC
Confidence 2233578899999999988899999999999999999999999974332111 1 1 1111 111000 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+......+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.71 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=202.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|.+.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56777899999999999999864 79999999997655555677889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999986 3457889999999999999999999 99999999999999999999999999998765433221
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||...+..... . .....+ . +. ..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~----~~~~~~-~-----~~--~~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-T-----PE--LQ 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--e----eeccCC-C-----CC--CC
Confidence 22335788999999999888999999999999999999999999743321100 0 000000 0 00 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223346789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.66 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=207.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+....|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34567888999999999999999876 68899999876543 34457889999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .++++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998873 4568999999999999999999996 25899999999999999999999999999865432
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc-----chhhHHHHHHHhHhcCCeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 586 (679)
.. .....++..|+|||++.+..++.++|||||||++|++++|+.||...... ....+..+.........
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 21 12345889999999998888999999999999999999999999743321 11122233333222111
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
+.+. ....+..+.+++.+|++.||.+|||++|+++..
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1110 112345688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.43 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=198.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch---------hHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
|.+...||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456789999999999999875 5889999988643221 125688899999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999973 4568899999999999999999998 9999999999999999999999999999887
Q ss_pred cccCccc-----ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 509 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 509 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
....... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... .. +.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~-~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QA---IFKIG-EN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HH---HHHHh-cc-
Confidence 6532111 111234788999999999888999999999999999999999999732211 11 11111 11
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+ ..+......+.+++.+||+.+|.+||++.||++
T Consensus 228 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 112223457889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=303.80 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=203.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|+..+.||.|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45666788999999999999876 58899999987543 34557788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998863 458899999999999999999999 9999999999999999999999999999976543322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||....... ... ....+. ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~---------~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF----LIPKNN---------PP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh----hhhcCC---------CC
Confidence 1223347889999999988889999999999999999999999997332111 111 011111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......+..+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456678999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.04 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=200.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||.||++..+ +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4678899999999999999887 7899999988654 2334567889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++........+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988753334478999999999999999999996 25999999999999999999999999999876533221
Q ss_pred ccccccCCccccCCcccCCC------CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 516 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... ......... .+..
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~----- 227 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGDP----- 227 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcCC-----
Confidence 223478899999998554 34889999999999999999999997332211 111111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+......+.+++.+||+.+|.+||+++++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112234457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.88 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|.+.+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4667889999999999999876 68899999986432 233456778999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 6 5888888643 4568899999999999999999999 99999999999999999999999999998764332211
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---CCeeeeec--
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 589 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 589 (679)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... ........... ......++
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 122346889999998765 457889999999999999999999997443321 11111111100 00000000
Q ss_pred -------ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 -------PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 -------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001122346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=309.83 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=196.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456789999999999999876 68999999986432 223467888999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+ ++|.+++........+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6888888754445678999999999999999999999 9999999999999999999999999999876533221
Q ss_pred ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc--C---------C
Q 005750 516 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--G---------D 583 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~---------~ 583 (679)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ........... . .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence 11223468899999988654 578999999999999999999999974322110 11100000000 0 0
Q ss_pred ----eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 ----VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......... .........++.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=323.08 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=199.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
+....|++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34467788899999999999999887 68899999986421 223456788999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999999863 357888899999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. .............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSL 266 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 54333233345689999999998653 3788999999999999999999999743321 1111122111111
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
...+ .......+.+++.+||+..+.+ ||+++|+++.
T Consensus 267 ~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 1122346789999999844433 7899988875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.31 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=160.5
Q ss_pred ccccCcCccEEEEEEEEc---CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc--cceEEEEEEecC
Q 005750 362 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 436 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 436 (679)
.++||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986542 23457789999999999999999998843 456889999985
Q ss_pred CCcHhhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc----cCCCcEEEeeccCc
Q 005750 437 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 506 (679)
Q Consensus 437 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfgla 506 (679)
++|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877765321 22358899999999999999999999 999999999999999 45678999999999
Q ss_pred cccccCccc--ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 507 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 507 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
......... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876443221 1223458999999999876 46899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.13 Aligned_cols=259 Identities=25% Similarity=0.309 Sum_probs=192.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhc---cCCCcccccccccc-----cce
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 427 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~~ 427 (679)
|++.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 566789999999999999876 689999999865321 2234566777777766 69999999998754 345
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+. ++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 799999997 5888888643 24458999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---CCe
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDV 584 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~ 584 (679)
....... .....++..|+|||++.+..++.++||||+||++|+|++|++||........ +.... ..... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~-~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIF-DLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHH-HHhCCCChhhC
Confidence 6543221 1234578899999999988999999999999999999999999974332211 11111 11100 000
Q ss_pred e-------eeeccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 I-------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ..+.+... ..........+.+++.+||++||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011123446789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.46 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=200.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.++||.|+||.||+|... +++.|++|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999876 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|..++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998887642 3568999999999999999999998 99999999999999999999999999988754332211
Q ss_pred ccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 516 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.....++..|+|||++. ...++.++|||||||++|+|++|+.||..... . ........ .......
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~----~~~~~~~~-~~~~~~~-- 236 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--M----RVLLKIAK-SEPPTLS-- 236 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--H----HHHHHHhc-CCCccCC--
Confidence 12334788999999984 34568899999999999999999999963221 1 11111111 1111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122346889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.36 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=198.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 455688999999999999876 68999999986432 12235577899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
. ....|+..|+|||++.+..++.++||||+||++|+|++|+.||............ ........ ..
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~~~------~~--- 223 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVQ------EE--- 223 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhhhh------hh---
Confidence 1 2235899999999999989999999999999999999999999743221111111 11111000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
........+.+++.+||+.||++||| ++|+++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11112336789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.48 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=200.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
|++.+.||+|+||.||++.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 566789999999999999876 58889999886543 2344678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++.. ...+++..+..++.|+++||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999973 4668999999999999999999997 2589999999999999999999999999987653321
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee-----------
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 585 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 585 (679)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCCC
Confidence 22345788999999998888999999999999999999999999643321 1111111000000000
Q ss_pred ---------eeecccc---cCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 586 ---------SIVDPVL---IGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 586 ---------~~~d~~l---~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+..+... ....+ ......+.+++.+||+.+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0123468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.00 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=202.6
Q ss_pred HHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 356778899999999999999874 88999999875432 678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998642 4578999999999999999999998 9999999999999999999999999999887654322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. . ...... +.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~---~-~~~~~~-----~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IF---M-IPNKPP-----PTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hh---h-hccCCC-----CCC--C
Confidence 12233478899999999988999999999999999999999999973322110 00 0 000000 000 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|.+|||++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223346889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.36 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=200.9
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc---CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
.+....|++.+.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456888999999999999999754 3678999987643 23568999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+|||++. ++|.+++. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68888884 35679999999999999999999999 99999999999999999999999999999765
Q ss_pred ccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee--e
Q 005750 510 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S 586 (679)
Q Consensus 510 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 586 (679)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+...+...... .
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 443221 2223468999999999999999999999999999999999999997544332111111111111100000 0
Q ss_pred -----------eecccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 -----------IVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 -----------~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+.......+. ......+.+++.+||+.||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0113467889999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.55 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=193.7
Q ss_pred cccCcCccEEEEEEEEc----CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCccccccccc-ccceEEEEEEecC
Q 005750 363 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 436 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 436 (679)
+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999988543 2344577889999999999999999999765 4556889999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc-
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 515 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~- 515 (679)
+|+|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998743 3446778888999999999999998 99999999999999999999999999998765332110
Q ss_pred --ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 516 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 516 --~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
......++..|+|||.+.+..++.++|||||||++|||++| .+||... ........+ . .+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~---~-~~~~~~------ 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYL---L-QGRRLL------ 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH---h-cCCCCC------
Confidence 11122356789999999888899999999999999999995 5555421 111222211 1 111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011123468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.87 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=187.9
Q ss_pred ccCcCccEEEEEEEEcC-------------------------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccc
Q 005750 364 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 418 (679)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 23589999876544455678889999999999999999
Q ss_pred cccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC--
Q 005750 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 496 (679)
Q Consensus 419 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 496 (679)
++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988642 4568899999999999999999998 9999999999999997543
Q ss_pred -----cEEEeeccCccccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHH-hCCCCCCcccccchh
Q 005750 497 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 569 (679)
Q Consensus 497 -----~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~ell-tG~~pf~~~~~~~~~ 569 (679)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987654322 11236788999998865 56899999999999999985 6999987332211
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
..... .... ... ......+.+++.+||+.+|++|||+++|++.|.
T Consensus 230 -~~~~~----~~~~-------~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERFY----EKKH-------RLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----Hhcc-------CCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 1100 000 011236889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.78 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=195.5
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
...||+|+||.||+|.+. +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 468999999999999865 5788999998776666677899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCccccccCccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 519 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla~~~~~~~~~~~~~ 519 (679)
.+++.........++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||.+........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999753211123788889999999999999998 99999999999999976 67999999999876543222 1222
Q ss_pred ccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 520 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 520 ~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+...... .....+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----------~~~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-----------IHPEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----------cCCCCC
Confidence 3478899999998654 37889999999999999999999996322111 1111110000 001112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223456889999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=316.86 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=196.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 567899999999999999876 5899999998642 122345688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999998642 4568999999999999999999999 9999999999999999999999999999876544333
Q ss_pred cccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 515 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.......|++.|+|||++.. ..++.++||||+||++|+|++|+.||...... +.............+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccCCC
Confidence 22333458999999999863 45788999999999999999999999743221 11111121111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~ 628 (679)
........+.+++.+|+..++ ..||+++++++.
T Consensus 232 ------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011123467788888775533 348899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.11 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=195.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc------
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------ 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 426 (679)
...|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 356777899999999999999875 68999999986532 234567889999999999999999999885433
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 5666554 247888899999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh------------H---
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------I--- 571 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~------------~--- 571 (679)
....... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...... .
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7643321 1223457899999999999999999999999999999999999997543211100 0
Q ss_pred -HHHHHHhHhcCCe------eeeeccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 572 -VHWARSMIKKGDV------ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 572 -~~~~~~~~~~~~~------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+......... .+....... ..........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001111110000 000000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.29 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=201.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4667889999999999999876 68999999987543 344567889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++.. ..+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999873 378999999999999999999998 99999999999999999999999999999876543221
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ... . .+...... .+...
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~---~-~~~~~~~~-----~~~~~ 221 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVL---F-LIPKNNPP-----SLEGN 221 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHH---H-HhhhcCCC-----CCccc
Confidence 22335788999999999888999999999999999999999999733211 111 1 11111111 11111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+.+++.+||+.+|++|||++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.25 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=197.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|+..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 445688999999999999876 689999999865321 2234578899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888643 23469999999999999999999999 9999999999999999999999999999876533221
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||....... .... +.........
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~-~~~~~~~~~~---------- 222 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREE-VDRRVLETEE---------- 222 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHhhhcccc----------
Confidence 123358999999999998899999999999999999999999997332211 1111 1111111110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.+.......+.+++.+|++.+|++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111122346789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=338.75 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=203.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.++||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3567889999999999999876 58999999987532 2335678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 434 YMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
|++||+|.+++.... .....++..++.++.||++||+|||+ +||+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999886421 12345677889999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc-----------------cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch
Q 005750 506 SRQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568 (679)
Q Consensus 506 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~ 568 (679)
+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k- 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK- 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence 986521110 01112458999999999999999999999999999999999999997422111
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKI 635 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 635 (679)
... .... .++.-. ......+..+.+++.+|++.||++|| +++++++.|+.....
T Consensus 239 --i~~--~~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 --ISY--RDVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --hhh--hhhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 0000 000000 00112334688999999999999996 677888888887664
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.53 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.3
Q ss_pred cccCcCccEEEEEEEEcC---CcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 46799998875432 34457889999999999999999999999988999999999999
Q ss_pred cHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 439 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 439 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 22356777888999999999999999 999999999999999999999999999987643322211
Q ss_pred -cccccCCccccCCcccCCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 517 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 517 -~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .... ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1223467889999998642 35789999999999999996 999996332211 1111 111 111111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12335778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.25 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=203.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||.|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4667889999999999999875 578999999986655567889999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 3578999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred cccccCCccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 517 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+... .... ....... .+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~~~~---~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKSNFP---PPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhccCC---Cccc-
Confidence 2234578899999998776 88999999999999999999999997433211 1111 1111000 0011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.+|.+|||+++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.34 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=202.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.+.||.|++|.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35778899999999999999875 68999999987665666678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 4568999999999999999999999 99999999999999999999999999988765432221
Q ss_pred ccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 516 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.. ... .. +..+.....
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~----~~-~~~~~~~~~--- 228 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVL----LK-ILKSEPPTL--- 228 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHH----HH-HhcCCCCCc---
Confidence 22334788999999874 345678999999999999999999999733211 111 11 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.15 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=189.6
Q ss_pred cccCcCccEEEEEEEEcCCc-----------EEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 363 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+.||+|+||.||+|.+.+.. .|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999887432 5788877654333 6788999999999999999999999887 778999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-------cEEEeecc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 504 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kL~Dfg 504 (679)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999753 2268999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhc
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
++...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||....... ...+.. .
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~----~ 221 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ----D 221 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh----c
Confidence 98865431 123356789999999876 78999999999999999999 577776332111 111110 1
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.... +......+.+++.+||..+|.+|||+.||++.|+
T Consensus 222 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1000 0001157889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.85 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=196.0
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc------cceE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 428 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------~~~~ 428 (679)
..|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++.. ....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 44667789999999999999876 58899999986543 3346788999999998 69999999999864 2468
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+++|||+++++|.+++... ....+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999998753 24568899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
...... ......|+..|+|||++. +..++.++|||||||++|+|++|+.||...+.... .. . .....
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~---~-~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LF---L-IPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HH---H-HhcCC
Confidence 543222 123345888999999985 34678899999999999999999999963221110 00 0 01111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. +.. ........+.+++.+||+.+|.+|||++|+++
T Consensus 233 ~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 A-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 111 11122346889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.67 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=197.8
Q ss_pred cccCcCccEEEEEEEEcC-------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998653 2579999886543 24466788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-----cEEEeeccC
Q 005750 435 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 505 (679)
Q Consensus 435 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~Dfgl 505 (679)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987532 22457889999999999999999998 9999999999999999877 899999999
Q ss_pred ccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 506 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 506 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
+........ .......++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ...... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcCC
Confidence 876533211 11122235678999999999899999999999999999998 9999863221 111111 11111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.. ......+..+.+++.+||+.+|.+||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1112234578899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.63 Aligned_cols=250 Identities=33% Similarity=0.557 Sum_probs=201.5
Q ss_pred hhccccCcCccEEEEEEEEcC-----CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
++.+.||.|+||.||++...+ +..||+|++...... ..+.+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356889999999999998764 488999999765433 56789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999987432 1228999999999999999999999 999999999999999999999999999998765442
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+. ....+.+ ..+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~------ 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL----KKGYRLP------ 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCCCC------
Confidence 222222336789999999988889999999999999999998 8888863211 1222211 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
........+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111345788999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.26 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=199.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccc-cceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E~ 434 (679)
|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567899999999999999876 57899999986432 3345678899999999999999999998764 4467899999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ....+++.+++.++.|++.|+++||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999998753 24568999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.. ....... .+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~--------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKLP--------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcCCC---------
Confidence 222345788999999999999999999999999999999999999733221 1111111 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223347889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.98 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=193.7
Q ss_pred hccccCcC--ccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 361 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 361 ~~~~LG~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999875 78999999987542 233456778999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458999999999999999999999 99999999999999999999999999865443211110
Q ss_pred ------ccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 516 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 516 ------~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........ +.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~-----~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLN-----GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhc-----CCcccc
Confidence 0112235678999999876 46889999999999999999999999732211 11111100 000000
Q ss_pred ec-------------------c-----------------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VD-------------------P-----------------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d-------------------~-----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
++ . .............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 0000111123447889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.68 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=205.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||+|.|+.|-+|++- +|..||||++.+.. .....++.+|++.|+.++|||||++|++...+..+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 556688999999999999865 79999999997653 334567899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc-cCCCcEEEeeccCccccccCcc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
.+|+|++++-+. ...+.+.-..+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.....
T Consensus 100 D~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred CCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999764 5679999999999999999999999 999999999999866 5678999999999987765433
Q ss_pred cccccccCCccccCCcccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
-...+|+..|-|||++.+..|. ++.||||||||||.|+.|+.||+.....+.. .-++|-.
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK-- 235 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK-- 235 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc--
Confidence 2446799999999999988775 7899999999999999999999843332221 1122221
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
-.++.....++.+||..||..||.+|.+.+||+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1344555668999999999999999999998864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.86 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=198.6
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc------chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 45678899999999999998889999999886432 122356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999973 3568899999999999999999998 99999999999999999999999999998764321
Q ss_pred c-----ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 513 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 513 ~-----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
. ........++..|+|||++.+..++.++|||||||++|+|++|+.||...+... .... .. ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-~~--~~~~~~--- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY-IG--AHRGLM--- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH-hh--hccCCC---
Confidence 1 111123357889999999998889999999999999999999999997322111 1100 00 000111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.+ +......+.+++.+||+.+|.+||++.|+++
T Consensus 228 --~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 --PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1123346889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.39 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=163.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
....|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3445778899999999999999876 5788999985432 23468999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
++. ++|.+++.. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 688888764 34578999999999999999999999 999999999999999999999999999987533221
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
. .....|+..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 A--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 12345899999999999999999999999999999999865554
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=305.18 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=189.9
Q ss_pred cccCcCccEEEEEEEEcC--------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.||+|+||.||+|..+. ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 235888888655555567788999999999999999999999998899999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc--------EEEeeccCc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 506 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~Dfgla 506 (679)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3468999999999999999999999 99999999999999987665 699999988
Q ss_pred cccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCC-CCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||...+... ... .... .
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~-~- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYED-R- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHc-c-
Confidence 754332 22346789999999976 45789999999999999999985 5554221111 111 1111 0
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
. ..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.11 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=190.1
Q ss_pred cccCcCccEEEEEEEEcC---CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997543 4578888876443 234467889999999999999999999999999999999999999
Q ss_pred cHhhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc-c
Q 005750 439 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 515 (679)
Q Consensus 439 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~-~ 515 (679)
+|.+++..... ....++.....++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975431 2345678888999999999999999 9999999999999999999999999999875432211 1
Q ss_pred ccccccCCccccCCcccC-------CCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 516 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
......++..|+|||++. ...++.++|||||||++|||++ |..||..... . .. .......+. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~-~~---~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--E-QV---LKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--H-HH---HHHHhhccC-ccC
Confidence 112233567899999864 3456889999999999999999 7888863221 1 11 111122211 112
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.++.+ .......+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222 1223345677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.50 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=195.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc------ce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 427 (679)
..|++.+.||+|+||.||++... .++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 46777899999999999999865 68999999987532 23446778899999999999999999987543 35
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 7999999965 6666664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHH-------------
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH------------- 573 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~------------- 573 (679)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...... ..+
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543221 223458999999999999899999999999999999999999997543221110 000
Q ss_pred --HHHHhHhcC-Ceeeeecccc-----c---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 574 --WARSMIKKG-DVISIVDPVL-----I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 574 --~~~~~~~~~-~~~~~~d~~l-----~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+....... .......+.. . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 001111100 0000000000 0 00111123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.80 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=205.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC-Cc----EEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
....+++.+.||+|+||.||+|.+++ |+ .||+|....... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34566788999999999999998653 33 689998876543 345678899999999999999999999887 788
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+..
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998753 3458999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccccc-ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 509 AEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 509 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||...... .+.+. +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~- 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL----LEKGERL- 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhCCCCC-
Confidence 653322211 11223568999999988889999999999999999998 99999743221 12221 1111110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+......+.+++.+||..+|.+||++.++++.|+++..
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122367899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.13 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=199.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 445688999999999999864 689999999864321 1346788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 510 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~ 510 (679)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++|+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999873 4568899999999999999999999 9999999999999998765 59999999987765
Q ss_pred cCccc---ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 511 EDLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 511 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~----- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASAT----- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccC-----
Confidence 43211 11233578899999999888899999999999999999999999974332221111 11111100
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+......+.+++.+|++.+|.+||++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011222334457889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.58 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=203.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||.|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 567789999999999999765 6889999987643 2344567889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997542 4568999999999999999999998 9999999999999999999999999999876644332
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .+...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC--------
Confidence 22334578999999999888889999999999999999999999973221 11111111 1211111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......++.+++.+||+.+|.+||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=299.34 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=198.4
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57889999986532 346788999999999999999999998765 4799999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999999754 24468899999999999999999998 999999999999999999999999999987643221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...... ...+ .+..+....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~--------- 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE----CVEKGYRME--------- 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhCCCCCC---------
Confidence 11224568999999988899999999999999999998 99999733221 1111 111111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111233578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=297.82 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=198.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
|+..+.||+|++|.||+|..+ +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455688999999999999887 78999999886432 234567889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999873 4568899999999999999999999 99999999999999999999999999998765433
Q ss_pred cccccccccCCccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... .. .............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~----~~~~~~~~~~~~~------ 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GV----AAVFKIGRSKELP------ 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HH----HHHHHHHhcccCC------
Confidence 2 122345788999999987766 8999999999999999999999997322 11 1111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122346789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.30 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=198.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3566789999999999999986 589999998865322 2346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|..+... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999887652 3458999999999999999999999 9999999999999999999999999999876544322
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHh-------HhcCCee
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSM-------IKKGDVI 585 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~-------~~~~~~~ 585 (679)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+. ..+..+.... .......
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 1223347889999999865 4578899999999999999999999974332111 0111100000 0000000
Q ss_pred -eeecccccC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 -SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 -~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+.... .........+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001123457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.82 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=194.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 68999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999873 4678999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 515 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 515 ----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011245899999999999999999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005750 561 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 628 (679)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 628 (679)
....... ............. +.+. ......+.+++.+|+. +|.+|++ +.|+++.
T Consensus 237 ~~~~~~~------~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE------TYRKVMNWKETLV-FPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH------HHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7433211 1111111110000 1110 0122357788888774 9999995 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.17 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=198.1
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 98875 3568999999999999999999998 99999999999999999999999999998755433221 2234
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||++.+..++.++|||||||++|+|++|+.||...+.. ..... +....... . ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~----~~~~~~~~-----~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR----LRDSPPPK-----L--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhccCCCC-----c--cccCCC
Confidence 5789999999999888999999999999999999999999733221 11111 11111000 0 001112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+.+++.+||+.+|.+||+++|+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3468899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=321.86 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=193.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+||+++++++...+..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 4566789999999999999876 57899999643 2345689999999999999999999999999999999994
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc-c
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 515 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~-~ 515 (679)
++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 244 -~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 -SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred -CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 7888887642 3469999999999999999999999 9999999999999999999999999999986543221 1
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc-----chhhHHHHHHHhHhc-CCeeeeec
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKK-GDVISIVD 589 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~d 589 (679)
......||..|+|||++.+..++.++|||||||++|||++|..|+...... ....+.+.+...... ........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 122345899999999999999999999999999999999988765422211 111122221111000 00000000
Q ss_pred ccc------------cCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVL------------IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l------------~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+ ..... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000 0112257899999999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=299.54 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=190.1
Q ss_pred cccCcCccEEEEEEEEcCC---cEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 356677665433 344578999999999999999999999999999999999999999
Q ss_pred cHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC-cccc
Q 005750 439 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 516 (679)
Q Consensus 439 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~-~~~~ 516 (679)
+|.+++.... .....++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997543 23456777788999999999999999 99999999999999999999999999988643221 1111
Q ss_pred cccccCCccccCCcccCC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 517 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... . +.....+.. ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~---~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---R---EVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHHhh-cccccC
Confidence 223457889999998743 245789999999999999997 5677752221 1 111112222 222233
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
++.+...+ ...+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 246778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.25 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=196.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.++||+|+||.||+++.+ +++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 567789999999999999877 57889999986421 22334578899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 4568999999999999999999999 9999999999999999999999999999876543333
Q ss_pred cccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 515 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC--
Confidence 2333456899999999985 34678999999999999999999999974322 1111222211110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGF--SRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 628 (679)
+ .........+.+++.+|+..++. .|++++|+++.
T Consensus 230 p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00112234677889998865444 47899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.20 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=201.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567789999999999999875 68999999987543 334567899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+++|.+++... ...+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998743 3668999999999999999999999 99999999999999999999999999998876543322
Q ss_pred ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC-----------
Q 005750 516 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 583 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 583 (679)
......++..|+|||.+.+. .++.++||||+||++|+|++|.+||...... ..............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22334578899999998654 5689999999999999999998888633221 11111111111000
Q ss_pred -eeeeecccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 -VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 -~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......+.. ...........+.+++.+||+.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.36 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+++.+ +++.||+|++.+.. ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 567789999999999999876 58899999986521 22345578899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568899999999999999999999 9999999999999999999999999999987654433
Q ss_pred cccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 515 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.. +............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ-FP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc-CC
Confidence 22333468999999999865 46788999999999999999999999733221 11111111111000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
+. .......+.+++.+|+...+.+ |++++++++.
T Consensus 231 ~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0112346888999999866544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=297.93 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=201.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCccccccccc--ccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E 433 (679)
|++.+.||.|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++. .....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456789999999999999865 6889999998643 2344567889999999999999999999775 3456799999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|+++++|.+++.... ....+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999987532 3467899999999999999999999211 2899999999999999999999999999998765
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+. ....+ .+..+..
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~------ 227 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKF------ 227 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCC------
Confidence 43321 2233578999999999988899999999999999999999999974331 11222 1222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+......+.+++.+|++.+|.+||++++|++.
T Consensus 228 ---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.94 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=195.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc------ce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 427 (679)
..|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45777899999999999999876 68899999987532 33456788999999999999999999987543 35
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999964 6777664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHH-------------
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH------------- 573 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~------------- 573 (679)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+...... +.+
T Consensus 175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6543221 223458999999999999999999999999999999999999997543321110 000
Q ss_pred --HHHHhHhcCC-eee-----eecccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 574 --WARSMIKKGD-VIS-----IVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 574 --~~~~~~~~~~-~~~-----~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+........ ... ...... ...........+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 000 000000 000011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.65 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=200.6
Q ss_pred HhhccccCcCccEEEEEEEEcC--CcEEEEEEecCC----------cchhHHHHHHHHHHHHh-ccCCCccccccccccc
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADS----------CSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 425 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~ 425 (679)
|.+.+.||+|+||.||+|.++. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567899999999999999875 788999987532 12234557788888875 6999999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998875422 34578999999999999999999995 2689999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .... . ...+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLAT---K-IVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHH---H-HhhccC
Confidence 998754432 223345788999999999888999999999999999999999999632211 1111 1 111111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
... . .......+.+++.+||+.||++||++.|+..++++
T Consensus 231 ~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 110 0 11123468899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.76 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=201.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|++|.||+|.++ +++.|++|+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3567889999999999999877 58899999986532 23346789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++++.+..+.. ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766554 34568999999999999999999999 9999999999999999999999999999887655433
Q ss_pred cccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh------------c
Q 005750 515 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------------K 581 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------~ 581 (679)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. .......+. .
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccC
Confidence 223334578899999999887 889999999999999999999999974322111 111111000 0
Q ss_pred CCee-----eeecccc-cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 582 GDVI-----SIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 582 ~~~~-----~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... ...++.. ...++.....++.+++++||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000 00111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=306.32 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=201.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
....++..+.||+|+||.||+|.+. +|+ .||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3445556789999999999999864 343 578998875432 3345788999999999999999999998754 46
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 7999999999999998742 3468899999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 509 AEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 509 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+++ ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC
Confidence 5432221 1112235678999999998899999999999999999997 9999963321 1222222 1111110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
........+.+++.+||..+|++||+++++++.|+++...
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 ---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111234688999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=303.65 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=198.2
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999875 6889999998765555667789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++......... ....
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 99885 3458899999999999999999999 99999999999999999999999999998765432221 2234
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+.. ........ . +.+.... ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~----~-----~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRD----N-----LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----c-----CCCcccc--cccc
Confidence 5788999999998888999999999999999999999999733221 11111111 0 0111111 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+.+++.+|++.+|.+|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3367899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.52 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=193.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCccccccccccc------ce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 427 (679)
..|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45777899999999999999865 688999999875422 2345677899999999999999999987543 35
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.+++++++ +++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 789988775 3468999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--- 583 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 583 (679)
...... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... +.. .........
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKR-IMEVVGTPSPEV 239 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence 654322 23458899999999876 5788999999999999999999999974332111 111 100000000
Q ss_pred --------eeeeec--ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 --------VISIVD--PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 --------~~~~~d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+. +.... .........+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 0000112347799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.65 Aligned_cols=261 Identities=19% Similarity=0.277 Sum_probs=190.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccC------CCccccccccccc-ce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~-~~ 427 (679)
...|++.++||+|+||+||+|.+. .++.||||+++... ...+.+..|+++++.++| .+++++++++... .+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 345777899999999999999875 58899999986432 233456678888877754 4588888888654 57
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-----------
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----------- 496 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----------- 496 (679)
.++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ +.||+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence 88999988 7788888863 4578999999999999999999996 24999999999999998765
Q ss_pred -----cEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 005750 497 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571 (679)
Q Consensus 497 -----~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~ 571 (679)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987643222 2345689999999999999999999999999999999999999975443222111
Q ss_pred HHHHHH-----------------hHhc-CCeeeeecccc-----cCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005750 572 VHWARS-----------------MIKK-GDVISIVDPVL-----IGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 572 ~~~~~~-----------------~~~~-~~~~~~~d~~l-----~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 626 (679)
...... .... +......++.. ... ........+.+||.+||+.||.+|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111100 0000 00000000000 000 0001123577999999999999999999999
Q ss_pred H
Q 005750 627 L 627 (679)
Q Consensus 627 ~ 627 (679)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 7
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.74 Aligned_cols=240 Identities=27% Similarity=0.317 Sum_probs=186.5
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhc---cCCCcccccccccccceEEEEEEecCC
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
||+|+||+||+|+.+ +++.||+|++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99999887 35678999999999999999999999 9999999999999999999999999999875432221 12
Q ss_pred ccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.. +... .+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~-~i~~~~~------~~~~~- 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYR-NIAFGKV------RFPKN- 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHH-HHHcCCC------CCCCc-
Confidence 334589999999998654 5789999999999999999999999743221 1111 1111111 00000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 627 (679)
.....+.+++.+||+.+|.+||+ +.|+++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12336789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=335.33 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=198.1
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc--cce
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 427 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 427 (679)
+.....|.+.+.||+|+||+||+|.+. +++.||+|++... .......+..|+.++++++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344456788999999999999999876 5778999988643 23345678999999999999999999998744 457
Q ss_pred EEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCccccCCCCCCccccC--------
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI-------- 494 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~----~~~ivH~Dlkp~NIll~~-------- 494 (679)
.++||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987532 2357999999999999999999999721 135999999999999964
Q ss_pred ---------CCcEEEeeccCccccccCcccccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 495 ---------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 495 ---------~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654322 1233458999999999854 45889999999999999999999999732
Q ss_pred cccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 564 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ....+. .+..+.. ..+ ......+.+||..||+.+|.+||++.|+++
T Consensus 247 ~~-----~~qli~-~lk~~p~-----lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLIS-ELKRGPD-----LPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHHH-HHhcCCC-----CCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111111 1211110 000 012346889999999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.17 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=194.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566789999999999999876 68999999986432 122356778999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
. ++|.+++... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 6 5787777642 4568999999999999999999999 99999999999999999999999999998765432221
Q ss_pred ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe------eeee
Q 005750 516 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------ISIV 588 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 588 (679)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.|+...... . ...+........... ....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-D-DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-H-HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999998664 4689999999999999999999987522211 1 111111111100000 0000
Q ss_pred cc----ccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DP----VLI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~----~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+. ... ..........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000 0111123357789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=297.97 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=201.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|+||.||++... +|+.||+|.+... .....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 566789999999999999875 6899999998643 2334567899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23457899999999999999999998 99999999999999999999999999999765443221
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+. .+.+..... +... .
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~---------~ 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYP---------P 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCC---------C
Confidence 2233478899999999988899999999999999999999999973221 111222111 1111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11223446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=307.86 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=159.8
Q ss_pred ccccCcCccEEEEEEEEc---CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccc--ccceEEEEEEecC
Q 005750 362 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYEYMH 436 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~ 436 (679)
..+||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35789999986542 2345778999999999999999999874 4567899999986
Q ss_pred CCcHhhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc----cCCCcEEEeeccCc
Q 005750 437 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 506 (679)
Q Consensus 437 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfgla 506 (679)
++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 23358899999999999999999999 999999999999999 56678999999999
Q ss_pred cccccCccc--ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 507 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 507 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
+........ ......+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1223457899999999876 45799999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=303.63 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=198.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|||++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 3567789999999999999887 58999999886432 22345678999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++++.|..++. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888765 34568999999999999999999999 9999999999999999999999999999987644321
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHHHh-------HhcCCe-
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSM-------IKKGDV- 584 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~-------~~~~~~- 584 (679)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+... ........ ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1122346789999999866 567899999999999999999999997433221111 11100000 000000
Q ss_pred eeeecccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+......+ ......+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000010000000 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.80 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=205.5
Q ss_pred hhccccCcCccEEEEEEEEc--CC--cEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 360 NFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.+.++||+|.||.|++|.|+ +| ..||||.++..... ...+|.+|+.+|.+|+|||++++||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45689999999999999887 34 46899999876544 66889999999999999999999999987 667899999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++.|+|.+.|++ .....+.......++.|||.||.||.+ +++|||||..+|+|+-....|||+|||+.+-......
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999997 356678888999999999999999999 9999999999999999999999999999988655432
Q ss_pred c--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 515 H--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 515 ~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. ......-...|+|||.++...++.++|||+|||+||||+| |..||.+... ..+.+. +|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~-------------iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKN-------------IDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHh-------------cccc
Confidence 2 2222334678999999999999999999999999999999 8999974332 122221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
-+-..+..+.+.+.+++..||..+|++|||+..|.+.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1123345677899999999999999999999999743
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.33 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=195.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccccc-----ccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~~~~ 429 (679)
.+|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 45667889999999999999876 5889999987643 22346688899999999 6999999999873 455789
Q ss_pred EEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 430 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999999876432 34568899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
...... ......|++.|+|||++.. ..++.++||||+||++|+|++|+.||....... .+. .. ....
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~----~~-~~~~ 245 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF----KI-PRNP 245 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh----hc-cccC
Confidence 543222 1223358899999999753 457889999999999999999999997322111 111 10 0111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.....++ ......+.+++.+||+.+|++|||+.||++.
T Consensus 246 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111 1122368899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.40 Aligned_cols=252 Identities=28% Similarity=0.376 Sum_probs=203.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
+++.+.||.|++|.||++.++ +++.|++|.+.... ....+++.+|++++++++||||+++++++...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 556789999999999999887 68999999987653 3445678999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999998753 2678999999999999999999997 379999999999999999999999999998765433221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .....+........ .. +.+.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~-----~~~~--- 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE-PP-----PRLP--- 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC-CC-----CCCC---
Confidence 145788999999999989999999999999999999999999733211 11222222222211 11 0110
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+++.+||..+|++|||+.|++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0113446889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.87 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=201.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999875 68899999986432 33456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999886 3468899999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ..... . +..+.. +
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~-----~---- 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF---L-IPKNNP-----P---- 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH---H-HhcCCC-----C----
Confidence 12233578899999999888889999999999999999999999963221 11111 1 111111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.92 Aligned_cols=250 Identities=29% Similarity=0.432 Sum_probs=200.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|+..+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 556789999999999999875 689999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999873 4568899999999999999999999 99999999999999999999999999998876543332
Q ss_pred ccc---cccCCccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 516 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 516 ~~~---~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
... ...++..|+|||++.+.. .+.++||||||+++|++++|+.||...+.. ...... +..+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~----~~~~~~----- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH----VGAGHK----- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHH----HhcCCC-----
Confidence 221 245788999999998766 889999999999999999999999733211 111111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.+.. .......+.+++.+||+.+|.+||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110 1112346789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.20 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=204.0
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc--cCCCcccccccccccc----eEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~~----~~~lV 431 (679)
+..+.+.||+|.||.||+|+|+ |+.||||++.. .+.+.+.+|.++++.+ +|+||+.+++.-..++ .++||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3445789999999999999998 99999999974 3456788888888765 9999999998764433 68999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
++|.+.|||+|+|. ..+++....++++..+|.||+|||- +-+..|.|||||..||||..++.+.|+|+|+|
T Consensus 288 TdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999997 4679999999999999999999994 23578999999999999999999999999999
Q ss_pred cccccCcc---cccccccCCccccCCcccCCCC------CCchhHHHHHHHHHHHHHhC----------CCCCCcccccc
Q 005750 507 RQAEEDLT---HISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISG----------KKPVSVEDFGA 567 (679)
Q Consensus 507 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvll~elltG----------~~pf~~~~~~~ 567 (679)
........ ......+||.+|||||++.... .-..+||||||.++||+... +.||.+-- +.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V-p~ 442 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV-PS 442 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC-CC
Confidence 88655432 2334567999999999986531 12478999999999999752 35664211 11
Q ss_pred hhhHHHHHHHhHhcCCeeeeeccccc-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLI-GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
+....+ ++..+- .+-+.|.+. .-.+.+.+..+.++++.||..+|.-|-|+=.|-+.|.++.+.+++
T Consensus 443 DPs~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 443 DPSFEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCHHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 122222 111111 111111111 112346777899999999999999999999999999888865443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=306.84 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=199.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 556789999999999999876 489999999875432 2456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34678999999999999999999998 9999999999999999999999999999875432211
Q ss_pred c----------------------------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc
Q 005750 515 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 566 (679)
Q Consensus 515 ~----------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~ 566 (679)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999743321
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 627 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 627 (679)
..... ... ... ...........+.+++.+||+.+|++||+ ++|+++
T Consensus 239 --~~~~~----~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 --ETFSN----ILK-KEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred --HHHHH----Hhc-CCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 111 110 00001113457899999999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.25 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=203.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 3567889999999999999865 68899999986532 335678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.++++.......+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999754333568999999999999999999998 99999999999999999999999999998776543322
Q ss_pred ---ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 516 ---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 516 ---~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
......++..|+|||++... .++.++|+|||||++|+|++|+.||...... ..... ..... . +.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~----~~~~~-~-----~~ 226 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML----TLQND-P-----PS 226 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH----HhcCC-C-----CC
Confidence 22334578899999998776 7899999999999999999999999733221 11111 11110 0 11
Q ss_pred ccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.... .......+.+++.+||+.+|++||+++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1133457889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.23 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=199.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|++|.||++... +++.+|+|.+... .......+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 566789999999999999875 6889999998653 2334567899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCccccccCcc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~~~~~~~ 514 (679)
++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999753 24568999999999999999999999 999999999999999854 4689999999987644322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ... ..... +.....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~---~~~~~-~~~~~~------- 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALV---LKIMS-GTFAPI------- 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHH---HHHHh-cCCCCC-------
Confidence 12245788999999999888899999999999999999999999743321 111 11111 111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+++.+||+.+|.+|||+.|+++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.34 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=198.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-----hHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456788999999999999876 6899999998754322 2355778999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+ +|+|.+++... ...+++..++.++.||++||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 89999999742 2379999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---------C
Q 005750 513 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------G 582 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---------~ 582 (679)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....... .+.... ..... .
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIF-EALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHH-HHcCCCchhhhhhcc
Confidence 221 122235778999998854 467899999999999999999988876433211 111111 11000 0
Q ss_pred CeeeeecccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 583 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 583 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
............. ........+.+++.+||+++|.+|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000001 112234578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=292.57 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=209.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.-+.+.++||+|+||.||+|.++ .|+.+|+|.+.- ..+.+++.+|+.++++++.|++|++||.+.....+++||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 445667899999999999999877 699999998764 45678899999999999999999999999888899999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
|..|++.++++. .++++++.++..+++..++||+|||. ..-+|||||+.|||++.+|.+||+|||.|....+...
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999986 36889999999999999999999998 8899999999999999999999999999988765543
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee--cccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV--DPVL 592 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~l 592 (679)
. .....||+.|||||++..-.|..++||||||++..||..|++||..-... +..-.+ .|..
T Consensus 185 K-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPP 247 (502)
T KOG0574|consen 185 K-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPP 247 (502)
T ss_pred h-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCC
Confidence 3 34557999999999999889999999999999999999999999722110 001111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.-..+.....++-++++.||-+.|++|-|+.++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 12234455668999999999999999999998875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.66 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=197.4
Q ss_pred hhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc------e
Q 005750 360 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 427 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~ 427 (679)
.+.+.||+|+||.||+|.+. +++.||+|++.... ....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45688999999999999764 36899999987542 334567889999999999999999999875432 2
Q ss_pred EEEEEEecCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 428 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
.++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999988875322 22357889999999999999999999 999999999999999999999999999
Q ss_pred CccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 505 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 505 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
.+......... ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||...+. ..+..+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----KG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----cC
Confidence 98865432211 1122235678999999988889999999999999999999 8899863322 12222111 11
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.... ........+.+++.+||+.+|++||+++|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0112335789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.03 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=192.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhccCCCcccccccccc--cceEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 430 (679)
|...+.||+|+||.||+|... +++.|++|++.... ......+.+|++++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455789999999999999875 58999999886431 2234568899999999999999999998765 457889
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
++||+++++|.+++.. ...+++...+.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999873 4468899999999999999999998 999999999999999999999999999987643
Q ss_pred cCcc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+.. ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence 2111 1112234788999999999888999999999999999999999999732211 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+ ..+......+.+++ +||..+|++||+++||++
T Consensus 227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 11222233566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.60 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=198.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|.+.+.||+|++|.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 567789999999999999876 58999999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 4678999999999999999999999 99999999999999999999999999998876543
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. ...+ . +..+.. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~------~--- 216 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE---K-ILEGKV------R--- 216 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhcCCc------c---
Confidence 22345788999999998888899999999999999999999999733311 1111 1 111111 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.+......+.+++.+||+.+|.+|| +++|+++
T Consensus 217 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 -FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111234788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.27 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=196.0
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc----------hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...+.||.|++|.||+|... +|+.||+|.++.... ...+.+.+|++++++++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999865 689999998753211 1124678899999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999874 3578999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCcccc-cccccCCccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 509 AEEDLTHI-SSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 509 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
........ .....++..|+|||.+.... ++.++|+||||+++|++++|..||...+.. ... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~~~-~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAM----FKLGNKR-SA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHH----HHhhccc-cC
Confidence 54322111 22334788999999987654 789999999999999999999999622211 111 1111111 11
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+.. .........+.+++.+||+++|.+||+++||++
T Consensus 231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.28 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=195.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc------cce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------~~~ 427 (679)
...|++.+.||.|+||.||+|... +++.+|+|++... .....++..|+.+++++ +||||+++++++.. .+.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 346677889999999999999875 6889999998654 23446688899999998 69999999998843 457
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 899999999999999987532 4458888899999999999999999 999999999999999999999999999987
Q ss_pred ccccCcccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
....... ......|+..|+|||.+. +..++.++|||||||++|+|++|+.||........ .. . ....
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~----~-~~~~ 241 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF----L-IPRN 241 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh----h-HhhC
Confidence 6543221 122345788999999875 34678899999999999999999999963221111 00 0 0000
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. +.. ........+.+++.+||+.+|.+||++.|+++
T Consensus 242 ~~-----~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP-----PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC-----CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000 01123347899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.71 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=200.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccc--cceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~ 434 (679)
+++.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.. .+..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 455789999999999999985 589999999875432 345778999999999999999999998854 3478999999
Q ss_pred cCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
+++++|.+++.... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998875432 34568899999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc--cchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .......++... ...... ...
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~ 231 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-KDE 231 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-ccC
Confidence 1 123467899999999988999999999999999999999999974422 111222222211 111111 100
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. .........+.+++.+||+.+|.+|||+.||++
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.72 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=198.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999876 57899999987543 22345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~- 513 (679)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999973 4568999999999999999999999 999999999999999999999999999886421100
Q ss_pred -------------ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh
Q 005750 514 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 514 -------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.... +......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~- 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI- 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-
Confidence 00111234678899999998888999999999999999999999999733221 1111111
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.+... .+.. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11110 0110 01223468899999999999999997777666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.73 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=195.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|+..+.||.|++|.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 456788999999999999876 68999999886432 223357889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
. ++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6888888643 24568999999999999999999998 99999999999999999999999999998765432221
Q ss_pred ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc-------------
Q 005750 516 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------- 581 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------------- 581 (679)
.....++..|+|||.+.+. .++.++|||||||++|+|+||+.||...+.. ....+.....-..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1222367889999988654 4688999999999999999999999743321 1111111100000
Q ss_pred --CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 582 --GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 582 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..........+. .........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000112235789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.02 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=194.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4567789999999999999876 689999999865432 22345678999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
. ++|.+++... ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 7 4899888643 3468899999999999999999998 99999999999999999999999999998754322111
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC---C--------
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---D-------- 583 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~-------- 583 (679)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .........+... .
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122236788999998865 457899999999999999999999996433111 1111111111000 0
Q ss_pred -eeee----e-cccccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 -VISI----V-DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 -~~~~----~-d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... . ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 00000000 0011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.25 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=201.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.+|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46777899999999999999865 68899999986554555677899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999863 457889999999999999999999 99999999999999999999999999988765433221
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||........ .......+. +. ..
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~------~~--~~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT------PE--LQ 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC------CC--CC
Confidence 2223578899999999888889999999999999999999999973322111 000000000 00 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.59 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=193.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhccCCCccccccccccc--ceEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 430 (679)
|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 456789999999999999876 58999999875321 22346788899999999999999999988653 46789
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
+|||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3457888999999999999999999 999999999999999999999999999987653
Q ss_pred cCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~----~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAI----FKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHH----HHHhcCCC-----
Confidence 22111 112234788999999998888999999999999999999999999732111 111 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+......+.+++.+|+. +|++||+++||++
T Consensus 227 ----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111223344568889999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.53 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=197.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhcc---CCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lV~E 433 (679)
|++.+.||+|+||.||+|.+. +++.||+|.+... ......++.+|++++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 556789999999999999875 6899999998654 2344567889999999996 9999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.++++. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999998863 368999999999999999999999 999999999999999999999999999988765433
Q ss_pred ccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.. .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ... .+.... .+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CCCC
Confidence 22 2233588899999988654 56899999999999999999999997332211 110 011110 0111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .....+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=315.05 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=210.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CC----cEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
++...+-.++||.|+||+||+|.+- .| -+||+|++... ......++++|+-+|.+++|||+++++++|.... .
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 3344445689999999999999763 33 47899998754 3445688999999999999999999999998776 7
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
.||++|+++|+|.++++.. +..+-....+.|..|||+||.|||+ ++++||||.++||||..-..+||.|||+++.
T Consensus 773 qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 8999999999999999874 5678889999999999999999998 9999999999999999999999999999998
Q ss_pred cccCcccccc-cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 509 AEEDLTHISS-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 509 ~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
...+...... ...-.+.|||-|.+....++.++|||||||++||++| |..|+++....+.. ..++.+..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~geR-- 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGER-- 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhcccc--
Confidence 7655433222 2223678999999999999999999999999999998 99999854433322 23333322
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
-..++-+..++..++.+||..|+..||+++++...+.++..
T Consensus 919 -------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 -------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 12233455678899999999999999999999988877654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.38 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=200.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||.|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 567789999999999999876 58999999987532 23457889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.+++|.+++.. ...+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999873 3578999999999999999999998 9999999999999999999999999999877544321
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....... ....... ..
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~----------~~ 219 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQETA----------DV 219 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhccc----------cc
Confidence 2234478899999999888899999999999999999999999984433211111 1111110 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 626 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 626 (679)
..+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122233678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=291.77 Aligned_cols=251 Identities=29% Similarity=0.406 Sum_probs=205.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
+++.+.||+|++|.||+|... +++.|++|++..... .....+.+|++.+++++|+|++++++++...+..++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456789999999999999887 599999999876543 456789999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++.. ...+++..++.++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 3678999999999999999999996 2899999999999999999999999999988765433221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||................ . ... + ..
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~-~~~-----~----~~ 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D-GPP-----P----SL 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c-CCC-----C----CC
Confidence 23347889999999999899999999999999999999999997443212222222211 1 111 0 11
Q ss_pred CHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 597 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 597 ~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
... ....+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=312.81 Aligned_cols=270 Identities=27% Similarity=0.419 Sum_probs=208.3
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc------ceEEEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVY 432 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~lV~ 432 (679)
..+.||+|+||.||+|+.+ +|+.||||.++... ....+...+|+++|++++|||||+++++-++. ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3578999999999999965 79999999998643 34567788999999999999999999986553 3568999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc--CCC--cEEEeeccCccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQ 508 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~Dfgla~~ 508 (679)
|||.||||+..+.+-.+...+++.+.+.++.+++.||.|||+ +||+||||||.||++- .+| ..||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999988788899999999999999999999999 9999999999999983 334 389999999999
Q ss_pred cccCcccccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
..++. ......||..|++||.+. .+.|+...|.|||||++|++.||..||.....+.......|....-+.......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 87654 345567999999999998 488999999999999999999999999733322111112221111111111112
Q ss_pred ecccccC------------CCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhhh
Q 005750 588 VDPVLIG------------NVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIKI 635 (679)
Q Consensus 588 ~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~~ 635 (679)
.++...+ .........+-..+..+|..+|++|. ...+....+.+++..
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 2221111 11233344567888899999999999 666666666666654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.77 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=199.9
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 430 (679)
+....|++.++||+||.+.||++...+.+.+|+|++... ......-|.+|+..|.+|+ |.+|+++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345567788999999999999999888888888876532 3445678999999999994 9999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||- ..+|..+|+... .....| .++.+..|++.|+.++|+ +||||.||||.|+|+ -.|.+||+|||.|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 99987 569999998542 222233 778899999999999999 999999999999998 46899999999999887
Q ss_pred cCcccc-cccccCCccccCCcccCCC-----------CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 511 EDLTHI-SSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 511 ~~~~~~-~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
.+.+.. ....+||+.||+||.+... ..++++||||||||||+|+.|+.||. ...+....+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aKl--- 582 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAKL--- 582 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHHH---
Confidence 665543 3456799999999988432 25689999999999999999999997 122222222
Q ss_pred HhcCCeeeeecccccCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 579 IKKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+.||.-.-+++ ....++++++++.||+.||.+||++.|+|+.
T Consensus 583 ------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 ------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2233332211111 1222349999999999999999999999863
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.55 Aligned_cols=252 Identities=28% Similarity=0.410 Sum_probs=198.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccccccc------ceE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE------HQR 428 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------~~~ 428 (679)
..|++.+.||+|++|.||+|..+ +++.+++|++..... ..+++.+|+++++++ +|+||+++++++... ...
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45777899999999999999886 578999999875433 456789999999999 699999999998653 358
Q ss_pred EEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 429 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999887532 24678999999999999999999998 999999999999999999999999999987
Q ss_pred ccccCcccccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
........ .....++..|+|||++.. ..++.++|||||||++|+|++|+.||..... .....+ .. .+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~-~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK----IP-RN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH----hh-cc
Confidence 65432221 223457889999998753 3467899999999999999999999963211 111111 11 11
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .+ .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 11 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.22 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=198.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
|++.+.||.|++|.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999986 689999999875432 234667789999999999999999999999999999999997
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+ +|.+++........+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 5 888888754334578999999999999999999998 99999999999999999999999999998765432211
Q ss_pred cccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHH-------HhHhc-CCee-
Q 005750 517 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR-------SMIKK-GDVI- 585 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~-------~~~~~-~~~~- 585 (679)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||...+..+... ..+... ..+.. ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122346788999998865 456889999999999999999999997544321111 100000 00000 0000
Q ss_pred ---eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 ---SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ---~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+... ..........+.+++.+|++.+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.45 Aligned_cols=260 Identities=23% Similarity=0.264 Sum_probs=197.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc--ceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lV~E 433 (679)
|++.+.||.|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 346788999999999999877 58999999997653 33346688999999999999999999999887 88999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++ ++|.+++... ...+++..++.++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 4888887642 2578999999999999999999999 999999999999999999999999999998765543
Q ss_pred ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---CCeeee--
Q 005750 514 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISI-- 587 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 587 (679)
........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........... ......
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccccc
Confidence 222223346788999997754 467899999999999999999999997433221 11111111100 000000
Q ss_pred ------------ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 ------------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+...........+.+++.+||+.+|.+||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000001112457899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=288.84 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=203.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
|...+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 445688999999999999886 6899999999876555667899999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
++|.+++... ...+++..+..++.|++.||++||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999998743 2578999999999999999999998 9999999999999999999999999999887654432 2
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ... .... .......+ .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~-~~~~~~~~-------~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALF---KIAT-NGPPGLRN-------P 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHH---HHHh-cCCCCcCc-------c
Confidence 33457889999999988889999999999999999999999997332211 111 1111 11111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+.+++.+||+.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111346889999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=295.31 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=198.5
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCc
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
..+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 3478999999999999865 689999999865544555678899999999999999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccccc
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~ 519 (679)
|.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 103 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 103 LTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999873 468999999999999999999999 9999999999999999999999999998876543222 1223
Q ss_pred ccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHH
Q 005750 520 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599 (679)
Q Consensus 520 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 599 (679)
..|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+. ...... +..... +... ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~-----~~~~--~~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLP-----PKLK--NLHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCC-----CCCc--cccc
Confidence 4578899999999888899999999999999999999999963221 111111 111111 0110 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 600 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2347899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.35 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=195.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccccccc-----ceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-----~~~~ 429 (679)
..|.+.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 34566789999999999999875 68899999986532 2346678899999999 799999999998643 3689
Q ss_pred EEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 430 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+||||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 9999999999999886432 34578999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
....... .....++..|+|||.+... .++.++|||||||++|+|++|+.||..... ...+.+ +..+.
T Consensus 178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~-----~~~~~ 249 (291)
T cd06639 178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFK-----IPRNP 249 (291)
T ss_pred ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHH-----HhcCC
Confidence 5432211 1233578899999998543 368899999999999999999999973221 111111 11111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+ .......+.+++.+||+.+|++||++.|+++
T Consensus 250 ~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 250 PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.08 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=196.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCccccccccccc--ceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 432 (679)
.|++.+.||.|+||.||+|..+ +++.+++|.++.... .....+.+|++++++++||||+++++++... +..++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5677899999999999999887 588999999864322 2234567899999999999999999998776 8899999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||++ ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5898888643 3468999999999999999999999 99999999999999999999999999998876543
Q ss_pred cccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHHHHH-----------Hh-
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR-----------SM- 578 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~-----------~~- 578 (679)
... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.......... +..... ..
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 221 1223467889999998654 46899999999999999999999997443221110 000000 00
Q ss_pred -HhcCCeeeeecccccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 579 -IKKGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 579 -~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.............+...+... ....+.+++.+||+.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000111111111 2456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=291.82 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=199.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456789999999999999876 58899999986431 234567889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccccCcc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~~~~ 514 (679)
++++|.+++... ....+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998753 23457999999999999999999999 9999999999999998875 469999999877654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
. .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....... +...
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~--------- 220 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFA--------- 220 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCC---------
Confidence 2 2233578899999999888899999999999999999999999963221 222222221 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+|++.+|++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111122346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.04 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=195.4
Q ss_pred HhhccccCcCccEEEEEEEEcC---CcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCccccccccccc--ceEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 430 (679)
|++.++||+|++|.||+|.... ++.||+|.+.... ......+.+|++++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5567889999999999998754 7899999997632 33346678899999999999999999999887 78999
Q ss_pred EEEecCCCcHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC----CCcEEEeecc
Q 005750 431 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 504 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~Dfg 504 (679)
||||+++ +|.+.+.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 6766664332 22478999999999999999999999 99999999999999999 9999999999
Q ss_pred CccccccCcc--cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccc-------hhhHHHH
Q 005750 505 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-------ELNIVHW 574 (679)
Q Consensus 505 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~-------~~~~~~~ 574 (679)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887543322 11223357889999998766 457899999999999999999999997443321 0011111
Q ss_pred HHHhHhc------------CCeeeeecccccCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 575 ARSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 575 ~~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+. .+.. .......+......++ . .....+.+++.+||++||++|||+.|+++
T Consensus 238 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 0000 0000000000000000 0 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=291.10 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=195.9
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 48999999986532 23446789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 3568999999999999999999999 999999999999999999999999999998765432 12233
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... . .+.......... ...++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~~~~---------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-P---MEIYNDILKGNG---------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-H---HHHHHHHhccCC---------CCCCCccc
Confidence 5788999999998888999999999999999999999999744321 1 111111111000 01112222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
...+.+++.+||+.+|.+||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=290.16 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=202.6
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|++|.||++..+ +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456789999999999999765 68899999987532 334567788999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 436 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999887532 24578999999999999999999998 999999999999999999999999999998765542
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.. .+.. ....+.. .
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~---------~ 219 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKY---------P 219 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCC---------C
Confidence 22234788999999999989999999999999999999999999743321 1111 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+|++.+|.+||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 122234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.93 Aligned_cols=239 Identities=32% Similarity=0.469 Sum_probs=197.4
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
.+.||.|+||.||.|++. +.+.||||.+.-.. ...-.++.+|+..|++++|||++.+-|+|-.+...+|||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 578999999999999865 68899999986432 234467899999999999999999999999999999999999 4
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+-.|++.- ..+++-+.++..|..+.+.||+|||+ ++.||||||+.|||+++.|.|||+|||.|......
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 677777764 35789999999999999999999999 99999999999999999999999999999876553
Q ss_pred ccccCCccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 518 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
..++|||.|||||++ ..+.|+-|+||||||++..||.-.++|+..-.. -..+.+ +..... |.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYH-----IAQNes-----PtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH-----IAQNES-----PTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHH-----HHhcCC-----CCCC-
Confidence 346799999999987 457899999999999999999999999862211 111222 222221 2222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 626 (679)
..+....+.+++..||++-|.+|||.++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 345666899999999999999999998876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=295.28 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=195.2
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
++.+.||.|++|.||+|..+ +|+.||+|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45688999999999999876 79999999986442 2233568889999999999999999999999999999999995
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999887432 2468999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC-------------
Q 005750 517 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 582 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 582 (679)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+... ...+.........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1122357889999987654 57899999999999999999999997433211 1111111000000
Q ss_pred --CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 --DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.. ..........+.+++.+|++.+|.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0111122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=295.46 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=192.1
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHH-HHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++.+.||+|+||.||+|.++ +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456789999999999999876 69999999987543 2334556666665 56668999999999999999999999999
Q ss_pred CCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 436 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 436 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
+ |+|.+++.... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68887776432 34578999999999999999999998 6 99999999999999999999999999988654322
Q ss_pred ccccccccCCccccCCcccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 514 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ...+ ...... ......
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~~-~~~~~~- 229 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVEE-PSPQLP- 229 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHhc-CCCCCC-
Confidence 1 122347889999998865 45688999999999999999999999632211 1111 111111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+++.+||+.+|.+||+++++++
T Consensus 230 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 -------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=305.26 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=205.3
Q ss_pred HHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.-++++..||.|+||.||+|..++ +-..|.|++........+++.-|++||..++||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456778899999999999998875 4445678887777778899999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
.||-...++-. -+..+++.++.-+++|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+....... .
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-Q 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-h
Confidence 99999887765 36789999999999999999999999 999999999999999999999999999886543322 2
Q ss_pred ccccccCCccccCCccc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 516 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
....+.|||.|||||+. ...+|+.++||||||++|.||.-+.+|-+.- +....+.. +.......++.|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllK-iaKSePPTLlqP 258 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLK-IAKSEPPTLLQP 258 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHH-HhhcCCCcccCc
Confidence 23456799999999986 4568999999999999999999999997621 22222211 222222223322
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+.+++.+||.+||..||++.++++
T Consensus 259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 234457889999999999999999999884
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.14 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=195.9
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||.|+||.||++... +|+.+++|++..... ...+.+.+|++++++++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 499999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc------
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 514 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~------ 514 (679)
.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 3478999999999999999999999 9999999999999999999999999999876433211
Q ss_pred -cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 -~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......++..|+|||...+...+.++||||||+++|++++|+.||...... ...+ .. ..+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~-~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---NI-LNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-hcCCcCC---C---
Confidence 1122334778999999998888899999999999999999999999733221 1111 11 1111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
........+.+++.+||+.+|.+|||++++.+.|+
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00012457889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.38 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=196.2
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEec--C--CcchhHHHHHHHHHHHHhccCCCcccccccccccce--EEEEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA--D--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE 433 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~lV~E 433 (679)
|..+||+|+|-+||+|.+. +|.+||=-.++ + ......++|..|+.+|+.|+||||+++++++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 5678999999999999876 57777632221 1 234456889999999999999999999999877654 778999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~~~~ 512 (679)
.+..|+|+.++++ .+.++...+..|++||++||.|||+ .+.+|+|||||.+||||+ ..|.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 5678899999999999999999998 468999999999999997 5689999999999987554
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.. ....|||.|||||.+. ..|.+..||||||+.++||+|+.+||.... ....+.+.+..-++...+..+-||
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccCCH--
Confidence 32 2367999999999988 689999999999999999999999997222 222333333332222223333333
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
++.++|.+|+.. ..+|||+.|+|+.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 577999999999 9999999999863
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.83 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=193.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3556789999999999999875 689999999865432 22346778999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
. +++.+.+... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 86 H-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred c-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 5 6777666532 3457888889999999999999999 99999999999999999999999999998764332211
Q ss_pred ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc---------CCee
Q 005750 516 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------GDVI 585 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~ 585 (679)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... ...+.+ ....... ....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEK-IWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHH-HHHHcCCCChhhhhhhhhcc
Confidence 1223468899999998654 5788999999999999999999999743321 111111 1100000 0000
Q ss_pred eeecccc----cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l----~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....... .... .......+.+++.+|++.||.+|||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0000 0011346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.40 Aligned_cols=270 Identities=19% Similarity=0.238 Sum_probs=189.8
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC--CcEEEEEE--------------ec---CCcchhHHHHHHHHHHHHhccCCCc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKI--------------MA---DSCSHRTQQFVTEVALLSRIHHRNL 415 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~hpnI 415 (679)
....|++.+.||+|+||.||++.++. +..++.|. +. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34578889999999999999987542 22222221 10 0112234568899999999999999
Q ss_pred ccccccccccceEEEEEEecCCCcHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
+++++++...+..++|+|++. ++|.+++.... .........+..++.||+.||+|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999985 57777665322 12233456678899999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc-chhhHH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIV 572 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-~~~~~~ 572 (679)
.++.+||+|||++...............|+..|+|||++.+..++.++|||||||++|||++|..++...... ....+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876554333333456899999999999999999999999999999999987654322221 122222
Q ss_pred HHHHHhHh-cCCee-------eeecccccC----CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 573 HWARSMIK-KGDVI-------SIVDPVLIG----NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 573 ~~~~~~~~-~~~~~-------~~~d~~l~~----~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+....... ...+. +.++..... ... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 21111000 00000 000000000 000 0112356788999999999999999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.79 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=187.3
Q ss_pred ccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHh---ccCCCcccccccccccceEEEEEEecC
Q 005750 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 589999998865321 222334455544443 379999999999998899999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999998873 4569999999999999999999999 9999999999999999999999999999875543221
Q ss_pred cccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....|+..|+|||.+. +..++.++||||+||++|+|++|..||..........+.+ .... ... .
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~----~ 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNV----E 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCc----C
Confidence 2235899999999986 4568899999999999999999999997433222111111 1100 011 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
.+......+.+++.+||+.||.+|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222345788999999999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.03 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=194.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
+.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 345678999999999999876 58999999986532 344567889999999996 999999999998888999999998
Q ss_pred CCCcHhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 436 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 436 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
. +++.++.... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 4554433211 124678999999999999999999997 2599999999999999999999999999987654332
Q ss_pred ccccccccCCccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 514 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.. ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ...+....... +. .+
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----~~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD-----PP 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC-----CC
Confidence 21 223478899999998766 68899999999999999999999997322 11111111111 11 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+...........+.+++.+||+.+|.+|||++||++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112222344578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.43 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=196.9
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc----
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 426 (679)
.....|++.+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34456778899999999999999986 58999999986532 223356778999999999999999999887654
Q ss_pred ------eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 427 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 427 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 676666532 3468999999999999999999999 99999999999999999999999
Q ss_pred eeccCccccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
+|||.+...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998764433222222335778999998764 45789999999999999999999999733221 1111111111
Q ss_pred hcC---Ceeee--------eccccc--C---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 580 KKG---DVISI--------VDPVLI--G---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 580 ~~~---~~~~~--------~d~~l~--~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ....+ .++... . ......+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 00000 000000 0 000112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=293.58 Aligned_cols=257 Identities=23% Similarity=0.263 Sum_probs=193.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhcc-CCCccccccccccc--ceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lV~E 433 (679)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 356788999999999999876 68999999987542 222334557899999885 99999999999877 88999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++ ++|.+.+... ...+++..++.++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 5888877642 3568999999999999999999999 99999999999999999 999999999998764332
Q ss_pred ccccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH-----------hc
Q 005750 514 THISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KK 581 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~-----------~~ 581 (679)
.. ....++..|+|||++. +..++.++||||+||++|+|++|+.||...+..+ ...+..... ..
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 21 2234788999999764 4567899999999999999999999997443211 111111111 11
Q ss_pred CCeeeeecccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 582 GDVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 582 ~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........+.... .........+.+++.+||+++|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111100000000 001123568999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.03 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=201.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|++|.||+|.++ +++.|++|++..... ....+.+|+++++.++|+|++++++++...+..++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3566788999999999999887 689999999876544 56778899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999999853 1379999999999999999999999 9999999999999999999999999998876543221 1
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ... ........ .
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~----~~~-~~~~~~~~-------~ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALF----LIT-TKGIPPLK-------N 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHH-hcCCCCCc-------c
Confidence 122346789999999988889999999999999999999999997322211 111 111 11111100 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+++.+||+.+|.+||++.+|++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.43 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=191.8
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99987532 3468999999999999999999999 9999999999999999999999999999876543211 1223
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||.+.+..++.++||||+||++|+|++|+.||.......... . +....... ....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~~~~~----------~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRRTLEM----------AVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhccccc----------cccCCccC
Confidence 46789999999988889999999999999999999999997433211111 1 11100000 00111122
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44688999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=293.43 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=197.3
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
..+||+|+||.||++..+ +++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 468999999999999875 6899999998655555567789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 3457899999999999999999999 9999999999999999999999999998876543321 12234
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.. ........... +.+. .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~---------~~~~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP---------PKLK--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC---------cccC--CcccC
Confidence 5788999999998888899999999999999999999999733221 11111111110 0000 00112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 336789999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.33 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=195.7
Q ss_pred cccCcC--ccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
..||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999875 79999999986432 23456788999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc-
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 516 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~- 516 (679)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999887542 3458899999999999999999998 999999999999999999999999997654322111100
Q ss_pred -----cccccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-----------
Q 005750 517 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----------- 578 (679)
Q Consensus 517 -----~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~----------- 578 (679)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 0112245679999998763 4789999999999999999999999743221 1111111000
Q ss_pred ---------------------HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 005750 579 ---------------------IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 634 (679)
Q Consensus 579 ---------------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 634 (679)
...+......+..+...........+.+++.+||+.||++|||++|+++ .++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000111111111222345567899999999999999999999974 3555444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.39 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=198.8
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
++.+.||.|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999876 689999999875432 245678899999999999999999999999999999999997
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+ +|.+++... ...+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence 5 888887642 3578999999999999999999999 9999999999999999999999999999877654431 1
Q ss_pred cccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC---Ceeeeec---
Q 005750 517 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD--- 589 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d--- 589 (679)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+. .......+... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2223477889999998776 789999999999999999999999964332111 11111111000 0000000
Q ss_pred --------c--cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 --------P--VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 --------~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ............++.+++.+||++||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=285.74 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=203.0
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCccccccccccc--ceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lV~E 433 (679)
|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345688999999999999887 689999999875542 4567889999999999999999999999888 88999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 82 YVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999874 3489999999999999999999999 999999999999999999999999999988765543
Q ss_pred cc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.. ......++..|+|||.+.+...+.++||||||+++|+|++|..||...+. .............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGE--------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCC---------
Confidence 21 12234578899999999888899999999999999999999999974331 1111111111011
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+......+.+++.+|++.+|.+||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122223457899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.37 Aligned_cols=246 Identities=30% Similarity=0.425 Sum_probs=195.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44777899999999999999876 68999999886432 233457889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5776766532 3468999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 513 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
....++..|+|||++. ...++.++||||||+++|+|++|+.||...+... . ... +.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~---~~~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LYH-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---H---HHH-HhcCCC-----
Confidence 1234788999999874 4568899999999999999999999996332211 1 111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 112234578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.33 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=195.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc-----ceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 430 (679)
.|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4667899999999999999865 68999999986432 23446688899999999999999999886543 35799
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|+||+. ++|.+.+. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 58877775 4568999999999999999999999 999999999999999999999999999987654
Q ss_pred cCccc--ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---e
Q 005750 511 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 584 (679)
Q Consensus 511 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~ 584 (679)
..... ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ........+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 1122457889999998654 568899999999999999999999997433211 1111111111000 0
Q ss_pred eeeeccc-------cc--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 005750 585 ISIVDPV-------LI--GNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 632 (679)
Q Consensus 585 ~~~~d~~-------l~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 632 (679)
..+.+.. .. ... .......+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 00 000 01123468899999999999999999999886 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.15 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=192.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhcc-CCCcccccccccccce-----EE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 429 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~-----~~ 429 (679)
|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 556789999999999999876 689999998765322 23457888999999995 6999999999876655 89
Q ss_pred EEEEecCCCcHhhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCc
Q 005750 430 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 506 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla 506 (679)
+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 78888764331 3568999999999999999999999 99999999999999998 899999999998
Q ss_pred cccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe-
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV- 584 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 584 (679)
......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+... ...+... .+.....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhCCCChh
Confidence 765332211 112236788999998765 467899999999999999999999997432211 1111111 1100000
Q ss_pred --eeeec-------ccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 --ISIVD-------PVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 --~~~~d-------~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+ +.. ...........+.++|.+||+++|.+||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000 00001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.72 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=204.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
-|.+.+.||+|.|+.|.+|++. ++..||+|++.+..- ...+.+.+|+++|..++|||||+++.+......+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3556789999999999999876 699999999987543 3345688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.+|.+++++. +.....+..+..++.|+.+|++|||+ +.|+|||||++|||++.+.++||+|||++..+...
T Consensus 137 a~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 137 ASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred ccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999998 45667778899999999999999999 99999999999999999999999999999987633
Q ss_pred cccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
......+|++.|.|||++.+..+ ++++|+||+|+++|.|+.|..||++..... .-++.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl~ 269 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVLR 269 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchhee
Confidence 34456779999999999988765 689999999999999999999998543321 1111111
Q ss_pred CCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.+ +.....++.++++++|-.+|.+|++++++.+.
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 11122367799999999999999999999764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.42 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=196.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCccccccccccc------c
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 426 (679)
...|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 355777899999999999999876 6899999998643 223445677899999999999999999987543 3
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5799999995 588887752 28889999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HH-----------HH
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV-----------HW 574 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~-----------~~ 574 (679)
........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +. ..
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87544322 223347889999999999999999999999999999999999997443211100 00 00
Q ss_pred ----HHHhHhcCC------eeeeeccc----ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 575 ----ARSMIKKGD------VISIVDPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 575 ----~~~~~~~~~------~~~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......... ........ ............+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000000 0011112335568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.89 Aligned_cols=249 Identities=30% Similarity=0.461 Sum_probs=203.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||.|++|.||++... +++.|++|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456788999999999999876 689999999875433 45677899999999999999999999999889999999999
Q ss_pred CCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 436 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999987542 24679999999999999999999999 899999999999999999999999999998765443
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+. .+....... ....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~--------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQYP--------- 221 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCCC---------
Confidence 122334578899999999888899999999999999999999999963321 111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+......+.+++.+||..+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111123357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.12 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=201.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 688999999976543 45578999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3678999999999999999999998 99999999999999999999999999999876543322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...+. ...... .. .... + .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~----~~-~~~~-----~----~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFR----IV-QDDH-----P----P 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH----Hh-ccCC-----C----C
Confidence 2233578899999999888889999999999999999999999973321 111111 11 1111 0 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||..+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122347889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.09 Aligned_cols=260 Identities=23% Similarity=0.226 Sum_probs=193.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCccccccccccc--ceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 432 (679)
.|++.+.||+|+||.||+|..+ +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4667889999999999999876 689999999864322 2233567899999999999999999998654 5689999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+. ++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888887643 3568999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC--Cee----
Q 005750 513 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVI---- 585 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~---- 585 (679)
... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+....... ...
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 211 122235778999999865 467899999999999999999999997433221 111111111100 000
Q ss_pred -----eee--cccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 -----SIV--DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 -----~~~--d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ....... ........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 00112446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.01 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=192.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc--------
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 426 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 426 (679)
.|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4677899999999999999876 68999999886432 222345678999999999999999999876543
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 5788777632 3468999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCccc---ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 507 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 507 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
......... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..........+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 11223467889999988654 46889999999999999999999997443322222222111111100
Q ss_pred Ceeee-----ecc-cccCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DVISI-----VDP-VLIGNVK---------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~~~-----~d~-~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..... .+. ....... ......+.+++.+||+.+|.+|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 0000000 001235679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.52 Aligned_cols=244 Identities=27% Similarity=0.311 Sum_probs=189.1
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHH-HhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALL-SRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.||+|+||.||+|... +++.||+|++..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 589999999865422 1223344555544 345899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 4568999999999999999999999 9999999999999999999999999998876433 1
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.. ...+ . +..+... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFD---N-ILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHhcccC------CCCccc
Confidence 2234788999999998888899999999999999999999999733221 1111 1 1111110 000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123457889999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.02 Aligned_cols=265 Identities=19% Similarity=0.300 Sum_probs=196.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccc----cceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 429 (679)
..|.+.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34566789999999999999876 69999999987542 2344667889999999999999999998753 34689
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689888863 4568999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcccc---cccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH--------
Q 005750 510 EEDLTHI---SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-------- 577 (679)
Q Consensus 510 ~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~-------- 577 (679)
....... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4322111 123357889999998765 4688999999999999999999999974432211110000000
Q ss_pred hHhcCCeeeeecc-cccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 578 MIKKGDVISIVDP-VLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 578 ~~~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...........+. ..... ........+.+++.+||+.+|.+||++++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 00000 011234578999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=293.34 Aligned_cols=250 Identities=31% Similarity=0.421 Sum_probs=197.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+..+...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|||++++++++.+++..++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 344667889999999999999875 68999999986432 23345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+. |+|.+.+.. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 104 MEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EeCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99996 577777653 24568999999999999999999999 9999999999999999999999999998875433
Q ss_pred CcccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
. ....++..|+|||.+. ...++.++|||||||++|+|++|+.||...+.. ..... ....+..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~~~~~---- 242 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH----IAQNESP---- 242 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----HHhccCC----
Confidence 2 2234788999999973 456889999999999999999999998633211 11111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
. .........+.+++.+||+.+|.+||++.+|++.+-.
T Consensus 243 --~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 --T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred --C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0 0111233468899999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=291.74 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=200.1
Q ss_pred HhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc----chhHHHHHHHHHHHHhc-cCCCcccccccccccceEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 429 (679)
|++.+.||+|++|.||+++.. +++.||||++++.. ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999999753 57889999987532 12345688999999999 5999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998873 4568899999999999999999998 99999999999999999999999999998765
Q ss_pred ccCcccccccccCCccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
............++..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ...+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK----- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-----
Confidence 443322223345788999999987654 7889999999999999999999996322211 1111112111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
+. .+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 229 --~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11 1111234678999999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=301.04 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=203.4
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc-----eEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~l 430 (679)
|++.+.||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 567789999999999999876 48999999987643 344567899999999999999999999987765 7899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
+|||++ ++|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 588888873 4489999999999999999999999 999999999999999999999999999998765
Q ss_pred cCcc--cccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc------
Q 005750 511 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 581 (679)
Q Consensus 511 ~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------ 581 (679)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHh
Confidence 4321 112233478899999999887 889999999999999999999999974432211 1111111000
Q ss_pred -----CCeeeeecc-ccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 005750 582 -----GDVISIVDP-VLI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 634 (679)
Q Consensus 582 -----~~~~~~~d~-~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 634 (679)
......+.. ... ..........+.+++.+||+++|.+||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 000 00011234568899999999999999999999974 665444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.43 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=197.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCccccccccccc-----ceEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 429 (679)
.|.+.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3566789999999999999875 6899999998653 223345677899999999999999999988654 3579
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 68888886 34679999999999999999999999 99999999999999999999999999999875
Q ss_pred ccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH--------hHh
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIK 580 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~--------~~~ 580 (679)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..........+.. .+.
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 43321 1223347889999998764 4688999999999999999999999974432111110000000 000
Q ss_pred cCCeeeee-------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 005750 581 KGDVISIV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 632 (679)
Q Consensus 581 ~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 632 (679)
.......+ ++... .........+.+++.+||+.+|++|||++|+++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 00000 0011234568899999999999999999999976 6544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=276.79 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=199.7
Q ss_pred ccccCcCccEEEEEEE-EcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCCCc
Q 005750 362 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
.+.||+|+|+.|--+. ..+|.++|||++.+.......++.+|++++.+.+ |+||++++++|+++...|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4789999999998885 5689999999999888888899999999999995 9999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cEEEeeccCcccccc--Ccc
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEE--DLT 514 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfgla~~~~~--~~~ 514 (679)
|..++. +.+.+++.++.++.++|+.||.+||. +||.|||+||+|||..+.. -+|||||.+...+.. +..
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46789999999999999999999998 9999999999999997554 489999988765322 111
Q ss_pred ----cccccccCCccccCCccc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc-----ch---hhHHHHHHH
Q 005750 515 ----HISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AE---LNIVHWARS 577 (679)
Q Consensus 515 ----~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-----~~---~~~~~~~~~ 577 (679)
..-...+|+..|||||+. ....|+.++|.|||||++|-|+.|.+||.+.-.. .+ ..-.+.+-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 112234688899999985 2346889999999999999999999999743221 00 011111222
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+++|.+. +.|. -......+..+++...+..++.+|.++.++++
T Consensus 317 sIQEGkYe-FPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYE-FPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCc-CChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23333321 1111 11223346678999999999999999999987
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=292.13 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=193.0
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566666666666555 6999999998754 3445678999999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc----
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 514 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~---- 514 (679)
+|.+++.... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997542 3468899999999999999999999 9999999999999999999999999998865432111
Q ss_pred --cccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh----cC----
Q 005750 515 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----KG---- 582 (679)
Q Consensus 515 --~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~----~~---- 582 (679)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+. .....+....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhh
Confidence 11122346778999999866 3578999999999999999999999973321 1111111110000 00
Q ss_pred ---Ceee----eecccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 583 ---DVIS----IVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 583 ---~~~~----~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.... ..++.. ...........+.+++.+||+.+|++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 011122334578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=286.69 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=186.3
Q ss_pred Hhhccc--cCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~--LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.+.+. ||+|+||.||++..+ +++.+|+|.+....... .|+.....+ +||||+++++++...+..++||||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 344455 599999999999875 68899999986532111 122222223 799999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~~~ 513 (679)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 91 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 164 (267)
T PHA03390 91 IKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence 999999999974 3489999999999999999999999 9999999999999999888 99999999987654322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
...++..|+|||++.+..++.++||||+|+++|+|++|+.||... .........+.... . ... .
T Consensus 165 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~-~~~-~------- 228 (267)
T PHA03390 165 -----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQ-Q-KKL-P------- 228 (267)
T ss_pred -----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CcchhhHHHHHHhh-c-ccC-C-------
Confidence 234788999999999888999999999999999999999999732 22222222222211 1 000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 627 (679)
........+.+++.+||+.+|.+||+ ++|+++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 --FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01123346889999999999999996 688874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.61 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=196.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhc-cCCCccccccccccc--ceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~ 429 (679)
...|.+.+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778899999999999999876 6889999988542 223345677899999999 999999999988643 4689
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 599888863 278889999999999999999999 99999999999999999999999999999865
Q ss_pred ccCcc----cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------
Q 005750 510 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-------- 576 (679)
Q Consensus 510 ~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-------- 576 (679)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43322 12223457889999998754 567889999999999999999999997433221110000000
Q ss_pred HhHhcCCeeeeeccccc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 577 SMIKKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+........++.... ..........+.+++.+||+.+|.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 00011134578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=289.99 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=199.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
|.+.+.||+|++|.||+|... +++.||+|++... .....+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 566789999999999999876 6999999998653 2233467889999999998 9999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
++++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999974 4579999999999999999999998 999999999999999999999999999988654432
Q ss_pred c-------------------cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 005750 514 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 514 ~-------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 574 (679)
. .......++..|+|||...+..++.++||||||++++++++|+.||...+. ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~- 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ- 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH-
Confidence 1 112233468899999999888899999999999999999999999973331 11111
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 627 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 627 (679)
..... . ...+......+.+++.+||+.+|.+||++ +|+++
T Consensus 233 --~~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 --KILKL-E----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHhc-C----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 01111224568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.72 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=186.3
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCcchhH-----------HHHHHHHHHHHhccCCCc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRT-----------QQFVTEVALLSRIHHRNL 415 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnI 415 (679)
+.++....|.+.+.||+|+||.||+|.+.+ +..+|+|+......... .....+...+..+.|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 445555678889999999999999998764 35667775432211110 112233344556689999
Q ss_pred ccccccccccc----eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 416 VPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 416 v~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
+++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ ++|+||||||+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil 158 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM 158 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99998764433 3467788763 466666552 2335778889999999999999999 99999999999999
Q ss_pred ccCCCcEEEeeccCccccccCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc
Q 005750 492 LDINMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 565 (679)
Q Consensus 492 l~~~~~~kL~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~ 565 (679)
++.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999865332111 11223589999999999999999999999999999999999999974422
Q ss_pred cch-hh--HHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 566 GAE-LN--IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 566 ~~~-~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
... .. ..++... +..+... ....+..+.+++..|++.+|++||+++++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKCDFIKR-LHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHHHHHHH-hhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 211 11 0111111 1111110 0112457889999999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.21 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=195.8
Q ss_pred HhhccccCcCccEEEEEEEE----cCCcEEEEEEecCCc----chhHHHHHHHHHHHHhc-cCCCcccccccccccceEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 429 (679)
|++.+.||.|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45678999999999999986 368999999987532 22346688899999999 5999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999873 4568899999999999999999999 99999999999999999999999999998775
Q ss_pred ccCcccccccccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ....+..........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~---- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP---- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC----
Confidence 44322222234578899999998653 4678999999999999999999999632221 111222222111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
..+......+.+++.+||+.+|.+|| ++++++.
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112234678999999999999997 6676655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.68 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=193.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 3566789999999999999876 689999999864322 2345688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla~~~~~~~ 513 (679)
++ ++|.+++... ....+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus 83 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 83 LD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 95 5787777543 23346888889999999999999999 99999999999999985 5679999999997654322
Q ss_pred ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC--Cee----e
Q 005750 514 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVI----S 586 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~----~ 586 (679)
.. .....+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...+..+. +.+ ........ ... .
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 RT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTS 233 (294)
T ss_pred cc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhcccccc
Confidence 11 122346789999998865 4578999999999999999999999974322111 111 10100000 000 0
Q ss_pred eec-----ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVD-----PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d-----~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000 001122346789999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=297.00 Aligned_cols=257 Identities=20% Similarity=0.213 Sum_probs=192.9
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchh--------------HHHHHHHHHHHHhccCCCccccccccccc
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 425 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 425 (679)
+.+.||.|+||.||+|..+ +++.||+|++....... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3577999999999999876 68999999986432211 12477899999999999999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 68998886 34568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCc-------------ccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 005750 506 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571 (679)
Q Consensus 506 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~ 571 (679)
+....... ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654111 0111122357789999998764 46899999999999999999999997443221 1
Q ss_pred HHHHHHhHhcCCe---eee--------ecccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 572 VHWARSMIKKGDV---ISI--------VDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 572 ~~~~~~~~~~~~~---~~~--------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+......... ... ....... .........+.+++.+||+.+|++||+++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111000 000 0000000 001112346889999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=284.08 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=194.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-----cchhHHHHHHHHHHHHhccCCCccccccccccc--ceEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 430 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 430 (679)
|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 566789999999999999875 5899999987432 123446788999999999999999999988653 46889
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3458899999999999999999998 999999999999999999999999999997653
Q ss_pred cCcc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... . ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~~~~----- 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--M----AAIFKIATQPT----- 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--H----HHHHHHHcCCC-----
Confidence 2111 111223478899999999988889999999999999999999999973211 1 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+......+.+++.+|++ +|..||++.+++.
T Consensus 227 ----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222334578899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=287.39 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=195.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEec
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|.+.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 346789999999999999986 588999999865432 23334567999999998 999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889998887532 3578999999999999999999999 99999999999999999999999999999865433221
Q ss_pred ccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchh-hHHH---------HHHHhHhcCCe
Q 005750 516 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH---------WARSMIKKGDV 584 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~-~~~~---------~~~~~~~~~~~ 584 (679)
....++..|+|||.+. +..++.++|+||||+++++|++|+.||......+.. .... |..........
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 2234788999999874 456789999999999999999999999644322111 0000 00000000000
Q ss_pred eeeecccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.... ...........+.+++.+||+.+|++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 00001111357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.63 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=194.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhc---cCCCcccccccccccce-----
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ----- 427 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----- 427 (679)
|++.+.||+|+||.||+|.++ +++.||+|++..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 345788999999999999987 489999999874322 2234566788877766 59999999999987766
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 48988886432 3468999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee--
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 585 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 585 (679)
........ ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+..............
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcC
Confidence 76433221 2223678899999999888999999999999999999999998743321 11111111110000000
Q ss_pred -------eeeccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 -------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 -------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+..... ..........+.+++.+||+.||.+||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 1111233457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.48 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=186.6
Q ss_pred ccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHH---HHhccCCCcccccccccccceEEEEEEecC
Q 005750 364 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.||+|+||.||+|... +++.||+|.+.+... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 589999999865321 112223444443 444579999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
||+|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999886 34579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....|+..|+|||.+.++ .++.++||||+||++|+|++|+.||............ ..... ....+.
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------~~~~~~-- 219 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------MAVELP-- 219 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc------cCCCCC--
Confidence 233588999999998754 6889999999999999999999999743222111111 11110 011111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
......+.+++.+|+..+|.+|| ++.++++
T Consensus 220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11234788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.00 Aligned_cols=249 Identities=29% Similarity=0.420 Sum_probs=195.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
...+|...+.||+|++|.||+|+.. +++.+++|.+... .....+++.+|+++++.++|+|++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4455667789999999999999876 5789999988642 22344578889999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6787776532 3468899999999999999999998 999999999999999999999999999987654
Q ss_pred cCcccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 511 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.. ....++..|+|||.+. ...++.++|||||||++|+|++|+.||...+... .... ...+.....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~-----~~~~~~~~~ 234 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH-----IAQNESPAL 234 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH-----HhhcCCCCc
Confidence 32 2234788999999874 3567889999999999999999999986322111 1111 111111100
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 629 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 629 (679)
........+.+++.+||+.+|.+||+++++++.-
T Consensus 235 --------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0112334688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=283.00 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=194.4
Q ss_pred HhhccccCcCccEEEEEEEEcC-CcEEEEEEecCC-----cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
|.+.+.||+|+||.||++.... +..+++|+++.. ......++..|+.++++++||||+++++++.+.+..++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5677899999999999998763 455666665432 1223345778999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 433 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||+|+||++++ +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886432 34679999999999999999999999 99999999999999975 5699999999876543
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+.. +
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~~-----~- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGPT-----P- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCCC-----C-
Confidence 322 12234478899999999888889999999999999999999999963221 11111111 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.08 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=193.4
Q ss_pred HHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCc-chhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
..+.+.+.||+|++|.||+|.+++ ++.||||.++... ......+.+|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 345678999999999999999875 8999999987543 234456677887777774 9999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+. +++.+.+... ...+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 5777766532 3478999999999999999999996 2599999999999999999999999999987654332
Q ss_pred ccccccccCCccccCCcccCCCC----CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 514 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... ......
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPP 241 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCC
Confidence 21 2234678999999987553 788999999999999999999999632111 11111111111 100000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=275.71 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=196.1
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc----cceEEEEEEec
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 435 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~lV~E~~ 435 (679)
.++||-|-.|.|-....+ +|+.+|+|++... ....+|+++.-.. .|||||++++++.+ ...+.+|||.+
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 378999999999998776 6999999998753 4456788876555 59999999998754 45678999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~~~~~ 512 (679)
+||.|++.++.. ....+++.++..|++||..|+.|||+ .+|.||||||+|+|.. .+..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 46679999999999999999999999 9999999999999996 4567999999999986543
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... ...+-|+.|.|||++....|+...|+||+||++|-|+.|.+||... .+ ..+..-++..++.|.+. +.
T Consensus 218 ~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~-hg--~aispgMk~rI~~gqy~-FP---- 287 (400)
T KOG0604|consen 218 GDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN-HG--LAISPGMKRRIRTGQYE-FP---- 287 (400)
T ss_pred ccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc-CC--ccCChhHHhHhhccCcc-CC----
Confidence 322 2345799999999999999999999999999999999999999622 11 22222233444444321 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..-.....+...++|+.+|..+|.+|.|+.|++.
T Consensus 288 -~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 -EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1112344557889999999999999999999975
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=326.59 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=197.9
Q ss_pred ccccCcCccEEEEEEEE-cCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 362 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+.+||.|.||.||-|.. ++|+-.|+|-++-.. ......+.+|..++..++|||+|+++|+-.+.+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 46799999999999975 469999999876432 234467889999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc--
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 516 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~-- 516 (679)
+|.+.+. .+...++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1320 sLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999998 35556777777889999999999999 999999999999999999999999999999876553222
Q ss_pred -cccccCCccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 517 -SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 517 -~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
-....||+.|||||++.+. ....++||||+||++.||+||+.||...+. ...+... ...|...
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~----V~~gh~P------- 1460 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYH----VAAGHKP------- 1460 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhH----HhccCCC-------
Confidence 2345699999999999653 456799999999999999999999973332 2222222 2222222
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.+.....+-.+++.+||+.||++|+++.|+++
T Consensus 1461 --q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 --QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 223334446679999999999999999987765
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.03 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=191.7
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccccc----------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE---------- 425 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---------- 425 (679)
.+|.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 35667889999999999999875 6899999998765555667788999999999999999999876543
Q ss_pred ----ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEE
Q 005750 426 ----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKV 500 (679)
Q Consensus 426 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 500 (679)
...++||||++ ++|.+++. ...+++..++.++.||++||.|||+ .+++||||||+||+++ +++.++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 58888775 3468899999999999999999998 9999999999999997 4567899
Q ss_pred eeccCccccccCcccc--cccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 005750 501 SDFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 577 (679)
+|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh
Confidence 9999987653322111 122346889999998654 56788999999999999999999999633221110 000000
Q ss_pred hHh--c---CCeeeeecc-----cccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIK--K---GDVISIVDP-----VLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~--~---~~~~~~~d~-----~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... . ......+.. ..... .......++.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0 000000000 00000 00112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=290.55 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=199.1
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..-++||+|+||.||..+.+ +|+.+|.|.+.+.. .......++|-++|.+++.+.||.+--.|++.+.+|+|+..|
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 34578999999999999765 69999999886532 223345788999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+||+|.-+|... ..+.+++..++.++.+|+.||.+||+ .+||+||+||+|||+|+.|+++|+|+|+|..+.+....
T Consensus 268 NGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 268 NGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred cCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 999999888754 35689999999999999999999999 99999999999999999999999999999998776544
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.. .+||.+|||||++.++.|+...|.||+||+||||+.|+.||........ .+.+.+...+. + ..
T Consensus 344 ~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~-------~---~e 408 (591)
T KOG0986|consen 344 RG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLED-------P---EE 408 (591)
T ss_pred cc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcc-------h---hh
Confidence 33 3699999999999999999999999999999999999999972221111 11111111111 1 12
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
++....++..++.+..|++||.+|.-..
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3334445778899999999999997443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.88 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=202.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch---hHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
-..+.|.+.||+|.||.|.+++-+ +++.+|+|++++...- ....-+.|-++|+..+||.+..+--.|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 345668899999999999999876 6999999999876433 334456799999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||..||.|.-+|. ....+++...+.+-..|+.||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998887 35678888889999999999999999 9999999999999999999999999999986332
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. .......+|||.|+|||++....|+.+.|.|.+||++|||++|+.||...+...-..++- ..+-++
T Consensus 321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~kF------- 387 (516)
T KOG0690|consen 321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLKF------- 387 (516)
T ss_pred c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhccC-------
Confidence 2 223456789999999999999999999999999999999999999997544432221111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
+.....+...|+...|.+||.+|. .++||.+
T Consensus 388 -----Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 -----PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -----CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 112223567899999999999997 4555543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=270.11 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=195.6
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
++...||.|..|.||+++.+ +|...|||.+.+.. ....++++..++++..-+ +|+||+.+|||..+....+.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 35678999999999999877 58999999997653 445677888888877664 8999999999999888899999883
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
.-+..+++.. .+++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|++||||||.+.+.-+...+
T Consensus 175 -~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 175 -TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 3444444432 4568888888999999999999998 699999999999999999999999999999887665443
Q ss_pred cccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 517 SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
....|-+.|||||.+. ...|+.++||||||+.++||.||+.||.+.+.+- .. +...+.+.. |.+.
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~---ltkvln~eP------P~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV---LTKVLNEEP------PLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH---HHHHHhcCC------CCCC
Confidence 3345889999999985 4478889999999999999999999998544321 11 112222111 2222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.. .....+.+++..||++|+.+||...++++.
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 133468899999999999999999988753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=286.29 Aligned_cols=244 Identities=30% Similarity=0.427 Sum_probs=192.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+...++||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 444578999999999999875 68899999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+. |++.+.+.. ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 577777753 24568999999999999999999998 99999999999999999999999999988653221
Q ss_pred cccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 515 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
....++..|+|||++. ...++.++|||||||++|+|++|..||...+.. .... ..... .....
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~---~~~~~-~~~~~---- 240 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY---HIAQN-DSPTL---- 240 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHH---HHHhc-CCCCC----
Confidence 2335788999999974 456888999999999999999999998733221 1111 11111 11110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.83 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=197.2
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 45678999999999999877 58999999987653 2334677889999999999999999999999999999999997
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||.+.........
T Consensus 82 -~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 -MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred -cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 5899999743 2468999999999999999999999 99999999999999999999999999998875443221
Q ss_pred cccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC---------Ce--
Q 005750 517 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DV-- 584 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~-- 584 (679)
.....++..|+|||.+.+. .++.++|||||||++|++++|+.||....... ............ ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccc
Confidence 1222356789999998766 78999999999999999999999997433211 111111110000 00
Q ss_pred -eeeecc---cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 -ISIVDP---VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 -~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...... .............+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0000001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=277.62 Aligned_cols=236 Identities=30% Similarity=0.396 Sum_probs=192.7
Q ss_pred cCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 365 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
||.|+||.||++... +++.+++|++..... .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 589999999875432 2456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~ 520 (679)
.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999973 3468999999999999999999999 9999999999999999999999999999877544321 12234
Q ss_pred cCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 521 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
.++..|+|||...+...+.++|+||||+++|++++|+.||...+. ....+ .... ... ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999973332 11111 1111 110 111112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQE 624 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~e 624 (679)
...+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 457889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=291.08 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=191.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCccccccccccc--------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-------- 425 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------- 425 (679)
..|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|++++++++||||+++++++...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45667889999999999999876 689999998864322 2234567899999999999999999987443
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
...++|+||+.+ ++.+.+.. ....+++..+..++.|+++||+|||+ ++++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999964 67666653 24579999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcccc----------cccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 005750 506 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 506 a~~~~~~~~~~----------~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 574 (679)
+.......... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 97654322111 112346788999998765 4578999999999999999999999974333211111100
Q ss_pred HHHhHhcC------CeeeeecccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 575 ARSMIKKG------DVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 575 ~~~~~~~~------~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........ ......+.......+ ......+.+++.+||+.+|.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 000000000000000 112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=312.52 Aligned_cols=245 Identities=28% Similarity=0.405 Sum_probs=184.9
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccc---------------
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 424 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------------- 424 (679)
.+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+..|.+|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 468999999999999988 89999999987543 3345678899999999999999998521100
Q ss_pred --------------------------------------------------------------------------------
Q 005750 425 -------------------------------------------------------------------------------- 424 (679)
Q Consensus 425 -------------------------------------------------------------------------------- 424 (679)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------c--------ceEEEEEEecCCCcHhhhhcccCCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005750 425 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPL-DWLTRLQIAHDAAKGLEYLHTGCNPG 479 (679)
Q Consensus 425 ----------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~qia~aL~~LH~~~~~~ 479 (679)
+ ..+|+-||||+...+.++++.+. .. .....++++++|++||.|+|+ +|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 0 12578899999988888887432 22 466789999999999999999 99
Q ss_pred ccccCCCCCCccccCCCcEEEeeccCccccc------c-----------CcccccccccCCccccCCcccCCCC---CCc
Q 005750 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQQ---LTE 539 (679)
Q Consensus 480 ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ 539 (679)
||||||||.|||++++..|||+|||+|.... + ......+..+||.-|+|||++.+.. |+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 0111223456999999999997654 999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCC
Q 005750 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 619 (679)
Q Consensus 540 ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 619 (679)
|+|+||||++++||+ .||. ..+ +... +...++.+.+... ..+.......=..+|++|++.||.+|
T Consensus 798 KiDmYSLGIVlFEM~---yPF~-TsM-ERa~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFG-TSM-ERAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCC-chH-HHHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 999999999999998 4565 222 1111 2222334443332 11222333355689999999999999
Q ss_pred CCHHHHHH
Q 005750 620 PKMQEIVL 627 (679)
Q Consensus 620 Pt~~evl~ 627 (679)
|||.|+++
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999984
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=272.09 Aligned_cols=203 Identities=26% Similarity=0.385 Sum_probs=170.8
Q ss_pred HHhhccccCcCccEEEEEEEEcC-----CcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccc-cceEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~ 429 (679)
.|+.+.+||+|.||.||+|..++ .+.+|+|.++.... .-.....+|+.+++.++|||++.+..+|-. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46678999999999999996442 34799999875422 223567789999999999999999999877 77899
Q ss_pred EEEEecCCCcHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC----CcEEEeec
Q 005750 430 LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDF 503 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Df 503 (679)
+++||.+. +|.++++-.+ ..+.++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 8888886544 44679999999999999999999999 889999999999999877 99999999
Q ss_pred cCccccccCcccc--cccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccc
Q 005750 504 GLSRQAEEDLTHI--SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVED 564 (679)
Q Consensus 504 gla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~ 564 (679)
|+++.+.+..... ....+-|..|+|||.+.+. .|+++.||||.|||+.||+|-++.|.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999987655433 2345579999999998764 78999999999999999999998887544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=310.00 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=212.1
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcC--------CcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
++......+.+.||+|.||.|++|..+. ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3444444667799999999999997541 4579999998653 34667899999999999 699999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
...+..++|+||+..|+|.++++..+ .. ..++....+.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998654 01 248999999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCccccccccc--CCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 566 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~ 566 (679)
||++.+..+||+|||+|+.............. -+..|||||.+....++.|+||||||++|||++| |..||.+ ..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--~~ 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--IP 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--CC
Confidence 99999999999999999975554333222212 2457999999999999999999999999999999 8999963 11
Q ss_pred chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 567 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
....+.+ .+++|...+ .+..+..++.++++.||+.+|++||++.|+++.++..+.
T Consensus 527 ~~~~l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222222 344444322 222335578899999999999999999999999999643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=311.71 Aligned_cols=254 Identities=26% Similarity=0.321 Sum_probs=208.6
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
+....|.+.+.||+|+||.|..++++ +++.||+|++.+. ......-|..|-.+|..-+.+-|++++-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 44567788999999999999999987 5889999999873 2345567899999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||++||+|..++... ..+++..++.++..|+-||.-||+ .|+|||||||+|||+|..|++||+|||.+..+
T Consensus 152 lVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999843 379999999999999999999999 99999999999999999999999999999988
Q ss_pred ccCcccccccccCCccccCCcccC----C-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..+..-.+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..+ .+++-......-.+.
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHKES 299 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchhhh
Confidence 877777777888999999999984 2 57899999999999999999999999722 233333333332222
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 627 (679)
..+.+. ........+||.+.+. +|+.|.. ++++-.
T Consensus 300 l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 300 LSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 222111 1133466788887775 5788887 777754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.46 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=190.4
Q ss_pred HhhccccCcCccEEEEEEEEc-C--CcEEEEEEecCCc--chhHHHHHHHHHHHHhc-cCCCcccccccccc----cceE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQR 428 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~ 428 (679)
|++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++++.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456789999999999999876 3 7899999986532 22345678899999999 59999999986532 2457
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++++||+. ++|.+.+. ....+++..++.++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88889885 68988886 35678999999999999999999998 9999999999999999999999999999986
Q ss_pred cccCccc---ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHH--------HH
Q 005750 509 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH--------WA 575 (679)
Q Consensus 509 ~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~--------~~ 575 (679)
....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+...... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1122357889999998765 568999999999999999999999997433211000 000 00
Q ss_pred HHhHhcC--Ceeeeec--c-cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 576 RSMIKKG--DVISIVD--P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 576 ~~~~~~~--~~~~~~d--~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....... ....... + .............+.+++.+||+.+|.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000 0 00000001123468899999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=287.62 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=193.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccc-cceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E 433 (679)
.|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4666899999999999999866 79999999876432 2234678899999999999999999998865 567899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+ +++|.+++. ...+++..+..++.|+++||+|||+ ++++||||+|+||++++++.++|+|||.+.......
T Consensus 91 ~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred hh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 98 568988876 3457888888999999999999999 999999999999999999999999999987543321
Q ss_pred ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHHH--------HHHhHhcCC
Q 005750 514 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHW--------ARSMIKKGD 583 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~~--------~~~~~~~~~ 583 (679)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... +.+. ...... +.
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS-EN 237 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc-hh
Confidence 22346788999998765 578999999999999999999999997443211110 1110 000000 00
Q ss_pred eeeeecc-cccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDP-VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+.. ......+ ......+.+++.+||+.+|++||++++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000111 1123578899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=288.95 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=195.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc------e
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~ 427 (679)
.+|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34667889999999999999865 68999999986432 223456889999999999999999999886543 4
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+ +++|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 58999999 779988875 3468999999999999999999999 999999999999999999999999999988
Q ss_pred ccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH----------
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR---------- 576 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~---------- 576 (679)
...... ....+++.|+|||.+.+ ..++.++|+|||||++|++++|+.||...+... .......
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 654322 22346889999998876 468899999999999999999999997433211 1111000
Q ss_pred HhHhcCCeeeeec--cccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 005750 577 SMIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 634 (679)
Q Consensus 577 ~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 634 (679)
..+.......... +... ..........+.+++.+|++.||.+|||+.++++ .++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000000000000 0000 0001122335889999999999999999999984 4554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.52 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=193.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc------ceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~ 428 (679)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3455789999999999999875 68999999986532 22345688999999999999999999988654 346
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 46766542 358899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------HhH
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMI 579 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~--------~~~ 579 (679)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+............ ...
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 53321 22346788999999866 468899999999999999999999997443211111000000 000
Q ss_pred hcCCeeeeec--ccc-cCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhh
Q 005750 580 KKGDVISIVD--PVL-IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 635 (679)
Q Consensus 580 ~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~ 635 (679)
.......... +.. .... .......+.+++.+||+.||.+||+++|++.. ++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000 000 0000 01123467899999999999999999999954 7777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=289.37 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=193.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccce------E
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------~ 428 (679)
.|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4566789999999999999886 58899999986532 2334567789999999999999999998866554 8
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++|+||+ +++|.+++. ...+++..++.++.|+++||+|||+ .||+||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 679999886 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc------
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 581 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------ 581 (679)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHH
Confidence 5433 122346888999998865 467899999999999999999999997432211 11111110000
Q ss_pred -----CCeeeeecccc---cCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 582 -----GDVISIVDPVL---IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 582 -----~~~~~~~d~~l---~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+.... ...+ .......+.+++.+||+.+|.+|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 0000 0112457889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=291.56 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=190.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc------ceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~ 428 (679)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 4556789999999999999764 68999999987532 22346678899999999999999999987532 346
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+++++++ +++|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 98 ~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7888877 789988875 3458999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh---------
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------- 578 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~--------- 578 (679)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... .+.......
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence 5332 123347889999998866 567899999999999999999999996332211 111100000
Q ss_pred -HhcCC-------eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 579 -IKKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 579 -~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.... ......... .+........+.+++.+|++.+|.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000000 00000123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=273.53 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=207.2
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccc-c
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-E 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~ 425 (679)
+.+++.+....+-+|.||+||+|.|.+ .+.|.+|.++... .-....++.|.-.+..+.|||+.++.+++.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 445555556789999999999996653 4567888876543 3455678889999999999999999998754 5
Q ss_pred ceEEEEEEecCCCcHhhhhc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 426 HQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
...++++.++.-|+|..++. +......++..+...++.|++.|++|||. +++||.||..+|.+||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEe
Confidence 57789999999999999998 33345568888899999999999999998 99999999999999999999999
Q ss_pred eeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHh
Q 005750 501 SDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 501 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
+|-.+++..-... .........+..||+||.+.+..|+.++|||||||++|||+| |+.|+..-|.-+ ..+ .
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~----y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEH----Y 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHH----H
Confidence 9999998754433 223333446789999999999999999999999999999999 999997332211 111 2
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
+++|.. -..+..+++++..++.-||+..|++||+++|++.-|.+-
T Consensus 511 lkdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 LKDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred Hhccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222221 122446778999999999999999999999999988763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=272.17 Aligned_cols=221 Identities=22% Similarity=0.213 Sum_probs=176.3
Q ss_pred CccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhhhhcc
Q 005750 368 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 446 (679)
Q Consensus 368 G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 446 (679)
|.+|.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 68999999987542 233455555566799999999999999999999999999999999873
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccc
Q 005750 447 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526 (679)
Q Consensus 447 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y 526 (679)
...+++..+..++.|+++||+|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3468999999999999999999999 999999999999999999999999999876554321 122356789
Q ss_pred cCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHH
Q 005750 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 606 (679)
Q Consensus 527 ~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (679)
+|||.+.+..++.++||||+|+++|+|++|+.|+...... ..... .. ..+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~-----~~----~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT-----TL----NIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc-----cc----CCcccCCHHHHH
Confidence 9999998888899999999999999999999887521110 00000 00 011122346889
Q ss_pred HHHHhcccCCCCCCCHHH
Q 005750 607 VAIQCVEQRGFSRPKMQE 624 (679)
Q Consensus 607 li~~cl~~dP~~RPt~~e 624 (679)
++.+|++.||.+||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=291.36 Aligned_cols=239 Identities=25% Similarity=0.349 Sum_probs=193.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|++...+|.|+|+.|-.+.+. +++..++|++.+. ..+..+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 345677788999999999888765 6889999999765 23344677776666 79999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc-cCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~Dfgla~~~~~~ 512 (679)
.+.|+-+.+.+.. .+ .....+..|+.+|+.|+.|||+ +|+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KP-EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cc-hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988887763 22 2336777899999999999999 999999999999999 68999999999999887655
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ ..+...+..+.+.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc-------
Confidence 12223578999999999999999999999999999999999999733322 1222333333332
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........+|+.+||+.||.+||+|.|+..
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 223346789999999999999999999865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-33 Score=265.98 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=195.2
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCCCc
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
..||.|+||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..++.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 57999999999999887 699999999986544 5667888898876555 79999999999999999999999994 46
Q ss_pred Hhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 440 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 440 L~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|..+-+.. .....+++.-+-.|....+.||.||.+ +..|+|||+||+|||++..|.+||||||.+....++.. .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 54433211 145678888888899999999999998 58999999999999999999999999999987655432 2
Q ss_pred ccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 518 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
+...|-..|||||.+.. ..|+.++||||||++|||+.||+.|+...+. ..+.+.... .|+...+..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~~~---- 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLFDK---- 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecCcc----
Confidence 33457889999999854 3588999999999999999999999974332 233333322 23332222111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........+..+|.-||.+|-.+||...++.++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112344578899999999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=276.72 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=205.5
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-C-C----Cccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-R----NLVPLIGYCE 423 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nIv~l~~~~~ 423 (679)
..+....+|.+...+|+|.||.|-...+. .+..||||+++.- ..-.++.+-|+++|+++. + | -+|++.++|+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 45666888999999999999999999765 4789999998743 344566777999999993 2 3 3788889999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---------
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------- 494 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------- 494 (679)
-.++.|+|+|.+ |.|+.+++..+ +..+++...+..++.|+++++++||+ .+++|.||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence 999999999998 77999999865 46788999999999999999999999 99999999999999932
Q ss_pred -----------CCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 495 -----------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 495 -----------~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
+..++++|||.|....... ...+.|..|.|||++.+-.++..+||||+||||+|++||...|+..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2358999999998755443 3445789999999999999999999999999999999999999855
Q ss_pred cccchhhHHHHHHH--------------hHhcCCee-----------eeecccc----cCCCCHHHHHHHHHHHHHhccc
Q 005750 564 DFGAELNIVHWARS--------------MIKKGDVI-----------SIVDPVL----IGNVKIESIWRIAEVAIQCVEQ 614 (679)
Q Consensus 564 ~~~~~~~~~~~~~~--------------~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~li~~cl~~ 614 (679)
+..+.....+.+.. ....+.+. ...++.. .......+...|.+|+++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 43222212221111 11111000 0000000 0011234555799999999999
Q ss_pred CCCCCCCHHHHHH
Q 005750 615 RGFSRPKMQEIVL 627 (679)
Q Consensus 615 dP~~RPt~~evl~ 627 (679)
||.+|+|+.|+++
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=284.11 Aligned_cols=265 Identities=26% Similarity=0.376 Sum_probs=207.4
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
.+.||.|.||+||-|+++ +|+.||||++.+.. .....++.+|+.||++++||.||.+-..|+..++.++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 578999999999999875 79999999997642 34457899999999999999999999999999999999999955
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC---CcEEEeeccCccccccCccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfgla~~~~~~~~~ 515 (679)
++.+++-.. ..+++++..-..++.||+.||.|||. ++|+|+||||+|||+.+. .++||||||.|+.+++...
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555554433 46789998888999999999999998 999999999999999643 5799999999999876533
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....||+.|+|||+++++.|...-|+||.||++|.-++|..||. ++. ++-+ .+++..+ ++.+..
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-EdE----dInd----QIQNAaF--MyPp~P--- 787 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-EDE----DIND----QIQNAAF--MYPPNP--- 787 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-Ccc----chhH----Hhhcccc--ccCCCc---
Confidence 345679999999999999999999999999999999999999997 222 1111 1222111 122222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--------HHHhhhhhhcCCCCccccCCC
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--------AIQDSIKIEKGGDQKFSSSSS 648 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--------~L~~~~~~~~~~~~~~~~~~s 648 (679)
..+.....+++|...|+..-.+|.|.+.-+. ...++..+|...-+++-.+.|
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThes 847 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHES 847 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcc
Confidence 2233346789999999999999999887653 234455566555555543333
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=304.67 Aligned_cols=144 Identities=32% Similarity=0.459 Sum_probs=129.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|.+.++||+|+||.||+|.+. +++.||||+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3567889999999999999887 68999999987532 2334678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
|+.+++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999873 4568889999999999999999999 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=273.49 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=200.1
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchh---HHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
.+.+....++|..+||+|+||.|-+|..+ +.+.+|||++++...-. .+--..|-++|... +-|.+++++..|+.-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 34667778899999999999999999776 46789999998764322 22334567777666 578899999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
+++|+||||+.||+|.-+++ +-+.+.+..+..++..||-||-+||+ +||++||||.+||++|.+|++||+|||+
T Consensus 423 DRLyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred hheeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccc
Confidence 99999999999999988887 45678888889999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
++.---+. ......+||+.|+|||++...+|+.+.|.||+||+||||+.|++||++++..+-. + . +.
T Consensus 497 cKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~---a-I~----- 563 (683)
T KOG0696|consen 497 CKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---Q---A-IM----- 563 (683)
T ss_pred ccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H---H-HH-----
Confidence 98632222 2245678999999999999999999999999999999999999999976553221 1 1 11
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 621 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 621 (679)
+.. -.++.....+...+....|.+.|.+|..
T Consensus 564 ---ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 ---EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 1234444557788999999999999963
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=281.87 Aligned_cols=240 Identities=23% Similarity=0.294 Sum_probs=201.1
Q ss_pred HhhccccCcCccEEEEEEEEcCCc-EEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.+....||-|+||.|=++..+... .+|+|++++.. ....+.+..|-.+|...+.|.||++|..|.+++..|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344567999999999999887543 48999987643 34456688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
|-||.|...|+ .++.++..+...++..+++|++|||+ ++||+|||||+|.+++.+|-+||.|||+|+.+....
T Consensus 502 ClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 502 CLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999998 56789999999999999999999999 999999999999999999999999999999886543
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.+..++||+.|.|||++.+...+.+.|.||||+++|||++|.+||.+.+.....+++-.-...+
T Consensus 575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------- 638 (732)
T KOG0614|consen 575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------- 638 (732)
T ss_pred -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------------
Confidence 3456789999999999999999999999999999999999999999776654433322111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK 621 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt 621 (679)
..+........+++++.+..+|.+|.-
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112223345679999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=238.92 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=197.3
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
.++||+|.||+||+|+.. +++.||+|.++-. ...-.....+|+-+++.++|.|||+++++...++...+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 478999999999999865 6889999998643 22334567899999999999999999999999999999999995 5
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|..+... -++.++.+.+..++.|+++||.++|+ +++.|||+||+|.+|+.+|.+|++|||+++-++-.... .+
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ys 159 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YS 159 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-ee
Confidence 78777764 35678999999999999999999999 99999999999999999999999999999877654322 22
Q ss_pred cccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCe---eeeeccccc
Q 005750 519 VARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV---ISIVDPVLI 593 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~l~ 593 (679)
...-|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..++..-+-|......+... ..+.|-...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 33468999999998765 67899999999999999987 77777655544433322222222222211 111221111
Q ss_pred CCCCH-----HHHH----HHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKI-----ESIW----RIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~-----~~~~----~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.++. +... .=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11211 1111 3468888999999999999998876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=259.75 Aligned_cols=238 Identities=31% Similarity=0.437 Sum_probs=193.0
Q ss_pred ccEEEEEEEEc-CCcEEEEEEecCCcchh-HHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhhhhcc
Q 005750 369 SFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 446 (679)
Q Consensus 369 ~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 446 (679)
+||.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654444 67899999999999999999999999998999999999999999999874
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccc
Q 005750 447 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526 (679)
Q Consensus 447 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y 526 (679)
. ..+++..++.++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 338999999999999999999999 899999999999999999999999999998765432 22234578899
Q ss_pred cCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHH
Q 005750 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 606 (679)
Q Consensus 527 ~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (679)
++||.+.+..++.++||||||++++++++|..||.... ......+... .+..... ........++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG----KPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh----ccCCCCc-------cccccCCHHHHH
Confidence 99999988888999999999999999999999997321 1112222211 1111000 000003347889
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005750 607 VAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 607 li~~cl~~dP~~RPt~~evl~ 627 (679)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=257.43 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=193.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecC--CcchhHHHHHHHHHHHHhccCCCcccccccccc--------cc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 426 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~~ 426 (679)
.|+-..++|+|.||.||+|+.+ +|+.||+|++-- ....-.....+|+++|+.++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4444578999999999999876 578889986532 222233456789999999999999999998843 23
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..|+||.+|+. +|..++... ...++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.+|.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 48999999965 888887642 3678899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCccc---ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 507 RQAEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 507 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
+.+...... .....+-|..|++||.+.+ ..++++.|||+.||++.||+|+.+-+++........++......+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765432221 1223446899999998765 589999999999999999999999998554433333333222211111
Q ss_pred C--------eeeee--cccccCCCC--HHHH------HHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 D--------VISIV--DPVLIGNVK--IESI------WRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~--------~~~~~--d~~l~~~~~--~~~~------~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. +...+ +|...+.+. .+.. ....+|+.+++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 00111 111111110 0111 15679999999999999999999885
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=290.56 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=168.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-C----CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccc------cccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEE 425 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~~~~ 425 (679)
..|.+.+.||+|+||.||+|++. + +..||+|++...... +....| .++...+.++..++.. ....
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 34667899999999999999876 4 689999987643211 111111 1122223333333222 2456
Q ss_pred ceEEEEEEecCCCcHhhhhcccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVN-----------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 488 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~ 488 (679)
...++||||+.+++|.+++..... ........+..++.|++.||+|||+ ++|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHH
Confidence 678999999999999998864310 0111233456799999999999999 99999999999
Q ss_pred CccccC-CCcEEEeeccCccccccCcccccccccCCccccCCcccCCC----------------------CCCchhHHHH
Q 005750 489 NILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYS 545 (679)
Q Consensus 489 NIll~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~ksDVwS 545 (679)
|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 68999999999987654443344455689999999965322 2334679999
Q ss_pred HHHHHHHHHhCCCCCCccccc-------chhhHHHHHHHhHhcCCeeeeecccccCCC--CHHHHHHHHHHHHHhcccCC
Q 005750 546 FGVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWRIAEVAIQCVEQRG 616 (679)
Q Consensus 546 lGvll~elltG~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~dP 616 (679)
|||++|||+++..++...... .......|....... ..+.+...+ .........+|+.+||+.||
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999987765411000 000111111110000 000000000 00011235589999999999
Q ss_pred CCCCCHHHHHHH
Q 005750 617 FSRPKMQEIVLA 628 (679)
Q Consensus 617 ~~RPt~~evl~~ 628 (679)
.+|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=266.42 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=197.2
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcc-------hhHHHHHHHHHHHHhccCCCccccccccc-
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCE- 423 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 423 (679)
.....+|-+.+.||+|||+.||+|.+ ...+.||||+-.-... .-.+...+|.+|.+.|.||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34555666778999999999999964 4688999998542211 12245778999999999999999999985
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEE
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKV 500 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL 500 (679)
+.+..|-|+|||+|.+|.-+|+ ..+.+++.+++.|+.||+.||.||.+. ..+|||-||||.|||+- .-|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 4567889999999999999998 467899999999999999999999974 47999999999999995 4578999
Q ss_pred eeccCccccccCccc------ccccccCCccccCCcccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh
Q 005750 501 SDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 570 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~ 570 (679)
+|||+++.+.++... ......||.+|++||.+. ...++.|.||||.|||+|+++.|+.||... . ..++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-q-sQQd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-Q-SQQD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-h-hHHH
Confidence 999999987654322 234457999999999873 236788999999999999999999999722 2 1222
Q ss_pred HHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 571 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.+.-. .++..... + ...+....+...+|++||++--++|....++..
T Consensus 693 ILqeNT-IlkAtEVq------F--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENT-ILKATEVQ------F--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhc-hhcceecc------C--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 222111 11111110 0 111222335678999999999999988877654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=283.99 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=202.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccccc-----ccceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~~~~l 430 (679)
+++|.+.||.|.+|.||+++.. +++.+|+|++... ....+++..|.++++.. +|||++.++|++. .++.++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 4557899999999999999865 6899999998754 33456788899999988 6999999999884 3678999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|||||.+||..|+++... +..+.|..+..|++.++.|+.|||. ..++|||||-.|||++.++.|||+|||.+....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999998775 8889999999999999999999998 999999999999999999999999999998765
Q ss_pred cCcccccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
.... ......||+.|||||++.- ..|+..+|+||||++..||.-|.+|+.. +. ....+-...+
T Consensus 175 sT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D--mH----PmraLF~IpR----- 242 (953)
T KOG0587|consen 175 STVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD--MH----PMRALFLIPR----- 242 (953)
T ss_pred cccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC--cc----hhhhhccCCC-----
Confidence 4332 3345679999999999843 3567799999999999999999999962 21 1111111111
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.|...-.-+....+++.++|..||.+|-++||++.++++
T Consensus 243 ---NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 ---NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111112234556678999999999999999999988874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=253.27 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=198.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+.+.++||+|+|+.|..++++ +.+.+|+|++++.. ..+.+-+..|-.+..+. +||.+|-++.+|..+.++++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 445689999999999999876 67899999998642 33445567777777776 79999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++||+|.-+++ .+..++++.++.+...|.-||.|||+ +||+.||||.+|+|+|..|++||+|+|+++.--.+.
T Consensus 332 yv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 332 YVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999987776 46779999999999999999999999 999999999999999999999999999998643322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc-chhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
...+..+||+.|+|||++++..|+...|.|++||+++||+.|+.||+.-... .+.+-.+++-+.+-+..+.
T Consensus 406 -d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------- 477 (593)
T KOG0695|consen 406 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------- 477 (593)
T ss_pred -cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-------
Confidence 2345678999999999999999999999999999999999999999844433 3344444544444332221
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPK 621 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt 621 (679)
.+....-+...+++.-|.+||.+|..
T Consensus 478 ---iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ---IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11111224567888999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=275.02 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=177.7
Q ss_pred HHHhhccccCcCccEEEEEEEE-----------------cCCcEEEEEEecCCcchhHHH--------------HHHHHH
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVA 405 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~ 405 (679)
..|.+.++||+|+||.||+|.+ ..++.||||++........++ ...|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3466789999999999999964 235689999986543322223 334677
Q ss_pred HHHhccCCCc-----ccccccccc--------cceEEEEEEecCCCcHhhhhcccC---------------------CCC
Q 005750 406 LLSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQK 451 (679)
Q Consensus 406 ~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~ 451 (679)
++.+++|.++ ++++++|.. .+..++||||+++++|.++++... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766544 677777643 346799999999999999887421 112
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcc
Q 005750 452 PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531 (679)
Q Consensus 452 ~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 531 (679)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 34677888999999999999999 999999999999999999999999999997654332221122234789999998
Q ss_pred cCCCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCccccc-c-----hhhHHHHHHHhHhcC
Q 005750 532 YGNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDFG-A-----ELNIVHWARSMIKKG 582 (679)
Q Consensus 532 l~~~~~----------------------s~ksDVwSlGvll~elltG~~-pf~~~~~~-~-----~~~~~~~~~~~~~~~ 582 (679)
+..... ..+.||||+||++|+|++|.. ||.....- . ......|.. ....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hccc
Confidence 754321 124699999999999999875 66421110 0 011111111 1111
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 627 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 627 (679)
. ++-.. .........+++.+||..+| .+|+|++|+++
T Consensus 460 ~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 K----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 01111 11223467899999999766 68999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=282.99 Aligned_cols=241 Identities=26% Similarity=0.438 Sum_probs=186.1
Q ss_pred ccccCcCccE-EEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCCCc
Q 005750 362 CKKIGKGSFG-SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 362 ~~~LG~G~~g-~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
.+.+|.|+.| .||+|... |++||||++-.. ..+-..+|+..|+.- .|||||++++.-.++...|+..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 3678999987 56999987 889999988643 334567899999988 6999999999999999999999999 469
Q ss_pred Hhhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---C--CcEEEeeccCccccccCc
Q 005750 440 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 440 L~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~Dfgla~~~~~~~ 513 (679)
|.+++... ...........+.++.|+++||+|||+ .+||||||||+||||+. + .+++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999863 111111214457889999999999999 99999999999999975 2 579999999999976654
Q ss_pred cccc--ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 514 THIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 514 ~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.... ....||-+|+|||++....-+.+.||||+||++|..++| .+||. .....+.++.. .......+.+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG-d~~~R~~NIl~-------~~~~L~~L~~ 737 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG-DSLERQANILT-------GNYTLVHLEP 737 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC-chHHhhhhhhc-------Cccceeeecc
Confidence 4332 345699999999999998888899999999999998885 99997 22222222211 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 626 (679)
. .++ +..+||.+|+.++|..||++.+|+
T Consensus 738 ~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 L------PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred C------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 111 677999999999999999999997
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=267.13 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=169.6
Q ss_pred ccccCcCccEEEEEEE-EcCCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 362 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
++.||-|+||.|.+++ .++...+|+|.+++.. ......++.|.+||.....+-||+|+-.|.+.+.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 4679999999999996 4457789999987653 23445688899999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc------
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 511 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~------ 511 (679)
|++..+|. ..+.+.+..++.++..+..|+++.|. .|+|||||||+|||||.+|++||+|||++.-+.-
T Consensus 714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999987 35678888888999999999999998 9999999999999999999999999999854210
Q ss_pred --Ccccc---------------------------------cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhC
Q 005750 512 --DLTHI---------------------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 556 (679)
Q Consensus 512 --~~~~~---------------------------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG 556 (679)
...+. .-..+||+.|+|||++....++..+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 00000 0112489999999999999999999999999999999999
Q ss_pred CCCCCccccc
Q 005750 557 KKPVSVEDFG 566 (679)
Q Consensus 557 ~~pf~~~~~~ 566 (679)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999855444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=265.95 Aligned_cols=277 Identities=22% Similarity=0.260 Sum_probs=216.3
Q ss_pred CCccccCChhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc------CCCc
Q 005750 343 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------HRNL 415 (679)
Q Consensus 343 ~~~~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnI 415 (679)
....|.+.+.|+...+|.+....|+|-|++|.+|.+. .|..||||++.... ...+.=++|+++|++|+ --|+
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3446677889999999999999999999999999866 48899999998653 33455578999999995 3489
Q ss_pred ccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 495 (679)
++++..|...+++|||+|-+ ..+|.+.|+.......+....+..++.|+.-||..|.. .||+|.||||+|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence 99999999999999999988 56999999987777889999999999999999999998 999999999999999865
Q ss_pred -CcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 005750 496 -MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 496 -~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 574 (679)
..+||||||.|....+.... .+.-+..|.|||++.|-+|+...|+||.||+||||+||+..|.+.....-..+.--
T Consensus 573 k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 56899999999887654322 22235679999999999999999999999999999999999986554322222111
Q ss_pred HH-----HhHhcCCeee-eec--------------------------c------cccC--CC---CHHHHHHHHHHHHHh
Q 005750 575 AR-----SMIKKGDVIS-IVD--------------------------P------VLIG--NV---KIESIWRIAEVAIQC 611 (679)
Q Consensus 575 ~~-----~~~~~~~~~~-~~d--------------------------~------~l~~--~~---~~~~~~~l~~li~~c 611 (679)
++ ..++.+.+.+ -+| | .+.. .+ .......+.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 11 1111111100 000 1 0000 12 234455789999999
Q ss_pred cccCCCCCCCHHHHHH
Q 005750 612 VEQRGFSRPKMQEIVL 627 (679)
Q Consensus 612 l~~dP~~RPt~~evl~ 627 (679)
|..||++|.|..|.|+
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=233.72 Aligned_cols=196 Identities=25% Similarity=0.393 Sum_probs=165.1
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCC
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
-...||+|++|.|-+-++. +|+..|+|.+.... ....++.++|+.+..+. .+|.+|.++|........++.||.|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 3578999999999888765 79999999997643 34556788898886655 79999999999988889999999994
Q ss_pred CcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 438 GTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 438 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
.||..+-++.. .+..+++..+-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+....++...
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 57766554332 57789999999999999999999999 589999999999999999999999999999876654322
Q ss_pred cccccCCccccCCcccCC----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 517 SSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
+...|-..|+|||.+.. ..|+-|+||||||+++.||.+++.||.
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 22347889999998743 478999999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=248.17 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=192.4
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccc-----eEEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYE 433 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lV~E 433 (679)
.+.||.|+||.||.+++. +|+.||+|++..... ...+.+.+|+++|..++|.|++..+++..-.. ..|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 367999999999999875 799999999875422 34577889999999999999999988764432 4578888
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
.+ ..+|..++- ....++...+.-+++||++||+|||+ .+|.||||||.|.|++.+..+||||||+++..+.+.
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457777665 46678888899999999999999999 999999999999999999999999999999866554
Q ss_pred ccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh-----------c
Q 005750 514 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------K 581 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~-----------~ 581 (679)
........-|..|.|||++.+. .|+.+.||||.||++.||+..+..|+....-...+++ ...+. +
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHHHHHHhh
Confidence 4333344468899999999875 7899999999999999999999999744332222211 11111 1
Q ss_pred CCeeeeecc-----cccCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 582 GDVISIVDP-----VLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 582 ~~~~~~~d~-----~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
|...-++.. .+..-+ ....--+-+.+..+++..||.+|.+..+.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111110 000000 0011124567888999999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=249.60 Aligned_cols=139 Identities=26% Similarity=0.448 Sum_probs=117.9
Q ss_pred CChhHHHH-HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-----C---CCcccc
Q 005750 349 IPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLVPL 418 (679)
Q Consensus 349 ~~~~~l~~-~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l 418 (679)
+...|.-. .+|.+.++||.|.|++||++.+. +.+.||+|+.+.. ..-.+....|+++|++++ | .+||+|
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 33455555 88888999999999999999765 6789999998754 445677889999999994 2 369999
Q ss_pred cccccc----cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc
Q 005750 419 IGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 492 (679)
Q Consensus 419 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 492 (679)
++.|.. ..+.|||+|++ |.+|..+|... ..+.++...+.+|++||+.||.|||. ..||||.||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 999854 56899999999 77898888765 47789999999999999999999999 4799999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=231.54 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=195.6
Q ss_pred HHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCccccccccccc--ceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lV 431 (679)
...|++.+++|+|-++.||.|.. .+.+.++||++++ -..+.+.+|+.+|+.|+ ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45688899999999999999974 5688999999984 35677899999999997 99999999998664 467899
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 510 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~~~ 510 (679)
+||+.+.+...+. +.++...+..++.+++.||.|||+ +||.|||+||.|++||.. -.++|+|+|+|-++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988776653 457888899999999999999999 999999999999999964 569999999998876
Q ss_pred cCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh--------Hhc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IKK 581 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~--------~~~ 581 (679)
..... .....+..|--||.+-. ..|+..-|+|||||++..|+..+.||. ...+...+++..++-. +..
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF-hG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc-CCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 55432 22345778899998854 467889999999999999999999997 3333333444433211 111
Q ss_pred CCeeeeecccccC----------------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 582 GDVISIVDPVLIG----------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 582 ~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
-.+ .+||...+ +...-...+.++++.+.|..|-++|||++|.+..
T Consensus 262 Y~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred Hcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111 12222110 0000112467899999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=233.97 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=183.1
Q ss_pred cCcCccEEEEEEEEcC-CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhh
Q 005750 365 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 442 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 442 (679)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998874 899999998765332 35678999999999999999999999999899999999999999999
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCccccccCccccccccc
Q 005750 443 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 521 (679)
Q Consensus 443 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~ 521 (679)
++... ...+++..++.++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98742 1468999999999999999999999 89999999999999999 89999999999987654321 122234
Q ss_pred CCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 522 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 522 gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
+...|++||..... ..+.+.|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67899999999887 888999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=257.98 Aligned_cols=195 Identities=25% Similarity=0.425 Sum_probs=168.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch--------hHHHHHHHHHHHHhcc---CCCccccccccccc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--------RTQQFVTEVALLSRIH---HRNLVPLIGYCEEE 425 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~ 425 (679)
.|...+.+|+|+||.|+++.++ +...|++|.+.+...- ..-.+-.|++||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 3555788999999999999988 4678999998764211 1123567999999997 99999999999999
Q ss_pred ceEEEEEEec-CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 426 HQRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 426 ~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+.+|++||.. ++-+|++++. -.+.+++.+...|++|++.|+++||+ .||||||||-+|+.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 9999999975 5569999998 46789999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~ 561 (679)
.+....... ....+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 987754432 345679999999999999876 677899999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=228.66 Aligned_cols=250 Identities=18% Similarity=0.316 Sum_probs=187.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccc-ccccceEEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVYE 433 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~lV~E 433 (679)
..|++.+.||+|.||.+-++.++ +.+.+++|.+... ....++|.+|..---.| .|.||+.-+++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45778899999999999999987 5788999988765 33467888887765555 59999998875 677788889999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc--CCCcEEEeeccCcccccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfgla~~~~~ 511 (679)
|++.|+|.+-+. ...+.+....+++.|+++||.|+|+ +++||||||.+||||- +..++||||||..+..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998876 4568888889999999999999999 9999999999999993 445899999999876543
Q ss_pred CcccccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
.-.. ..-+..|.+||.... -...+.+|||.||+++|.++||+.||+ .+........+|..-.-+. ..
T Consensus 176 tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk--~~- 247 (378)
T KOG1345|consen 176 TVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRK--NP- 247 (378)
T ss_pred eehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhccc--Cc-
Confidence 2211 123557999997633 245678999999999999999999998 4444444455544322221 11
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+...+. .....+.++.++-+.++|++|--..++-+
T Consensus 248 ----~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 ----ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ----cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1111111 12235678888999999999954444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=229.99 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=171.4
Q ss_pred hhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456889999999999999875 899999999866554 667899999999999999999999999998999999999999
Q ss_pred CcHhhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 438 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 438 gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
++|.+++... .. +++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 8899999999999999999999 899999999999999999999999999988765442111
Q ss_pred cccccCCccccCCccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 517 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2233467889999998 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=231.01 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=189.8
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc------ceEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVY 432 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~lV~ 432 (679)
.+.+|.|.- .|..|.+. .+++||+|.+.... ....+...+|..++..++|+||++++.+|.-. ...|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 356788887 56666443 58999999875432 22345677899999999999999999998543 3579999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+| ..+|.+.+. -.++..++..|+.|++.|++|||+ .||+||||||+||++..+..+||.|||+|+..+..
T Consensus 101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 999 468888776 347888899999999999999999 99999999999999999999999999999876544
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhH----------------HHHHH
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI----------------VHWAR 576 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~----------------~~~~~ 576 (679)
...+....+..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+.-+.... ...++
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 344556688999999999998899999999999999999999999986553322111 11111
Q ss_pred HhHhcC------Ceeeee-cccccC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 577 SMIKKG------DVISIV-DPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 577 ~~~~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...... .+.+.+ |..... +.+.-......+++.+||-.+|++|.+++++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111100 000000 100000 1111233457899999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=253.21 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=203.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|+..+++|.|.||.||+++++ .++..|+|+++-....+..-+.+|+-+++..+||||+.++|.+...+..+++||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4567889999999999999876 689999999987777777888899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+.-+ -..++++.++..+.+..++||+|||+ .|-+|||||-.||++++.|.+|++|||.+..+......
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999877 46789999999999999999999999 99999999999999999999999999998876543332
Q ss_pred cccccCCccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 517 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....||+.|||||+. +.+.|..++|||++|+...|+---++|..... ....+ ..... ..++|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l-----~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRAL-----FLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHHHH-----HHhhc----cCCCCCcc
Confidence 3345699999999985 56688999999999999999988777754111 11111 11111 11122111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.-.......+.++++.|+.++|.+||+++.+++
T Consensus 238 -kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 -KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112233456889999999999999999987763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=228.29 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=190.6
Q ss_pred HhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
|...++||+|.|++||++.+. .++.||+|.+.... ....+.+|+++|..+ -+.||+++.+++..++..++|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 445789999999999999754 36789999886543 235688999999999 59999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~~~~ 512 (679)
|++.....++... ++...+..+++.++.||+++|. .|||||||||+|+|.+ ..+.-.|.|||+|...+..
T Consensus 116 ~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999988888763 5688899999999999999999 9999999999999997 4577899999999721100
Q ss_pred c-------------cc------------------------------ccccccCCccccCCcccCC-CCCCchhHHHHHHH
Q 005750 513 L-------------TH------------------------------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGV 548 (679)
Q Consensus 513 ~-------------~~------------------------------~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGv 548 (679)
. .. ......||++|.|||++.. +..+++.||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 0112359999999999855 45688999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHHHHHHHh---------HhcCC--eee------e---------ec-ccccC-CC----
Q 005750 549 VLLELISGKKPVSVEDFGAELNIVHWARSM---------IKKGD--VIS------I---------VD-PVLIG-NV---- 596 (679)
Q Consensus 549 ll~elltG~~pf~~~~~~~~~~~~~~~~~~---------~~~~~--~~~------~---------~d-~~l~~-~~---- 596 (679)
+++.+++++.||.... .+...+.+.+.-+ ...|. +.+ + ++ ..+.. ..
T Consensus 267 I~Lslls~~~PFf~a~-dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAK-DDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eeehhhccccccccCc-cccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999997332 2222233222111 01111 111 0 00 00000 00
Q ss_pred ----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 ----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....+..+.+++.+|++.||.+|.|++|.|+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1111226789999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=261.11 Aligned_cols=195 Identities=19% Similarity=0.259 Sum_probs=138.5
Q ss_pred hccC-CCcccccccc-------cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005750 409 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480 (679)
Q Consensus 409 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 480 (679)
.++| +||++++++| ...+..+.++|++ +++|.+++.. ....+++.+++.++.||++||+|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3455 6888888887 2234567788887 6799999974 24569999999999999999999999 999
Q ss_pred cccCCCCCCccccCCC-------------------cEEEeeccCccccccCc--------c-------cccccccCCccc
Q 005750 481 IHRDVKSSNILLDINM-------------------RAKVSDFGLSRQAEEDL--------T-------HISSVARGTVGY 526 (679)
Q Consensus 481 vH~Dlkp~NIll~~~~-------------------~~kL~Dfgla~~~~~~~--------~-------~~~~~~~gt~~y 526 (679)
+||||||+||||+..+ .+|++|||+++...... . .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45566666654321100 0 000113478889
Q ss_pred cCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHH
Q 005750 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 606 (679)
Q Consensus 527 ~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (679)
+|||++.+..++.++|||||||+||||++|..|+.... .......... +.+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~---------~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRV---------LPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhh---------cChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988875111 0111110000 01100 111234568
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005750 607 VAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 607 li~~cl~~dP~~RPt~~evl~ 627 (679)
++.+||+++|.+||++.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=205.86 Aligned_cols=169 Identities=21% Similarity=0.214 Sum_probs=127.1
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
|+|.++++.. +..+++..++.++.|++.||+|||+ ++ ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6889988742 4569999999999999999999998 55 999999999999999 99987654422
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...... ..... +.. ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~-~~~~~------~~~-~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNG-MPADD------PRD-RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHH-hccCC------ccc-cccH
Confidence 2478999999999999999999999999999999999999963221 11111111111 11100 000 0011
Q ss_pred HHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 598 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 598 ~~~~--~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.... ..+.+++.+||+.+|.+||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1122 258999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=213.22 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=198.3
Q ss_pred HHhhccccCcCccEEEEEEEEcCC--cEEEEEEecCCcchhHHHHHHHHHHHHhccC----CCcccccccc-cccceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~l 430 (679)
.|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.. .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 677889999999999999987653 5899998765433333377889999998863 6888999888 57778899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-----CcEEEeeccC
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 505 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~Dfgl 505 (679)
||+.+ |.+|.++..... ...++..++..|+.|++.+|++||+ .|++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999776543 5789999999999999999999999 999999999999999754 4699999999
Q ss_pred cc--ccccCcc----cc---cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 005750 506 SR--QAEEDLT----HI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576 (679)
Q Consensus 506 a~--~~~~~~~----~~---~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 576 (679)
++ .+..... .. .....||..|+++....+...+.+.|+||++.++.+++.|..||............ .
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---E 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---H
Confidence 98 4222111 11 12345999999999999999999999999999999999999999744432221111 1
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
.......... .... .+..+.++...+-..+..++|....+...|++....+
T Consensus 251 ~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR------FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc------ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111111100 0111 2234555666666689999999999999998887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=201.17 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=194.5
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecC--CcchhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
.+.-...++..+|.+...|..|+|+|+ |..+++|++.- ......++|..|.-.|+-+.||||+.+++.|....+..+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 344455667789999999999999998 66677787753 233345789999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEe--eccCccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQ 508 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~--Dfgla~~ 508 (679)
+..||+.|+|+..+++. ....++..+..+++.++|+|++|||+. ..-|..--|....+++|++.+++|+ |--++..
T Consensus 265 isq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999999999975 355678889999999999999999983 2333344688999999999887774 3322221
Q ss_pred cccCcccccccccCCccccCCcccCCCCC---CchhHHHHHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHHhHhcCCe
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDV 584 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~ksDVwSlGvll~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 584 (679)
. ....-.+.|++||.++..+- -.++|+|||++++|||.|...||......+ +..+.
T Consensus 343 e--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 343 E--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred c--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 1 11123689999999977654 358999999999999999999997333221 11110
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
-+.++...++.....+.+|+.-|+..||.+||.++.|+-.|+++.
T Consensus 403 ----leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ----LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 012233344445557889999999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=212.61 Aligned_cols=163 Identities=20% Similarity=0.176 Sum_probs=126.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc--CCcEEEEEEecCC-----cchhHHHHHHHHHHHHhccCCCccc-ccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP-LIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~ 427 (679)
...|.+.+.||+|+||+||+|.++ +++.||||++... .....+.+.+|+++|++++|+|+++ ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 345777899999999999999875 5778899986533 1223566899999999999999985 4432 35
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCC-CCCCccccCCCcEEEeeccCc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~Dfgla 506 (679)
.++||||++|++|... . ... ...++.|+++||.|||+ +||+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 7999999999999632 1 111 14678899999999999 99999999 999999999999999999999
Q ss_pred cccccCccccc-------ccccCCccccCCcccCCC
Q 005750 507 RQAEEDLTHIS-------SVARGTVGYLDPEYYGNQ 535 (679)
Q Consensus 507 ~~~~~~~~~~~-------~~~~gt~~y~aPE~l~~~ 535 (679)
+.......... ....+++.|.|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 87654321111 234578889999998543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=192.65 Aligned_cols=274 Identities=19% Similarity=0.255 Sum_probs=204.8
Q ss_pred HHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
--|++.++||+|+||.++.|+. -++++||||.-.. ....-++..|.+..+.| ..++|..++-|..+..+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3467789999999999999973 4799999997543 23346788899999988 579999999888888899999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-----CCcEEEeeccCcccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQA 509 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfgla~~~ 509 (679)
+ |.||.|+..- .+..++.++++.++.|++.-++|+|+ +.+|.|||||+|+||.. ...+.++|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 8899888763 57889999999999999999999999 99999999999999964 345899999999998
Q ss_pred ccCccccc------ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 510 EEDLTHIS------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 510 ~~~~~~~~------~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
.+..+... ....||.+||+-....+...+.+.|+=|+|-++..++.|..||++-.......-.+. +.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hcccc
Confidence 76654332 234599999999999999999999999999999999999999986554422222221 21111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh---hcCCCCccccCC
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKFSSSS 647 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~---~~~~~~~~~~~~ 647 (679)
...-++..+ .. .+.++..-+.-.-..+-.+-|..+-+...+.+++.. ..+...+|..-.
T Consensus 256 r~T~i~~Lc-~g----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 256 RSTPIEVLC-EG----FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred ccCCHHHHH-hc----CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 111111111 11 223444444444456778888888887777776663 233444444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=196.87 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=197.7
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcch---hHHHHHHHHHHHHhccCC-CcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lV~E~ 434 (679)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 445678999999999999887 88999998765332 367899999999999988 799999999777778999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~~~ 513 (679)
+.++++.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999999777632111378899999999999999999999 9999999999999999888 79999999998654433
Q ss_pred cc-----ccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccccc-chhhHHHHHHHhHhcCCe
Q 005750 514 TH-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV 584 (679)
Q Consensus 514 ~~-----~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 584 (679)
.. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........+.. ...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCC
Confidence 22 2345568999999999987 67899999999999999999999997643321 01111111111 111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. .................+.+++.+|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001223467899999999999999999988765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=225.13 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=185.5
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEec----CC-cch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DS-CSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
..+.+|.|++|.|+..... ..+..+.|... .. ... ....+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988777543 33434444332 11 111 11226667777788899999998888877666666699
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
||++ +|..++.. ...+...++..++.|+..|++|+|+ .||.|||+|++|++++.+|.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999873 3478888899999999999999999 999999999999999999999999999987754433
Q ss_pred c---cccccccCCccccCCcccCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 514 T---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 514 ~---~~~~~~~gt~~y~aPE~l~~~~~s~-ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
. .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... .+ ............
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~----~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT----NNYSDQRNIFEG 549 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh----hccccccccccC
Confidence 3 4455667999999999999988865 6899999999999999999998443332211 00 000000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........+.....++.+||+++|.+|.|+++|++
T Consensus 550 ---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 ---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00112234556789999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=180.52 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=195.3
Q ss_pred HHHHHHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcchhHHHHHHHHHHHHhccC-CCcccccccccccceEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV 431 (679)
+....|.+.++||.|+||.+|.|.. .+|++||+|+-.... ...++..|..+.+.|++ ..|..+..|..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4455678899999999999999974 579999999865432 33567889999999974 6788888888889999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~ 508 (679)
|+.+ |.+|.+++.- ....++..+++.++-|++.-++|+|. ++++||||||+|+|..- ...+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 9998 8899988763 46778999999999999999999998 99999999999999964 45699999999998
Q ss_pred cccCcccc------cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 509 AEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 509 ~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
+.+..+.. .....||..|.+-....+...+...|+=|+|.+|..+-.|..||++-.........+. +.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk----I~Ek 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK----ISEK 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH----HHHh
Confidence 75543322 2334689999998888887888999999999999999999999986544322222221 1122
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
.....++. +...+ +.++.-.+.-|-..--++-|...-+-+.+.-+.
T Consensus 240 K~s~~ie~-LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 240 KMSTPIEV-LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred hcCCCHHH-HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 22111211 11122 224555666666666677777665555544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=219.43 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=180.6
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc-chhHHHHHH---HHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.+.+.+.||.+.|=.|.+|+++.|. |+||++-+.. ....+.+.+ |++ ...++|||.+++.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556789999999999999999887 9999986543 333444444 444 455589999999998888888899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc--ccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEE 511 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~--~~~ 511 (679)
|+. -+|.|.+. .++.+...+.+.|+.|++.||..+|. .||+|||||.+||||+.-.=+.|+||..-+. ..+
T Consensus 102 yvk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 985 59999997 57788888999999999999999999 9999999999999999999999999976543 122
Q ss_pred Ccc----cccccccCCccccCCcccCCC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 005750 512 DLT----HISSVARGTVGYLDPEYYGNQ----------Q-LTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 575 (679)
Q Consensus 512 ~~~----~~~~~~~gt~~y~aPE~l~~~----------~-~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 575 (679)
+.. ........-..|+|||.+... . .+++.||||+||++.||++ |++||. +.+..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHH
Confidence 211 111122234579999986331 2 6789999999999999998 788886 11211
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. +.+. ....+..+. .... ..+.+++..|++.||.+|.++++.++.
T Consensus 246 aY--r~~~-~~~~e~~Le-~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AY--RSGN-ADDPEQLLE-KIED---VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hH--hccC-ccCHHHHHH-hCcC---ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 1111 000001110 0000 147799999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-21 Score=187.70 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=135.8
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHH---------HHHHHHHHHHhccCCCccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 421 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~hpnIv~l~~~ 421 (679)
.+++....|+..+.||.|+||.||++.. ++..+|+|++.+....... .+.+|++.+.++.||+|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4567778888899999999999999766 5778999999764333222 26789999999999999999888
Q ss_pred cccc--------ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 422 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 422 ~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
+... ...+++|||++|.+|.++.. ++. ....+++.+|..+|+ .|++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 5532 35789999999999988632 222 245699999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 554 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ell 554 (679)
.++ ++|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 888 999999987655322111 00233345567899999999877553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=182.76 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=110.2
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcch--h------------------------HHHHHHHHHHHHhccCCCc
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 415 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI 415 (679)
.+.||+|++|.||+|...+|+.||||+++..... . .....+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754211 0 1123459999999988877
Q ss_pred ccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCccccCCCCCCccccC
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~Dlkp~NIll~~ 494 (679)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.++ |+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 44433322 22389999999877654432 245688999999999999999999 67 8999999999999998
Q ss_pred CCcEEEeeccCcccccc
Q 005750 495 NMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~ 511 (679)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 57899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=172.75 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=111.7
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcch--------------------------hHHHHHHHHHHHHhccCCCc
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------------------------RTQQFVTEVALLSRIHHRNL 415 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpnI 415 (679)
.+.||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999888999999998754211 01224578999999999987
Q ss_pred ccccccccccceEEEEEEecCCCcHhhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
.....+... ..++||||++|+++... +. ...++......++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 554443332 24899999998855433 32 3457788899999999999999997 37999999999999998
Q ss_pred CCcEEEeeccCcccccc
Q 005750 495 NMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~ 511 (679)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=182.41 Aligned_cols=230 Identities=21% Similarity=0.303 Sum_probs=148.8
Q ss_pred hccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhcc----------CCCcccccccc----
Q 005750 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH----------HRNLVPLIGYC---- 422 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------hpnIv~l~~~~---- 422 (679)
..+.||.|+++.||.+++. +++++|||++.-. .....+++++|.-....+. |-.++-.++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3678999999999999987 5899999997432 2334567777765555432 21222222221
Q ss_pred -----ccc---c-----eEEEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCC
Q 005750 423 -----EEE---H-----QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 485 (679)
Q Consensus 423 -----~~~---~-----~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl 485 (679)
... . ..+++|+-+ .++|.+++.... ....+....++.+..|+++.+++||+ .|++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 111 1 236778877 568877765311 12234455667778999999999999 99999999
Q ss_pred CCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCC--------CCCCchhHHHHHHHHHHHHHhCC
Q 005750 486 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGK 557 (679)
Q Consensus 486 kp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSlGvll~elltG~ 557 (679)
+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999987765543322 224578999997633 25788999999999999999999
Q ss_pred CCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCC
Q 005750 558 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 619 (679)
Q Consensus 558 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 619 (679)
.||........... ...... ..++.+..||.++|+++|.+|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99984433211100 112333 567789999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=168.29 Aligned_cols=183 Identities=15% Similarity=0.135 Sum_probs=138.6
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcch----hHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecC
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++|+ |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999998766 5788887777654321 1235789999999995 5889999886 34699999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCC-CCCCccccCCCcEEEeeccCccccccCccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
|.+|.+.+.. . ...++.|++++|+++|+ .||+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998754321 1 13577899999999999 99999999 799999999999999999999865433210
Q ss_pred ----c--------cccccCCccccCCcccCCC-CCC-chhHHHHHHHHHHHHHhCCCCCCc
Q 005750 516 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSV 562 (679)
Q Consensus 516 ----~--------~~~~~gt~~y~aPE~l~~~-~~s-~ksDVwSlGvll~elltG~~pf~~ 562 (679)
. ......++.|++|+...-. ..+ ...+.++-|+-+|.++|+..+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0112256778888754322 233 678999999999999999998763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.8e-19 Score=188.99 Aligned_cols=217 Identities=28% Similarity=0.411 Sum_probs=164.7
Q ss_pred HHhccCCCcccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-cccCC
Q 005750 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI-IHRDV 485 (679)
Q Consensus 407 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-vH~Dl 485 (679)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.....++++|+.||+|||. ..| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 4568899999999999999999999999999999999985 35678999999999999999999998 444 99999
Q ss_pred CCCCccccCCCcEEEeeccCccccccCc-ccccccccCCccccCCcccCCC-------CCCchhHHHHHHHHHHHHHhCC
Q 005750 486 KSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGK 557 (679)
Q Consensus 486 kp~NIll~~~~~~kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSlGvll~elltG~ 557 (679)
++.|.++|....+||+|||+........ ........-..-|.|||.+.+. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987764310 0111111134579999998763 2467899999999999999999
Q ss_pred CCCCcccccch-hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 558 KPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 558 ~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.||........ ..++..+.. .-...+-|.+.... +....+..++.+||..+|.+||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99984333322 223333222 11111222221111 3344789999999999999999999999988877664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=196.70 Aligned_cols=251 Identities=22% Similarity=0.247 Sum_probs=180.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc---CCCcccccccccccceEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l 430 (679)
+....+.+.+.||+|+||.||+|...+|+.||+|+-+...... |---.+++.+|+ -+.|..+...+.-.+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3444555678899999999999998889999999987654432 111122333333 3455666666666777899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-------CCCcEEEeec
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-------INMRAKVSDF 503 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kL~Df 503 (679)
|+||.+.|+|.+++. ..+.+++.-++.++.|++..+++||. .+||||||||+|++|. +...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999998 57789999999999999999999999 9999999999999994 2345999999
Q ss_pred cCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC
Q 005750 504 GLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582 (679)
Q Consensus 504 gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 582 (679)
|.+..+.--.. ......++|-.+-.+|...|...+.++|.|.++-+++.|+.|++-- ..+|
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g 907 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNG 907 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCC
Confidence 99876432111 1233445788999999999999999999999999999999997532 1111
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
... .+++.+......+ ..-++...+|..|-..=|...++...+++....
T Consensus 908 ~~~-~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 908 SSW-MVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred cce-eccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 111 1111111111112 223555566666666667888888888777653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-19 Score=193.01 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=180.2
Q ss_pred ccCcCccEEEEEEE----EcCCcEEEEEEecCCcch--hHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecC
Q 005750 364 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.+|+|.||.|++++ .+.|+.+|+|++++.... .......|..++..++ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 335788999998764321 1124556888888886 9999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
||.|...+. ....+++.....+...++-+++++|+ .+++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998887 45677888888899999999999999 99999999999999999999999999999875443221
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
+||..|||||++. ....+.|.||||++++||+||..||.. +.++.+++. ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 7899999999998 457789999999999999999999983 112222221 1122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
+.+......+++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33444467788888999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=163.59 Aligned_cols=133 Identities=17% Similarity=0.187 Sum_probs=104.8
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-----cCCCcccccccccccc---eEE-EE
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---QRI-LV 431 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~~~-lV 431 (679)
.+.||+|+||.||. +. ++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 36899999999996 44 3444 69988765444567899999999999 5799999999998864 333 78
Q ss_pred EEe--cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCccccCCCCCCccccC----CCcEEEeecc
Q 005750 432 YEY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 504 (679)
Q Consensus 432 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~Dfg 504 (679)
+|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +.+++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 557999999963 235554 35678888777 99999 99999999999999973 3479999954
Q ss_pred Cc
Q 005750 505 LS 506 (679)
Q Consensus 505 la 506 (679)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=165.23 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=110.4
Q ss_pred HhhccccCcCccEEEEEEE--EcCCcEEEEEEecCCcch------------------------hHHHHHHHHHHHHhccC
Q 005750 359 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 412 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 412 (679)
|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 458999999998743210 11235689999999975
Q ss_pred CC--cccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ccccCCCCCC
Q 005750 413 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 489 (679)
Q Consensus 413 pn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-ivH~Dlkp~N 489 (679)
.. +.+++++ ...++||||+++++|..... ........+...++.|++.++++||+ .| ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 33 3344432 23589999999988876543 23445666778999999999999999 89 9999999999
Q ss_pred ccccCCCcEEEeeccCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~ 511 (679)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999998875443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=163.79 Aligned_cols=197 Identities=19% Similarity=0.236 Sum_probs=138.7
Q ss_pred cCCCcccccccccc---------------------------cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHH
Q 005750 411 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 463 (679)
Q Consensus 411 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 463 (679)
+|||||++.++|.+ ....|+||..++ .+|.+++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 49999999987633 235789998874 58988886 34466667778999
Q ss_pred HHHHHHHHHHhcCCCCccccCCCCCCcccc--CCC--cEEEeeccCccccccC-----cccccccccCCccccCCcccCC
Q 005750 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQAEED-----LTHISSVARGTVGYLDPEYYGN 534 (679)
Q Consensus 464 qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~ 534 (679)
|+++|+.|||+ +||.|||+|.+|||+. +|+ .+.|+|||++--.... .....-...|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 9999999999999994 333 4788999987542221 1111122347778999999754
Q ss_pred CC------CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHH
Q 005750 535 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 608 (679)
Q Consensus 535 ~~------~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 608 (679)
.+ --.|+|.|+.|.+.||+++...||...... ..+... .++..+ | ..+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~r~--Yqe~qL-----P----alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDTRT--YQESQL-----P----ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eechhh--hhhhhC-----C----CCcccCChHHHHHH
Confidence 32 135899999999999999999999732111 111000 111111 1 22334445788999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 005750 609 IQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 609 ~~cl~~dP~~RPt~~evl~~L~ 630 (679)
...|+.||.+|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876665554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=158.60 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=113.2
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
+.||+|++|.||+|.+ .|..|++|+...... .....+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899998654321 1124578899999999999988877777777788999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++|++|.+.+... . . .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 778899999999999999 9999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=154.30 Aligned_cols=137 Identities=20% Similarity=0.235 Sum_probs=108.7
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc----------------------hhHHHHHHHHHHHHhccCCC--
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHRN-- 414 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hpn-- 414 (679)
+.+.+.||+|+||.||++..++|+.||||++..... .....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 666789999999999999988899999998754221 01123677899999998774
Q ss_pred cccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 415 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
+...++. ...++||||++|++|.+.... .....++.+++.++.++|+ .+++||||||+||+++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4444432 345899999999998765431 2346788999999999999 99999999999999999
Q ss_pred CCcEEEeeccCcccccc
Q 005750 495 NMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~ 511 (679)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=155.88 Aligned_cols=131 Identities=24% Similarity=0.421 Sum_probs=107.0
Q ss_pred ccCcCccEEEEEEEEcCCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.||+|++|.||+|.+ ++..|++|+...... .....+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 478899998653211 12356778999999999887665555555666779999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+|++|.+.+... .. .++.+++.+|.+||+ .+++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887531 11 789999999999999 9999999999999999 899999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-17 Score=171.35 Aligned_cols=173 Identities=27% Similarity=0.365 Sum_probs=132.4
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..|+.|++|...+|.+++.+.......++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777788889999999999999999 58999999999999999999999999998
Q ss_pred cccccCc-----ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHh
Q 005750 507 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 507 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
....... ........||..||+||.+.+..|+.|+||||||++|+|++. =.-++. ... ...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r~~-----t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----RIA-----TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----HHH-----hhhhhh
Confidence 7765443 122344569999999999999999999999999999999996 222221 000 011122
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE 624 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 624 (679)
.+.+ +|....+++. =..++.+++.+.|.+||++.+
T Consensus 474 ~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 2222 2222223332 247899999999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.4e-16 Score=173.68 Aligned_cols=133 Identities=24% Similarity=0.370 Sum_probs=108.7
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEE-ecCCcc-------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..+.||+|+||.||+|.+.+.. +++|+ ..+... ...+.+.+|+++++.++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3688999999999999876443 44443 222111 12356889999999999999988877777777789999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
||+++++|.+++. ....++.|++++|.+||+ .+++||||||+||++ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998875 346789999999999999 999999999999999 6789999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-16 Score=177.05 Aligned_cols=207 Identities=26% Similarity=0.342 Sum_probs=141.4
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+-++.+..|+||.||.++++ ..+.+|+|+-++.. +.+- ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------c
Confidence 34689999999999999988 47788886533211 1110 22222333333 3
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-----
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL----- 513 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~----- 513 (679)
+=...++ +.+.++... +.+++|||+ .||+|||+||+|.+|+.-|++|+.|||+++..-...
T Consensus 137 Dc~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3333343 233444332 788999998 999999999999999999999999999987532111
Q ss_pred ---------ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 514 ---------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 514 ---------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
.......+||+.|+|||++....|+...|.|++|+++||.+.|+.||.++...+ .+...+...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~-- 274 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDD-- 274 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhh--
Confidence 111234579999999999999999999999999999999999999998554321 112222211
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
....+.+...+.+..+++.+.|+.+|.+|--..
T Consensus 275 ------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 ------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ------ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111112233344788999999999999997433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=141.43 Aligned_cols=138 Identities=22% Similarity=0.301 Sum_probs=98.6
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcch--hHHH----------------------HHHHHHHHHhccCCC--c
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHRN--L 415 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--I 415 (679)
.+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753221 1111 134566666664332 3
Q ss_pred ccccccccccceEEEEEEecCCCcHhhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
.+++++ ...++||||++++.+... +... ... .....++.+++.++.++|+ ..+|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 344432 235899999998543221 1110 011 5678899999999999996 38999999999999999
Q ss_pred CCcEEEeeccCcccccc
Q 005750 495 NMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~~ 511 (679)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 99999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=134.18 Aligned_cols=134 Identities=22% Similarity=0.207 Sum_probs=113.6
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccC--CCcccccccccccceEEEEEEecCCCc
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999864 7899999865433 5678899999999976 589999998888888999999998877
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+... +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4556678899999999999984445799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-14 Score=143.41 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=105.6
Q ss_pred ccccC-cCccEEEEEEEEcCCcEEEEEEecCCc-------------chhHHHHHHHHHHHHhccCCCc--cccccccccc
Q 005750 362 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE 425 (679)
Q Consensus 362 ~~~LG-~G~~g~Vy~a~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~ 425 (679)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999876 7789999875311 1233567889999999998775 6677664332
Q ss_pred c----eEEEEEEecCC-CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 426 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 426 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
. ..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+ .||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888763 334443 35789999999999 99999999999999999899999
Q ss_pred eeccCcccc
Q 005750 501 SDFGLSRQA 509 (679)
Q Consensus 501 ~Dfgla~~~ 509 (679)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-15 Score=171.82 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=187.0
Q ss_pred HHhhccccCcCccEEEEEEEEcC--CcEEEEEEecCCc--chhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34556779999999998876543 4456666665432 223344555777777776 999999999999999999999
Q ss_pred EecCCCcHhhhh-cccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCccccCCCCCCccccCCC-cEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~ 509 (679)
+|..++++.+.+ ... ....+....-.++.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888 422 224556667788999999999999 6 9999999999999999999 9999999999887
Q ss_pred cc--CcccccccccC-CccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 510 EE--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 510 ~~--~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~-- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GR-- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cc--
Confidence 65 23333344567 9999999998874 55788999999999999999999998443322 1111221111 00
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..............+++.+++..+|..|.+.+++..
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000111122235668888999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5e-13 Score=146.37 Aligned_cols=140 Identities=24% Similarity=0.321 Sum_probs=99.6
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhH----------------------------------------HHHHH
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 402 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 402 (679)
+.||.|++|.||+|++++|+.||||+.++...... -++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865421110 02445
Q ss_pred HHHHHHhcc-----CCCcccccccc-cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 005750 403 EVALLSRIH-----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTG 475 (679)
Q Consensus 403 E~~~l~~l~-----hpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~ 475 (679)
|.+.+.+++ ++++ .+-.++ ......++||||++|++|.+...... ...+ ...++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLR- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHh-
Confidence 555555552 2332 222222 22345799999999999988765321 1122 3456666666 4678888
Q ss_pred CCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 476 ~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
.|++|+|+||.||+++.+++++++|||++.....
T Consensus 276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=146.04 Aligned_cols=95 Identities=35% Similarity=0.397 Sum_probs=76.1
Q ss_pred CcceeecCCce--EEEEEecccCcccceeeeehhhhcccC-CCcceeeecccCcccCCCCceEEEeecCCcccccccCcc
Q 005750 1 MQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLG-PSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSY 77 (679)
Q Consensus 1 ~~~a~~~~~~~--~~~~~~~~~~~~~~~~~~~f~e~~~~~-~~~~r~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 77 (679)
||||+++.+++ ++++|.+.|...+|+++||||||+.+. ..++|+||| ++||+..+..++|.+
T Consensus 237 ~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~I---------------yiN~~~~~~~~~~~~ 301 (347)
T PF12819_consen 237 YQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDI---------------YINGQTAYSDVSPPY 301 (347)
T ss_pred HHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEE---------------EECCeEccCccCccc
Confidence 79999998887 999999999999999999999999985 455899994 555554444444433
Q ss_pred c-------------ccccceEEEEEEeecCCCccccceeeeeeeee
Q 005750 78 M-------------NVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 110 (679)
Q Consensus 78 ~-------------~~~~~~~~~~~l~~~~~s~l~p~~na~e~~~~ 110 (679)
+ .++..+.+.++|.++..|+|||+|||+|||++
T Consensus 302 ~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 302 LGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred ccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 2 33334578899999999999999999999974
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3e-13 Score=134.70 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=142.6
Q ss_pred HHHHhccCCCccccccccccc-----ceEEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005750 405 ALLSRIHHRNLVPLIGYCEEE-----HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478 (679)
Q Consensus 405 ~~l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 478 (679)
..|-++-|.|||+++.|+.+. .+..++.||+..|++..+|++.. ++..+......+|+.||..||.|||+ |..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 334455799999999998653 35789999999999999998765 66788889999999999999999998 779
Q ss_pred CccccCCCCCCccccCCCcEEEeeccCccccc---cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 005750 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAE---EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555 (679)
Q Consensus 479 ~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~---~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt 555 (679)
.|+|+++..+-|++..+|-+|+.--.-..... ...........+-++|.+||+=.....+.++|||+||....+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999988875321111100 001111122346789999999777777889999999999999988
Q ss_pred CCCCCCccccc--chhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 556 GKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 556 G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+..--...... .+.++.. .+...-++ + =..++.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~---------~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN---------VIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhh---------heeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 76542211111 1111111 00000011 1 125778999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.7e-13 Score=160.89 Aligned_cols=146 Identities=29% Similarity=0.526 Sum_probs=101.8
Q ss_pred CCchhHHHHHHHHHhhcCC--CCCCCCCC-CCCCCCCCceEEEeCCCCCceEEEEcCCCcccccCCccccCCCCCCEEEC
Q 005750 116 KTEWQDVMVLEALRSISDE--SERTNDRG-DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWL 192 (679)
Q Consensus 116 ~t~~~~~~~l~~l~~~~~~--~~~~~w~~-~~c~~~~w~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L 192 (679)
-..++|..+|.++|+.... ....+|+. +.|| .|.|++|+.. ++|+.|+|++|+++|.+|..|..|++|+.|+|
T Consensus 25 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 25 MLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred CCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 4567899999999987743 23457863 3443 7999999753 48999999999999999888999999999999
Q ss_pred CCCcCCCCCC-C-CCCCCCCcEEEecCccCCCCCC----------------------CCCCCCCccceecccccCCCCCC
Q 005750 193 DGNFLTGPLP-D-MSRLIDLRIVHLENNELTGSLP----------------------SYMGSLPNLQELHIENNSFVGEI 248 (679)
Q Consensus 193 ~~N~l~~~~p-~-~~~l~~L~~L~l~~N~l~g~~p----------------------~~~~~l~~L~~L~l~~N~l~g~i 248 (679)
++|+++|.+| + +.++++|++|+|++|+++|.+| ..++.+++|++|+|++|.+++.+
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 9999988777 3 4467777777777666665544 44555555555555555555555
Q ss_pred CccccC--CceeeeecCCC
Q 005750 249 PPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 249 p~~~~~--~~~~~~~~~n~ 265 (679)
|..+.. .+..+.+++|.
T Consensus 181 p~~~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQ 199 (968)
T ss_pred ChhhhhCcCCCeeeccCCC
Confidence 554432 23444555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=137.96 Aligned_cols=254 Identities=23% Similarity=0.243 Sum_probs=184.6
Q ss_pred hhHHHHHHHhhccccCc--CccEEEEEEEE---cCCcEEEEEEecCCcc--hhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 351 LPELEEATNNFCKKIGK--GSFGSVYYGKM---KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~--G~~g~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
..+.......+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+.....+ .|++.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34566677777899999 99999999976 3688899998443222 2233334567766677 499999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCccccCCCCCCccccCC-Cc
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MR 497 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 497 (679)
...+..++-+|++ +.+|.++.+.. ...++...++.+..+..+ ||.++|+ .+++|-|+||.||+...+ ..
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccce
Confidence 9999999999998 47887777642 334777788888888888 9999999 999999999999999998 88
Q ss_pred EEEeeccCccccccCccc----ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHH
Q 005750 498 AKVSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 573 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~ 573 (679)
.+++|||+...+...... ......|...|++||...+ .++.++|+|++|.++.+..++..+....... .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------S 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------C
Confidence 999999999887654321 1122247788999999876 6788999999999999999887766522111 0
Q ss_pred HHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 574 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
|. .++.+- +- .++-......+...+..|++.+|..|++.+.+..
T Consensus 335 W~--~~r~~~---ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WS--QLRQGY---IP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--cccccc---Cc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 011100 00 0111111124555889999999999999887754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.2e-14 Score=127.79 Aligned_cols=166 Identities=25% Similarity=0.416 Sum_probs=133.8
Q ss_pred EEeecCCCccccceeeeeeeeeeec---cCCCchhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCceEE
Q 005750 89 SFVKTRDSTLGPLLNAIEISKYQKI---AAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITK 165 (679)
Q Consensus 89 ~l~~~~~s~l~p~~na~e~~~~~~~---~~~t~~~~~~~l~~l~~~~~~~~~~~w~~~~c~~~~w~~~~c~~~~~~~l~~ 165 (679)
+|..+.-+.+||-|..+-.+.++.+ +....|..+..|.+++......+..+-. | .|. +..+.|..
T Consensus 39 tLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~l--p------rgf----gs~p~lev 106 (264)
T KOG0617|consen 39 TLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNIL--P------RGF----GSFPALEV 106 (264)
T ss_pred hcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcC--c------ccc----CCCchhhh
Confidence 3667778889999766555555554 4467788999999998765443333222 1 121 23468999
Q ss_pred EEcCCCcccc-cCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCC
Q 005750 166 IALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 166 L~L~~n~l~g-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 244 (679)
|||+.|+|+. .+|..|..|+.|+-|+|+.|.|.-.+|++++|++|+.|.+..|.+- ++|.+++.|+.|++|++.+|++
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 9999999975 4899999999999999999999999999999999999999999999 9999999999999999999999
Q ss_pred CCCCCccccC-----CceeeeecCCCCcc
Q 005750 245 VGEIPPALLT-----GKVIFKYDNNPKLH 268 (679)
Q Consensus 245 ~g~ip~~~~~-----~~~~~~~~~n~~~~ 268 (679)
+ .+|++++. ....+....|||..
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 9 99999876 23456678889864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-11 Score=131.32 Aligned_cols=167 Identities=20% Similarity=0.222 Sum_probs=128.9
Q ss_pred EcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHH
Q 005750 378 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 457 (679)
Q Consensus 378 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 457 (679)
..++.+|.|...+...........+-++.|+.++||||+++++.++.++..|+|+|.+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688999988876655455667788899999999999999999999999999999985 56666653 23556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCC
Q 005750 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537 (679)
Q Consensus 458 ~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 537 (679)
+...++||+.||.+||. +.+++|++|.-+.|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 67789999999999996 48999999999999999999999999988765433221 011111223466676553322
Q ss_pred CchhHHHHHHHHHHHHHhCC
Q 005750 538 TEKSDVYSFGVVLLELISGK 557 (679)
Q Consensus 538 s~ksDVwSlGvll~elltG~ 557 (679)
-..|.|.|||+++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=117.31 Aligned_cols=127 Identities=18% Similarity=0.181 Sum_probs=95.8
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcc-cccccccccceEEEEEEecCCCcHh
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 441 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~ 441 (679)
+.|+.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.+++ +++.+.. ...++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56899999999999876 78899999765432 223567899999998655544 4444433 3358999999998775
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----ccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 442 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 442 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+.- .....++.+++++|+.||+ .+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 0113457899999999998 55 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.1e-12 Score=138.44 Aligned_cols=139 Identities=20% Similarity=0.265 Sum_probs=89.6
Q ss_pred cccCcCccEEEEEEEEcC-CcEEEEEEecCCcchh----------------------------------HHH------HH
Q 005750 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQQ------FV 401 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~----------------------------------~~~------~~ 401 (679)
+.||.|++|.||+|++++ |+.||||+.++..... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 111 33
Q ss_pred HHHHHHHhcc----CCCcccccccccc-cceEEEEEEecCCCcHhhhhcccCCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 005750 402 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQ---KPLDWLTRLQIAHDAAKGLEYLH 473 (679)
Q Consensus 402 ~E~~~l~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~aL~~LH 473 (679)
+|...+.+++ +...+.+-.++.+ ....++||||++|+.+.+.-.-...+ ..+....+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 3444444432 2222322222222 34568999999999997742211011 122222233333333 3
Q ss_pred hcCCCCccccCCCCCCccccCCC----cEEEeeccCcccccc
Q 005750 474 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 511 (679)
Q Consensus 474 ~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfgla~~~~~ 511 (679)
. .|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 8999999999999999888 999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-10 Score=112.13 Aligned_cols=137 Identities=15% Similarity=0.174 Sum_probs=100.1
Q ss_pred cccCcCccEEEEEEEEcC-------CcEEEEEEecCCc----------------------chhHHHH----HHHHHHHHh
Q 005750 363 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC----------------------SHRTQQF----VTEVALLSR 409 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~ 409 (679)
..||.|--+.||.|...+ +..+|||+.+... ....+.+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 4799999974210 0112233 389999999
Q ss_pred ccC--CCcccccccccccceEEEEEEecCCCcHhh-hhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCccccCC
Q 005750 410 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 485 (679)
Q Consensus 410 l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~Dl 485 (679)
+.. -++..++++ ...++||||+.+..+.. .++ ...++..+...+..+++.+|..| |+ .|++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 953 456666654 45689999997653321 222 22345556677889999999999 77 89999999
Q ss_pred CCCCccccCCCcEEEeeccCcccccc
Q 005750 486 KSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 486 kp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
++.||+++ ++.++|+|||.+....+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 57899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.4e-11 Score=137.03 Aligned_cols=125 Identities=26% Similarity=0.500 Sum_probs=98.2
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCC-Ccccee
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~~L~~L 237 (679)
.++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++.+ .++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 46899999999999999999999999999999999999999995 9999999999999999999999998764 577889
Q ss_pred cccccCCCCCCCccccCCceeeeecCCCCccccc-ccccceeeeeechhhhhHHHHHHHhHhh
Q 005750 238 HIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFLCSL 299 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~~~~~-~~~~~~~ii~~~~i~~~~~l~v~~~~~~ 299 (679)
++.+|.....+|. +. .|... .......++++++++++++++.+ ++++
T Consensus 521 ~~~~N~~lc~~p~-l~-------------~C~~~~~~~~~i~~~~~~~~~~l~~~~~~-~~~~ 568 (623)
T PLN03150 521 NFTDNAGLCGIPG-LR-------------ACGPHLSVGAKIGIAFGVSVAFLFLVICA-MCWW 568 (623)
T ss_pred EecCCccccCCCC-CC-------------CCcccCCCceEEEEEhHHHHHHHHHHHHH-hhhe
Confidence 9999986544543 11 13222 12345666777776655555444 4444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.1e-12 Score=114.00 Aligned_cols=84 Identities=31% Similarity=0.481 Sum_probs=81.1
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
..+++.|.||+|+|+ .+|+.|.+|.+|+.|++++|+|+..+++++.|++|+.|+++-|++. .+|..||.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 357899999999999 9999999999999999999999999999999999999999999999 99999999999999999
Q ss_pred cccCCC
Q 005750 240 ENNSFV 245 (679)
Q Consensus 240 ~~N~l~ 245 (679)
.+|+++
T Consensus 110 tynnl~ 115 (264)
T KOG0617|consen 110 TYNNLN 115 (264)
T ss_pred cccccc
Confidence 999997
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.2e-10 Score=111.41 Aligned_cols=142 Identities=21% Similarity=0.314 Sum_probs=111.1
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccC--CCccccccccccc---ceEEEEEEecC
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEE---HQRILVYEYMH 436 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~~lV~E~~~ 436 (679)
+.|+.|..+.||++...+|+.+++|+...... .....+.+|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999765322 134578899999999965 3456777776654 25689999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC---------------------------------------- 476 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 476 (679)
|.++.+.+. ...++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988877553 135677788888999999999998521
Q ss_pred -------------CCCccccCCCCCCccccC--CCcEEEeeccCccc
Q 005750 477 -------------NPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 508 (679)
Q Consensus 477 -------------~~~ivH~Dlkp~NIll~~--~~~~kL~Dfgla~~ 508 (679)
...++|||+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256799999999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-10 Score=125.08 Aligned_cols=243 Identities=22% Similarity=0.228 Sum_probs=173.3
Q ss_pred hhccccCcCccEEEEEEEEc--CCcEEEEEEecCCcchhHH--HHHHHHHHHHhc-cCCCcccccccccccceEEEEEEe
Q 005750 360 NFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQ--QFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..+..||.|.|+.|+....+ ++..+++|.+.+....... .-..|+.+...+ .|.++++.+..+...++.|+=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34678999999999988643 6788999988765333222 234577777776 589999988888888888899999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++..... ....+++..++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+....-..
T Consensus 348 ~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 348 CEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec
Confidence 99998776553 34557778889999999999999998 999999999999999875 788999999886522111
Q ss_pred ccccccccC-Cccc-cCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 514 THISSVARG-TVGY-LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 514 ~~~~~~~~g-t~~y-~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. .... +..| .+|+......+..+.|+++||..+.+..++...-.. ..+|.. +..+.. +.
T Consensus 422 ~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~--i~~~~~-----p~ 482 (524)
T KOG0601|consen 422 G----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLT--IRSGDT-----PN 482 (524)
T ss_pred c----cccccccccccchhhccccccccccccccccccccccccCcccCcc--------ccccee--eecccc-----cC
Confidence 1 1112 2233 356666777888999999999999999998754321 011100 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.+.. ...+..+...+..+++..||.+.++....+..
T Consensus 483 ----~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 ----LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----CCch-HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 14667888899999999999999887655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-09 Score=100.24 Aligned_cols=131 Identities=24% Similarity=0.367 Sum_probs=100.5
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCC-cc-------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADS-CS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~-~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..+++|+-+.+|.+.+. |.++++|.-.+. -. -....-.+|..++.+++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 445677754321 11 1234567899999999766665555566667777899999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++|..|.+.+... ...++..+-.-+.-||. .||+||||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888742 24567778888899998 9999999999999997654 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-08 Score=107.22 Aligned_cols=170 Identities=21% Similarity=0.297 Sum_probs=130.5
Q ss_pred ccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccc----ccceEEEEEEecCC-CcHhh
Q 005750 369 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 442 (679)
Q Consensus 369 ~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~ 442 (679)
...+.|++..+ ||..|++|+++............-+++++++.|+|+|++.++|. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34688999766 89999999995433333333345688899999999999999886 35578999999986 46766
Q ss_pred hhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 443 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 443 ~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
.--... ++...++..+|.++.|+..||.++|+ .|+.-+-|.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 442211 34467889999999999999999999 999999999999999999999999888766554
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~p 559 (679)
.+.. |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4321 11111 2467999999999999999654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.8e-09 Score=98.20 Aligned_cols=143 Identities=20% Similarity=0.240 Sum_probs=104.6
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEe-cCCc-------chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSC-------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...+-+|+-+.|+++.+. |+..+||.- .+.- .-..++..+|.+.|.+++--.|.-..-++.+.....++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 357889999999999987 777666653 2211 1134567889999999875555544445666666789999
Q ss_pred ecCC-CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cEEEeeccCcccc
Q 005750 434 YMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 509 (679)
Q Consensus 434 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfgla~~~ 509 (679)
|++| .++.+++..... ..........++.+|-+.+.-||. .+|+||||..+||++..++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 478888775432 223333336789999999999998 9999999999999996544 3589999998653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.1e-08 Score=100.04 Aligned_cols=272 Identities=15% Similarity=0.126 Sum_probs=169.0
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCccccccc----c---cccceEEEEE
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY----C---EEEHQRILVY 432 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~----~---~~~~~~~lV~ 432 (679)
.++.||+|+.+.+|..-- -...+.|++.........+. +..|... .||-+-.-+.+ . .......+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 357899999999996521 12235577766544333332 2333333 45543331111 1 1223367888
Q ss_pred EecCCC-cHhhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 433 EYMHNG-TLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 433 E~~~~g-sL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
..+.+. .+.++.... ..-....|.-.++.++.++.+.+-||. .|.+-||+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 888764 233333221 134457899999999999999999999 9999999999999999999999998654333
Q ss_pred cccCcccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCccccc-chhhHHHHHHHhHhc
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKK 581 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG-~~pf~~~~~~-~~~~~~~~~~~~~~~ 581 (679)
..++. ......|...|.+||.-. +..-+...|-|.||+++++++.| ++||.+-... ......+ ..+..
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~ 241 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAH 241 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhc
Confidence 32222 222345888999999754 34556789999999999999886 9999854332 1111111 00111
Q ss_pred CCeeeeeccccc-----CCCC-HHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhhhhhcCCCCcccc
Q 005750 582 GDVISIVDPVLI-----GNVK-IESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLAIQDSIKIEKGGDQKFSS 645 (679)
Q Consensus 582 ~~~~~~~d~~l~-----~~~~-~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 645 (679)
+.+...-+.... ...+ .-.+..+.-+..+|+.. .+.-|||++..+..|..+.+...+..-...+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 222211111100 0111 12233566778888865 3678999999999999888876665544443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=9e-09 Score=99.19 Aligned_cols=126 Identities=25% Similarity=0.309 Sum_probs=83.3
Q ss_pred EEEEEEEcCCcEEEEEEecCCc--------------c------------hhHHHHHHHHHHHHhccCC--Cccccccccc
Q 005750 372 SVYYGKMKDGKEVAVKIMADSC--------------S------------HRTQQFVTEVALLSRIHHR--NLVPLIGYCE 423 (679)
Q Consensus 372 ~Vy~a~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~ 423 (679)
.||.|...+|..+|||+.+... . .......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999974210 0 0123467899999999755 456666442
Q ss_pred ccceEEEEEEecC--CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 424 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 424 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
..++||||++ |..+..+... .++......++.+++..+.. +|. .||+||||++.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 5555443321 11133445677788886665 567 999999999999999887 9999
Q ss_pred eeccCccccc
Q 005750 501 SDFGLSRQAE 510 (679)
Q Consensus 501 ~Dfgla~~~~ 510 (679)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.2e-08 Score=100.19 Aligned_cols=139 Identities=17% Similarity=0.174 Sum_probs=99.6
Q ss_pred cCcCccEEEEEEEEcCCcEEEEEEecCCcch-----------hHHHHHHHHHHHHhccCCCc--ccccccccc-----cc
Q 005750 365 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNL--VPLIGYCEE-----EH 426 (679)
Q Consensus 365 LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~~ 426 (679)
+-.-....|+++.+ +|+.|.||........ ....+.+|...+.++...+| +.++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333345667766 4788999977433211 11247789999988854333 344555432 23
Q ss_pred eEEEEEEecCCC-cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-------CCcE
Q 005750 427 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRA 498 (679)
Q Consensus 427 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~ 498 (679)
..++|+|++++. +|.+++.... ....+......++.+++..+..||. .||+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999876 8988875321 2345666778899999999999999 99999999999999975 4679
Q ss_pred EEeeccCccc
Q 005750 499 KVSDFGLSRQ 508 (679)
Q Consensus 499 kL~Dfgla~~ 508 (679)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999997753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.9e-10 Score=119.45 Aligned_cols=84 Identities=30% Similarity=0.366 Sum_probs=67.2
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
...|+.||||+|+|. ..|..+.+-.++-+|+||+|+|..+|.. |.+|+.|-+||||+|+|. .+|..+..|..|+.|.
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 446788888888888 7888888888888888888888877665 778888888888888888 7888888888888888
Q ss_pred ccccCCC
Q 005750 239 IENNSFV 245 (679)
Q Consensus 239 l~~N~l~ 245 (679)
|++|.+.
T Consensus 180 Ls~NPL~ 186 (1255)
T KOG0444|consen 180 LSNNPLN 186 (1255)
T ss_pred cCCChhh
Confidence 8888754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.6e-08 Score=97.63 Aligned_cols=137 Identities=23% Similarity=0.209 Sum_probs=100.4
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc----------------------chhHHHHHHHHHHHHhccCC--C
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------------SHRTQQFVTEVALLSRIHHR--N 414 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp--n 414 (679)
+.++..||-|--+.||.|....|.++|||.=+... .-......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34578999999999999999999999999742110 01223467899999999644 6
Q ss_pred cccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 415 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
+.+.++ .++..+|||+++|-.|...- ++......++..|++-+..+-. .||||||+++-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 666665 45678999999886664321 1233344455555555555555 89999999999999999
Q ss_pred CCcEEEeeccCccccc
Q 005750 495 NMRAKVSDFGLSRQAE 510 (679)
Q Consensus 495 ~~~~kL~Dfgla~~~~ 510 (679)
+|.++++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998665543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-09 Score=82.98 Aligned_cols=59 Identities=41% Similarity=0.539 Sum_probs=33.8
Q ss_pred CCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCC
Q 005750 186 ALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 186 ~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 244 (679)
+|+.|+|++|+|+..+++ |.++++|+.|+|++|+++..-|..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455556666655555552 55566666666666666544444556666666666666653
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.3e-10 Score=121.29 Aligned_cols=168 Identities=21% Similarity=0.317 Sum_probs=125.8
Q ss_pred EEeecCCCccccceeeeeeeeeeeccCCCchhHHHHHHHHHhhcCCCCCCCCCC--CCCCCCCCceEEEeCCCCCceEEE
Q 005750 89 SFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRG--DPCVPVPWEWVTCSTTTPPRITKI 166 (679)
Q Consensus 89 ~l~~~~~s~l~p~~na~e~~~~~~~~~~t~~~~~~~l~~l~~~~~~~~~~~w~~--~~c~~~~w~~~~c~~~~~~~l~~L 166 (679)
+-+.-.-+-+||-|..+.++.-+.++....|.--.+|-.+..+...+...|-.. .-|. ..| .+|..|
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~-~~W----------~~lEtL 273 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTE-GEW----------ENLETL 273 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccH-HHH----------hhhhhh
Confidence 333334456788888888888888876665555555555544332111111110 1121 012 389999
Q ss_pred EcCCCcccccCCccccCCCCCCEEECCCCcCC--CCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCC
Q 005750 167 ALSGKNLKGEIPPELKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 167 ~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 244 (679)
+||+|+|+ .+|..+.+|++|+.|++.+|+|+ |+|..|+.|.+|+.+++++|+|. .+|+++..|.+|+.|.|+.|++
T Consensus 274 NlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 274 NLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred ccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence 99999999 99999999999999999999876 44556999999999999999999 9999999999999999999999
Q ss_pred CCCCCccc--cCCceeeeecCCCCcccc
Q 005750 245 VGEIPPAL--LTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 245 ~g~ip~~~--~~~~~~~~~~~n~~~~~~ 270 (679)
- ++|+.+ ..++..+.+-.||.+--.
T Consensus 352 i-TLPeaIHlL~~l~vLDlreNpnLVMP 378 (1255)
T KOG0444|consen 352 I-TLPEAIHLLPDLKVLDLRENPNLVMP 378 (1255)
T ss_pred e-echhhhhhcCCcceeeccCCcCccCC
Confidence 9 999975 456677788888877543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.7e-09 Score=120.38 Aligned_cols=242 Identities=20% Similarity=0.238 Sum_probs=162.1
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
.+-+-.|.++.++.+.-. .|...+.|+.... ...+.+....+-.++-..++|-+++..-.+.-....+|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 456788889988877533 3433344433221 111222233333333334567777666555666778999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC-----
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED----- 512 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~----- 512 (679)
++|...++. .+..+.......+..+..++++||+ ..+.|+|++|.|+++..+++.++.|||........
T Consensus 889 ~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999884 3456666667778888999999998 77999999999999999999999999833221100
Q ss_pred c---------------------c----cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc
Q 005750 513 L---------------------T----HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 567 (679)
Q Consensus 513 ~---------------------~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~ 567 (679)
. . .......+|+.|.+||.+.+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 0 01122358999999999999999999999999999999999999997332211
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 623 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 623 (679)
. . .. +..+.. + .............+++.+.+..+|.+|-.|.
T Consensus 1043 ~---f---~n-i~~~~~-----~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I---F---EN-ILNRDI-----P--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h---h---hc-cccCCC-----C--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 1 11 111111 0 1122223334566888888999999998877
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.7e-09 Score=80.59 Aligned_cols=60 Identities=35% Similarity=0.482 Sum_probs=54.9
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccC
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 220 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l 220 (679)
++|+.|+|++|+|+...+..|.++++|++|+|++|.|+...| .|.++++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 479999999999995555789999999999999999999988 599999999999999986
|
... |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.6e-09 Score=108.50 Aligned_cols=144 Identities=21% Similarity=0.213 Sum_probs=89.4
Q ss_pred eeeeeeccC---CCchhHHHHHHHHHhhcC-CCCCCCCCCC-CCCCCCCceEEEeCCCCCceEEEEcCCCcccccCCccc
Q 005750 107 ISKYQKIAA---KTEWQDVMVLEALRSISD-ESERTNDRGD-PCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPEL 181 (679)
Q Consensus 107 ~~~~~~~~~---~t~~~~~~~l~~l~~~~~-~~~~~~w~~~-~c~~~~w~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~~ 181 (679)
+...+.|+. .+.|.+...++.+..... .++..+|-+. -| ..++++.|+|++|-|. .+|.++
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~-------------~l~kLt~L~L~NN~Ln-~LP~e~ 454 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELS-------------QLQKLTFLDLSNNLLN-DLPEEM 454 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHH-------------hhhcceeeecccchhh-hcchhh
Confidence 445555553 466777777777776553 3455566542 22 3468999999999988 999999
Q ss_pred cCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCC-CCCCCccceecccccCCCCCCCccccC--Ccee
Q 005750 182 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVI 258 (679)
Q Consensus 182 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~ 258 (679)
+.+..|+.||||.|+|...|..+..+..|+.+-.++|++. .+|.+ +.+|.+|+.|||.+|.+. .||+.+++ ....
T Consensus 455 ~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 455 GSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRH 532 (565)
T ss_pred hhhhhhheecccccccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeE
Confidence 9999999999999988654444444444444444445554 33333 555555555555555555 55555443 2334
Q ss_pred eeecCCCC
Q 005750 259 FKYDNNPK 266 (679)
Q Consensus 259 ~~~~~n~~ 266 (679)
+.++|||.
T Consensus 533 LeL~gNpf 540 (565)
T KOG0472|consen 533 LELDGNPF 540 (565)
T ss_pred EEecCCcc
Confidence 44555553
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.9e-10 Score=114.11 Aligned_cols=104 Identities=21% Similarity=0.327 Sum_probs=86.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
..+|.-|+|.+|++. .+| +|..++.|+.|+++.|+|+-.+.+ ..+|.+|.+|||.+|++. ++|+++.-+.+|.+||
T Consensus 205 l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLD 281 (565)
T KOG0472|consen 205 LESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLD 281 (565)
T ss_pred hhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhc
Confidence 346777888888888 777 788888888888888888877766 558999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCccccCC-ceeeeecCCCCc
Q 005750 239 IENNSFVGEIPPALLTG-KVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~-~~~~~~~~n~~~ 267 (679)
+|+|.++ .+|.++++- +..+.+.|||..
T Consensus 282 lSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 282 LSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ccCCccc-cCCcccccceeeehhhcCCchH
Confidence 9999999 899988773 345567888854
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.3e-09 Score=98.29 Aligned_cols=102 Identities=26% Similarity=0.426 Sum_probs=39.5
Q ss_pred CceEEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCC-CCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~ 238 (679)
.+++.|+|.+|+|+ .+. .++ .|++|+.|||++|.|+.. +.+..|++|+.|+|++|+++ .+++.+ ..+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 37899999999999 554 566 689999999999999975 57888999999999999999 776555 4689999999
Q ss_pred ccccCCCCCCCcc----ccCCceeeeecCCCCc
Q 005750 239 IENNSFVGEIPPA----LLTGKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~~----~~~~~~~~~~~~n~~~ 267 (679)
|++|+|. .+-+- -+..+..+++.+||..
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 9999998 54331 1335677889999963
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-07 Score=105.32 Aligned_cols=141 Identities=24% Similarity=0.312 Sum_probs=91.5
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHH----------------------------------------HHHH
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ----------------------------------------QFVT 402 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 402 (679)
+-|+.++-|.||+|++++|+.||||+.++....... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999999999999998654221110 1233
Q ss_pred HHHHHHhcc-----CCCcccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 005750 403 EVALLSRIH-----HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTGC 476 (679)
Q Consensus 403 E~~~l~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~~ 476 (679)
|...+.+++ .+++.-..=|.+-.....|+|||++|-.+.+...-. ....+...+ +..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHh--
Confidence 444444432 222221111222345678999999998888874321 233443332 3333322 222222
Q ss_pred CCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 477 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
.|+.|+|.+|.||+++.+|++.+.|||+.....+
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 7999999999999999999999999999877654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-08 Score=108.59 Aligned_cols=106 Identities=19% Similarity=0.173 Sum_probs=63.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
..|..|+||.|.|...-++.+.-..+|+.|+|++|+|+...+ +|..|+.|+.|+|++|+++-.--..|..+++|+.|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 345566666666665556666666666666666666666666 3666666666666666666222234666667777777
Q ss_pred cccCCCCCCCccc--cCC---ceeeeecCCCC
Q 005750 240 ENNSFVGEIPPAL--LTG---KVIFKYDNNPK 266 (679)
Q Consensus 240 ~~N~l~g~ip~~~--~~~---~~~~~~~~n~~ 266 (679)
++|.|++.|.+.. +.| +..+.+.||..
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCcee
Confidence 7777776666532 223 24455666654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7e-09 Score=113.99 Aligned_cols=150 Identities=18% Similarity=0.252 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc--------ccccCCccccCCcccCC
Q 005750 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS--------SVARGTVGYLDPEYYGN 534 (679)
Q Consensus 463 ~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~l~~ 534 (679)
.+++.|+.|+|. ..++||++|.|++|.++..+..||+.|+.+........... ....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999998 58999999999999999999999999998765443211111 11124567999999999
Q ss_pred CCCCchhHHHHHHHHHHHHH-hCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcc
Q 005750 535 QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 613 (679)
Q Consensus 535 ~~~s~ksDVwSlGvll~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 613 (679)
...+.++|+||+||++|.+. .|+.-+............. ..+..-...+..+.+.++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence 88899999999999999999 4555444222211111110 011111112334556688899999999
Q ss_pred cCCCCCCCHHHHHH
Q 005750 614 QRGFSRPKMQEIVL 627 (679)
Q Consensus 614 ~dP~~RPt~~evl~ 627 (679)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-06 Score=85.63 Aligned_cols=137 Identities=20% Similarity=0.230 Sum_probs=103.3
Q ss_pred CcCccEEEEEEEEcCCcEEEEEEecCCc------chhHHHHHHHHHHHHhccC--CCcccccccccc-----cceEEEEE
Q 005750 366 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEE-----EHQRILVY 432 (679)
Q Consensus 366 G~G~~g~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~-----~~~~~lV~ 432 (679)
|+||-+.|++.... |+.+-+|.-.... +.....|.+|...++++.. -.+.+++ ++.. ..+.+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 66899999998776 4478888764211 3356789999999999953 2245555 3321 23468999
Q ss_pred EecCC-CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc--EEEeeccCccc
Q 005750 433 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 508 (679)
Q Consensus 433 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfgla~~ 508 (679)
|-+.| -+|.+++... .-.+.+...+..++.+++.+++-||+ .|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 5888887643 23356777788999999999999999 99999999999999986667 99999986654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.1e-07 Score=88.54 Aligned_cols=107 Identities=27% Similarity=0.305 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHHhccCC--Cccccccccccc----ceEEEEEEecCCC-cHhhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 005750 397 TQQFVTEVALLSRIHHR--NLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469 (679)
Q Consensus 397 ~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 469 (679)
.....+|...+..|..- ...+++++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34677888888888533 345556655432 2458999999884 799988742 2266667788999999999
Q ss_pred HHHHhcCCCCccccCCCCCCccccCCC---cEEEeeccCcccc
Q 005750 470 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 509 (679)
Q Consensus 470 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfgla~~~ 509 (679)
+-||+ .||+|+|+++.|||++.++ .+.++||+-+...
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 9999999999999999877 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=85.29 Aligned_cols=138 Identities=24% Similarity=0.305 Sum_probs=97.5
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchh-------------------H-----HHHHHHHHHHHhcc--CCCcc
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-------------------T-----QQFVTEVALLSRIH--HRNLV 416 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~-------------------~-----~~~~~E~~~l~~l~--hpnIv 416 (679)
..|+.|--+.||+|...++..+|+|+++...... . .-..+|+..|+++. +=.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3578888899999998889999999986432111 0 11456788888774 44555
Q ss_pred cccccccccceEEEEEEecCCCc-HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC
Q 005750 417 PLIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495 (679)
Q Consensus 417 ~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 495 (679)
+.+++.. ..|||||+.... -.-.| ...++.......+..++++.+.-|-. ..++||+||+.-|||+. +
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 6665543 379999995431 11111 22233333566778888888888775 38999999999999999 8
Q ss_pred CcEEEeeccCcccccc
Q 005750 496 MRAKVSDFGLSRQAEE 511 (679)
Q Consensus 496 ~~~kL~Dfgla~~~~~ 511 (679)
+.+.++|+|.|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 9999999998876554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.1e-07 Score=104.17 Aligned_cols=98 Identities=24% Similarity=0.367 Sum_probs=57.2
Q ss_pred CceEEEEcCCCcccccCCccccC-----------------CCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCC
Q 005750 161 PRITKIALSGKNLKGEIPPELKN-----------------MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 223 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~-----------------l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~ 223 (679)
.+|+.|+|++|+|+ .+|....+ +++|+.|+|++|+|++.++. .++|+.|+|++|+|+ .
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-s 416 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-S 416 (788)
T ss_pred cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-C
Confidence 35777777777777 34432211 13455566666666553322 245666666666666 4
Q ss_pred CCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 224 LPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 224 ~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
+|.. ..+|+.|+|++|+|+ .+|..++. .+..+.+++|+..
T Consensus 417 IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 417 LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 6643 235667777777777 67766543 3456677777755
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.8e-08 Score=113.21 Aligned_cols=104 Identities=29% Similarity=0.425 Sum_probs=90.8
Q ss_pred CceEEEEcCCCcccccCCc-cccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.+|+.|+|++|.|. ++|. .+.+|..|+.|+||+|+|+.++-.+.++..|++|...+|+|. ..| .+..++.|+.+|+
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 58999999999998 7775 588999999999999999998877999999999999999999 899 8999999999999
Q ss_pred cccCCC-CCCCcccc-CCceeeeecCCCCc
Q 005750 240 ENNSFV-GEIPPALL-TGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~-g~ip~~~~-~~~~~~~~~~n~~~ 267 (679)
+.|+|+ +.+|..+. ..+..+.++||+++
T Consensus 460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999987 34455554 56678899999865
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-07 Score=108.60 Aligned_cols=84 Identities=27% Similarity=0.376 Sum_probs=72.8
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
..|..|+|++|.|+ .+|.. .++|+.|+|++|+|++. |.+ ..+|+.|+|++|+|+ .+|.+++++++|+.|+|+
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~LssI-P~l--~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTSL-PML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCCC-Ccc--hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 47899999999999 57754 36899999999999985 432 346889999999999 999999999999999999
Q ss_pred ccCCCCCCCccc
Q 005750 241 NNSFVGEIPPAL 252 (679)
Q Consensus 241 ~N~l~g~ip~~~ 252 (679)
+|+|+|.+|..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 999999888765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.2e-07 Score=98.50 Aligned_cols=152 Identities=18% Similarity=0.233 Sum_probs=110.2
Q ss_pred EeecCCCccccceeeeeeeeeeeccC----CCchhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCceEE
Q 005750 90 FVKTRDSTLGPLLNAIEISKYQKIAA----KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITK 165 (679)
Q Consensus 90 l~~~~~s~l~p~~na~e~~~~~~~~~----~t~~~~~~~l~~l~~~~~~~~~~~w~~~~c~~~~w~~~~c~~~~~~~l~~ 165 (679)
+.++.-..+|-...+.-....+.+.. .-+.++..++.+++..-...+..+--..||.|. ..+++.
T Consensus 109 l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~-----------~~ni~~ 177 (873)
T KOG4194|consen 109 LNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPA-----------KVNIKK 177 (873)
T ss_pred eccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCC-----------CCCceE
Confidence 45555555665554444333333332 344577778877776555545555555677542 147999
Q ss_pred EEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCC-CCCCCCCCccceecccccC
Q 005750 166 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIENNS 243 (679)
Q Consensus 166 L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~ 243 (679)
|+|++|.|+..-...|..|.+|..|.|+.|+++..++ .|.+|++|+.|+|..|+|. .+ --.|.+|++|+.|.|..|.
T Consensus 178 L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~ 256 (873)
T KOG4194|consen 178 LNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRND 256 (873)
T ss_pred EeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcC
Confidence 9999999996667789999999999999999999988 6888999999999999987 44 3457888888888888888
Q ss_pred CCCCCCccccC
Q 005750 244 FVGEIPPALLT 254 (679)
Q Consensus 244 l~g~ip~~~~~ 254 (679)
+. .+-++.|-
T Consensus 257 I~-kL~DG~Fy 266 (873)
T KOG4194|consen 257 IS-KLDDGAFY 266 (873)
T ss_pred cc-cccCccee
Confidence 87 77777654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-08 Score=101.32 Aligned_cols=89 Identities=28% Similarity=0.382 Sum_probs=71.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC-ccCCCCCCC-CCCCCCccce
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPS-YMGSLPNLQE 236 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~-N~l~g~~p~-~~~~l~~L~~ 236 (679)
|+..++|+|..|+|+-..|..|+.|.+|+.||||+|+|+.+-| .|.+|.+|..|-+-+ |+|+ .+|. .|+.|..|+.
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 5678999999999994445679999999999999999999988 599999987776665 8999 7776 4777877777
Q ss_pred ecccccCCCCCCCc
Q 005750 237 LHIENNSFVGEIPP 250 (679)
Q Consensus 237 L~l~~N~l~g~ip~ 250 (679)
|.+.-|++. -++.
T Consensus 145 LllNan~i~-Cir~ 157 (498)
T KOG4237|consen 145 LLLNANHIN-CIRQ 157 (498)
T ss_pred HhcChhhhc-chhH
Confidence 777766666 4443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.9e-08 Score=90.58 Aligned_cols=82 Identities=24% Similarity=0.392 Sum_probs=42.4
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCC-CCCCCCcEEEecCccCCCCCC--CCCCCCCcccee
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 237 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L 237 (679)
.+|+.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|+|. .+- ..+..|++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCccee
Confidence 58999999999999 565 5888999999999999999876555 46999999999999998 443 357789999999
Q ss_pred cccccCCC
Q 005750 238 HIENNSFV 245 (679)
Q Consensus 238 ~l~~N~l~ 245 (679)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999998
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=85.16 Aligned_cols=132 Identities=15% Similarity=0.125 Sum_probs=86.1
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC--cccccccccccceEEEEEEecCCCc-
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 439 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs- 439 (679)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25568889876533 3355788999999986433 4677778777777889999998863
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------cCCCC
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT----------------------------------------GCNPG 479 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~----------------------------------------~~~~~ 479 (679)
+...+. .+......++.++++.+.-||+ .....
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 211111 0011111122222222222221 11246
Q ss_pred ccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 480 IIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 480 ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
++|+|+.|.||++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.9e-06 Score=82.76 Aligned_cols=140 Identities=16% Similarity=0.208 Sum_probs=90.3
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHH---------HHHHHHHHHhccCCCcccc---c
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ---------FVTEVALLSRIHHRNLVPL---I 419 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv~l---~ 419 (679)
+++....+...+.+-......|.+...+ |+.+++|..+.......+. ..+++..+.+++...+..+ +
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 3445555555666666666666665554 7899999877544332222 2344454555533222222 2
Q ss_pred ccc-----cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC
Q 005750 420 GYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494 (679)
Q Consensus 420 ~~~-----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 494 (679)
.+. ......+++|||++|..|.+... +++ .+...+++++.-+|+ .|++|||.+|.|+++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEEC
Confidence 221 22334568999999988766532 222 245677888999999 99999999999999985
Q ss_pred CCcEEEeeccCcc
Q 005750 495 NMRAKVSDFGLSR 507 (679)
Q Consensus 495 ~~~~kL~Dfgla~ 507 (679)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.8e-07 Score=104.86 Aligned_cols=97 Identities=25% Similarity=0.380 Sum_probs=68.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
+..|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. .+|+.|+|++|++. .+|..+. ++|+.|+|
T Consensus 198 p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 198 PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 346888888888888 6777654 578888888888886544443 35777777777777 6776654 46777777
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 005750 240 ENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
++|+|+ .+|..+..++..+.+++|.
T Consensus 270 s~N~L~-~LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 270 FHNKIS-CLPENLPEELRYLSVYDNS 294 (754)
T ss_pred cCCccC-ccccccCCCCcEEECCCCc
Confidence 777777 6777666666666666664
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-07 Score=96.66 Aligned_cols=102 Identities=24% Similarity=0.332 Sum_probs=81.6
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc-c
Q 005750 165 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN-N 242 (679)
Q Consensus 165 ~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N 242 (679)
..+.++-+|+ .+|..+- ..-..|+|..|+|+.++| .|+.+++|+.||||+|+|+-.-|+.|..+.+|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3455556666 6775544 456789999999999999 599999999999999999977799999999998877766 9
Q ss_pred CCCCCCCccccCCceee-eecCCCCcccc
Q 005750 243 SFVGEIPPALLTGKVIF-KYDNNPKLHKE 270 (679)
Q Consensus 243 ~l~g~ip~~~~~~~~~~-~~~~n~~~~~~ 270 (679)
+|+ .+|...|.++..+ .+..|++.|.+
T Consensus 127 kI~-~l~k~~F~gL~slqrLllNan~i~C 154 (498)
T KOG4237|consen 127 KIT-DLPKGAFGGLSSLQRLLLNANHINC 154 (498)
T ss_pred chh-hhhhhHhhhHHHHHHHhcChhhhcc
Confidence 999 9999999876432 34667777653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=101.97 Aligned_cols=94 Identities=20% Similarity=0.352 Sum_probs=42.1
Q ss_pred eEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccccc
Q 005750 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242 (679)
Q Consensus 163 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 242 (679)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.++.+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|
T Consensus 264 L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N 335 (754)
T PRK15370 264 LQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGEN 335 (754)
T ss_pred CCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCC
Confidence 444444444444 3343332 244444444444444332222 23444444444444 3443322 35555555555
Q ss_pred CCCCCCCccccCCceeeeecCCC
Q 005750 243 SFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 243 ~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
.|+ .+|..+...+..+.+++|.
T Consensus 336 ~Lt-~LP~~l~~sL~~L~Ls~N~ 357 (754)
T PRK15370 336 ALT-SLPASLPPELQVLDVSKNQ 357 (754)
T ss_pred ccc-cCChhhcCcccEEECCCCC
Confidence 555 3555554444555555553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.8e-08 Score=85.32 Aligned_cols=105 Identities=26% Similarity=0.338 Sum_probs=88.2
Q ss_pred CceEEEEcCCCcccccCCccccC-CCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKN-MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.+|+.++|++|.+. .+|+.|.. ++.++.|+|++|.|+..|-++..|+.|+.|+++.|.|. ..|.-+..|.+|.+|+.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 47999999999999 77777664 57999999999999998889999999999999999999 88998888999999999
Q ss_pred cccCCCCCCCccccCCc--eeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALLTGK--VIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~~--~~~~~~~n~~~~ 268 (679)
.+|.+. +||..++... ....+.++||.-
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 999998 8998765432 223344556543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.6e-06 Score=81.10 Aligned_cols=142 Identities=20% Similarity=0.259 Sum_probs=84.7
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCC--Ccccccccc---cccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYC---EEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~---~~~~~~~lV~E~~~~ 437 (679)
+.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.+. ......+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999887 69999997654 4567788999999988533 355666543 223357899999999
Q ss_pred CcHhh----------------hhc---cc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 005750 438 GTLRD----------------RLH---GS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 474 (679)
Q Consensus 438 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~~LH~- 474 (679)
..+.. .+. .. .......... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 111 01 0011111100 0000 111222 2333332
Q ss_pred ---cCCCCccccCCCCCCcccc-CCCcEEEeeccCcc
Q 005750 475 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSR 507 (679)
Q Consensus 475 ---~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~ 507 (679)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1246799999999999999 66777899998664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=88.98 Aligned_cols=141 Identities=19% Similarity=0.244 Sum_probs=90.9
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchh----H---------------------------H------HHHHHHH
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR----T---------------------------Q------QFVTEVA 405 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~----~---------------------------~------~~~~E~~ 405 (679)
+.||.-+.|.||+|++++|+.||||+-++..... . + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999975432111 0 0 1444554
Q ss_pred HHHhc----cCCC------cccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005750 406 LLSRI----HHRN------LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475 (679)
Q Consensus 406 ~l~~l----~hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 475 (679)
...+. +|-+ |.+++- .-.....|+||||+|..+.|.-.- ....++...+. ..+.++... ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~---~~l~~~~~~--qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDIL---NKLVEAYLE--QI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHH---HHHHHHHHH--HH
Confidence 44433 3444 222222 223467999999999877664321 23345554433 333333222 11
Q ss_pred CCCCccccCCCCCCccccC----CCcEEEeeccCccccccC
Q 005750 476 CNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 476 ~~~~ivH~Dlkp~NIll~~----~~~~kL~Dfgla~~~~~~ 512 (679)
...|++|+|-+|.||+++. ++.+.+-|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 1278999999999999983 678999999998876543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.3e-07 Score=101.17 Aligned_cols=163 Identities=21% Similarity=0.249 Sum_probs=103.7
Q ss_pred EEeecCCCccccceeeeeeeeeeeccC---CCchhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCceEE
Q 005750 89 SFVKTRDSTLGPLLNAIEISKYQKIAA---KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITK 165 (679)
Q Consensus 89 ~l~~~~~s~l~p~~na~e~~~~~~~~~---~t~~~~~~~l~~l~~~~~~~~~~~w~~~~c~~~~w~~~~c~~~~~~~l~~ 165 (679)
+|-.+.-+.||=-..+|..+..+.+.. ++.++-+..|.++.-.....+..+--.++- |. --|..
T Consensus 81 DlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~l---------C~----lpLkv 147 (722)
T KOG0532|consen 81 DLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGL---------CD----LPLKV 147 (722)
T ss_pred hccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhh---------hc----Cccee
Confidence 344444555555444444443333332 444555555555443332222222223321 11 14677
Q ss_pred EEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCC
Q 005750 166 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 166 L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 245 (679)
|.+++|+++ .+|+.++.+..|..||.+.|++...++.+++|.+|+.|++..|++. .+|.++..| .|..||+|.|+++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 888888887 8888888778888888888888888778888888888888888887 777777744 4777888888887
Q ss_pred CCCCccccC--CceeeeecCCCCcc
Q 005750 246 GEIPPALLT--GKVIFKYDNNPKLH 268 (679)
Q Consensus 246 g~ip~~~~~--~~~~~~~~~n~~~~ 268 (679)
.||-.+.. .+..+.+++||...
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCC
Confidence 78877654 45667777887653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.4e-07 Score=102.41 Aligned_cols=89 Identities=28% Similarity=0.466 Sum_probs=84.6
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
.|+.|||++|.++ ..|..+..+.+|+.|+++.|.|...+-+.+++++|++|+|.+|++. .+|.++..+.+|++|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 5999999999998 9999999999999999999999999888999999999999999999 9999999999999999999
Q ss_pred cCCCCCCCcccc
Q 005750 242 NSFVGEIPPALL 253 (679)
Q Consensus 242 N~l~g~ip~~~~ 253 (679)
|.|. .+|..+.
T Consensus 124 N~f~-~~Pl~i~ 134 (1081)
T KOG0618|consen 124 NHFG-PIPLVIE 134 (1081)
T ss_pred hccC-CCchhHH
Confidence 9998 8988664
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.1e-06 Score=101.78 Aligned_cols=105 Identities=19% Similarity=0.329 Sum_probs=86.2
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
+.+|+.|+|++|+|. .+|..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.+++.+++|+.|++
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 458999999999988 7888899999999999998877778888999999999999998766699999999999999999
Q ss_pred cccCCCCCCCccc-cCCceeeeecCCC
Q 005750 240 ENNSFVGEIPPAL-LTGKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g~ip~~~-~~~~~~~~~~~n~ 265 (679)
++|...+.+|..+ ...+..+.+.+|.
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCC
Confidence 9876555888765 2344555666654
|
syringae 6; Provisional |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=79.99 Aligned_cols=139 Identities=19% Similarity=0.172 Sum_probs=85.0
Q ss_pred cCcCcc-EEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCCCcHhh
Q 005750 365 IGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 442 (679)
Q Consensus 365 LG~G~~-g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 442 (679)
|..|.+ ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789999765 4789999876442 345678999998884 4446677777766667899999999987754
Q ss_pred hh-------------------cccC-CCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005750 443 RL-------------------HGSV-NQKPLDW--LTRLQIAH--------------------DAAKGLEYLHT----GC 476 (679)
Q Consensus 443 ~l-------------------~~~~-~~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~~ 476 (679)
.. +... ...+... ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1100 0001110 00000000 01111122211 11
Q ss_pred CCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 477 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2568999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.6e-06 Score=62.24 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=19.7
Q ss_pred CCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCC
Q 005750 186 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 221 (679)
Q Consensus 186 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~ 221 (679)
+|++|+|++|+|+..+|.+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 456666666666654444566666666666666555
|
... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.3e-05 Score=73.11 Aligned_cols=129 Identities=22% Similarity=0.292 Sum_probs=90.6
Q ss_pred hhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccc-ccccccccceEEEEEEecCCC
Q 005750 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~~~lV~E~~~~g 438 (679)
+..+.||+|.+|.||++.+. |.++|+|+-+.++ ....+..|+++|..+.-.++.+ ++.|..+ .+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 34678999999999999998 6689999876543 3567889999999997665543 4433332 3459999988
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCC-CCCccccCCCcEEEeeccCccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK-SSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kL~Dfgla~~ 508 (679)
+|.+.-... +.. -+..++++---|.. .||-|+.|. |..+++-.++.+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887654421 222 23445555334554 899999997 4555555566999999998874
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.7e-06 Score=62.15 Aligned_cols=37 Identities=38% Similarity=0.666 Sum_probs=22.8
Q ss_pred CCCcEEEecCccCCCCCCCCCCCCCccceecccccCCC
Q 005750 208 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 208 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 245 (679)
++|+.|+|++|+|+ .+|..+++|++|+.|++++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35666666666666 56666666666666666666666
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.2e-06 Score=95.62 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=134.2
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC-cccccccccccceEEEEEEecCCC-
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 438 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~~g- 438 (679)
+-+.+++|+++.+++.+-.-.+....+.+... ....-++++|.+++||| .++.++-++.++...++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 44667899999999987554444445555432 33445889999999999 777777778888889999999876
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+-..-.. .....+...+...+.+.-+++++++|+ ..-+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2221111 122334444555667777889999998 4458888 777654 778999999887765544 234
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
...+++.++|||+.....+..+-|+|++|+--.++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999987777777777654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.2e-07 Score=102.01 Aligned_cols=125 Identities=23% Similarity=0.296 Sum_probs=96.1
Q ss_pred CCCCCCCCCCce---EEEeCCC----------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCC
Q 005750 141 RGDPCVPVPWEW---VTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSR 206 (679)
Q Consensus 141 ~~~~c~~~~w~~---~~c~~~~----------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~ 206 (679)
.||.|....|.- ..|+|.. .+.|+.|||++|+++. .. .+..|++|++|||++|.|...+- ...+
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhccccccchhh
Confidence 468887767764 5566543 4678999999999984 33 88999999999999999998766 5666
Q ss_pred CCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCC---CCccccCCceeeeecCCCCcccc
Q 005750 207 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE---IPPALLTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 207 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~---ip~~~~~~~~~~~~~~n~~~~~~ 270 (679)
+. |..|+|.||-++ .+- .+.+|.+|+.|||++|-|.+. .|-+....+..+.+.|||.-|..
T Consensus 232 c~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 66 999999999998 443 377899999999999998742 12223334456788999988854
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.3e-07 Score=95.71 Aligned_cols=103 Identities=26% Similarity=0.414 Sum_probs=91.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
...|+.|||+.|+++ .+|..+..|+ |+.|-+++|+++..+++++.+..|..||.+.|++. .+|..++.+.+|+.|++
T Consensus 120 L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 120 LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 457899999999999 9999999886 99999999999999999999999999999999999 99999999999999999
Q ss_pred cccCCCCCCCccccC-CceeeeecCCCC
Q 005750 240 ENNSFVGEIPPALLT-GKVIFKYDNNPK 266 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~-~~~~~~~~~n~~ 266 (679)
..|++. .+|++++. .+..+.|+.|..
T Consensus 197 rRn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred hhhhhh-hCCHHHhCCceeeeecccCce
Confidence 999999 89998884 235566776653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.7e-06 Score=92.76 Aligned_cols=102 Identities=28% Similarity=0.506 Sum_probs=90.4
Q ss_pred CceEEEEcCCCcccccCCccccCCC-CCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
..++.|++.+|.++ .+|+..+.++ +|+.|++++|++...+..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 46899999999999 8999999995 999999999999998878999999999999999999 99998888999999999
Q ss_pred cccCCCCCCCcc--ccCCceeeeecCCC
Q 005750 240 ENNSFVGEIPPA--LLTGKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g~ip~~--~~~~~~~~~~~~n~ 265 (679)
++|+++ .+|.. ....+..+...+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 89986 45556677777775
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.8e-06 Score=85.86 Aligned_cols=89 Identities=24% Similarity=0.298 Sum_probs=68.2
Q ss_pred EEeCCCCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCc
Q 005750 154 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPN 233 (679)
Q Consensus 154 ~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 233 (679)
.....+...|++||||+|.++ .+..++.-++.++.|+||+|.|...-. +..|++|+.||||+|.|+ .+-..-..|-|
T Consensus 277 ~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 277 LVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 333444457889999999998 888889989999999999999886544 888899999999999988 66555455556
Q ss_pred cceecccccCCC
Q 005750 234 LQELHIENNSFV 245 (679)
Q Consensus 234 L~~L~l~~N~l~ 245 (679)
++.|.|++|.+.
T Consensus 354 IKtL~La~N~iE 365 (490)
T KOG1259|consen 354 IKTLKLAQNKIE 365 (490)
T ss_pred EeeeehhhhhHh
Confidence 666666666554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.3e-06 Score=85.02 Aligned_cols=83 Identities=25% Similarity=0.468 Sum_probs=56.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC----------------------CCCCCCCcEEEecC
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------------------MSRLIDLRIVHLEN 217 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~----------------------~~~l~~L~~L~l~~ 217 (679)
.|.+..|+||+|+|. .+.. +..|++|+.||||+|.|+...-- ++.|-+|..||+++
T Consensus 306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~LSGL~KLYSLvnLDl~~ 383 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIETLSGLRKLYSLVNLDLSS 383 (490)
T ss_pred ccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhhhhhhHhhhhheeccccc
Confidence 478999999999998 5554 89999999999999998764321 22333455666666
Q ss_pred ccCCCCCC--CCCCCCCccceecccccCCC
Q 005750 218 NELTGSLP--SYMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 218 N~l~g~~p--~~~~~l~~L~~L~l~~N~l~ 245 (679)
|++. .+. .++|+||.|+.|.|-+|.+.
T Consensus 384 N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 384 NQIE-ELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred cchh-hHHHhcccccccHHHHHhhcCCCcc
Confidence 6655 333 24566666666666666665
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.4e-05 Score=88.17 Aligned_cols=79 Identities=13% Similarity=0.304 Sum_probs=57.8
Q ss_pred ccccCcCccEEEEEEEEcCC---cEEEEEEecCCc-chhHHHHHHHHHHHHhcc-CCCc--cccccccccc---ceEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 431 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lV 431 (679)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 467888764422 123457889999999995 6654 7777777654 467899
Q ss_pred EEecCCCcH
Q 005750 432 YEYMHNGTL 440 (679)
Q Consensus 432 ~E~~~~gsL 440 (679)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.4e-05 Score=96.67 Aligned_cols=101 Identities=19% Similarity=0.290 Sum_probs=71.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
+++|+.|+|++|...+.+|.++++|++|+.|+|++|..-+.+|...++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 35899999999988889999999999999999999865555665337777888888776544455543 346677777
Q ss_pred cccCCCCCCCccccC--CceeeeecCC
Q 005750 240 ENNSFVGEIPPALLT--GKVIFKYDNN 264 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~--~~~~~~~~~n 264 (679)
++|.++ .+|.++.. .+..+.+.++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCC
Confidence 777776 66665432 3344444443
|
syringae 6; Provisional |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.7e-05 Score=73.68 Aligned_cols=105 Identities=24% Similarity=0.218 Sum_probs=83.4
Q ss_pred HHHHHHHHhccC-CCcccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005750 401 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479 (679)
Q Consensus 401 ~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 479 (679)
..|.-+++.+++ +++.+++|+|.. ++|.||...+++...-.....-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888898965 699999999954 679999987766432110001234789999999999999999999866566
Q ss_pred ccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 480 ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 679 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-56 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-157
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 323 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 380
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 381 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 441 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 500 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 558
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 559 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 618
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 619 RPKMQEIVLAIQDSIKIEK 637
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-129
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 353 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 409
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 410 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 468
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 529 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 586
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-123
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 353 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 400
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 401 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 460
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 519
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 520 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 577
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 578 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 4e-88
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 349 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 406
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 407 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 463 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 516 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 569
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 570 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 623
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 624 EIVLAIQD 631
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 9e-75
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 406
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 9e-74
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 347 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 406
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 525
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 582
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 642
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 643 F----SSSSSKGQSSRKTLLTSFLEIES 666
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-70
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 335 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 393
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 394 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 446
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 447 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 501
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 502 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-67
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 404
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 516
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-67
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 406
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 407 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 524
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 525 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 559
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-66
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 349 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 404
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 405 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 459
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 460 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 507
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 508 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 560 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 609
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 610 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 648
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-64
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 406
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 525
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 526 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-64
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 349 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 406
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 522
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 523 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 559
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 4e-62
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 526
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-61
Identities = 76/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 351 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 406
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 407 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 463 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 514
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ ++
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 515 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568
+ GT Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 569 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 619
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 620 PKMQEIVLAIQDSIKIEKGGDQKF 643
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 351 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 406
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 407 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 463 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 514
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 515 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 569 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 622
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 623 QEIV-----LAIQDSIKI 635
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 418
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 419 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 475 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 526
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 527 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 420 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 474 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 418
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 533
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 534 NQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-42
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-42
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-41
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 541 SDVYSFGVVLLELIS-GKKP 559
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 422 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 525
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 342 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 396
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 397 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 455
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 456 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 514
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-41
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 421 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 364 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 419
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 417
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 538 TEKSDVYSFGVVLLELIS-GKKP 559
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 415
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 531
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 532 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 407
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 408 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 421 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 521
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 522 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 554
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 422 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 528
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 529 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 405
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 406 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 521
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-39
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)
Query: 282 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 333
+I L+ C S I+ + + + + A++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 334 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 385
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 386 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 444
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 445 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 342 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 396
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 397 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 454
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 455 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 512
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 9e-39
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 421 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 540 KSDVYSFGVVLLELIS-GKKP 559
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 417
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 536 QLTEKSDVYSFGVVLLELIS-GKKP 559
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 342 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 396
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 397 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 455
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 456 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 514
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 407
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 408 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 523
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 414
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 532
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 533 GNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-38
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 418
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 537 LTEKSDVYSFGVVLLELIS-GKKP 559
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 406
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 407 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 522
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 561
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 402
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 403 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 514
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 515 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 405
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 406 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 521
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 407
EE + ++GKG+FGSV G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 408 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 523
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 417
+KIG+GSFG K DG++ +K + + S + ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 472
EE +V +Y G L R++ + LDW QI L+++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H + I+HRD+KS NI L + ++ DFG++R + + GT YL PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
N+ KSD+++ G VL EL + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 407
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 408 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 523
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 555
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 415
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 533
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 534 NQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 416
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 535
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 536 QLTEKSDVYSFGVVLLELIS-GKKP 559
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 417
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 418 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 533
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 534 NQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 418
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 471
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 528
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 529 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 419
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 420 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 477 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 417
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 537 LTEKSDVYSFGVVLLELISGKKP 559
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 420 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 464
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 521
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 522 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 556
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 421
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 482 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 532
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 533 --GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 339 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 392
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 393 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 447
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 448 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 504
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 505 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 405
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 406 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 460
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 521 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 573
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 574 WARSMIKKGDV 584
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 413
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 466
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 525
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 353 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 406
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 407 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 464
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 522
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 561
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 415
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 462
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 522
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)
Query: 297 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 356
I + S ++ + S ++T + + + L E+
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 357 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 409
+ +G G+FG VY G++ +VAVK + + CS + + F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 410 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 465
+H+N+V IG + R ++ E M G LR+ L L L +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 521
A G +YL IHRD+ + N LL AK+ DFG++R A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 416
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 417 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 468
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 527
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 418
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 539 EKSDVYSFGVVLLELISGKKP 559
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 416
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 417 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 467
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 526
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 417
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 537 LTEKSDVYSFGVVLLELISGKKP 559
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 421 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 522
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 523 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 418
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 477
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 537
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 538 TEKSDVYSFGVVLLELISGKKP 559
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 404
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 405 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 452
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 511
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 512 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 418
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 530
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 531 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 585 ISI 587
I
Sbjct: 259 IEF 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 35/238 (14%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 421
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 422 CEEEHQRILVYEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+ + E N L+D + N K + + A G+ +LH +
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133
Query: 478 PGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR--- 521
IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 522 GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572
GT G+ PE ++LT D++S G V ++S K + + E NI+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 418
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 474
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 531
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 403
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 404 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 450
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 451 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 509
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 510 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 414
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 461
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 520
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 521 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 476
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 477 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 533
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 417
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 418 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 530
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 422 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 480 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 534
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 457
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 516
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 306 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 363
R+ + +S +S + + S A P+ E + K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 364 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 413
+G+G FG V K K+ VAVK++ D + + V+E+ ++ I H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 460
N++ L+G C ++ ++ EY G LR+ L V ++ + + +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 461 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260
Query: 521 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 418
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 474
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE--------VAVKIMADSCSHRTQQ-FVTEVALLSRI- 410
K +G+G+FG V + + VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 411 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 457
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 518 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 418
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 474
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 418
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 530
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 531 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 585 ISI 587
I
Sbjct: 240 IEF 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 312 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 371
Q YE + T S+ Y ++D + E F K +G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 372 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 423
V + VAVK++ + ++ ++E+ +++++ H N+V L+G C
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 424 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 463
L++EY G L + L ++ L+ LT L A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 522
AKG+E+L +HRD+ + N+L+ K+ DFGL+R + + AR
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 413
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 452
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 513 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 417
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 418 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 476 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 532 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 559
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 413 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 458
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 519 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 478
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 539 EKSDVYSFGVVLLELISGKKP 559
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 461
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 520
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 418
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 530
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 531 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 585 ISI 587
I
Sbjct: 287 IEF 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 6e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 418
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 419 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 473 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 590 PVLIGNVKIESI 601
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 418
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 539 EKSDVYSFGVVLLELISGKKP 559
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 413
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 452
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 513 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 554
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 555 S-GKKP 559
S G +P
Sbjct: 271 SYGLQP 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 417
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 418 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 476 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 532 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 559
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 478
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 539 EKSDVYSFGVVLLELISGKKP 559
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 363 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 459
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 460 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 519
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 520 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)
Query: 319 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 376
L + ++Y + P E + + +G+G+F VY
Sbjct: 28 FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 377 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430
D ++ +K+ + + L + ++ +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 431 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 488
V E GTL + + + + +K + + A +E +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201
Query: 489 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 536
N +L D++ + D G S + A+ T G+ E N+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 537 LTEKSDVYSFGVVLLELISGKKP 559
+ D + + ++ G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 364 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 420
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 421 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 477
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 534
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 475
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 530
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 531 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 478
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 539 E-----KSDVYSFGVVLLELISGKKP 559
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 419 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 449
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 450 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 510 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 559
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 478
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 539 EKSDVYSFGVVLLELISGKKP 559
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 361 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 415
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 472
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 526
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 527 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 418
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 478 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 518
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 519 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 342 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 397
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 398 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 457
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 515
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 567
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 415
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 474 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 421 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 471
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 528
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 529 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 559
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 417
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 473
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 529
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 530 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 412
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 413 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 448
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 449 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 509 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 557
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 558 KP--------VSVEDFGAELNIVHWARSMIKK 581
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 417
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 476 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 477 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 414
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 463
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 464 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 495
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 496 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 550
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 551 LELISGKKP 559
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 413
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 471
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 472 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 529 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 411
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 469
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 530 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 406
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 407 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 464
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 521
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 5e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 415
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 416 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 448
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 449 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 509 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 475
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 536 QLTE---KSDVYSFGVVLLELISGKKP 559
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 417
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 473
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 529
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 530 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 477 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 530
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 338 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 393
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 394 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 450
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 451 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 511 EDLTHISSVAR----GTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ A+ G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 176 -----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 416
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 475 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 417
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 470
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 471 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 416
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 475 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 530
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 531 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 414
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 467
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 468 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 522
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 421 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 479 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 416
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 475 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 412
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 470
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 531 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)
Query: 306 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 360
+K D + +++ + + P P + + +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272
Query: 477 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ + +D++S GV+ L+SG P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 475
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 476 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 412
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 470
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 471 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 402
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 403 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 453
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 454 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 514 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 479 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 529
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 530 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 413
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 471
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 472 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 529 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 417
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 476 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 412
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 470
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 471 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 363 KKIGKGSFGSVYYGKMK-DG-----KEVA--------------VKIMA------------ 390
+ +G+G FG V+ K K D K + VK +A
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 391 ---------------------------DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423
S ++ + +N V +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483
+ + + L+D ++ + + + L I A+ +E+LH + G++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVGYLDPEYY 532
D+K SNI ++ KV DFGL ++D + + GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ K D++S G++L EL+
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 417
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 476 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 412
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 470
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 471 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 412
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 470
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 471 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 417
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 475 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 417
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 418 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 468
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 524
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 525 GYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ PE + G K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 473
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 529
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 530 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 413
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 467
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 528 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF----GAELNIVHW--- 574
PE Y G + +++S GV L L+ + P + A ++ +
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSK 249
Query: 575 -ARSMIKKGDVISIVDP 590
S++ + P
Sbjct: 250 ELMSLVSG---LLQPVP 263
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 416
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 469
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 470 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 419
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 531
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+ +G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 478
E ++ +LV EY+ G L DR+ +++ LT L +G+ ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QM 206
Query: 479 GIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
I+H D+K NIL + K+ DFGL+R+ + V GT +L PE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDF 264
Query: 537 LTEKSDVYSFGVVLLELISGKKP 559
++ +D++S GV+ L+SG P
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 421 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 473
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 474 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 416
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L ++ +V E M G L D++ +++ + I K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133
Query: 475 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Q D++S GV+L +++G P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 473
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 529
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 530 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 470
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 471 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 413
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 414 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 467
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 527 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)
Query: 364 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 419
G + ++VA+ + Q+ ++ LSRI + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
++V E++ G+L++ + ++ A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+ S + + I+ ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 573
+ D+ G L L+ + P+ + L
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 418
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 530
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 3e-24
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 139 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 194
D C W V C T T R+ + LSG NL IP L N+ L L++
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 195 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N L GP+P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 222
+ + LS L+G+ + + ++ L N L L + +L + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 223 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 267
+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 218
P + I G + G IP + L T + + N LTG +P + L +L V L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
L G GS N Q++H+ NS ++
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 219
+ S L G +PP + ++ L + DGN ++G +PD S+L + + N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
LTG +P +L NL + + N G+
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 221
KI L+ +L ++ ++ + L L L N + G LP +++L L +++ N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 222 GSLPSYMGSLPNLQELHIENNSFVGEIP 249
G +P G+L NN + P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 218
+ + L + G +P L ++ L L + N L G +P L + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 219 ELTGS-LPS 226
L GS LP+
Sbjct: 303 CLCGSPLPA 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 411
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 465
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 524
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 525 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 574
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 575 --ARSMIKKGDVISIVDP 590
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 415
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 467
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 468 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 521
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 421 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 473
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 474 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 362 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 419
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 420 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 468
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 527
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 528 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 557
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 415
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 535 QQLTEKSDVY-------SFGVVLLELISGKKP 559
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 415
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 535 QQLTEKSDVYSFGVVLLELISGKKPVSVED 564
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 415
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 535 QQLTEKS---DVYSFGVVLLELISGKKP 559
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 337 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 392
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 393 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 443
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 444 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 499
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 500 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 422 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 480 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 531
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 415
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 473
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKP 559
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 418
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 530
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 362 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 418
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 419 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 467
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 526
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 527 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 418
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE----- 530
++HRD+K N+LLD +M AK++DFGLS ++ + S G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y G + D++S GV+L L+ G P
Sbjct: 191 LYAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 415
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 535 QQLTEKS-----DVYSFGVVLLELISGKKP 559
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 420 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 470
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T V T Y PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193
Query: 531 -YYGNQQLTEKSDVYSFGVVLLELISGK 557
+ D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 420 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 594 GNVKIESIWRIAEVAIQCVEQRGFSRPK 621
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-21
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 147 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 205
+P + S ++ + L L+GEIP EL ++ L L LD N LTG +P +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 206 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+L + L NN LTG +P ++G L NL L + NNSF G IP L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-21
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 219
+ + L +L GEIP L N L + L N LTG +P + RL +L I+ L NN
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 268
+G++P+ +G +L L + N F G IP A+ + GK N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 269 K--ESRRRMRFKLILGTSIGVLAILLVLFL 296
+ + + F+ I + L+ +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-20
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)
Query: 147 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 206
WV + +A+SG + G++ + L L + N + +P +
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 207 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 264
L+ + + N+L+G + + L+ L+I +N FVG IPP L + + +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-20
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 216
+ ++ L G+IPP L N L L L N+L+G +P + L LR + L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N L G +P + + L+ L ++ N GEIP L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-19
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 218
+T + LSG + G +PP + L L L N +G LP + ++ L+++ L N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 219 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 252
E +G LP + +L +L L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-18
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 160 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 216
+ + LS N G I P L L EL+L N TG +P +S +L +HL
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N L+G++PS +GSL L++L + N GEIP L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-18
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 139 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 195
+ +PC ++ VTC ++T I LS K L + L ++ L L+L +
Sbjct: 34 SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87
Query: 196 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 253
+ G + L + L N L+G + + GS L+ L++ +N+ +
Sbjct: 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-18
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 218
+ + +S G IPP +++L L L N TG +PD L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 253
G++P + GS L+ L + +N+F GE+P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-17
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 218
+ ++L+ GEIP L + LT L L GN G +P L + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 219 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 252
+G LP + + L+ L + N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-17
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
+ +ALS N GE+P + L M L L L N +G LP+ + L + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 218 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 252
N +G + + LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-16
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 219
++ + G P N ++ L + N L+G +P + + L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 260
++GS+P +G L L L + +N G IP A+ L+G + F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 261 ------YDNNPKL 267
+ NNP L
Sbjct: 728 TFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 161 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 216
+T + LS +L G + L + L L + N L + +L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 217 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 254
N ++G+ L+ L I N G++ +
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-14
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 166 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 224
A + +G +L + + G + + + N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 225 PSYMGSLPNLQELHIENNSFVGEIPPAL 252
P +GS+P L L++ +N G IP +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 167 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 223
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 224 LPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 420 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 594 GNVKIESIWRIAEVAIQCVEQRGFSRPK 621
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 420 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 532
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 533 ------GNQQLTEKSDVYSFGVVLLELISGK 557
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 412
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 413 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 469
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 530 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 559
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 420 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 532
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 533 GNQQLTEKSDVYSFGVVLLELISGK 557
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 415
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 467
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 528 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 559
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 411
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 412 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 463
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 464 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 523
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 524 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 415
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 535 QQLTEKSDVYSFGVVLLELISGKKPVSVED 564
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 418
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 475
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 476 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 535 QQLTEKS-DVYSFGVVLLELISGKKP 559
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 414
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 468
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 525
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 526 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 415
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 416 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 530
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 531 Y-YGNQQLTEKSDVYSFGVVLLELISGK 557
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 418
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 419 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 471
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 472 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 528
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 529 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 361 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 412
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 413 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 450
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 451 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 494
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 495 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 530
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 531 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 559
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 413
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 530
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 531 Y-YGNQQLTEKSDVYSFGVVLLELISGK 557
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 362 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 418
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 419 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 441
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 442 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 497 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 554
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 555 SGK 557
GK
Sbjct: 237 LGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 419
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 420 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 522
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 523 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 557
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 364 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 415
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 469
V L + + +LV+E++ D L ++ + LQ+ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 526
Y H ++HRD+K N+L++ K++DFGL+R TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166
Query: 527 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
P+ G+++ + D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 413
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 530
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 531 Y-YGNQQLTEKSDVYSFGVVLLELISGK 557
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 414
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 468
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 525
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 526 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 419
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 420 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 470
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 527
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 528 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 557
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 418
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 419 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 471
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 532 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 557
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 417
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 418 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 528
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 529 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 557
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 420
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 421 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 477 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 527
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 415
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 416 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 467
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 468 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 521
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 522 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 415
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 467
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 468 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 523
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 364 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 420 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 472
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 473 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 525
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 526 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 415
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 467
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 468 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 523
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 410
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 411 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 463 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 512
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 513 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 413
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 414 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 467
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 468 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 521 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 416
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 417 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 467
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 524
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 525 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 420 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 465
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 524
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 525 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 563
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 564 DFG 566
Sbjct: 256 PTN 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 360 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 411
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 466
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 467 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 516
L +LH GII+RD+K NI+L+ K++DFGL +++ + +TH
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
+ GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 420 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 468
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 522
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 523 TVGYLDPEYYGNQQLTE 539
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 359 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 408
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 409 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 462
+ H N+V L E LV+EY+ +D L ++ Q+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 519
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161
Query: 520 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 420
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 421 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 477 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 508
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 414
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 467
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 468 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 521
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 522 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 420
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 421 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 477 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 525
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 364 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 414
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 475 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 526
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 527 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 411
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 412 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 464
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 465 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 517
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 420
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 421 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 477 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 527
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 410
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 411 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 465
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 466 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 518 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 564
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 7e-16
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 411
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 400
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 470
L L C + R+ V EY++ G L H + + A + A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLF 456
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 530
+L + GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE 512
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
Q + D ++FGV+L E+++G+ P ED
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 364 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 414
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 415 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 466
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 527 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 411
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 469
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 527
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 411
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 470
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 528
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 529 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 411
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 469
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 527
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 414
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 415 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 530
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 411
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 412 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 470
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 471 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 527
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 363 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 406
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 407 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 462
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 463 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 516
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 517 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 559
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 349 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 401
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 402 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 441
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 442 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 500 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 545
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 546 FGVVLLELISGKKP 559
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 139 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 198
N + + V+ ++ R+T ++L G G +P + + L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 199 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 251
+S + + Y +L + I ++ I +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 252 ---LLTGKVIFKYDNN 264
L I + NN
Sbjct: 179 SRITLKDTQIGQLSNN 194
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 163 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 221
I I + NLK + L+ M+ L L N L G LP I L ++L N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 222 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 256
++ G ++ L +N IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 212
+T + + ++P LK + + + + N L D ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 213 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 249
+++ N L T + + + + L L N G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 203
T+I N+ + + + L + ++ +
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 204 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 263
L DL V + N LP+++ +LP +Q +++ N + + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303
Query: 264 NPKLHK 269
K+
Sbjct: 304 GEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 221
+ K ++ + I + T++ N +T + RL LR ++ N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 222 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ +L +L ++ + N + ++P L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 161 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 214
+T I L L + + + + L + L N + P S L I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 215 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+ N P + P+L +L I +N + +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 215
+ I LS + L+ + L GN LT + L + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 216 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 252
N+LT +LP L + + NSF + P
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)
Query: 157 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 200
T P ++ + LK IP + K++ ++ + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 201 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L + I++ ++L NN+++ + L +++ N EIP L
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 168 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 224
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 225 PSYMGSLPNLQELHIENNSFVGEIPPALL 253
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 221
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 222 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 252
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 213
P + I LS + P + N L GN P+ ++ L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNNPKL 267
+ +N++ + PN+ L I++N + + G + YD +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 364 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 408
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 409 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 461
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 462 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 520
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 521 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 557
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 350 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 401
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 402 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 447
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 448 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 501 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 546
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 547 GVVLLELISGKKP 559
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 415
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 416 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 467
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 524
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 525 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 557
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
P + + LS ++ +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L +G L L+EL++ +N P +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 168 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 225
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPAL 252
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
++ + L+G ++ + +L +L L L L+ +++ +N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 220 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ LP Y +L NL+ L + +N L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 218
+ + LS + + +E L L + L L +L + + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ L +L+ L + NSF P + T
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 219
+T + LS L+ P ++ +L L + N L L+++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 220 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 249
+ S + P +L L++ N F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 172 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 230
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 231 LPNLQELHIENNSFVGEIPPAL 252
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 226
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 227 YMGSLPNLQELHIENNSFVGEIPPAL 252
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 218
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 219 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 252
++ + + L + L + N P A
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 218
+ + +S N K + +L L N + + L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 219 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 252
+ + ++ + + ++L +E P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 216
+ + LS ++ +L+ + + L L N + P + I L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 217 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 249
NN + ++ + L L+ + F E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)
Query: 162 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 216
R+ K+ L + ++ + L L D S L L + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 217 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 264
L + L N+ + + + + G + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 413
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 414 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 495
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 496 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 540 KSDVYSFGVVLLELISGK 557
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 411
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 412 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 434
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 494
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 495 NMRAKVSDFGLSR 507
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 3e-12
Identities = 100/676 (14%), Positives = 185/676 (27%), Gaps = 206/676 (30%)
Query: 17 NLEDFPANARAFAYFAEIQDLGPSETRKFKL--------EQPY--F------ADYSNAVV 60
+++D P + + I + + +L E+ F +Y +
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 61 NIAENAN---GSYTLYEPSYMNVTLNFVLSFS--FVKTRDSTLGPLLNAI-EISKYQKI- 113
I +Y + N F+ V +R L A+ E+ + +
Sbjct: 97 PIKTEQRQPSMMTRMYI-EQRDRLYNDNQVFAKYNV-SRLQPYLKLRQALLELRPAKNVL 154
Query: 114 ------AAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 167
+ KT + L+ S + + D + W +
Sbjct: 155 IDGVLGSGKT----WVALDVCL--SYKVQCKMDFK-----IFW---------------LN 188
Query: 168 LSGKNLKGEIPPELKNMEALTELW--LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 225
L N + +E L +L +D N+ D S I LRI + + L
Sbjct: 189 LKNCNSPETV------LEMLQKLLYQIDPNWT--SRSDHSSNIKLRI-----HSIQAELR 235
Query: 226 SYMGSLPNLQEL----HIEN----NSF--------------VGEIPPALLTGKVIFKYDN 263
+ S P L +++N N+F V + A T + + +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 264 NPKLHKESRRRMRFKLILGTSIGVL---AILLVLFLCSLI--VLRKLRRKISNQKSYEKA 318
E + L L + S+I +R N K
Sbjct: 296 MTLTPDEVKS--LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC- 352
Query: 319 DSLRTSTKPS-NTAYSIARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGS 372
D L T + S N F V F IP L
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLS----------------- 393
Query: 373 VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--------IHHRNLVPLIGYCEE 424
+ + + + V ++ + + L+ + I L L E
Sbjct: 394 LIWFDV---IKSDVMVVVNKLHKYS--------LVEKQPKESTISIPSIYLE-LKVKLEN 441
Query: 425 E---HQRIL-VYEYMHNGTLRDRLHGSVNQKPLD--WLTRLQIAHDAAKGLEYLH-TGCN 477
E H+ I+ Y + + LD + + I H H
Sbjct: 442 EYALHRSIVDHYNI-----PKTFDSDDLIPPYLDQYFYS--HIGH---------HLKNIE 485
Query: 478 PGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
R + LD + K+ + A + + ++Y
Sbjct: 486 HP--ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT---------LQQLKFYK-PY 533
Query: 537 LTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPVLIG 594
+ + Y L++ ++ DF E N++ S K D++ I L
Sbjct: 534 ICDNDPKYE------RLVN-----AILDFLPKIEENLI---CS--KYTDLLRI---AL-- 572
Query: 595 NVKIESIWRIAEVAIQ 610
+ E+I+ A +Q
Sbjct: 573 MAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 388 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 441
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 442 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 488
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 489 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 542
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 543 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 600
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 653
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 654 RKTLLTSFLEIESPDLSNE 672
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 217
T P + L L + P + + L + +D L LPD M + L + L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N L +LP+ + SL L+EL I + E+P L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 223
+ L ++ +P + N++ L L + + L+ P + L L + L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 224 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 267
P G L+ L +++ S + +P + LT L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 168 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 217
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 225
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPALLT 254
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 221
+ + L E+P ++ L L L N L LP ++ L LR + + ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 222 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 252
LP + S L NLQ L +E +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 223
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 224 LPSYMGSLP 232
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 207
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 208 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 214
R+ + L+ L + +L ++ L L + L+ + +L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 215 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L N L LP L+ +E N+ +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 217
+ + LS L +E L EL L N + + L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 268
N++ P ++ L L + N + L N +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
P + + L L LTEL L N + + + +L + L +N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L+ + L NLQEL + NN L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
P IT + L+ L+ LT L + N ++ P++ +L L++++L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
EL+ NL ELH+ +NS
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
++T + + + P + + L L L N L+ + +L +HL +N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ + NL L + +N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 226
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 217
I +I LS + +L L L L L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 277
N + + L L+ L +++N+ + G I+ LH + F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 278 KLILGTSIGVLAILLVLFL 296
I L L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+T++ L +++ + L L L N L+ +L +L+ + L NN
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 219 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 252
++ + + +L++L + +N P
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 215
+ K+ LS +K P + L L+L+ L L + +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 216 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 252
N++L+ + + L NL L + N+ +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)
Query: 154 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 211
T + + + L+ + + L L L N + L L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 252
++L N+ + +P+LQ L + + V P
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 211
+T + LS N+ L+ +E L L L N L GP+ + L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
I++LE+N L L+ + + N+
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 215
+ + + ++ G + L L L +F + L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N+++ L +L+ L + N E+ G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 168 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 225
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPALLTG 255
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 210
P++ L N++ L + + L L +F + L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 270
+++E+N++ G + L NL+ L + N+ F + LH
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386
Query: 271 SRRRMRFKLILGTSIGVLAILLVLFL 296
+ + + I + L L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 218
+ I L NL N +L L L N +T + +L + + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 265
+ S + + E H P G + +D +
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 172 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 231
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 232 PNLQELHIENNSFVGEIPPAL 252
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 210
+T + L ++P L ++ L L + N L D +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 211 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 252
+I ++ N L S + + L L +N A
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 11/102 (10%)
Query: 176 EIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENNELTGSLPS 226
+ + + + L+ + + N + P S+L I H E N + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 268
+ + P+L +L I +N ++ L I +NP +
Sbjct: 801 GITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)
Query: 139 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 198
N + + V R+T ++L+G KG +P + + L L + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 199 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 244
+ + + + ++ L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 218
+T I +N KN LT + L N LT L D + L L + + N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 219 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 252
+ S P+ + L+ I N + + P +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 161 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 212
++ + S LK IP K++ + + N + ++S + I+
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 213 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 256
V L NE+ + + + + NN IP L K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 218
P+I + NL+ E P L+ M L L N + L + L + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605
Query: 219 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 256
++ +P + ++ L +N IP
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 213
P ++ + +S P + N L +GN + P ++ L +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 267
+ +N++ + + P L L I +N V + P + G + YD +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 168 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 222
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 223 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)
Query: 165 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
AL GKN + N EL + G+ L + R+ L L
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 279
G +P +G L L+ L +S + + ++M
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 280 ILGTSIGVLAILLVLFLCSLIVLRKLRR 307
++ L + + ++K R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 218
+ + LS + +E L L + L L L + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L +L L + NSF +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
++ + L+G ++ P + +L L L +LI L+ +++ +N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 220 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ LP+Y +L NL + + N I L
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 168 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 225
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPALL 253
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
+ + LS ++ + L+ L L GN + P S L L + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L +G L L++L++ +N PA +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 226
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTG 255
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
P I LS LK N L L L + L L + L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ P L +L+ L +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+T + LS L+ + L L + N L ++L L + N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSF 244
+ S +L ++ NNS
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 218
+ + L + + L +L + NF+ LP S L +L V L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 219 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 255
+ + + L L + N I G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 174 KGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSYMGS 230
KG I + + +L+ L L N L+ LR + L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 231 LPNLQELHIENNSFVGEIPPALLTG 255
L LQ L ++++ +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 227
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 228 MGSLPNLQELHIENNSF 244
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 322 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 380
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 381 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 434
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 435 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 494 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 550
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 551 LELISGK 557
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 18/94 (19%), Positives = 29/94 (30%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 221
+ I L L EL L L+ + L L+ + L N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 222 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ P+L L I+ N+ E+ L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 218
+ + LS K L L L L L L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
L S LP LQ L+++ N F
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 216
P +T +++ G + E+ L+N+E L EL L + + ++ L L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
NE P L+ L + + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
P + S L + LT L L + D L + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L + + L+ L I L
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 15/84 (17%), Positives = 35/84 (41%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
R+ + LS +L +++ + + L N LT + + ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 221 TGSLPSYMGSLPNLQELHIENNSF 244
+ LPS + L + +++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
R+ + L+ L L +AL L+ ++ L ++L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
++ L+ L +NN+ + ++
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
+T + L+ + ++ L L L N L S L+ +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
++ + + L+ L++ +N P
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 226
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTG 255
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
P + + + L N + L L+L N ++ L+++ +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 219 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 255
+ M SL L++ N I P
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 215
+ + LS L + AL L L GN + + L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+L+ SL + + + +N AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 218
+ K+ LS + N +LT L + GN L + L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 219 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 255
++ S + +L +LQ L++ N + +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 215
+ G I LKN +++L + P + + + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ + + LQEL + E+P L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 7/99 (7%)
Query: 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 218
+ L+G ++ I P + L G + S + L + E+
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 219 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPALLTG 255
+ P+ L +++ ++++ + F I
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHC 276
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 217
+ + LS + + +E L L + L + + S L +L + + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ + L +L+ L + NSF P + T
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 160 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 215
P T++ L L+ +P + LT+L L N L+ L+ + L
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
N + ++ S L L+ L ++++ ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 216
++ + NLK ++ ++ L L + + + L L ++ +
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158
Query: 217 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N + + L NL L + ++ P
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 178 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 235
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 236 ELHIENNSFVGEIPPALLTG 255
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
+T + LS L+ ++ P ++ +L L + N L L L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 218 NELTGSLPSYMGSLP-NLQELHIENNSF 244
N + S + P +L L++ N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 277
+ + NL+ + N F + + KL ++
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 278 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 311
+ L F LI L++ + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ ++ LSG L +L L L L N L D+ L LR + L NN +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L P+++ LH NN+ + + G
Sbjct: 93 Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
R ++ +LK + ++ + EL L GN L+ + L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 180 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 240 ENNSFVGEIPPALLTG 255
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 225
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 226 SYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 183 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 242 NSFVGEIPP 250
N E
Sbjct: 68 NVLY-ETLD 75
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 154 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 210
+ S + + LS + + +E L L + L + + S L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423
Query: 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ + + + L +L+ L + NSF P + T
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
++ + L+G ++ + + +L +L L L + + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 218 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N + LP Y +L NL+ L + +N I L
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+ + ++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 219 ELTGSLPSYM-GSLPNLQELHIENNSF 244
+L S+P + L +LQ++ + N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 226
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 227 YMGSLPNLQELHIENNSFVGEIPPALLTG 255
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 216
P + LS L+ + + L L L + + D + L L + L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N + L +LQ+L + + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 218
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 219 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 255
++ + + L + L + N I P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
P + + LS ++ I +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L +G L L+EL++ +N P +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 216
+ ++ + N G E+ ++ +L L L N L+ S L+ + L
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 251
N + ++ S L L+ L ++++ ++
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 161 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 218
P + + LS L KG +L L L N + + L L + +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 219 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L + S SL NL L I + + G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 1/65 (1%)
Query: 178 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237
+K++ L L + N ++ + ++ L L + L NN+L +G L NL L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 238 HIENN 242
+ N
Sbjct: 317 FLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 219
++ + + + L N+ L L+L+ N L ++ L +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 220 LTGSLPSYMGSLPNLQELHIENN 242
+T P + SL + N
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
R+ + + + + P L N+ LT L + N ++ + + L L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ S + +L L L + NN E +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 162 RITKI-ALSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 210
++ + ++ +L +I P L ++ +L N +T + ++ + L
Sbjct: 166 KVKDVTPIANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD-ITPVANMTRL 223
Query: 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENN 242
+ + NN++T P + +L L L I N
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
ITK+ ++G+ + ++ + L L L+GN +T + +S L+ L +++ N++
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T S + +L NL+EL++ +
Sbjct: 101 TD--ISALQNLTNLRELYLNED 120
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T + + + L+N+ L EL+L+ + ++ + ++ L + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
S S + ++ L L + +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ ++ L+ N+ L N+ + L L N L +S + L + + +++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
P + +L +L L + N P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 179 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 239 IENNSFVGEIPPALLT 254
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 175 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 234
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 235 QELHIENNSFVGEIPPALLT 254
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++ + L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
Query: 221 T 221
Sbjct: 346 K 346
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+T + L N+ P + ++ L L+ N ++ + ++ L ++ + +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 264
+ P + +L + +L + + ++ P I N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIP 249
+ P + L L L + N P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+T + L+ + P L + LTEL L N ++ + ++ L L + L N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
S + +L NL L + N+ P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T++ L + P L + ALT L L+ N L + +S L +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ P + SL LQ L NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ ++ +S + L + L L N ++ + + L +L + L N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+ SL NL +L + NN P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T + +K ++ + LT++ N LT + + L L + + NN++
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+ + +L NL L + NN P LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ + + + P L + L EL L+GN L + ++ L +L + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIP 249
+ P + L L EL + N P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 222
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 223 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
P + +L L ++ + NN P A LT
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 222
+T+I S L I P LKN+ L ++ ++ N + + ++ L +L + L NN++T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
Query: 223 SLPSYMGSLPNLQELHIENNS 243
P + +L NL L + +N+
Sbjct: 127 IDP--LKNLTNLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ ++ LS + L + +L +L L ++ L L + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+ S + L NL+ L NN P +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 6/80 (7%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 222
+T + L + I P LKN+ L L L N ++ + +S L L+ + N +T
Sbjct: 114 LTGLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQ-VTD 169
Query: 223 SLPSYMGSLPNLQELHIENN 242
P + +L L+ L I +N
Sbjct: 170 LKP--LANLTTLERLDISSN 187
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
I ++ + P L N+ +T+L L+ T + + +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267
P+ + + E I N T +V + + +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 217
PP + L + EI KN++ L L L N ++ P + L+ L ++L
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N+L LP LQEL + N ++ ++ G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 159 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 215
PP +T++ L G + ++ LK + L +L L N ++ + + ++ LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267
NN+L +P + +Q +++ NN+ I
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 159 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 214
P + ++ + + ++ + + + L N L + + + L +
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 215 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ + +T ++P G P+L ELH++ N ++ A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 213
P + ++ L+ L ++P L + + + ++L N ++ P ++ V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 214 HLENNELT-GSLPSYM-GSLPNLQELHIENN 242
L +N + + + + + N
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
+ K+ LS ++ + L N L EL L+ N L ++ +++V+L NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 220 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 255
++ P Y + + + +N EI P+
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
PP + + +S L+ ++P EL+N L + +D N L LPD+ L + NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L LP + +LP L ++ +NNS ++P
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 157 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 213
P I L E PEL+N+ LT ++ D N L LPD+ L +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
++ +N LT LP SL L + E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 157 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 216
+ PP + + S ++ + + L EL + N L LP + L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N L +P NL++LH+E N E P
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)
Query: 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 218
PP + ++ +S L E+P L L N L +P++ +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367
Query: 219 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 252
L P S+ NL++LH+E N E P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 213
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 207
T+ + + PP EL L+ L+ LP+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90
Query: 208 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L + N LT LP SL +L + + ++PP L
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 157 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 214
P + L + E+P +N L +L ++ N L PD + DLR
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDLR--- 422
Query: 215 LENNELTGSLPSYMGSLPNLQELHIENN 242
+ + + + L++ E++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 26/128 (20%)
Query: 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI------ 212
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNSHLAE 390
Query: 213 ----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIFK 260
+H+E N L P ++++L + + V E
Sbjct: 391 VPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 261 YDNNPKLH 268
++++ H
Sbjct: 447 FEHHHHHH 454
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 217
P T + L ++ E+ + K ++ L L L N ++ S L L+ +++
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N L +P +L EL I +N ++P + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 213
P + ++ L L +P L +++ L ++L N +T P+ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 214 HLENNELT-GSLPSYM-GSLPNLQELHIENN 242
L NN + + + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 226
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 227 YM-GSLPNLQELHIENNSFVGEIPPAL 252
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
+ + L N +I + + L +L++ N L +P L + + +N
Sbjct: 78 QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134
Query: 220 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 255
+ +P + L N+ + + N P G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 204
V C T PP + T + LS L L LT+L LD LT L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73
Query: 205 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L L + L +N+L SLP +LP L L + N +P L G
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
P +T + +S L +P + + L EL+L GN L LP ++ L + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 218 NELTGSLPSYM-GSLPNLQELHIENN 242
N LT LP+ + L NL L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 181 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 240 ENNSFVGEIPP 250
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 222
+T I L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102
Query: 223 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L +L L I +++ I +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+T + +S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ P L +L+ +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
P + + +S NL L L EL++ N L LPD S L ++ + N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFV 245
L L +LQ++ + N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 218
+ + + EI + +L EL + L + + D+ + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 278
E L + L +++ L + + + + L + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 279 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 311
+L +L + V F C+L L S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 5/99 (5%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 216
+ + LS + I L+ L L L + + + L L + L
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+N L+ S+ G L +L+ L++ N + +L
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)
Query: 161 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 217
+ + L G + + N+ L L + + D + L L + ++
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L + S+ ++ L + + +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 154 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 211
+ P + + LS +L+ + L ++ LT L + N +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413
Query: 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
++L + + + + L+ L + NN+ L
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 215
++ +I + + +P +++++L L L N + S L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 216 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 252
N L S+ +L NL L I N+F +P +
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 176 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 235
++ ++ L L L N L P+ + + L NN+L + + NL+
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 236 ELHIENNSFVGEIPPALLTG 255
+ N F +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 218
P I + + N+ + + ++L N +T L D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 219 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 250
E+ + S L+ L+++ N ++
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 219
R ++ +LK + ++ + EL L GN L+ D++ L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 180 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 240 ENNSFVGEIPPALLTGK 256
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 177 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 235
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 236 ELHIENNSFVGEIPP 250
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
P + ++ L I + + L L L + +P+++ L+ L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 220 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ L +L++L + N+ V I G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+ + L +++ +I + +L L L N+LT L LR + L NN
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 219 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ S+PSY +P+L L + + I G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 215
+ ++ +SG + EI P + +L +LW+ + ++ ++ L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273
Query: 216 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 245
+N L+ SLP + L L ELH+ +N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 179 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 236
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 237 LHIENNSFVGEIPPALLTG 255
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+T + LS L+ +PP L + L L N L + ++ L L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 221 TGSLPS--YMGSLPNLQELHIENN 242
+ + S P L L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 156 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 215
+ + L+ K+L + L+ + +T L L N L P ++ L L ++
Sbjct: 436 LKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA 493
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENN 242
+N L ++ + +LP LQEL + NN
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 179 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 232
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 233 NLQEL 237
++ +
Sbjct: 561 SVSSI 565
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
P + ++ L I + + L L L L +P+++ LI L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 220 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
L+ ++ L +LQ+L + + I
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
+ + LS +++ I + L L L N LT +P+ L L+ + L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N + S+PSY +P+L+ L + + I G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
++ ++ LSG +L I P + + L +LW+ + + + L L ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 219 ELTGSLPSYM-GSLPNLQELHIENNSFV 245
LT LP + L +L+ +H+ +N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 216
+ + L L IP + L ELWL N + +P +R+ LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169
Query: 217 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 249
L+ + L NL+ L++ + EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 179 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 233
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 234 LQELHIENNSFVGEIPPALLTG 255
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 217
+ + LS + I L+ L L L N + D S L L + L
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 267
N L+ +L S L +L L++ N + + LT I + N
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 239
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 240 ENNSF 244
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLEN 217
+ + LS L + K + +LT L L GN G S L L+I+ + N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ + L L+EL I+ + P L
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
+TK+ +S + + + +++ L L + N L + S L L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
LT S+P+ L L L + + + I
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 160 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 216
P + L +K + + + L EL L+ N ++ + + L +LR + L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88
Query: 217 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+N L +P + L NL +L I N V + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+ ++ L NL IP E L ++ L L L + RL L+++ + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
++ NL L I + + +P +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 215
+ + LS + I L + L E+ L G L ++ L R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303
Query: 216 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 245
N+LT +L + S+ NL+ L +++N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 218
+T ++++ NL +P ++++ L L L N ++ M L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 219 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+L + Y L L+ L++ N + ++
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 156 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 215
S +T + ++ ++ ++ + LT+L N +T D+S+ +L +
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 265
++N+LT +L + L L L+ + N ++ + N
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ ++ N+ ++ L LT L N LT D++ L L N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267
T L + +L L LH + EI T + F+ + K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T++ ++ LT L N +T D+S+ L ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T L + L L +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 227
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 228 MGSLPNLQELHIENN 242
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++ + + E+ L L L+L+ LT L D+S L+ + N +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
S +G +P L + +P LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
+T ++T + +L EI L + L +G L D++ L ++ +
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
+T L + P L L++ N E+ + T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T + L ++ + LT L N LT D+S L + N+
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160
Query: 221 TGSLPSYMGSLPNLQELHIENNSF 244
L + L L N
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 7e-08
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 143 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 191
D C P + C+ + + T++ + + + L+ + L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 192 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 245
+ + L PD L ++L N L SL +LQEL + N
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 176 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 232
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 233 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 265
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 159 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
TP + ++ L K+ G+I L L L L + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 218 NELTGSLPSYMGSLPNLQELHIENN 242
N + G L LPNL L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
R+ ++ +S L + + + L L L N L + + L ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 221 TGSLPSYMGSLPNLQELHIENNSF 244
+L + + L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
I K+ + ++ +PP + +N+ LT L L+ N L+ LP L + + N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N L + + +LQ L + +N + +L+
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 159 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 216
T + ++ ++P L + + L L+ + + ++ +++
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 217 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N + LP ++ ++P L L +E N +P +
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
++ + L+ ++ EI + +L++ N + LP + L ++ LE
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N+L+ SLP + + P L L + NN+ I
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
P + ++ S ++ + + LT L L N LT + L V L NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265
Query: 220 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 252
L + + + L+ L+I NN V +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSF 244
N LT + +P+L ++ N
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N LT + + P L E+ + N +I
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 179 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 235
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 236 ELHIENNSFVGEIPPALLTG 255
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 159 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
TP + ++ L ++ +G++ E L L LT + ++ +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 218 NELTGSLPSYMGSLPNLQELHIENN 242
N ++G L PNL L++ N
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 218
++ K+ LS + G + + LT L L GN + + + +L +L+ + L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 219 ELTGSLPSY----MGSLPNLQEL 237
E+T +L Y LP L L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 160 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 215
P + LS NL + E + L L L N L + + +LR + L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95
Query: 216 ENNELTGSLPSYM-GSLPNLQELHIENN 242
+N L +L ++ L L+ L + NN
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 35/174 (20%), Positives = 60/174 (34%), Gaps = 25/174 (14%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
+ + LS +L I E + L L L N L L + S L L ++ L N
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYN 121
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMR 276
N + + + LQ+L++ N P L+ + PKL +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNK 174
Query: 277 FKLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 318
K + T + L + L C L L R++S+ +++
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
R+ + L L+ E+ P + + AL L+L N L LPD L +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N ++ S+P L +L L + N + P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 176 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 231
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 232 PNLQELHIENNSFVGEIPPALLTG 255
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 154 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 212
C + + L+ +P + A ++L GN ++ P +L I
Sbjct: 7 VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 213 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ L +N L + + L L++L + +N+ + + PA G
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
+T + L G + +P + + +L L L N + + L L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 218 NELTGSLPSY-MGSLPNLQELHIENNSFV 245
N L+ +LP+ + L LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 217
+ ++ ++P L + + L L+ + + + ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
N + LP ++ ++P L L +E N +P +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 219
+T + L NL L N L E+ L N L ++ L +++ NN
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 220 LTGSLPSYMGSLPNLQELHIENN 242
L +L Y +P L+ L + +N
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 217
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSF 244
N LT + +P+L ++ N
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N LT + + P L E+ + N +I
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
P + + LS +L + + L L+LD N + L +S L+ + L +N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
+ S N+ +++ +I L G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 154 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 197
TCS P IT+I L +K IPP + L + L N +
Sbjct: 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 198 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
+ L L L + L N++T LP + L +LQ L + N
Sbjct: 69 SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 164 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 220
+ L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 221 TGSLPSYMGSLPNLQELHIENNSF 244
L +Q +H+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 157 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 216
P + K+ + G L +P L EL + N L LP + +L +
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
NN+LT SLP LQEL + +N +P
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 223
+ + L +P L +T L + N LT LP +LR + + N+LT S
Sbjct: 43 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95
Query: 224 LPSYMGSLPNLQELHIENNSFVGEIPPAL 252
LP L L +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 158 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 217
T P + K+ L +P L EL + GN LT LP + +L+ + +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVL--PSELKELMVSG 250
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
N LT SLP L L + N +P +L
Sbjct: 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 202
PP + + +SG L +P + L +LW+ GN LT LP
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137
Query: 203 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
L+ + + +N+L SLP+ L +L NN +P
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 363 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 414
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 415 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 466
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 507
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 508 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 557
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)
Query: 150 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 199
V CS P I ++ L+ + K + L ++ N +T
Sbjct: 13 GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 200 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
+ + + + L +N L ++ M L +L+ L + +N
Sbjct: 72 -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 164 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 221
+I L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 222 GSLPSYMG---SLPNLQELHIENNSF 244
++ G +L +L L++ N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 217
+ T + +S + ++ ++ L L + N + L +L + L +
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78
Query: 218 NELTGSLPSYMGSLPNLQELHIENNSF 244
N+L + NL+ L + N+F
Sbjct: 79 NKLV-KISC--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 215
+ S L + ++ L L L N L L ++ + L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381
Query: 216 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 254
N ++ +L L++ +N I L
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
+ + +S L I L + L L N + + +L L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455
Query: 220 LTGSLPSYM-GSLPNLQELHIENNSF 244
L S+P + L +LQ++ + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 187 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 243
L L L N LP + L+ + L L S + L + L + +
Sbjct: 92 LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 244 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 303
+ + P L + N LH F IL S+ +A L + + ++
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 304 KLRRKISNQKSYEKADSLRTST 325
K +S + L T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ + + L LQ L++ N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 181 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 241 NN 242
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
Query: 221 TGSLPSYMGSLPNLQELHIENNSFV 245
++ +L + + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
I +I + ++K + ++ + +T+L+L+GN LT + ++ L +L + L+ N++
Sbjct: 46 NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
L S + L L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 68 PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ + + LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 226
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 227 YM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 160 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 213
P + ++ L L+ EL + + L L+L+ N+L P + S L LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 265
L +N LT L NL+ L I N + P + + +N
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 216
P + + L + + P+ + + L EL L L+ + L L + L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 217 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
N++ L G L +L+ + +N + L
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)
Query: 163 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 220
+ + LS + + + ++ L L L N + + L +L++++L N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 221 TGSLPSYM-GSLPNLQELHIENNSF 244
L S LP + + ++ N
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 161 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 212
P + + L+ + +L +L+L N L L L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 213 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 255
++L +N L P L L+ L + +N + L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 22/146 (15%), Positives = 44/146 (30%), Gaps = 10/146 (6%)
Query: 168 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 223
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 224 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 281
+ L L + NS + F+ N L + + +
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR---NMVLEILDVSGNGWTVDI 220
Query: 282 -GTSIGVLAILLVLFLCSLIVLRKLR 306
G ++ L +
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAG 246
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 218
+ + L+ + +I E ++ L L L N L + L + + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSF 244
+ L LQ L + +N+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ + L + I P L + L L + ++ L ++ L L + ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 265
+ + + SLPNL E+H++NN P A + I N
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ +++ + ++ P L N+ LT L D N ++ + ++ L +L VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 266
+ + + + NL + + N + P V+ P
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
I + L+ ++ P L + L L+LD N +T + ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ L + +L L L ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
IT ++ G + I ++ + L L L N +T L + L + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
++ + + L +++ L + + + ++ P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ + L + ++ P LKN+ +TEL L GN L + ++ L ++ + L + ++
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T + + L NLQ L+++ N
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
KIA N+ + +++ +T L G +T + + L +L + L++N++
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T L + +L + EL + N
Sbjct: 76 T-DLAP-LKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++T + + +I P L ++ L E+ L N ++ + ++ +L IV L N +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 263
T + P + NL ++ I PA ++ + N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 416
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 417 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 468
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 503
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 504 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 556
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 557 K 557
Sbjct: 256 S 256
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 156 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 214
++ + LS +L+ L L L L + L ++
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280
Query: 215 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 246
L N L PS LP + L ++ N F+
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 211
P + ++++ + +++ AL+ L L N G L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250
+ + +G + + LQ L + +NS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 143 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 202
+PC + P + E+ +++E L +D G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 203 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALL 253
D+ + + L+ + + + + + LQEL +EN G PP LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)
Query: 161 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 213
+ ++ L + G PP L L L L ++ L L+++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
+ + P L L + +N +GE
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)
Query: 143 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 201
DP CS + L ++P + + + L N +
Sbjct: 2 DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47
Query: 202 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
SRL DL+ + +E + + L +L L ++ N F+ ++ G
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 217
+ ++ L+ + +I + L +L L NFL + L L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 218 NELTGSLPSYM-GSLPNLQELHIENN 242
N + +L LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 164 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 220
K+ LS L I + +N++ L L L N + L D S L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 221 TGSLPSYM-GSLPNLQELHIENNSF 244
S+P + L +LQ++ + N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 216
+ + L ++ + L L L L G L L L ++ L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 217 NNELTGSLPSYM-GSLPNLQELHIENN 242
+N + P+ ++ L + N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ + G L LQ L++ N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
+ + L +K ++ LK+++ L L L+ N ++ + + L L ++L NN++
Sbjct: 87 KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T + + L L L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
K L K++ + + ++ ++ + + + + + L ++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
T + + +L NL L ++ N
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
P++ + L + +I L + L L L+ N ++ + ++ L L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ L + L NL L + + + +
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 220
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 65 PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121
Query: 221 TGSLPSYMGSLPNLQELHIENN 242
+ + + + LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 217
P I++I +S ++ N+ +T + + LT PD L L+ + + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 218 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 255
L P + + S L I +N ++ IP G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 154 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 209
C ++ K+++ +PP L L L +P S L +
Sbjct: 9 ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56
Query: 210 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ +++ + L L S+ +L + + I N + I P L
Sbjct: 57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 363 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 414
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 415 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 466
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 507
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 508 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 557
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)
Query: 157 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 213
T P I L +P + L L + N LT LP++ L +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185
Query: 214 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 253
+ N L SLP+ + +E N IP +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 157 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 211
+ +++ L+ NL +P L +T L + N L LP++ L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103
Query: 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252
+ +N L+ +LP +L+ L ++NN +P
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 164 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 220
+ L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121
Query: 221 TGSLPSYM-GSLPNLQELHIENN 242
SLP + SL L L + N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 203
V CS T P I K+ L L +P + + L L+L+ N L LP
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78
Query: 204 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)
Query: 154 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 208
+C+ + S K L IP + +L L N L+ LP RL
Sbjct: 13 SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61
Query: 209 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
LR+++L +N+L +LP+ + L NL+ L + +N +P +
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 217
++ + L+G ++ + + +L +L L L + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 218 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 255
N + S Y +L NL+ L + +N I L
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)
Query: 143 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 186
+PCV T P + LS L+ + +
Sbjct: 1 EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53
Query: 187 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
L L L + + D L L + L N + SL L +LQ+L
Sbjct: 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 188 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 203
V CS P I T++ L G +P EL N + LT + L N ++ L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 204 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 242
S + L + L N L +P L +L+ L + N
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 203
V C + P I K+ L L + + LT L LD N L L
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 204 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 242
L +L + L NN+L SLP G L L +L++ N
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 23/62 (37%), Positives = 31/62 (50%), Gaps = 9/62 (14%)
Query: 186 ALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIE 240
L +L+L GN L LP RL L+ + L N+L S+P+ G L NLQ L +
Sbjct: 108 QLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFDKLTNLQTLSLS 163
Query: 241 NN 242
N
Sbjct: 164 TN 165
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
R ++ L G + I ++ + N + L L L+ + + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 220 LTGSLPSYMGSLPNLQELHIENN 242
+ +LP+L EL + NN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNN 98
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 160 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 216
PPR ++LS ++ E+ ++ + L L L N + L DL + +
Sbjct: 51 PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 217 NNELTGSLPSYMGSLPNLQELHIENNSF 244
+N L ++ + +L+ L + N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 226
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 227 YMGSLPNLQELHIENNS 243
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 155 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 214
+ I + LS L G + L + L L N + D++ L L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 215 LENNELTGSLP-SYMGSLPNLQELHIENNSF 244
+ +N+L S+P L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 226
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 227 YMG---SLPNLQELHIENNSFVGEIPPALLT 254
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 161 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 217
+ KI +S ++ I + N+ L E+ + N L P+ L +L+ + + N
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 218 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 255
+ LP L I++N + I G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 203
V C T+ P I T + L +LK + +LT+L+L GN L LP+
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70
Query: 204 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 242
++L L ++L N+L SLP+ G L L+EL + N
Sbjct: 71 VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 204
+T S P K L K++ + + + ++ ++ + + + + +
Sbjct: 3 ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59
Query: 205 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244
L ++R + L N+L + + L NL L + N
Sbjct: 60 QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 163 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 221
I +I + ++K L N + L L GN L + + L +L + L N+L
Sbjct: 43 IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98
Query: 222 GSLPS-YMGSLPNLQELHIENNS 243
SLP+ L NL+EL + N
Sbjct: 99 -SLPNGVFDKLTNLKELVLVENQ 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 187 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 241
L EL L N L LPD +L +L ++L +N+L SLP G L NL EL +
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166
Query: 242 N 242
N
Sbjct: 167 N 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 9/61 (14%)
Query: 187 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 241
LT L L GN L LP+ +L +L+ + L N+L SLP G L NL L++ +
Sbjct: 87 LTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPD--GVFDKLTNLTYLNLAH 142
Query: 242 N 242
N
Sbjct: 143 N 143
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 153 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 203
V C + P I + L + P ++ L EL+L N L LP
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 204 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 242
L L ++ L N+LT LPS L +L+EL + N
Sbjct: 83 VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 187 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242
LT L L N LT LP RL+ L+ + + N+LT LP + L +L L ++ N
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 13/111 (11%), Positives = 35/111 (31%), Gaps = 9/111 (8%)
Query: 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYC 422
K +G + Y + + + + +K+ T E ++ + + VP ++ +
Sbjct: 20 KDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79
Query: 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ L+ + D + +I A+ + H
Sbjct: 80 RHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECIRLFH 122
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.71 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.55 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.5 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.41 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.4 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.37 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.36 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.35 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.34 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.34 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.33 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.33 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.32 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.29 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.28 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.27 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.27 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.21 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.2 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.2 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.19 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.18 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.17 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.13 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.13 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.11 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.1 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.1 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.1 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.1 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.08 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.08 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.07 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.06 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.06 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.05 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.05 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.05 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.05 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.03 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.03 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.02 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.01 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.01 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.99 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.97 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.96 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.95 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.93 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.91 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.85 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.77 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.76 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.75 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.74 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.72 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.7 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.7 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.67 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.67 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.67 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.66 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.64 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.62 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.53 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.51 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.3 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.24 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 97.62 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.59 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.44 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.37 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.88 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.69 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.39 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.33 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 93.05 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.14 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 91.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 90.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.32 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 89.82 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 87.72 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.53 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.37 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=439.03 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=209.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
..+.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34566789999999999999875 478999999987766777889999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcE
Q 005750 431 VYEYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 498 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 498 (679)
|||||++|+|.++++... ...++++.+++.|+.||++||+|||+ ++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997542 23469999999999999999999999 999999999999999999999
Q ss_pred EEeeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 005750 499 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 576 (679)
Q Consensus 499 kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 576 (679)
||+|||+|+...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHH--
Confidence 999999998764432 223344569999999999999999999999999999999999 8999974322 122222
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+..+... ..+...+..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 273 --i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 --ITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2222211 11223345788999999999999999999999999988763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=436.73 Aligned_cols=263 Identities=27% Similarity=0.458 Sum_probs=216.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
|....+.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 33445667899999999999999864 478899999987766777889999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc
Q 005750 428 RILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 497 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 497 (679)
.++|||||++|+|.++|+... ....+++.+++.|+.||++||+|||+ ++|+||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCc
Confidence 999999999999999997531 24579999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 005750 498 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 575 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 575 (679)
+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~-- 241 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE-- 241 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH--
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--
Confidence 99999999987544322 22333458999999999999999999999999999999999 8999974322 12222
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+..+.... .+...+.++.+|+.+||+.||++|||++||++.|+++...
T Consensus 242 --~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 --CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222222211 1223345788999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=436.20 Aligned_cols=265 Identities=24% Similarity=0.409 Sum_probs=216.5
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
+.++...+++|.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 33455566788999999999999999863 468999999975433 34578999999999999999999999999
Q ss_pred ccceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCc
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 490 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 490 (679)
+++..++|||||++|+|.++|.... ....+++..++.|+.|||+||+|||+ ++|+||||||+||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NI 176 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNV 176 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccce
Confidence 9999999999999999999996432 12468999999999999999999999 9999999999999
Q ss_pred cccCCCcEEEeeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccch
Q 005750 491 LLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 568 (679)
Q Consensus 491 ll~~~~~~kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~ 568 (679)
|+++++.+||+|||+++...... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--- 253 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 253 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999998764332 223344568999999999999999999999999999999998 8999974332
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+.+. +..+.... .+...+..+.+|+.+||+.||++||||+||++.|+....
T Consensus 254 ~~~~~~----i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 254 QDVVEM----IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHHH----HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222222 22232211 122344578899999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=423.71 Aligned_cols=258 Identities=31% Similarity=0.511 Sum_probs=203.5
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.+.+.++||+|+||+||+|++++ .||||+++.. .....+.|.+|++++++++|||||+++|++.+ +..++|||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 34678999999999999998763 5999998643 33456789999999999999999999999865 4689999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-c
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~-~ 514 (679)
++|+|.++++.. ...+++.+++.|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 114 ~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 114 EGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp SSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999743 4579999999999999999999999 999999999999999999999999999998754322 2
Q ss_pred cccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 515 HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ..+.. .+..+.. .|.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~----~~~~~~~----~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIF----MVGRGYA----SPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHH----HHHTTCC----CCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHH----HHhcCCC----CCC
Confidence 22344579999999999854 46899999999999999999999999743221 11111 2222211 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
+ .......+..+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 12223345578999999999999999999999999987754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=427.77 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.++||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4788899999999999999876 6999999999754 234567899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
|+||+|.+++... ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999743 34568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+. .+....... +.... .
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~~~-----~-- 245 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-GSFPP-----V-- 245 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCCCC-----C--
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCCCC-----C--
Confidence 22345699999999999999999999999999999999999999974332 122222222 22211 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+......+.+||.+||+.||++|||++|+++
T Consensus 246 --~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 --SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=425.51 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=207.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3667789999999999999986 699999999976555556678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
||+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 155 gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 155 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence 9999999973 469999999999999999999999 99999999999999999999999999999876554332
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. ..... +..+.... + ..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~----i~~~~~~~-----~--~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----IRDNLPPR-----L--KN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSSCCC-----C--SC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH----HHcCCCCC-----C--Cc
Confidence 34457999999999999999999999999999999999999999743221 12221 11111111 0 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+|+.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122347889999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=423.12 Aligned_cols=260 Identities=24% Similarity=0.271 Sum_probs=209.2
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
+.+.++||+|+||.||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 456788999999999999986 699999999975422 24699999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccccCccc-
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 515 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~~~~~- 515 (679)
|+|.++++. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999974 4579999999999999999999999 9999999999999999887 6999999999876543221
Q ss_pred ---ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 516 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 516 ---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||......... .. ... +...
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~----i~~-~~~~------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--LK----IAS-EPPP------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--HH----HHH-SCCG-------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HH----HHc-CCCC-------
Confidence 123356999999999999999999999999999999999999999754332211 11 111 1110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcCCCCcc
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF 643 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~ 643 (679)
....+......+.+++.+||+.||.+|||++|+++.|...+.....-.-+|
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 001122334578899999999999999999999999988877544443344
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=409.48 Aligned_cols=244 Identities=29% Similarity=0.438 Sum_probs=197.7
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc----cceEEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 432 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV~ 432 (679)
+|.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||+++++|.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999876 6899999998643 23455779999999999999999999999864 45689999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCcccc-CCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~ 509 (679)
|||+||+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999984 4679999999999999999999998 77 99999999999998 4799999999999864
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||..... ...+ ...+..+.....++
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~----~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQI----YRRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHH----HHHHTTTCCCGGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHH----HHHHHcCCCCCCCC
Confidence 432 2334579999999999876 599999999999999999999999963322 1111 12222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+ ....++.+++.+||+.||++|||++|+++
T Consensus 253 ~--------~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 K--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11236889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=418.41 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=206.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788999999999999999876 69999999997532 2345679999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999984 4679999999999999999999999 999999999999999999999999999998765432
Q ss_pred -ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 -~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. .+. .... .+.. .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~---~~i~-~~~~------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIF---AKII-KLEY------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-HTCC------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-cCCC------CC
Confidence 22344567999999999999999999999999999999999999999743321 111 1111 2221 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 626 (679)
...+ ..++.+|+.+||+.||++|||++|++
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1122 34688999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=426.93 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=207.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3667889999999999999986 699999999976555556778999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
||+|.++++. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+........
T Consensus 232 gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 232 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred CCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence 9999999973 459999999999999999999999 99999999999999999999999999999876554332
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... ..... +..+.... +. .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~----i~~~~~~~-----~~--~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----IRDNLPPR-----LK--N 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSCCCC-----CS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH----HHcCCCCC-----Cc--c
Confidence 33457999999999999999999999999999999999999999743221 11221 11111111 10 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+||.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122346889999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=421.95 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=215.1
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCcc-hhHHHHHHHHHHHHhccC-CCcccccccccc-
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEE- 424 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~- 424 (679)
+....+++.+.||+|+||.||+|.+.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 444567889999999999999998753 36899999976543 445779999999999965 999999999866
Q ss_pred cceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
++..++|||||++|+|.++|+... ....+++..++.++.|||+||+|||+ ++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 456899999999999999997532 13458999999999999999999999 99999999999999
Q ss_pred ccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchh
Q 005750 492 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 569 (679)
Q Consensus 492 l~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~ 569 (679)
+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999876543322 2334568999999999999999999999999999999998 999997433221
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
.+ ...+..+.... .+...+.++.+++.+||+.||++|||++||++.|+++++..
T Consensus 296 ~~----~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 EF----CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HH----HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH----HHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 12 22233332211 11223457889999999999999999999999999988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=403.53 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=191.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||+||+|+.. +|+.||+|++.+.. ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5788899999999999999876 69999999997542 2335679999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6899999873 5679999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
......||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...+.. .+.+ .+..+.. .+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~----~i~~~~~------~~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK----NISNGVY------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC------CC
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC------CC
Confidence 2234569999999999988776 58999999999999999999999743221 1111 1222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ....+.+++.+||+.||++|||++|+++
T Consensus 232 p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 2346789999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=408.78 Aligned_cols=267 Identities=25% Similarity=0.383 Sum_probs=201.1
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc----eEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lV~E~ 434 (679)
+.+.++||+|+||+||+|+++ |+.||||++.... .....+..|+..+.+++|||||++++++.+++ ..++||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456789999999999999985 8999999996432 22223345666677889999999999997653 57999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
|++|+|.++++. ..+++..+.+++.|++.||+|||+. ...+|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999973 4689999999999999999999972 1239999999999999999999999999999876
Q ss_pred ccCccc---ccccccCCccccCCcccCCC------CCCchhHHHHHHHHHHHHHhCCCCCCcccccc---------hhhH
Q 005750 510 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGA---------ELNI 571 (679)
Q Consensus 510 ~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvll~elltG~~pf~~~~~~~---------~~~~ 571 (679)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12235699999999998764 46789999999999999999988775322110 0111
Q ss_pred HHHHHHhHhcCCeeeeecccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
.+ ....+..+. ++|.+... ...+.+..+.+|+.+||+.||++||||+||++.|+++.+.+
T Consensus 239 ~~-~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EE-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HH-HHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HH-HHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 11 222221111 12222111 12356678999999999999999999999999999887643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=409.93 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=195.5
Q ss_pred HHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
.|++.+.||+|+||+||+|+.. +++.||||++++.. ......+.+|+++|++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5788999999999999999863 47899999997542 22344688899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
||||+||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999984 4679999999999999999999999 9999999999999999999999999999986543
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. .. ..... .+.. .
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~-~~~~------~ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ET---MTMIL-KAKL------G 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHH-HCCC------C
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HH---HHHHH-cCCC------C
Confidence 322 223457999999999999999999999999999999999999999743321 11 11112 1211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 627 (679)
. +......+.+++.+||+.||++|||+ +|+++
T Consensus 245 ~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 M----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11223468899999999999999985 56553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=397.12 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=189.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc---------
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------- 426 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--------- 426 (679)
.|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4677899999999999999976 69999999986543 344577999999999999999999999986543
Q ss_pred ---eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeec
Q 005750 427 ---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 503 (679)
Q Consensus 427 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 503 (679)
..|+|||||++|+|.+++.........++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 478999999999999999854333445677788999999999999999 99999999999999999999999999
Q ss_pred cCccccccCccc-----------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHH
Q 005750 504 GLSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572 (679)
Q Consensus 504 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~ 572 (679)
|+|+........ .....+||+.|||||++.+..++.++|||||||++|||++ ||.... ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999876543221 1123469999999999999999999999999999999996 775211 111
Q ss_pred HHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 573 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... .+........ .......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~-~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLT-DVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1122221111 1122335678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=397.71 Aligned_cols=261 Identities=20% Similarity=0.308 Sum_probs=200.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccc------ccceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE------EEHQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~------~~~~~ 428 (679)
.|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++. +.+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4778899999999999999886 79999999997543 334567889999999999999999999865 34678
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
|+|||||+ |+|.+++. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999995 68999997 45689999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCc---ccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 509 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 509 ~~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+. ...+.........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCh
Confidence 64322 1223446799999999998775 569999999999999999999999985443221 1111111110000
Q ss_pred ee--eec--------ccccC--CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 585 IS--IVD--------PVLIG--NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 585 ~~--~~d--------~~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. .+. ..+.. ..+ ......+.+|+.+||+.||.+|||++|+++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 00000 000 0112467899999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=382.17 Aligned_cols=277 Identities=41% Similarity=0.716 Sum_probs=241.9
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
.|++.+.||+|+||.||+|++++++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 34557899999999999999888999999998876666778899999999999999999999999999999999999999
Q ss_pred CcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-cc
Q 005750 438 GTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 515 (679)
Q Consensus 438 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~-~~ 515 (679)
|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....... ..
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999997543 23468999999999999999999999 999999999999999999999999999998654322 22
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.............|.......+.....+++.+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 22334589999999999888999999999999999999999999986555555566777766667777777888888777
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
........+.+++.+||+.||++|||++||++.|+.+....+
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 888899999999999999999999999999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=383.56 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=167.4
Q ss_pred HHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.++||+|+||+||+|+.+ +++.||+|++.+.. ...++.+|+++|+.+ +||||+++++++.+.++.|+||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4778899999999999999864 46889999986543 345678999999998 6999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCcccccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 511 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~~~~ 511 (679)
||+++|+|.+++. .+++.++..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999984 38899999999999999999999 999999999999999876 8999999999976543
Q ss_pred Cccc---------------------------ccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCc
Q 005750 512 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSV 562 (679)
Q Consensus 512 ~~~~---------------------------~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~ 562 (679)
.... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2111 11234699999999998775 589999999999999999999999963
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=381.02 Aligned_cols=288 Identities=39% Similarity=0.698 Sum_probs=242.0
Q ss_pred CChhHHHHHH--HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCccccccccccc
Q 005750 349 IPLPELEEAT--NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 425 (679)
Q Consensus 349 ~~~~~l~~~~--~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 425 (679)
+++.++.... |.+.+.||+|+||.||+|+.++++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 4455555544 445789999999999999988899999999876432 2234689999999999999999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998654 34469999999999999999999999222299999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc--cchhhHHHHHHHhHhcC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKG 582 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~ 582 (679)
++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......+|+.......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9987765544445555699999999999888899999999999999999999999963221 13345677777777777
Q ss_pred CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 583 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
......+..+...........+.+++.+||+.||.+|||++||++.|++....+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 777788888888888899999999999999999999999999999999755443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=403.17 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=208.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4778899999999999999886 699999999987666667889999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC--CcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~Dfgla~~~~~~~~ 514 (679)
||+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 238 gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999864 24579999999999999999999999 999999999999999854 8999999999998754332
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+... . ... +...... +.+....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~---~~~-i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---T---LRN-VKSCDWN--MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHH-HHTTCCC--CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHH-HHhCCCC--CCccccc
Confidence 234569999999999999999999999999999999999999997443221 1 111 1111110 1111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ...+.+||.+||+.||.+|||++|+++
T Consensus 382 ~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 346789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=399.30 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=197.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHH---HHHHHHhccCCCcccccccccccceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ......+.+ ++.+++.++|||||+++++|.+.+..|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 566789999999999999887 69999999996432 112223333 45666777899999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
||||+||+|.+++.. ...+++..++.++.||+.||+|||+ +|||||||||+|||++.+|++||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999984 4679999999999999999999999 9999999999999999999999999999987654
Q ss_pred CcccccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.. ....+||+.|+|||++. +..|+.++||||+||++|||++|+.||.+........+.. ... ....
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~-~~~~------ 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL-TMAV------ 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHH-HCCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhc-CCCC------
Confidence 33 23457999999999996 4579999999999999999999999997443332222221 111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.. +......+.+||.+||+.||.+|++ ++||++
T Consensus 412 ~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 1122346889999999999999998 677764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.15 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=214.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
...|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 345667899999999999999886 6899999998776667778899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999753 4679999999999999999999999 9999999999999999999999999999987644322
Q ss_pred cc-------------cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch---hhHHHHHHHh
Q 005750 515 HI-------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSM 578 (679)
Q Consensus 515 ~~-------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~---~~~~~~~~~~ 578 (679)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 11 1134689999999999999999999999999999999999999874322211 111111111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.. +...+..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 243 ------------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 ------------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ------------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 11122358899999999999999999999999999877543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.74 Aligned_cols=262 Identities=34% Similarity=0.511 Sum_probs=204.3
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
....|++.+.||+|+||+||+|++. |+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3456778899999999999999874 8899999987543 334567899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||+++|+|.+++........+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.+||+|||++....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999853322349999999999999999999998 88 9999999999999999999999999997654
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+. ......
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~---~~~~~~----- 258 (309)
T 3p86_A 191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVG---FKCKRL----- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHH---HSCCCC-----
T ss_pred cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hcCCCC-----
Confidence 3322 123345899999999999999999999999999999999999999743221 1111111 111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+......+.+++.+||+.+|.+|||++|+++.|+.+....
T Consensus 259 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 ----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111222346889999999999999999999999999988753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=368.47 Aligned_cols=264 Identities=24% Similarity=0.452 Sum_probs=214.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
...|.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 355677899999999999999863 356799999976533 3457899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 492 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 492 (679)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997542 12458999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 005750 493 DINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 570 (679)
Q Consensus 493 ~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~ 570 (679)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544322 12223346789999999999999999999999999999999 999997443321
Q ss_pred HHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 571 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
+... +..+... ..+......+.+++.+||+.+|.+|||++|+++.|+++......
T Consensus 314 ~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHH----HHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 2221 2222111 11222345788999999999999999999999999999886543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.51 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=212.6
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..|++.+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 45677899999999999999998899999999976533 34678999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999742 4568999999999999999999999 999999999999999999999999999998765443333
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .... . +..+.. . .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~---~-~~~~~~-----~----~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---D-ISTGFR-----L----Y 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCC-----C----C
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---H-HhcCcc-----C----C
Confidence 334456788999999998899999999999999999999 99999743221 1111 1 111110 0 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+......+.+++.+||+.+|.+|||++|+++.|+++..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111123468899999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.54 Aligned_cols=264 Identities=26% Similarity=0.485 Sum_probs=213.2
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
++....|++.+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 445567788899999999999999885 3556999999765 33455789999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999642 4579999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 508 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 508 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... ..... +..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS----VEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH----HHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCCC
Confidence 76543222 1222335778999999998899999999999999999999 99999733221 11111 111111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
...+......+.+++.+||+.||.+|||++||++.|+.+....+
T Consensus 273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11122234578899999999999999999999999999987544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=356.58 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=205.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||+||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4667789999999999999864 689999999876555556788999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++.. ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999973 358999999999999999999999 99999999999999999999999999999876543332
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......+.. .. ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~-~~-------~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL-------QN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC-------SC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC-CC-------CC
Confidence 2344689999999999999999999999999999999999999974322111 1111111111 00 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+......+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223346889999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.02 Aligned_cols=259 Identities=28% Similarity=0.455 Sum_probs=213.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....|++.+.||+|+||.||+|.++++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3456778899999999999999999888999999975433 346789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999753 3468999999999999999999999 9999999999999999999999999999987655443
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... .. .. +..+.. ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~~~~~~--~~~---- 226 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV---LK-VSQGHR--LYR---- 226 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HH-HHTTCC--CCC----
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH---HH-HHcCCC--CCC----
Confidence 33334456778999999988889999999999999999999 999997433211 11 11 111111 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+......+.+++.+||+.+|.+|||++|+++.|+.+...
T Consensus 227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111234688999999999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.12 Aligned_cols=279 Identities=37% Similarity=0.591 Sum_probs=225.8
Q ss_pred cCChhHHHHHHHhhc--------cccCcCccEEEEEEEEcCCcEEEEEEecCCc----chhHHHHHHHHHHHHhccCCCc
Q 005750 348 FIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNL 415 (679)
Q Consensus 348 ~~~~~~l~~~~~~~~--------~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnI 415 (679)
.+++.++...+.+|. +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 456889999988885 5699999999999987 58899999986532 3345789999999999999999
Q ss_pred ccccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC
Q 005750 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 495 (679)
Q Consensus 416 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 495 (679)
+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+ ++|+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999999765456679999999999999999999999 999999999999999999
Q ss_pred CcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 005750 496 MRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 496 ~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 574 (679)
+.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~ 246 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDI 246 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHH
Confidence 99999999999875543221 2233468999999999876 578999999999999999999999974433221 1111
Q ss_pred HHHhHh-cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 575 ARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 575 ~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
...... ...+...+++.+ ..........+.+++.+||+.+|.+|||++||++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111 112233344333 34456777889999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=352.71 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=211.7
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....|++.+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3456778899999999999999999889999999976533 346789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999753 3569999999999999999999999 9999999999999999999999999999987654433
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...+. +..+.. .
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~--- 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEH----IAQGLR-----L--- 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH----HHTTCC-----C---
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHH----HhcccC-----C---
Confidence 33333446788999999998889999999999999999998 99999743321 11111 111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+......+.+++.+||+.+|.+|||++|+++.|+++...+
T Consensus 241 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 241 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 011112346889999999999999999999999999988653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.68 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=209.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45778899999999999999876 6899999998543 2334577899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999974 4579999999999999999999999 99999999999999999999999999999876554
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.........||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ......+... .... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~-~~-- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV-TT-- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH-HH--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc-ch--
Confidence 433344456899999999999999999999999999999999999999743221 1111112111 1100 01
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhhhcC
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~~ 638 (679)
......+..+.+++.+||+.||.+|| +++++.+.|+.+......
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11122345788999999999999999 999999999988765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=364.40 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=208.0
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc----eEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lV~ 432 (679)
..|++.+.||+|+||.||+|++. ++.||||++... ........+|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 45677899999999999999887 899999998654 333455667999999999999999999987643 479999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CccccCCCCCCccccCCCcEEEee
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
||+++|+|.++++. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999973 459999999999999999999998 7 999999999999999999999999
Q ss_pred ccCccccccCccc-ccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchh-------
Q 005750 503 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------- 569 (679)
Q Consensus 503 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~------- 569 (679)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 2233468999999999976 35667899999999999999999999754332111
Q ss_pred ---hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 570 ---NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 570 ---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
....+...... ......+.... ........+.+++.+||+.||++|||++||++.|+++...
T Consensus 255 ~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVH-KKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTT-SCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhc-ccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111 11111111110 1224556799999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=363.21 Aligned_cols=267 Identities=28% Similarity=0.448 Sum_probs=209.6
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-----CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc--cc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EH 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~ 426 (679)
+....|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34456778899999999999999842 589999999987766677889999999999999999999998854 34
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 689999999999999999753 3458999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHH
Q 005750 507 RQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWA 575 (679)
Q Consensus 507 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~ 575 (679)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654322 1222334677899999999889999999999999999999999998732211 001111111
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
...+..+.. ...+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 242 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222222111 11122334578999999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.13 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 4667899999999999999984 7999999998654 234556788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 96 ASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999974 4569999999999999999999999 999999999999999999999999999998764432
Q ss_pred cccccccCCccccCCcccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
......||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+.. +.... +..+...
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~-i~~~~~~-------- 232 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRER-VLRGKYR-------- 232 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCC--------
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--------
Confidence 23345699999999999887764 8999999999999999999999744321 11111 1112110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+......+.+++.+||+.||.+|||++|+++.
T Consensus 233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111123468899999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=365.50 Aligned_cols=273 Identities=24% Similarity=0.433 Sum_probs=218.6
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 422 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 422 (679)
++....|.+.+.||+|+||.||+|++. .++.||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344557788899999999999999863 24689999997653 34457899999999999 899999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
...+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999975421 2469999999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~ 567 (679)
||++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987654322 22233457889999999999999999999999999999999 99999743321
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcCCCCccc
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 644 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 644 (679)
.+.+ .+..+.... .+......+.+++.+||+.||++|||++||++.|+++.......+....
T Consensus 301 --~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 --ELFK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp --HHHH----HHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred --HHHH----HHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1222 222221111 1112234788999999999999999999999999999987665554443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=352.36 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=204.7
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 34568999999999999987 79999999997665666778999999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 128 ~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~ 199 (321)
T 2c30_A 128 ALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK 199 (321)
T ss_dssp BHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BC
T ss_pred CHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-cc
Confidence 9999986 3469999999999999999999999 99999999999999999999999999999876543322 23
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... +....... + ....
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~----~~~~~~~~-----~--~~~~ 265 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR----LRDSPPPK-----L--KNSH 265 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSSCCC-----C--TTGG
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhcCCCCC-----c--Cccc
Confidence 446899999999999999999999999999999999999999743221 11111 11111111 0 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.....+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223468899999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.90 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=201.6
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHh--ccCCCcccccccccc----cceEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRIL 430 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~----~~~~~l 430 (679)
..|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4567789999999999999988 5899999998643 34556667777776 789999999998643 456899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
||||+++|+|.++++ ...+++..++.++.|++.||+||| + ++|+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999996 457999999999999999999999 7 9999999999999999999999999
Q ss_pred ccCccccccCcccc---cccccCCccccCCcccCCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCcc
Q 005750 503 FGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVE 563 (679)
Q Consensus 503 fgla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvll~elltG----------~~pf~~~ 563 (679)
||++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 2234689999999999876 455799999999999999999 8888633
Q ss_pred cccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 564 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.... ..................... ..........+.+++.+||+.||.+|||++||++.|+++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPND-PSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSS-CCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-cchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221 111111111111111111100 112234667899999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.26 Aligned_cols=273 Identities=21% Similarity=0.308 Sum_probs=214.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc--eEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lV~E 433 (679)
.|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4667899999999999999887 58999999997543 234567889999999999999999999987654 7899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc----cCCCcEEEeeccCcccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 509 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfgla~~~ 509 (679)
|+++++|.+++........+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++...
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999865545559999999999999999999999 999999999999999 78888999999999876
Q ss_pred ccCcccccccccCCccccCCcccC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc-hhhHHHHHHHhHh
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIK 580 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~-~~~~~~~~~~~~~ 580 (679)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 54432 22345899999999875 5788999999999999999999999997433321 1122211111111
Q ss_pred cCCeeeee---------cc--cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 581 KGDVISIV---------DP--VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 581 ~~~~~~~~---------d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
........ .+ .............+.+++.+||+.||++|||++|+++...+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 11111110 00 111234567777899999999999999999999999998876654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.21 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=200.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
....|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567788999999999999998753 5679999987643 344567999999999999999999999985 45689
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999743 4568999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
............+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... ....+ ..+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~~~~--- 236 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGERL--- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCC---
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcCCCC---
Confidence 5543333333446789999999988899999999999999999997 999997443321 22211 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+...+..+.+++.+||+.||.+|||+.|+++.|+++...+
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111223457889999999999999999999999999988754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.31 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=211.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...+.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345677899999999999999987 789999999875432 344578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.++++.. +..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999742 3468999999999999999999999 999999999999999999999999999998654332
Q ss_pred cccc-ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 514 THIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 514 ~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...+ .+..+...
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~------ 334 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKGGRL------ 334 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTTCCC------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC------
Confidence 2111 12235678999999988889999999999999999998 99999743221 1111 22222111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+...+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11122345788999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=365.69 Aligned_cols=261 Identities=27% Similarity=0.479 Sum_probs=201.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
+....|.+.+.||+|+||.||+|+++ ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34456777899999999999999875 57789999997643 34557899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999742 4579999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccccc--ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 509 AEEDLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 509 ~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ....+. +..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~----i~~~~~- 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA----VDEGYR- 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----HHTTEE-
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCC-
Confidence 654322111 12235678999999998899999999999999999998 9999973322 112221 111111
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...+...+..+.+++.+||+.||.+||+++||++.|+++...
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 111223345789999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=376.78 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=212.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+....+++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3345677889999999999999999989999999997643 34678999999999999999999999987 567899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.++++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999743 13368889999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.. ...+.+ ..+...
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~------- 404 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM------- 404 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH----HHTCCC-------
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC-------
Confidence 222233346788999999988899999999999999999999 99999743221 122211 111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+...+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11122345788999999999999999999999999988764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=355.09 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=203.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++++.. ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4667899999999999999886 69999999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999873 4578999999999999999999999 999999999999999999999999999998643322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .... +.. .
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~-~~~------~-- 223 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILM-EEI------R-- 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CCC------C--
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CCC------C--
Confidence 2 223456899999999999999999999999999999999999999743221 1111 1111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
.+......+.+++.+||+.||.+|| +++||++.
T Consensus 224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112234688999999999999999 89999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=343.85 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=211.5
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35667899999999999999998899999999976533 34678999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999753 4568999999999999999999999 999999999999999999999999999998765433222
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ...+ . +..+... .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~-i~~~~~~---------~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---D-ISTGFRL---------Y 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCCC---------C
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH---H-HhcCCcC---------C
Confidence 233456788999999988889999999999999999999 89999743221 1111 1 1111110 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+......+.+++.+||+.+|.+|||++|+++.|+++..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111123468899999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.83 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=217.8
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
+....|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34556778899999999999999987 4889999999754 345678999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999754 34569999999999999999999999 99999999999999999999999999999877655
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+... ....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~----~~~~------- 230 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KDYR------- 230 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TTCC-------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----ccCC-------
Confidence 4444444457889999999998899999999999999999999 999997443322 222111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
...+...+..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus 231 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111223357889999999999999999999999999987743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=350.68 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=200.9
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||+||+|++.+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 34677899999999999999998899999999875422 2346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++ |+|.+.+... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 101 ME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 97 4888877642 4569999999999999999999999 9999999999999999999999999999987653322
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee--------
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-------- 585 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 585 (679)
. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+..........
T Consensus 175 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 S-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTTS
T ss_pred c-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhcc
Confidence 2 223458999999999876 56899999999999999999999999754433221 1111111111000
Q ss_pred --------eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 --------SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 --------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.............++.+++.+||+.||.+|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000001112346889999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=354.01 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=201.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4667899999999999999887 789999999864432 33466889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-c
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~-~ 514 (679)
++|+|.+++. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++....... .
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999997 45679999999999999999999999 999999999999999999999999999998654322 2
Q ss_pred cccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......+... ... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~----~~~---~----- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEK----KTY---L----- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTT----CTT---S-----
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcc----ccc---C-----
Confidence 22234568999999999987765 78999999999999999999999743332 1122221111 100 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.........+.+++.+||+.||.+|||++|+++.
T Consensus 229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011223467899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=377.95 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=215.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
+....+++.+.||+|+||.||+|.++. ++.||||+++... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 344567788999999999999999874 8899999997643 34678999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999754 34568999999999999999999999 99999999999999999999999999999876544
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||...+... ..+.+ ..+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~-------- 436 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDY-------- 436 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTC--------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC--------
Confidence 3333333446789999999998899999999999999999999 999997443322 22221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
....+...+..+.+++.+||+.||.+|||++||++.|+.+..
T Consensus 437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111122334578899999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=353.74 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=204.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch------hHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4677899999999999999987 6899999999754321 34778999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC----cEEEeeccCc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 506 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfgla 506 (679)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999997 35679999999999999999999999 9999999999999998776 7999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .... . +..+...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~---~-i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---N-ITAVSYD- 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHTTCCC-
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhcCCC-
Confidence 87654322 23446999999999999999999999999999999999999999743321 1111 1 1111110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+++..... ....+.+++.+||+.||.+|||++|+++
T Consensus 237 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111 2246889999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.17 Aligned_cols=264 Identities=16% Similarity=0.191 Sum_probs=212.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+++++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 35677899999999999999874 79999999986432 334678899999999 799999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc-----EEEeeccCcccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQA 509 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfgla~~~ 509 (679)
+ +++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||++...
T Consensus 88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 99999999753 4569999999999999999999999 99999999999999987766 999999999876
Q ss_pred ccCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 510 EEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 510 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543321 12345689999999999999999999999999999999999999985443332222222221111111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
... +.. ..+..+.+++.+||+.||.+||++++|++.|+++.....
T Consensus 242 ~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 LRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 110 111 123478899999999999999999999999999887543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.04 Aligned_cols=266 Identities=27% Similarity=0.454 Sum_probs=213.3
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 425 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 425 (679)
++....|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 444566788999999999999999853 46789999997543 34556789999999999999999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cE
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RA 498 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 498 (679)
...++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997543 23468999999999999999999999 9999999999999999554 59
Q ss_pred EEeeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 005750 499 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 576 (679)
Q Consensus 499 kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 576 (679)
||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ...+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~-- 298 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF-- 298 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 999999997643221 122233457899999999988899999999999999999998 99999743221 12221
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+..+... ..+......+.+++.+||+.+|.+|||++||++.|+.+.....
T Consensus 299 --i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 299 --VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp --HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --HHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1122111 1112223468899999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=356.17 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=209.5
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEE-----cCCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc-
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE- 425 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 425 (679)
.+....|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34445577889999999999999984 368999999997543 23457789999999999999999999999776
Q ss_pred -ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 426 -HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 426 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 6789999999999999999643 4569999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc--------cchhhHHHH
Q 005750 505 LSRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--------GAELNIVHW 574 (679)
Q Consensus 505 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~--------~~~~~~~~~ 574 (679)
++........ .......+|..|+|||.+.+..++.++|||||||++|+|++|..|+..... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 223344578889999999988999999999999999999999998752210 001111111
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
....+..+.. ...+......+.+++.+||+.||.+|||++|+++.|++++
T Consensus 252 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1122222111 1112233457889999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.04 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=207.3
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
......|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344567888999999999999999886 68999999997542 344567899999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC---CcEEEeeccCc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 506 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfgla 506 (679)
+||||+++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999987 35678999999999999999999999 999999999999999864 45999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+.. .+..+...
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~----~i~~~~~~- 248 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYD- 248 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC-
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhCCCC-
Confidence 87654322 23346899999999999999999999999999999999999999743321 1111 11122111
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0011223468899999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.86 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=213.0
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
....|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3455777899999999999999862 35889999997643 3455789999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCC
Q 005750 428 RILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 486 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk 486 (679)
.++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999975432 2348999999999999999999999 999999999
Q ss_pred CCCccccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccc
Q 005750 487 SSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVED 564 (679)
Q Consensus 487 p~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~ 564 (679)
|+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443222 1223346788999999988889999999999999999999 999997443
Q ss_pred ccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 565 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
... .... +..+... ..+......+.+++.+||+.||.+|||++|+++.|+++...
T Consensus 258 ~~~---~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER---LFNL----LKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG---HHHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---HHHH----hhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 322 2221 1121111 11122335788999999999999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.32 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=205.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc------hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...|.+.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999986 689999999865432 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC----cEEEeecc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 504 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg 504 (679)
++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 5679999999999999999999999 9999999999999998877 89999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+ . ....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~---~-~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANV---S-AVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---H-HTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---H-hcCC
Confidence 9987653322 233458999999999999999999999999999999999999997432211 11111 1 1110
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. . ...... .....+.+++.+||+.||.+|||++|+++
T Consensus 235 ~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-F-EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C-CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-c-Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 000001 12346889999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.55 Aligned_cols=260 Identities=19% Similarity=0.228 Sum_probs=209.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||.||+|... +++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4567899999999999999874 789999999865422 34688999999999 9999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc-----EEEeeccCccccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 510 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfgla~~~~ 510 (679)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999753 4679999999999999999999999 99999999999999998887 9999999998764
Q ss_pred cCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 511 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 511 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 43221 123456899999999999999999999999999999999999999854433322222222111111000
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+.. ..+ .+.+++.+||+.+|.+||++++|++.|+++...
T Consensus 242 -----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 242 -----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 112 788999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.89 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=211.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345677899999999999999875 34899999997653 33457799999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCC
Q 005750 429 ILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 487 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp 487 (679)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+ ++|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 999999999999999975321 2579999999999999999999999 9999999999
Q ss_pred CCccccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccc
Q 005750 488 SNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 565 (679)
Q Consensus 488 ~NIll~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~ 565 (679)
+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999976543321 22233457889999999988889999999999999999999 9999974322
Q ss_pred cchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 566 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
. .... .+..+.... .+...+..+.+++.+||+.||.+|||+.||++.|+++....
T Consensus 283 ~---~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 E---EVIY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H---HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred H---HHHH----HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1111 222222211 11123347889999999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.72 Aligned_cols=250 Identities=31% Similarity=0.435 Sum_probs=194.1
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc----hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 34667899999999999999986 89999999875432 23467889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---ccccCCCCCCccccC--------CCcEEEe
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVS 501 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kL~ 501 (679)
||+++++|.+++. ...+++..++.++.|++.||+|||+ ++ |+||||||+||+++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999986 4579999999999999999999999 77 999999999999986 7789999
Q ss_pred eccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 502 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 502 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+... . .......
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V---AYGVAMN 229 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H---HHHHHTS
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHhhhcC
Confidence 9999986544322 23458999999999998899999999999999999999999997432211 1 1111111
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.. ....+......+.+++.+||+.||.+|||++|+++.|+++
T Consensus 230 -~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -KL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 1111222345788999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.25 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=207.0
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
....+++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 344567889999999999999999988899999997643 335679999999999999999999999876 678999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999743 23568999999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... ...+ .+..+..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~--------- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYR--------- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCC---------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC---------
Confidence 22333446789999999988899999999999999999999 99999743221 1111 1122211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
...+...+..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 0112233457889999999999999999999999999887643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.02 Aligned_cols=261 Identities=28% Similarity=0.492 Sum_probs=203.4
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 34667899999999999999886 789999998643 345788999999999999999999999874 3789999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc-EEEeeccCccccccCccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~Dfgla~~~~~~~~~ 515 (679)
+|+|.+++........+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999986443345789999999999999999999844468999999999999998886 7999999997654322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... . ...+.... ...
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~---~-~~~~~~~~-----~~~- 227 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMW---A-VHNGTRPP-----LIK- 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHH---H-HHTTCCCC-----CBT-
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHH---H-HhcCCCCC-----ccc-
Confidence 2235899999999999999999999999999999999999999733221 111111 1 11111111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcCCC
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 640 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 640 (679)
..+..+.+++.+||+.||.+|||++|+++.|+.+...-...+
T Consensus 228 ---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 228 ---NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 223468899999999999999999999999999887544433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=345.65 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=211.6
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...|++.+.||+|+||.||+|..++++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35677889999999999999999888899999987543 345778999999999999999999999874 4589999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999999742 12368999999999999999999999 99999999999999999999999999999876554333
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...+. +..+.. .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~---- 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LERGYR-----M---- 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCC-----C----
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH----HhcccC-----C----
Confidence 3334456789999999988889999999999999999999 99999743221 11111 111111 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+......+.+++.+||+.+|++|||++++++.|+++....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 111122347889999999999999999999999999987753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.43 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=197.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCC----cEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
....|++.+.||+|+||.||+|.+... ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345677889999999999999987643 27999999754 344567899999999999999999999999776655
Q ss_pred ------EEEEEecCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 429 ------ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 429 ------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 22368999999999999999999999 9999999999999999999999
Q ss_pred EeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 005750 500 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 500 L~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 577 (679)
|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||....... .....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~-- 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYL-- 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH--
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHHH--
Confidence 999999987544322 12223346788999999999899999999999999999999 999997443322 11111
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
. .+... .........+.+++.+||+.||.+|||++|+++.|+++..-.
T Consensus 253 -~-~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 -I-GGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -H-TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -h-cCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11110 111223357889999999999999999999999999998853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=357.67 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=210.1
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
....|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3455777899999999999999742 468999999976433 3457799999999999 7999999999987754
Q ss_pred -eEEEEEEecCCCcHhhhhcccCC--------------------------------------------------------
Q 005750 427 -QRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 449 (679)
Q Consensus 427 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 449 (679)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999975421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc-ccccccc
Q 005750 450 -------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVAR 521 (679)
Q Consensus 450 -------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~ 521 (679)
...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........ .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1228999999999999999999999 9999999999999999999999999999987543322 2233445
Q ss_pred CCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHH
Q 005750 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600 (679)
Q Consensus 522 gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 600 (679)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||....... .... .+..+.... .+...
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~~---------~~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMR---------APDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCCCC---------CCTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCCCC---------CCCCC
Confidence 7889999999998899999999999999999998 999997443321 1111 122221111 11122
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 601 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...+.+++.+||+.||.+|||++||++.|++++..
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 34688999999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=339.95 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=203.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchh-------HHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
...|++.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 355777899999999999999885 78999999986532211 167899999999999999999999997765
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCccccCCCc-----EEE
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AKV 500 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kL 500 (679)
++||||+++|+|.+.+.. ....+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 699999999999998864 34579999999999999999999998 88 999999999999988776 999
Q ss_pred eeccCccccccCcccccccccCCccccCCccc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
+|||++...... .....|++.|+|||++ ....++.++|||||||++|+|++|+.||........ ..... .
T Consensus 171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~---~ 242 (287)
T 4f0f_A 171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINM---I 242 (287)
T ss_dssp CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHH---H
T ss_pred CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHH---H
Confidence 999999754432 2334689999999998 455678999999999999999999999974433221 11111 1
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
...+.. + ..+......+.+++.+||+.||.+|||++|+++.|+++
T Consensus 243 ~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLR-----P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCC-----C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 1 11222345788999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=363.01 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=205.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
...|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456888999999999999999875 68999999987543 234567899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~~ 509 (679)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999874 4679999999999999999999999 9999999999999998 5688999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+.. .... .+..+... ...
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~~-~~~ 234 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ----QIKAGAYD-FPS 234 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCC-CCT
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHHhCCCC-CCc
Confidence 543322 23356999999999999999999999999999999999999999743321 1111 12222111 001
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+ ........+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 111223468899999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=353.14 Aligned_cols=260 Identities=23% Similarity=0.410 Sum_probs=203.9
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
+....|++.+.||+|+||+||+|++. +++ +||+|.+.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 34456778899999999999999865 344 46888876432 344578999999999999999999999998765
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++|+||+.+|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 78999999999999999753 4679999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 508 QAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 508 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... +..+...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~~~ 238 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERL 238 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----HHcCCCC
Confidence 76443222 1223346889999999999999999999999999999999 999997443322 2221 1111110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+......+.+++.+||+.+|.+||+++|+++.|+.+...
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11122334788999999999999999999999999988763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.17 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=212.2
Q ss_pred HHHHhhccccCcCccEEEEEEEE-----cCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccc--ccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 428 (679)
...|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 45677889999999999999984 368899999998776667788999999999999999999999875 45678
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999753 3468999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc--------hhhHHHHHHHh
Q 005750 509 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSM 578 (679)
Q Consensus 509 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~--------~~~~~~~~~~~ 578 (679)
....... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||....... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543321 2233457888999999998889999999999999999999999986322110 00001111111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
...+. ....+......+.+++.+||+.||.+|||++|+++.|+.+.....
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111 111223334578999999999999999999999999999877544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.52 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=199.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV 431 (679)
..|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 34677899999999999999987 58899999997542 22335678899999887 899999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999974 4579999999999999999999999 9999999999999999999999999999986332
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc--hhhHHHHHHHhHhcCCeeeeec
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.....+.....
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 22 22344569999999999999999999999999999999999999996432221 11111222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
..+......+.+++.+||+.||.+||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111223468899999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.74 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=194.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--------------------------hhHHHHHHHHHHHHhc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRI 410 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l 410 (679)
.|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4677899999999999999876 689999999865421 1135688999999999
Q ss_pred cCCCcccccccccc--cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCC
Q 005750 411 HHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 488 (679)
Q Consensus 411 ~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~ 488 (679)
+||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||+|||+ ++|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999876 568899999999999988654 4579999999999999999999999 99999999999
Q ss_pred CccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCCCcccc
Q 005750 489 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDF 565 (679)
Q Consensus 489 NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvll~elltG~~pf~~~~~ 565 (679)
||+++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999876543222 23346899999999997764 47899999999999999999999974322
Q ss_pred cchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 566 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ... . .+....... + ........+.+++.+||+.||.+|||++|+++
T Consensus 246 ~---~~~---~-~~~~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M---CLH---S-KIKSQALEF---P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H---HHH---H-HHHHCCCCC---C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H---HHH---H-HHhcccCCC---C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111 1 111111110 0 01112346889999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.48 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=204.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4667899999999999999887 5889999998754 3445678899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC--CCcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfgla~~~~~~~~ 514 (679)
+|+|.+++.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++........
T Consensus 85 g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999974 23569999999999999999999999 99999999999999987 78999999999987654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..... +... .++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~-~~~~--~~~~~~~ 228 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII---ENIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHH-TCCC--CCHHHHT
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH---HHHHc-CCCC--CChhhhc
Confidence 23345899999999999988999999999999999999999999743221 111 11111 1110 0000001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.....+.+++.+||+.||.+|||+.|+++.
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123468899999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.60 Aligned_cols=263 Identities=29% Similarity=0.429 Sum_probs=213.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEE------cCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
....|.+.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 345677889999999999999985 2478999999976533 3457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ ++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999975421 2258999999999999999999999 99999999999999
Q ss_pred ccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchh
Q 005750 492 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 569 (679)
Q Consensus 492 l~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~ 569 (679)
++.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 999999999999999876544322 2223446789999999988899999999999999999999 999997433221
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...... ..+.. . ..+......+.+++.+||+.||.+|||++|+++.|+++...
T Consensus 256 ~~~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 KFYKMI----KEGFR-----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHH----HHTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHh----ccCCC-----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111111 11111 0 11112234788999999999999999999999999998874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=364.42 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=207.1
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc-eEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~~ 435 (679)
..+++.+.||+|+||.||+|.++ ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 45667899999999999999986 7899999997643 4578999999999999999999999976654 789999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999854 23457999999999999999999999 999999999999999999999999999998643321
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .... +..+...
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~--------- 405 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM--------- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCC---------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC---------
Confidence 12246889999999999999999999999999999998 999997443322 2221 1222111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223345788999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.90 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred hhccccCcCccEEEEEEEEc-----CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccc--cceEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV 431 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV 431 (679)
++.+.||+|+||.||++.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 77899999999999998653 58899999998653 3446779999999999999999999999976 4678999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999973 348999999999999999999999 9999999999999999999999999999987654
Q ss_pred Ccc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc--------hhhHHHHHHHhHhc
Q 005750 512 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSMIKK 581 (679)
Q Consensus 512 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~--------~~~~~~~~~~~~~~ 581 (679)
... .......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...........+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 332 12233457888999999998889999999999999999999999997322110 00011111122222
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+. ....+......+.+++.+||+.||.+|||++|+++.|+++...-.
T Consensus 267 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 267 GE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 11 111222334578999999999999999999999999999877543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.73 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=205.5
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
+....|++.+.||+|+||.||+|..+ +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567889999999999999999876 68999999985321 1235778999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc---EEEeec
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDF 503 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Df 503 (679)
.++||||+++|+|.+.+.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988876432 34568999999999999999999999 99999999999999986554 999999
Q ss_pred cCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 504 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 504 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..... . +..+.
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~-i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---G-IIKGK 248 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---H-HHHTC
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---H-HHcCC
Confidence 99987654322 2234468999999999999999999999999999999999999997421 11111 1 11111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ..+..... ....+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 00000111 2346889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.61 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=206.8
Q ss_pred HHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..|.+.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.++ ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 456778999999999999998653 3469999987653 34567899999999999999999999998754 56899
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999753 4568999999999999999999999 9999999999999999999999999999987655
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ....+ ..+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~~---- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRLP---- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCCC----
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCCC----
Confidence 43333344457889999999988899999999999999999998 999997433322 22211 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.+......+.+++.+||+.||.+|||+.|+++.|+++...+.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 235 -----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 111123468899999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.55 Aligned_cols=259 Identities=19% Similarity=0.289 Sum_probs=198.5
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
|++.+.||+|+||.||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 567889999999999999998899999999865432 234678899999999999999999999999999999999997
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 999888742 4678999999999999999999999 99999999999999999999999999999765432221
Q ss_pred cccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe---e-----ee
Q 005750 517 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---I-----SI 587 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~ 587 (679)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.. +......... . ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcccc
Confidence 223358999999999876 468999999999999999999999997433221 1111 1111111000 0 00
Q ss_pred eccccc-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.++... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011000 0011123456889999999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=356.91 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=199.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 428 (679)
+....|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34455778899999999999999886 58999999997532 23446688899999988 799999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999974 4579999999999999999999999 9999999999999999999999999999986
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. ...... +..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~-~~~---- 241 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL---FEAILN-DEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHH-CCC----
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH---HHHHHc-CCC----
Confidence 43322 2233456999999999999888999999999999999999999999743321 11 111111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 627 (679)
.++......+.+++.+||+.||.+||++ +|+++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111223468899999999999999998 67765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.18 Aligned_cols=257 Identities=22% Similarity=0.390 Sum_probs=205.0
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC-C-------cEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 425 (679)
+....|.+.+.||+|+||.||+|.+.. + +.||+|++........+.+.+|++++++++||||+++++++.+.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567788999999999999998663 3 57999999776666678899999999999999999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc--------
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------- 497 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 497 (679)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999753 3448999999999999999999999 99999999999999998887
Q ss_pred EEEeeccCccccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 005750 498 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 576 (679)
+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..|+...... .......
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~- 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFY- 231 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH-
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHh-
Confidence 999999998765432 22347889999999987 67899999999999999999965544312211 1111111
Q ss_pred HhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
......... ....+.+++.+||+.||.+|||++|+++.|+++..-..
T Consensus 232 --~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 232 --EDRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp --HTTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred --hccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111111111 12257799999999999999999999999998877433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.55 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=180.9
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCCCcH
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
+.||+|+||.||+|.++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999986 6899999998643 3466788999999997 99999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cEEEeeccCccccccCccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfgla~~~~~~~~~~~ 517 (679)
.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||++......... .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999984 5679999999999999999999999 9999999999999997665 8999999999865443222 2
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ....+ ....+..+.... .. ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~--~~----~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF--EG----EA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC--CS----HH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC--Cc----cc
Confidence 334579999999999999999999999999999999999999974433211 11122 222222222110 00 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0122347889999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.79 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=199.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc--------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 426 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 426 (679)
..|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45777899999999999999987 79999999987533 345678999999999999999999999875432
Q ss_pred -------------------------------------------------eEEEEEEecCCCcHhhhhcccCCCCCCCHHH
Q 005750 427 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 457 (679)
Q Consensus 427 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 457 (679)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998655455667778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc-----------cccccccCCccc
Q 005750 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 526 (679)
Q Consensus 458 ~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~-----------~~~~~~~gt~~y 526 (679)
++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 9999999999999999999999999999987654421 112334589999
Q ss_pred cCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHH
Q 005750 527 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 606 (679)
Q Consensus 527 ~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (679)
+|||++.+..++.++|||||||++|+|++|..|+. ....... ......... ........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIIT-DVRNLKFPL---------LFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHH-HHHTTCCCH---------HHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHH-HhhccCCCc---------ccccCChhHHH
Confidence 99999999999999999999999999999977753 1111111 111111110 11223346789
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005750 607 VAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 607 li~~cl~~dP~~RPt~~evl~ 627 (679)
++.+||+.||.+|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.55 Aligned_cols=266 Identities=26% Similarity=0.411 Sum_probs=209.9
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
+....|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34456778899999999999999862 46789999997542 33457899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 485 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl 485 (679)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999975421 1348999999999999999999999 99999999
Q ss_pred CCCCccccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcc
Q 005750 486 KSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVE 563 (679)
Q Consensus 486 kp~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~ 563 (679)
||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876543321 2233457889999999988899999999999999999998 99999744
Q ss_pred cccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 564 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.... .... .+..+.. ...+......+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 279 ~~~~--~~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDA--NFYK----LIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSH--HHHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHH--HHHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3221 1112 1222111 01112224578899999999999999999999999999877533
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.04 Aligned_cols=265 Identities=24% Similarity=0.447 Sum_probs=213.0
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc--------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 424 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 424 (679)
....|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3456778899999999999999863 46789999997653 34557789999999999 89999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 9999999999999999999985431 2358999999999999999999999 99999999999999
Q ss_pred ccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchh
Q 005750 492 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 569 (679)
Q Consensus 492 l~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~ 569 (679)
++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 999999999999999876543221 1223346789999999988889999999999999999999 99999743221
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
.+... +..+... ..+......+.+++.+||+.+|.+|||++|+++.|+++......
T Consensus 267 ~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ELFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHH----HhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11111 1122111 11122334688999999999999999999999999999886554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=354.62 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=206.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4777899999999999999886 689999999987666666789999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC--CCcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfgla~~~~~~~~ 514 (679)
+|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 132 gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999874 24579999999999999999999999 99999999999999974 57899999999987654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .... .... .... .++..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~i~~-~~~~--~~~~~-- 273 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKR-CDWE--FDEDA-- 273 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHH-CCCC--CCSST--
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCCC--CCccc--
Confidence 22345899999999999999999999999999999999999999743221 1111 1111 1110 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......+.+++.+||+.||.+|||++|+++.
T Consensus 274 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 --FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11223468899999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=340.97 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=199.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3567899999999999999886 68999999997543 33457788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++ ++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 83 CDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 975 55555543 35679999999999999999999999 9999999999999999999999999999987653322
Q ss_pred cccccccCCccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee---ee---
Q 005750 515 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---SI--- 587 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 587 (679)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .. .....+.......... ..
T Consensus 157 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~-~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VD-DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HH-HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HH-HHHHHHHHHhCCCChhhhhhhccc
Confidence 2 23345899999999987765 79999999999999999998888642221 11 1222221111110000 00
Q ss_pred ec---------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VD---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+ ..............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00001111233457889999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=349.49 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=199.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|..+++++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4677899999999999999987 58999999997542 33456788999999988 8999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999974 4579999999999999999999999 99999999999999999999999999999864322
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch--hhHHHHHHHhHhcCCeeeeecc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+.....
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 21 23345699999999999999999999999999999999999999974222110 0111122222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 622 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 622 (679)
. .+......+.+++.+||+.||.+||++
T Consensus 237 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 R----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 111223468899999999999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=337.44 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=204.5
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc--ceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|+++ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45677899999999999999986 8999999997543 34456799999999999999999999999876 7889999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999853 23468999999999999999999998 88 9999999999999999999999998876533
Q ss_pred cCcccccccccCCccccCCcccCCCCCC---chhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s---~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.. ...||+.|+|||.+.+...+ .++|||||||++|+|++|+.||...... +........+..
T Consensus 165 ~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~--- 229 (271)
T 3kmu_A 165 SP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR--- 229 (271)
T ss_dssp CT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC---
T ss_pred cc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC---
Confidence 22 23578999999999876544 4899999999999999999999733221 111112222111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
+ ..+......+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus 230 --~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 1112233468899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=338.71 Aligned_cols=260 Identities=24% Similarity=0.414 Sum_probs=210.6
Q ss_pred HHhhcc-ccCcCccEEEEEEEEc---CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 358 TNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~-~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.+.+.+ .||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344445 8999999999999864 57889999998643 34567899999999999999999999999 455689999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999874 24569999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccc--cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 513 LTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 513 ~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... ..... +..+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~~---- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRM---- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCC----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCcC----
Confidence 3221 223346789999999988889999999999999999998 99999743321 12221 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 639 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 639 (679)
..+...+..+.+++.+||+.+|.+||++.|+++.|+++.......
T Consensus 233 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 112233457889999999999999999999999999998865543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.38 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=203.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45778899999999999999876 58899999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+.+|+|.+++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998 35679999999999999999999999 99999999999999999999999999999876443
Q ss_pred cccccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 513 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................. ...
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~----- 237 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVV----- 237 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCC-----
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----ccc-----
Confidence 2 2234569999999999864 4589999999999999999999999974443332222222111 110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 627 (679)
.++......+.+++.+||+.||.+||+ +++|++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111222347889999999999999998 666654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.95 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=202.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++.+.. ....+.+.+|..+++.++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4667899999999999999886 69999999997532 1234678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999974 4578999999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ .. .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~~------~-- 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-EL------R-- 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-CC------C--
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CC------C--
Confidence 23456899999999999999999999999999999999999999743221 111122211 11 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 222 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1112234688999999999999999 8888874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=347.17 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=194.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccc--------c
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC--------E 423 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~--------~ 423 (679)
+....|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 33446778899999999999999976 68999999987666666778999999999996 99999999988 4
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCccccCCCcEEEe
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVS 501 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~ 501 (679)
.....++||||+. |+|.+++........+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence 4556899999995 7999988754456679999999999999999999998 88 9999999999999999999999
Q ss_pred eccCccccccCcccc-----------cccccCCccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccc
Q 005750 502 DFGLSRQAEEDLTHI-----------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 567 (679)
Q Consensus 502 Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~ 567 (679)
|||++.......... .....|++.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 999998765432211 1133489999999998 5677899999999999999999999999732211
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
..... .. ...........+.+++.+||+.||.+|||++|+++.|+++.....
T Consensus 260 -----~~~~~-----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 -----RIVNG-----KY--------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------------C--------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----HhhcC-----cc--------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 00000 00 000011112247799999999999999999999999999887543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.31 Aligned_cols=270 Identities=17% Similarity=0.233 Sum_probs=207.3
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCcchhH-----------HHHHHHHHHHHhccCCCccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRT-----------QQFVTEVALLSRIHHRNLVP 417 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~ 417 (679)
....|++.+.||+|+||.||+|.+.. ++.||||++........ ..+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34467788999999999999998864 47899999876532111 12344566677778999999
Q ss_pred cccccccc----ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 418 LIGYCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 418 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 99998664 5689999999 9999999975 24679999999999999999999999 9999999999999999
Q ss_pred --CCCcEEEeeccCccccccCcccc------cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc
Q 005750 494 --INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 565 (679)
Q Consensus 494 --~~~~~kL~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~ 565 (679)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 1234489999999999999999999999999999999999999974322
Q ss_pred cchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 566 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
. ............ .....++++.+... ..+..+.+++..||+.+|.+||++++|++.|+++....
T Consensus 267 ~--~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 D--PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp C--HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C--HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 2 122222221111 12223333322211 12347889999999999999999999999999988753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.54 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=201.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV 431 (679)
..|.+.+.||+|+||.||+|+.+ +|+.||+|++++.. ....+.+..|.+++..+ +||||+++++++.+.+..++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45667899999999999999986 68999999997532 23346678899999887 899999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999974 4568999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ . +..+.. .
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~-i~~~~~------~ 236 (345)
T 1xjd_A 171 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH---S-IRMDNP------F 236 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHCCC------C
T ss_pred CCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH---H-HHhCCC------C
Confidence 221 233456999999999999999999999999999999999999999743321 1111 1 111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 626 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 626 (679)
. +......+.+++.+||+.||.+||++. ||+
T Consensus 237 ~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 111234688999999999999999997 665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=346.86 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=193.9
Q ss_pred HHHHhhccccCcCccEEEEEEEE----cCCcEEEEEEecCCc----chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
...|++.+.||+|+||.||+|+. .+++.||+|++++.. ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34677889999999999999987 478999999997642 2234567889999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999974 4568999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .. ...... ...
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~---~~~i~~-~~~--- 238 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KT---IDKILK-CKL--- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHH-TCC---
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHh-CCC---
Confidence 6433222 223446899999999999989999999999999999999999999743321 11 111111 111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
..+......+.+++.+||+.||.+|| ++.|+++
T Consensus 239 -------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 -------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11112234688999999999999999 7778775
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.24 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=200.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 4667899999999999999974 78999999986432 1223578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+ +|+|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 7899998873 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||......... ..+...
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~- 223 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSC- 223 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSS-
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcC-
Confidence 2 234468999999999988776 78999999999999999999999743322110 000000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+......+.+++.+||+.||.+|||++|+++.
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 001122233468899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=353.72 Aligned_cols=269 Identities=19% Similarity=0.271 Sum_probs=204.5
Q ss_pred HHhhccccCcC--ccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.+.||+| +||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46778999999 99999999987 69999999997542 334567889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999754 24569999999999999999999999 99999999999999999999999999988654322
Q ss_pred cc------cccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh----
Q 005750 513 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 580 (679)
Q Consensus 513 ~~------~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 580 (679)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccc
Confidence 11 11122358899999999987 6789999999999999999999999974333211 1111100000
Q ss_pred c-----C-------------Ceeeeec---cc------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHh
Q 005750 581 K-----G-------------DVISIVD---PV------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQD 631 (679)
Q Consensus 581 ~-----~-------------~~~~~~d---~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~ 631 (679)
. . .....+. +. ............+.+++.+||+.||.+|||++|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 0 0000000 00 0000112223468899999999999999999999864 444
Q ss_pred h
Q 005750 632 S 632 (679)
Q Consensus 632 ~ 632 (679)
+
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=354.91 Aligned_cols=271 Identities=22% Similarity=0.312 Sum_probs=214.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc--eEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lV~E 433 (679)
.|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4667899999999999999987 58999999997543 234567889999999999999999999987654 7899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc----cCCCcEEEeeccCcccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 509 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Dfgla~~~ 509 (679)
|+++|+|.+++........+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999865445559999999999999999999999 999999999999999 77888999999999876
Q ss_pred ccCcccccccccCCccccCCcccCC--------CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~ 242 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG 242 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHS
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcC
Confidence 54322 223458999999999864 4678899999999999999999999974332211 11112222221
Q ss_pred C---Ceeeee-----------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 582 G---DVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 582 ~---~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
. ...... +..............+.+++.+||+.||++||+++|+++.+++++..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1 111000 00111234467777899999999999999999999999999998774
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=345.27 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=190.7
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 35677899999999999999876 68999999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
++ |+|.+++.... ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 97 69998886432 23468999999999999999999999 9999999999999999999999999999987643
Q ss_pred CcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC--ee-e-
Q 005750 512 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VI-S- 586 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~-~- 586 (679)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+........ .. .
T Consensus 161 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 161 PVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGG
T ss_pred Cccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhh
Confidence 3222 223458999999999876 468999999999999999999999997443321 1111111111000 00 0
Q ss_pred ----eecccc------------cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 ----IVDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ----~~d~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.. ...........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 00000112346889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.62 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=202.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 5778899999999999999875 7999999998752 23455778999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999987432 35678999999999999999999999 99999999999999999999999999998875443
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+.. .+.........
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~---- 259 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEQCDYPPLP---- 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHH----HHHTTCSCCCC----
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHH----HhhcccCCCCc----
Confidence 221 22345899999999999999999999999999999999999999743221 111111 12222211111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.......+.+++.+||+.||.+|||++||++.|+++.....
T Consensus 260 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 260 ----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11223468899999999999999999999999999988644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.38 Aligned_cols=264 Identities=30% Similarity=0.532 Sum_probs=199.3
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
.|+....|++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|++++++++||||+++++++. ....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccE
Confidence 3555667788899999999999999865 359999987543 344577999999999999999999999764 45689
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999999643 4679999999999999999999999 99999999999999999999999999999765
Q ss_pred ccCc-ccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 510 EEDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 510 ~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
.... ........|++.|+|||.+. +..++.++||||||+++|+|++|+.||...... ....+. ...+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~----~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEM----VGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHH----HHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHH----hcccccC
Confidence 4321 12223345899999999986 667899999999999999999999999743221 122222 2222221
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+. ......+..+.+++.+||+.+|.+|||++|+++.|+++..
T Consensus 245 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 1122334578999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.52 Aligned_cols=268 Identities=25% Similarity=0.394 Sum_probs=204.5
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc--cCCCccccccccccc----
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE---- 425 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~---- 425 (679)
.+.....|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 4455678889999999999999999887 899999998643 234455566666554 899999999998776
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CccccCCCCCCccccCCCc
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP--------GIIHRDVKSSNILLDINMR 497 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~--------~ivH~Dlkp~NIll~~~~~ 497 (679)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCC
Confidence 688999999999999999973 469999999999999999999998 6 9999999999999999999
Q ss_pred EEEeeccCccccccCcccc---cccccCCccccCCcccCCCCCCch------hHHHHHHHHHHHHHhC----------CC
Q 005750 498 AKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KK 558 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~k------sDVwSlGvll~elltG----------~~ 558 (679)
+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997654432221 123468999999999987665554 9999999999999999 66
Q ss_pred CCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 559 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 559 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
||....... ..... .......... .+..... ........+.+++.+||+.||.+|||++||++.|+++....
T Consensus 261 p~~~~~~~~-~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 261 PYHDLVPSD-PSYED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTTSCSS-CCHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cHhhhcCCC-Cchhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 665322211 11111 1111111111 1111111 12256778999999999999999999999999999988754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.74 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=203.3
Q ss_pred HHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccc-cccceEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lV 431 (679)
.|++.+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++ ..++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 35667899999999999998653 3368999987643 34557899999999999999999999985 556688999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 106 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 106 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999974 34568999999999999999999999 9999999999999999999999999999987644
Q ss_pred Ccc---cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 512 DLT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 512 ~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...... ...... ..+...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~----~~~~~~-- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL----LQGRRL-- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHH----HTTCCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH----hcCCCC--
Confidence 321 11223457789999999998899999999999999999999 55566532221 111111 111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+...+..+.+++.+||+.+|.+|||++|+++.|+++...-
T Consensus 252 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 001112346889999999999999999999999999988753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=360.84 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=203.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.++||+|+||+||+|+++ +++.||+|++.+... .....+.+|..++..++||||++++++|.+.+..++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4566889999999999999987 488999999865321 122348899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999742 4679999999999999999999999 999999999999999999999999999998765544
Q ss_pred ccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 514 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ...+......-...
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~p--- 303 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQFP--- 303 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCCC---
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccCC---
Confidence 44444567999999999986 56789999999999999999999999974432211 11111100001111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
.... .....+.+++.+||+.+|++ ||+++|+++.
T Consensus 304 --~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 --TQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --SSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --cccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0001 12346889999999888888 9999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.13 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=212.3
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+....+++.++||+|+||.||+|.++++..||||+++... ...+.+.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3345567889999999999999999988899999997643 335679999999999999999999999876 67899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999743 23468999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+ .+..+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~------- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM------- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH----HHHTTCCC-------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 222233346789999999988899999999999999999999 99999743221 1122 12222111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+......+.+++.+||+.||++|||+++|++.|+++...
T Consensus 484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11122345788999999999999999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.54 Aligned_cols=269 Identities=25% Similarity=0.404 Sum_probs=212.5
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHh--ccCCCcccccccccccc--
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH-- 426 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~-- 426 (679)
..+.....|.+.+.||+|+||.||+|++. ++.||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34566678888999999999999999985 899999998643 34667889999887 68999999999998765
Q ss_pred --eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCccccCCCCCCccccCCC
Q 005750 427 --QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 427 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| + .+|+||||||+||+++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCC
Confidence 78999999999999999973 46899999999999999999999 7 8999999999999999999
Q ss_pred cEEEeeccCccccccCccc---ccccccCCccccCCcccCCC------CCCchhHHHHHHHHHHHHHhC----------C
Q 005750 497 RAKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------K 557 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvll~elltG----------~ 557 (679)
.+||+|||++......... ......|++.|+|||++.+. .++.++|||||||++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 12344689999999998775 334789999999999999999 7
Q ss_pred CCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 558 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 558 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
.||...... ......+..... .... .+.+... ........+.+++.+||+.||.+|||++||++.|+++...+
T Consensus 265 ~p~~~~~~~-~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 265 LPYYDLVPS-DPSVEEMRKVVC-EQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CTTTTTSCS-SCCHHHHHHHHT-TSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCccccCcC-cccHHHHHHHHH-HHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 788633221 111222222211 1111 1111111 12356678999999999999999999999999999987754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.79 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=201.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+++ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4566889999999999999987 58999999986421 1123457899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++||+|.+++.. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999873 358999999999999999999999 999999999999999999999999999998765544
Q ss_pred ccccccccCCccccCCcccCCCC----CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 514 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... ....+......-... +
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~~~~p---~ 296 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMNHKNSLTFP---D 296 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHHCCCC---T
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHHhccccccCC---C
Confidence 33344567999999999987654 7899999999999999999999997443221 111111100000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 628 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 628 (679)
.......+.+++.+||+.+|.+ ||+++||++.
T Consensus 297 -------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 -------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0012246889999999999988 9999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=346.91 Aligned_cols=258 Identities=23% Similarity=0.400 Sum_probs=201.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
...|++.+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 445777899999999999999875 444 3577777543 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+|+||+.+|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999753 4569999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 510 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 510 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
...... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||....... +... +..+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~~~~-- 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERL-- 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCC--
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC--
Confidence 443221 1223346788999999999999999999999999999999 999997443322 2121 1111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+......+.+++.+||+.||.+|||++|+++.|+++...
T Consensus 239 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 -------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11122334688999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=346.16 Aligned_cols=262 Identities=29% Similarity=0.483 Sum_probs=205.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC-----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 427 (679)
+....|.+.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|++++++++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 344556667899999999999998753 2469999997643 3345678999999999999999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999742 4679999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 508 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 508 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...... .+.+ .+..+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~----~~~~~~~ 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMK----AINDGFR 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHCCCc
Confidence 76543221 1122335778999999998899999999999999999999 99999733221 1111 1222211
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
. ..+......+.+++.+||+.+|.+||++.|+++.|+++....
T Consensus 269 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 111123447889999999999999999999999999988743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=352.24 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 6899999999876666678899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc--cCCCcEEEeeccCccccccCcccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 9988642 3568999999999999999999999 999999999999999 5678999999999987654322 22
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCH
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 598 (679)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......... .. ......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~--~~-~~~~~~---- 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW--DL-EDEEFQ---- 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC--CS-CSGGGT----
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC--CC-Chhhhc----
Confidence 3458999999999999999999999999999999999999997433211 1111111110 00 011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 005750 599 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 632 (679)
Q Consensus 599 ~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 632 (679)
.....+.+++.+||+.||.+|||++|+++ .+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12346889999999999999999999997 45544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.03 Aligned_cols=274 Identities=24% Similarity=0.382 Sum_probs=198.9
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHH--HHhccCCCcccccccc-----cccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYC-----EEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~-----~~~~~~~ 429 (679)
..|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+ ......+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 3567789999999999999987 58999999986432 3334444444 4558999999999743 3445678
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CccccCCCCCCccccCCCcEEE
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~kL 500 (679)
+||||+++|+|.+++.. ...++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 99999999999999973 345889999999999999999998 7 9999999999999999999999
Q ss_pred eeccCccccccCcc-------cccccccCCccccCCcccCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCccccc
Q 005750 501 SDFGLSRQAEEDLT-------HISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 566 (679)
Q Consensus 501 ~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~ 566 (679)
+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643221 11223458999999999987 45678999999999999999997776522221
Q ss_pred ch-hh----------HHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 567 AE-LN----------IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 567 ~~-~~----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.. .. .................+.... .........+.+++.+||+.||++|||++|+++.|++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 00 0001111111111111111111 11234566799999999999999999999999999999986
Q ss_pred hcCCCCcc
Q 005750 636 EKGGDQKF 643 (679)
Q Consensus 636 ~~~~~~~~ 643 (679)
-+....+.
T Consensus 320 ~~~~~~~~ 327 (336)
T 3g2f_A 320 WERNKSVS 327 (336)
T ss_dssp CCC-----
T ss_pred HHhcccCC
Confidence 55544443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.38 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=206.0
Q ss_pred HhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceE-EEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lV~ 432 (679)
+...+.||+|+||.||+|.+.+ +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 3446899999999999998642 23799999876433 4557889999999999999999999999766655 9999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+.+|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999975 35678999999999999999999999 99999999999999999999999999999865433
Q ss_pred cc---cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 513 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 513 ~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++|..|+..... ......... .+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~~---- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRRL---- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCCC----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCCC----
Confidence 21 122234578899999999999999999999999999999996655542222 112222211 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
..+......+.+++.+||+.||.+|||++|+++.|+++......
T Consensus 248 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 -----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11112234688999999999999999999999999999876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=349.25 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=202.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4667899999999999999986 69999999986532 2234678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999974 3568999999999999999999999 99999999999999999999999999999876443
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .. ... +..+.. .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~---~~~-i~~~~~------~-- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI---YEK-IVSGKV------R-- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHH-HHHCCC------C--
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HH---HHH-HHcCCC------C--
Confidence 22346899999999999999999999999999999999999999743221 11 111 111211 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.+......+.+++.+||+.||.+||+ ++||++
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122346889999999999999998 888875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.02 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCccccccccc----ccceEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRIL 430 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~l 430 (679)
...|++.+.||+|+||.||++... +++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 345778899999999999999974 79999999987665666788999999999999999999999986 3457899
Q ss_pred EEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 431 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999987532 35679999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCccc--------ccccccCCccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 510 EEDLTH--------ISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 510 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
...... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSVALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchhhHHh---
Confidence 322111 011234789999999987654 688999999999999999999999621111 11111111
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
... . . ..........+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 261 -~~~-~-~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QNQ-L-S-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hcc-C-C-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 110 0 0 00111223478899999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=340.08 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=200.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45777899999999999999976 689999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999974 4568999999999999999999999 99999999999999999999999999999876544
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+..... . +
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~---~-- 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R---P-- 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C---G--
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C---c--
Confidence 333333456899999999999999999999999999999999999999733221 11112221110 0 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhhh
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 636 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 636 (679)
.......+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 255 -~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 -STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001112233688999999999999999 9999999999877643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.42 Aligned_cols=266 Identities=24% Similarity=0.284 Sum_probs=198.6
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-----chhHHHHHHHHHHHHhcc---CCCcccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIH---HRNLVPLIGYC 422 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~ 422 (679)
.++....|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|++++++++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4455667888999999999999999975 68999999986322 112346677888877775 99999999998
Q ss_pred cccc-----eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc
Q 005750 423 EEEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 497 (679)
Q Consensus 423 ~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 497 (679)
.... ..++||||+. |+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 7644 5799999996 6999999854 23459999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 005750 498 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 577 (679)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFD 233 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHH
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999999987644322 234468999999999998899999999999999999999999997433221 1111111
Q ss_pred hHhcC---Ceeeee---cccccC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIKKG---DVISIV---DPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~~~---~~~~~~---d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..... ...... ...... .........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11110 000000 000000 001122347889999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.74 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=204.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
...|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356788899999999999999887 5789999999776556678899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~~~ 511 (679)
+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998874 4568999999999999999999999 999999999999999 7889999999999987654
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... .....|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .... .+..+.... ...
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~-~~~- 229 (277)
T 3f3z_A 162 GKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVML----KIREGTFTF-PEK- 229 (277)
T ss_dssp TSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCC-CHH-
T ss_pred ccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhCCCCC-Cch-
Confidence 322 2334589999999998765 899999999999999999999999743221 1111 111111100 000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .....+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 12346889999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=348.15 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
..|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 45667899999999999999875 344 38888875432 233456778999999999999999999986 456899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999743 3578899999999999999999999 999999999999999999999999999998765
Q ss_pred cCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 511 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 511 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..+. +..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcCCCCCC-
Confidence 43322 2234457889999999998899999999999999999999 999997443322 1111 112211111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+......+.+++.+||+.||.+|||++|+++.|+++...
T Consensus 239 --------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 --------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011122467999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=342.93 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=198.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3567899999999999999986 589999999865432 3356788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++. ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 84 CDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999887 35669999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------HhHhcCCee
Q 005750 515 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGDVI 585 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~ 585 (679)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ .........
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2 223458999999999865 678999999999999999999999997543322211111100 000000000
Q ss_pred ---eeecccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 586 ---SIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 586 ---~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...++..... ........+.+++.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 001223468899999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.59 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=188.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.+.||+|+||.||+|++. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 34677899999999999999987 58899999997542 3466889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~~~~~ 512 (679)
++|+|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++......
T Consensus 131 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 131 TGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999973 4568999999999999999999999 99999999999999975 889999999999875433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ... .. +...... ...
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~-~~~---~~-i~~~~~~-~~~--- 272 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-Q-FMF---RR-ILNCEYY-FIS--- 272 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-H-HHH---HH-HHTTCCC-CCT---
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-H-HHH---HH-HHhCCCc-cCC---
Confidence 2 123345899999999999999999999999999999999999999733221 1 111 11 1111110 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||++|||+.|+++
T Consensus 273 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 --PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123347889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.43 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=193.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 35778899999999999999987 78999999997543 23466889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc--EEEeeccCccccccCc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDL 513 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfgla~~~~~~~ 513 (679)
++|+|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 99 SGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999873 4569999999999999999999999 99999999999999987665 9999999987533221
Q ss_pred ccccccccCCccccCCcccCCCCCCch-hHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~k-sDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ............ ... .
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~-~~~-~----- 241 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSV-KYS-I----- 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTT-CCC-C-----
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcC-CCC-C-----
Confidence 1233458999999999988777655 899999999999999999997433321 122222222211 110 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.........+.+++.+||+.||.+|||++|+++.
T Consensus 242 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 --PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001123468899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=349.06 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=202.2
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 429 (679)
....|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3345777899999999999999987 48899999997532 23346688899999988 7999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999974 3569999999999999999999999 99999999999999999999999999999864
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+ ...... +..
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~-~~~----- 238 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQSIME-HNV----- 238 (353)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHH-CCC-----
T ss_pred ccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HH---HHHHHh-CCC-----
Confidence 32222 233456999999999999999999999999999999999999999743321 11 111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.++......+.+++.+||+.||.+||+ ++||++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011122346889999999999999995 466654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.42 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=208.8
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc-----
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----- 424 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----- 424 (679)
.+......|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 34556677888999999999999999987 79999999987543 356789999999999999999998754
Q ss_pred -----------cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 425 -----------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 425 -----------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 45689999999999999999754 24578999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 573 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~ 573 (679)
.++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+... ..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~ 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH
Confidence 999999999999987654322 22345899999999999989999999999999999999999887511 11
Q ss_pred HHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcC
Q 005750 574 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 638 (679)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 638 (679)
.. ..+..+... ..+ ...+.+++.+||+.||.+|||+.|+++.|+.+....+.
T Consensus 227 ~~-~~~~~~~~~--------~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 227 FF-TDLRDGIIS--------DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HH-HHHHTTCCC--------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HH-HHhhccccc--------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11 111222111 111 23578999999999999999999999999988775443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.32 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=205.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch------hHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999987 6899999998654221 357799999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC----cEEEeecc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 504 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg 504 (679)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 5678999999999999999999999 9999999999999999887 79999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .... . +.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---N-ITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHhccc
Confidence 9987654322 23345899999999999999999999999999999999999999743221 1111 1 111110
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..++..... ....+.+++.+||+.||.+|||++|+++
T Consensus 236 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111111 2246889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.68 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=195.2
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccC--CCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+++..++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 466789999999999999999889999999986542 3345778999999999976 999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
+.+++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++ ++.+||+|||++.......
T Consensus 90 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999984 5678999999999999999999999 9999999999999997 6789999999998765433
Q ss_pred cc-ccccccCCccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 514 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 514 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... . ..........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~----~~~~~~~~~~ 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-Q----ISKLHAIIDP 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-H----HHHHHHHHCT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-H----HHHHHHHhcC
Confidence 22 2234568999999999854 6789999999999999999999999973211 1 1111111211
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. ....+......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 111111123468899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.58 Aligned_cols=262 Identities=24% Similarity=0.428 Sum_probs=211.7
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 426 (679)
+....|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 33456778899999999999999765 378899999975433 34567899999999999999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999987532 12467899999999999999999999 9999999999999999999999
Q ss_pred EeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 005750 500 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 500 L~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 577 (679)
|+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... ....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---- 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR---- 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH----
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH----
Confidence 9999999865443221 2223346889999999988889999999999999999999 89999743221 1111
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+..+.... ........+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 252 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 122222111 112233468899999999999999999999999998766
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.50 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=198.1
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
..++....|++.++||+|+||+||+|++. +|+.||||++.... .........|+..+.++ +||||+++++++.+.+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34566778889999999999999999987 79999999986543 23344556666666665 8999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 67998888753 4569999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
........ .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..... . ..+..+...
T Consensus 205 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~-----~~~~~~~~~- 270 (311)
T 3p1a_A 205 VELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----W-----QQLRQGYLP- 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----H-----HHHTTTCCC-
T ss_pred eecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----H-----HHHhccCCC-
Confidence 87644322 233458999999999886 689999999999999999999777652111 1 111111111
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.... .....+.+++.+||+.||++|||++|+++
T Consensus 271 ---~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 12347889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=334.16 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=206.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccc-cccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E 433 (679)
...|++.+.||+|+||.||+|++. +++.||||++.... ....+.+|+++++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 356778899999999999999874 78999999875432 224578899999999988877777665 56778899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCccccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~~ 510 (679)
|+ +++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998742 4569999999999999999999999 999999999999999 789999999999998765
Q ss_pred cCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 511 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 511 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 43321 123456899999999999999999999999999999999999999854433222222221111111110
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+..... .+..+.+++.+||+.||++|||++||++.|+++.....
T Consensus 240 -----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000111 12478899999999999999999999999999987544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.94 Aligned_cols=258 Identities=29% Similarity=0.443 Sum_probs=197.4
Q ss_pred HhhccccCcCccEEEEEEEEc--C--CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccc-ccceEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK--D--GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 432 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lV~ 432 (679)
|++.+.||+|+||.||+|.+. + +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456789999999999999864 2 2468999987543 345678999999999999999999999864 456789999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999974 34568999999999999999999999 99999999999999999999999999999865433
Q ss_pred ccc---ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 513 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 513 ~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
... ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+ ....+ ..+... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRL--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCCC--C
Confidence 211 1223346788999999998899999999999999999999 677776333222 11111 111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.+...+..+.+++.+||+.||.+|||++|+++.|+++...-.
T Consensus 317 -------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 -------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223478899999999999999999999999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=333.12 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=207.3
Q ss_pred HHhhccccCcCccEEEEEEEE-cCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccc-cccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||.||+|++ .+++.||+|++..... .+.+.+|+++++.++|++++..+.++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 466789999999999999997 4799999999865432 34688999999999988877766655 5567789999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~~~~ 512 (679)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++......
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999742 4579999999999999999999999 999999999999999 48899999999999876544
Q ss_pred ccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 513 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 513 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 321 123446899999999999999999999999999999999999999854433222222221111111000
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+.+... .+..+.+++.+||+.||.+|||++||++.|+++.....
T Consensus 240 ---~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ---EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 001111 22468899999999999999999999999999887544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.31 Aligned_cols=263 Identities=26% Similarity=0.433 Sum_probs=200.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccc-
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH- 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 426 (679)
+....|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34456777899999999999999765 3458999998754 2344577899999999999999999999987654
Q ss_pred ----eEEEEEEecCCCcHhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEE
Q 005750 427 ----QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 499 (679)
Q Consensus 427 ----~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 499 (679)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 3599999999999999985322 34679999999999999999999999 9999999999999999999999
Q ss_pred EeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 005750 500 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 500 L~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 577 (679)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~-- 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL-- 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH--
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH--
Confidence 999999987644322 12223446889999999999999999999999999999999 899997433321 11111
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+... ..+......+.+++.+||+.||.+|||++++++.|+++...
T Consensus 263 --~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 263 --LHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 11112234788999999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=356.59 Aligned_cols=254 Identities=24% Similarity=0.252 Sum_probs=201.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|+.+ +|+.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34566789999999999999986 69999999997532 122345889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++... +..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 141 E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp CCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999742 3479999999999999999999999 99999999999999999999999999999876554
Q ss_pred cccccccccCCccccCCcccC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 513 LTHISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||...+.... ...+......-..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~~~~~- 291 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKIVHYKEHLSL- 291 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccCcCC-
Confidence 433334457999999999986 45789999999999999999999999974332211 1111110000000
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVLA 628 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 628 (679)
+.. .......+.+++.+||+ +|.+| |+++||++.
T Consensus 292 ----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 100 11123468899999999 99998 589998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.27 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=197.0
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccc----eE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QR 428 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~ 428 (679)
..|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 35777899999999999999874 78999999997642 233467889999999999999999999987654 34
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 92 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999974 4579999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 509 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 509 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCc
Confidence 6543221 223345899999999999999999999999999999999999999743221 11111222111110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV-LAIQDSIKI 635 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~~~~~ 635 (679)
... .......+.+++.+||+.||.+||++.+++ +.+......
T Consensus 240 ---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 ---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 000 011234688999999999999999666554 556555443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.78 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=206.2
Q ss_pred HHHhhcc-ccCcCccEEEEEEEEc---CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 357 ATNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 357 ~~~~~~~-~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
..|.+.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455666 8999999999999653 47889999997543 23357899999999999999999999999 5567899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999984 4569999999999999999999999 999999999999999999999999999998765
Q ss_pred cCcccc--cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 511 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 511 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERM-- 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC--
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCC--
Confidence 433221 122336788999999988889999999999999999999 99999743221 1111 12222111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
..+......+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 240 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1112234578899999999999999999999999999887544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.09 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=211.1
Q ss_pred HHHHhhccccCcCccEEEEEEEE------cCCcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccccc-
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH- 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~- 426 (679)
...|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 45677889999999999999975 2468999999976543 3456789999999999 7999999999987654
Q ss_pred eEEEEEEecCCCcHhhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999985431 1238999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 005750 494 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 571 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~ 571 (679)
.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... ..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~ 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HH
Confidence 999999999999987644322 22233457889999999988899999999999999999998 999997433221 11
Q ss_pred HHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.. .+..+.... .+......+.+++.+||+.||.+|||+.||++.|+++.+...
T Consensus 261 ~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 261 CR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HH----HhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11 122221111 111123468899999999999999999999999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.94 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=211.7
Q ss_pred HHHHhhccccCcCccEEEEEEEE-----cCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc--eE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~ 428 (679)
...|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 44567789999999999999984 368999999998776667788999999999999999999999886644 78
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999753 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccccc---------chhhHHHHHHH
Q 005750 509 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 577 (679)
Q Consensus 509 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~~~ 577 (679)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ........+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543321 122334677899999998888999999999999999999999998632110 00111111122
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+..+... ..+...+..+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22221111 11222345788999999999999999999999999998763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=330.22 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56778899999999999999886 68999999986432 34457889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++. ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 35679999999999999999999999 9999999999999999999999999999986543221
Q ss_pred -cccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 515 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 515 -~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ......+.. .... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~~~~---~---- 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE----KKTY---L---- 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHT----TCTT---S----
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhh----cccc---c----
Confidence 12234568999999999987665 78999999999999999999999743322 112222211 1000 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||.+|||++|+++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122346889999999999999999999876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.22 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=201.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|++.+.||+|+||.||+|..+ +++.||+|++.+... ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456788899999999999999887 689999999975432 235688888888 79999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC----CcEEEeeccCcccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 509 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfgla~~~ 509 (679)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||+.++ +.+||+|||++...
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999973 5679999999999999999999999 999999999999998432 35999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+.. .+..+...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFS---- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCC----
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcc----
Confidence 54322 2234468999999999988888999999999999999999999997433222222222 22222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+...........+.+++.+||+.||.+|||+.|+++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111223347889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.26 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=198.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888999999999999999876 68999999987543 3345789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCcccc
Q 005750 434 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQA 509 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~ 509 (679)
|+++|+|.+.+.... ....+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886432 34679999999999999999999999 999999999999999 45688999999999875
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
..... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||....... ... .... ........
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~---~~~~-~~~~~~~~ 247 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQ---KATY-KEPNYAVE 247 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CCCCCCC-
T ss_pred CCccc--CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHh---hhcc-CCcccccc
Confidence 44322 233458999999999864 68999999999999999999999997433221 111 1111 11000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ....+.+++.+||+.||.+|||++|+++
T Consensus 248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1246789999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.36 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=199.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-----cchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 466788999999999999999875 6889999998643 2345578999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 005750 430 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 472 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~aL~~L 472 (679)
+||||+++|+|.+++.... ....+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 022346778889999999999999
Q ss_pred HhcCCCCccccCCCCCCccccCCC--cEEEeeccCccccccCcc---cccccccCCccccCCcccCC--CCCCchhHHHH
Q 005750 473 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 545 (679)
Q Consensus 473 H~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS 545 (679)
|+ ++|+||||||+||+++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99 9999999999999998776 899999999986543221 12234568999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005750 546 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 625 (679)
Q Consensus 546 lGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 625 (679)
|||++|+|++|+.||...... +............. .+ ........+.+++.+||+.||.+|||+.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NP-----NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SG-----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Cc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999999743321 11112222111000 00 011123468899999999999999999999
Q ss_pred HH
Q 005750 626 VL 627 (679)
Q Consensus 626 l~ 627 (679)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.37 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=199.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 4667899999999999999876 578999999864321 224678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999874 3568999999999999999999998 999999999999999999999999999986544322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... . +.....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~--------- 224 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK---R-ISRVEF--------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHHTCC---------
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHH---H-HHhCCC---------
Confidence 223458999999999999999999999999999999999999997433221 111 1 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111223468899999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.81 Aligned_cols=269 Identities=19% Similarity=0.202 Sum_probs=201.7
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCcch-----------hHHHHHHHHHHHHhccCCCccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVP 417 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~ 417 (679)
++....|.+.+.||+|+||.||+|.+. ++..||+|+....... ....+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 344456778899999999999999886 5788999998754321 1134667889999999999999
Q ss_pred ccccccc----cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 418 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 418 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
+++++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence 9999877 77899999999 9999999984 3379999999999999999999999 9999999999999998
Q ss_pred CCC--cEEEeeccCccccccCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc
Q 005750 494 INM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 565 (679)
Q Consensus 494 ~~~--~~kL~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~ 565 (679)
.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999876433211 11344689999999999999999999999999999999999999963222
Q ss_pred cchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 566 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
. .......... .... ....+..... ....+..+.+++.+||+.||.+|||+++|++.|+++..
T Consensus 266 ~-~~~~~~~~~~-~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 D-PVAVQTAKTN-LLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp C-HHHHHHHHHH-HHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred c-cHHHHHHHHh-hccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 1111111111 1111 0000000000 00223478899999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.95 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=202.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
...|.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457788999999999999999886 6999999999866555556789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~~~ 511 (679)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999874 4568999999999999999999999 999999999999999 7889999999999876543
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+ .+..+... ...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~~--~~~- 228 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----KIKEGYYE--FES- 228 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHCCCC--CCT-
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCC--CCc-
Confidence 21 22335899999999999999999999999999999999999999743221 1111 11122110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||.+|||++|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 ---PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111123357889999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.24 Aligned_cols=263 Identities=24% Similarity=0.262 Sum_probs=204.1
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-----CCCccccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEEE 425 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~ 425 (679)
.++....|.+.++||+|+||.||+|++. +++.||||++... ....+.+..|+++++.++ ||||+++++++...
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 3444557888999999999999999885 6899999999743 344566788999999996 99999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-----------
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----------- 494 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----------- 494 (679)
+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred CeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchh
Confidence 9999999999 99999999854 23468999999999999999999999 99999999999999975
Q ss_pred --------------CCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 495 --------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 495 --------------~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998654322 2346899999999999999999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhHhcC-----------Ceeeeecc-c----ccCCC-CH---------------HHHHHHHHHH
Q 005750 561 SVEDFGAELNIVHWARSMIKKG-----------DVISIVDP-V----LIGNV-KI---------------ESIWRIAEVA 608 (679)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~d~-~----l~~~~-~~---------------~~~~~l~~li 608 (679)
......... ..+....... .....++. . ..... .. .....+.+++
T Consensus 260 ~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 260 RTHEHMEHL---AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CCSSHHHHH---HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCcHHHHH---HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 744322211 1111111000 00000000 0 00000 00 0114677999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 005750 609 IQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 609 ~~cl~~dP~~RPt~~evl~ 627 (679)
.+||+.||.+|||++|+++
T Consensus 337 ~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCChhhCCCHHHHhc
Confidence 9999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=346.34 Aligned_cols=264 Identities=30% Similarity=0.502 Sum_probs=208.9
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc-CCcE--EEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
+.+....|++.+.||+|+||.||+|++. ++.. ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 3444466788999999999999999876 5664 4999887532 33456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEc
Confidence 9999999999999999997532 23479999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 572 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~ 572 (679)
.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------ 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ 248 (327)
T ss_dssp GGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------
T ss_pred CCCeEEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------
Confidence 999999999999875432211 122346789999999988889999999999999999998 99999743221
Q ss_pred HHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 573 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
+... .+..+... ..+......+.+++.+||+.+|.+|||++|+++.|+++....
T Consensus 249 ~~~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 249 ELYE-KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHH-HGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHH-HhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 12222110 111223357889999999999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=344.34 Aligned_cols=265 Identities=16% Similarity=0.196 Sum_probs=206.7
Q ss_pred HHHhhccccCcCccEEEEEEEEcC---------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccc---------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL--------- 418 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l--------- 418 (679)
..|.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 456778999999999999998764 789999998754 467899999999999999984
Q ss_pred ------cccccc-cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcc
Q 005750 419 ------IGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 491 (679)
Q Consensus 419 ------~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 491 (679)
++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 455544 67889999999 99999999853 23679999999999999999999999 99999999999999
Q ss_pred ccCCC--cEEEeeccCccccccCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 005750 492 LDINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 563 (679)
Q Consensus 492 l~~~~--~~kL~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~ 563 (679)
++.++ .+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99988 8999999999876543221 112346899999999999999999999999999999999999999743
Q ss_pred cccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 564 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
... ...+......... ......+.... .......+.+++.+||+.||.+|||++||++.|+++.....
T Consensus 272 ~~~-~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPN-TEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTC-HHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcC-HHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 322 2222222222211 11112211110 00112478899999999999999999999999999987644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=336.54 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=199.3
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc-cceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 435 (679)
..|++.+.||+|+||.||+|..+ |+.||||++.... ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 45778899999999999999876 8999999987543 45778999999999999999999998654 45789999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999743 12347899999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+..+.. .
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~-----~---- 233 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGYK-----M---- 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTCC-----C----
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCCC-----C----
Confidence 22346889999999988899999999999999999998 99999743322 1111 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+...+..+.+++.+||+.||.+|||+.|+++.|+++...+
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 111223457889999999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.29 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=203.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4667899999999999999987 799999999865321 234678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999997 35679999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .+.. .+..+...
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~----~i~~~~~~------- 234 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFK----KICDGIFY------- 234 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHH----HHHTTCCC-------
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCcC-------
Confidence 2 234468999999999988765 78999999999999999999999743321 1111 11122110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.||.+|||++|+++
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01112246889999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.39 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=211.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 427 (679)
...|.+.+.||+|+||.||+|.+.. .+.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4556778999999999999998753 2489999997653 34557799999999999 89999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 428 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999987532 13468999999999999999999999 9999999999999999999
Q ss_pred cEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 005750 497 RAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 574 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 574 (679)
.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHH
Confidence 9999999999875443221 2223446789999999988899999999999999999998 999997433221 11121
Q ss_pred HHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 575 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
. ..+... ..+...+..+.+++.+||+.||.+|||++||++.|+++....
T Consensus 280 ~----~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 280 V----KDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp H----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----hcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1 111110 011112347889999999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.07 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=196.2
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhcc--CCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 46778999999999999999888999999998653 2345578999999999996 5999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
+.+++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||++.......
T Consensus 137 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp -CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred -cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 568899999984 4578999999999999999999999 9999999999999995 5899999999998765433
Q ss_pred cc-ccccccCCccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 514 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 514 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... . .......+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~----~~~~~~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-Q----ISKLHAIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-H----HHHHHHHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-H----HHHHHHHhCc
Confidence 22 2234569999999999865 4689999999999999999999999973221 1 1111222211
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
... ...+......+.+++.+||+.||.+|||++|+++.
T Consensus 284 ~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 11111113468899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.49 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=194.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHH-HHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..|++.+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 45778899999999999999987 588999999975432 233456677776 5678999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999974 4568999999999999999999999 9999999999999999999999999999986433
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. ...... +.. .
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~-~~~------~ 257 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM---YDNILN-KPL------Q 257 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HH---HHHHHH-SCC------C
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHHh-ccc------C
Confidence 221 233456999999999999999999999999999999999999999743221 11 111111 111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
+ +......+.+++.+||+.||.+||++.+.++.+.
T Consensus 258 ~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 258 L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp C----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred C----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 1 1112346889999999999999999865444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.23 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=201.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhccCCCccccccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 425 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 425 (679)
....|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3456778899999999999999875 689999999875421 1334577899999999999999999999999
Q ss_pred ceEEEEEEecCCC-cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 426 HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 426 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
+..++||||+.+| +|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997 35679999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ..
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~--- 238 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE--- 238 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT---
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh---
Confidence 9987654332 223458999999999988776 88999999999999999999999731110 00
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
... ..+......+.+++.+||+.||.+|||++|+++.
T Consensus 239 ------~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ------AAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------hcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011123468899999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.21 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=202.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 4667899999999999999876 58999999986532 33457788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc---EEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfgla~~~~~ 511 (679)
+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999988874 4568999999999999999999999 99999999999999976655 99999999977654
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... +..+... ...+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~----~~~~~~~-~~~~- 229 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYD-YPSP- 229 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCC-CCTT-
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHH----HHhcccc-CCch-
Confidence 332 22345899999999999999999999999999999999999999743221 11111 1111111 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
........+.+++.+||+.||.+|||++|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01122346889999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.12 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=181.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 4667899999999999999875 799999999864321 224678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 92 MCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999742 3578999999999999999999999 999999999999999999999999999998764332
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .... .. +..
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~------~~~-- 230 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV-LA------DYE-- 230 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS------CCC--
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh-hc------ccC--
Confidence 21 22345899999999999988999999999999999999999999743322110 0000 00 001
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 --MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11122346889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=367.06 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=203.0
Q ss_pred ccCcCccEEEEEEEEc---CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCc
Q 005750 364 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
.||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 46789999997643 3456789999999999999999999999976 56899999999999
Q ss_pred HhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc--c
Q 005750 440 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 517 (679)
Q Consensus 440 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~--~ 517 (679)
|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999743 4569999999999999999999999 999999999999999999999999999998764432211 1
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+ .+..+... ..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~---------~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRM---------EC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH----HHHTTCCC---------CC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCCC---------CC
Confidence 22235689999999998899999999999999999998 99999743322 1222 22222211 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+...+..+.+++.+||+.+|++||++++|++.|+.+.....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 22334578899999999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.98 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=205.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc------hhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456788999999999999999987 689999999865321 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC----cEEEeecc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 504 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg 504 (679)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999973 4578999999999999999999999 9999999999999998877 89999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...... .... . +.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLT---N-ISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---H-HHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHH---H-hHhccc
Confidence 9987644322 22345899999999999999999999999999999999999999743321 1111 1 111111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 634 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 634 (679)
. ..+.... .....+.+++.+||+.||.+|||+.|+++ .++.+..
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 0000001 12346889999999999999999999997 4565544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.07 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=196.6
Q ss_pred Hhh-ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEec
Q 005750 359 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 359 ~~~-~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
|++ .+.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 445 367999999999999865 6999999999776555667899999999985 7999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc---EEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfgla~~~~~~ 512 (679)
++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999974 4568999999999999999999999 99999999999999988776 999999998765322
Q ss_pred cc------cccccccCCccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCcccccch--------hhHHH
Q 005750 513 LT------HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIVH 573 (679)
Q Consensus 513 ~~------~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~--------~~~~~ 573 (679)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11123458999999999865 4578999999999999999999999975432210 00011
Q ss_pred HHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 574 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+..+... ..+. ... .....+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111122222110 0000 000 12346889999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.25 Aligned_cols=267 Identities=27% Similarity=0.458 Sum_probs=209.5
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccc
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 424 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 424 (679)
.++....|++.+.||+|+||.||+|++. +++.||||++.... .....++.+|+.++++++||||+++++++..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3455667888999999999999999842 47799999997543 3455678999999999999999999999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMR 497 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 497 (679)
.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999998643 12458999999999999999999999 99999999999999984 456
Q ss_pred EEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 005750 498 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 575 (679)
Q Consensus 498 ~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 575 (679)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||..... ....+.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~- 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF- 257 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH-
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHH-
Confidence 99999999876433221 12223457889999999988889999999999999999998 9999973322 112221
Q ss_pred HHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 576 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+..+... .........+.+++.+||+.||.+||++.||++.|+.+.....
T Consensus 258 ---~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 ---VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---HhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 1121111 1111223478899999999999999999999999998877543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=334.01 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 34667899999999999999987 58899999986532 345577889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999998873 4578999999999999999999999 99999999999999999999999999999876433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... +..... .+
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~------~~ 234 (294)
T 2rku_A 169 GER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLR-IKKNEY------SI 234 (294)
T ss_dssp TCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTTCC------CC
T ss_pred ccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhhccC------CC
Confidence 222 233458999999999999899999999999999999999999997433211 1111 111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+......+.+++.+||+.||++|||++|+++.
T Consensus 235 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 ----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223468899999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=340.46 Aligned_cols=247 Identities=29% Similarity=0.398 Sum_probs=200.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
...|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345777899999999999999874 79999999986532 23346789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+. |+|.+.+... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6888877542 4678999999999999999999999 9999999999999999999999999999987543
Q ss_pred CcccccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ........... ..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~-~~-- 272 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PA-- 272 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CC--
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC-CC--
Confidence 2 2345899999999983 567899999999999999999999999733221 11111222111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. .......+.+++.+||+.||.+|||++|+++.
T Consensus 273 ---~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ---LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 11123468899999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.67 Aligned_cols=260 Identities=19% Similarity=0.256 Sum_probs=192.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
..|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 35778899999999999999876 789999999975432 234567899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-----CCCcEEEeeccCccc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVSDFGLSRQ 508 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kL~Dfgla~~ 508 (679)
|++ |+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 114 ~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 114 YAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred cCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 997 599999874 4569999999999999999999999 9999999999999994 555699999999987
Q ss_pred cccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---e
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 584 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~ 584 (679)
....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+..... ...... .
T Consensus 187 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~ 262 (329)
T 3gbz_A 187 FGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFE-VLGLPDDTTW 262 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTTTS
T ss_pred cCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHH-HhCCCchhhh
Confidence 6433222 2234579999999998774 58999999999999999999999997433221 1111111 111000 0
Q ss_pred eeee--------cccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIV--------DPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~--------d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... .+...... .......+.+++.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000000 0012346889999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=332.54 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=197.7
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCCcH
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
...||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 358999999999999875 6889999999876666677899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCccccccCccccccc
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 519 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla~~~~~~~~~~~~~ 519 (679)
.+++........+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999865444567899999999999999999999 99999999999999987 89999999999987644322 1233
Q ss_pred ccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 520 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 520 ~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
..|++.|+|||++.+. .++.++||||||+++|+|++|+.||........ .... .... .. .+. .+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~~~~-~~-----~~~----~~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFK---VGMF-KV-----HPE----IP 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHH---HHHH-CC-----CCC----CC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHh---hccc-cc-----ccc----cc
Confidence 4589999999998664 378999999999999999999999963222111 1111 0010 00 111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 223347889999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.19 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=193.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 35777899999999999999876 6899999998753 2233456788999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+||+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999874 4578999999999999999999995 279999999999999999999999999999864333
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .... ... .
T Consensus 303 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~-~~~------~- 367 (446)
T 4ejn_A 303 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILM-EEI------R- 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CCC------C-
T ss_pred Cc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHHh-CCC------C-
Confidence 22 223456999999999999999999999999999999999999999743321 1111 1111 111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1112234688999999999999999 9999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.97 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4677899999999999999987 589999999865432 3356688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++++|.+++. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999988866 34579999999999999999999999 9999999999999999999999999999987544322
Q ss_pred cccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH----------hHhcCC
Q 005750 515 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS----------MIKKGD 583 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~----------~~~~~~ 583 (679)
. .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||........ ....... ......
T Consensus 180 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 V-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcc
Confidence 2 2334589999999998775 789999999999999999999999974432211 1111100 000000
Q ss_pred -eeeeecccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 -VISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 -~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
......+...... .......+.+++.+||+.||.+|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000001111111 1123457899999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.89 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=192.0
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhcc-CCCccccccccccc--ce
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQ 427 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~ 427 (679)
.....|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34456778899999999999999876 6899999998653 2345567889999999997 99999999998644 37
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 689998873 468999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCc--------------------ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccccc
Q 005750 508 QAEEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 566 (679)
Q Consensus 508 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~ 566 (679)
...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 653211 111233468999999999876 67899999999999999999999999754432
Q ss_pred chhhHHHHHHHhHhcCCeeee---ec-----------------ccccCCC-------------CHHHHHHHHHHHHHhcc
Q 005750 567 AELNIVHWARSMIKKGDVISI---VD-----------------PVLIGNV-------------KIESIWRIAEVAIQCVE 613 (679)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~---~d-----------------~~l~~~~-------------~~~~~~~l~~li~~cl~ 613 (679)
.. ...+...+.......+ .. ....... .......+.+++.+||+
T Consensus 238 ~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HH---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HH---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 21 1111111110000000 00 0000000 00123468899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005750 614 QRGFSRPKMQEIVLA 628 (679)
Q Consensus 614 ~dP~~RPt~~evl~~ 628 (679)
.||.+|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=339.16 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=203.2
Q ss_pred hHHHHHHHhhc-cccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 352 PELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 352 ~~l~~~~~~~~-~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
.+.....|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445566665 88999999999999887 69999999987543 23357889999999999 5799999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeec
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDF 503 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Df 503 (679)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999998643 34679999999999999999999999 99999999999999987 789999999
Q ss_pred cCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 504 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 504 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
|++........ .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ...+. ...
T Consensus 179 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~----~~~ 249 (327)
T 3lm5_A 179 GMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNIS----QVN 249 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HTC
T ss_pred ccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHH----hcc
Confidence 99987654322 2234589999999999999999999999999999999999999974332211 11111 111
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. .............+.+++.+||+.||.+|||++|+++.
T Consensus 250 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 V------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00011112233468899999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.26 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=202.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccc--cccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~lV~ 432 (679)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ ......++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4667899999999999999886 68999999997542 34557799999999999999999999987 4467899999
Q ss_pred EecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----ccccCCCCCCccccCCCcEEEeeccCc
Q 005750 433 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999997543 34569999999999999999999999 77 999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
......... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+.+ .+..+....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG----KIREGKFRR 235 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCCCC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH----HHhhccccc
Confidence 876443221 2234589999999999998999999999999999999999999974322 11111 222222211
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 630 (679)
.+......+.+++.+||+.||.+|||++||++.+.
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11122347889999999999999999999988554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.99 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=204.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+....|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34456777899999999999999887 68999999997653 34457799999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 110 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999974 3568999999999999999999998 5 89999999999999999999999999987653
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH-H--------hHh-
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-S--------MIK- 580 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-~--------~~~- 580 (679)
... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+............ . ...
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 321 223468999999999999999999999999999999999999997433221110000000 0 000
Q ss_pred -------------cCCeeeeec----ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 581 -------------KGDVISIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 581 -------------~~~~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.....+.++ ..............+.+++.+||+.||.+|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000 000000011123468899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.00 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=193.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCccccccccccc------ceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~ 428 (679)
.|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4677899999999999999876 6899999999754 234457788999999999999999999998554 467
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999975 5666664 248999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHHH-------------
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHW------------- 574 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~~------------- 574 (679)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+... +.+.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 65432 2234568999999999999999999999999999999999999998544322111 1000
Q ss_pred --HHHhHhcCC-e-----eeeecccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 575 --ARSMIKKGD-V-----ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 575 --~~~~~~~~~-~-----~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......... . ...+...+.... .......+.+|+.+||+.||.+|||++|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0 000000000000 01124578999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=333.74 Aligned_cols=247 Identities=29% Similarity=0.432 Sum_probs=204.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3667899999999999999875 68999999987543 345678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 103 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999986 3568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... +..+.. +.+...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~~~~ 242 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPKNNP-----PTLEGN 242 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSCC-----CCCCSS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhcCCC-----CCCccc
Confidence 123345899999999999999999999999999999999999999733221 11111 111111 111112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
....+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 ----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23468899999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=368.82 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=200.3
Q ss_pred cccCcCccEEEEEEEEc---CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
++||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999664 468899999976432 345789999999999999999999999965 458899999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc--c
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT--H 515 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~--~ 515 (679)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 5679999999999999999999999 9999999999999999999999999999987654322 1
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.... ...+ .+..+...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~--------- 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERM--------- 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC---------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------
Confidence 1223346788999999999899999999999999999998 99999743321 1111 22222211
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+...+..+.+++.+||+.||++||++++|++.|+++..
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122334578899999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.28 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=203.1
Q ss_pred HHHhhccccCcCccEEEEEEEE----cCCcEEEEEEecCCc----chhHHHHHHHHHHHHhc-cCCCcccccccccccce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 427 (679)
..|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4577889999999999999987 368999999986532 22345677899999999 69999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 3568999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC---
Confidence 765444433445569999999999985 3578999999999999999999999974333221 112222222111
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
+ ..+......+.+++.+||+.||.+|| +++|+++.
T Consensus 283 ----~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ----P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1 11122234688999999999999999 99999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.64 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=202.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45677899999999999999886 58899999986432 122467889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999974 3568999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... . ... +..... .
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~-~~~~~~------~- 230 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---T---HRR-IVNVDL------K- 230 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHH-HHTTCC------C-
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---H---HHH-Hhcccc------C-
Confidence 2 233458999999999999999999999999999999999999997432211 1 111 111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.||.+|||++|+++
T Consensus 231 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 ---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11122346889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.95 Aligned_cols=245 Identities=29% Similarity=0.436 Sum_probs=196.5
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc----cceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV 431 (679)
|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456788999999999999876 6889999998653 23456778999999999999999999998754 4568999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCcccc-CCCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~ 508 (679)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+ .+ |+||||||+||+++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999974 3568999999999999999999998 78 99999999999997 789999999999976
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..... ....+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR----RVTSGVKPASF 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----HHTTTCCCGGG
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH----HHhccCCcccc
Confidence 44332 223458999999998875 5899999999999999999999999732221 11111 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+. .....+.+++.+||+.||.+|||++|+++
T Consensus 252 ~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11236889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.13 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=199.9
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 430 (679)
....|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467788999999999999999987 7999999998754 234557788999999999 99999999999999999999
Q ss_pred EEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC--------------
Q 005750 431 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------- 495 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 495 (679)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997542 23668999999999999999999999 999999999999999844
Q ss_pred -----CcEEEeeccCccccccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchh
Q 005750 496 -----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 569 (679)
Q Consensus 496 -----~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~ 569 (679)
..+||+|||.+....... ...|++.|+|||.+.+. .+++++|||||||++|+|++|.+|+...+
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999998765432 23489999999999776 66789999999999999999998775221
Q ss_pred hHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 570 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .+..+.... + +......+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~-----~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWH-----EIRQGRLPR-----I----PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH-----HHHTTCCCC-----C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-----HHHcCCCCC-----C----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 112222111 1 1122346889999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.11 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=188.7
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc----cceEEEEEEecC
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYMH 436 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~lV~E~~~ 436 (679)
+.||+|+||.||+|.++ +++.||||++... ..+.+|++++.++ +||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999876 6899999998643 4567888887554 89999999998865 667899999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccccccCc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~~~~~~ 513 (679)
+|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999853 23569999999999999999999999 99999999999999987 7899999999998654322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... +..+... ...+
T Consensus 219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~-~~~~-- 289 (400)
T 1nxk_A 219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE-FPNP-- 289 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-CCTT--
T ss_pred c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-CCCc--
Confidence 1 2344689999999999999999999999999999999999999974432211 111111 1111111 0000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
........+.+++.+||+.||.+|||++|+++.
T Consensus 290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011223468899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.26 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=203.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
..|.+.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45667899999999999999887 5889999998653 2345577899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998873 4578999999999999999999999 99999999999999999999999999999876433
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... . ... +..... .+
T Consensus 195 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~-~~~~~~------~~ 260 (335)
T 2owb_A 195 GER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T---YLR-IKKNEY------SI 260 (335)
T ss_dssp TCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHH-HHHTCC------CC
T ss_pred ccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---H---HHH-HhcCCC------CC
Confidence 221 233458999999999998889999999999999999999999997432211 1 111 111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. .....+.+++.+||+.||.+|||++|+++
T Consensus 261 ~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 PK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 12246789999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=359.65 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=204.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+.+ +|+.||+|++.+.. ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 3556789999999999999886 69999999986532 2234668899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++||+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 265 y~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999998753 23459999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch-hhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+... +.....
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i~~~~~-------- 406 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----VKEVPE-------- 406 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----HHHCCC--------
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----hhcccc--------
Confidence 2 2234699999999999999999999999999999999999999985433211 112221 111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
.++......+.+++.+||+.||.+|| +++||++
T Consensus 407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11112234788999999999999999 7888875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.88 Aligned_cols=192 Identities=26% Similarity=0.393 Sum_probs=154.0
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccc-----ccceE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-----EEHQR 428 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~~ 428 (679)
..|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++. .....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 35778899999999999999876 68999999986532 344577899999999999999999999984 34578
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
|+||||+ +|+|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 579999987 35679999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcc--------------------------cccccccCCccccCCccc-CCCCCCchhHHHHHHHHHHHHHh
Q 005750 509 AEEDLT--------------------------HISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELIS 555 (679)
Q Consensus 509 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvll~ellt 555 (679)
...... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 643211 112334689999999976 56679999999999999999999
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.65 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=194.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3567889999999999999987 7899999998654322 1224567999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
+ |+|.+++... ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 83 D-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp S-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 7 5898888753 4568999999999999999999999 99999999999999999999999999999865433222
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC---Ceeeeec--
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD-- 589 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-- 589 (679)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+....... .......
T Consensus 157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 -YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcch
Confidence 223457999999999876 578999999999999999999999997543322 122222211110 0000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 -------~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00112346789999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.20 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=194.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|.+.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4667899999999999999987 79999999986432 1234678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999974 3568999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ...+ .+..+.. ..
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~------~~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFK----KIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH----HhhcCcc------cC
Confidence 2 223458899999999988765 68999999999999999999999743221 1111 1111111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+......+.+++.+||+.||.+|||++|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123468899999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.18 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=198.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccc--------c
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 425 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 425 (679)
..|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 35778899999999999999985 789999999865432 234678899999999999999999999876 4
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
+..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 777777643 3569999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCc---ccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 506 SRQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 506 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98754322 112233458999999999876 46899999999999999999999999854332221111111110000
Q ss_pred CCeeee-----ecc---cccCCCCH-HH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 582 GDVISI-----VDP---VLIGNVKI-ES------IWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 582 ~~~~~~-----~d~---~l~~~~~~-~~------~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...... .+. ........ .. ...+.+++.+||+.||.+|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 000 00000000 00 2357899999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.56 Aligned_cols=263 Identities=20% Similarity=0.208 Sum_probs=197.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-----hHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
...|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 356778899999999999999986 5899999998753221 1246789999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 89 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999975 888888742 4568889999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---ee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI 585 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~ 585 (679)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+..... ...... ..
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~-~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE-TLGTPTEEQWP 238 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTTTSS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HcCCCChhhhh
Confidence 54322 22334589999999998654 58999999999999999999999997433211 1111111 111100 00
Q ss_pred ------eeecccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 586 ------SIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 586 ------~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.+........+ ......+.+++.+||+.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000001 1223578999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=332.91 Aligned_cols=259 Identities=28% Similarity=0.408 Sum_probs=198.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc--CCc--EEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...|++.+.||+|+||.||+|++. +++ .||+|+++.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 346778899999999999999864 233 6899998754 2345678999999999999999999999998765 7
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999753 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 509 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 509 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .. ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI---LHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HH---HHHHHccCCCC
Confidence 6543321 1223447788999999988889999999999999999999 99999743221 11 11222211110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.........+.+++.+||+.||.+|||++++++.|+++...
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01112335788999999999999999999999999987764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=349.15 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=193.2
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--------chhHHHHHHHHHHHHhccCCCccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
......|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445567888999999999999999876 68999999986432 112235789999999999999999999986
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC---CcEEE
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 500 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL 500 (679)
.+ ..++||||+++|+|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.+ ..+||
T Consensus 211 ~~-~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AE-DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SS-EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cC-ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 54 5799999999999999887 35679999999999999999999999 999999999999999754 45999
Q ss_pred eeccCccccccCcccccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 577 (679)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.+.
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~--- 356 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--- 356 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH---
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH---
Confidence 9999998765432 2234568999999999853 578899999999999999999999997432221 11111
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+..+..... +.... .....+.+++.+||+.||.+|||++|+++
T Consensus 357 -i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 -ITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HhcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111111100 00001 12346889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=333.48 Aligned_cols=251 Identities=20% Similarity=0.352 Sum_probs=198.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
..|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34677899999999999999987 58999999997665566788999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 99 PGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 999999988642 4568999999999999999999999 9999999999999999999999999998764322111
Q ss_pred ccccccCCccccCCccc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 516 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
......|++.|+|||++ .+..++.++||||||+++|+|++|+.||...+.. ......... ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~-- 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS-DPPTLL-- 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCS--
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhcc-CCcccC--
Confidence 11234589999999998 4677899999999999999999999999743221 111111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.||.+|||+.|+++
T Consensus 244 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122346889999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.77 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=195.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc------eE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~ 428 (679)
.|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4677899999999999999885 69999999986532 334567899999999999999999999987653 46
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999873 468999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC----
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 583 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 583 (679)
.... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..... ..+........
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHH
Confidence 5443 223458999999999876 67899999999999999999999999854432111 11111000000
Q ss_pred --------------eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 005750 584 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 632 (679)
Q Consensus 584 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 632 (679)
........+ ..........+.+++.+||+.||.+|||++|+++. +++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000000 01111223468899999999999999999999873 5443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.33 Aligned_cols=253 Identities=16% Similarity=0.165 Sum_probs=204.8
Q ss_pred HHHHhhccccCcCccEEEEEEE------EcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc---CCCcccccccccccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~ 426 (679)
...|.+.+.||+|+||.||+|. ..+++.||||++.... ...+.+|+++++.++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3456778999999999999994 3468999999997543 456777888888876 999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC----------
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---------- 494 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---------- 494 (679)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999997432 35679999999999999999999999 99999999999999988
Q ss_pred -CCcEEEeeccCccccccC-cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHH
Q 005750 495 -NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572 (679)
Q Consensus 495 -~~~~kL~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~ 572 (679)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999764321 1222344569999999999999999999999999999999999999996322110
Q ss_pred HHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhh
Q 005750 573 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKI 635 (679)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~ 635 (679)
..+...+.... ....+.+++..|++.+|.+| |+++++.+.|++....
T Consensus 293 -------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 -------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111111 23467789999999999998 5889999999988775
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.08 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=199.9
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
+.....|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 334556778899999999999999887 58999999987542 346788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999863 24678999999999999999999999 9999999999999999999999999999987654
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .. .........
T Consensus 178 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~-~~~~~~~~~---- 245 (314)
T 3com_A 178 TMAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI---FM-IPTNPPPTF---- 245 (314)
T ss_dssp TBSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HH-HHHSCCCCC----
T ss_pred hccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH---HH-HhcCCCccc----
Confidence 3222 233458999999999999899999999999999999999999997332211 11 11 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122347889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.78 Aligned_cols=252 Identities=27% Similarity=0.368 Sum_probs=203.2
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
....|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567889999999999999999986 78999999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~ 508 (679)
|||+.+|+|.+.+.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998874 4579999999999999999999999 9999999999999995 466799999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.... .... . +..+......
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~-i~~~~~~~~~ 243 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---R-VETGKYAFDL 243 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHTCCCSCS
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCCCCC
Confidence 654322 233468999999999976 5899999999999999999999999743221 1111 1 1122111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+ ........+.+++.+||+.||.+|||+.|+++.
T Consensus 244 -~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011223468899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=331.86 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=198.7
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccc--cceEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 432 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lV~ 432 (679)
..|++.+.||+|+||.||+|+.. +++.||+|++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 45778899999999999999875 7899999998743 3467889999999997 9999999999987 66789999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCcccccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 511 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~ 511 (679)
||+++++|.+++. .+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++.....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999875 37899999999999999999999 9999999999999999766 899999999987654
Q ss_pred CcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH--------HhHhcC
Q 005750 512 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 582 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~--------~~~~~~ 582 (679)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233458999999999877 67899999999999999999999999632221 111111111 001100
Q ss_pred Ce--------------eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 583 DV--------------ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 583 ~~--------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ....+..............+.+++.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000001111111223457899999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.19 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=202.3
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
....|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567888999999999999999987 68999999987543 23457789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~ 508 (679)
|||+++|+|.+.+.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998873 4568999999999999999999999 99999999999999976 45599999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .+.. . +..+....
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~-i~~~~~~~-- 256 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILR---K-VEKGKYTF-- 256 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHTCCCC--
T ss_pred CCCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCCC--
Confidence 654322 233468999999999874 6899999999999999999999999743321 1111 1 11121110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 633 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 633 (679)
+...... ....+.+++.+||+.||.+|||++|+++. +++..
T Consensus 257 ~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 257 DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 0111111 23468899999999999999999999863 55543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.60 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=186.7
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-h-hHHHHHHHHHHHHhccCCCcccccccccccceEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-H-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
...|++.+.||+|+||.||+|... +|+.||+|++..... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 345677899999999999999875 789999999975432 2 2233445555678889999999999999999999999
Q ss_pred EecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 433 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||++ |+|.+++.... ....+++..++.++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 58877775422 45679999999999999999999998 7 99999999999999999999999999998765
Q ss_pred cCcccccccccCCccccCCccc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 511 EDLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
.... .....|++.|+|||++ .+..++.++|||||||++|+|++|+.||...... ...+ ......... .
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~-~ 233 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQL----KQVVEEPSP-Q 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHH----HHHHHSCCC-C
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHH----HHHhccCCC-C
Confidence 4322 2233589999999996 5667899999999999999999999999732221 1111 111221111 0
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 L--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 01122346889999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.21 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=202.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|+.+ +|+.||+|++.+... ...+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 444678999999999999986 699999999965321 2346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 435 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
++||+|.+++.... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999987543 24579999999999999999999999 999999999999999999999999999998765433
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+....... ...
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~-~~~--------- 410 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE-QAV--------- 410 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH-CCC---------
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh-ccc---------
Confidence 22 2334699999999999999999999999999999999999999974432211 1111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 627 (679)
.++......+.+++.+||+.||.+||++ +||++
T Consensus 411 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112223468899999999999999975 55553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=347.15 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=207.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccC-CCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.++||+|+||.||+|++. +++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4667899999999999999874 699999998765432 2457889999999976 55566666667788889999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla~~~~~~ 512 (679)
+++|.+++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999742 4579999999999999999999999 999999999999999 68899999999999876544
Q ss_pred cccc------cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 513 LTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 513 ~~~~------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 3221 2245689999999999999999999999999999999999999985444332222222221111111111
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
+...+ +.++.+++.+||+.+|++||++++|++.|+++....
T Consensus 240 -----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 -----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00111 347889999999999999999999999999987643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=356.01 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=206.4
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
+....|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888999999999999999987 79999999986532 334678999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc---cCCCcEEEeeccCc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLS 506 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfgla 506 (679)
+||||+.+|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999987 35679999999999999999999999 999999999999999 56789999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ..... +..+....
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKK----VEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHcCCCCC
Confidence 87654322 233458999999999876 6899999999999999999999999743321 11111 12222110
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.. + ........+.+++.+||+.+|.+|||+.|+++.
T Consensus 247 ~~-~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 EL-P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CS-G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 0 011223468899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.05 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=205.1
Q ss_pred hhHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc--------CCCccccccc
Q 005750 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLIGY 421 (679)
Q Consensus 351 ~~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~ 421 (679)
..++....|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.++ |+||++++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34444567888999999999999999875 6899999999754 344577889999999995 7889999999
Q ss_pred cc----ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCC
Q 005750 422 CE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINM 496 (679)
Q Consensus 422 ~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~ 496 (679)
+. .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 87 567899999999 56666666533 23569999999999999999999999 7 999999999999998775
Q ss_pred -------------------------------------------------cEEEeeccCccccccCcccccccccCCcccc
Q 005750 497 -------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGYL 527 (679)
Q Consensus 497 -------------------------------------------------~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~ 527 (679)
.+||+|||++....... ....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCccc
Confidence 79999999998765432 2345899999
Q ss_pred CCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch---hhHHHHHHHhHhc--------CCe-eeeecc-----
Q 005750 528 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMIKK--------GDV-ISIVDP----- 590 (679)
Q Consensus 528 aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~---~~~~~~~~~~~~~--------~~~-~~~~d~----- 590 (679)
|||++.+..++.++|||||||++|+|++|+.||........ ......+...... +.. ...+..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999998999999999999999999999999975443221 1111111111111 000 000000
Q ss_pred -----cc---------cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 591 -----VL---------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 591 -----~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01234566778999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=327.17 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=196.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc----chhHHHHHHHHHHHHhccCCCcccccccc--cccceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~l 430 (679)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4667899999999999999875 68999999987532 23457799999999999999999999998 45568899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||++++ |.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99999876 76766643 35679999999999999999999999 999999999999999999999999999998754
Q ss_pred cCc-ccccccccCCccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 511 EDL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 511 ~~~-~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
... ........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...+ .+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~~--- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE----NIGKGSY--- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHCCC---
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH----HHhcCCC---
Confidence 322 12223445899999999987644 478999999999999999999999743221 1111 1112211
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.+ +......+.+++.+||+.||.+|||++|+++.
T Consensus 231 ---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11223468899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=345.00 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=165.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccccc-----ceEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 429 (679)
.|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... +..|
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 5677899999999999999876 58899999997542 34457889999999999999999999998765 5789
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+. |+|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999985 69999997 35679999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCccc---------------------ccccccCCccccCCccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 510 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 510 ~~~~~~---------------------~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
...... ......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 443211 12345689999999985 56679999999999999999998655543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.41 Aligned_cols=247 Identities=16% Similarity=0.145 Sum_probs=188.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC---cchhHHHHHHHHH---HHHhccCCCccccc-------cccc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVA---LLSRIHHRNLVPLI-------GYCE 423 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~hpnIv~l~-------~~~~ 423 (679)
.|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++ ++++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 4566789999999999999974 6999999998632 3345678999995 45555799999998 4444
Q ss_pred ccc-----------------eEEEEEEecCCCcHhhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccc
Q 005750 424 EEH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 482 (679)
Q Consensus 424 ~~~-----------------~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 482 (679)
+.+ ..++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 332 378999999 689999997532 12234568888999999999999999 99999
Q ss_pred cCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCC-----------CCCchhHHHHHHHHHH
Q 005750 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLL 551 (679)
Q Consensus 483 ~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlGvll~ 551 (679)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986433 2233457 999999999877 8999999999999999
Q ss_pred HHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HH
Q 005750 552 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AI 629 (679)
Q Consensus 552 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L 629 (679)
||++|+.||......... ..+.. . ... ....+.+++.+||+.||.+|||+.|+++ .+
T Consensus 305 elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS---------------EWIFR-S-CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------CCS---------------GGGGS-S-CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccccch---------------hhhhh-h-ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999733221100 00000 0 011 2346889999999999999999999986 45
Q ss_pred Hhhhh
Q 005750 630 QDSIK 634 (679)
Q Consensus 630 ~~~~~ 634 (679)
+++..
T Consensus 364 ~~~~~ 368 (377)
T 3byv_A 364 EQLRT 368 (377)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 54443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=331.48 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=198.6
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhccCCCccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 423 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 423 (679)
......|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 445678889999999999999999876 589999999865321 12345889999999999999999999987
Q ss_pred ccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc---EEE
Q 005750 424 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKV 500 (679)
Q Consensus 424 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL 500 (679)
.++ .++||||+++++|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 665 899999999999999887 35679999999999999999999999 99999999999999987654 999
Q ss_pred eeccCccccccCcccccccccCCccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 577 (679)
+|||++........ .....|++.|+|||++ ....++.++|||||||++|+|++|+.||....... .+...+
T Consensus 159 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-- 232 (322)
T 2ycf_A 159 TDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 232 (322)
T ss_dssp CCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH--
T ss_pred ccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH--
Confidence 99999987654321 2234589999999996 35678999999999999999999999997433221 121211
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+.... .+.... .....+.+++.+||+.||.+|||++|+++
T Consensus 233 --~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 --TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110 000111 12346889999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=336.19 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=200.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
..|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45666789999999999999986 799999999865431 1245678999999999 7999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999973 4579999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ..... +.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~----i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM----IM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH----HH
Confidence 87654322 23356899999999885 336889999999999999999999999733211 11111 11
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+.... ..+. .. .....+.+++.+||+.||.+|||++|+++
T Consensus 319 ~~~~~~-~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF-SSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC-CHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC-CCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111100 0000 00 11236889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=333.78 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=184.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 45667899999999999999865 68999999986532 33456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 435 MHNGTLRDRLHGSV-----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 435 ~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+++++|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999986421 24568999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcc----cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 510 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 510 ~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ... .... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~~~~-~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LML----TLQN-DP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH----HHTS-SC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHH----Hhcc-CC
Confidence 43211 11223458999999999865 4689999999999999999999999974332211 111 1111 11
Q ss_pred ee----eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 IS----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ..++.... .....+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 11111111 22346889999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=362.88 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=207.8
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
+....|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 344567788999999999999998752 5679999987643 3345779999999999999999999999854 568
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999742 4568999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... ..... +..+...
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~----i~~~~~~-- 611 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERL-- 611 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHHTCCC--
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCCC--
Confidence 65543333334456789999999988899999999999999999997 99999743221 12111 1111111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
..+...+..+.+++.+||+.||.+|||+.||++.|+++...+
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111223357889999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.13 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=199.6
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-------------hhHHHHHHHHHHHHhccCCCcccccccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 422 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 422 (679)
..|.+.++||+|+||+||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45778899999999999999986 588999999875421 2346788999999999999999999999
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC---cEE
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 499 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 499 (679)
.+.+..++||||+++|+|.+.+.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999998874 4569999999999999999999999 9999999999999998765 699
Q ss_pred EeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH
Q 005750 500 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 500 L~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.... .+.. .+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK----KV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HH
Confidence 999999987654322 233458999999999875 6899999999999999999999999743321 1111 11
Q ss_pred hcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 580 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+.... +...... ....+.+++.+||+.||.+|||++|+++.
T Consensus 260 ~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222110 0000011 12468899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.77 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=192.0
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc-----------hhHHHHHHHHHHHHhccCCCcccccccc---
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-----------HRTQQFVTEVALLSRIHHRNLVPLIGYC--- 422 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~--- 422 (679)
..|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 34566899999999999999988899999999854321 1237789999999999999999999998
Q ss_pred --cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEE
Q 005750 423 --EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500 (679)
Q Consensus 423 --~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 500 (679)
......++||||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 33447899999997 688888874 34579999999999999999999999 99999999999999999999999
Q ss_pred eeccCccccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhH
Q 005750 501 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 501 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+....
T Consensus 176 ~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~ 250 (362)
T 3pg1_A 176 CDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVV 250 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred EecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHc
Confidence 99999975443322 233458899999999876 6789999999999999999999999975432211 11111111
Q ss_pred hcCCee-----------eeeccccc-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 580 KKGDVI-----------SIVDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 580 ~~~~~~-----------~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...... ..+..... ..........+.+++.+||+.||.+|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 100000 00000000 00011223468899999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.52 Aligned_cols=265 Identities=21% Similarity=0.234 Sum_probs=196.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc-----------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 424 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------- 424 (679)
..|++.+.||+|+||.||+|.+. +|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 35677899999999999999875 799999999865422 23479999999999999999998843
Q ss_pred ---------------------------cceEEEEEEecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005750 425 ---------------------------EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC 476 (679)
Q Consensus 425 ---------------------------~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~ 476 (679)
....++||||++ |+|.+.+.... ....+++..++.++.||+.||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 334889999997 58777765422 45679999999999999999999998
Q ss_pred CCCccccCCCCCCcccc-CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHH
Q 005750 477 NPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELI 554 (679)
Q Consensus 477 ~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~ell 554 (679)
+||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999998 689999999999987644332 2234579999999998765 5899999999999999999
Q ss_pred hCCCCCCcccccchhhHHHHHHHhHhc----------CCeeeeeccccc-----CCCCHHHHHHHHHHHHHhcccCCCCC
Q 005750 555 SGKKPVSVEDFGAELNIVHWARSMIKK----------GDVISIVDPVLI-----GNVKIESIWRIAEVAIQCVEQRGFSR 619 (679)
Q Consensus 555 tG~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~R 619 (679)
+|+.||.+.+..+ .+...+. .... .......-+... ...+......+.+++.+||+.||.+|
T Consensus 237 ~g~~pf~~~~~~~--~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 237 LGKPLFSGETSID--QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred hCCCCCCCCChHH--HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999997543321 1111111 1100 000000000000 00112234468899999999999999
Q ss_pred CCHHHHHHH--HHhhhh
Q 005750 620 PKMQEIVLA--IQDSIK 634 (679)
Q Consensus 620 Pt~~evl~~--L~~~~~ 634 (679)
||+.|+++. ++++..
T Consensus 314 ~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCHHHHHTSGGGHHHHH
T ss_pred CCHHHHhcCHHHHHHHh
Confidence 999999853 544433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=363.50 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=203.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 430 (679)
...|++.+.||+|+||.||+|+.+ +++.||||++++.. ....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 345677899999999999999876 58899999987532 23446788899999988 79999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999984 3579999999999999999999999 999999999999999999999999999998643
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... +..
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~~------ 559 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME-HNV------ 559 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHS-SCC------
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-CCC------
Confidence 3222 234456999999999999999999999999999999999999999743321 11112221 111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 627 (679)
.++......+.+|+.+||+.||.+||++ +||++
T Consensus 560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112233478899999999999999998 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.33 Aligned_cols=258 Identities=22% Similarity=0.277 Sum_probs=190.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccc------eE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~ 428 (679)
.|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4677899999999999999876 6899999998753 2344567889999999999999999999987654 78
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||++ |+|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999996 57888875 248899999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHH-------------
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA------------- 575 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~------------- 575 (679)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.... +....
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTT
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHH
Confidence 54332 12334689999999999999999999999999999999999999975432211 10000
Q ss_pred -----HHhHhcCCe------eeeecccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 576 -----RSMIKKGDV------ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 576 -----~~~~~~~~~------~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
......... ...+........ .......+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000000000000 11235578999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=332.43 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=199.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc-----ceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 430 (679)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4677899999999999999876 68899999997543 33457789999999999999999999998654 46899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+. |+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999996 599998863 469999999999999999999999 999999999999999999999999999998765
Q ss_pred cCcccc--cccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee-
Q 005750 511 EDLTHI--SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS- 586 (679)
Q Consensus 511 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 586 (679)
...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.......... .+...........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHHHH
Confidence 432221 23446899999999864 4568999999999999999999999997544332211 1111111000000
Q ss_pred --e--------ecccc-cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 --I--------VDPVL-IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 --~--------~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. ..... .... .......+.+++.+||+.||.+|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 0000 01123468899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.24 Aligned_cols=260 Identities=23% Similarity=0.274 Sum_probs=192.9
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc------eEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~lV 431 (679)
.|.+.+.||+|+||.||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677899999999999999998777799998864322 2236999999999999999999985433 47899
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEeeccCccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 510 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~~ 510 (679)
|||++++.+............+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999875444333222245679999999999999999999999 9999999999999999 79999999999998764
Q ss_pred cCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh----------H
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----------I 579 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~----------~ 579 (679)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+ .+....... .
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhh
Confidence 4322 2234589999999998764 58999999999999999999999998543321 111111110 0
Q ss_pred h----cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 580 K----KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 580 ~----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
. .......-...............+.+++.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 000000000000000111233478999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.72 Aligned_cols=249 Identities=25% Similarity=0.302 Sum_probs=201.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---------chhHHHHHHHHHHHHhcc-CCCcccccccccccc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---------SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 426 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 426 (679)
.|++.+.||+|+||.||+|.++ +|+.||||++.... ....+.+.+|+++++++. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4667899999999999999986 68999999986542 123456889999999995 999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999974 4578999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
........ .....+++.|+|||++. ...++.++||||||+++|+|++|+.||...... .... . +.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~-~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR---M-IM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH---H-Hh
Confidence 87654322 23345899999999874 457889999999999999999999999733221 1111 1 11
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+... ... .........+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~-~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc-cCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111 000 111223457889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.59 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=182.4
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCccccccccccc------ce
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 427 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 427 (679)
..|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 35677899999999999999865 6899999998653 234557788999999999999999999998653 56
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.++|+|++ +++|.+++. ...+++..+..++.||++||+|||+ .||+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 789998886 3569999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe--
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV-- 584 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 584 (679)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ...+.........
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 75432 223468999999999877 6889999999999999999999999975443211 1111111110000
Q ss_pred ---------eeeecccc-cCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 585 ---------ISIVDPVL-IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 585 ---------~~~~d~~l-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...+.... ..... ......+.+|+.+||+.||.+|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00000 1123468899999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.10 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=193.0
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc-----------
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 424 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------- 424 (679)
..|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45778899999999999999975 7999999998643 3455778999999999999999999998743
Q ss_pred --cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 425 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 425 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 46789999999999999999752 4567889999999999999999999 9999999999999999999999999
Q ss_pred ccCccccccCc-------------ccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccch
Q 005750 503 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568 (679)
Q Consensus 503 fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~ 568 (679)
||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 99998754321 1112234588999999999764 78999999999999999998 55411 111
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..... . +.... ..............+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~---~-~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILK---K-LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH---H-HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH---h-ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111 1 11111 11112233334456889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.62 Aligned_cols=251 Identities=10% Similarity=0.034 Sum_probs=178.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhc--cCCCccccccc-------cccc
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLIGY-------CEEE 425 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~l~~~-------~~~~ 425 (679)
|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+++++.+ +||||++++.. +...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 567899999999999999976 789999999986532 3456678886655555 59998885532 2211
Q ss_pred -----------------ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCccc
Q 005750 426 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 482 (679)
Q Consensus 426 -----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~ivH 482 (679)
...++||||++ |+|.+++... +..+.+..+ ..++.||+.||+|||+ ++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 44899999998 8999999853 223344455 6778999999999999 99999
Q ss_pred cCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 483 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 483 ~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
|||||+|||++.++.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998764322 13346799999999987 68999999999999999999999999
Q ss_pred CcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 561 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......... .........................+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 8443221100 0000000000001111111133457889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=330.72 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=203.4
Q ss_pred HHHHhhccccCcCccEEEEEEEE-c-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC------cccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~~~ 427 (679)
...|++.+.||+|+||.||+|.. + +++.||||++... ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 44678889999999999999987 3 6899999999754 344577889999999997654 9999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-------------
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------- 494 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~------------- 494 (679)
.++||||+ +++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998754 23468999999999999999999999 99999999999999987
Q ss_pred ------CCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch
Q 005750 495 ------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 568 (679)
Q Consensus 495 ------~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~ 568 (679)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 2234589999999999999999999999999999999999999975433222
Q ss_pred hhHHHHHHHh-----HhcCCeeeee---------------------ccc-ccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005750 569 LNIVHWARSM-----IKKGDVISIV---------------------DPV-LIGNVKIESIWRIAEVAIQCVEQRGFSRPK 621 (679)
Q Consensus 569 ~~~~~~~~~~-----~~~~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 621 (679)
.......... .......... .+. -...........+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1111111000 0000000000 000 001112345678999999999999999999
Q ss_pred HHHHHHH
Q 005750 622 MQEIVLA 628 (679)
Q Consensus 622 ~~evl~~ 628 (679)
++|+++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=339.99 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=182.9
Q ss_pred HHhh-ccccCcCccEEEEEEEEc---CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccc--cccceEEEE
Q 005750 358 TNNF-CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRILV 431 (679)
Q Consensus 358 ~~~~-~~~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~lV 431 (679)
.|++ .++||+|+||.||+|+++ +++.||||++.... ....+.+|++++++++||||+++++++ ......++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 568999999999999976 57899999997542 235678999999999999999999999 457789999
Q ss_pred EEecCCCcHhhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc----cCCCcEEEe
Q 005750 432 YEYMHNGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVS 501 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~ 501 (679)
|||+. |+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 58877775321 22359999999999999999999999 999999999999999 678899999
Q ss_pred eccCccccccCcc--cccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccc------hhhHH
Q 005750 502 DFGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------ELNIV 572 (679)
Q Consensus 502 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~------~~~~~ 572 (679)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654322 12234568999999999877 458999999999999999999999997443210 01111
Q ss_pred HHHHHhHhcCCe--eeeec-------------ccccCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 573 HWARSMIKKGDV--ISIVD-------------PVLIGNVK---------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 573 ~~~~~~~~~~~~--~~~~d-------------~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..+...+..... ...+. ........ ......+.+|+.+||+.||.+|||++|+++.
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111110000 00000 00000000 0012367899999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=330.68 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=193.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc------cceEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------~~~~~ 429 (679)
.|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4667899999999999999985 68999999986542 3457788999999999 79999999999866 56889
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 999999999999999754 24578999999999999999999999 99999999999999999999999999999875
Q ss_pred ccCcccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||....... .. ..... ...
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~-~~~ 251 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---AL---FLIPR-NPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHH-SCC
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HH---HHhhc-Ccc
Confidence 43322 122345899999999986 5678999999999999999999999997332211 11 11111 111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... .......+.+++.+||+.||.+||+++|+++
T Consensus 252 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 1112347889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.50 Aligned_cols=198 Identities=26% Similarity=0.328 Sum_probs=171.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc------cCCCcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~~~~~~ 429 (679)
..|++.+.||+|+||.||+|... +++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 45778899999999999999876 5899999999754 33456778899988887 4679999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc--EEEeeccCcc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSR 507 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfgla~ 507 (679)
+||||+. ++|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++.
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999995 6999988754 23458999999999999999999999 99999999999999999887 9999999997
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccc
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~ 564 (679)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 223468999999999999999999999999999999999999997544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=334.05 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcch-----------------hHHHHHHHHHHHHhccCCCccccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------------RTQQFVTEVALLSRIHHRNLVPLI 419 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpnIv~l~ 419 (679)
..|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3567789999999999999999 8999999998643211 117899999999999999999999
Q ss_pred ccccccceEEEEEEecCCCcHhhh------hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 420 GYCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 420 ~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
+++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+||+||||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 999999999999999999999998 5432 25779999999999999999999996 37999999999999999
Q ss_pred CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCcccccchhhH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-ksDVwSlGvll~elltG~~pf~~~~~~~~~~~ 571 (679)
.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|+.||...... ...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 9999999999999876443 22344689999999999887 6666 999999999999999999999743331 112
Q ss_pred HHHHHHhHhcCCeeeeec------cccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 572 VHWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+. +..+......+ +... ..........+.+++.+||+.||.+|||++|+++
T Consensus 262 ~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 22221111000 0000 0001223457889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.69 Aligned_cols=273 Identities=20% Similarity=0.318 Sum_probs=205.7
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-----------CCCcccccccc
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYC 422 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~ 422 (679)
....|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3456788899999999999999875 6899999999753 334567889999999886 89999999998
Q ss_pred cccc----eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCcccc----
Q 005750 423 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD---- 493 (679)
Q Consensus 423 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~---- 493 (679)
...+ ..++|||++ +++|.+++... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence 7654 789999999 89999999754 24568999999999999999999999 8 999999999999994
Q ss_pred --CCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccch---
Q 005750 494 --INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--- 568 (679)
Q Consensus 494 --~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~--- 568 (679)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998765432 234589999999999999999999999999999999999999984432211
Q ss_pred hhHHHHHHHhHhc--------CC----------eeeeecc----------cccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005750 569 LNIVHWARSMIKK--------GD----------VISIVDP----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRP 620 (679)
Q Consensus 569 ~~~~~~~~~~~~~--------~~----------~~~~~d~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 620 (679)
......+...+.. +. ....+.. .-....+......+.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111111100 00 0000000 001123456677899999999999999999
Q ss_pred CHHHHHH--HHHhhhhhhc
Q 005750 621 KMQEIVL--AIQDSIKIEK 637 (679)
Q Consensus 621 t~~evl~--~L~~~~~~~~ 637 (679)
|++|+++ .+++....+.
T Consensus 327 t~~ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTLGMEE 345 (373)
T ss_dssp CHHHHHTCGGGTTCTTCTT
T ss_pred CHHHHhhChhhhcccCccc
Confidence 9999987 4555544433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=330.71 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=198.2
Q ss_pred HHhhccccCcCccEEEEEEEEc--CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhc---cCCCccccccccc-----cc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 425 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~~ 425 (679)
.|++.+.||+|+||.||+|++. +|+.||+|++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 4677899999999999999983 688999999864322 1223566788877776 7999999999986 56
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
...++||||+. |+|.+++... ....+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 78899999997 6999998754 24458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..........
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 98765332 2233458999999999999999999999999999999999999997433221 111111111100000
Q ss_pred ee----------ec---ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SI----------VD---PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~----------~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. +. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 00000111223456889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.98 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=191.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccc--------------
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-------------- 422 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-------------- 422 (679)
.|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4667899999999999999987 4899999999876666678899999999999999999999876
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEe
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 501 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~ 501 (679)
.+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 34467899999997 69999986 3568999999999999999999999 9999999999999997 57799999
Q ss_pred eccCccccccCccc--ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 502 DFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 502 Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...... .
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~-~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILE-S 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-H
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-h
Confidence 99999876432211 1223347889999998755 6789999999999999999999999974432211 111110 0
Q ss_pred Hhc----------CCeeeeeccccc-CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 579 IKK----------GDVISIVDPVLI-GN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 579 ~~~----------~~~~~~~d~~l~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ......+..... .. ........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000000 00 00112347889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.90 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=196.0
Q ss_pred HHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhcc--CCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~l 430 (679)
....|++.+.||+|+||.||+|...+++.||+|++... .....+.+.+|++++++++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34457778999999999999999988999999998643 2345578899999999997 5999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||| +.+++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+||+++ ++.+||+|||++....
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999 568899999984 4578999999999999999999999 9999999999999996 4899999999998765
Q ss_pred cCccc-ccccccCCccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 511 EDLTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 511 ~~~~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
..... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .. ......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~----~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QI----SKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HH----HHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HH----HHHHHH
Confidence 43221 1233458999999999875 4788999999999999999999999973221 11 111112
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
...... ...+......+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 211111 11111123468899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.71 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=197.7
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||.||+|.+++ .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 446778999999999999998864 49999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 513 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~- 513 (679)
+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++ ++.+||+|||++.......
T Consensus 111 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 111 CKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999742 4568999999999999999999999 9999999999999998 6899999999987643211
Q ss_pred ---ccccccccCCccccCCcccCC---------CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 514 ---THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 514 ---~~~~~~~~gt~~y~aPE~l~~---------~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .... .+..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~----~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIW----QMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHH----HHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----Hhcc
Confidence 111223458899999999864 45789999999999999999999999743221 1111 1122
Q ss_pred CCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 005750 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 636 (679)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 636 (679)
+........ .....+.+++.+||+.||.+|||++|+++.|+++....
T Consensus 258 ~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 211111111 11235889999999999999999999999999987753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=343.44 Aligned_cols=258 Identities=24% Similarity=0.275 Sum_probs=192.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc------cceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~l 430 (679)
.|++.+.||+|+||.||+|++. +|+.||||++.... ....+|++++++++||||+++++++.. ....++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4667899999999999999986 59999999986542 223479999999999999999998843 234679
Q ss_pred EEEecCCCcHhhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-CcEEEeeccCccc
Q 005750 431 VYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 508 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfgla~~ 508 (679)
||||+++ +|.+.+... .....+++..++.++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 666555432 145679999999999999999999999 999999999999999955 6789999999987
Q ss_pred cccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-------Hh
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IK 580 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-------~~ 580 (679)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.. ..+.+.+... +.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 544322 2234589999999998764 7899999999999999999999999754322 1222222110 00
Q ss_pred --cCCeeeeecccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 581 --KGDVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 581 --~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.....+..-+.+... +.......+.+|+.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 001111111111000 11122357899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=333.77 Aligned_cols=266 Identities=19% Similarity=0.240 Sum_probs=187.0
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc------
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------ 426 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 426 (679)
.....|++.+.||+|+||.||+|++. +|+.||||++.... .......+|++.++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34456777899999999999999986 68999999986542 22345667888889999999999999985533
Q ss_pred -eEEEEEEecCCCcHhhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCccccCCCCCCccccC-CCcEEEe
Q 005750 427 -QRILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVS 501 (679)
Q Consensus 427 -~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 501 (679)
..++||||++++ |.+.+.. ......+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEe
Confidence 378999999864 4443332 224667899999999999999999999 7 99999999999999996 8999999
Q ss_pred eccCccccccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh--
Q 005750 502 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-- 578 (679)
Q Consensus 502 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-- 578 (679)
|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+... .+.......
T Consensus 175 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~ 250 (360)
T 3e3p_A 175 DFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGC 250 (360)
T ss_dssp CCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCC
T ss_pred eCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCC
Confidence 9999987654332 2234589999999998654 48999999999999999999999997443321 111111110
Q ss_pred --------Hhc-CCeeeeecc------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 579 --------IKK-GDVISIVDP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 579 --------~~~-~~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+.. .......+. .............+.+++.+||+.||.+|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000000 00111122245679999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.60 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=196.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCccccccccccc-----ceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~l 430 (679)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4667899999999999999986 68999999997543 33456788999999999999999999987653 67899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||+. |+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999996 699998873 468999999999999999999999 999999999999999999999999999998764
Q ss_pred cCccc---------ccccccCCccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh
Q 005750 511 EDLTH---------ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 511 ~~~~~---------~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.... ...+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhC
Confidence 32211 112245899999999875 47889999999999999999999999975432211 111111111
Q ss_pred cCCeee------------eecc--cccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 581 KGDVIS------------IVDP--VLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 581 ~~~~~~------------~~d~--~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...... .+.. .... .........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000 0000 000122346889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.10 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=193.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceE------
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR------ 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~------ 428 (679)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 5667889999999999999876 68999999997642 33457788999999999999999999999876654
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 123 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 68888774 348999999999999999999999 9999999999999999999999999999986
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+. +.. +....... ..+.
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~-~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVP-GTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC-CHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCC-cHHH
Confidence 5433 223458999999999877 6889999999999999999999999974432211 111 11100000 0000
Q ss_pred ---------------ecccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 588 ---------------VDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 588 ---------------~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
+....... ........+.+++.+||+.||.+|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 001123478899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.25 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=203.9
Q ss_pred hHHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 352 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 352 ~~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
.......|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678889999999999999999986 68999999986532 23457889999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC---CcEEEeeccC
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGL 505 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfgl 505 (679)
++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+ ++++||||||+||+++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999998873 3568999999999999999999999 999999999999999754 4799999999
Q ss_pred ccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
+........ .....+++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .... .+..+...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----RVETGKYA 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCCC
Confidence 987644322 1223478899999998764 899999999999999999999999743221 1111 12222211
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.... ... .....+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~--~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLP--QWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSG--GGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCch--hhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1000 001 12346889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.78 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=194.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccce------E
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------~ 428 (679)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4666789999999999999876 69999999997542 2345678899999999999999999999877653 4
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+. ++|.+++. ..+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus 105 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 68888764 348999999999999999999999 9999999999999999999999999999986
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcC-----
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG----- 582 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~----- 582 (679)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ...+.......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 5432 223458999999999877 6789999999999999999999999975432211 11111110000
Q ss_pred -------------CeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 583 -------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 583 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......+.+ ..........+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 11112334578999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.19 Aligned_cols=200 Identities=28% Similarity=0.314 Sum_probs=170.2
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CC-----CcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~~~~~~ 429 (679)
..|++.+.||+|+||.||+|... +++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 45777899999999999999876 6889999999754 334567788999998885 55 4899999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc--CCCcEEEeeccCcc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSR 507 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfgla~ 507 (679)
+||||+. |+|.+++... ....+++..++.++.|++.||.|||+ ...+|+||||||+|||++ .++.+||+|||++.
T Consensus 133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999995 5999998754 23568999999999999999999994 127999999999999995 57889999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccc
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~ 564 (679)
...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 210 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764432 23468999999999999999999999999999999999999998443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.30 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=200.9
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CC-cEEEEEEecCCcchhHHHHHHHHHHHHhccCCC------cccccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEE 424 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~ 424 (679)
+.....|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 333457788999999999999999875 34 78999999754 344577889999999997665 8889999999
Q ss_pred cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccc------------
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL------------ 492 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll------------ 492 (679)
.+..++||||+ ++++.+.+... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 66777776643 23569999999999999999999999 999999999999999
Q ss_pred -------cCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccc
Q 005750 493 -------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 565 (679)
Q Consensus 493 -------~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~ 565 (679)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 567899999999998654332 234689999999999999999999999999999999999999974433
Q ss_pred cchhhHHHHHHHhHhc--------CCeee-eeccc---------------------ccCCCCHHHHHHHHHHHHHhcccC
Q 005750 566 GAELNIVHWARSMIKK--------GDVIS-IVDPV---------------------LIGNVKIESIWRIAEVAIQCVEQR 615 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~--------~~~~~-~~d~~---------------------l~~~~~~~~~~~l~~li~~cl~~d 615 (679)
.... ..+...... ..... ..... ............+.+++.+||+.|
T Consensus 245 ~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 245 REHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp HHHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HHHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 2211 111111100 00000 00000 000112234557899999999999
Q ss_pred CCCCCCHHHHHH
Q 005750 616 GFSRPKMQEIVL 627 (679)
Q Consensus 616 P~~RPt~~evl~ 627 (679)
|.+|||++|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.95 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=177.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHH-HHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||.||+|..+ +|+.||||++.... .....++..|+. +++.++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 4566789999999999999986 68999999997643 233455666666 67777999999999999999999999999
Q ss_pred cCCCcHhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+++ +|.+++.... ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 975 8877765311 25678999999999999999999999 7 999999999999999999999999999987654
Q ss_pred CcccccccccCCccccCCccc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 512 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
... .....|++.|+|||++ .+..++.++|||||||++|+|++|+.||...... .+...... .+..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~--- 247 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVV-KGDP--- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC---
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHh-cCCC---
Confidence 322 2223589999999998 4567899999999999999999999999732211 01000000 0111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+.+...........+.+++.+||+.||.+|||+.|+++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111223457889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.20 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=172.7
Q ss_pred HHhhc-cccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc----cceEEEE
Q 005750 358 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 431 (679)
Q Consensus 358 ~~~~~-~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV 431 (679)
.|.+. +.||+|+||.||+|.++ +++.||||++.... ....+....++.++||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 45553 46999999999999987 69999999986531 112222334566799999999999865 5568999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~ 508 (679)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||++..
T Consensus 105 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 105 MECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999854 24579999999999999999999999 99999999999999976 45599999999986
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......+..+..
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~---- 250 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY---- 250 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc----
Confidence 54322 2234579999999999988999999999999999999999999973322111 0000011111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQD 631 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 631 (679)
.............+.+++.+||+.||.+|||++|+++ .+++
T Consensus 251 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 251 --GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0000111123447889999999999999999999997 4444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=335.52 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=185.7
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecCCCc
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
..+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 35789999999998776678999999998643 245678899999987 89999999999999999999999995 69
Q ss_pred HhhhhcccCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCC-------------CcEEEee
Q 005750 440 LRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSD 502 (679)
Q Consensus 440 L~~~l~~~~~~~----~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kL~D 502 (679)
|.+++....... ..++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999997542111 11333457899999999999999 999999999999999754 4899999
Q ss_pred ccCccccccCccc---ccccccCCccccCCcccCC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 005750 503 FGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 571 (679)
Q Consensus 503 fgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~ 571 (679)
||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..... ...
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~-- 248 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-RES-- 248 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-HHH--
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-hHH--
Confidence 9999876543321 1223468999999999865 678999999999999999999 9999963221 111
Q ss_pred HHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
....... .. +.............+.+++.+||+.||.+|||+.||++
T Consensus 249 -~i~~~~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NIIRGIF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHTCC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111100 00 01111123455678999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=348.17 Aligned_cols=270 Identities=22% Similarity=0.310 Sum_probs=206.6
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccc------cce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 427 (679)
...|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 356888999999999999999875 6899999998764 34456779999999999999999999998765 677
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCc---EEEeecc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFG 504 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg 504 (679)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+ .||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 89999999999999999865545578999999999999999999999 99999999999999997665 9999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...|..........
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 9987654332 2334689999999999999999999999999999999999999973221 11111111000000
Q ss_pred eeeec----c--------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhhhh
Q 005750 585 ISIVD----P--------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIKI 635 (679)
Q Consensus 585 ~~~~d----~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----vl~~L~~~~~~ 635 (679)
..... . .............+.+++.+||+.||.+|||++| ..+.++++...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 0 0112234456778999999999999999999988 45666666554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.41 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=190.6
Q ss_pred HHHHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch------hHHHHHHHHHHHHhc----cCCCccccccc
Q 005750 353 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRI----HHRNLVPLIGY 421 (679)
Q Consensus 353 ~l~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~l~~~ 421 (679)
+.....|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445667888999999999999999875 6899999999654321 223466799999999 89999999999
Q ss_pred ccccceEEEEEEe-cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEE
Q 005750 422 CEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 499 (679)
Q Consensus 422 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 499 (679)
+...+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999974 4568999999999999999999999 9999999999999999 899999
Q ss_pred EeeccCccccccCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh
Q 005750 500 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578 (679)
Q Consensus 500 L~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 578 (679)
|+|||++....... .....|+..|+|||++.+..+ +.++|||||||++|+|++|+.||.... +.
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~---- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EI---- 245 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH----
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HH----
Confidence 99999998765432 233458999999999876655 459999999999999999999997211 10
Q ss_pred HhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 579 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. ... . ........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~-~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LE-AEL------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HH-TCC------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh-hcc------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 0 11122346889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.44 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=178.9
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-hh-HHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
..|++.+.||+|+||.||+|.+. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34667889999999999999986 689999999976432 22 2334455567888899999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
|+ ++.+..+... ....+++..++.++.|++.||.|||+ + +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5566555542 24578999999999999999999998 6 9999999999999999999999999999765443
Q ss_pred cccccccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 513 LTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
.. .....+++.|+|||++. +..++.++|||||||++|+|++|+.||...... ... ......... ...
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~---~~~~~~~~~-~~~ 250 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEV---LTKVLQEEP-PLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHH---HHHHHHSCC-CCC
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHH---HHHHhccCC-CCC
Confidence 22 22345899999999984 557889999999999999999999999732221 111 112222111 100
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.. .......+.+++.+||+.||.+||+++|+++
T Consensus 251 -----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 -----PG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----Cc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0112346889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=322.83 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=196.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch------hHHHHHHHHHHHHhcc--CCCcccccccccccc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEH 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~ 426 (679)
...|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ ||||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 345778899999999999999875 6899999998654221 2245678999999996 599999999999999
Q ss_pred eEEEEEEecCC-CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc-CCCcEEEeecc
Q 005750 427 QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFG 504 (679)
Q Consensus 427 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg 504 (679)
..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999976 899999874 4578999999999999999999999 9999999999999999 78999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 583 (679)
++....... .....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .. .. +.
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~----~~-~~ 259 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EI----IR-GQ 259 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH----HH-CC
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hh----hc-cc
Confidence 998765432 223458999999999876655 788999999999999999999997221 10 11 11
Q ss_pred eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ..... ....+.+++.+||+.||.+|||++||++
T Consensus 260 ~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111 2346889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=328.88 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=184.6
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 4556789999999997766666799999999875432 2356799999999 79999999999999999999999996
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-----CCcEEEeeccCcccccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfgla~~~~~ 511 (679)
|+|.+++... .....+..++.++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||++.....
T Consensus 102 -g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 -ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp -EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred -CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6999999753 2334455667899999999999999 99999999999999953 33588999999987654
Q ss_pred Ccc--cccccccCCccccCCcccC---CCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 512 DLT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 512 ~~~--~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||..... .. .. ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~---~~---~~~~~~~~- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQ---AN---ILLGACSL- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HH---HH---HHTTCCCC-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HH---HH---HHhccCCc-
Confidence 321 1223456999999999997 4567889999999999999999 9999962221 11 11 11111110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... .........+.+++.+||+.||.+|||++||++
T Consensus 248 ~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 111233446789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.20 Aligned_cols=236 Identities=14% Similarity=0.189 Sum_probs=184.3
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
....|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3445778899999999999999986 489999999976432 334778999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||++|++|.++++. . ....++..++.|++.||+|||+ +||+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999863 2 3556788999999999999999 999999999999999999999998443
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
|++ .++.++|||||||++|+|++|+.||...+........ .... .+.. ..+
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~~---~~~ 225 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQP---IEP 225 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSCB---CCH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccCC---CCh
Confidence 333 3689999999999999999999999844332100000 0000 0000 000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.......+..+.+++.+||+.||.+| |+.|+++.|+++.....
T Consensus 226 ---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00011233468899999999999999 99999999999887544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=344.12 Aligned_cols=241 Identities=18% Similarity=0.291 Sum_probs=194.3
Q ss_pred HHHHhhccccCcCccEEEEEEEEc--CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccce-----
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----- 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 427 (679)
...|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 356788899999999999999986 58999999986543 3445678999999999999999999999987655
Q ss_pred EEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 428 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
.|+||||+++++|.+++. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+||+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 799999999999988765 268999999999999999999999 999999999999999875 89999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------- 283 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------- 283 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------
Confidence 76543 3345899999999987654 899999999999999999998886321110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIK 634 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 634 (679)
.............+.+++.+||+.||.+|| +++++.+.|.....
T Consensus 284 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ---LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000000112234688999999999999999 56677777776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.44 Aligned_cols=243 Identities=19% Similarity=0.234 Sum_probs=187.3
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCc--------chhHHHHHHHHHHHHhcc--------------
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIH-------------- 411 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~-------------- 411 (679)
+....|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+++++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4456788999999999999999998 68999999997542 223477889999999886
Q ss_pred ------------CCCcccccccccc-------------cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHH
Q 005750 412 ------------HRNLVPLIGYCEE-------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 466 (679)
Q Consensus 412 ------------hpnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia 466 (679)
||||+++++++.+ .+..++||||+++|++.+.+. ...+++..++.++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHH
Confidence 6666777776664 778999999999998777664 35689999999999999
Q ss_pred HHHHHHH-hcCCCCccccCCCCCCccccCCC--------------------cEEEeeccCccccccCcccccccccCCcc
Q 005750 467 KGLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 525 (679)
Q Consensus 467 ~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~Dfgla~~~~~~~~~~~~~~~gt~~ 525 (679)
.||+||| + ++|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 9999999999999999887 8999999999876532 2358999
Q ss_pred ccCCcccCCCCCCchhHHHHHHHH-HHHHHhCCCCCCcccccchhhHHHHH-HHhHhcCCeeeeecccccCCCCHHHHHH
Q 005750 526 YLDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWA-RSMIKKGDVISIVDPVLIGNVKIESIWR 603 (679)
Q Consensus 526 y~aPE~l~~~~~s~ksDVwSlGvl-l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 603 (679)
|+|||++.+.. +.++||||+|++ .+++++|..||... ...... .......... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998766 899999998777 77889999998511 000111 1111111110 00011112345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHH
Q 005750 604 IAEVAIQCVEQRGFSRPKMQEIV 626 (679)
Q Consensus 604 l~~li~~cl~~dP~~RPt~~evl 626 (679)
+.+++.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.92 Aligned_cols=224 Identities=21% Similarity=0.299 Sum_probs=176.0
Q ss_pred Hhhc-cccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHH-HhccCCCcccccccccc----cceEEEE
Q 005750 359 NNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILV 431 (679)
Q Consensus 359 ~~~~-~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~~~lV 431 (679)
|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|++++ +.++||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4444 77999999999999875 6899999998642 4567888888 55589999999999876 7788999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 508 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~~ 508 (679)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp ECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999999854 24579999999999999999999999 99999999999999997 78899999998864
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
.. +..++.++|||||||++|+|++|+.||........ .........
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~ 215 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIR 215 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHh
Confidence 32 23467899999999999999999999973321100 000000000
Q ss_pred cccccCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
... ...+ ......+.+++.+||+.||.+|||++|+++
T Consensus 216 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 MGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 0011 122457889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.83 Aligned_cols=239 Identities=15% Similarity=0.100 Sum_probs=179.3
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHHHHHHHHhccC-CCccccccc------------
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHH-RNLVPLIGY------------ 421 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~l~~~------------ 421 (679)
+...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|......+
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 344678999999999999965 699999999874322 235779999999999976 332221111
Q ss_pred ---------ccc-----cceEEEEEEecCCCcHhhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccc
Q 005750 422 ---------CEE-----EHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 483 (679)
Q Consensus 422 ---------~~~-----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~ 483 (679)
+.. ....+++|+++ +++|.++++.. .....+++..++.++.|+++||+|||+ ++|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 111 12356677765 68999888421 124568888999999999999999999 999999
Q ss_pred CCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCccc----------CCCCCCchhHHHHHHHHHHHH
Q 005750 484 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLEL 553 (679)
Q Consensus 484 Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~ksDVwSlGvll~el 553 (679)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999998875543 233457 999999998 666789999999999999999
Q ss_pred HhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 554 ISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 554 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
++|+.||........ .+..+... ...+..+.+++.+||+.||.+||++.|+++
T Consensus 311 ltg~~Pf~~~~~~~~-------------------~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 311 WCADLPNTDDAALGG-------------------SEWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHSSCCCCTTGGGSC-------------------SGGGGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCcchhhh-------------------HHHHHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999974332111 00011100 011256889999999999999999887754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-29 Score=281.21 Aligned_cols=187 Identities=17% Similarity=0.138 Sum_probs=132.3
Q ss_pred cccCcCccEEEEEEEEc-CCcEEEEEEecCCc----------chhHHHHHHHHHHHHhc-cCCCcccccccccccceEEE
Q 005750 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 430 (679)
...+.|+.|.+..++.. .|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45677787777766433 58999999996531 12346799999999999 79999999999999999999
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 510 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~ 510 (679)
||||++|++|.+++.. ..+++.. +|+.||+.||+|+|+ +|||||||||+|||++.++++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999984 4566654 578999999999999 999999999999999999999999999998765
Q ss_pred cCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 511 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 511 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
..... ....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 54332 233469999999999976 4677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=249.22 Aligned_cols=183 Identities=17% Similarity=0.204 Sum_probs=145.4
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcc--------hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.+.||+|+||.||+|... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999544 78899988643211 123558999999999999999976666667777899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999873 46899999999999999 99999999999999998 99999999999875532
Q ss_pred ccc------cccccCCccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 514 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 514 ~~~------~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
... .....||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 234568999999999976 567888999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=206.77 Aligned_cols=141 Identities=15% Similarity=0.113 Sum_probs=115.7
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCCcc------------------hhHHHHHHHHHHHHhccCCCcccccccc
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 422 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 422 (679)
+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4589999999999999997799999999864321 13467899999999999 5 7777765
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
.. +..++||||++||+|.+ +.. .....++.|++.||.|||+ +||+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 44 55699999999999988 431 1234699999999999999 9999999999999999 99999999
Q ss_pred ccCccccccCcccccccccCCccccCCcccC
Q 005750 503 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533 (679)
Q Consensus 503 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 533 (679)
||++.. +..+.|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999863 34567888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=8.8e-19 Score=178.10 Aligned_cols=135 Identities=23% Similarity=0.246 Sum_probs=105.2
Q ss_pred hhccccCcCccEEEEEEEE-cCCcE--EEEEEecCCcch------------------------hHHHHHHHHHHHHhccC
Q 005750 360 NFCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 412 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 412 (679)
.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|++++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4568899999999999998 67999 999997543111 12367899999999988
Q ss_pred CCc--ccccccccccceEEEEEEecCC-C----cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCccccC
Q 005750 413 RNL--VPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRD 484 (679)
Q Consensus 413 pnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~D 484 (679)
+++ ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .||+|||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 864 333332 356899999942 4 66665432 234456789999999999999 8 9999999
Q ss_pred CCCCCccccCCCcEEEeeccCcccc
Q 005750 485 VKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 485 lkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999988 9999999999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=173.90 Aligned_cols=150 Identities=27% Similarity=0.496 Sum_probs=128.5
Q ss_pred CchhHHHHHHHHHhhcCC-CCCCCCCC-CCCCCCCCceEEEeCCC-CCceEEEEcCCCcccc--cCCccccCCCCCCEEE
Q 005750 117 TEWQDVMVLEALRSISDE-SERTNDRG-DPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 191 (679)
Q Consensus 117 t~~~~~~~l~~l~~~~~~-~~~~~w~~-~~c~~~~w~~~~c~~~~-~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~ 191 (679)
..++|..+|.++|..... ....+|.. .+||.+.|.||+|+... ..+|+.|+|++|+++| .+|+.|+++++|++|+
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 457899999999998843 24557864 34444569999997642 2699999999999999 9999999999999999
Q ss_pred CCC-CcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCC
Q 005750 192 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 192 L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~ 266 (679)
|++ |.+.+.+| .|+++++|++|+|++|+++|.+|..++.+++|++|+|++|+++|.+|..+.. .+..+.+++|..
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 995 99999988 5999999999999999999999999999999999999999999999987754 556777888764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-16 Score=183.38 Aligned_cols=158 Identities=20% Similarity=0.243 Sum_probs=130.4
Q ss_pred eeeeeeeeeeccC---CCchhHHHHHHHHHhhcCCCCCCCCCCCC------CCCCCC------------ceEEEeCCCCC
Q 005750 103 NAIEISKYQKIAA---KTEWQDVMVLEALRSISDESERTNDRGDP------CVPVPW------------EWVTCSTTTPP 161 (679)
Q Consensus 103 na~e~~~~~~~~~---~t~~~~~~~l~~l~~~~~~~~~~~w~~~~------c~~~~w------------~~~~c~~~~~~ 161 (679)
|+++-.+.+|+.. .+..+|..||.++|+..... +|+.+. |+.|.| .||+|++. .
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~--~ 323 (876)
T 4ecn_A 249 NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN--G 323 (876)
T ss_dssp TSEEEEEEEEECCCCCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT--S
T ss_pred cccccccccceeccccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCC--C
Confidence 4446666777653 34458999999999987543 665322 223689 99999873 6
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEEC-CCCcCCCC----------------------------------------
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWL-DGNFLTGP---------------------------------------- 200 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L-~~N~l~~~---------------------------------------- 200 (679)
+|+.|+|++|+|+|.+|++|++|++|+.|+| ++|.++|.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l 403 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence 9999999999999999999999999999999 88765544
Q ss_pred ------------------------------------CC-CCCCCCCCcEEEecCccCCC-----------------CCCC
Q 005750 201 ------------------------------------LP-DMSRLIDLRIVHLENNELTG-----------------SLPS 226 (679)
Q Consensus 201 ------------------------------------~p-~~~~l~~L~~L~l~~N~l~g-----------------~~p~ 226 (679)
+| +|++|++|+.|+|++|+|+| .+|.
T Consensus 404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~ 483 (876)
T 4ecn_A 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483 (876)
T ss_dssp HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence 56 59999999999999999998 4999
Q ss_pred CCC--CCCccceecccccCCCCCCCccccC--CceeeeecCCC
Q 005750 227 YMG--SLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 227 ~~~--~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
.++ +|++|++|+|++|++.|.+|..+.. .+..+.+++|.
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 998 9999999999999999999987764 56778888886
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=168.12 Aligned_cols=138 Identities=16% Similarity=0.152 Sum_probs=98.5
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc--------------hhHHH--------HHHHHHHHHhccCCCcc
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------------HRTQQ--------FVTEVALLSRIHHRNLV 416 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~hpnIv 416 (679)
|.+.+.||+|++|.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 556789999999999999999999999999753210 00111 23455556665443332
Q ss_pred cccccccccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC
Q 005750 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 496 (679)
Q Consensus 417 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 496 (679)
...-+ . ....++||||++|++|.++... .....++.|++.+|.+||+ .|||||||||.|||+++++
T Consensus 177 vp~p~-~-~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPI-A-QSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEE-E-EETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeee-e-ccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 11111 1 1234799999999998765431 1235678999999999999 9999999999999998776
Q ss_pred ----------cEEEeeccCccccc
Q 005750 497 ----------RAKVSDFGLSRQAE 510 (679)
Q Consensus 497 ----------~~kL~Dfgla~~~~ 510 (679)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999776543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.4e-16 Score=178.83 Aligned_cols=146 Identities=18% Similarity=0.240 Sum_probs=122.5
Q ss_pred CCchhHHHHHHHHHhhcCCCCCC----------CCCCCCCCCCCC---ceEEEeCCCCCceEEEEcCCCcccccCCcccc
Q 005750 116 KTEWQDVMVLEALRSISDESERT----------NDRGDPCVPVPW---EWVTCSTTTPPRITKIALSGKNLKGEIPPELK 182 (679)
Q Consensus 116 ~t~~~~~~~l~~l~~~~~~~~~~----------~w~~~~c~~~~w---~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~~~ 182 (679)
.....|..||.+++.......+. +|..+. .+|.| .||+|+.. ++|+.|+|++|+++|.+|++|+
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~-~~c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK-ELDMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSS-CGGGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCC-CcccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHh
Confidence 34457999999999876543222 676432 12479 99999865 6999999999999999999999
Q ss_pred CCCCCCEEECCCCc------------------------------------------------------------------
Q 005750 183 NMEALTELWLDGNF------------------------------------------------------------------ 196 (679)
Q Consensus 183 ~l~~L~~L~L~~N~------------------------------------------------------------------ 196 (679)
+|++|+.|+|++|.
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 99999999999994
Q ss_pred ------------CCCCCC-CCCCCCCCcEEEecCccCCCC-----------------CCCCCC--CCCccceecccccCC
Q 005750 197 ------------LTGPLP-DMSRLIDLRIVHLENNELTGS-----------------LPSYMG--SLPNLQELHIENNSF 244 (679)
Q Consensus 197 ------------l~~~~p-~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l 244 (679)
|+| +| +|+++++|+.|+|++|+|+|. +|..++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 445 56 599999999999999999986 999999 999999999999999
Q ss_pred CCCCCccccC--CceeeeecCCC
Q 005750 245 VGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 245 ~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
.|.+|..+.. .+..+.+++|.
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCT
T ss_pred CccChHHHhcCCCCCEEECcCCC
Confidence 9999988764 55777888886
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.8e-15 Score=142.94 Aligned_cols=121 Identities=23% Similarity=0.304 Sum_probs=106.1
Q ss_pred CCCceEEEeCC--------CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCc
Q 005750 148 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 218 (679)
Q Consensus 148 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N 218 (679)
|.|..+.|+.. .+.+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++.++ .|.+|++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666777643 2457999999999999 899999999999999999999999988 4999999999999999
Q ss_pred cCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 219 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|++..|..|..+++|+.|+|++|+|+ .+|...+. .+..+.+.+||+.|++
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 999777788999999999999999999 77776543 4577899999999975
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.56 E-value=6.1e-15 Score=142.65 Aligned_cols=123 Identities=19% Similarity=0.214 Sum_probs=106.9
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccCCc-cccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
|.|..+.|+... +.+|+.|+|++|+|++..+. .|+++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 568888887532 34899999999999966654 49999999999999999999988 599999999999999
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCcccc
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~~ 270 (679)
|+|++..|..|..+++|++|+|++|+|++.+|..+.. .+..+.+++|++.|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999888888999999999999999999777776643 5678899999999864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.9e-15 Score=177.34 Aligned_cols=111 Identities=32% Similarity=0.436 Sum_probs=102.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+++|.+|..|++|++|+.|+|++|+|+|.+| +|++|++|+.|||++|+|+|.+|..++.+++|++|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 4579999999999999999999999999999999999999999 599999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccc-cCCceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~-~~~~~~~~~~~n~~~~~~ 270 (679)
|++|+|+|.||..- +......++.|||++|+.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999753 344456678999999974
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=143.44 Aligned_cols=108 Identities=23% Similarity=0.344 Sum_probs=84.4
Q ss_pred CCCCCCCCCCceEEEeCC--------CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCc
Q 005750 141 RGDPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR 211 (679)
Q Consensus 141 ~~~~c~~~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~ 211 (679)
....| .|.++.|+.. .+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|+
T Consensus 15 ~~~~C---s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 15 SQCSC---SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp TTCEE---ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCEE---eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 33455 6999999763 245788999999999987788888888888888888888877764 78888888
Q ss_pred EEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccc
Q 005750 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 252 (679)
Q Consensus 212 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~ 252 (679)
.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 131 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI 131 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc
Confidence 8888888888555555777777777777777777 677655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-14 Score=136.46 Aligned_cols=126 Identities=20% Similarity=0.307 Sum_probs=107.6
Q ss_pred CCCCCCCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEE
Q 005750 143 DPCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 213 (679)
Q Consensus 143 ~~c~~~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L 213 (679)
+.| .|.|.++.|+... +++|+.|+|++|++++..+..|+++++|++|+|++|+|++.++. |.++++|+.|
T Consensus 3 ~~C-~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRC-SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTC-EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCC-EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 345 3679999997632 45899999999999976667789999999999999999998885 8999999999
Q ss_pred EecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 214 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|++|+|++..|..+..+++|+.|+|++|+|+ .+|...+. .+..+.+++|++.|..
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999999766667899999999999999999 67776543 4577889999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-14 Score=139.50 Aligned_cols=111 Identities=19% Similarity=0.198 Sum_probs=99.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 46899999999999987788999999999999999999999985 99999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~~ 270 (679)
|++|+|++..|..+.. .+..+.+++||+.|++
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9999999655665543 5577899999999864
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.8e-14 Score=138.33 Aligned_cols=110 Identities=20% Similarity=0.286 Sum_probs=95.9
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 35899999999999988899999999999999999999988875 78999999999999999988888999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
|++|+|+ .+|...+. .+..+.+.+||+.|++
T Consensus 135 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 135 LYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCC-EECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999999 55554333 4567889999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-14 Score=150.87 Aligned_cols=147 Identities=18% Similarity=0.172 Sum_probs=117.7
Q ss_pred CchhHHHHHHHHHhhcC--C-CCCCCCC---CCCCCCCCCceEEEeC-------CCCCceEEEEcCCCcccccCCccccC
Q 005750 117 TEWQDVMVLEALRSISD--E-SERTNDR---GDPCVPVPWEWVTCST-------TTPPRITKIALSGKNLKGEIPPELKN 183 (679)
Q Consensus 117 t~~~~~~~l~~l~~~~~--~-~~~~~w~---~~~c~~~~w~~~~c~~-------~~~~~l~~L~L~~n~l~g~~p~~~~~ 183 (679)
...++..+|.+||.... . .+...|. ...-..|.|.|++|.. ...++|+.|+|++|+++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 44578899999998652 1 2334662 1111123799999952 23468999999999999 89999999
Q ss_pred CCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCcccc----------
Q 005750 184 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---------- 253 (679)
Q Consensus 184 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~---------- 253 (679)
|++|++|+|++|.|+..+..++++++|+.|+|++|+|+ .+|..++.+++|++|+|++|++.|.+|..+.
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 99999999999999944446999999999999999999 9999999999999999999999999999873
Q ss_pred -CCceeeeecCCC
Q 005750 254 -TGKVIFKYDNNP 265 (679)
Q Consensus 254 -~~~~~~~~~~n~ 265 (679)
..+..+.+++|.
T Consensus 182 l~~L~~L~L~~n~ 194 (328)
T 4fcg_A 182 LVNLQSLRLEWTG 194 (328)
T ss_dssp STTCCEEEEEEEC
T ss_pred CCCCCEEECcCCC
Confidence 345556666664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=128.32 Aligned_cols=104 Identities=27% Similarity=0.332 Sum_probs=88.5
Q ss_pred eEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 163 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 163 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
.+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 357999999999 6887774 8999999999999999884 99999999999999999966566689999999999999
Q ss_pred cCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 242 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 242 N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
|+|+ .+|+..+. .+..+.+++||+.|.+
T Consensus 88 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999 66665433 5578889999999865
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-13 Score=162.59 Aligned_cols=131 Identities=19% Similarity=0.324 Sum_probs=85.4
Q ss_pred CCchhHHHHHHHHHhhcCCC-CCCCCCC-CCCCCCCCceEEEeCCCCCceEEEEcCCCccccc---CCccccCCCCCCEE
Q 005750 116 KTEWQDVMVLEALRSISDES-ERTNDRG-DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE---IPPELKNMEALTEL 190 (679)
Q Consensus 116 ~t~~~~~~~l~~l~~~~~~~-~~~~w~~-~~c~~~~w~~~~c~~~~~~~l~~L~L~~n~l~g~---~p~~~~~l~~L~~L 190 (679)
....+|..||.++|+...+. ...+|.. ..| |.|.||+|+ .++|+.|+|+++++.|. +|+.|++|+.|+.+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~--C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNP--CTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCG--GGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCCCcccccCCCCCCCC--cCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 44568999999999877533 4668863 333 379999998 36999999999999998 77666555555555
Q ss_pred ECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCC--CCCCCCccceecccccCCCCCCCcc
Q 005750 191 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPA 251 (679)
Q Consensus 191 ~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~ip~~ 251 (679)
+++.|.+...++.|+++++|++|+|++|+++|.+|. .++++++|++|+|++|.++|.+|..
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 145 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHH
Confidence 555555444333455555555555555555555555 5555555555555555555555543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.2e-13 Score=126.85 Aligned_cols=103 Identities=22% Similarity=0.345 Sum_probs=89.2
Q ss_pred EEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccccc
Q 005750 164 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242 (679)
Q Consensus 164 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 242 (679)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67999999997 8898775 899999999999999988 5999999999999999999644455789999999999999
Q ss_pred CCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 243 SFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 243 ~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|+ .+|+..+. .+..+.+.+|++.|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 999 67776433 5577889999999864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=3.6e-13 Score=127.44 Aligned_cols=102 Identities=23% Similarity=0.272 Sum_probs=89.8
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCc
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 218 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N 218 (679)
|.|+.+.|+... +.+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 567778886532 35789999999999988899999999999999999999999886 799999999999999
Q ss_pred cCCCCCCCCCCCCCccceecccccCCCCCCC
Q 005750 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249 (679)
Q Consensus 219 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip 249 (679)
+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9996666679999999999999999985443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.41 E-value=7.6e-13 Score=129.32 Aligned_cols=121 Identities=23% Similarity=0.356 Sum_probs=94.6
Q ss_pred CCCCCCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEE
Q 005750 144 PCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 214 (679)
Q Consensus 144 ~c~~~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~ 214 (679)
.| .|.|.++.|+... +++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |.++++|+.|+
T Consensus 4 ~C-~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 4 RC-SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TC-EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CC-EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 45 4689999997632 45789999999999966666788999999999999999988775 78899999999
Q ss_pred ecCccCCCCCCCCCCCCCccceecccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 215 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 215 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
|++|+|++..+..++.+++|++|+|++|+++ .+|+..+ ..+..+.+++|..
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCcc
Confidence 9999999555556788999999999999998 5555433 2445666677654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.40 E-value=8.2e-13 Score=136.30 Aligned_cols=110 Identities=27% Similarity=0.340 Sum_probs=97.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 46899999999999977778899999999999999999999885 89999999999999999944444578899999999
Q ss_pred ccccCCCCCCCccccCC--ceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLTG--KVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~--~~~~~~~~n~~~~~~ 270 (679)
|++|+|+ .+|..++.. +..+.+.+|||.|++
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9999999 899988764 567889999999974
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=129.71 Aligned_cols=121 Identities=21% Similarity=0.201 Sum_probs=100.0
Q ss_pred CCCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 147 PVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 147 ~~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
.|.|..+.|+... +.+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..| .|.++++|+.|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 3568888887532 3579999999999997777799999999999999999999988 599999999999999
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCcccc--CCceeeeecCCCCc
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 267 (679)
|+|++..+..|..+++|+.|+|++|+|++..|..+. ..+..+.+++|...
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 999944444578999999999999999955555443 24567788888654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.6e-13 Score=148.56 Aligned_cols=107 Identities=21% Similarity=0.188 Sum_probs=84.4
Q ss_pred CCceEEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++.+|..+. +|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|++ +|..++.+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 35788888888888887777776 788888888888888877 444468888889999998884 555688888999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCccc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 269 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~ 269 (679)
|++|+|+ .+|..+.. .+..+.+++|++.|+
T Consensus 221 Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence 9999998 57776543 456778889988875
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-12 Score=129.75 Aligned_cols=109 Identities=20% Similarity=0.266 Sum_probs=95.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 46899999999999977777899999999999999999999886 89999999999999999966666899999999999
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCCccc
Q 005750 239 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHK 269 (679)
Q Consensus 239 l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~~~ 269 (679)
|++|+|+ .+|+..+ ..+..+.+.+|++.|.
T Consensus 162 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999 5555433 2557889999999885
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=6.1e-13 Score=140.76 Aligned_cols=102 Identities=21% Similarity=0.246 Sum_probs=90.4
Q ss_pred EEcCCC-cccccCCccccCCCCCCEEECCC-CcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccccc
Q 005750 166 IALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242 (679)
Q Consensus 166 L~L~~n-~l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 242 (679)
++++++ +|+ .+|. |..+++|+.|+|++ |+|++.+| .|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 466676 888 6888 99999999999996 99999998 5999999999999999999888889999999999999999
Q ss_pred CCCCCCCccccCC--ceeeeecCCCCcccc
Q 005750 243 SFVGEIPPALLTG--KVIFKYDNNPKLHKE 270 (679)
Q Consensus 243 ~l~g~ip~~~~~~--~~~~~~~~n~~~~~~ 270 (679)
+|+ .+|+..+.. +..+.+.+|++.|++
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 999 788777654 577889999999874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-13 Score=143.07 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=97.8
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
.|+.|+|++|.+++.+|..|.++++|+.|+|++|.+++.+|.+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++
T Consensus 198 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 277 (313)
T 1ogq_A 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence 38899999999998889999999999999999999999998899999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-cCCceeeeecCCCCcccc
Q 005750 242 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 242 N~l~g~ip~~~-~~~~~~~~~~~n~~~~~~ 270 (679)
|+++|.+|... ...+..+.+.+||++|+.
T Consensus 278 N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCCccccccChHHhcCCCCccCC
Confidence 99999999862 224466788999999974
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.2e-12 Score=124.88 Aligned_cols=110 Identities=20% Similarity=0.267 Sum_probs=95.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. |.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 36899999999999966666789999999999999999998885 89999999999999999966666789999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
|++|+++ .+|...+. .+..+.+++|++.|..
T Consensus 131 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCCCccc-eeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999999 56665433 5577889999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=128.22 Aligned_cols=120 Identities=14% Similarity=0.162 Sum_probs=101.0
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccCCc-cccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
|.|..+.|+... +..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++.++ .|.++++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 567888887532 34678999999999977664 58999999999999999999998 699999999999999
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
|+|++..|..|..+++|++|+|++|+|++..|..+.. .+..+.+++|...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 9999777778999999999999999999665665543 4567788888644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=126.50 Aligned_cols=91 Identities=22% Similarity=0.341 Sum_probs=86.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++.+|..+..+++|++|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999998899999999999999999999999985 99999999999999999999999999999999999
Q ss_pred ccccCCCCCCCc
Q 005750 239 IENNSFVGEIPP 250 (679)
Q Consensus 239 l~~N~l~g~ip~ 250 (679)
|++|.+++..+-
T Consensus 133 L~~N~l~c~c~l 144 (192)
T 1w8a_A 133 LASNPFNCNCHL 144 (192)
T ss_dssp CTTCCBCCSGGG
T ss_pred eCCCCccCcCcc
Confidence 999999987664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.2e-12 Score=121.40 Aligned_cols=90 Identities=19% Similarity=0.272 Sum_probs=81.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+.+|+.|+|++|+|++..|..|++|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 45789999999999988899999999999999999999999886 79999999999999999955555699999999999
Q ss_pred ccccCCCCCCCc
Q 005750 239 IENNSFVGEIPP 250 (679)
Q Consensus 239 l~~N~l~g~ip~ 250 (679)
|++|.+. ..|.
T Consensus 112 L~~N~~~-c~~~ 122 (174)
T 2r9u_A 112 LYNNPWD-CECR 122 (174)
T ss_dssp CCSSCBC-TTBG
T ss_pred eCCCCcc-cccc
Confidence 9999998 4444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.33 E-value=4.7e-12 Score=129.23 Aligned_cols=112 Identities=18% Similarity=0.162 Sum_probs=96.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++++..|..|+++++|+.|+|++|+|++.++. +.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 46899999999999977777799999999999999999999885 79999999999999999977777789999999999
Q ss_pred ccccCCCCCCCcccc--CCceeeeecCCCCccccc
Q 005750 239 IENNSFVGEIPPALL--TGKVIFKYDNNPKLHKES 271 (679)
Q Consensus 239 l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~~~~ 271 (679)
|++|++++..|..+. ..+..+.+.+|++.|..+
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999954443332 356788999999988643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=137.35 Aligned_cols=108 Identities=16% Similarity=0.236 Sum_probs=90.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|+++ .+|..++++++|+.|+|++|.|++.++.++++++|+.|+|++|++.+.+|..++.+++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 457889999999988 8888899999999999999999987778888999999999999888889988889999999999
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALLT--GKVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~ 268 (679)
++|++.+.+|..+.. .+..+.+++|+...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 998888888887653 45677778876543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.33 E-value=5.1e-12 Score=128.83 Aligned_cols=111 Identities=22% Similarity=0.282 Sum_probs=98.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..|..|.++++|+.|+|++|.|++.++. |.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 108 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 46899999999999987778899999999999999999998885 89999999999999999966666799999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCccccc
Q 005750 239 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 271 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~ 271 (679)
|++|+++ .+|...+. .+..+.+.+||+.|++.
T Consensus 188 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9999999 67766443 45778999999999753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.4e-12 Score=147.05 Aligned_cols=112 Identities=16% Similarity=0.177 Sum_probs=99.0
Q ss_pred CCceEEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
.+.++.|+|++|++. +.+|..|..+++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..|..|+.+++|++|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 468999999999854 4578889999999999999999999998 59999999999999999998888889999999999
Q ss_pred cccccCCCCCCCcccc---CCceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALL---TGKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~~~~~ 271 (679)
+|++|+|++..|..+. ..+..+.+++||+.|++.
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999976676654 346778999999999863
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.1e-12 Score=136.30 Aligned_cols=108 Identities=21% Similarity=0.269 Sum_probs=56.1
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCC----CCCCccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYM----GSLPNLQ 235 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~----~~l~~L~ 235 (679)
++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..| .|.++++|+.|+|++|+|+ .+|..+ ..+++|+
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~ 166 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCC
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCC
Confidence 455555555555554444445555555555555555555544 3555555555555555555 344332 3455555
Q ss_pred eecccccCCCCCCCccccCCc-----eeeeecCCCCcccc
Q 005750 236 ELHIENNSFVGEIPPALLTGK-----VIFKYDNNPKLHKE 270 (679)
Q Consensus 236 ~L~l~~N~l~g~ip~~~~~~~-----~~~~~~~n~~~~~~ 270 (679)
.|+|++|+|+ .+|...+... ..+.+.+||+.|++
T Consensus 167 ~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 167 LLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp EEECCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred EEECCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 5555555555 4443222111 23567777777764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.1e-12 Score=127.74 Aligned_cols=127 Identities=22% Similarity=0.339 Sum_probs=93.3
Q ss_pred CCCCCCCCC-CCCceEEEeCC--------CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCC
Q 005750 139 NDRGDPCVP-VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLI 208 (679)
Q Consensus 139 ~w~~~~c~~-~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~ 208 (679)
.|.|..|.. ..|..+.|+.. .++.++.|+|++|++++..+..|.++++|++|+|++|.|+..++. |.+++
T Consensus 6 ~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~ 85 (270)
T 2o6q_A 6 KKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85 (270)
T ss_dssp GGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT
T ss_pred CCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC
Confidence 455555522 23455666532 134688999999999866666889999999999999999887775 68899
Q ss_pred CCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 209 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 209 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
+|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|+..+ ..+..+.+++|..
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcC
Confidence 9999999999998655566788999999999999998 4555433 2456667777643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.3e-12 Score=120.21 Aligned_cols=105 Identities=22% Similarity=0.267 Sum_probs=89.9
Q ss_pred CCceEEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.|++. +.+.++++|+.|+|++|++++.+|..+..+++|++|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 468999999999998 88999999999999999999999988 7799999999999999999977888888899999999
Q ss_pred ccccCCCCCCC--ccccC--CceeeeecCCCC
Q 005750 239 IENNSFVGEIP--PALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g~ip--~~~~~--~~~~~~~~~n~~ 266 (679)
|++|+++ .+| ..+.. .+..+.+++|+.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCcC
Confidence 9999998 555 33332 446677777753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=124.12 Aligned_cols=106 Identities=23% Similarity=0.289 Sum_probs=84.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+++++.|+|++|++++..|..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+..+++|++|+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 35688899999998877777888889999999999988888874 88888888888888888866666788888888888
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 239 IENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
|++|+|+ .+|+..+ ..+..+.+++|..
T Consensus 114 L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCcCC-CcChhHhccCCcccEEECcCCcC
Confidence 8888888 6666543 2445666676643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.4e-12 Score=118.65 Aligned_cols=104 Identities=19% Similarity=0.252 Sum_probs=88.6
Q ss_pred CceEEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.|++. +.++++++|+.|+|++|++++.+|..++.+++|+.|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 58999999999998 88999999999999999999999988 77999999999999999999778888888999999999
Q ss_pred cccCCCCCCC--ccccC--CceeeeecCCCC
Q 005750 240 ENNSFVGEIP--PALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 240 ~~N~l~g~ip--~~~~~--~~~~~~~~~n~~ 266 (679)
++|++++ +| ..+.. .+..+.+++|+.
T Consensus 96 s~N~i~~-~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 96 SGNKIKD-LSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp TTSCCCS-HHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCcCCC-hHHHHHHhhCCCCCEEeCcCCcc
Confidence 9999984 43 44432 456677777753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=7.9e-12 Score=137.11 Aligned_cols=112 Identities=19% Similarity=0.225 Sum_probs=97.9
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|.+++..|..|+++++|+.|+|++|.|++.+| .|.++++|+.|+|++|++++..|..++.+++|++|
T Consensus 297 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 376 (455)
T 3v47_A 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376 (455)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence 34689999999999998888899999999999999999998888 48999999999999999998889999999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~ 271 (679)
+|++|+++ .+|+..+. .+..+.+++||+.|.++
T Consensus 377 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp ECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999 57765543 55778899999998754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=9.6e-12 Score=129.03 Aligned_cols=111 Identities=16% Similarity=0.169 Sum_probs=98.8
Q ss_pred CCceEEEEcCCCcccc-cCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
.++|+.|+|++|.+++ .+|..+..+++|+.|+|++|+|++.+| .|.++++|+.|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 4689999999999997 689999999999999999999999988 59999999999999999996666689999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|++|++++..|..+.. .+..+.+++|++.|++
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99999999888876654 4577899999998864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=8.5e-12 Score=128.07 Aligned_cols=110 Identities=19% Similarity=0.276 Sum_probs=95.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..+..|+++++|+.|+|++|+|++.++. |.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 128 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 207 (285)
T 1ozn_A 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (285)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEee
Confidence 46899999999999976667799999999999999999998885 99999999999999999988899999999999999
Q ss_pred ccccCCCCCCCcc-cc--CCceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPA-LL--TGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~-~~--~~~~~~~~~~n~~~~~~ 270 (679)
|++|+++ .+|.. +. ..+..+.+++||+.|++
T Consensus 208 l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CCSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCC-cCCHHHcccCcccCEEeccCCCccCCC
Confidence 9999999 46644 32 34577889999999864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=134.94 Aligned_cols=110 Identities=24% Similarity=0.327 Sum_probs=98.1
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.+| .|.++++|+.|+|++|++++..|..|..+++|+.|
T Consensus 183 ~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 260 (440)
T 3zyj_A 183 GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260 (440)
T ss_dssp TCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred cccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence 3568999999999999 666 58999999999999999999988 59999999999999999998888899999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~ 271 (679)
+|++|+|+ .+|...+. .+..+.+++||+.|++.
T Consensus 261 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp ECTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ECCCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 99999999 67776544 45778999999999763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=9.2e-12 Score=140.04 Aligned_cols=118 Identities=17% Similarity=0.200 Sum_probs=99.1
Q ss_pred CCCCceEEEeCCC----------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEe
Q 005750 147 PVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 215 (679)
Q Consensus 147 ~~~w~~~~c~~~~----------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l 215 (679)
.|+|.|+ |++.. +++|+.|+|++|++++..|..|+++++|++|+|++|+|++.+| .|+++++|+.|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 3589998 88752 3579999999999998888999999999999999999999988 5999999999999
Q ss_pred cCccCCCCCCCCCCCCCccceecccccCCCC-CCCccccC--CceeeeecCCC
Q 005750 216 ENNELTGSLPSYMGSLPNLQELHIENNSFVG-EIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 216 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~ip~~~~~--~~~~~~~~~n~ 265 (679)
++|++++..|..++.+++|++|+|++|++++ .+|..+.. .+..+.+++|.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence 9999997777779999999999999999985 34554433 44566677765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=130.02 Aligned_cols=103 Identities=20% Similarity=0.234 Sum_probs=86.3
Q ss_pred CCCCCCCceEEEeCC-C---------CCceEEEEcCC-CcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCc
Q 005750 144 PCVPVPWEWVTCSTT-T---------PPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR 211 (679)
Q Consensus 144 ~c~~~~w~~~~c~~~-~---------~~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~ 211 (679)
.|..|.|..+.|+.. . ..+|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++.+|. |.+|++|+
T Consensus 4 ~c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred cCccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 353467888988765 1 24599999996 999987778999999999999999999999995 89999999
Q ss_pred EEEecCccCCCCCCCCCCCCCccceecccccCCCCC
Q 005750 212 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE 247 (679)
Q Consensus 212 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 247 (679)
.|+|++|+|++..|..+..++ |+.|+|++|.|...
T Consensus 84 ~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp EEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred EEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999999999954444555555 99999999999843
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=8.3e-12 Score=142.48 Aligned_cols=106 Identities=15% Similarity=0.060 Sum_probs=90.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
|..++.|||++|+|++..|..|.+|++|++|+|++|+|++++| .|.+|++|++|+|++|+|++..|..|.+|++|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 4579999999999997777889999999999999999999988 499999999999999999955556789999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCC
Q 005750 239 IENNSFVGEIPPALLT---GKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---~~~~~~~~~n~~ 266 (679)
|++|+|+ .+|+..+. .+..+.+++|..
T Consensus 131 Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 131 AVETNLA-SLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp CTTSCCC-CSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCcCC-CCChhhhhcCcccCeeccccCcc
Confidence 9999999 66665433 456677777754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=141.16 Aligned_cols=111 Identities=19% Similarity=0.144 Sum_probs=96.5
Q ss_pred CCceEEEEcCCCcccc-cCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
.++|+.|+|++|.+++ .+|..|+.+++|+.|+|++|++++.+|. |.++++|+.|+|++|++++.+|..++.+++|+.|
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 4688999999999988 4788899999999999999999998884 8999999999999999998889999999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~ 271 (679)
+|++|+|+ .+|..+.. .+..+.+.+||+.|++.
T Consensus 527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999998 88887543 35778899999998753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.3e-11 Score=129.46 Aligned_cols=120 Identities=21% Similarity=0.153 Sum_probs=88.7
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
|.+..+.|+... +..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456667776532 34578899999999876666676 88888899998888888887 488888888888888
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
|+|++..+..|..+++|+.|+|++|+|++..|..+.. .+..+.+++|...
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 8888655667888888888888888888433443322 4456666776543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.20 E-value=5e-11 Score=122.88 Aligned_cols=107 Identities=28% Similarity=0.350 Sum_probs=95.1
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 4578999999999999 8999999999999999999999999985 9999999999999999996666678999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKL 267 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~ 267 (679)
+|++|+|+ .+|...+. .+..+.+++|...
T Consensus 154 ~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 99999999 78887654 4567788888654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.1e-11 Score=133.89 Aligned_cols=110 Identities=23% Similarity=0.301 Sum_probs=97.6
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|++++ +| .+..+++|+.|+|++|.|++.+| .|.++++|+.|+|++|++++..|..|..+++|+.|
T Consensus 194 ~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 271 (452)
T 3zyi_A 194 GLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271 (452)
T ss_dssp TCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence 35689999999999994 54 58999999999999999999988 59999999999999999998889999999999999
Q ss_pred cccccCCCCCCCccccC---CceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~~ 271 (679)
+|++|+|+ .+|...+. .+..+.+++||+.|++.
T Consensus 272 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 272 NLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp ECCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ECCCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 99999999 67766543 45778999999999763
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.5e-11 Score=134.86 Aligned_cols=125 Identities=16% Similarity=0.183 Sum_probs=99.4
Q ss_pred CCCC-CCCCce--EEEeCCC-------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC--CCCCCCCC
Q 005750 143 DPCV-PVPWEW--VTCSTTT-------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDL 210 (679)
Q Consensus 143 ~~c~-~~~w~~--~~c~~~~-------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L 210 (679)
|||. .|.|.+ +.|+... +++|+.|+|++|.+++..|..|++|++|++|+|++|.+.+.++ .|.++++|
T Consensus 2 ~p~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L 81 (455)
T 3v47_A 2 DPGTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81 (455)
T ss_dssp -----CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTC
T ss_pred CCccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccC
Confidence 4553 244555 6666432 3579999999999998889999999999999999999987764 49999999
Q ss_pred cEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCcc--cc--CCceeeeecCCCCc
Q 005750 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA--LL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 211 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~--~~--~~~~~~~~~~n~~~ 267 (679)
+.|+|++|++++..|..|+++++|++|+|++|++++.+|.. +. ..+..+.+++|...
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 99999999999888999999999999999999999766554 32 24566777777543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.2e-11 Score=114.55 Aligned_cols=90 Identities=22% Similarity=0.338 Sum_probs=80.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 36899999999999966666789999999999999999999885 89999999999999999955555578899999999
Q ss_pred ccccCCCCCCC
Q 005750 239 IENNSFVGEIP 249 (679)
Q Consensus 239 l~~N~l~g~ip 249 (679)
|++|.+++..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999997665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-11 Score=122.63 Aligned_cols=140 Identities=14% Similarity=0.071 Sum_probs=109.1
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 445677888888999999865 6899999986432223346889999999994 67788899998888899999999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC----------------------------------------- 476 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------------------------------- 476 (679)
.+|.+.+.. ......++.+++++|+.||+..
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876421 1123467889999999999710
Q ss_pred ---------------CCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 477 ---------------NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 477 ---------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
...++|||++|.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799999764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=128.91 Aligned_cols=116 Identities=20% Similarity=0.244 Sum_probs=97.5
Q ss_pred CCCCceEEEeCCC----------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEe
Q 005750 147 PVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 215 (679)
Q Consensus 147 ~~~w~~~~c~~~~----------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l 215 (679)
+|+|.++ |+++. +++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.+| .|.++++|+.|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 4588887 87642 3589999999999997666689999999999999999999988 4999999999999
Q ss_pred cCccCCCCCCCC-CCCCCccceecccccCCCCCCCc-cccC---CceeeeecCCC
Q 005750 216 ENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPP-ALLT---GKVIFKYDNNP 265 (679)
Q Consensus 216 ~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~ip~-~~~~---~~~~~~~~~n~ 265 (679)
++|+++ .+|.. ++.+++|++|+|++|+++ .+|. ..+. .+..+.+++|.
T Consensus 108 s~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 999999 45554 899999999999999999 7877 4332 45667777774
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.4e-11 Score=118.78 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=96.9
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 46899999999999855556689999999999999999999885 899999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
|++|+|+ .+|...+. .+..+.+.+||+.|.+
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999999 67765443 5577889999999865
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.18 E-value=8.7e-11 Score=119.77 Aligned_cols=107 Identities=22% Similarity=0.290 Sum_probs=90.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++++..+..|+++++|++|+|++|+|++.++. |.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 46899999999999977777789999999999999999998885 89999999999999999976667789999999999
Q ss_pred ccccCCCCCCCcccc---CCceeeeecCCCCc
Q 005750 239 IENNSFVGEIPPALL---TGKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~ 267 (679)
|++|+++ .+|+..+ ..+..+.+.+|...
T Consensus 164 l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCcC-ccCHHHhcCCccCCEEECCCCcCC
Confidence 9999999 5555443 35567778887654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.1e-11 Score=137.40 Aligned_cols=107 Identities=16% Similarity=0.215 Sum_probs=98.7
Q ss_pred CceEEEEcCCCcccccCCcccc--CCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEe------cCccCCCCCCCCCCCCC
Q 005750 161 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSLP 232 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l------~~N~l~g~~p~~~~~l~ 232 (679)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|..++.++
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 38999999999999 8999998 999999999999999995447999999999999 56889999999999999
Q ss_pred ccceecccccCCCCCCCccccCCceeeeecCCCCccc
Q 005750 233 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 269 (679)
Q Consensus 233 ~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~~~ 269 (679)
+|+.|+|++|+| +.+|..++..+..+.+++|+..|-
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 999999999999 599999988888999999998873
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.8e-11 Score=115.20 Aligned_cols=88 Identities=25% Similarity=0.284 Sum_probs=80.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.|++..+..|.+|++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 4689999999999998778889999999999999999999999 599999999999999999955555699999999999
Q ss_pred ccccCCCCC
Q 005750 239 IENNSFVGE 247 (679)
Q Consensus 239 l~~N~l~g~ 247 (679)
|++|.+...
T Consensus 133 L~~N~~~C~ 141 (193)
T 2wfh_A 133 IGANPLYCD 141 (193)
T ss_dssp CCSSCEECS
T ss_pred eCCCCeecC
Confidence 999999754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=5.9e-11 Score=121.15 Aligned_cols=107 Identities=15% Similarity=0.030 Sum_probs=89.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++ .|.++++|+.|+|++|++++..|..+..+++|++|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3469999999999997777789999999999999999999888 599999999999999999977778899999999999
Q ss_pred ccccCCCCCCCcccc--CCceeeeecCCCC
Q 005750 239 IENNSFVGEIPPALL--TGKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g~ip~~~~--~~~~~~~~~~n~~ 266 (679)
+++|++++..+..+. ..+..+.+++|..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCcc
Confidence 999999843333333 2456677777754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=4.5e-11 Score=134.74 Aligned_cols=102 Identities=25% Similarity=0.312 Sum_probs=85.2
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
.|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.|++|++|+.|+|++|+|++ +| .++.|++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 57889999999995 776 999999999999999999554469999999999999999995 78 899999999999999
Q ss_pred cCCCCCC-CccccC--CceeeeecCCCCc
Q 005750 242 NSFVGEI-PPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 242 N~l~g~i-p~~~~~--~~~~~~~~~n~~~ 267 (679)
|+|++.+ |..+.. .+..+.+++|+..
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 9999655 777654 5577788888754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=8.2e-11 Score=123.38 Aligned_cols=106 Identities=23% Similarity=0.283 Sum_probs=94.3
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
++|+.|+|++|.+++..|..|.++++|+.|+|++|.|++.++ .+.++++|+.|+|++|+++ .+|..+..+++|++|+|
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 589999999999998889999999999999999999999988 5999999999999999999 99999999999999999
Q ss_pred cccCCCCCCCccccC---------CceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~---------~~~~~~~~~n~~~~ 268 (679)
++|+++ .+|...+. ....+.+.+||..+
T Consensus 271 ~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 999999 67765543 23457788998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-11 Score=144.60 Aligned_cols=107 Identities=22% Similarity=0.309 Sum_probs=86.3
Q ss_pred CceEEEEcCCCccc-----ccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCcc
Q 005750 161 PRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 234 (679)
Q Consensus 161 ~~l~~L~L~~n~l~-----g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 234 (679)
++|+.|+|++|.++ +..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+. ++|
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L 528 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANL 528 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccc
Confidence 46666777777665 34445688899999999999999999885 89999999999999999965555555 899
Q ss_pred ceecccccCCCCCCCccccCCceeeeecCCCCcccc
Q 005750 235 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 235 ~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~~~~ 270 (679)
+.|+|++|+|+|.+|.. +..+..+.+++||+.|++
T Consensus 529 ~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 529 EILDISRNQLLAPNPDV-FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSS
T ss_pred cEEECCCCcCCCCChhH-hCCcCEEEecCCCccccc
Confidence 99999999999766655 456778899999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=128.79 Aligned_cols=119 Identities=22% Similarity=0.258 Sum_probs=97.7
Q ss_pred CCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCcc
Q 005750 149 PWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 219 (679)
Q Consensus 149 ~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~ 219 (679)
.|..+.|+... +.+++.|+|++|+|++..|..|.++++|+.|+|++|.|++..| .|.++++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 36678887532 4578999999999998888899999999999999999999988 59999999999999999
Q ss_pred CCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 220 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 220 l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
+++..+..|+++++|++|+|++|++++..|..+.. .+..+.+++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence 99544456899999999999999999655555432 4566777777543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=128.31 Aligned_cols=115 Identities=20% Similarity=0.237 Sum_probs=97.0
Q ss_pred CceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccC
Q 005750 150 WEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 220 (679)
Q Consensus 150 w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l 220 (679)
|..+.|+... +++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 4567776532 4579999999999998889999999999999999999999988 599999999999999999
Q ss_pred CCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCC
Q 005750 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 265 (679)
Q Consensus 221 ~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~ 265 (679)
++..+..+..+++|++|+|++|+++ .+|...+. .+..+.+++|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 9666667999999999999999999 77775543 34556666644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.2e-11 Score=138.35 Aligned_cols=106 Identities=17% Similarity=0.269 Sum_probs=97.7
Q ss_pred CceEEEEcCCCcccccCCcccc--CCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecC------ccCCCCCCCCCCCCC
Q 005750 161 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLP 232 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~------N~l~g~~p~~~~~l~ 232 (679)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+|++ |++.+.+|..++.++
T Consensus 728 ~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~ 806 (876)
T 4ecn_A 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806 (876)
T ss_dssp GGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCC
Confidence 38999999999999 8999998 99999999999999999655799999999999976 889999999999999
Q ss_pred ccceecccccCCCCCCCccccCCceeeeecCCCCcc
Q 005750 233 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 268 (679)
Q Consensus 233 ~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~~ 268 (679)
+|+.|+|++|+| +.||..++..+..+.+++|+...
T Consensus 807 ~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 807 SLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp SCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 999999999999 69999998888889999998764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.2e-11 Score=138.33 Aligned_cols=105 Identities=27% Similarity=0.360 Sum_probs=79.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
...|+.|+|++|.+. .+|..+++|++|+.|+|++|.|+.++++|++|++|+.|+|++|+|+ .+|..|+.|++|++|+|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 357788888888887 7787777888888888888888844335888888888888888888 77888888888888888
Q ss_pred cccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 240 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
++|.|+ .||..+.. .+..+.+++|+..
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 888886 77877543 4466677777654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.12 E-value=4.4e-11 Score=119.40 Aligned_cols=104 Identities=21% Similarity=0.323 Sum_probs=88.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCc-CCCCCC-CCCCCCCCcEEEecC-ccCCCCCCCCCCCCCccce
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDLRIVHLEN-NELTGSLPSYMGSLPNLQE 236 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~ 236 (679)
+.+|+.|+|++|++++..+..|.++++|+.|+|++|+ +++.++ .|.++++|+.|+|++ |++++..|..|..+++|++
T Consensus 30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 4589999999999997777789999999999999997 888888 599999999999999 9999655578999999999
Q ss_pred ecccccCCCCCCCccccC--Cce---eeeecCCC
Q 005750 237 LHIENNSFVGEIPPALLT--GKV---IFKYDNNP 265 (679)
Q Consensus 237 L~l~~N~l~g~ip~~~~~--~~~---~~~~~~n~ 265 (679)
|++++|+++ .+|. +.. .+. .+.+++|+
T Consensus 110 L~l~~n~l~-~lp~-~~~l~~L~~L~~L~l~~N~ 141 (239)
T 2xwt_C 110 LGIFNTGLK-MFPD-LTKVYSTDIFFILEITDNP 141 (239)
T ss_dssp EEEEEECCC-SCCC-CTTCCBCCSEEEEEEESCT
T ss_pred EeCCCCCCc-cccc-cccccccccccEEECCCCc
Confidence 999999999 5887 322 223 67778884
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.3e-11 Score=129.53 Aligned_cols=107 Identities=18% Similarity=0.210 Sum_probs=63.8
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.++.+..+++|+.|+|++|+++ .+|..++.+++|+.|+|+
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 326 (390)
T 3o6n_A 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326 (390)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECC
Confidence 4555666666666655555666666666666666666655444555666666666666666 555555566666666666
Q ss_pred ccCCCCCCCccccCCceeeeecCCCCccc
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHK 269 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~~~~~ 269 (679)
+|+++ .+|......+..+.+++||+.|.
T Consensus 327 ~N~i~-~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 327 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCccc-eeCchhhccCCEEEcCCCCccch
Confidence 66665 45544444555666677776653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.4e-11 Score=137.04 Aligned_cols=107 Identities=18% Similarity=0.210 Sum_probs=68.4
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|.+++.+|..|+++++|+.|+|++|.|++.++.+..+++|+.|+|++|.|+ .+|..++.+++|+.|+|+
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~ 332 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECC
Confidence 4566666666666666666666666666666666666665445556666666666666666 566666666666666666
Q ss_pred ccCCCCCCCccccCCceeeeecCCCCccc
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNPKLHK 269 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~~~~~ 269 (679)
+|+|+ .+|...+..+..+.+++||+.|.
T Consensus 333 ~N~l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 333 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 66666 44544455566677777777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=6e-11 Score=133.73 Aligned_cols=89 Identities=28% Similarity=0.330 Sum_probs=82.4
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCC-CCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +|.|++|++|+.|+|++|+|++.. |..++.|++|+.|
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 3468999999999999 999999999999999999999999 469999999999999999999776 9999999999999
Q ss_pred cccccCCCCCCC
Q 005750 238 HIENNSFVGEIP 249 (679)
Q Consensus 238 ~l~~N~l~g~ip 249 (679)
+|++|+|++..|
T Consensus 539 ~L~~N~l~~~~~ 550 (567)
T 1dce_A 539 NLQGNSLCQEEG 550 (567)
T ss_dssp ECTTSGGGGSSS
T ss_pred EecCCcCCCCcc
Confidence 999999995443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=131.88 Aligned_cols=107 Identities=18% Similarity=0.066 Sum_probs=82.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+.+|+.|+|++|++++..+..|.++++|++|+|++|+|++.+| .|.++++|+.|+|++|++++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 4578888888888887777788888888888888888888877 488888888888888888877788888888888888
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCC
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~ 266 (679)
|++|++++..|..+.. .+..+.+++|..
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCC
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcc
Confidence 8888887333344332 345566666653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.8e-11 Score=130.62 Aligned_cols=109 Identities=17% Similarity=0.195 Sum_probs=96.3
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.+|+.|+|++|++++..+..|.++++|+.|+|++|.|++.++. |.++++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus 224 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 303 (477)
T 2id5_A 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303 (477)
T ss_dssp CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEEC
T ss_pred ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEEC
Confidence 3789999999999944336799999999999999999998884 999999999999999999888999999999999999
Q ss_pred cccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 240 ENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
++|+|+ .+|+..+. .+..+.+++||+.|++
T Consensus 304 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 999999 67776544 4577899999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2e-10 Score=117.70 Aligned_cols=108 Identities=20% Similarity=0.204 Sum_probs=90.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 36899999999999987788899999999999999999988885 89999999999999999955555689999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
|++|++++..|..+.. .+..+.+++|...
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence 9999999666766643 4566777777544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.10 E-value=8.9e-11 Score=111.38 Aligned_cols=102 Identities=23% Similarity=0.261 Sum_probs=84.9
Q ss_pred CceEEEEcCCCcccccCCccccCCC-CCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCC-CCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 238 (679)
.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|.|++. +.|.++++|+.|+|++|+|+ .+|.. ++.+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEE
Confidence 58999999999999 5654 55555 999999999999987 78999999999999999999 56655 48999999999
Q ss_pred ccccCCCCCCCc--cccC--CceeeeecCCCCc
Q 005750 239 IENNSFVGEIPP--ALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~--~~~~--~~~~~~~~~n~~~ 267 (679)
|++|+|+ .+|. .+.. .+..+.+++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999997 7886 4432 4567788888754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=131.67 Aligned_cols=112 Identities=19% Similarity=0.190 Sum_probs=91.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCC-CCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
.++|+.|+|++|.+.+.+|..+.++++|+.|+|++|.++ +.+| .+..+++|+.|+|++|++++..|..++.+++|+.|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 467888888888888888888888999999999999887 5566 58899999999999999998888899999999999
Q ss_pred cccccCCCCCCCcccc--CCceeeeecCCCCccccc
Q 005750 238 HIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKES 271 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~~~~ 271 (679)
+|++|++++..|..+. ..+..+.+.+||+.|.++
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 9999999854444333 345778889999988643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.09 E-value=7.8e-11 Score=113.99 Aligned_cols=104 Identities=14% Similarity=0.206 Sum_probs=84.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..|..|+.|++|+.|+|++|++++..| .++++++|+.|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 4689999999999998888899999999999999999998766 58899999999999998333777 688899999999
Q ss_pred ccccCCCCCCCc-cccCCceeeeecCCC
Q 005750 239 IENNSFVGEIPP-ALLTGKVIFKYDNNP 265 (679)
Q Consensus 239 l~~N~l~g~ip~-~~~~~~~~~~~~~n~ 265 (679)
+++|+++ .+|. .-...+..+.+.+|+
T Consensus 166 l~~n~i~-~~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 166 IQFDGVH-DYRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CTTBCCC-CCTTGGGCSSCCEEEECBC-
T ss_pred CCCCCCc-ChHHhccCCCCCEEEeeCcc
Confidence 9999998 4552 223355667777776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-10 Score=117.30 Aligned_cols=130 Identities=17% Similarity=0.090 Sum_probs=98.2
Q ss_pred ccC-cCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC--cccccccccccceEEEEEEecCCCcH
Q 005750 364 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 364 ~LG-~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998777888999997653 2345778999999996444 55688888777788999999999888
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 476 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 476 (679)
. ... .+ ...++.++++.|+.||+..
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 221 11 2357788888888888721
Q ss_pred -----------CCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 477 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 477 -----------~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=131.47 Aligned_cols=129 Identities=13% Similarity=0.012 Sum_probs=98.2
Q ss_pred CCCCCCCCCC-CCceEEEeCC--------CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCC
Q 005750 139 NDRGDPCVPV-PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLI 208 (679)
Q Consensus 139 ~w~~~~c~~~-~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~ 208 (679)
.|.+.+|... .+.-+.|+.. -+..++.|+|++|.+++..|..|+++++|++|+|++|++++..| .|.+++
T Consensus 2 ~~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 2 TSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ----CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred ccccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 3555566421 2334666542 24578999999999998888899999999999999999999988 599999
Q ss_pred CCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCcccc--CCceeeeecCCCCc
Q 005750 209 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 209 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 267 (679)
+|+.|+|++|++++..|..|+.+++|++|+|++|++++..|..+. ..+..+.+++|...
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~ 142 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc
Confidence 999999999999988899999999999999999999843233332 24456666766543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-10 Score=133.06 Aligned_cols=109 Identities=20% Similarity=0.213 Sum_probs=64.8
Q ss_pred CceEEEEcCCCccccc---CCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccce
Q 005750 161 PRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 236 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~---~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 236 (679)
++|+.|+|++|.+++. .+..+..+++|+.|+|++|++++.+| .|.++++|+.|+|++|++++..|..+..+++| .
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 4555566666555542 12345556666666666666666655 36666666666666666666666666666666 6
Q ss_pred ecccccCCCCCCCcccc--CCceeeeecCCCCcccc
Q 005750 237 LHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 237 L~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~~~ 270 (679)
|+|++|++++.+|..+. ..+..+.+.+||+.|++
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 66666666643333222 24456777888888754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.2e-11 Score=139.10 Aligned_cols=93 Identities=31% Similarity=0.399 Sum_probs=85.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+.++++|++|++|+.|+|++|+|+ .||..|+.|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 468999999999999 9999999999999999999999955447999999999999999998 99999999999999999
Q ss_pred cccCCCCCCCccccC
Q 005750 240 ENNSFVGEIPPALLT 254 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~ 254 (679)
++|+|+|.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 999999888876643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.9e-10 Score=116.01 Aligned_cols=105 Identities=19% Similarity=0.240 Sum_probs=71.0
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
++|+.|+|++|++++..+..|.++++|+.|+|++|.|++.+| .|.++++|+.|+|++|++++..+..++.+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 467777777777776555667777777777777777777766 3777777777777777777555556777777777777
Q ss_pred cccCCCC-CCCccccC--CceeeeecCCC
Q 005750 240 ENNSFVG-EIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g-~ip~~~~~--~~~~~~~~~n~ 265 (679)
++|++++ .+|..+.. .+..+.+++|.
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCC
Confidence 7777764 24555442 44555666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=122.48 Aligned_cols=106 Identities=22% Similarity=0.206 Sum_probs=93.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.+| .+..+++|+.|+|++|+++ .+|..++.+++|+.|+|
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 589999999999998888899999999999999999999988 5999999999999999999 99999999999999999
Q ss_pred cccCCCCCCCccccCC---------ceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALLTG---------KVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~---------~~~~~~~~n~~~~ 268 (679)
++|+++ .+|...+.+ ...+.+.+||+.+
T Consensus 272 ~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp CSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 999999 666554432 3467888999774
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1e-10 Score=110.00 Aligned_cols=88 Identities=28% Similarity=0.334 Sum_probs=47.9
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC--CCCCCCCCCcEEEecCccCCCCCCC----CCCCCCcc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL--PDMSRLIDLRIVHLENNELTGSLPS----YMGSLPNL 234 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L 234 (679)
++|+.|+|++|.+++.+|..+.++++|+.|+|++|.|++.+ +.+.++++|+.|+|++|.++ .+|. .+..+++|
T Consensus 71 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L 149 (168)
T 2ell_A 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQL 149 (168)
T ss_dssp SSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSC
T ss_pred CCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccC
Confidence 35555555555555545555555555555555555555543 24555555555555555555 2332 45555555
Q ss_pred ceecccccCCCCCCCc
Q 005750 235 QELHIENNSFVGEIPP 250 (679)
Q Consensus 235 ~~L~l~~N~l~g~ip~ 250 (679)
++|++++|.+. ++|+
T Consensus 150 ~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 150 TYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CEETTEETTSC-BCCS
T ss_pred cEecCCCCChh-hccc
Confidence 55555555555 4444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.6e-10 Score=136.98 Aligned_cols=108 Identities=16% Similarity=0.154 Sum_probs=78.8
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC-C-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccce
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-P-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 236 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 236 (679)
-+++|+.|+|++|.+++..|..|.+|++|++|+|++|.+.+.+ | .|.+|++|+.|+|++|++++..|..|+++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 3467888888888888777778888888888888888666655 4 4788888888888888888777778888888888
Q ss_pred ecccccCCCCCCCcc--cc--CCceeeeecCCCC
Q 005750 237 LHIENNSFVGEIPPA--LL--TGKVIFKYDNNPK 266 (679)
Q Consensus 237 L~l~~N~l~g~ip~~--~~--~~~~~~~~~~n~~ 266 (679)
|+|++|.+++.+|.. +. ..+..+.+++|..
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 888888887666654 22 2345556666643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-10 Score=128.46 Aligned_cols=105 Identities=19% Similarity=0.198 Sum_probs=90.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..|..|++|++|+.|+|++|.|++.++. |+++++|+.|+|++|+|++..|..|+.+++|+.|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 46899999999999987788889999999999999999988886 79999999999999999988888899999999999
Q ss_pred ccccCCCCCCCccccCCceeeeecCCC
Q 005750 239 IENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
|++|.++ .+|...+..+..+.+++|.
T Consensus 178 L~~N~l~-~~~~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 178 LSSNRLT-HVDLSLIPSLFHANVSYNL 203 (597)
T ss_dssp CTTSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred CcCCCCC-CcChhhhhhhhhhhcccCc
Confidence 9999998 5666666666666666664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.7e-10 Score=128.62 Aligned_cols=109 Identities=23% Similarity=0.303 Sum_probs=74.5
Q ss_pred CCceEEEEcCCCcccc--cCCccccCCCCCCEEECCCCcCCCCCC-C-CCCC----------------------CCCcEE
Q 005750 160 PPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLP-D-MSRL----------------------IDLRIV 213 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~~~~p-~-~~~l----------------------~~L~~L 213 (679)
.++|+.|+|++|++++ .+|..++++++|+.|+|++|++++.+| . +..+ ++|+.|
T Consensus 376 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L 455 (562)
T 3a79_B 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL 455 (562)
T ss_dssp CSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEE
T ss_pred cCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEE
Confidence 3466777777777764 234556666777777777777666333 2 4333 466677
Q ss_pred EecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 214 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|...+. .+..+.+++||+.|++
T Consensus 456 ~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp ECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred ECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 77777776 67777778888888888888888 78876332 4466788999998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.05 E-value=5.5e-11 Score=109.43 Aligned_cols=89 Identities=18% Similarity=0.212 Sum_probs=79.1
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCC-CCCCCCCCCccce
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQE 236 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~ 236 (679)
..++|+.|+|++|.+++. ..++++++|+.|+|++|.|++.+|. +.++++|+.|+|++|++++. .|..++.+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 346899999999999966 8899999999999999999998885 77799999999999999963 4588999999999
Q ss_pred ecccccCCCCCCCc
Q 005750 237 LHIENNSFVGEIPP 250 (679)
Q Consensus 237 L~l~~N~l~g~ip~ 250 (679)
|++++|+++ .+|.
T Consensus 118 L~l~~N~l~-~~~~ 130 (149)
T 2je0_A 118 LDLFNCEVT-NLND 130 (149)
T ss_dssp EECTTCGGG-GSTT
T ss_pred EeCcCCccc-chHH
Confidence 999999999 4554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.3e-10 Score=118.95 Aligned_cols=116 Identities=22% Similarity=0.331 Sum_probs=96.6
Q ss_pred CCCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 147 PVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 147 ~~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
.|.|..+.|+... +++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 3568888887532 3578999999999997778899999999999999999999988 599999999999999
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCC
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 266 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~ 266 (679)
|+++ .+|..+. ++|++|++++|+++ .+|...+. .+..+.+++|..
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCC
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcc
Confidence 9999 8888776 89999999999998 67765433 446677777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=120.93 Aligned_cols=107 Identities=21% Similarity=0.196 Sum_probs=90.4
Q ss_pred CCceEEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++. |....+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 35899999999999987777764 789999999999999887 44456899999999999999 5777799999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCccc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 269 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~ 269 (679)
|++|+|+ .+|..+.. .+..+.+++|++.|+
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 9999999 78887643 557788999998874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.9e-11 Score=123.58 Aligned_cols=106 Identities=18% Similarity=0.218 Sum_probs=86.0
Q ss_pred CCceEEEEcCCCcccccCCccc--cCCCCCCEEECCCCcCCCCCCCCCCC-----CCCcEEEecCccCCCCCCCCCCCCC
Q 005750 160 PPRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLP 232 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~ 232 (679)
.++|+.|+|++|+++|.+|..+ +.+++|+.|+|++|+|++.++.++++ ++|+.|+|++|++++..|..++.++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 4589999999999999999886 89999999999999999984347666 8999999999999977778899999
Q ss_pred ccceecccccCCCCCC--Cccc----cCCceeeeecCCC
Q 005750 233 NLQELHIENNSFVGEI--PPAL----LTGKVIFKYDNNP 265 (679)
Q Consensus 233 ~L~~L~l~~N~l~g~i--p~~~----~~~~~~~~~~~n~ 265 (679)
+|++|+|++|++.|.+ |..+ ...+..+.+++|.
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 9999999999987652 3333 2345666777775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3.7e-10 Score=130.46 Aligned_cols=91 Identities=20% Similarity=0.204 Sum_probs=56.0
Q ss_pred ccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccc---cCCc
Q 005750 181 LKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---LTGK 256 (679)
Q Consensus 181 ~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~---~~~~ 256 (679)
|.++++|+.|+|++|+|+..++. |.++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+ +..+
T Consensus 532 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L 611 (680)
T 1ziw_A 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTC
T ss_pred hcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhccccccc
Confidence 45555555666666666544443 6666666666666666663333345666777777777777763333222 2345
Q ss_pred eeeeecCCCCccccc
Q 005750 257 VIFKYDNNPKLHKES 271 (679)
Q Consensus 257 ~~~~~~~n~~~~~~~ 271 (679)
..+.+.+|||.|++.
T Consensus 612 ~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 612 TELDMRFNPFDCTCE 626 (680)
T ss_dssp SEEECTTCCCCBCCC
T ss_pred CEEEccCCCcccCCc
Confidence 677889999999764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.03 E-value=9.6e-11 Score=111.17 Aligned_cols=87 Identities=22% Similarity=0.201 Sum_probs=79.5
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCC--CCCCCCcccee
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 237 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L 237 (679)
++|+.|+|++|.|++. +.|+.+++|+.|+|++|+|++.+|. +.++++|+.|+|++|+|+ .+|. .++.+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999965 7899999999999999999998877 599999999999999997 7887 89999999999
Q ss_pred cccccCCCCCCCcc
Q 005750 238 HIENNSFVGEIPPA 251 (679)
Q Consensus 238 ~l~~N~l~g~ip~~ 251 (679)
++++|.++ .+|..
T Consensus 119 ~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 119 CILRNPVT-NKKHY 131 (176)
T ss_dssp ECCSSGGG-GSTTH
T ss_pred EecCCCCC-CcHhH
Confidence 99999998 77764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.1e-10 Score=123.07 Aligned_cols=115 Identities=19% Similarity=0.206 Sum_probs=95.9
Q ss_pred CceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccC
Q 005750 150 WEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 220 (679)
Q Consensus 150 w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l 220 (679)
|..+.|.... +..++.|+|++|++++..+..|.+|++|+.|+|++|.|++..+ .|.++++|+.|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 5567776532 3578999999999998888999999999999999999999887 599999999999999999
Q ss_pred CCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCC
Q 005750 221 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 265 (679)
Q Consensus 221 ~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~ 265 (679)
++..+..|..+++|++|+|++|+++ .+|...+. .+..+.+++|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCC
Confidence 9555567999999999999999999 67765443 34556666654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.7e-10 Score=118.76 Aligned_cols=105 Identities=19% Similarity=0.198 Sum_probs=89.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|.+++..|..|+++++|+.|+|++|.|+..++. |.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 46899999999999987788899999999999999999987776 68999999999999999977788899999999999
Q ss_pred ccccCCCCCCCccccCCceeeeecCCC
Q 005750 239 IENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
+++|+++ .++...+..+..+.+++|.
T Consensus 172 l~~n~l~-~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 172 LSSNRLT-HVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp CCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred CCCCcCC-ccccccccccceeeccccc
Confidence 9999998 5666666666666666664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.6e-10 Score=126.21 Aligned_cols=109 Identities=20% Similarity=0.272 Sum_probs=70.0
Q ss_pred CCceEEEEcCCCcccc--cCCccccCCCCCCEEECCCCcCCCCCC-C-CCCCC----------------------CCcEE
Q 005750 160 PPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLP-D-MSRLI----------------------DLRIV 213 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~~~~p-~-~~~l~----------------------~L~~L 213 (679)
.++|+.|+|++|++++ .+|..++++++|+.|+|++|.+++.+| . +..++ +|+.|
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L 426 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVL 426 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEE
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEE
Confidence 3567777777777775 455667777777777777777776433 2 44444 55555
Q ss_pred EecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 214 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|...+. .+..+.+++||+.|++
T Consensus 427 ~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 427 DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 55555555 56666667777777777777777 67765322 3456677788877753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=6.5e-10 Score=124.86 Aligned_cols=108 Identities=18% Similarity=0.130 Sum_probs=74.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCC------------------CCCCCCcEEEecCccCC
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM------------------SRLIDLRIVHLENNELT 221 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~------------------~~l~~L~~L~l~~N~l~ 221 (679)
.++|+.|+|++|+++ .+|..++.+++|+.|+|++|+|++.+..+ .++++|+.|+|++|+|+
T Consensus 386 l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~ 464 (549)
T 2z81_A 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK 464 (549)
T ss_dssp CTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC
Confidence 356777777777777 56777777777777777777766543221 25677777888888777
Q ss_pred CCCCCCCCCCCccceecccccCCCCCCCcccc--CCceeeeecCCCCcccc
Q 005750 222 GSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 222 g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~~~ 270 (679)
.+|. .+.+++|+.|+|++|++++.+|..+. ..+..+.+++||+.|++
T Consensus 465 -~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 465 -TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp -SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred -cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 6776 45678888888888888855554333 34567788888888764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.00 E-value=6e-10 Score=115.40 Aligned_cols=108 Identities=19% Similarity=0.296 Sum_probs=92.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCC-CCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~-~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
.++|+.|+|++|.+.+..|..+.++++|+.|+|++|.+++ .+| .+.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 4689999999999998889999999999999999999998 455 59999999999999999998788999999999999
Q ss_pred cccccCCCCCCCc-ccc--CCceeeeecCCCCcc
Q 005750 238 HIENNSFVGEIPP-ALL--TGKVIFKYDNNPKLH 268 (679)
Q Consensus 238 ~l~~N~l~g~ip~-~~~--~~~~~~~~~~n~~~~ 268 (679)
+|++|+++ .+|. .+. ..+..+.+++|+...
T Consensus 205 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 205 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp ECTTSCCS-BCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred ECCCCccC-ccChhhccCcccCCEeECCCCCCcc
Confidence 99999999 4554 332 355677888886543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=7.5e-10 Score=116.00 Aligned_cols=115 Identities=24% Similarity=0.409 Sum_probs=88.2
Q ss_pred CCCceEEEeCC--------CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCc
Q 005750 148 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 218 (679)
Q Consensus 148 ~~w~~~~c~~~--------~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N 218 (679)
|.|..+.|+.. .++.++.|+|++|++++..+..|+++++|++|+|++|+|++..| .|.++++|+.|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 46777777642 24578889999999987666788899999999999999998877 5888999999999999
Q ss_pred cCCCCCCCCCCCCCccceecccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 219 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
+++ .+|..+. ++|+.|++++|+++ .+|...+ ..+..+.+++|..
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCC
T ss_pred cCC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcC
Confidence 988 7887765 78899999999988 4554332 2445666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.97 E-value=3.5e-10 Score=117.51 Aligned_cols=105 Identities=21% Similarity=0.341 Sum_probs=73.2
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
..++|+.|+|++|.+++. ++ ++.+++|+.|+|++|+|++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+
T Consensus 127 ~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 201 (308)
T 1h6u_A 127 GLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVH 201 (308)
T ss_dssp TCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred CCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEE
Confidence 346788888888888743 33 7788888888888888887655 7788888888888888874 443 77788888888
Q ss_pred ccccCCCCCCCccccCCceeeeecCCCCcc
Q 005750 239 IENNSFVGEIPPALLTGKVIFKYDNNPKLH 268 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~~~~~~~~~n~~~~ 268 (679)
|++|++++..|-.-...+..+.+++|+..+
T Consensus 202 L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 202 LKNNQISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CTTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred ccCCccCccccccCCCCCCEEEccCCeeec
Confidence 888888743321222344566777776543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.97 E-value=4.5e-10 Score=108.58 Aligned_cols=102 Identities=17% Similarity=0.209 Sum_probs=63.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|+++ .+| .+..+++|+.|+|++|.++.. +.+.++++|+.|+|++|++++..|..++.+++|++|+|+
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 35667777777766 555 566677777777777754432 356666777777777777766666666677777777777
Q ss_pred ccCCCCCCCccccC--CceeeeecCCC
Q 005750 241 NNSFVGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 241 ~N~l~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
+|++++..|..+.. .+..+.+++|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 77776545544432 33445555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.97 E-value=7.3e-10 Score=125.07 Aligned_cols=104 Identities=17% Similarity=0.217 Sum_probs=86.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|+ |.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 35789999999999977778899999999999999999998884 999999999999999999 78887 889999999
Q ss_pred ccccCCCC-CCCccccC--CceeeeecCCCC
Q 005750 239 IENNSFVG-EIPPALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 239 l~~N~l~g-~ip~~~~~--~~~~~~~~~n~~ 266 (679)
|++|++++ .+|..+.. .+..+.+++|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcc
Confidence 99999984 33455543 456667777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.9e-10 Score=125.87 Aligned_cols=109 Identities=14% Similarity=0.129 Sum_probs=92.4
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCC--CCC-CCCCCCCCcEEEecCccCCCCCCCC-CCCCCcc
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLP-DMSRLIDLRIVHLENNELTGSLPSY-MGSLPNL 234 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~--~~p-~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L 234 (679)
..++|+.|+|++|.+++.+|..++++++|+.|+|++|+|++ .+| .+.++++|+.|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 45689999999999998899999999999999999999997 345 4889999999999999999768865 7888999
Q ss_pred ceecccccCCCCCCCccccCCceeeeecCCCCc
Q 005750 235 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 235 ~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~ 267 (679)
+.|+|++|++++.+|..+...+..+.+++|...
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp CEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred CEEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 999999999988888877666777777777543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-09 Score=126.65 Aligned_cols=85 Identities=26% Similarity=0.320 Sum_probs=46.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
++|+.|+|++|++++..+..|+++++|++|+|++|.+++.+|. |+++++|+.|+|++|++++..+..|+.+++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 3566666666666654444566666666666665555555553 555555555555555555222224555555555555
Q ss_pred cccCCC
Q 005750 240 ENNSFV 245 (679)
Q Consensus 240 ~~N~l~ 245 (679)
++|+++
T Consensus 105 ~~n~l~ 110 (680)
T 1ziw_A 105 MSNSIQ 110 (680)
T ss_dssp CSSCCC
T ss_pred CCCccC
Confidence 555555
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.9e-10 Score=119.65 Aligned_cols=107 Identities=17% Similarity=0.193 Sum_probs=75.8
Q ss_pred CCceEEEEcCCCccccc--CC--ccccCCCCCCEEECCCCcCCCCCC---C-CCCCCCCcEEEecCccCCCCCCCCCCCC
Q 005750 160 PPRITKIALSGKNLKGE--IP--PELKNMEALTELWLDGNFLTGPLP---D-MSRLIDLRIVHLENNELTGSLPSYMGSL 231 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~--~p--~~~~~l~~L~~L~L~~N~l~~~~p---~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l 231 (679)
.++|+.|+|++|++.+. ++ ..++++++|++|+|++|+|+...+ . +.++++|+.|+|++|+|++.+|..++.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 45777788887777653 22 224677777777777777764433 1 4677888888888888887777777776
Q ss_pred ---CccceecccccCCCCCCCccccCCceeeeecCCCCc
Q 005750 232 ---PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 232 ---~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~ 267 (679)
++|++|+|++|+|+ .+|..++..+..+.+++|...
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence 58888888888888 788877766677777777543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.95 E-value=3.2e-10 Score=118.05 Aligned_cols=104 Identities=18% Similarity=0.239 Sum_probs=62.0
Q ss_pred CceEEEEcCCCccccc--CCccc--cCCCCCCEEECCCCcCCCCC--C-C-CCCCCCCcEEEecCccCCCCCC-CCCCCC
Q 005750 161 PRITKIALSGKNLKGE--IPPEL--KNMEALTELWLDGNFLTGPL--P-D-MSRLIDLRIVHLENNELTGSLP-SYMGSL 231 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~--~p~~~--~~l~~L~~L~L~~N~l~~~~--p-~-~~~l~~L~~L~l~~N~l~g~~p-~~~~~l 231 (679)
++|+.|+|++|++.|. +|..+ +++++|+.|+|++|+|++.. + . +.++++|+.|+|++|++++.+| ..+..+
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 4666666666666654 23343 66666666666666666422 2 2 3456666666666666665554 334556
Q ss_pred CccceecccccCCCCCCCccccCCceeeeecCCC
Q 005750 232 PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 232 ~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
++|++|+|++|+|+ .+|..++..+..+.+++|.
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~ 285 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNR 285 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCCSEEEEEECCSSC
T ss_pred CCCCEEECCCCccC-hhhhhccCCceEEECCCCC
Confidence 66666666666666 6666665444555556554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.93 E-value=8.5e-10 Score=123.92 Aligned_cols=109 Identities=25% Similarity=0.364 Sum_probs=67.9
Q ss_pred CCCCCC--CCCceE-EEeCCCCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCc
Q 005750 142 GDPCVP--VPWEWV-TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 218 (679)
Q Consensus 142 ~~~c~~--~~w~~~-~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N 218 (679)
++||.. ..|.++ .|.+. +|+.|+|++|+|++ +|..+. ++|+.|+|++|+|+. +| ..+++|+.|+|++|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~~---~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N 110 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLIN---QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDN 110 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHHT---TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSS
T ss_pred CCccccccchhhhccccccC---CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCC
Confidence 456632 147777 67653 57777777777775 666553 667777777777774 33 44666777777777
Q ss_pred cCCCCCCCCCCCCCccceecccccCCCCCCCccccCCceeeeecCCC
Q 005750 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 219 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
+|++ +|. +.. +|+.|+|++|+|++ +|. ....+..+.+++|.
T Consensus 111 ~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~ 151 (571)
T 3cvr_A 111 RLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQ 151 (571)
T ss_dssp CCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSC
T ss_pred CCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCc
Confidence 7764 666 544 66666666666663 665 44444555555554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.93 E-value=9.2e-10 Score=109.70 Aligned_cols=103 Identities=22% Similarity=0.284 Sum_probs=74.9
Q ss_pred CceEEEEcCC-CcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCc---EEEecCc-cCCCCCCCCCCCCCccc
Q 005750 161 PRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR---IVHLENN-ELTGSLPSYMGSLPNLQ 235 (679)
Q Consensus 161 ~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~---~L~l~~N-~l~g~~p~~~~~l~~L~ 235 (679)
++|+.|+|++ |++++..+..|.++++|+.|+|++|.|++ +|.+.++++|+ .|+|++| ++++..+..|..+++|+
T Consensus 80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 4788888887 88886555677888888888888888877 44477777777 8888888 77744445677888888
Q ss_pred -eecccccCCCCCCCccccCC--ceeeeecCCC
Q 005750 236 -ELHIENNSFVGEIPPALLTG--KVIFKYDNNP 265 (679)
Q Consensus 236 -~L~l~~N~l~g~ip~~~~~~--~~~~~~~~n~ 265 (679)
.|++++|+++ .+|...+.. +..+.+++|+
T Consensus 159 ~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred eEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8888888887 777765543 3455666664
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.92 E-value=4.1e-10 Score=124.80 Aligned_cols=106 Identities=20% Similarity=0.143 Sum_probs=78.0
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC--C---------------CCCCCCcEEEecCccCC
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--M---------------SRLIDLRIVHLENNELT 221 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~---------------~~l~~L~~L~l~~N~l~ 221 (679)
..++|+.|+|++|.+++..| |+.+++|+.|+|++|.|++.++. + ..+++|+.|+|++|+|+
T Consensus 56 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~ 133 (487)
T 3oja_A 56 PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133 (487)
T ss_dssp TCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCC
T ss_pred CCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCC
Confidence 34688889999998887665 88888888888888877664321 1 23567788888888888
Q ss_pred CCCCCCCCCCCccceecccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 222 GSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 222 g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
+..|..++.+++|+.|+|++|.|++.+|..++ ..+..+.+++|..
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 77787888888888888888888877776664 3456666777654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=2e-09 Score=114.31 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=106.3
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEec--CCc-chhHHHHHHHHHHHHhcc--CCCccccccccccc---ceEEEEEE
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYE 433 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lV~E 433 (679)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 357899999999999876 4678888875 322 123457888999999996 45678888888765 45899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------------------------------------- 476 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------- 476 (679)
|++|..+.+.. ...++......++.+++++|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998775422 234678888899999999999999720
Q ss_pred ------------------CCCccccCCCCCCccccCCCc--EEEeeccCccc
Q 005750 477 ------------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 508 (679)
Q Consensus 477 ------------------~~~ivH~Dlkp~NIll~~~~~--~kL~Dfgla~~ 508 (679)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987653 68999998864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.2e-09 Score=120.92 Aligned_cols=86 Identities=19% Similarity=0.346 Sum_probs=56.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCC-CCCCCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ 238 (679)
++|+.|+|++|.+++..|..|+++++|++|+|++|++++.++ .++++++|+.|+|++|++++ .+|..++++++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~ 155 (570)
T 2z63_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (570)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred hhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEe
Confidence 466666666666665555666666666666666666666655 46666666666666666664 3566666666666666
Q ss_pred ccccCCCC
Q 005750 239 IENNSFVG 246 (679)
Q Consensus 239 l~~N~l~g 246 (679)
+++|++++
T Consensus 156 l~~n~l~~ 163 (570)
T 2z63_A 156 LSSNKIQS 163 (570)
T ss_dssp CTTSCCCE
T ss_pred CcCCccce
Confidence 66666663
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=114.85 Aligned_cols=105 Identities=18% Similarity=0.216 Sum_probs=76.1
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCC--CCCCCCccce
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 236 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~ 236 (679)
.++|+.|+|++|++++..|..|+++++|++|+|++|+|++.++. |.++++|+.|+|++|+++ .+|. .+..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 35788888888888877777788888888888888888877665 788888888888888888 5665 6778888888
Q ss_pred ecccccC-CCCCCCccccC---CceeeeecCCCC
Q 005750 237 LHIENNS-FVGEIPPALLT---GKVIFKYDNNPK 266 (679)
Q Consensus 237 L~l~~N~-l~g~ip~~~~~---~~~~~~~~~n~~ 266 (679)
|++++|+ ++ .+++..+. .+..+.+++|..
T Consensus 154 L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 154 LRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp EEEEESSSCC-EECTTTTTTCCEEEEEEEEETTC
T ss_pred EECCCCcccc-ccCHHHccCCCCCCEEECCCCCc
Confidence 8888884 44 55443332 334556666643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.8e-09 Score=114.28 Aligned_cols=107 Identities=19% Similarity=0.181 Sum_probs=87.9
Q ss_pred CCCCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC--CCCCCCCCcE-EE
Q 005750 146 VPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRI-VH 214 (679)
Q Consensus 146 ~~~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~-L~ 214 (679)
|.|.|..|.|+... +.+++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+| .|.+|++|+. +.
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 34567789998632 3579999999999994444579999999999999999988776 3899999775 77
Q ss_pred ecCccCCCCCCCCCCCCCccceecccccCCCCCCCcccc
Q 005750 215 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 253 (679)
Q Consensus 215 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~ 253 (679)
+++|+|++..|..|..+++|++|++++|+++ .+|+..+
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~ 124 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTT
T ss_pred ccCCcccccCchhhhhccccccccccccccc-cCCchhh
Confidence 7889999666788999999999999999999 5665443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=2e-09 Score=111.82 Aligned_cols=84 Identities=17% Similarity=0.198 Sum_probs=47.5
Q ss_pred ceEEEEcCCCcccccCCccc--cCCCCCCEEECCCCcCCCCCCC-----CCCCCCCcEEEecCccCCCCCCCCCCCCCcc
Q 005750 162 RITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 234 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p~-----~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 234 (679)
+|+.|+|++|++++.+|..+ .++++|+.|+|++|.+++..|. +..+++|+.|+|++|++++..|..++.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 35555666666655555555 5555666666666665554431 3345556666666666555555555555566
Q ss_pred ceecccccCCC
Q 005750 235 QELHIENNSFV 245 (679)
Q Consensus 235 ~~L~l~~N~l~ 245 (679)
++|+|++|++.
T Consensus 172 ~~L~Ls~N~l~ 182 (310)
T 4glp_A 172 TSLDLSDNPGL 182 (310)
T ss_dssp CEEECCSCTTC
T ss_pred CEEECCCCCCc
Confidence 66666666554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.84 E-value=2e-09 Score=113.47 Aligned_cols=104 Identities=18% Similarity=0.316 Sum_probs=71.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ +|+ +..+++|+.|+|++|.+++. +.+..+++|+.|+|++|++++ +| .+..+++|+.|++
T Consensus 220 ~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 3577888888888874 333 77778888888888877764 567777777777777777774 43 4677777777777
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALL--TGKVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~ 268 (679)
++|++++..|..+. ..+..+.+++|+...
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 77777755554433 244566677776544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.83 E-value=3.6e-09 Score=108.88 Aligned_cols=102 Identities=23% Similarity=0.388 Sum_probs=78.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ + +.+..+++|+.|+|++|+|++. +.+.++++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 4578888898888885 3 5688888899999999888886 678888889999999998885444 888888999999
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPPALL--TGKVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~~~~--~~~~~~~~~~n~~~~ 268 (679)
++|+++ .+|. +. ..+..+.+++|+..+
T Consensus 186 ~~N~i~-~l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 186 SKNHIS-DLRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred CCCcCC-CChh-hccCCCCCEEECcCCcccC
Confidence 999888 5654 32 244566677776443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4.9e-09 Score=107.93 Aligned_cols=101 Identities=24% Similarity=0.319 Sum_probs=64.2
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|.+++ +| .+..+++|+.|+|++|+|++. +.+.++++|+.|+|++|++++ + ..++.+++|+.|+|
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEc
Confidence 3467777777777764 33 377777777777777777764 556777777777777777774 3 45677777777777
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 005750 240 ENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
++|++++..|-.-...+..+.+++|.
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred cCCccccchhhcCCCccCEEECCCCc
Confidence 77777743331112234555666664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=5.1e-09 Score=108.68 Aligned_cols=102 Identities=25% Similarity=0.438 Sum_probs=81.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ +|. +..+++|+.|+|++|.+++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 4689999999999985 443 8999999999999999988766 8899999999999999994 555 889999999999
Q ss_pred cccCCCCCCCc-cccCCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~-~~~~~~~~~~~~~n~~~ 267 (679)
++|+++ .+|. .-...+..+.+++|...
T Consensus 181 ~~n~l~-~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 181 DDNKIS-DISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCccC-cChhhcCCCCCCEEEccCCccC
Confidence 999998 4554 22335566777777644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.6e-09 Score=104.81 Aligned_cols=101 Identities=26% Similarity=0.322 Sum_probs=65.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|+|++ +|+ +.+|++|+.|+|++|+|++.++ +.. ++|+.|+|++|++++ +| .++.+++|+.|+|
T Consensus 62 l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 62 FTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 3577788888888774 343 7778888888888888777443 333 777777777777774 43 4677777777777
Q ss_pred cccCCCCCCCc-cccCCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~-~~~~~~~~~~~~~n~~~ 267 (679)
++|+++ .+|. .-...+..+.+++|...
T Consensus 136 s~N~i~-~~~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 136 RNNKLK-SIVMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp TTSCCC-BCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCcCC-CChHHccCCCCCEEECCCCcCc
Confidence 777777 3442 11223455566666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.5e-09 Score=104.84 Aligned_cols=100 Identities=20% Similarity=0.302 Sum_probs=84.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++.+| +.++++|+.|+|++|+++ .+|.... ++|+.|+|
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFL 113 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEEC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEc
Confidence 368999999999999 677 79999999999999999999888 999999999999999999 5666444 99999999
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 267 (679)
++|+++ .+|. +. ..+..+.+++|...
T Consensus 114 ~~N~l~-~~~~-l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CSSCCS-BSGG-GTTCTTCCEEECTTSCCC
T ss_pred cCCccC-CChh-hcCcccccEEECCCCcCC
Confidence 999999 4553 32 34567778887543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.4e-09 Score=112.65 Aligned_cols=185 Identities=23% Similarity=0.261 Sum_probs=121.7
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCC--cccccccccccc---eEEEEEEecC
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 436 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lV~E~~~ 436 (679)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568899999999864 56889986532 34567889999999883 332 344444443333 3478999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC---------------------------------------- 476 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 476 (679)
|.++.+... ..++..++..++.++++.|+.||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865332 23677777888899999999988610
Q ss_pred ---------------CCCccccCCCCCCccccC--CCcEEEeeccCccccccCccccccccc-----CC-------ccc-
Q 005750 477 ---------------NPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVAR-----GT-------VGY- 526 (679)
Q Consensus 477 ---------------~~~ivH~Dlkp~NIll~~--~~~~kL~Dfgla~~~~~~~~~~~~~~~-----gt-------~~y- 526 (679)
...++|||++|.||+++. +..+.|+||+.+..-..... ...... +. ..|
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcC
Confidence 135799999999999998 45678999998765322111 000000 00 011
Q ss_pred -cC-CcccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 527 -LD-PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 527 -~a-PE~l~~~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
.. |+... ......+.|+++.++|.+.+|..+|.
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 11110 01123689999999999999988764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.9e-09 Score=115.26 Aligned_cols=96 Identities=21% Similarity=0.234 Sum_probs=65.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCcc------
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL------ 234 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L------ 234 (679)
++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++.++ |. ++|+.|+|++|+|+ .+|. +.. +|
T Consensus 140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~ 208 (571)
T 3cvr_A 140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEET 208 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------C
T ss_pred ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhccccc
Confidence 567777777777774 665 56777777777777777444 55 77777777777777 7777 554 66
Q ss_pred -ceecccccCCCCCCCccccC--CceeeeecCCCCcc
Q 005750 235 -QELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLH 268 (679)
Q Consensus 235 -~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~ 268 (679)
+.|+|++|+|+ .||..++. .+..+.+++|+..+
T Consensus 209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 77777777777 67776654 44566777776654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.78 E-value=6.3e-09 Score=117.97 Aligned_cols=101 Identities=23% Similarity=0.388 Sum_probs=79.1
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|.|++ + +.+..|++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+|
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 182 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence 4688899999999885 3 4688889999999999998887 678888999999999999986656 888889999999
Q ss_pred cccCCCCCCCcccc--CCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 267 (679)
++|+|+ .+|. +. ..+..+.+++|+..
T Consensus 183 s~N~i~-~l~~-l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 183 SKNHIS-DLRA-LAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEECCSEEEE
T ss_pred cCCCCC-CChH-HccCCCCCEEEccCCcCc
Confidence 999888 4543 22 24556667776543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.77 E-value=8.1e-09 Score=117.10 Aligned_cols=100 Identities=24% Similarity=0.317 Sum_probs=60.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|.|++ +| .|..|++|+.|+|++|+|++. +.+.+|++|+.|+|++|+|++. ..++.|++|+.|+|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 161 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECc
Confidence 466666666666663 33 566666666666666666653 4566666677777777766643 456666777777777
Q ss_pred ccCCCCCCCccccCCceeeeecCCC
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
+|+|++..|-.-+..+..+.+++|.
T Consensus 162 ~N~l~~~~~l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 162 DNQISDIVPLAGLTKLQNLYLSKNH 186 (605)
T ss_dssp SSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred CCcCCCchhhccCCCCCEEECcCCC
Confidence 7777644442222344555566654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.7e-09 Score=112.83 Aligned_cols=100 Identities=27% Similarity=0.306 Sum_probs=77.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|++++..|..|.++++|+.|+|++|.+++.+| +..+++|+.|+|++|++++ +| .+++|+.|+++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~ 107 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAA 107 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECC
Confidence 478888898888887767788888889999999888888766 8888888888888888883 33 33788888888
Q ss_pred ccCCCCCCCccccCCceeeeecCCCCc
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~~~ 267 (679)
+|+++ .+|...+..+..+.+++|...
T Consensus 108 ~n~l~-~~~~~~~~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 108 NNNIS-RVSCSRGQGKKNIYLANNKIT 133 (317)
T ss_dssp SSCCS-EEEECCCSSCEEEECCSSCCC
T ss_pred CCccC-CcCccccCCCCEEECCCCCCC
Confidence 88887 455555666677777777543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.75 E-value=8.1e-11 Score=113.96 Aligned_cols=104 Identities=24% Similarity=0.222 Sum_probs=78.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ +| .+.++++|+.|+|++|.|+..++.+..+++|+.|+|++|++++ +| .++.+++|+.|+|
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 3578888888888885 77 8888888888888888888544446677888888888888884 66 5778888888888
Q ss_pred cccCCCCCCCc--cc--cCCceeeeecCCCCcc
Q 005750 240 ENNSFVGEIPP--AL--LTGKVIFKYDNNPKLH 268 (679)
Q Consensus 240 ~~N~l~g~ip~--~~--~~~~~~~~~~~n~~~~ 268 (679)
++|+++ .+|. .+ ...+..+.+++|+..|
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCCcCC-chhHHHHHhcCCCCCEEEecCCcccc
Confidence 888887 4443 22 2245667777776543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.74 E-value=8.5e-09 Score=113.46 Aligned_cols=82 Identities=30% Similarity=0.415 Sum_probs=52.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|.+++..+ +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++..| ++.+++|+.|++
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 3567777777777774333 6667777777777777766544 6666666666666666665444 556666666666
Q ss_pred cccCCCC
Q 005750 240 ENNSFVG 246 (679)
Q Consensus 240 ~~N~l~g 246 (679)
++|++++
T Consensus 339 ~~n~l~~ 345 (466)
T 1o6v_A 339 YNNKVSD 345 (466)
T ss_dssp CSSCCCC
T ss_pred CCCccCC
Confidence 6666663
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.72 E-value=2.8e-08 Score=109.01 Aligned_cols=95 Identities=25% Similarity=0.262 Sum_probs=48.4
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|++++ +| ++++++|++|+|++|.|++. | ++++++|+.|+|++|++++ +| ++.+++|++|+++
T Consensus 64 ~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 355555555555553 22 55555555555555555554 2 5555555555555555553 33 5555555555555
Q ss_pred ccCCCCCCCccccCCceeeeecCC
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNN 264 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n 264 (679)
+|++++ +|-.-...+..+.+++|
T Consensus 136 ~N~l~~-l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 136 RNTLTE-IDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TSCCSC-CCCTTCTTCCEEECTTC
T ss_pred CCccce-eccccCCcCCEEECCCC
Confidence 555553 33222233344444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.70 E-value=3.7e-08 Score=111.92 Aligned_cols=75 Identities=28% Similarity=0.390 Sum_probs=41.8
Q ss_pred CCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--Cceeeeec
Q 005750 185 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYD 262 (679)
Q Consensus 185 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~ 262 (679)
++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.. .+..+.++
T Consensus 221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 45555566666555533 33455666666666666 4555 4456666666666666 56655432 33445556
Q ss_pred CCCCc
Q 005750 263 NNPKL 267 (679)
Q Consensus 263 ~n~~~ 267 (679)
+|+..
T Consensus 293 ~N~l~ 297 (622)
T 3g06_A 293 GNPLS 297 (622)
T ss_dssp SCCCC
T ss_pred CCCCC
Confidence 66543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-08 Score=110.77 Aligned_cols=101 Identities=27% Similarity=0.351 Sum_probs=55.8
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|.+++..| +..+++|+.|+|++|.+++.++ +..+++|+.|+|++|++++..| ++.+++|+.|+|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence 355555555555554333 5555666666666666655544 5556666666666666664332 5566666666666
Q ss_pred ccCCCCCCCccccCCceeeeecCCCC
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNPK 266 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~~ 266 (679)
+|++++..|-.-...+..+.+.+|+.
T Consensus 318 ~n~l~~~~~~~~l~~L~~L~l~~n~l 343 (466)
T 1o6v_A 318 FNNISDISPVSSLTKLQRLFFYNNKV 343 (466)
T ss_dssp SSCCSCCGGGGGCTTCCEEECCSSCC
T ss_pred CCcCCCchhhccCccCCEeECCCCcc
Confidence 66666444433333445555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.67 E-value=5.1e-08 Score=106.85 Aligned_cols=97 Identities=27% Similarity=0.314 Sum_probs=78.2
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|+|++|++++ +| .|+++++|++|+|++|++++.+..+ .+|+.|+|++|++++ +| .++.+++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 589999999999995 78 6999999999999999999844333 489999999999995 77 58999999999999
Q ss_pred ccCCCCCCCccccCCceeeeecCCCC
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNPK 266 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~~ 266 (679)
+|+++ .+|... .....+.+++|..
T Consensus 204 ~N~l~-~l~~~~-~~L~~L~l~~n~l 227 (454)
T 1jl5_A 204 NNSLK-KLPDLP-LSLESIVAGNNIL 227 (454)
T ss_dssp SSCCS-SCCCCC-TTCCEEECCSSCC
T ss_pred CCcCC-cCCCCc-CcccEEECcCCcC
Confidence 99998 466543 3556667777643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.67 E-value=3.6e-08 Score=108.15 Aligned_cols=90 Identities=19% Similarity=0.248 Sum_probs=73.4
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
..++|+.|+|++|++++ +| ++.+++|+.|+|++|+|++. +++++++|+.|+|++|+|++ +| ++.+++|+.|+
T Consensus 168 ~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 34688999999999986 55 88899999999999999887 48888999999999999996 77 88889999999
Q ss_pred ccccCCCCCCCccccCCce
Q 005750 239 IENNSFVGEIPPALLTGKV 257 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~~~ 257 (679)
+++|++++ +|...+..+.
T Consensus 240 l~~N~l~~-~~~~~l~~L~ 257 (457)
T 3bz5_A 240 CSVNPLTE-LDVSTLSKLT 257 (457)
T ss_dssp CCSSCCSC-CCCTTCTTCC
T ss_pred eeCCcCCC-cCHHHCCCCC
Confidence 99999985 5544444333
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.67 E-value=5.5e-10 Score=108.04 Aligned_cols=102 Identities=23% Similarity=0.334 Sum_probs=85.5
Q ss_pred CceEEEEcCCCcccccCCc------cccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCcc
Q 005750 161 PRITKIALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 234 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 234 (679)
.+++.++|+++.++|.+|. .|+++++|+.|+|++|.|++ +|.+.++++|+.|+|++|+++ .+|..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 3667777888888888887 99999999999999999999 459999999999999999999 899988889999
Q ss_pred ceecccccCCCCCCCccccC--CceeeeecCCCC
Q 005750 235 QELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 266 (679)
Q Consensus 235 ~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~ 266 (679)
+.|+|++|+++ .+| .+.. .+..+.+++|..
T Consensus 96 ~~L~L~~N~l~-~l~-~~~~l~~L~~L~l~~N~i 127 (198)
T 1ds9_A 96 EELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKI 127 (198)
T ss_dssp SEEEEEEEECC-CHH-HHHHHHHSSEEEESEEEC
T ss_pred CEEECcCCcCC-cCC-ccccCCCCCEEECCCCcC
Confidence 99999999999 466 3322 345666666653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.66 E-value=8e-08 Score=109.11 Aligned_cols=54 Identities=28% Similarity=0.360 Sum_probs=39.3
Q ss_pred CCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccCCceeeeecCCCCc
Q 005750 208 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 208 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~ 267 (679)
++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|+ .+|. ....+..+.+++|...
T Consensus 221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC
T ss_pred CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC
Confidence 67888888888888 466 45577888888888888 6777 4455666777777544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2.5e-08 Score=109.37 Aligned_cols=62 Identities=27% Similarity=0.302 Sum_probs=44.1
Q ss_pred CCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCC--CCCcccc
Q 005750 185 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALL 253 (679)
Q Consensus 185 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~ip~~~~ 253 (679)
++|+.|+|++|+|++.++. +++|+.|+|++|+++ .+|. .+++|+.|++++|+++| .+|.++.
T Consensus 317 ~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 317 PSLEELNVSNNKLIELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp TTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred CcCCEEECCCCcccccccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence 4777888888887774333 467778888888777 5776 36777788888888776 6666553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=104.67 Aligned_cols=102 Identities=19% Similarity=0.256 Sum_probs=73.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|++++|.+.+..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++ + ..+..+++|+.|++
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 4578888888888875433 7788888888888888887766 7788888888888888874 4 35777888888888
Q ss_pred cccCCCCCCCc-cccCCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~-~~~~~~~~~~~~~n~~~ 267 (679)
++|+++ .+|. .-...+..+.+++|+..
T Consensus 273 ~~n~l~-~~~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 273 GSNQIS-DISVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp CSSCCC-CCGGGGGCTTCSEEECCSSCCC
T ss_pred cCCccC-CChhhcCCCCCCEEECcCCcCC
Confidence 888887 4543 11234566677777654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.53 E-value=5e-09 Score=112.29 Aligned_cols=84 Identities=21% Similarity=0.351 Sum_probs=39.2
Q ss_pred ceEEEEcCCCccc-ccCC---ccccCCCCCCEEECCCCcCC--C---CCC-CCCCCCCCcEEEecCccCC----CCCCCC
Q 005750 162 RITKIALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPSY 227 (679)
Q Consensus 162 ~l~~L~L~~n~l~-g~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p-~~~~l~~L~~L~l~~N~l~----g~~p~~ 227 (679)
+|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | ..| .+.++++|+.|+|++|+|+ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4445555555544 2233 23444445555555555444 2 233 3444455555555555543 344444
Q ss_pred CCCCCccceecccccCCC
Q 005750 228 MGSLPNLQELHIENNSFV 245 (679)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~ 245 (679)
+..+++|+.|+|++|.++
T Consensus 240 l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp GGGCTTCCEEECTTCCCC
T ss_pred HccCCCcCEEECCCCCCc
Confidence 444455555555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.51 E-value=5.7e-09 Score=111.82 Aligned_cols=108 Identities=16% Similarity=0.202 Sum_probs=90.7
Q ss_pred CceEEEEcCCCccc--c---cCCccccCCCCCCEEECCCCcCC----CCCC-CCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSGKNLK--G---EIPPELKNMEALTELWLDGNFLT----GPLP-DMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~n~l~--g---~~p~~~~~l~~L~~L~L~~N~l~----~~~p-~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
++|+.|+|++|+++ | .+|..+..+++|+.|+|++|.|+ +.+| .+..+++|+.|+|++|+|++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 58999999999998 4 35558999999999999999996 5566 589999999999999999966 677
Q ss_pred CC--CCCCccceecccccCCCC----CCCccc---cCCceeeeecCCCCcc
Q 005750 227 YM--GSLPNLQELHIENNSFVG----EIPPAL---LTGKVIFKYDNNPKLH 268 (679)
Q Consensus 227 ~~--~~l~~L~~L~l~~N~l~g----~ip~~~---~~~~~~~~~~~n~~~~ 268 (679)
.+ +.+++|+.|+|++|.+++ .+|..+ +..+..+.+.+|+..+
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 76 459999999999999996 488876 3566788888887553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=5.6e-08 Score=97.97 Aligned_cols=66 Identities=26% Similarity=0.411 Sum_probs=41.8
Q ss_pred cCCCCCCEEECCCCcCCCC--CCC-CCCCCCCcEEEecCccCCCCCCCCCCCCC--ccceecccccCCCCCCC
Q 005750 182 KNMEALTELWLDGNFLTGP--LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP--NLQELHIENNSFVGEIP 249 (679)
Q Consensus 182 ~~l~~L~~L~L~~N~l~~~--~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~ip 249 (679)
.+|++|+.|+|++|+|+++ +|+ +..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 4566777777777777764 333 55677777777777777643 2233333 67777777777776665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.42 E-value=2e-08 Score=106.58 Aligned_cols=105 Identities=18% Similarity=0.189 Sum_probs=69.3
Q ss_pred CceEEEEcCCCcccccCC----ccccCCC-CCCEEECCCCcCCCCCC-CCCCC-----CCCcEEEecCccCCCCCCCCCC
Q 005750 161 PRITKIALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLP-DMSRL-----IDLRIVHLENNELTGSLPSYMG 229 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p----~~~~~l~-~L~~L~L~~N~l~~~~p-~~~~l-----~~L~~L~l~~N~l~g~~p~~~~ 229 (679)
.+|+.|+|++|.+++..+ ..|.+++ +|+.|+|++|.|++..+ .+..+ ++|+.|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 357788888888775555 5677777 78888888888777765 35543 7788888888887765555433
Q ss_pred C----C-CccceecccccCCCCCCCcccc-------CCceeeeecCCC
Q 005750 230 S----L-PNLQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 265 (679)
Q Consensus 230 ~----l-~~L~~L~l~~N~l~g~ip~~~~-------~~~~~~~~~~n~ 265 (679)
. + ++|+.|+|++|++++..+..+. ..+..+.+++|.
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 149 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND 149 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence 3 3 6788888888887744333221 244556666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=7.7e-07 Score=90.04 Aligned_cols=135 Identities=17% Similarity=0.111 Sum_probs=99.1
Q ss_pred ccCcCccE-EEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCCCcH
Q 005750 364 KIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 364 ~LG~G~~g-~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 68988765 467899998653 34567888999999884 33467788888888899999999999888
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 475 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------------------------------------------- 475 (679)
.+..... ......+..+++..|+.||+.
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765421 122345677888888888851
Q ss_pred ----------CCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 476 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 476 ----------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
....++|||+++.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877777999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-06 Score=89.70 Aligned_cols=135 Identities=15% Similarity=0.187 Sum_probs=95.6
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCC---Cccccccccc-ccceEEEEEEecCCC
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 438 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~~~g 438 (679)
+.++.|....||+. |+.+++|+-.. ......+.+|.++|+.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788888999988 56788898532 33456788999999999642 3555666653 455678999999998
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 475 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 475 (679)
++.+... ..++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8866322 1234555566666666666666641
Q ss_pred --------------CCCCccccCCCCCCccccC---CCc-EEEeeccCccc
Q 005750 476 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 508 (679)
Q Consensus 476 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~Dfgla~~ 508 (679)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999997754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.1e-07 Score=99.33 Aligned_cols=103 Identities=12% Similarity=0.080 Sum_probs=61.4
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC-CC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.+++.|+|++|.+.+..+. +..+++|+.|+|++|.+++. +| .+.++++|+.|+|++|++++.+|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4566666777666654443 45666777777777766654 44 366666777777777766666666666667777777
Q ss_pred cccc-CCCCC-CCccc--cCCceeeeecCC
Q 005750 239 IENN-SFVGE-IPPAL--LTGKVIFKYDNN 264 (679)
Q Consensus 239 l~~N-~l~g~-ip~~~--~~~~~~~~~~~n 264 (679)
|++| .+++. +|..+ ...+..+.+++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 7766 45532 33322 123344555555
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=1.1e-07 Score=95.93 Aligned_cols=79 Identities=22% Similarity=0.339 Sum_probs=66.2
Q ss_pred CCceEEEEcCCCcccc--cCCccccCCCCCCEEECCCCcCCCCCCCCCCCC--CCcEEEecCccCCCCCCC-------CC
Q 005750 160 PPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLPS-------YM 228 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~--~L~~L~l~~N~l~g~~p~-------~~ 228 (679)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|. .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 5689999999999998 6778889999999999999999987 3333333 999999999999988874 36
Q ss_pred CCCCccceecc
Q 005750 229 GSLPNLQELHI 239 (679)
Q Consensus 229 ~~l~~L~~L~l 239 (679)
..+++|+.||=
T Consensus 248 ~~~P~L~~LDg 258 (267)
T 3rw6_A 248 ERFPKLLRLDG 258 (267)
T ss_dssp HHCTTCCEESS
T ss_pred HHCcccCeECC
Confidence 77889988763
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.7e-06 Score=91.19 Aligned_cols=101 Identities=15% Similarity=0.165 Sum_probs=58.7
Q ss_pred ceEEEEcCC-CcccccCCccccCCC-CCCEEECCCCcCCCCCCCCCCCCCCcEEEecC-ccCCCCCCC-CCCCCCcccee
Q 005750 162 RITKIALSG-KNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN-NELTGSLPS-YMGSLPNLQEL 237 (679)
Q Consensus 162 ~l~~L~L~~-n~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~-N~l~g~~p~-~~~~l~~L~~L 237 (679)
++..|++.+ +++....+..|..+. .|+.|+|++|+|+.+++......+|+.|++++ |+++ .||. .|..+++|+.|
T Consensus 129 ~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~L 207 (350)
T 4ay9_X 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 207 (350)
T ss_dssp SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEE
T ss_pred hhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchh
Confidence 455666644 445433333455553 46667777777766665555556667777664 3444 5554 35666777777
Q ss_pred cccccCCCCCCCccccCCceeeeecCC
Q 005750 238 HIENNSFVGEIPPALLTGKVIFKYDNN 264 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~~~~~~~~~~n 264 (679)
+|++|+|+ .+|...+.++..+...++
T Consensus 208 dLs~N~l~-~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 208 DISRTRIH-SLPSYGLENLKKLRARST 233 (350)
T ss_dssp ECTTSCCC-CCCSSSCTTCCEEECTTC
T ss_pred hcCCCCcC-ccChhhhccchHhhhccC
Confidence 77777776 666666555555444433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.1e-07 Score=99.40 Aligned_cols=111 Identities=19% Similarity=0.297 Sum_probs=92.5
Q ss_pred CCceEEEeCCCCCceEEEEcCCCcccccCCccccCC--CCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCC-CC
Q 005750 149 PWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM--EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS-LP 225 (679)
Q Consensus 149 ~w~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~-~p 225 (679)
.|..+.|+ +..++.|+|++|++. |..+..+ ++|+.|+|++|.+++.++.+.++++|+.|+|++|++++. +|
T Consensus 38 ~W~~~~~~---~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASD---ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTC---STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcC---chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 45555442 235789999999987 5678888 999999999999999999988999999999999999976 88
Q ss_pred CCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCC
Q 005750 226 SYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
..+..+++|+.|+|++|++++.+|..+.. .+..+.+++|.
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 88999999999999999998777765543 45667777774
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.23 E-value=1e-07 Score=101.07 Aligned_cols=102 Identities=14% Similarity=0.043 Sum_probs=85.6
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC----C-CCCCC-CCcEEEecCccCCCCCCCCCCCC-----Cc
Q 005750 165 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP----D-MSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 233 (679)
Q Consensus 165 ~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p----~-~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~ 233 (679)
.++|++|+++|.+|..+...++|+.|+|++|.|++..+ + +.+++ +|+.|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999988888889999999999999876 3 77888 89999999999998878777775 99
Q ss_pred cceecccccCCCCCCCcccc-------CCceeeeecCCCC
Q 005750 234 LQELHIENNSFVGEIPPALL-------TGKVIFKYDNNPK 266 (679)
Q Consensus 234 L~~L~l~~N~l~g~ip~~~~-------~~~~~~~~~~n~~ 266 (679)
|++|+|++|++++..+..+. ..+..+.+++|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 121 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcC
Confidence 99999999999966655332 3456677777763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=2.6e-06 Score=89.89 Aligned_cols=80 Identities=5% Similarity=0.037 Sum_probs=56.7
Q ss_pred ccc-CcCccEEEEEEEEc-------CCcEEEEEEecCCc---chhHHHHHHHHHHHHhcc-C--CCccccccccccc---
Q 005750 363 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 425 (679)
Q Consensus 363 ~~L-G~G~~g~Vy~a~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~--- 425 (679)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998765 26789999865432 101245778999998884 3 3567778776654
Q ss_pred ceEEEEEEecCCCcHhh
Q 005750 426 HQRILVYEYMHNGTLRD 442 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~ 442 (679)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.1e-06 Score=86.07 Aligned_cols=92 Identities=15% Similarity=0.085 Sum_probs=79.0
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCc-EEEecCccCCCCCCCCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
++|+.|+|++|+++..-+..|.+|++|+.|+|++| ++.+.+ .|.++++|+ .|+|++ +++..-+..|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 58999999999999444456999999999999998 777666 599999999 999999 78733346799999999999
Q ss_pred ccccCCCCCCCccccCC
Q 005750 239 IENNSFVGEIPPALLTG 255 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~~ 255 (679)
+++|+++ .|+...|.+
T Consensus 304 l~~n~i~-~I~~~aF~~ 319 (329)
T 3sb4_A 304 ATGDKIT-TLGDELFGN 319 (329)
T ss_dssp ECSSCCC-EECTTTTCT
T ss_pred eCCCccC-ccchhhhcC
Confidence 9999999 888877754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.95 E-value=3.2e-07 Score=100.26 Aligned_cols=108 Identities=18% Similarity=0.181 Sum_probs=79.8
Q ss_pred CCceEEEEcCCCcccccCCccccCC-----CCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccCCCCCCCCCC
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMG 229 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~ 229 (679)
.++|+.|+|++|.+++..+..+... ++|+.|+|++|.+++. ++ .+..+++|+.|+|++|++++..+..+.
T Consensus 283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 362 (461)
T 1z7x_W 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362 (461)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence 3689999999999876555554433 6899999999998876 34 367788999999999998865554443
Q ss_pred C-----CCccceecccccCCCC----CCCcccc--CCceeeeecCCCCc
Q 005750 230 S-----LPNLQELHIENNSFVG----EIPPALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 230 ~-----l~~L~~L~l~~N~l~g----~ip~~~~--~~~~~~~~~~n~~~ 267 (679)
. +++|+.|+|++|++++ .+|..+. ..+..+.+++|+..
T Consensus 363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 2 6789999999999885 5666543 35567777887643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=1.9e-05 Score=82.32 Aligned_cols=140 Identities=16% Similarity=0.206 Sum_probs=80.8
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc--CCCccccccc------ccccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRNLVPLIGY------CEEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~------~~~~~~~~lV~E~ 434 (679)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.|. .-.+.+++.. ....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677889999987655 5899998752 234445666666663 1233444431 1235677899999
Q ss_pred cCCCcHh--------------hhhcccCC----C-------CCCCHHHH-------------------------------
Q 005750 435 MHNGTLR--------------DRLHGSVN----Q-------KPLDWLTR------------------------------- 458 (679)
Q Consensus 435 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 458 (679)
++|..+. ..++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11111100 0 00122110
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 459 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 459 ~~i~~qia~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
..+..++..++.+|++ .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666652 024789999999999999888899999999764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.93 E-value=1.4e-07 Score=103.09 Aligned_cols=85 Identities=22% Similarity=0.245 Sum_probs=40.8
Q ss_pred CceEEEEcCCCcccccC-----CccccCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccCCCCCCCCCCC
Q 005750 161 PRITKIALSGKNLKGEI-----PPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMGS 230 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 230 (679)
++|+.|+|++|.+++.- +..+..+++|+.|+|++|.|+.. ++ .+.++++|+.|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 35556666666555321 11122455566666666655552 22 2444555555555555554332222221
Q ss_pred -----CCccceecccccCCC
Q 005750 231 -----LPNLQELHIENNSFV 245 (679)
Q Consensus 231 -----l~~L~~L~l~~N~l~ 245 (679)
.++|+.|+|++|.++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~ 326 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFT 326 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCB
T ss_pred HhccCCccceeeEcCCCCCc
Confidence 135555555555554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=2.6e-05 Score=83.51 Aligned_cols=75 Identities=15% Similarity=0.187 Sum_probs=49.4
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc-------hhHHHHHHHHHHHHhccC--CC-cccccccccccceEEE
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RN-LVPLIGYCEEEHQRIL 430 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-Iv~l~~~~~~~~~~~l 430 (679)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999765 478899998653221 123456789999988842 33 3345543 2344689
Q ss_pred EEEecCCC
Q 005750 431 VYEYMHNG 438 (679)
Q Consensus 431 V~E~~~~g 438 (679)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.75 E-value=1.4e-06 Score=92.57 Aligned_cols=84 Identities=25% Similarity=0.256 Sum_probs=40.4
Q ss_pred ceEEEEcCCCcccccCCccc-----cCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccCCCC----CCCC
Q 005750 162 RITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGS----LPSY 227 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~----~p~~ 227 (679)
+|+.|+|++|+|+..-...+ ...++|+.|+|++|.|+.. ++ .+..+++|+.|+|++|+|+.. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 45555555555543322222 1245555555555555431 11 134455555555555555421 2333
Q ss_pred CCCCCccceecccccCCC
Q 005750 228 MGSLPNLQELHIENNSFV 245 (679)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~ 245 (679)
+..+++|+.|+|++|.|+
T Consensus 207 L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp GGGCSCCCEEECCSSCCC
T ss_pred HhcCCCcCeEECCCCCCC
Confidence 444455555555555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=3.9e-05 Score=82.92 Aligned_cols=79 Identities=11% Similarity=0.095 Sum_probs=49.1
Q ss_pred CCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCC---CCCchhHHHHHHHHHHHH
Q 005750 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLEL 553 (679)
Q Consensus 477 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvll~el 553 (679)
...++|||+++.||+++.++ ++++||+.+..-............-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 37899999999999998776 99999998875332111100000012346666654321 122345666888888887
Q ss_pred HhC
Q 005750 554 ISG 556 (679)
Q Consensus 554 ltG 556 (679)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00016 Score=74.66 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=90.7
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc---CCCcccccccccccceEEEEEEecCCCc
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46899999999999864 678899987532 3567889999999884 3567888888877788999999999875
Q ss_pred Hhh-----------hhcccCC-------------------CCCCCHHHHH---HHH----------------HHHHHHH-
Q 005750 440 LRD-----------RLHGSVN-------------------QKPLDWLTRL---QIA----------------HDAAKGL- 469 (679)
Q Consensus 440 L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~qia~aL- 469 (679)
+.. .|+.... .-.-+|.... ++. .+++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 421 1221110 0012344321 111 1122222
Q ss_pred HHHHh-cCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 470 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 470 ~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1246899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00011 Score=74.79 Aligned_cols=74 Identities=19% Similarity=0.271 Sum_probs=54.8
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-C--CCcccccccccccceEEEEEEecCCC
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
.+.+|.|..+.||+.+..+|+.|++|+...........+..|.+.|+.|. . -.+.+++++. ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 46789999999999999999999999876544444456888999999884 2 1244444432 237899999876
Q ss_pred c
Q 005750 439 T 439 (679)
Q Consensus 439 s 439 (679)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=2.1e-05 Score=73.90 Aligned_cols=98 Identities=20% Similarity=0.141 Sum_probs=60.3
Q ss_pred cceeecCCceEEEEEec-ccCcccceeeeehhhhcccCCCcceeeecccCcccCCC-CceEEEeecCCcccccccCccc-
Q 005750 2 QTAVVGTEGVLSYRLNL-EDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYS-NAVVNIAENANGSYTLYEPSYM- 78 (679)
Q Consensus 2 ~~a~~~~~~~~~~~~~~-~~~~~~~~~~~~f~e~~~~~~~~~r~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~p~~~- 78 (679)
|||-... .+++|.. .+....|.+-|||||+.. .+.+.|.||| |.++.- ...|||+...+. ..++.-.|.
T Consensus 58 ~TaR~~~---~~~tY~f~v~~~G~Y~VrLhF~ei~~-~~~~~rvFdV---~ing~~~l~~fdi~~~ag~-~~~~~~~~~~ 129 (174)
T 2jwp_A 58 QTERYNE---DSFGYDIPIKEEGEYVLVLKFAEVYF-AQSQQKVFDV---RVNGHTVVKDLDIFDRVGH-STAHDEIIPI 129 (174)
T ss_dssp TCCCCCC---SCEEEEEECCSCEEEEEEEEEECCSC-CCSSSSCEEE---EETTEEEEEEECHHHHHSS-SSCEEEEEEE
T ss_pred hhhccCC---CCeEEEEEeCCCeEEEEEEEEecccc-CCCCCeEeEE---EECCEEeecCcCHHHhhCC-CeeEEEEEEE
Confidence 5664433 2567767 566789999999999984 4678999997 555521 133555443321 111111111
Q ss_pred cc------------ccceEEEEEEeecCCCccccceeeeeeee
Q 005750 79 NV------------TLNFVLSFSFVKTRDSTLGPLLNAIEISK 109 (679)
Q Consensus 79 ~~------------~~~~~~~~~l~~~~~s~l~p~~na~e~~~ 109 (679)
++ ...+.+.+.+.+. +.-.|+|||+||++
T Consensus 130 ~v~~~~l~i~~~~~~~~g~L~I~f~p~--~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 130 SIKKGKLSVQGEVSTFTGKLSVEFVKG--YYDNPKVCALFIMK 170 (174)
T ss_dssp EEETTEEEETTEEEECCSEEEEEEECS--SSCSSSEEEEEEES
T ss_pred EEecCceeeeeeecccCCeEEEEEecc--CCCCcEEEEEEEEe
Confidence 11 2456788888864 35679999999975
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.59 E-value=4.9e-06 Score=88.45 Aligned_cols=85 Identities=18% Similarity=0.135 Sum_probs=52.5
Q ss_pred CceEEEEcCCCcccccCCccc-cCCCCCCEEECCCCcCCCCCC-CC-----CCCCCCcEEEecCccCCC----CCCCCCC
Q 005750 161 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DM-----SRLIDLRIVHLENNELTG----SLPSYMG 229 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~-~~l~~L~~L~L~~N~l~~~~p-~~-----~~l~~L~~L~l~~N~l~g----~~p~~~~ 229 (679)
.+|+.|+|++|.|+..-...+ ..|++|+.|+|++|.|+.... .+ ...++|+.|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 367777777777764333333 235667777777777765432 12 345667777777777753 2344445
Q ss_pred CCCccceecccccCCC
Q 005750 230 SLPNLQELHIENNSFV 245 (679)
Q Consensus 230 ~l~~L~~L~l~~N~l~ 245 (679)
.+++|++|+|++|.|+
T Consensus 181 ~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLG 196 (372)
T ss_dssp TCSSCCEEECTTSSCH
T ss_pred cCCCcCEEeCCCCCCC
Confidence 6677777777777775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.44 E-value=1.1e-05 Score=76.67 Aligned_cols=85 Identities=22% Similarity=0.298 Sum_probs=67.4
Q ss_pred CceEEEEcCCC-ccccc----CCccccCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
+.|+.|+|++| .|... +...+...++|++|+|++|.|+.. +. .+...++|+.|+|++|+|... +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47999999999 88642 455677789999999999998753 22 255678899999999999843 566
Q ss_pred CCCCCCccceecc--cccCCC
Q 005750 227 YMGSLPNLQELHI--ENNSFV 245 (679)
Q Consensus 227 ~~~~l~~L~~L~l--~~N~l~ 245 (679)
.+...++|+.|+| ++|.|.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCCCceEEEecCCCCCCC
Confidence 7778889999999 889987
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.37 E-value=1.1e-05 Score=90.88 Aligned_cols=107 Identities=15% Similarity=0.073 Sum_probs=75.4
Q ss_pred CCceEEEEcC----CCccccc-----CCccccCCCCCCEEECCCC--cCCCCCC-CC-CCCCCCcEEEecCccCCC-CCC
Q 005750 160 PPRITKIALS----GKNLKGE-----IPPELKNMEALTELWLDGN--FLTGPLP-DM-SRLIDLRIVHLENNELTG-SLP 225 (679)
Q Consensus 160 ~~~l~~L~L~----~n~l~g~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p-~~-~~l~~L~~L~l~~N~l~g-~~p 225 (679)
.++|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+ .+ ..+++|+.|+|++|++++ .++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 4689999996 7788763 4445777899999999753 3665543 33 347889999999998876 355
Q ss_pred CCCCCCCccceecccccCCCCCCCccc---cCCceeeeecCCCC
Q 005750 226 SYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPK 266 (679)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l~g~ip~~~---~~~~~~~~~~~n~~ 266 (679)
..+..+++|+.|+|++|.|++.....+ ...+..+.+++|+.
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred HHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 556778889999999998874433322 23556777888873
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.30 E-value=1.2e-05 Score=76.37 Aligned_cols=85 Identities=15% Similarity=0.246 Sum_probs=68.6
Q ss_pred CceEEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEe--cCccCCCC----CC
Q 005750 161 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHL--ENNELTGS----LP 225 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l--~~N~l~g~----~p 225 (679)
.+|+.|+|++|.|... +...+...++|+.|+|++|.|+.. +. .+...++|+.|+| ++|.|... +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 5899999999999743 445566778999999999999874 22 4788889999999 88999844 34
Q ss_pred CCCCCCCccceecccccCCC
Q 005750 226 SYMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l~ 245 (679)
..+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 45556689999999999886
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00056 Score=71.08 Aligned_cols=141 Identities=12% Similarity=0.058 Sum_probs=73.9
Q ss_pred cccCcCccEE-EEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-C-CCcccccccccccceEEEEEEecCCCc
Q 005750 363 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-RNLVPLIGYCEEEHQRILVYEYMHNGT 439 (679)
Q Consensus 363 ~~LG~G~~g~-Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-pnIv~l~~~~~~~~~~~lV~E~~~~gs 439 (679)
+.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+. + -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565554 6677654477788887543311 33456777777774 2 23455666543333 78999997766
Q ss_pred HhhhhcccC---------------------C--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 005750 440 LRDRLHGSV---------------------N--QKPLDWLTRL-------Q-------------IAHDAAKGLEYLH--- 473 (679)
Q Consensus 440 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~qia~aL~~LH--- 473 (679)
+.+.+.... . ...++..... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654332110 0 0112111100 0 0001111222221
Q ss_pred hcCCCCccccCCCCCCccccCC----CcEEEeeccCccc
Q 005750 474 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 508 (679)
Q Consensus 474 ~~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfgla~~ 508 (679)
......++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123689999999999999874 6799999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00078 Score=69.52 Aligned_cols=142 Identities=15% Similarity=0.220 Sum_probs=80.3
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC--cccccccc------cccceEEEEEEe
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYC------EEEHQRILVYEY 434 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~------~~~~~~~lV~E~ 434 (679)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+.... +.+++... ...+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987755 6889988652 12245567888888774222 33444221 123567899999
Q ss_pred cCCCcHhh--------------hhcccC---CCC---CC---CHHHHHH------------HHHHHHHHHHHHHhc----
Q 005750 435 MHNGTLRD--------------RLHGSV---NQK---PL---DWLTRLQ------------IAHDAAKGLEYLHTG---- 475 (679)
Q Consensus 435 ~~~gsL~~--------------~l~~~~---~~~---~l---~~~~~~~------------i~~qia~aL~~LH~~---- 475 (679)
++|..+.. .++... ... .. .|..... +...+.+.++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 111110 000 01 1221100 001234455555531
Q ss_pred CCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 476 ~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
...+++|+|+++.||+++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13579999999999999877666899999765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00083 Score=72.56 Aligned_cols=72 Identities=17% Similarity=0.324 Sum_probs=50.3
Q ss_pred cccCcCccEEEEEEEEcC--------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCc-ccccccccccceEEEEEE
Q 005750 363 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E 433 (679)
+.|+.|....||++...+ ++.+++|+...... ...+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888899999998753 57899999854211 1455679999998853333 566666543 38999
Q ss_pred ecCCCcH
Q 005750 434 YMHNGTL 440 (679)
Q Consensus 434 ~~~~gsL 440 (679)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0011 Score=70.21 Aligned_cols=141 Identities=17% Similarity=0.186 Sum_probs=84.5
Q ss_pred cccCcCccEEEEEEEEc--------CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 363 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+.|..|....+|+.... +++.+++|+.... ........+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899998864 2578999986432 223456678999999884 3334566766654 28999
Q ss_pred ecCCCcHhhh-----------------hcccC--CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 005750 434 YMHNGTLRDR-----------------LHGSV--NQKPL--DWLTRLQIAHDAAK-------------------GLEYLH 473 (679)
Q Consensus 434 ~~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~qia~-------------------aL~~LH 473 (679)
|++|.+|..- ++... -.+.. -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998654311 11110 01122 24455555544422 223332
Q ss_pred h-----cCCCCccccCCCCCCccccCC----CcEEEeeccCccc
Q 005750 474 T-----GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 508 (679)
Q Consensus 474 ~-----~~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfgla~~ 508 (679)
+ .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123578999999999999876 7899999997753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.003 Score=65.25 Aligned_cols=141 Identities=13% Similarity=0.174 Sum_probs=82.0
Q ss_pred ccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCC--Cccccccc-----ccccceEEEEEEecC
Q 005750 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGY-----CEEEHQRILVYEYMH 436 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~-----~~~~~~~~lV~E~~~ 436 (679)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+... .+++++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999887778889999986431 2345677788888888422 24444443 112445678999998
Q ss_pred CCcHhh--------------hhccc---C---CCCCCCHHHH----------------------HHHHHHHHHHHHHHHh
Q 005750 437 NGTLRD--------------RLHGS---V---NQKPLDWLTR----------------------LQIAHDAAKGLEYLHT 474 (679)
Q Consensus 437 ~gsL~~--------------~l~~~---~---~~~~l~~~~~----------------------~~i~~qia~aL~~LH~ 474 (679)
|..+.. .++.. . .....++... ...+.+++..+..+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 754320 01110 0 0112222211 1111122222222211
Q ss_pred -cCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 475 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 475 -~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
.....++|||+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999998 4 899999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00065 Score=69.57 Aligned_cols=71 Identities=10% Similarity=0.095 Sum_probs=44.9
Q ss_pred ccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCc-ccccccccccceEEEEEEec-CCCc
Q 005750 362 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGT 439 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~-~~gs 439 (679)
.+.|+.|....+|+. +.+++|+....... .....+|..+++.+....+ .++++++.+ ..++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 467888999999998 56889987643211 1123468888888743223 455554433 347899999 6544
Q ss_pred H
Q 005750 440 L 440 (679)
Q Consensus 440 L 440 (679)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00073 Score=60.00 Aligned_cols=55 Identities=31% Similarity=0.408 Sum_probs=34.5
Q ss_pred EEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCC
Q 005750 165 KIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 221 (679)
Q Consensus 165 ~L~L~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~ 221 (679)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+.+.+. |..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777777776 35664332 3566777777777666663 566666666666666553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00019 Score=80.79 Aligned_cols=78 Identities=13% Similarity=0.111 Sum_probs=34.7
Q ss_pred ceEEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCCC----CC-CCCCCCCcEEEecCccCCCCCCCCCCCCC
Q 005750 162 RITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNELTGSLPSYMGSLP 232 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 232 (679)
+|+.|+|++|.+++. ++..+.++++|+.|+|++|.+++.. +. +.++++|+.|+|++|.+.+ +|..+..++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455555555554433 2223344455555555555554221 11 3344555555555555442 333333444
Q ss_pred ccceeccc
Q 005750 233 NLQELHIE 240 (679)
Q Consensus 233 ~L~~L~l~ 240 (679)
+|+.|+++
T Consensus 244 ~L~~L~l~ 251 (592)
T 3ogk_B 244 NLEEFCGG 251 (592)
T ss_dssp TCCEEEEC
T ss_pred HHHhhccc
Confidence 44444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.00 E-value=6.6e-05 Score=70.21 Aligned_cols=83 Identities=12% Similarity=0.103 Sum_probs=64.7
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCc-CCCC-CCCCCCC----CCCcEEEecCcc-CCCCCCCCCCCCCc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGP-LPDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPN 233 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~-~p~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~ 233 (679)
.+|+.|||+++.++..--..+..|++|+.|+|+++. |+.. +..++.+ ++|+.|+|+++. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999876555668899999999999985 6543 3345554 479999999985 77433345778999
Q ss_pred cceecccccC
Q 005750 234 LQELHIENNS 243 (679)
Q Consensus 234 L~~L~l~~N~ 243 (679)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0026 Score=69.10 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=48.1
Q ss_pred cccCcCccEEEEEEEEcC-CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCc-ccccccccccceEEEEEEecCCCcH
Q 005750 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
+.|+.|....+|+....+ +..+++|+........ -.-.+|..+++.|...++ .++++++.. .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 568888899999998875 5789999875432111 112579999999864444 566766632 359999987554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.95 E-value=4.2e-05 Score=86.21 Aligned_cols=106 Identities=14% Similarity=0.107 Sum_probs=76.9
Q ss_pred CCceEEEEcC--C----Ccccc-----cCCccccCCCCCCEEECCCCcCCCCCC-CCCC-CCCCcEEEecCccCCCCCCC
Q 005750 160 PPRITKIALS--G----KNLKG-----EIPPELKNMEALTELWLDGNFLTGPLP-DMSR-LIDLRIVHLENNELTGSLPS 226 (679)
Q Consensus 160 ~~~l~~L~L~--~----n~l~g-----~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~-l~~L~~L~l~~N~l~g~~p~ 226 (679)
.++|+.|+|+ + |++++ .++..+..+++|+.|+|++ .+++..+ .+.. +++|+.|+|++|.+++..+.
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 4789999999 4 56662 2233377889999999977 6665433 4555 89999999999999866555
Q ss_pred CC-CCCCccceecccccCCCCCCCcccc---CCceeeeecCCCC
Q 005750 227 YM-GSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 266 (679)
Q Consensus 227 ~~-~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~ 266 (679)
.+ ..+++|+.|+|++|.+++..+..+. ..+..+.+++|+.
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 54 6689999999999999644333232 3456677777764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0042 Score=59.51 Aligned_cols=104 Identities=12% Similarity=0.047 Sum_probs=69.1
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccccc
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~ 517 (679)
-+|.++|... +.+++++++|.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 3788988864 67899999999999999998876220 1111233456888999999888764 1110
Q ss_pred ccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005750 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 560 (679)
Q Consensus 518 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf 560 (679)
.....+.|||... ...+.+.=|||||+++|..+--..|-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0133567888864 35578999999999999998765553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.88 E-value=7.3e-05 Score=84.21 Aligned_cols=83 Identities=12% Similarity=0.174 Sum_probs=61.9
Q ss_pred CceEEEEcCCCcccccCCcccc-CCCCCCEEECCCC-cCCCC-CCC-CCCCCCCcEEEecCccCCCCCCCCC----CCCC
Q 005750 161 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGN-FLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYM----GSLP 232 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~-~~~l~~L~~L~l~~N~l~g~~p~~~----~~l~ 232 (679)
++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++. +.++++|+.|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788888888888877777776 6888888888888 55443 444 4478888888888888776544333 3667
Q ss_pred ccceecccccC
Q 005750 233 NLQELHIENNS 243 (679)
Q Consensus 233 ~L~~L~l~~N~ 243 (679)
+|+.|+|++|.
T Consensus 185 ~L~~L~l~~~~ 195 (594)
T 2p1m_B 185 SLVSLNISCLA 195 (594)
T ss_dssp CCCEEECTTCC
T ss_pred cCcEEEecccC
Confidence 88888888887
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.001 Score=69.04 Aligned_cols=77 Identities=19% Similarity=0.055 Sum_probs=65.8
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCC-EEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALT-ELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~-~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.+|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++.+.+ .|.++++|+.|+|++|+++..-+..|.++++|+.|+
T Consensus 250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 58999999998 7744556799999999 999999 7887777 599999999999999999944445799999999886
Q ss_pred c
Q 005750 239 I 239 (679)
Q Consensus 239 l 239 (679)
.
T Consensus 328 ~ 328 (329)
T 3sb4_A 328 K 328 (329)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.005 Score=64.19 Aligned_cols=68 Identities=13% Similarity=0.249 Sum_probs=45.3
Q ss_pred CcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc---CCCcccccccc------cccceEEEEEEecC
Q 005750 366 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYC------EEEHQRILVYEYMH 436 (679)
Q Consensus 366 G~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~------~~~~~~~lV~E~~~ 436 (679)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|.+++++... ...+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999988777 899998765432 35666676663 23255555432 23567899999999
Q ss_pred CCcH
Q 005750 437 NGTL 440 (679)
Q Consensus 437 ~gsL 440 (679)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.003 Score=66.64 Aligned_cols=73 Identities=14% Similarity=0.189 Sum_probs=45.0
Q ss_pred cccCcCccEEEEEEEEcC---------CcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC-cccccccccccceEEEEE
Q 005750 363 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~ 432 (679)
+.|+.|....+|+....+ ++.+++|+...... .......|.++++.+...+ ..++++.+. .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 567888888999998764 26899998754322 1112357888888885333 345665442 26899
Q ss_pred EecCCCcH
Q 005750 433 EYMHNGTL 440 (679)
Q Consensus 433 E~~~~gsL 440 (679)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0022 Score=56.81 Aligned_cols=49 Identities=27% Similarity=0.342 Sum_probs=29.4
Q ss_pred EEECCCCcCC--CCCCCCCCCCCCcEEEecCccCCCCCCC-CCCCCCccceeccc
Q 005750 189 ELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIE 240 (679)
Q Consensus 189 ~L~L~~N~l~--~~~p~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~ 240 (679)
.++.+++.|+ ..+..+. .+|+.|+|++|+|+ .||. .|..+++|+.|+|+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~ 63 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLG 63 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEec
Confidence 6778888887 4443432 34777777777777 4544 35556666554333
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00028 Score=74.43 Aligned_cols=106 Identities=14% Similarity=0.233 Sum_probs=70.3
Q ss_pred CCceEEEEcCCCcccccCCcccc--CCCCCCEEECCC--CcCCCC--C----CCC--CCCCCCcEEEecCccCCCCCCCC
Q 005750 160 PPRITKIALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP--L----PDM--SRLIDLRIVHLENNELTGSLPSY 227 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~L~~--N~l~~~--~----p~~--~~l~~L~~L~l~~N~l~g~~p~~ 227 (679)
.++|+.|+|..+++....-..+. ++++|+.|+|+. |...+. + +.+ ..+++|+.|+|.+|.+.+..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 36899999998888755444554 789999999863 332222 1 222 35789999999999987544333
Q ss_pred C---CCCCccceecccccCCCCC----CCccc--cCCceeeeecCCC
Q 005750 228 M---GSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNP 265 (679)
Q Consensus 228 ~---~~l~~L~~L~l~~N~l~g~----ip~~~--~~~~~~~~~~~n~ 265 (679)
+ ..+++|+.|+|+.|.+++. ++..+ +..+..+.+.+|.
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 2 3578999999999998853 23221 2234556666654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.00025 Score=74.73 Aligned_cols=105 Identities=17% Similarity=0.149 Sum_probs=67.9
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CC--CCCCCCcEEEecC--ccCCCC-----CCCCC
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DM--SRLIDLRIVHLEN--NELTGS-----LPSYM 228 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~--~~l~~L~~L~l~~--N~l~g~-----~p~~~ 228 (679)
..|+|+.|+|++|.-. .+++ +. +++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +...+
T Consensus 170 ~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 170 AMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred cCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 3479999999887311 3444 43 8999999999888765322 23 3789999999964 332222 11122
Q ss_pred --CCCCccceecccccCCCCCCCccc-----cCCceeeeecCCCC
Q 005750 229 --GSLPNLQELHIENNSFVGEIPPAL-----LTGKVIFKYDNNPK 266 (679)
Q Consensus 229 --~~l~~L~~L~l~~N~l~g~ip~~~-----~~~~~~~~~~~n~~ 266 (679)
..+++|+.|+|.+|.+....+..+ ...+..+.++.|..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 358999999999999874333222 23456667766653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0054 Score=65.50 Aligned_cols=100 Identities=16% Similarity=0.174 Sum_probs=68.5
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCC-----CCCC-CCCCCCCCcEEEecCccCCCCCC-CCCCCCCc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-----GPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPN 233 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~-----~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~ 233 (679)
..|+.|.| .++++..-+..|.+|++|+.|+|.+|.+. .+.+ .|.++++|+.++|. |+++ .|+ ..|.+|++
T Consensus 248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~ 324 (401)
T 4fdw_A 248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRK 324 (401)
T ss_dssp CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCS
T ss_pred CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCC
Confidence 36778888 45566444567888888888888888776 2233 48888888888888 4476 554 45778888
Q ss_pred cceecccccCCCCCCCccccC--CceeeeecCCC
Q 005750 234 LQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 234 L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
|+.|.|.+| ++ .|+...|. .+..+.+.+|.
T Consensus 325 L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 325 VTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp CCEEEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred ccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 888888554 65 66666554 33455566653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.008 Score=64.19 Aligned_cols=89 Identities=16% Similarity=0.193 Sum_probs=53.5
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCC----CCC-CCCCCCCCcc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT----GSL-PSYMGSLPNL 234 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~----g~~-p~~~~~l~~L 234 (679)
.+|+.|+|.+| ++..-...|.+ .+|+.+.| .|.++.+.+ .|.++++|+.++|.+|.+. ..| +..|.+|++|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 35677777653 44222334544 67777777 444555544 4777777777777776654 113 3456777777
Q ss_pred ceecccccCCCCCCCccccC
Q 005750 235 QELHIENNSFVGEIPPALLT 254 (679)
Q Consensus 235 ~~L~l~~N~l~g~ip~~~~~ 254 (679)
+.+.|. |.++ .|+...|.
T Consensus 303 ~~l~l~-~~i~-~I~~~aF~ 320 (401)
T 4fdw_A 303 ARFEIP-ESIR-ILGQGLLG 320 (401)
T ss_dssp CEECCC-TTCC-EECTTTTT
T ss_pred CeEEeC-CceE-EEhhhhhc
Confidence 777777 4465 66666554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.079 Score=56.71 Aligned_cols=140 Identities=14% Similarity=0.190 Sum_probs=84.6
Q ss_pred cccCcCccEEEEEEEEcC--------CcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 363 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+.+..|-...+|+....+ ++.+++|+...... ..-+..+|.++++.+. +.-..++++.+. .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567778888999998763 58899998654321 1122357888888884 333445555432 278999
Q ss_pred ecCCCcHhh--h---------------hccc-------C---CCCCCCHHHHHHHHHHHH-------------------H
Q 005750 434 YMHNGTLRD--R---------------LHGS-------V---NQKPLDWLTRLQIAHDAA-------------------K 467 (679)
Q Consensus 434 ~~~~gsL~~--~---------------l~~~-------~---~~~~l~~~~~~~i~~qia-------------------~ 467 (679)
|++|..|.. + ++.. . ...+..+.++.++..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865421 0 0100 0 111112444444433321 2
Q ss_pred HHHHHHh---------------------cCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 468 GLEYLHT---------------------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 468 aL~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233321 11356899999999999 8888999999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.77 E-value=0.0066 Score=57.68 Aligned_cols=84 Identities=14% Similarity=0.180 Sum_probs=60.7
Q ss_pred CceEEEEcCCC-cccc----cCCccccCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSGK-NLKG----EIPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~n-~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|... +- .+..-+.|+.|+|++|+|... |-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 47899999986 6642 2445577778999999999999743 12 245567899999999999743 233
Q ss_pred CCCCCCccceecccccCC
Q 005750 227 YMGSLPNLQELHIENNSF 244 (679)
Q Consensus 227 ~~~~l~~L~~L~l~~N~l 244 (679)
.+..-+.|+.|+|++|..
T Consensus 121 aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HTTTTCCCSEEECCCCSS
T ss_pred HHhhCCceeEEECCCCcC
Confidence 455556799999987643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.10 E-value=0.33 Score=51.48 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=25.2
Q ss_pred CccccCCCCCCccc------cCCCcEEEeeccCccc
Q 005750 479 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 508 (679)
Q Consensus 479 ~ivH~Dlkp~NIll------~~~~~~kL~Dfgla~~ 508 (679)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 45799999999999 4567799999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=93.05 E-value=0.014 Score=54.28 Aligned_cols=70 Identities=10% Similarity=0.125 Sum_probs=50.6
Q ss_pred cCCccccCCCCCCEEECCCCcCCCC-CCCCCCCCCCcEEEecCcc-CCCCCCCCCCCC----CccceecccccC-CC
Q 005750 176 EIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENNS-FV 245 (679)
Q Consensus 176 ~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~ 245 (679)
.+|.....--+|+.|||+++.++.. +..+.++++|+.|+|+++. ++..--..++.+ ++|++|+|+++. ++
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 3454433335799999999997764 4558899999999999995 664333335543 479999999975 65
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.55 E-value=0.16 Score=53.15 Aligned_cols=88 Identities=16% Similarity=0.117 Sum_probs=53.1
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCC-CCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ 238 (679)
..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +..... .|.++++|+.+.+.+|.++ .|+ ..|.+|.+|+.+.
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~ 316 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVT 316 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEE
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEE
Confidence 35667777654 44233445666777777777543 443333 3677777777777777776 444 3566777777777
Q ss_pred ccccCCCCCCCcccc
Q 005750 239 IENNSFVGEIPPALL 253 (679)
Q Consensus 239 l~~N~l~g~ip~~~~ 253 (679)
|..+ ++ .|+...|
T Consensus 317 lp~~-l~-~I~~~aF 329 (379)
T 4h09_A 317 LPTA-LK-TIQVYAF 329 (379)
T ss_dssp CCTT-CC-EECTTTT
T ss_pred cCcc-cc-EEHHHHh
Confidence 7543 54 5555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.14 Score=54.11 Aligned_cols=70 Identities=11% Similarity=0.074 Sum_probs=44.8
Q ss_pred cccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCC-CCCCCCCccceecccccCCCCCCCccccC
Q 005750 180 ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPALLT 254 (679)
Q Consensus 180 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~ip~~~~~ 254 (679)
.+..+++|+.+.+.+| ++.+.. .|.++++|+.++|.++ ++ .|+ ..|.+|++|+.+.|..| ++ .|++..|.
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~ 363 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQ 363 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBT
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhh
Confidence 4666777777777654 444434 4777777777777644 55 443 45777777777777655 55 66665554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=91.79 E-value=0.38 Score=50.69 Aligned_cols=87 Identities=13% Similarity=0.222 Sum_probs=46.1
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCC-CCCCCCCccceecc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHI 239 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l 239 (679)
.|+.+.+.++..+ .-...|.++++|+.+.+. +.++.+.. .|.++.+|+.++|..| ++ .|. ..|.+|.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEE
Confidence 3444444433222 223345566666666664 33444433 3666777777777644 44 343 34666777777766
Q ss_pred cccCCCCCCCccccC
Q 005750 240 ENNSFVGEIPPALLT 254 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~ 254 (679)
..+ ++ .|+...|.
T Consensus 342 p~s-v~-~I~~~aF~ 354 (394)
T 4gt6_A 342 PSS-VT-KIPESAFS 354 (394)
T ss_dssp CTT-CC-BCCGGGGT
T ss_pred Ccc-cC-EEhHhHhh
Confidence 533 55 56555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=90.60 E-value=0.33 Score=51.17 Aligned_cols=81 Identities=12% Similarity=0.197 Sum_probs=63.3
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCC-CCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ 238 (679)
..|+.+.+. ++++..-...|.++++|+.++|..| ++.+-. .|.++.+|+.+.|..+ ++ .|.. .|.+|++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 468888886 5566334456899999999999865 555545 5999999999999765 77 6654 689999999999
Q ss_pred ccccCCC
Q 005750 239 IENNSFV 245 (679)
Q Consensus 239 l~~N~l~ 245 (679)
+.+|...
T Consensus 364 ~~~~~~~ 370 (394)
T 4gt6_A 364 YSGSRSQ 370 (394)
T ss_dssp ESSCHHH
T ss_pred ECCceee
Confidence 9887643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.41 Score=50.00 Aligned_cols=88 Identities=16% Similarity=0.269 Sum_probs=61.8
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCC-CCCCCCccceecc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 239 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l 239 (679)
.+..+.+..+ +...-...+.+++.|+.+.+..+ ++.+-. .|.++.+|+.+.+..+ +. .++. .|..|++|+.+.+
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccc
Confidence 5666666544 44344556778888888888766 555444 4888888888888654 55 4544 5788888888888
Q ss_pred cccCCCCCCCccccC
Q 005750 240 ENNSFVGEIPPALLT 254 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~ 254 (679)
.+|.++ .|++..|.
T Consensus 294 ~~~~i~-~I~~~aF~ 307 (379)
T 4h09_A 294 DNSAIE-TLEPRVFM 307 (379)
T ss_dssp CCTTCC-EECTTTTT
T ss_pred cccccc-eehhhhhc
Confidence 888887 77777664
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=89.82 E-value=0.023 Score=53.93 Aligned_cols=84 Identities=17% Similarity=0.150 Sum_probs=57.4
Q ss_pred CceEEEEcCCCcccccC----CccccCCCCCCEEECCCCcCCCC----CC-CCCCCCCCcEEEecCccC---CC----CC
Q 005750 161 PRITKIALSGKNLKGEI----PPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNEL---TG----SL 224 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~----p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l---~g----~~ 224 (679)
..|+.|+|++|+|...- ...+..=+.|+.|+|++|.|+.. +- .+..-+.|+.|+|++|.. .. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 48999999999997433 33455668999999999999864 22 366667799999997643 21 12
Q ss_pred CCCCCCCCccceecccccCC
Q 005750 225 PSYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 225 p~~~~~l~~L~~L~l~~N~l 244 (679)
-..+..-+.|+.|+++.|.+
T Consensus 150 a~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCcCeEeccCCCc
Confidence 23333445677777765543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.86 E-value=0.29 Score=33.78 Aligned_cols=15 Identities=27% Similarity=0.319 Sum_probs=5.9
Q ss_pred eeechhhhhHHHHHH
Q 005750 280 ILGTSIGVLAILLVL 294 (679)
Q Consensus 280 i~~~~i~~~~~l~v~ 294 (679)
+.++++|++++++++
T Consensus 14 A~gVVgGv~~~~ii~ 28 (44)
T 2ks1_B 14 ATGMVGALLLLLVVA 28 (44)
T ss_dssp THHHHHHHHHHHHHH
T ss_pred EeehhHHHHHHHHHH
Confidence 333333344433333
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=87.72 E-value=0.36 Score=50.91 Aligned_cols=79 Identities=11% Similarity=0.071 Sum_probs=62.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCC-CCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L 237 (679)
..+|+.+.+.++ ++..-...|.++++|+.++|.++ ++.+-. .|.++++|+.++|..| ++ .|+ ..|.+|++|+.+
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKV 371 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEE
Confidence 357889998765 66344556999999999999755 666555 5999999999999877 77 555 469999999999
Q ss_pred ccccc
Q 005750 238 HIENN 242 (679)
Q Consensus 238 ~l~~N 242 (679)
+|..|
T Consensus 372 ~lp~~ 376 (394)
T 4fs7_A 372 ELPKR 376 (394)
T ss_dssp EEEGG
T ss_pred EECCC
Confidence 99765
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.53 E-value=0.28 Score=33.74 Aligned_cols=24 Identities=13% Similarity=0.483 Sum_probs=11.0
Q ss_pred eeeeechhhhhHHHHHHHhHhhhh
Q 005750 278 KLILGTSIGVLAILLVLFLCSLIV 301 (679)
Q Consensus 278 ~ii~~~~i~~~~~l~v~~~~~~~~ 301 (679)
..+.+.++|+++++++++.+++++
T Consensus 12 ~~Ia~~vVGvll~vi~~l~~~~~~ 35 (44)
T 2jwa_A 12 TSIISAVVGILLVVVLGVVFGILI 35 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHhhe
Confidence 345666666443333333333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.38 E-value=0.61 Score=32.13 Aligned_cols=15 Identities=27% Similarity=0.472 Sum_probs=5.9
Q ss_pred eeechhh-hhHHHHHH
Q 005750 280 ILGTSIG-VLAILLVL 294 (679)
Q Consensus 280 i~~~~i~-~~~~l~v~ 294 (679)
|.+.+++ ++++++++
T Consensus 12 IA~gVVgGv~~v~ii~ 27 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVG 27 (44)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHH
Confidence 3333444 44433333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.37 E-value=3.3 Score=39.41 Aligned_cols=115 Identities=12% Similarity=0.136 Sum_probs=79.1
Q ss_pred cCCCcccccccccccceEEEEEEecCCC-cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 411 HHRNLVPLIGYCEEEHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 411 ~hpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
.||++++. .+-.+++...+.++.-+.+ ++.. + ...+...+++++.+|+....+++. -+|--|+|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888866 4555566656656554322 3332 2 347788899999999988866653 4788899999
Q ss_pred ccccCCCcEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 561 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~ 561 (679)
++++.++.+++.-.|+... ++|. ..+...=.-.+=|++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999986664322 2222 22334445567889999999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 679 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-67
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 418
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 536
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 537 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-65
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-64
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-64
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 7e-64
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 422
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 423 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 476
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 477 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 530
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 531 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 580
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 581 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 634
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 635 I 635
+
Sbjct: 303 M 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 6e-63
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 354 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 409
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 410 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 530 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 564
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 421 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 540 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 599
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 600 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-60
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 541 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 600
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 601 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 3e-59
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 351 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 401
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 402 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 446
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 447 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 500
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 501 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 560 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 619
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 620 PKMQEIVLAIQ 630
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 417
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 478 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 535
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-58
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 361 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 417
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 418 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 474 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 2e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 360 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 539 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 599 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 5e-58
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 353 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 397
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 398 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 456
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 457 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 517 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 571
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 632 SIK 634
I+
Sbjct: 290 MIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-58
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 353 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 405
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 406 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 465
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 466 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 523
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 524 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 584 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 416
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 417 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 474 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-57
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 355 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 409
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 410 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 525
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 5e-57
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 418
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 535
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 363 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 536
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 537 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 625
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 5e-56
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 416
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 534
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 535 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 418
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 539 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 598
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 599 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 361 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 412
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 457
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 516
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-55
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 482 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 541
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 542 DVYSFGVVLLELISGKKP 559
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-55
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 360 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 414
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 415 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 461
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 462 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 521
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 522 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 582 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 9e-54
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 361 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 412
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 413 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 452
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 453 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 513 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 571
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 361 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 413
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 531
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-53
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 351 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 408
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 409 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 527
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 528 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 557
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 361 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 415
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 361 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 413
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 466
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 467 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 525
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 526 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 1e-50
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 482 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 540 KSDVYSFGVVLLELISGKKP 559
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 2e-50
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 482 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 540 KSDVYSFGVVLLELISGKKP 559
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-50
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 363 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 416
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 626
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-49
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 361 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 416
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 535
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-49
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 361 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 412
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 413 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 458
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 459 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 517
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 518 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 577
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-48
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 361 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 410
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 411 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 457
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 458 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 517
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 518 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 577 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 630
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 41/200 (20%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 482 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 540 KSDVYSFGVVLLELISGKKP 559
+D++S G ++ L+SG P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 2e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 418
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 419 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 532
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 1e-45
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 411
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 412 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 532 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 559
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-45
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 360 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 417
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 418 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 477
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 478 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
I+HRD+K N+L D + + +SDFGLS+ + ++ GT GY+ PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ ++ D +S GV+ L+ G P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (415), Expect = 2e-45
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 359 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 409
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 410 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 470 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 529
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 530 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 578
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-45
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 415
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 476 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 535
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 536 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 582
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 7e-45
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 418
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 539 EKSDVYSFGVVLLELISGKKP 559
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 2e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 422 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 481 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 531
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 4e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 420
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 540
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 541 SDVYSFGVVLLELISGKKP 559
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 5e-43
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 422 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 481
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 482 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 530
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 531 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 7e-43
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 355 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 413
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 414 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 467
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 468 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 526
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 527 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 559
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 540 KSDVYSFGVVLLELISGKKP 559
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-42
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 363 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 415
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 472
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 473 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 533 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 583
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 416
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 535
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 536 QLTEKSDVYSFGVVLLELISGKKP 559
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 420
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 421 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 480
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 481 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 537
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 538 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 420
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 421 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 477 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 479
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 480 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 539
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 540 KSDVYSFGVVLLELISGKKP 559
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 415
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 416 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 475
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 476 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 531
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 416
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 417 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 536
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 537 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 413
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 474 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 532
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 533 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 574
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 5e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 418
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 419 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 539 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 576
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 419
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 420 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 471
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 472 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 528
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 529 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 572
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 420 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 478
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 479 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 538
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 539 EKSDVYSFGVVLLELISGKKP 559
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 361 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 418
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 419 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 476
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 477 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 534
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 363 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 413
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 414 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 531
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 532 YGNQQLTEKSDVYSFGVVLLELISGKKP 559
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 420 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 474
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 475 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 534
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 535 QQLTEKSDVYSFGVVLLELISGKKP 559
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 363 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 419
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 420 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 473
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 474 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 533
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 534 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 570
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 6e-31
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 363 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 421
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 422 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 522
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 523 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 412
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 413 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 468
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 469 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 150 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 209
+ +T + L N+ P + ++ L L+ N ++ ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 210 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242
+ + +N+++ P + +L + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 6e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 183 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 243 SFVGEIPPALLT 254
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 5/78 (6%)
Query: 165 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 224
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 225 PSYMGSLPNLQELHIENN 242
P + +L L ++ + NN
Sbjct: 83 P--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 182 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 242 NSFVGEIPPALLT 254
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 219
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274
Query: 220 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 259
++ P S + +L NL L + N+ P + LT
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 260 KYDNN 264
+ NN
Sbjct: 335 FFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 183 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 242
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 243 SFVGEIP 249
P
Sbjct: 252 QISNLAP 258
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.7 bits (148), Expect = 7e-11
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 145 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 204
+ + + L + G +P L ++ L L + N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 205 SRLIDLRIVHLENN-ELTGS-LPS 226
L + NN L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 9/141 (6%)
Query: 120 QDVMVLEALR-SISDESERT--NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG 175
QD L ++ + + + + D C W V C T R+ + LSG NL
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 176 --EIPPELKNMEALTELWLDG--NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 231
IP L N+ L L++ G N + P +++L L +++ + ++G++P ++ +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 232 PNLQELHIENNSFVGEIPPAL 252
L L N+ G +PP++
Sbjct: 125 KTLVTLDFSYNALSGTLPPSI 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 214 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 267
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 191 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 249
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 4e-08
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 154 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 212
C + S L+ ++P +L L L N +T D L +L
Sbjct: 9 QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 213 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 264
+ L NN+++ P L L+ L++ N E+P + + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 196
PP +T++ L G + LK + L +L L N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 197 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 247
L ++ +++V+L NN ++ P Y + + + +N E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 248 IPPA 251
I P+
Sbjct: 289 IQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.3 bits (85), Expect = 0.004
Identities = 13/81 (16%), Positives = 28/81 (34%), Gaps = 3/81 (3%)
Query: 172 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 231
++ + L M + + L + + + +T ++P G
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLP 170
Query: 232 PNLQELHIENNSFVGEIPPAL 252
P+L ELH++ N +L
Sbjct: 171 PSLTELHLDGNKITKVDAASL 191
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 152 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 211
+ PP + ++ +S L E+P L L N L +P++ + +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327
Query: 212 IVHLENNELTGSLPSYMGSLPNLQ 235
+H+E N L P S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 139 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 198
+ P + + + EI +L EL + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 199 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 252
LP + L + N L +P NL++LH+E N +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 212
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 4e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 168 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 210
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 211 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 247
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 178 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 238 HIEN 241
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 202 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 254
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 187 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 240
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 241 NNSFVGEIPPALLTG 255
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)
Query: 143 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 202
D C P + C+ + L E LTEL+++ L
Sbjct: 3 DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48
Query: 203 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 258
+ L +LR + + + L P P L L++ N+ + + G
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 259 FKYDNNP 265
NP
Sbjct: 108 LVLSGNP 114
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 175 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 234
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 235 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 268
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 180 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 240 ENNSFVGEIPPALLT 254
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.8 bits (89), Expect = 0.001
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 352 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 410
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 411 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 469
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 470 EYLHTGCNPGIIHRD 484
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 29/112 (25%)
Query: 168 LSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 218
+ GK+LK + L +++ E+ L GN +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------T 45
Query: 219 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK-YDNNPKLHK 269
E L + S +L+ + +++ + PKLH
Sbjct: 46 EAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.31 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.3 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.3 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.22 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.21 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.18 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.17 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.11 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.98 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.88 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.82 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.68 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.62 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.53 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.5 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.5 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.46 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.0 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.89 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.85 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.37 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.18 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.67 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.56 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.13 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.14 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.12 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.96 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=410.19 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=200.3
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+++.+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|+|..++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 56788999999999999999989999999997643 34578999999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...........
T Consensus 86 ~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999998753 4678999999999999999999999 99999999999999999999999999999877655444444
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... ...+.+.+ ..+... .. +
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i----~~~~~~--~~-------p 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDI----STGFRL--YK-------P 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHH----HHTCCC--CC-------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HhcCCC--CC-------c
Confidence 45689999999999999999999999999999999995 55554211 11222222 222111 11 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
......+.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223478899999999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-50 Score=412.14 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=215.5
Q ss_pred HHHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 355 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 355 ~~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
....+++.++||+|+||+||+|+++ +++.||||+++... ...+++.+|+++|++++|||||+++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3445778899999999999999987 58899999987543 345789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998754 35679999999999999999999999 999999999999999999999999999999876654
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
........|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+.+ .+..+..
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~----~i~~~~~--------- 234 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYE----LLEKDYR--------- 234 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH----HHHTTCC---------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHH----HHhcCCC---------
Confidence 4444445588999999999999999999999999999999997777652221 112222 2222211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
...+...+..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122234578999999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=409.76 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=210.9
Q ss_pred HHHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
...|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 34577889999999999999999988999999997543 345779999999999999999999998865 4579999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
++|+|.+++... ....+++..++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987643 23468999999999999999999999 99999999999999999999999999999987655444
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
......||+.|+|||++.+..++.++|||||||++|||+||..|+..... .....+. +..+... .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~~~~---------~ 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERGYRM---------V 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCC---------C
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCCC---------C
Confidence 44455689999999999988999999999999999999996665542221 1122222 2222111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.+...+..+.+++.+||+.||++||||+||++.|++...
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111233468899999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=406.21 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=207.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4677899999999999999875 699999999976555556789999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
||+|.+++.. ..+++.+++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+........
T Consensus 101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 9999998763 469999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. +........+... . ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~-~-------~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-L-------QN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-C-------SS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC-C-------CC
Confidence 33456999999999999999999999999999999999999999743321 1111222222111 0 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+......+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223357889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-49 Score=408.06 Aligned_cols=256 Identities=26% Similarity=0.454 Sum_probs=199.6
Q ss_pred HhhccccCcCccEEEEEEEEcC-C---cEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+++.+.||+|+||+||+|+++. + ..||||.+.... ....+.|.+|+++|++++|||||+++|++.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 4445789999999999998762 3 368999887543 3455789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 108 y~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 108 FMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999998874 34579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccc----cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 514 THI----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 514 ~~~----~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+...+ ..+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i----~~~~~---- 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI----EQDYR---- 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCC----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCC----
Confidence 211 112347899999999999999999999999999999998 8999974322 1222222 22211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...+...+..+.+|+.+||+.||.+|||++||++.|+++++.
T Consensus 252 -----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 -----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111223345788999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=405.00 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=203.3
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34567899999999999999875 36999998653 34456789999999999999999999998865 457999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999743 4569999999999999999999999 9999999999999999999999999999987654322
Q ss_pred -cccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 515 -HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 515 -~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+.. .+..+.....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~~~~p~~-- 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRGYLSPDL-- 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHTSCCCCG--
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcCCCCCcc--
Confidence 22344568999999999864 357999999999999999999999997432211 1111 12222111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.......+..+.+++.+||+.||.+|||++||++.|+.+..
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122334578899999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=398.71 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=211.5
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCCC
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 438 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 438 (679)
+++.++||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 45789999999999999999989999999998653 34578999999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccccc
Q 005750 439 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 518 (679)
Q Consensus 439 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~~~ 518 (679)
+|.+++... ...+++..+++++.|+++||+|||+ +||+||||||+||++++++.+||+|||+++...........
T Consensus 85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999987643 4568899999999999999999999 99999999999999999999999999999876554444444
Q ss_pred cccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCCC
Q 005750 519 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 597 (679)
Q Consensus 519 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (679)
...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+... ..+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~----~i~~~~~~---------~~p 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE----HIAQGLRL---------YRP 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH----HHHTTCCC---------CCC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH----HHHhCCCC---------CCc
Confidence 4568999999999999999999999999999999998 89999744321 1221 22222111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 598 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 598 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
...+..+.+++.+||+.||++|||++||++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12235788999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=402.52 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=202.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3677899999999999999986 69999999987543 233467899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc-c
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 514 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~-~ 514 (679)
++|+|.+++. ....+++..++.++.||++||+|||+ +||+||||||+|||+++++.+||+|||+|+...... .
T Consensus 86 ~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 86 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999997 45689999999999999999999999 999999999999999999999999999998764432 2
Q ss_pred cccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ...... .......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~----~~~~~~~-------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYL-------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH----HTTCTTS--------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH----hcCCCCC--------
Confidence 22345579999999999988776 678999999999999999999997433221 111111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122346789999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=401.34 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=205.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||+||+|+++ +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3678899999999999999986 68999999986432 2335678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|.......
T Consensus 87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999973 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ...+ .+..+.. .
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~------~-- 222 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK----RISRVEF------T-- 222 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHTTCC------C--
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC------C--
Confidence 23456999999999999999999999999999999999999999743321 1111 1122211 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+......+.+++.+||+.||++|||++|+++
T Consensus 223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11122346889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=401.11 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=193.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccc--cceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~ 432 (679)
.|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 3677899999999999999876 68999999987543 3445678999999999999999999998854 45689999
Q ss_pred EecCCCcHhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
||+++|+|.+++.... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999987533 4567999999999999999999999821 124999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .+.. .+..+....
T Consensus 165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~----~i~~~~~~~--- 233 (269)
T d2java1 165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG----KIREGKFRR--- 233 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCCC---
T ss_pred ccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHH----HHHcCCCCC---
Confidence 543322 23456899999999999999999999999999999999999999743221 1111 222232211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+ +.....++.+++.+||+.||.+|||++|+++
T Consensus 234 --~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1122346889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=402.43 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=206.2
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3677899999999999999976 689999999987666677889999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|........ .
T Consensus 93 ~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 93 GGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999987642 4579999999999999999999999 9999999999999999999999999999976543322 2
Q ss_pred cccccCCccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 517 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ... .... +.....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~-~~~~~~---- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAK-SEPPTL---- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHH-SCCCCC----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHc-CCCCCC----
Confidence 23456999999999983 4568999999999999999999999997443221 111 1111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..+......+.+++.+||+.||.+|||++|+++
T Consensus 236 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457889999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=393.20 Aligned_cols=244 Identities=29% Similarity=0.440 Sum_probs=196.8
Q ss_pred hhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc----cceEEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 432 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV~ 432 (679)
+|.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999886 6889999998653 23455679999999999999999999999854 45689999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ccccCCCCCCcccc-CCCcEEEeeccCcccc
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 509 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfgla~~~ 509 (679)
||+++|+|.+++.. ...+++..++.++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 4679999999999999999999998 77 99999999999996 5789999999999864
Q ss_pred ccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...+. ..+..+.....++
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~----~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPASFD 235 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCGGGG
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHH----HHHHcCCCCcccC
Confidence 4332 234569999999999876 589999999999999999999999973322 11111 1222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. . ...++.+++.+||++||++|||++|+++
T Consensus 236 ~----~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----c----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1 1235889999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=396.99 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=207.2
Q ss_pred hhcc-ccCcCccEEEEEEEEc---CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 360 NFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 360 ~~~~-~LG~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.+.+ +||+|+||+||+|.++ ++..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 4999999999999765 35689999997653 3456789999999999999999999999875 457999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+++|+|.+++.. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 90 AGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp CTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred CCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999998864 24679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred c--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 515 H--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 515 ~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.. .+..+....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~~----- 232 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRME----- 232 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCCC-----
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC-----
Confidence 2 2233458899999999998999999999999999999998 99999743321 2222 223332211
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 233 ----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1222345788999999999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=395.84 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=200.7
Q ss_pred cccCcCccEEEEEEEEcC---CcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecCC
Q 005750 363 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 437 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 437 (679)
++||+|+||+||+|.+++ ++.||||+++... ....+.+.+|+++|++++|||||+++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998653 5689999996532 33457899999999999999999999999654 57899999999
Q ss_pred CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc--
Q 005750 438 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 515 (679)
Q Consensus 438 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~-- 515 (679)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999973 5679999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 516 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .+.. .+..+...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~--------- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERM--------- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC---------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCCCC---------
Confidence 2233468999999999999999999999999999999998 89999743221 2222 22222211
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
..+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 112223457889999999999999999999999888754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=396.88 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=202.9
Q ss_pred HHhhccccCcCccEEEEEEEEcCC-----cEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
.+++.+.||+|+||.||+|.+++. ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 355678999999999999987642 479999987543 33456799999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+.+|++.+.+.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998764 34679999999999999999999999 9999999999999999999999999999987654
Q ss_pred Ccc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 512 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 512 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+. +..+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~~~----- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----INDGFR----- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----HHTTCC-----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH----HhccCC-----
Confidence 322 222334589999999999999999999999999999999997666642221 1122222 222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
...+...+..+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 112223345789999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=408.97 Aligned_cols=269 Identities=22% Similarity=0.331 Sum_probs=206.5
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
...|++.++||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.++++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 345777899999999999999976 68999999987543 3445789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|++||+|.+++.+ ...+++..+..++.|++.||.|||+ .+||+||||||+|||++.++.+||+|||+|.......
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999974 4579999999999999999999997 1489999999999999999999999999998764322
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHH-HHHHhHhc--------CC-
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH-WARSMIKK--------GD- 583 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~~~~--------~~- 583 (679)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+......... ........ ..
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234579999999999999999999999999999999999999997544321110000 00000000 00
Q ss_pred -------------eeeeecccc---cCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 005750 584 -------------VISIVDPVL---IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 632 (679)
Q Consensus 584 -------------~~~~~d~~l---~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 632 (679)
..+..+... .... ......++.+++.+||+.||.+|||++|+++ .+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000000000 0000 0011246889999999999999999999987 46543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=397.33 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=204.4
Q ss_pred HHHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
..+++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 457889999999999999999998889999999754 3345789999999999999999999999865 45789999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999988754 24569999999999999999999999 999999999999999999999999999998765544444
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 596 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (679)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+..... .......+. .+... ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~----~~~~~---------~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE----RGYRM---------PC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTCCC---------CC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH----hcCCC---------CC
Confidence 4445689999999999999999999999999999999997666652221 122222222 12111 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 597 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 597 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
+.....++.+++.+||+.||++|||+++|+++|++...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 22234578899999999999999999999999998665
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=399.63 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4778999999999999999986 69999999986432 2344678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 y~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999998873 5679999999999999999999999 999999999999999999999999999998765432
Q ss_pred -ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 514 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 514 -~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+. .. +..+.. .+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~---~~-i~~~~~------~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF---QK-IIKLEY------DF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HHTTCC------CC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH---HH-HHcCCC------CC
Confidence 22233456999999999999999999999999999999999999999743221 111 11 112211 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
+......+.+||.+||+.||.+|||++|+++
T Consensus 230 ----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 ----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1122346889999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=397.49 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=190.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
..|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34788999999999999999986 68999999997543 23346688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCcccccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~~~~ 511 (679)
|+||+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+||++. +++.+||+|||+|+....
T Consensus 89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999997 35679999999999999999999999 9999999999999994 578999999999987644
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 591 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 591 (679)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .... +... ...
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~~-~~~~--~~~- 230 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFE---QILK-AEYE--FDS- 230 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHT-TCCC--CCT-
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---HHhc-cCCC--CCC-
Confidence 322 23456999999999999999999999999999999999999999743221 1111 1111 1110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 592 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 592 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+++.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 ---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111222346889999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=402.36 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=206.6
Q ss_pred HHHHhhccccCcCccEEEEEEEEcC------CcEEEEEEecCC-cchhHHHHHHHHHHHHhc-cCCCcccccccccccce
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 427 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 427 (679)
...+++.+.||+|+||+||+|++.. ...||+|++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3457789999999999999998753 236999998654 334456789999999998 89999999999999999
Q ss_pred EEEEEEecCCCcHhhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCC
Q 005750 428 RILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 487 (679)
Q Consensus 428 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp 487 (679)
.++|||||++|+|.++++.... ...+++..++.++.||++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999975421 2358999999999999999999999 9999999999
Q ss_pred CCccccCCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccc
Q 005750 488 SNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 565 (679)
Q Consensus 488 ~NIll~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~ 565 (679)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2234457999999999999999999999999999999998 8999974433
Q ss_pred cchhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 005750 566 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 631 (679)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 631 (679)
.. .+.+ .+..+.. ...+...+..+.+|+.+||+.||++|||++||++.|..
T Consensus 273 ~~--~~~~----~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DA--NFYK----LIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SH--HHHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHH----HHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 2222 2222211 11122234578999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=392.25 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred HHHhhccccCcCccEEEEEEEEcC----CcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
..|++.+.||+|+||.||+|++.. +..||||.++... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 457788999999999999998753 4578999986543 3345679999999999999999999999964 578999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998764 35679999999999999999999999 9999999999999999999999999999987665
Q ss_pred CcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
..........||+.|+|||++.+..++.++|||||||++|||++ |.+||...... .+... +..+....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~~---- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLP---- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCCC----
Confidence 44444445568999999999999999999999999999999998 89999744332 22222 22222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
.+...+..+.+|+.+||+.||++|||++||++.|+.+++.++
T Consensus 230 -----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 230 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 122234578999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-47 Score=400.76 Aligned_cols=250 Identities=21% Similarity=0.350 Sum_probs=208.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4778899999999999999875 799999999987666667788999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc--CCCcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfgla~~~~~~~~ 514 (679)
||+|.+.+.. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|........
T Consensus 110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988764 34579999999999999999999999 9999999999999997 678999999999988755432
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.. .... . +..+... +..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~---~-i~~~~~~--~~~---- 249 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---N-VKRCDWE--FDE---- 249 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHHCCCC--CCS----
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCC--CCc----
Confidence 23456899999999999999999999999999999999999999743322 1111 1 1111111 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.........+.+|+.+||+.||.+|||++|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222346889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-47 Score=401.31 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=208.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5788899999999999999876 699999999987766667889999999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc--CCCcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~Dfgla~~~~~~~~ 514 (679)
||+|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999864 24569999999999999999999999 9999999999999995 468899999999987654432
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. .. ...... +... ++...
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~---~~~i~~-~~~~--~~~~~-- 248 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET---LRNVKS-CDWN--MDDSA-- 248 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHH-TCCC--SCCGG--
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCCC--CCccc--
Confidence 23456899999999999999999999999999999999999999744321 11 111111 1110 00111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......+.+++.+||+.||++|||++|+++.
T Consensus 249 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 --FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223468899999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-47 Score=392.52 Aligned_cols=246 Identities=28% Similarity=0.373 Sum_probs=202.0
Q ss_pred HHHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
...|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345777899999999999999876 68999999987543 23446789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
||||.+|+|..++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999977665 35679999999999999999999999 9999999999999999999999999999987544
Q ss_pred CcccccccccCCccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 512 DLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +........ ......
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~~~~ 235 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPALQ 235 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCS
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CCCCCC
Confidence 2 23469999999999864 46899999999999999999999999733221 111122221 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 589 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 589 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ......+.+++.+||+.||.+|||++|+++
T Consensus 236 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112346889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=388.22 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=199.3
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc-cceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~ 436 (679)
.+++.+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3567899999999999999986 789999999754 345779999999999999999999998854 566899999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcccc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 516 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~~ 516 (679)
+|+|.+++... ....+++..+++++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999999743 23458999999999999999999999 999999999999999999999999999998754432
Q ss_pred cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccCC
Q 005750 517 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 595 (679)
Q Consensus 517 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 595 (679)
....++..|+|||++.+..+++++|||||||++|||+| |+.||..... ..+...+ .++....
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~~~~--------- 220 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMD--------- 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCC---------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCC---------
Confidence 23347889999999998899999999999999999998 7888763322 2233322 2222111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 596 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 596 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+......+.+++.+||+.||.+|||++||+++|++++.-
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1222335788999999999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=390.31 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=204.3
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc------chhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
..|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35778899999999999999985 79999999986432 123578999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC----cEEEeeccC
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGL 505 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfgl 505 (679)
+|||||++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999974 4579999999999999999999999 9999999999999998776 599999999
Q ss_pred ccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 506 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 506 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+... ... . +..+...
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~-i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---N-VSAVNYE 234 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHTTCCC
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH---H-HHhcCCC
Confidence 987654322 233468999999999999999999999999999999999999997433211 111 1 1111110
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. .+.... .....+.+++.+||+.||.+|||++|+++
T Consensus 235 ~--~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 F--EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000001 12346789999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=391.90 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=204.8
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 678899999999999999975 79999999997532 23457788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++||+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999884 5678999999999999999999999 9999999999999999999999999999987544322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. .+.+ .+..+.. .+..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~----~i~~~~~------~~p~ 226 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------RFPR 226 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CCCT
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH----HHhcCCC------CCCc
Confidence 233456999999999999999999999999999999999999999854321 1111 1222211 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
. ....+.+||.+||++||.+||+ ++|+++
T Consensus 227 ~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 T----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp T----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2 2346789999999999999995 788876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=390.14 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=208.1
Q ss_pred HHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCcc-hhHHHHHHHHHHHHhccCCCcccccccccccceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 430 (679)
.+++.+.||+|+||+||+|+++ +++.||||+++.... ...+++.+|++++++++||||+++++++...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4677899999999999999875 357899999976443 345679999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCC
Q 005750 431 VYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 489 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 489 (679)
+|||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 999999999999986421 13358999999999999999999999 999999999999
Q ss_pred ccccCCCcEEEeeccCccccccCc-ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCcccccc
Q 005750 490 ILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGA 567 (679)
Q Consensus 490 Ill~~~~~~kL~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~-~pf~~~~~~~ 567 (679)
||++.++.+||+|||+|+...... ........+++.|+|||.+.+..++.++|||||||++|||++|. +||...+.
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999998654332 22233456889999999999999999999999999999999986 56653222
Q ss_pred hhhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 005750 568 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 633 (679)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 633 (679)
..+.. .+..+..... +...+..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 249 -~e~~~----~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EEVIY----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHHH----HHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 12222 2233332211 1223347889999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-46 Score=386.23 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=203.9
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
|++.+.||+|+||+||+|+++ +|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 677899999999999999986 69999999986432 23456789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
++||+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCcccccccc---ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999887 45678899999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. +....... +.. .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~-~~~------~--- 219 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN-AEL------R--- 219 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-CCC------C---
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHc-CCC------C---
Confidence 3456999999999999999999999999999999999999999743221 11112221 111 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 628 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 628 (679)
.+......+.+++.+||+.||.+|| |++|+++.
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1112234688999999999999996 89999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-46 Score=380.18 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=202.0
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccc----eEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~ 429 (679)
.|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4778899999999999999875 79999999997543 234567899999999999999999999986643 478
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||++||+|.+++.. ...+++.+++.++.||+.||+|||+ +||+||||||+|||++.++..+++|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998873 4679999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcc--cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 510 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 510 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
..... .......||+.|+|||++.+..+++++|||||||++|||+||+.||...+. .+.....+.......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP- 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCC-
Confidence 33222 223345699999999999999999999999999999999999999974322 122222333222111
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 633 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 633 (679)
.... ...+..+.+++.+||++||.+|| |++++++.|.++.
T Consensus 235 --~~~~----~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 --SARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GGTS----SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --chhc----cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111 12234688999999999999999 8999999888764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=387.04 Aligned_cols=255 Identities=23% Similarity=0.413 Sum_probs=202.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCc----EEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccccceEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
.|++.+.||+|+||+||+|.+. +|+ +||+|.++.. .....+++.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 3677899999999999999875 343 6899988654 334567899999999999999999999999875 46788
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
+|++.+|+|.+.+.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998875 35679999999999999999999999 9999999999999999999999999999987654
Q ss_pred Cccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeeeeec
Q 005750 512 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 589 (679)
Q Consensus 512 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 589 (679)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+..... +... +..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~~~~~---- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERL---- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHHTCCC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC----
Confidence 3322 2233458999999999999999999999999999999998 889987443322 2222 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 590 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 590 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
..+...+..+.+|+.+||+.||.+|||++||++.|+.+..
T Consensus 233 -----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1122234578899999999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.09 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=205.7
Q ss_pred hhccccCcCccEEEEEEEEcC----CcEEEEEEecCC-cchhHHHHHHHHHHHHhccCCCcccccccccc-cceEEEEEE
Q 005750 360 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 433 (679)
Q Consensus 360 ~~~~~LG~G~~g~Vy~a~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E 433 (679)
+|.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|+++|++++||||++++|++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999998753 236899999753 34456789999999999999999999999765 568899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+++|+|.+++... ...+++..+++++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998753 5567888999999999999999999 999999999999999999999999999998765432
Q ss_pred cc---ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 514 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 514 ~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ...+..+ +..+.... .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~----i~~g~~~~--~- 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY----LLQGRRLL--Q- 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCCC--C-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHcCCCCC--C-
Confidence 22 22234689999999999999999999999999999999998888763221 1112221 12222111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+...+..+.+++.+||+.||++||+|+||++.|+++...
T Consensus 256 ------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112234788999999999999999999999999999763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=385.52 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=200.1
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCcccccccccc-cc
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-EH 426 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~ 426 (679)
...|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.. +.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 346788999999999999999864 24689999997543 34456788888888887 68999999998765 45
Q ss_pred eEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
..++|||||++|+|.++++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 6899999999999999997532 13458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCcccccchhhH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNI 571 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~-~pf~~~~~~~~~~~ 571 (679)
+++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...... ..+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 9999999999999875443322 233456899999999999999999999999999999999964 577533222 112
Q ss_pred HHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
. ..+..+..... +......+.+++.+||+.||++|||++||++.|+++++.
T Consensus 247 ~----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 C----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp H----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2 22222322111 112234688999999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=383.91 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=208.1
Q ss_pred HHHhhccccCcCccEEEEEEEEcC--------CcEEEEEEecCCcc-hhHHHHHHHHHHHHhc-cCCCcccccccccccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 426 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 426 (679)
..|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 357788999999999999998642 35799999976543 4457888999999888 7999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 493 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 493 (679)
..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997543 13468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccCccccccCccc-ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhH
Q 005750 494 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 571 (679)
Q Consensus 494 ~~~~~kL~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~ 571 (679)
.++.+||+|||+++........ ......+++.|+|||.+.++.+++++|||||||++|||++ |+.||...... .+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence 9999999999999876554332 2334568899999999999999999999999999999998 78888633221 12
Q ss_pred HHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 572 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
. ..+..+..... +...+..+.+|+.+||+.||.+|||++||++.|+++...
T Consensus 247 ~----~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 F----KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp H----HHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2 22333322111 112234688999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=378.89 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=197.4
Q ss_pred HHHhhccccCcCccEEEEEEEEcC--C--cEEEEEEecCC---cchhHHHHHHHHHHHHhccCCCcccccccccccceEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 429 (679)
..|++.+.||+|+||.||+|+++. + ..||||++.+. .....+.|.+|+++|++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 346788999999999999998652 2 47899998654 233457899999999999999999999999764 678
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+||||+++|++.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887753 4569999999999999999999999 99999999999999999999999999999986
Q ss_pred ccCccc--ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccchhhHHHHHHHhHhcCCeee
Q 005750 510 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 586 (679)
Q Consensus 510 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (679)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+.. .. .....+.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~---~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI---LHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HH---HHHHHhCCCCCC
Confidence 544332 2233457889999999999999999999999999999998 89999743221 12 222222222111
Q ss_pred eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 005750 587 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 632 (679)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 632 (679)
.+...+..+.+|+.+||+.||++|||++||++.|++.
T Consensus 236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122234788999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=382.45 Aligned_cols=264 Identities=29% Similarity=0.425 Sum_probs=212.6
Q ss_pred HHHHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhc-cCCCccccccccccc
Q 005750 354 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 425 (679)
Q Consensus 354 l~~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 425 (679)
+....+++.++||+|+||.||+|++. +++.||||+++... ......+.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 33456778999999999999999863 46789999997643 34556789999999999 699999999999999
Q ss_pred ceEEEEEEecCCCcHhhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCc
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 490 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 490 (679)
+..++||||+++|+|.++++... ....+++..+..++.||++||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999997542 23368999999999999999999999 9999999999999
Q ss_pred cccCCCcEEEeeccCccccccCcc-cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcccccch
Q 005750 491 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 568 (679)
Q Consensus 491 ll~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~ellt-G~~pf~~~~~~~~ 568 (679)
+++.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987655433 22334568999999999999999999999999999999999 55555422221
Q ss_pred hhHHHHHHHhHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 569 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
..+.+. +..+.. ...+...+..+.+|+.+||+.||.+||||+||+++|++.+..
T Consensus 255 ~~~~~~----i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYKM----IKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH----HhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112222 222211 111122335789999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-45 Score=374.35 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=202.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---------hhHHHHHHHHHHHHhcc-CCCcccccccccccc
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 426 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 426 (679)
.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 4667899999999999999875 799999999865321 12346889999999997 999999999999999
Q ss_pred eEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCc
Q 005750 427 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 506 (679)
Q Consensus 427 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla 506 (679)
..|+||||+++|+|.++++. ...+++..++.++.||++||+|||+ +||+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999974 4579999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcccccccccCCccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHh
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 580 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 580 (679)
+....... .....||+.|+|||.+. ...++.++||||+||++|+|++|+.||...... ... ..+.
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~----~~i~ 228 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LML----RMIM 228 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHH----HHHH
Confidence 87655332 23456999999999874 345788999999999999999999999843321 111 1111
Q ss_pred cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 581 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+... ...........++.+++.+||++||++|||++||++
T Consensus 229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 011111223357889999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.37 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=205.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCc--EEEEEEecCC-cchhHHHHHHHHHHHHhc-cCCCcccccccccccceEEEE
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV 431 (679)
..+++.+.||+|+||.||+|+++ +|. .||||++... .....+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 44567899999999999999886 344 5788887643 333556799999999999 799999999999999999999
Q ss_pred EEecCCCcHhhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcE
Q 005750 432 YEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 498 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 498 (679)
|||+++|+|.++++.. .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999753 134679999999999999999999999 999999999999999999999
Q ss_pred EEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCC-CCCcccccchhhHHHHHHH
Q 005750 499 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARS 577 (679)
Q Consensus 499 kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~-pf~~~~~~~~~~~~~~~~~ 577 (679)
||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||...+ ...+.+
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE---- 237 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH----
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHH----
Confidence 99999999865443322 23458999999999999999999999999999999999764 565222 112222
Q ss_pred hHhcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 578 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
.+..+... ..+...+..+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 238 ~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12222111 11222345788999999999999999999999999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=379.42 Aligned_cols=256 Identities=20% Similarity=0.195 Sum_probs=195.8
Q ss_pred ccccCcCccEEEEEEEEc-CCcEEEEEEecCCcch-----hHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 362 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999976 6999999998653221 1346889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
.++++..+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9888877665 45678999999999999999999999 99999999999999999999999999999876554322
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeec-----
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD----- 589 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 589 (679)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ....+.............+
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 223468999999999865 467999999999999999999999997443221 1111111111100000000
Q ss_pred ----ccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 590 ----PVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 590 ----~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.......+ ......+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000011 112346889999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=379.69 Aligned_cols=249 Identities=19% Similarity=0.298 Sum_probs=203.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEecC
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 436 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 436 (679)
.|++.+.||+|+||+||+|.++ +|+.||||+++... .....+.+|+++|++++||||+++++++.+++..|+|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3677899999999999999986 68999999997653 344668899999999999999999999999999999999999
Q ss_pred CCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC--CCcEEEeeccCccccccCcc
Q 005750 437 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 437 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~Dfgla~~~~~~~~ 514 (679)
||+|.+++... +..+++.+++.++.||+.||+|||+ +||+||||||+|||++. ...+||+|||++........
T Consensus 85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999742 3479999999999999999999999 99999999999999985 45899999999987654322
Q ss_pred cccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccccC
Q 005750 515 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 594 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 594 (679)
.....+++.|+|||.+.+..++.++||||+||++|+|++|+.||...... .. ...... +... ++.....
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~---~~~i~~-~~~~--~~~~~~~ 228 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI---IENIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHH-TCCC--CCHHHHT
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCCC--CChhhcc
Confidence 23345899999999999999999999999999999999999999743321 11 111111 1110 0000011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 595 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 595 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ....+.+++.+||+.||.+|||++|+++
T Consensus 229 ~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 E----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1236789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-45 Score=386.22 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=203.7
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 433 (679)
.|++.+.||+|+||.||+|+++ +|+.||||++.+.. ....+.+.+|+++|+.++||||+++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5777899999999999999986 79999999986432 2334678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCc
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 513 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~ 513 (679)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999874 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeeccccc
Q 005750 514 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 593 (679)
Q Consensus 514 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 593 (679)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.. .. ..... .+.. ..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~---~~~i~-~~~~------~~- 257 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI---YEKIV-SGKV------RF- 257 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHH-HCCC------CC-
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HH---HHHHh-cCCC------CC-
Confidence 2356999999999999999999999999999999999999999743221 11 11111 1211 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005750 594 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 627 (679)
Q Consensus 594 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 627 (679)
+......+.+++.+||+.||.+|+ |++|+++
T Consensus 258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112234688999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=383.15 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=201.3
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc---chhHHHHHHHHHHHH-hccCCCcccccccccccceEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVY 432 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lV~ 432 (679)
.|++.+.||+|+||+||+|+++ +|+.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3677899999999999999886 69999999996532 223456667777765 689999999999999999999999
Q ss_pred EecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccC
Q 005750 433 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 433 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~ 512 (679)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999984 4578999999999999999999999 99999999999999999999999999999875543
Q ss_pred cccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecccc
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 592 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 592 (679)
... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. .+.. .+..+.. ..
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~----~i~~~~~------~~ 222 (320)
T d1xjda_ 157 DAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH----SIRMDNP------FY 222 (320)
T ss_dssp TCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC
T ss_pred ccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCC------CC
Confidence 322 33456999999999999999999999999999999999999999743321 1111 1222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005750 593 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 627 (679)
Q Consensus 593 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 627 (679)
+......+.+|+.+||+.||.+|||+. |+++
T Consensus 223 ----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112234688999999999999999996 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=381.47 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=196.3
Q ss_pred HHhhc-cccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhc-cCCCcccccccccc----cceEEE
Q 005750 358 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRIL 430 (679)
Q Consensus 358 ~~~~~-~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~l 430 (679)
.|.+. +.||+|+||+||+|++. +++.||||++++. ..+.+|++++.++ +||||++++++|.+ +...|+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 35555 46999999999999875 6899999998643 4577899987665 89999999999865 567899
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC---CCcEEEeeccCcc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 507 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~Dfgla~ 507 (679)
|||||+||+|.+++... ....+++.+++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 87 vmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999743 24579999999999999999999999 99999999999999975 5679999999998
Q ss_pred ccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 508 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 508 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+...... ...+...+..+..
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY--- 234 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC---
Confidence 7654332 2345699999999999999999999999999999999999999974332211 1111111111110
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.............+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000111223457899999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=377.15 Aligned_cols=269 Identities=26% Similarity=0.357 Sum_probs=201.0
Q ss_pred HhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccccc----eEEEEEEe
Q 005750 359 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 434 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lV~E~ 434 (679)
+.+.+.||+|+||.||+|+++ |+.||||+++... ........|+..+.+++||||+++++++.+++ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 446789999999999999974 8999999986432 21222334555556789999999999997643 68999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
+++|+|.++++. ..+++..+++++.|++.||+|||+. ..++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999974 4699999999999999999999962 1369999999999999999999999999999876
Q ss_pred ccCccc---ccccccCCccccCCcccCCCC------CCchhHHHHHHHHHHHHHhCCCCCCcccccch--------hhHH
Q 005750 510 EEDLTH---ISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIV 572 (679)
Q Consensus 510 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvll~elltG~~pf~~~~~~~~--------~~~~ 572 (679)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543322 223456999999999987643 57799999999999999999988753221100 0111
Q ss_pred HHHHHhHhcCCeeeeecccccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 005750 573 HWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 637 (679)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 637 (679)
+........+.. +|.+.... ..+....+.+++.+||+.||++|||+.||++.|+++...+.
T Consensus 239 ~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 112222221111 12111111 23456679999999999999999999999999999887543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=385.09 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=196.7
Q ss_pred HhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc---hhHHHHHH---HHHHHHhccCCCcccccccccccceEEEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 431 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 431 (679)
|++.+.||+|+||.||+|+.. +|+.||||++.+... .....+.+ |+++++.++|||||++++++.+++..|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 667899999999999999986 699999999864321 11223344 46667777899999999999999999999
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 5678999999999999999999999 9999999999999999999999999999987654
Q ss_pred CcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeeecc
Q 005750 512 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 590 (679)
Q Consensus 512 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 590 (679)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..........+. .. ..... .
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~-~~~~~------~ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RM-TLTMA------V 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HH-SSSCC------C
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-cccCC------C
Confidence 32 234569999999999864 56899999999999999999999999754433221111 11 11110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 591 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 591 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
.. +......+.++|.+||+.||.+||| ++|+++
T Consensus 227 ~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 1122346889999999999999999 688875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=379.63 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=210.4
Q ss_pred HHHHhhccccCcCccEEEEEEEEc------CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccceE
Q 005750 356 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 356 ~~~~~~~~~LG~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 428 (679)
...+++.++||+|+||+||+|.++ +++.||||+++... ......+.+|++++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 345678899999999999999874 25789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEe
Q 005750 429 ILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 501 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 501 (679)
++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+ ++|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999886431 23457899999999999999999999 999999999999999999999999
Q ss_pred eccCccccccCcccc-cccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCcccccchhhHHHHHHHhH
Q 005750 502 DFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMI 579 (679)
Q Consensus 502 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~ 579 (679)
|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||+||. .||.... ..+.... +
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~-i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRF-V 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHH-H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHH-H
Confidence 999998765443322 23345899999999999999999999999999999999985 6665321 1122222 2
Q ss_pred hcCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 005750 580 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 634 (679)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 634 (679)
.++..... +...+..+.+++.+||+.+|.+|||++||++.|++.++
T Consensus 249 ~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22222111 11223479999999999999999999999999988755
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-44 Score=369.92 Aligned_cols=260 Identities=18% Similarity=0.261 Sum_probs=199.5
Q ss_pred HHhhccccCcCccEEEEEEEEcCCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.++||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|++++||||+++++++..++..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 3567889999999999999999999999999965432 23578999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 515 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~~ 515 (679)
.++.+..+.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp SEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 8877777665 45789999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---ee---e--
Q 005750 516 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI---S-- 586 (679)
Q Consensus 516 ~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~---~-- 586 (679)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.+ +........ .. .
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCChhhccchhhhh
Confidence 233358899999999865 456899999999999999999999997433221 1111 111111000 00 0
Q ss_pred -------eecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 587 -------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 587 -------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...+.............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000111122346889999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=370.09 Aligned_cols=263 Identities=20% Similarity=0.274 Sum_probs=197.4
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc--hhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|++++++++||||+++++++.+++..|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 3566789999999999999975 799999999965432 2356789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.++ +.+.+... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||.|+.......
T Consensus 83 ~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 83 LHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred cCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9765 44444322 35679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccccCCccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc--CCeeeee-cc
Q 005750 515 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVISIV-DP 590 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-d~ 590 (679)
. .....||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+..+ .+.......... ....... .+
T Consensus 158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccc
Confidence 2 33346899999999876655 5889999999999999999999997433211 111111111000 0000000 00
Q ss_pred cccC------CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 591 VLIG------NV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 591 ~l~~------~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.... .. .......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00 01122468899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=369.03 Aligned_cols=238 Identities=25% Similarity=0.395 Sum_probs=194.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcc------hhHHHHHHHHHHHHhcc--CCCcccccccccccceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~ 428 (679)
.|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ ||||+++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4678899999999999999876 789999999864321 12234678999999996 89999999999999999
Q ss_pred EEEEEecCC-CcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-CCcEEEeeccCc
Q 005750 429 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 506 (679)
Q Consensus 429 ~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfgla 506 (679)
++||||+.+ +++.+++.. ...+++..++.++.||++||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 678888763 4679999999999999999999999 99999999999999985 579999999999
Q ss_pred cccccCcccccccccCCccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCee
Q 005750 507 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 585 (679)
Q Consensus 507 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (679)
....... .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.... .+ .+ +..
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~-~~~- 221 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IR-GQV- 221 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HH-CCC-
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hh-ccc-
Confidence 8654332 234569999999999977655 678999999999999999999997321 11 11 111
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
...... ..++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111122 246889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=365.46 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=196.5
Q ss_pred HHHhhccccCcCccEEEEEEEEc-C-CcEEEEEEecCCcc--hhHHHHHHHHHHHHhc---cCCCccccccccc-----c
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----E 424 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~ 424 (679)
..|++.++||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+++.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 35778899999999999999874 4 67799999864322 2234566788887776 7999999999884 3
Q ss_pred cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeecc
Q 005750 425 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 504 (679)
Q Consensus 425 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 504 (679)
....+++|||+.++.+...... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 4578999999998877554432 45678999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 505 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 505 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+. +.. +.........
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~~~~~~ 236 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLPGE 236 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCG
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCch
Confidence 988654332 23445699999999999999999999999999999999999999974432211 111 1111110000
Q ss_pred eee------ec-------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 585 ISI------VD-------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 585 ~~~------~d-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
... .. ..............+.+|+.+||++||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 000001111223467899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=361.10 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=194.8
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCC--cchhHHHHHHHHHHHHhccCCCcccccccccc--------c
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 425 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 425 (679)
..|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 35677899999999999999975 7999999998543 23345678899999999999999999998744 4
Q ss_pred ceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccC
Q 005750 426 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 505 (679)
Q Consensus 426 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgl 505 (679)
+..++||||+.++.+..... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46899999998877765544 45678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc---cccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhc
Q 005750 506 SRQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 581 (679)
Q Consensus 506 a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 581 (679)
+........ .......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+.+..... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCC
Confidence 976543221 122234689999999998765 6899999999999999999999999744322211 111111111
Q ss_pred ---CCeee--------eecccccCCCCHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 582 ---GDVIS--------IVDPVLIGNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 582 ---~~~~~--------~~d~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
..... .+........... ....+.+|+.+||++||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000 0000000011111 1225678999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=367.02 Aligned_cols=265 Identities=24% Similarity=0.250 Sum_probs=195.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccccccccc------cceEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 430 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~l 430 (679)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4666789999999999999986 699999999975432 23479999999999999999998843 335789
Q ss_pred EEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCcccc
Q 005750 431 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 509 (679)
Q Consensus 431 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~ 509 (679)
||||++++.+............+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544443322356689999999999999999999999 9999999999999999765 8999999999876
Q ss_pred ccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHH-----------H
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-----------S 577 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-----------~ 577 (679)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+ .+..... .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 54332 233468999999998765 578999999999999999999999997443221 1111111 0
Q ss_pred hHh---cCCeeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 005750 578 MIK---KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 633 (679)
Q Consensus 578 ~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 633 (679)
... .......................+.+|+.+||+.||++|||++|+++. ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 000000000000001112233468899999999999999999999863 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=358.37 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=193.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc-chhHHHHHHHHHHHHhccCCCcccccccccccc----eEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILV 431 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lV 431 (679)
.|++.++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3667899999999999999875 79999999997543 344568899999999999999999999986543 23455
Q ss_pred EEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccccc
Q 005750 432 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 511 (679)
Q Consensus 432 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~ 511 (679)
++++.+|+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 566779999999963 469999999999999999999999 9999999999999999999999999999987544
Q ss_pred Cccc--ccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeee--
Q 005750 512 DLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS-- 586 (679)
Q Consensus 512 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 586 (679)
.... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+..+...... ..........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLN 238 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh---hhccCCChhhhh
Confidence 3222 2344568999999999854 567899999999999999999999997443322111111 0000000000
Q ss_pred ---------eeccc-ccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 587 ---------IVDPV-LIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 587 ---------~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
..... .....+ .....++.+++.+||+.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000 0112368899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-41 Score=349.93 Aligned_cols=261 Identities=16% Similarity=0.195 Sum_probs=208.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccC-CCcccccccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~ 435 (679)
.|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4678899999999999999976 68999999986532 23457789999999965 89999999999999999999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccC-----CCcEEEeeccCccccc
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 510 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfgla~~~~ 510 (679)
+++|.+++.. ....+++.++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 7899998864 34579999999999999999999999 99999999999999964 5789999999998765
Q ss_pred cCccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCe
Q 005750 511 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 584 (679)
Q Consensus 511 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 584 (679)
..... ......||+.|+|||++.+..+++++|||||||++|||+||+.||.+............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 123456999999999999999999999999999999999999999855544333222222221111111
Q ss_pred eeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 585 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
. .+.... +.++.+++..|++.+|++||+++.+.+.|+++...
T Consensus 238 ~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 238 R-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp H-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1 111122 34688999999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=363.03 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=194.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccc------eE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~ 428 (679)
.|++.++||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5777899999999999999976 69999999997542 334567899999999999999999999987654 57
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
++||||+ +++|..+.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+|+.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 677887765 3569999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCcccccccccCCccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHh-----HhcC
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-----IKKG 582 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-----~~~~ 582 (679)
..... ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.............. +...
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65432 33468999999999865 46789999999999999999999999754322111111000000 0000
Q ss_pred C----------eeeeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 005750 583 D----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 634 (679)
Q Consensus 583 ~----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 634 (679)
. ........+ ..........+.+|+.+||+.||.+|||++|+++. ++++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0 000000000 00111122367899999999999999999999984 665543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-41 Score=348.89 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=198.6
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCCcccc-cccccccceEEEEEEec
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYM 435 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l-~~~~~~~~~~~lV~E~~ 435 (679)
+|++.+.||+|+||.||+|++. +|+.||||++.... ...++..|+++++.++|+|++.. .+++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4778899999999999999875 68999999986543 23457889999999987765555 55557778889999999
Q ss_pred CCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCcccc---CCCcEEEeeccCccccccC
Q 005750 436 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 512 (679)
Q Consensus 436 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Dfgla~~~~~~ 512 (679)
++++.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 86 -~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5566665543 35679999999999999999999999 9999999999999875 4567999999999886543
Q ss_pred ccc------ccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHH-HHHHHhHhcCCee
Q 005750 513 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKKGDVI 585 (679)
Q Consensus 513 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 585 (679)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ........ ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence 321 223456999999999999999999999999999999999999999754433222111 11111111 000
Q ss_pred eeecccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 005750 586 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 635 (679)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 635 (679)
+.+... .+.++.+++.+||+.+|++||+++++.+.|+++...
T Consensus 238 ----~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 234688999999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=348.31 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=202.8
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccccceEEEEEEe
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 434 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 434 (679)
.|++.++||+|+||+||+|++. +++.||||+++... .....++.+|+.+++.++||||+++++++.+.+..++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3667899999999999999975 78999999986443 34467899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccccccCcc
Q 005750 435 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 514 (679)
Q Consensus 435 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~~~~~~ 514 (679)
+.++++..++. ..+.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 83 CDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988876 45678999999999999999999999 9999999999999999999999999999987654433
Q ss_pred cccccccCCccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCC---ee---ee
Q 005750 515 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI---SI 587 (679)
Q Consensus 515 ~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~---~~ 587 (679)
. .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... .......+........ .. ..
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 22334778999999987654 68999999999999999999999752221 1112222221111100 00 00
Q ss_pred ec---------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 588 VD---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 588 ~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
.+ ..-...........+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000111222346789999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=357.31 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=201.5
Q ss_pred HhhccccCcCccEEEEEEEEc----CCcEEEEEEecCCc----chhHHHHHHHHHHHHhccC-CCcccccccccccceEE
Q 005750 359 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRI 429 (679)
Q Consensus 359 ~~~~~~LG~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 429 (679)
|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 788999999999999999762 48899999986432 2335678899999999976 89999999999999999
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
++|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 106 ~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999974 4567889999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcccccccccCCccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 587 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (679)
............|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.......... ......... .
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~-~---- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS-E---- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-C----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccC-C----
Confidence 55544444556799999999998654 46889999999999999999999997554332211 111111111 1
Q ss_pred ecccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005750 588 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 627 (679)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 627 (679)
+ ..+......+.+++.+||++||++||| ++|+++
T Consensus 253 --~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 111223457889999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-41 Score=351.89 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=195.1
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccc--cceEEEEEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVYE 433 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lV~E 433 (679)
.|++.++||+|+||+||+|++. +|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5788999999999999999985 6999999998754 3467889999999995 9999999999864 457899999
Q ss_pred ecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC-cEEEeeccCccccccC
Q 005750 434 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED 512 (679)
Q Consensus 434 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfgla~~~~~~ 512 (679)
|+.+++|..+. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|......
T Consensus 113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999997754 358999999999999999999999 9999999999999998654 6999999999876543
Q ss_pred cccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchh--hHHHHH-----HHhHhcCCe
Q 005750 513 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWA-----RSMIKKGDV 584 (679)
Q Consensus 513 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~--~~~~~~-----~~~~~~~~~ 584 (679)
.. .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... .+.... .........
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 2344689999999998765 5799999999999999999999999743322111 011000 000000000
Q ss_pred e------eee--------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005750 585 I------SIV--------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 627 (679)
Q Consensus 585 ~------~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 627 (679)
. ... ..............++.+|+.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 000011111122346889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=347.72 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=188.9
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCccccccccc------ccceE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE------EEHQR 428 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~------~~~~~ 428 (679)
.|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||++++++|. .....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3667899999999999999986 69999999997543 334567899999999999999999999985 34688
Q ss_pred EEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 429 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 429 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
|+||||+.++.+. .+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+++.
T Consensus 98 ~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 9999999765554 443 358999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchhh-HHH--------------
Q 005750 509 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH-------------- 573 (679)
Q Consensus 509 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~-~~~-------------- 573 (679)
..... ......+|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+...... +..
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54432 2234468999999999999999999999999999999999999997443221110 000
Q ss_pred -HHHHhHhcCC-e-----eeeecccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005750 574 -WARSMIKKGD-V-----ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 628 (679)
Q Consensus 574 -~~~~~~~~~~-~-----~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 628 (679)
.......... . ............ .......+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000011100 0 000000111111 12345578999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=347.75 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=194.5
Q ss_pred HHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCc--chhHHHHHHHHHHHHhccCCCcccccccccc-----cceEE
Q 005750 358 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 429 (679)
Q Consensus 358 ~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~ 429 (679)
+|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.. +...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4777899999999999999875 79999999997543 3345678899999999999999999998853 33446
Q ss_pred EEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEeeccCcccc
Q 005750 430 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 509 (679)
Q Consensus 430 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~~ 509 (679)
++++|+.+|+|.+++. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 6778888999999986 3569999999999999999999999 99999999999999999999999999999765
Q ss_pred ccCcccccccccCCccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCcccccchhhHHHHHHHhHhcCCeeeee
Q 005750 510 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 588 (679)
Q Consensus 510 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (679)
... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+...... .+........ .+..
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~-~~~~ 243 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPG-AELL 243 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC-HHHH
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCC-hHHh
Confidence 433 2334588999999987665 56899999999999999999999997543321111 1111100000 0000
Q ss_pred -----------ccccc--CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 005750 589 -----------DPVLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 632 (679)
Q Consensus 589 -----------d~~l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 632 (679)
...+. .... ......+.+|+.+||+.||.+|||++|+++ .+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000 112236789999999999999999999987 35543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-36 Score=322.49 Aligned_cols=284 Identities=20% Similarity=0.270 Sum_probs=202.1
Q ss_pred HHHhhccccCcCccEEEEEEEEc-CCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-----------CCCcccccccccc
Q 005750 357 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE 424 (679)
Q Consensus 357 ~~~~~~~~LG~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~~ 424 (679)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 34888999999999999999975 79999999997543 33467788999988875 5788999988754
Q ss_pred --cceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCC------
Q 005750 425 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------ 496 (679)
Q Consensus 425 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~------ 496 (679)
....+++++++..+..............+++..+..++.||+.||+|||+ ..||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 34566777776555433333333356778999999999999999999997 38899999999999998654
Q ss_pred cEEEeeccCccccccCcccccccccCCccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcccccchh----hHH
Q 005750 497 RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL----NIV 572 (679)
Q Consensus 497 ~~kL~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvll~elltG~~pf~~~~~~~~~----~~~ 572 (679)
.++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||...+..... .+.
T Consensus 170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 39999999987654322 3456899999999999999999999999999999999999999744332111 111
Q ss_pred HHHHHh-------HhcCC----------eeeeeccc----------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005750 573 HWARSM-------IKKGD----------VISIVDPV----------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 625 (679)
Q Consensus 573 ~~~~~~-------~~~~~----------~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 625 (679)
..+... ..... ....+... ............+.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 00000 00000000 0112345667789999999999999999999999
Q ss_pred HHH--HHhhhhhhcCCCCccccCC
Q 005750 626 VLA--IQDSIKIEKGGDQKFSSSS 647 (679)
Q Consensus 626 l~~--L~~~~~~~~~~~~~~~~~~ 647 (679)
++. +++....++...+...-++
T Consensus 326 L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred hcCcccCCCCCcccCCCCCcccCC
Confidence 984 7666655554444444333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1e-22 Score=195.12 Aligned_cols=162 Identities=15% Similarity=0.165 Sum_probs=119.1
Q ss_pred hccccCcCccEEEEEEEEcCCcEEEEEEecCCcc------------------hhHHHHHHHHHHHHhccCCCcccccccc
Q 005750 361 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 422 (679)
Q Consensus 361 ~~~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 422 (679)
+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5689999999999999998999999998753210 1123355788999999999998887653
Q ss_pred cccceEEEEEEecCCCcHhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccccCCCCCCccccCCCcEEEee
Q 005750 423 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 502 (679)
Q Consensus 423 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 502 (679)
. .+++|||+++..+.++ +......++.|++++|+|||+ +||+||||||+|||++++ .++|+|
T Consensus 84 ~----~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 G----NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp T----TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2 3799999988665432 223356789999999999999 999999999999999865 589999
Q ss_pred ccCccccccCcccccccccCCccccCC------cccCCCCCCchhHHHHHHHHH
Q 005750 503 FGLSRQAEEDLTHISSVARGTVGYLDP------EYYGNQQLTEKSDVYSFGVVL 550 (679)
Q Consensus 503 fgla~~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~s~ksDVwSlGvll 550 (679)
||.|.....+... .|... +.+ ...|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765433211 11110 111 24567788999976443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.74 E-value=1.1e-18 Score=180.11 Aligned_cols=151 Identities=26% Similarity=0.489 Sum_probs=128.4
Q ss_pred CchhHHHHHHHHHhhcCC-CCCCCCC-CCCCCCCCCceEEEeCCC-CCceEEEEcCCCcccc--cCCccccCCCCCCEEE
Q 005750 117 TEWQDVMVLEALRSISDE-SERTNDR-GDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 191 (679)
Q Consensus 117 t~~~~~~~l~~l~~~~~~-~~~~~w~-~~~c~~~~w~~~~c~~~~-~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~ 191 (679)
..++|..||.++|+.... ....+|. +..||.+.|.||+|+..+ ..||+.|+|++|+++| .+|++|++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 568999999999997754 4456775 444556689999998653 4589999999999998 5899999999999999
Q ss_pred CCC-CcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 192 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 192 L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
|++ |+|+|.+| +|++|++|++|+|++|+|.|..|..+..+.+|+.+++++|++.+.+|..+.. ....+.+++|...
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence 996 89999988 5999999999999999999999999999999999999999999999988765 3455667777543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.53 E-value=7.7e-15 Score=139.59 Aligned_cols=122 Identities=19% Similarity=0.213 Sum_probs=104.5
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccC-CccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecC
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEI-PPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 217 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~-p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 217 (679)
|.|..|.|+... +.+++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+.++ .+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 457778887432 457999999999998766 4568999999999999999999998 599999999999999
Q ss_pred ccCCCCCCCCCCCCCccceecccccCCCCCCCccccC---CceeeeecCCCCcccc
Q 005750 218 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 218 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~~~~ 270 (679)
|+|++..|..|.++++|++|+|++|+|+ .+|+..+. .+..+.+.+|++.|..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 9999666778999999999999999999 77777654 4567889999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=7.2e-13 Score=121.16 Aligned_cols=103 Identities=18% Similarity=0.192 Sum_probs=87.8
Q ss_pred EEcCCCcccccCCccccCCCCCCEEECCCC-cCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccC
Q 005750 166 IALSGKNLKGEIPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 243 (679)
Q Consensus 166 L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 243 (679)
++++++++. .+|..+..+++|+.|+|++| .|+.+.+ +|.+|++|+.|+|++|+|+..-|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 455666666 67888999999999999866 5888777 59999999999999999995557779999999999999999
Q ss_pred CCCCCCccccC--CceeeeecCCCCcccc
Q 005750 244 FVGEIPPALLT--GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 244 l~g~ip~~~~~--~~~~~~~~~n~~~~~~ 270 (679)
|+ .+|...+. ....+.+++||+.|++
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred Cc-ccChhhhccccccccccCCCcccCCc
Confidence 99 89988776 3467889999999865
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.31 E-value=1.5e-12 Score=114.01 Aligned_cols=98 Identities=26% Similarity=0.339 Sum_probs=76.2
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccCC
Q 005750 165 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 165 ~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 244 (679)
.|+|++|+|+ .++ .+..|++|++|+|++|+|+..+++++.+++|+.|+|++|+|+ .+| .++.+++|+.|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 5888899988 665 488888899999999998876667888888999999999888 566 488888899999999988
Q ss_pred CCCCCc--ccc--CCceeeeecCCCCc
Q 005750 245 VGEIPP--ALL--TGKVIFKYDNNPKL 267 (679)
Q Consensus 245 ~g~ip~--~~~--~~~~~~~~~~n~~~ 267 (679)
+ .+|. .+. .....+.+.+|+..
T Consensus 78 ~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 Q-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp C-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred C-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 8 5553 222 24456777888754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=4.6e-12 Score=126.48 Aligned_cols=111 Identities=28% Similarity=0.330 Sum_probs=100.6
Q ss_pred CCCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCcccee
Q 005750 159 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 237 (679)
Q Consensus 159 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 237 (679)
..++|+.|+|++|.+.+..+..+..+.+|+.|++++|.++..++. +..+++|+.|++++|+|++..|..|..+++|++|
T Consensus 98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L 177 (266)
T d1p9ag_ 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (266)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred cccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence 356899999999999977788899999999999999999999885 8899999999999999997777889999999999
Q ss_pred cccccCCCCCCCccccC--CceeeeecCCCCcccc
Q 005750 238 HIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~~ 270 (679)
+|++|+|+ .||++++. .+..+.+.+|||.|++
T Consensus 178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99999999 99998875 4577899999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.30 E-value=3.4e-13 Score=138.17 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=98.9
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
....++++++.+.|.+|..++.+++|+.|++++|.+++.+|+++.+++|+.|+|++|+|+|.+|.+|++|++|++|+|++
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-cCCceeeeecCCCCcccc
Q 005750 242 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 270 (679)
Q Consensus 242 N~l~g~ip~~~-~~~~~~~~~~~n~~~~~~ 270 (679)
|+|+|.||... ...+..+.+.+|+.+|+.
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 99999999642 234566788999999874
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=6.2e-12 Score=126.68 Aligned_cols=111 Identities=19% Similarity=0.235 Sum_probs=97.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
...|+.|++++|+|++..+..|..+++|+.|+|++|+|++.++ .|.++++|+.|++++|++++..|..|..+++|++|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 3589999999999996667789999999999999999999988 499999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCcccc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 270 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~~~~ 270 (679)
+++|++++..|..+.. .+..+.+++||+.|++
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999544444332 4578899999999964
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.21 E-value=7.2e-12 Score=109.64 Aligned_cols=83 Identities=28% Similarity=0.350 Sum_probs=76.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCC--CCCCCCCcccee
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 237 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L 237 (679)
..+|+.|+|++|.|+ .+|+.++.+++|+.|+|++|.|++. |++.++++|+.|++++|+++ .+| ..++.+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEE
Confidence 358999999999999 7899999999999999999999976 67999999999999999999 555 468999999999
Q ss_pred cccccCCC
Q 005750 238 HIENNSFV 245 (679)
Q Consensus 238 ~l~~N~l~ 245 (679)
++++|+++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=1.2e-11 Score=113.64 Aligned_cols=104 Identities=22% Similarity=0.266 Sum_probs=87.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCC-CCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 238 (679)
+.++++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.. +.|..+++|+.|+|++|+++ .+|.. +..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccce
Confidence 358999999999999 6787778899999999999999965 77999999999999999999 66655 56799999999
Q ss_pred ccccCCCCCCCc--cc--cCCceeeeecCCCCc
Q 005750 239 IENNSFVGEIPP--AL--LTGKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~--~~--~~~~~~~~~~~n~~~ 267 (679)
|++|+++ .+++ .+ ...+..+.+.+||..
T Consensus 94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ecccccc-ccccccccccccccchhhcCCCccc
Confidence 9999998 6664 22 235577888888753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.17 E-value=1.4e-11 Score=116.51 Aligned_cols=90 Identities=22% Similarity=0.353 Sum_probs=83.0
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++.+..+..+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|+.|..+++|++|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 46899999999999988899999999999999999999999985 99999999999999999976777899999999999
Q ss_pred ccccCCCCCCC
Q 005750 239 IENNSFVGEIP 249 (679)
Q Consensus 239 l~~N~l~g~ip 249 (679)
|++|.+.+..+
T Consensus 133 L~~N~~~~~~~ 143 (192)
T d1w8aa_ 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred ccccccccccc
Confidence 99999985443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.11 E-value=6.8e-11 Score=120.07 Aligned_cols=108 Identities=23% Similarity=0.290 Sum_probs=97.2
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++++.|+|++|.+++..+..|.+++.++.|++++|.+++..+ .+.++++|+.|+|++|+|+ .+|.++..+++|++|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 4689999999999999999999999999999999999999988 4899999999999999999 8999999999999999
Q ss_pred ccccCCCCCCCccccC---------CceeeeecCCCCccc
Q 005750 239 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLHK 269 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~---------~~~~~~~~~n~~~~~ 269 (679)
|++|+|+ .|+...+. .+..+.+.+||+.+.
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9999999 88876543 235678899998763
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=2.2e-10 Score=104.20 Aligned_cols=102 Identities=23% Similarity=0.241 Sum_probs=87.3
Q ss_pred CCCCCCCCceEEEeCC----------CCCceEEEEcCCCc-ccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCC
Q 005750 143 DPCVPVPWEWVTCSTT----------TPPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 210 (679)
Q Consensus 143 ~~c~~~~w~~~~c~~~----------~~~~l~~L~L~~n~-l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L 210 (679)
+.|+++.++++.|+.. ..++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+.+.|. |.++++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 5687778889999753 23578999998775 8855556799999999999999999999885 9999999
Q ss_pred cEEEecCccCCCCCCCCCCCCCccceecccccCCC
Q 005750 211 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 211 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 245 (679)
+.|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 88887666668999999999985
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=4.1e-10 Score=111.99 Aligned_cols=102 Identities=29% Similarity=0.262 Sum_probs=81.2
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++++.|+|++|+|++..+..|.++++|+.|+|++|+|+. +|.++.+++|+.|+|++|+++ .+|..+..+++|+.|+++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-cccccccccccccccccc
Confidence 578999999999996666779999999999999999985 456788999999999999998 667888899999999999
Q ss_pred ccCCCCCCCccccCC---ceeeeecCCC
Q 005750 241 NNSFVGEIPPALLTG---KVIFKYDNNP 265 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~---~~~~~~~~n~ 265 (679)
+|.+. .++...+.. ...+.+++|.
T Consensus 109 ~~~~~-~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 109 FNRLT-SLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp SSCCC-CCCSSTTTTCTTCCEEECTTSC
T ss_pred ccccc-eeeccccccccccccccccccc
Confidence 99988 566554432 2445555553
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=3.7e-10 Score=103.38 Aligned_cols=86 Identities=22% Similarity=0.242 Sum_probs=76.6
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCC--CCCCCCcccee
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 237 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L 237 (679)
.+|+.|+|++|.|+ .++ .|..|++|+.|+|++|+|+..++. +..+++|+.|+|++|+++ .+++ .+..+++|++|
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 117 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchh
Confidence 58999999999999 564 589999999999999999998887 678999999999999998 6664 68899999999
Q ss_pred cccccCCCCCCCc
Q 005750 238 HIENNSFVGEIPP 250 (679)
Q Consensus 238 ~l~~N~l~g~ip~ 250 (679)
++++|.++ ..|.
T Consensus 118 ~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 118 CILRNPVT-NKKH 129 (162)
T ss_dssp ECCSSGGG-GSTT
T ss_pred hcCCCccc-cccc
Confidence 99999998 6664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.82 E-value=4.1e-09 Score=106.58 Aligned_cols=97 Identities=23% Similarity=0.304 Sum_probs=61.7
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccccC
Q 005750 165 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 243 (679)
Q Consensus 165 ~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 243 (679)
.++.++++|+ .+|..+. ++|++|+|++|+|+..++ +|.++++|+.|++++|.++...|..|..+++|+.|++++|+
T Consensus 14 ~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence 3455556666 6666553 567777777777776666 46677777777777777775556666777777777777777
Q ss_pred CCCCCCccccCCceeeeecCCC
Q 005750 244 FVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 244 l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
++ .+|...+.....+....|.
T Consensus 91 l~-~l~~~~~~~l~~L~~~~n~ 111 (305)
T d1xkua_ 91 LK-ELPEKMPKTLQELRVHENE 111 (305)
T ss_dssp CS-BCCSSCCTTCCEEECCSSC
T ss_pred cC-cCccchhhhhhhhhccccc
Confidence 76 6666655554445444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=7e-09 Score=103.77 Aligned_cols=108 Identities=20% Similarity=0.204 Sum_probs=93.4
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCC-CCCCCCCcEEEecCccCCCCCCCCCCCCCccceec
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 238 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 238 (679)
.++|+.|+|++|++.+..+..+..+++|+.+++++|+|+++++. |.++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 46899999999999977778899999999999999999998884 89999999999999999977778899999999999
Q ss_pred ccccCCCCCCCccccC--CceeeeecCCCCc
Q 005750 239 IENNSFVGEIPPALLT--GKVIFKYDNNPKL 267 (679)
Q Consensus 239 l~~N~l~g~ip~~~~~--~~~~~~~~~n~~~ 267 (679)
+++|++++..|..+.. ....+.+++|...
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhhccccccChhHhhhhhhcccccccccccc
Confidence 9999999666666543 4466777777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.68 E-value=1.7e-08 Score=95.38 Aligned_cols=100 Identities=23% Similarity=0.331 Sum_probs=60.5
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
.+++.|+|++|+++ .++ .+..|++|++|+|++|+|++..| ++++++|+.|++++|.+. .+|. ++.+++|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-ccccccccccccc
Confidence 36667777777766 343 36667777777777777766544 667777777777777766 4443 6667777777777
Q ss_pred ccCCCCCCCccccCCceeeeecCCC
Q 005750 241 NNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 241 ~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
+|.+....+-.-+.....+.+++|.
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred ccccccccccchhhhhHHhhhhhhh
Confidence 7766632221222334445555553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.62 E-value=2.5e-10 Score=108.30 Aligned_cols=103 Identities=25% Similarity=0.233 Sum_probs=83.6
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
..+|+.|+|++|+|+ .++ .|..|++|+.|+|++|.|+...+.+..+++|+.|++++|+++ .++ .+..+++|+.|+|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 568999999999999 665 599999999999999999875444556678999999999999 554 4788999999999
Q ss_pred cccCCCCCCCc--cc--cCCceeeeecCCCCc
Q 005750 240 ENNSFVGEIPP--AL--LTGKVIFKYDNNPKL 267 (679)
Q Consensus 240 ~~N~l~g~ip~--~~--~~~~~~~~~~~n~~~ 267 (679)
++|+++ .++. .+ ...+..+.+.+||..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccc
Confidence 999998 5653 22 235677888998744
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=1.1e-08 Score=106.30 Aligned_cols=100 Identities=22% Similarity=0.267 Sum_probs=69.7
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
...+..++++.|.+++ ...+..+++|+.|+|++|+|++.. .+..+++|+.|+|++|+|+ .+| .+++|++|++|++
T Consensus 284 ~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 284 LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSA 358 (384)
T ss_dssp CTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEEC
T ss_pred cccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEEC
Confidence 3466778888888874 345777888888888888888764 4777888888888888887 455 5778888888888
Q ss_pred cccCCCCCCCccccCCceeeeecCC
Q 005750 240 ENNSFVGEIPPALLTGKVIFKYDNN 264 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~~~~~~~~~n 264 (679)
++|+|++-.|-.-+..+..+.+++|
T Consensus 359 ~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCcCCCChhhccCCCCCEeeCCCC
Confidence 8888884333121224445555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=5.3e-08 Score=92.62 Aligned_cols=82 Identities=26% Similarity=0.465 Sum_probs=58.2
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
+|+.|++++|.++. ++ .+..|++|+.|+|++|+|++.. .+++|++|+.|+|++|+++ .+| .+..+++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 57777777777773 33 3677777778888877777643 4667777778888777777 455 467777777777777
Q ss_pred cCCCCCCC
Q 005750 242 NSFVGEIP 249 (679)
Q Consensus 242 N~l~g~ip 249 (679)
|.+. .++
T Consensus 122 ~~~~-~~~ 128 (210)
T d1h6ta2 122 NGIS-DIN 128 (210)
T ss_dssp SCCC-CCG
T ss_pred cccc-ccc
Confidence 7776 444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=4.7e-08 Score=94.88 Aligned_cols=102 Identities=21% Similarity=0.261 Sum_probs=83.6
Q ss_pred CCCceEEEeCCC--------CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC--CCCCCCCCcEEEecC
Q 005750 148 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 217 (679)
Q Consensus 148 ~~w~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~ 217 (679)
|....+.|+... +.+++.|+|++|+|+...+..|.++++|++|+|++|.+...+| .|.++++++.|.+..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 455678887532 2479999999999994444578999999999999999988765 489999999999865
Q ss_pred -ccCCCCCCCCCCCCCccceecccccCCCCCCCc
Q 005750 218 -NELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 250 (679)
Q Consensus 218 -N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ip~ 250 (679)
|++....|..|..+++|+.|++++|.+. .+|.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~ 120 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 120 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC-SCCC
T ss_pred cccccccccccccccccccccccchhhhc-cccc
Confidence 7888677778999999999999999998 4544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=5.9e-08 Score=92.34 Aligned_cols=101 Identities=29% Similarity=0.416 Sum_probs=73.8
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ ++ .+++|++|+.|+|++|+|++ +|.+.++++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 4688999999999985 44 37889999999999999887 456888889999999998887 444 4777788888888
Q ss_pred cccCCCCCCCccccCCceeeeecCCC
Q 005750 240 ENNSFVGEIPPALLTGKVIFKYDNNP 265 (679)
Q Consensus 240 ~~N~l~g~ip~~~~~~~~~~~~~~n~ 265 (679)
++|.+++..+..-...+..+.+++|.
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccc
Confidence 88887732222223344555566554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.50 E-value=4.1e-08 Score=94.56 Aligned_cols=79 Identities=20% Similarity=0.362 Sum_probs=37.7
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
.+..+.++++.+.... .+.++++|+.|++++|.++... .++++++|+.|+|++|+++ .+|. ++++++|++|+|++
T Consensus 130 ~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~ 204 (227)
T d1h6ua2 130 NLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKN 204 (227)
T ss_dssp TCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTT
T ss_pred chhhhhchhhhhchhh--hhccccccccccccccccccch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcC
Confidence 4444455554444221 2444455555555555544322 2445555555555555555 2332 44555555555555
Q ss_pred cCCC
Q 005750 242 NSFV 245 (679)
Q Consensus 242 N~l~ 245 (679)
|+++
T Consensus 205 N~lt 208 (227)
T d1h6ua2 205 NQIS 208 (227)
T ss_dssp SCCC
T ss_pred CcCC
Confidence 5555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.50 E-value=5.3e-08 Score=100.98 Aligned_cols=98 Identities=24% Similarity=0.341 Sum_probs=57.1
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceeccc
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 240 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 240 (679)
++|+.|++++|.+++.. .+..++.++.++++.|.+++ ++.+..+++|+.|+|++|++++. + .+..+++|+.|+++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~ 337 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFA 337 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECC
T ss_pred ccCCEeeccCcccCCCC--cccccccccccccccccccc-ccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECC
Confidence 45666666666666332 25566666666666666665 23466666666666666666643 2 25666666666666
Q ss_pred ccCCCCCCCccccC--CceeeeecCCC
Q 005750 241 NNSFVGEIPPALLT--GKVIFKYDNNP 265 (679)
Q Consensus 241 ~N~l~g~ip~~~~~--~~~~~~~~~n~ 265 (679)
+|+|+ .+| .+.. .+..+.+++|.
T Consensus 338 ~n~l~-~l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 338 NNKVS-DVS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp SSCCC-CCG-GGGGCTTCCEEECCSSC
T ss_pred CCCCC-CCh-hHcCCCCCCEEECCCCc
Confidence 66666 444 2222 33455555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.46 E-value=1.4e-07 Score=88.83 Aligned_cols=99 Identities=26% Similarity=0.429 Sum_probs=70.5
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|+|++|++++ +++ +++|++|+.|++++|.+.... .+.++++|+.|++++|.+.. ++ .+..+++|+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred CCCcCcCccccccccC-ccc-ccCCccccccccccccccccc-cccccccccccccccccccc-cc-ccchhhhhHHhhh
Confidence 3578889999888885 333 888888999999888877643 47788888888888888773 32 3677888888888
Q ss_pred cccCCCCCCCcc-ccCCceeeeecCC
Q 005750 240 ENNSFVGEIPPA-LLTGKVIFKYDNN 264 (679)
Q Consensus 240 ~~N~l~g~ip~~-~~~~~~~~~~~~n 264 (679)
++|++. .+|.- -......+.+.+|
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSS
T ss_pred hhhhhc-ccccccccccccccccccc
Confidence 888887 55531 1223344555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.35 E-value=2.7e-07 Score=88.55 Aligned_cols=77 Identities=22% Similarity=0.341 Sum_probs=67.1
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
.++|+.|++++|.+.+.. .++++++|+.|+|++|++++. |.+.++++|+.|+|++|+++ .+|. ++++++|+.|+|
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~l 224 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTL 224 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEE
T ss_pred ccccccccccccccccch--hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEe
Confidence 468999999999998433 389999999999999999874 56999999999999999999 5663 889999999999
Q ss_pred cc
Q 005750 240 EN 241 (679)
Q Consensus 240 ~~ 241 (679)
++
T Consensus 225 sn 226 (227)
T d1h6ua2 225 TN 226 (227)
T ss_dssp EE
T ss_pred eC
Confidence 74
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.32 E-value=3.2e-09 Score=100.43 Aligned_cols=83 Identities=22% Similarity=0.421 Sum_probs=73.6
Q ss_pred CceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCC--CCCCCCCccceec
Q 005750 161 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 238 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~ 238 (679)
.+|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|+.. +.+.++++|+.|+|++|+++ .++ ..+..+++|+.|+
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred ccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceee
Confidence 58999999999998 7887777788999999999999974 56889999999999999998 555 4689999999999
Q ss_pred ccccCCCC
Q 005750 239 IENNSFVG 246 (679)
Q Consensus 239 l~~N~l~g 246 (679)
|++|+++.
T Consensus 147 L~~N~l~~ 154 (198)
T d1m9la_ 147 LAGNPLYN 154 (198)
T ss_dssp ECSSHHHH
T ss_pred cCCCcccc
Confidence 99999873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=4.6e-07 Score=88.75 Aligned_cols=137 Identities=14% Similarity=0.092 Sum_probs=95.9
Q ss_pred cccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEEecCCCcHh
Q 005750 363 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 441 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 441 (679)
+..+-++.+.||+...+ ++.+++|+...........+.+|...++.+. +-.+.+++.+...++..++||++++|.++.
T Consensus 20 ~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred EcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 33333444689998654 6667888876554444456778999988874 434677788888888899999999998886
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 005750 442 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC--------------------------------------------- 476 (679)
Q Consensus 442 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--------------------------------------------- 476 (679)
+..... .....++.++++.++.||+..
T Consensus 99 ~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 99 EEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred cccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence 654311 112345667777777777510
Q ss_pred -----------CCCccccCCCCCCccccCCCcEEEeeccCccc
Q 005750 477 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 477 -----------~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
...++|+|+.|.||++++++..-|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999776667999997653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.08 E-value=4.5e-06 Score=84.56 Aligned_cols=77 Identities=26% Similarity=0.393 Sum_probs=46.0
Q ss_pred ceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecccc
Q 005750 162 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 162 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
+++.|||++|+|+ .+|+. +++|++|+|++|+|+.. |+. +.+|+.|++++|+++ .++.- .++|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 4566777777776 56643 35667777777777644 321 245666667776666 44431 13466677777
Q ss_pred cCCCCCCCc
Q 005750 242 NSFVGEIPP 250 (679)
Q Consensus 242 N~l~g~ip~ 250 (679)
|.++ .+|.
T Consensus 108 n~l~-~lp~ 115 (353)
T d1jl5a_ 108 NQLE-KLPE 115 (353)
T ss_dssp SCCS-SCCC
T ss_pred cccc-cccc
Confidence 7666 5554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=3.6e-06 Score=81.73 Aligned_cols=130 Identities=17% Similarity=0.099 Sum_probs=89.6
Q ss_pred ccCcCcc-EEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccC--CCcccccccccccceEEEEEEecCCCcH
Q 005750 364 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGTL 440 (679)
Q Consensus 364 ~LG~G~~-g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL 440 (679)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 68999998888889999866432 2346778888887743 3356678877888889999999988765
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 005750 441 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 475 (679)
Q Consensus 441 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------------------------------------------- 475 (679)
.+.. ... ...+.++++.|+-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 111 12334555555556531
Q ss_pred ----------CCCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 476 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 476 ----------~~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01247999999999999987667899999764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.00 E-value=5.6e-06 Score=83.81 Aligned_cols=82 Identities=28% Similarity=0.478 Sum_probs=68.3
Q ss_pred CCceEEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCCCCCCCCCcEEEecCccCCCCCCCCCCCCCccceecc
Q 005750 160 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 239 (679)
Q Consensus 160 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 239 (679)
+++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++.. +.+. +.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 468999999999999 888764 5789999999999864 3332 46999999999999 7886 688999999999
Q ss_pred cccCCCCCCCcc
Q 005750 240 ENNSFVGEIPPA 251 (679)
Q Consensus 240 ~~N~l~g~ip~~ 251 (679)
++|.++ ..|..
T Consensus 128 ~~~~~~-~~~~~ 138 (353)
T d1jl5a_ 128 DNNSLK-KLPDL 138 (353)
T ss_dssp CSSCCS-CCCCC
T ss_pred cccccc-ccccc
Confidence 999998 55544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=4.7e-07 Score=82.10 Aligned_cols=73 Identities=25% Similarity=0.214 Sum_probs=51.3
Q ss_pred cCCccccCCCCCCEEECCCCcCCCCCC--C-CCCCCCCcEEEecCccCCCCCCC-CCCCCCccceecccccCCCCCCC
Q 005750 176 EIPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP 249 (679)
Q Consensus 176 ~~p~~~~~l~~L~~L~L~~N~l~~~~p--~-~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~ip 249 (679)
.++..+.++++|++|+|++|+|+...+ . +..+++|+.|+|++|+++ .+++ ......+|+.|++++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 444445678888888888888887643 3 667888888888888888 5554 22334568888888888875443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=1.5e-05 Score=76.42 Aligned_cols=95 Identities=16% Similarity=0.118 Sum_probs=55.3
Q ss_pred CceEEEEcCCCcccccCCccccCCC-CCCEEECCCCcCCCCCCCCCCCCCCcEE-EecCccCCCCCCC-CCCCCCcccee
Q 005750 161 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIV-HLENNELTGSLPS-YMGSLPNLQEL 237 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L-~l~~N~l~g~~p~-~~~~l~~L~~L 237 (679)
..+..+..+++.+...-+..+..++ .++.|++++|+++...+...+..+++.+ ++++|+|+ .+|. .|.++++|++|
T Consensus 128 ~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L 206 (242)
T d1xwdc1 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 206 (242)
T ss_dssp SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEE
T ss_pred cccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEE
Confidence 3555566666666644444555553 5666677777776655554444444433 45666666 5544 35666777777
Q ss_pred cccccCCCCCCCccccCCce
Q 005750 238 HIENNSFVGEIPPALLTGKV 257 (679)
Q Consensus 238 ~l~~N~l~g~ip~~~~~~~~ 257 (679)
+|++|+|+ .+|...+....
T Consensus 207 ~Ls~N~l~-~l~~~~~~~l~ 225 (242)
T d1xwdc1 207 DISRTRIH-SLPSYGLENLK 225 (242)
T ss_dssp ECTTSCCC-CCCSSSCTTCC
T ss_pred ECCCCcCC-ccCHHHHcCCc
Confidence 77777776 66665555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=1.2e-06 Score=79.34 Aligned_cols=78 Identities=23% Similarity=0.318 Sum_probs=43.7
Q ss_pred CceEEEEcCCCccccc--CCccccCCCCCCEEECCCCcCCCCCC-CCCCCCCCcEEEecCccCCCCCCCC-------CCC
Q 005750 161 PRITKIALSGKNLKGE--IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSY-------MGS 230 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~--~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~ 230 (679)
++|+.|+|++|+|+.. ++..+..|++|+.|+|++|.|+...+ .+....+|+.|+|++|.++...... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 4566666666666632 22345566666666666666666544 2223345666666666666443321 345
Q ss_pred CCccceec
Q 005750 231 LPNLQELH 238 (679)
Q Consensus 231 l~~L~~L~ 238 (679)
+|+|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 56666554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.51 E-value=8.7e-05 Score=76.76 Aligned_cols=76 Identities=16% Similarity=0.183 Sum_probs=49.1
Q ss_pred ccccCcCccEEEEEEEEcC-CcEEEEEEecCCc-------chhHHHHHHHHHHHHhcc-C--CCcccccccccccceEEE
Q 005750 362 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRIL 430 (679)
Q Consensus 362 ~~~LG~G~~g~Vy~a~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~l 430 (679)
.+.||.|....||++...+ ++.|+||.-.... .....+...|.+.|+.+. + ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3578999999999998764 6789999754311 112344567888888773 2 2345555443 345589
Q ss_pred EEEecCCCc
Q 005750 431 VYEYMHNGT 439 (679)
Q Consensus 431 V~E~~~~gs 439 (679)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.37 E-value=0.00023 Score=71.43 Aligned_cols=135 Identities=12% Similarity=0.141 Sum_probs=79.4
Q ss_pred EEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC--cccccc-----cccccceEEEEEEecCCCcHh--
Q 005750 371 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIG-----YCEEEHQRILVYEYMHNGTLR-- 441 (679)
Q Consensus 371 g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~-----~~~~~~~~~lV~E~~~~gsL~-- 441 (679)
-.||+++.++|+.|++|+.+.. ....+++..|.+.+..|.... ++..+. .+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999999999999998654 234577888999998885322 222221 223456678999999764321
Q ss_pred ----------------hhhcccC--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhcCCCCc
Q 005750 442 ----------------DRLHGSV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCNPGI 480 (679)
Q Consensus 442 ----------------~~l~~~~--~~~~l~~~----------------------~~~~i~~qia~aL~~L-H~~~~~~i 480 (679)
....... .....+.. .....+.++...+.-. .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0101000 11111211 1122223333333222 12224678
Q ss_pred cccCCCCCCccccCCCcEEEeeccCccc
Q 005750 481 IHRDVKSSNILLDINMRAKVSDFGLSRQ 508 (679)
Q Consensus 481 vH~Dlkp~NIll~~~~~~kL~Dfgla~~ 508 (679)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899997764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=2.2e-05 Score=82.22 Aligned_cols=84 Identities=31% Similarity=0.398 Sum_probs=44.5
Q ss_pred ceEEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCC----CC-CCC-CCCCCcEEEecCccCCCC----CCCC
Q 005750 162 RITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTGS----LPSY 227 (679)
Q Consensus 162 ~l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~----~p-~~~-~l~~L~~L~l~~N~l~g~----~p~~ 227 (679)
+++.|+|++|+|+- .++..+..+++|+.|||++|.|+.. +. .+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 44556666666551 2334455666666666666665421 11 121 223566666666666532 3445
Q ss_pred CCCCCccceecccccCCC
Q 005750 228 MGSLPNLQELHIENNSFV 245 (679)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~ 245 (679)
+..+++|++|+|++|.++
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred hhccccccccccccccch
Confidence 555666666666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.84 E-value=3.2e-05 Score=80.91 Aligned_cols=106 Identities=17% Similarity=0.173 Sum_probs=76.5
Q ss_pred CceEEEEcCCCccccc-CCccccCCCCCCEEECCCCcCCC----CCC-CCCCCCCCcEEEecCccCCC----CCCCCCC-
Q 005750 161 PRITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTG----PLP-DMSRLIDLRIVHLENNELTG----SLPSYMG- 229 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~-~p~~~~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~l~~N~l~g----~~p~~~~- 229 (679)
++|+.|||++|++++. +..-+..+++|++|+|++|.|+- .+. .+..+++|+.|||++|+|+. .+...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4799999999999864 24557788999999999999873 233 36789999999999999862 1233333
Q ss_pred CCCccceecccccCCCCC----CCcccc--CCceeeeecCCCC
Q 005750 230 SLPNLQELHIENNSFVGE----IPPALL--TGKVIFKYDNNPK 266 (679)
Q Consensus 230 ~l~~L~~L~l~~N~l~g~----ip~~~~--~~~~~~~~~~n~~ 266 (679)
..++|+.|+|++|+++.. ++..+. ..+..+.+++|+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 235899999999999732 222222 2456667777753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.00025 Score=69.72 Aligned_cols=36 Identities=22% Similarity=0.185 Sum_probs=17.6
Q ss_pred CCCCCcEEEecCc-cCCCCCCCCCCCCCccceecccc
Q 005750 206 RLIDLRIVHLENN-ELTGSLPSYMGSLPNLQELHIEN 241 (679)
Q Consensus 206 ~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~ 241 (679)
++++|+.|+|++| .+++..+..++++++|++|+|++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~ 209 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence 3445555555443 34444444445555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.00033 Score=68.76 Aligned_cols=82 Identities=22% Similarity=0.301 Sum_probs=63.2
Q ss_pred CceEEEEcCCC--ccccc-CCccccCCCCCCEEECCCC-cCCCCCC-CCCCCCCCcEEEecC-ccCCCCCCCCCCCCCcc
Q 005750 161 PRITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPSYMGSLPNL 234 (679)
Q Consensus 161 ~~l~~L~L~~n--~l~g~-~p~~~~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L 234 (679)
++|+.|+|++. +++.. +..-+.++++|+.|+|++| .+++... .+.++++|++|+|++ +++++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 57899999864 34432 3334567899999999886 5776544 688999999999999 46887777778889999
Q ss_pred ceeccccc
Q 005750 235 QELHIENN 242 (679)
Q Consensus 235 ~~L~l~~N 242 (679)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 99999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0028 Score=65.05 Aligned_cols=72 Identities=14% Similarity=0.240 Sum_probs=50.6
Q ss_pred cccCcCccEEEEEEEEcC--------CcEEEEEEecCCcchhHHHHHHHHHHHHhcc-CCCcccccccccccceEEEEEE
Q 005750 363 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 433 (679)
Q Consensus 363 ~~LG~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 433 (679)
+.|+.|-.-.+|++...+ .+.|++++..... ......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568889999999998754 3567888765322 2234568999999885 4434577777754 68999
Q ss_pred ecCCCcH
Q 005750 434 YMHNGTL 440 (679)
Q Consensus 434 ~~~~gsL 440 (679)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.60 E-value=0.0001 Score=74.66 Aligned_cols=85 Identities=21% Similarity=0.315 Sum_probs=50.7
Q ss_pred CceEEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCC-----C-CCCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~-----~-p~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
+.|+.|++++|.+.. .+...+..++.|+.|+|++|+|+.. + ..+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 356667777666642 2233455566777777777766531 1 2356666677777777766422 334
Q ss_pred CCCCCCccceecccccCCC
Q 005750 227 YMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 227 ~~~~l~~L~~L~l~~N~l~ 245 (679)
.+..+++|++|+|++|.|+
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HGGGCTTCCEEECTTCCCC
T ss_pred cccccccchhhhhhcCccC
Confidence 4556667777777777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.56 E-value=0.00014 Score=73.60 Aligned_cols=85 Identities=19% Similarity=0.191 Sum_probs=49.4
Q ss_pred CceEEEEcCCCccccc-----CCccccCCCCCCEEECCCCcCCCC----C-CCCCCCCCCcEEEecCccCCCCCC----C
Q 005750 161 PRITKIALSGKNLKGE-----IPPELKNMEALTELWLDGNFLTGP----L-PDMSRLIDLRIVHLENNELTGSLP----S 226 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~-----~p~~~~~l~~L~~L~L~~N~l~~~----~-p~~~~l~~L~~L~l~~N~l~g~~p----~ 226 (679)
..++.|+|++|++... +...+..+++|+.|+|++|.|+.. + ..+..+++|+.|+|++|.|++.-. .
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 3567777777776531 334456667777777777766432 1 235666777777777777663311 1
Q ss_pred CCC--CCCccceecccccCCC
Q 005750 227 YMG--SLPNLQELHIENNSFV 245 (679)
Q Consensus 227 ~~~--~l~~L~~L~l~~N~l~ 245 (679)
.+. ..++|+.|++++|+++
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCB
T ss_pred HhhhccCCCCCEEECCCCcCC
Confidence 121 1245677777777765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.46 E-value=0.00022 Score=64.17 Aligned_cols=85 Identities=14% Similarity=0.167 Sum_probs=64.9
Q ss_pred CceEEEEcCCC-ccccc----CCccccCCCCCCEEECCCCcCCCC--CC---CCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGP--LP---DMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~--~p---~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
+.|++|+|+++ .++.. +-..+...+.|+.|+|++|.|... .. .+...+.|+.|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 58999999974 46432 334577889999999999998743 11 256678899999999999843 233
Q ss_pred CCCCCCccceecccccCCC
Q 005750 227 YMGSLPNLQELHIENNSFV 245 (679)
Q Consensus 227 ~~~~l~~L~~L~l~~N~l~ 245 (679)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5677789999999999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.13 E-value=0.0092 Score=58.73 Aligned_cols=141 Identities=12% Similarity=0.088 Sum_probs=74.0
Q ss_pred ccCcCccEEEEEEEEcCCcEEEEEEecCCcchhHHHHHHHHHHHHhccCCC--ccccccc------ccccceEEEEEEec
Q 005750 364 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEYM 435 (679)
Q Consensus 364 ~LG~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lV~E~~ 435 (679)
.|..|.--+.|+.+.++|+ +++|+..... ..+++..|++++..|...+ +...+.. .........++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 4567777889999887665 8999986432 2345566777777774322 2222211 12234566777777
Q ss_pred CCCcHhh--------------hhcc----cCC--CCCCCHH------------------HHHHHHHHHHHHHHHHHh-cC
Q 005750 436 HNGTLRD--------------RLHG----SVN--QKPLDWL------------------TRLQIAHDAAKGLEYLHT-GC 476 (679)
Q Consensus 436 ~~gsL~~--------------~l~~----~~~--~~~l~~~------------------~~~~i~~qia~aL~~LH~-~~ 476 (679)
.+..... .++. ... ....... .....+..+...+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6543211 0000 000 0000000 011112222222222221 23
Q ss_pred CCCccccCCCCCCccccCCCcEEEeeccCcc
Q 005750 477 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 507 (679)
Q Consensus 477 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfgla~ 507 (679)
..|+||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999988777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.14 E-value=0.0011 Score=59.24 Aligned_cols=83 Identities=17% Similarity=0.158 Sum_probs=59.9
Q ss_pred CceEEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCCC-----CCCCCCCCCcEEEecCccCCCC-------C
Q 005750 161 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHLENNELTGS-------L 224 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~l~~N~l~g~-------~ 224 (679)
..|+.|+|++|.+... +...+...+.|+.|+|++|.|+..- ..+..-+.|+.|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 4799999999999743 2334666799999999999998641 1377788999999999987621 2
Q ss_pred CCCCCCCCccceecccccC
Q 005750 225 PSYMGSLPNLQELHIENNS 243 (679)
Q Consensus 225 p~~~~~l~~L~~L~l~~N~ 243 (679)
...+...++|+.|+++.+.
T Consensus 124 ~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCCccEeeCcCCC
Confidence 2334445677777765543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.12 E-value=0.0076 Score=53.38 Aligned_cols=85 Identities=21% Similarity=0.292 Sum_probs=59.6
Q ss_pred CceEEEEcCC-Cccccc----CCccccCCCCCCEEECCCCcCCCCCC-----CCCCCCCCcEEEecCccCCCC----CCC
Q 005750 161 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 226 (679)
Q Consensus 161 ~~l~~L~L~~-n~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~l~~N~l~g~----~p~ 226 (679)
+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++..-- .+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5889999987 456432 33456678999999999998876421 256678899999999988633 234
Q ss_pred CCCCCCccceecc--cccCCC
Q 005750 227 YMGSLPNLQELHI--ENNSFV 245 (679)
Q Consensus 227 ~~~~l~~L~~L~l--~~N~l~ 245 (679)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5667788886444 566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.96 E-value=0.0081 Score=53.20 Aligned_cols=84 Identities=14% Similarity=0.231 Sum_probs=62.4
Q ss_pred CceEEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCCC-----CCCCCCCCCcEEEe--cCccCCC----CCC
Q 005750 161 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHL--ENNELTG----SLP 225 (679)
Q Consensus 161 ~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~l--~~N~l~g----~~p 225 (679)
++|+.|+|++|.++.. +-..+...+.|+.|++++|.++..- ..+...++|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5899999999998754 3345667899999999999987542 24778889987666 5667752 244
Q ss_pred CCCCCCCccceecccccCC
Q 005750 226 SYMGSLPNLQELHIENNSF 244 (679)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l 244 (679)
..+...++|+.|+++.|+.
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 5566788899998876654
|